BackgroundMuch	O
of	O
our	O
current	O
knowledge	O
of	O
the	O
molecular	O
expression	O
profile	O
of	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hESCs	S-cell_type
)	O
is	O
based	O
on	O
transcriptional	O
approaches	O
.	O

(	O
D	O
)	O
General	O
cell	B-cellcomponent
surface	E-cellcomponent
expression	O
of	O
ERBB2	S-GP
,	O
in	O
the	O
same	O
field	O
of	O
view	O
as	O
(	O
A	O
)	O
.	O

In	O
addition	O
,	O
we	O
identified	O
42	O
examples	O
of	O
multiple	O
bands	O
for	O
a	O
single	O
protein	O
,	O
likely	O
to	O
be	O
protein	O
isoforms	O
and/or	O
post-translational	O
modifications	O
,	O
and	O
22	O
phosphorylation	O
events	O
in	O
cell	O
signaling	O
molecules	O
.	O

Detection	O
software	O
is	O
used	O
to	O
identify	O
proteins	O
based	O
on	O
their	O
expected	O
and	O
observed	O
gel	O
mobility	O
.	O

Compatible	O
combinations	O
of	O
primary	O
antibodies	O
are	O
predetermined	O
,	O
with	O
the	O
criterion	O
of	O
being	O
able	O
to	O
identify	O
proteins	O
that	O
do	O
not	O
co-migrate	O
.	O

For	O
the	O
Kinexus	O
assays	O
,	O
BG03	B-cell_type
hESCs	E-cell_type
were	O
maintained	O
in	O
MEF	S-cell_type
-conditioned	O
medium	O
(	O
MEF	S-cell_type
-CM	O
)	O
without	O
the	O
accumulation	O
of	O
karyotypic	S-cellcomponent
abnormalities	O
as	O
described	O
previously	O
[	O
14,26	O
]	O
.	O
hESCs	S-cell_type
were	O
also	O
maintained	O
in	O
a	O
defined	O
medium	O
as	O
indicated	O
.	O

(	O
A-K	O
)	O
Ten	O
proteins	O
that	O
were	O
detected	O
in	O
undifferentiated	O
hESCs	S-cell_type
by	O
western	O
blotting	O
were	O
also	O
detected	O
by	O
immunofluorescence	O
of	O
BG01	B-cell_type
cells	E-cell_type
grown	O
in	O
MEF	S-cell_type
-CM	O
.	O

(	O
M	O
)	O
Oct4	S-GP
was	O
expressed	O
uniformly	O
in	O
undifferentiated	O
cells	O
,	O
(	O
P	O
)	O
but	O
was	O
downregulated	O
in	O
morphologically	O
differentiated	O
areas	O
after	O
3	O
days	O
in	O
serum	O
(	O
arrowhead	O
)	O
.	O

In	O
parallel	O
,	O
the	O
protein	O
expression	O
levels	O
were	O
converted	O
to	O
a	O
+/-	O
format	O
based	O
on	O
these	O
criteria	O
:	O
i.u	O
.	O

The	O
membranes	O
were	O
blocked	O
and	O
clamped	O
in	O
a	O
manifold	O
that	O
created	O
40	O
lanes	O
across	O
each	O
membrane	O
.	O

To	O
expand	O
a	O
large-scale	O
culture	O
of	O
BG01	B-cell_type
cells	E-cell_type
for	O
this	O
assay	O
,	O
a	O
collagenase	S-GP
-	O
and	O
trypsin	S-GP
-	O
based	O
passaging	O
method	O
was	O
used	O
[	O
23	O
]	O
.	O

These	O
processes	O
may	O
also	O
be	O
highly	O
regulated	O
,	O
which	O
could	O
contribute	O
significantly	O
to	O
the	O
overall	O
conversion	O
of	O
genetic	O
information	O
to	O
actual	O
protein	O
function	O
.	O

Conversely	O
,	O
ERBB3	S-GP
was	O
highly	O
localized	O
to	O
a	O
concentrated	O
area	O
,	O
and	O
observed	O
in	O
cells	O
that	O
also	O
expressed	O
ZO1	S-GP
.	O

In	O
addition	O
,	O
we	O
highlighted	O
several	O
candidate	O
signaling	O
pathways	O
that	O
may	O
be	O
relevant	O
to	O
self-renewal	O
.	O

These	O
conditions	O
are	O
described	O
in	O
detail	O
elsewhere	O
(	O
TCS	O
,	O
AJR	O
,	O
submitted	O
)	O
.	O

These	O
analyses	O
suggested	O
that	O
the	O
change	O
in	O
expression	O
or	O
distribution	O
of	O
these	O
proteins	O
could	O
be	O
used	O
as	O
markers	O
for	O
undifferentiated	O
hESCs	S-cell_type
.	O

Prestained	O
size	O
markers	O
(	O
201.5	O
,	O
156.8	O
,	O
106	O
,	O
79.7	O
,	O
48.4	O
,	O
37.8	O
,	O
23.3	O
,	O
and	O
18.2	O
kD	O
)	O
and	O
predetermined	O
human	S-y
-specific	O
protein	O
migration	O
profiles	O
were	O
used	O
to	O
accurately	O
identify	O
proteins	O
using	O
the	O
Kinexus	O
immuno-reactivity	O
identification	O
system	O
(	O
IRIS	O
)	O
software	O
.	O

Functional	O
classification	O
of	O
proteins	O
expressed	O
in	O
hESCs	S-cell_type
The	O
PowerBlot	O
and	O
Kinexus	O
assays	O
identified	O
a	O
diverse	O
range	O
of	O
proteins	O
expressed	O
in	O
hESCs	S-cell_type
.	O

Scale	O
bar	O
for	O
M-R	O
:	O
(	O
M	O
,	O
N	O
,	O
P	O
,	O
Q	O
)	O
:	O
100	O
μm	O
;	O
(	O
O	O
,	O
R	O
)	O
:	O
50	O
μm.Preliminary	O
analyses	O
also	O
indicated	O
that	O
expression	O
of	O
some	O
of	O
these	O
proteins	O
was	O
downregulated	O
in	O
differentiated	O
cells	O
,	O
including	O
p130	B-GP
Cas	E-GP
and	O
the	O
Traf2-	B-GP
and	I-GP
Nck-interacting	I-GP
kinase	E-GP
(	O
TNIK	S-GP
)	O
.	O

All	O
identified	O
proteins	O
were	O
verified	O
by	O
visual	O
inspection	O
,	O
and	O
proteins	O
exhibiting	O
a	O
low	O
signal	O
intensity	O
,	O
with	O
an	O
averaged	O
signal	O
of	O
<	O
1000	O
i.u.	O
,	O
were	O
verified	O
by	O
visual	O
inspection	O
using	O
contrast	O
enhancement	O
in	O
Adobe	O
Photoshop	O
.	O

value	O
,	O
repeat	O
2	O
i.u	O
.	O

All	O
secondary	O
antibodies	O
were	O
tested	O
for	O
cross	O
reactivity	O
and	O
non-specific	O
immunoreactivity	O
.	O

TNIK	S-GP
was	O
expressed	O
highly	O
in	O
undifferentiated	O
hESCs	S-cell_type
,	O
and	O
in	O
the	O
undifferentiated	O
areas	O
at	O
day	O
3	O
,	O
but	O
was	O
downregulated	O
in	O
areas	O
undergoing	O
morphological	O
differentiation	O
(	O
Fig	O
4N	O
,	O
Q	O
)	O
.	O

The	O
pathways	O
and	O
complexes	O
identified	O
by	O
these	O
analyses	O
lay	O
a	O
framework	O
for	O
future	O
functional	O
analyses	O
of	O
signaling	O
networks	O
in	O
hESCs	S-cell_type
.Figure	O
5	O
Tight	B-cellcomponent
junction	E-cellcomponent
proteins	O
and	O
ERBB2/3	S-GP
expression	O
in	O
hESCs	S-cell_type
.	O

This	O
differentiation	O
potential	O
may	O
be	O
used	O
to	O
model	O
certain	O
aspects	O
of	O
human	S-y
embryogenesis	S-x
,	O
including	O
the	O
development	O
and	O
differentiation	O
of	O
pluripotent	O
and	O
other	O
stem	O
cell	O
types	O
during	O
the	O
processes	O
of	O
gastrulation	S-x
,	O
neurogenesis	S-x
and	O
organogenesis	S-x
.	O

Each	O
blot	O
contained	O
size	O
markers	O
and	O
39	O
lanes	O
.	O

(	O
A-E	O
)	O
One	O
set	O
of	O
blots	O
is	O
shown	O
at	O
a	O
contrast	O
that	O
highlights	O
most	O
bands	O
.	O

Additionally	O
,	O
the	O
PowerBlot	O
assay	O
was	O
performed	O
in	O
duplicate	O
,	O
and	O
was	O
shown	O
to	O
be	O
highly	O
reproducible	O
.	O

)	O
,	O
Karyopherin	B-GP
α	E-GP
(	O
80698	O
i.u	O
.	O

In	O
addition	O
,	O
genes	O
were	O
categorized	O
into	O
the	O
same	O
functional/signaling	O
pathways	O
as	O
per	O
the	O
western	O
blot	O
database	O
.	O

Post-translational	O
modifications	O
such	O
as	O
phosphorylation	O
and	O
glycosylation	O
,	O
and	O
the	O
receptors	O
and	O
signaling	O
pathways	O
active	O
in	O
the	O
pluripotent	O
state	O
,	O
or	O
during	O
early	O
differentiation	O
,	O
also	O
need	O
to	O
be	O
determined	O
.	O

For	O
example	O
,	O
four	O
closely	O
migrating	O
bands	O
were	O
observed	O
for	O
FGF2	S-GP
(	O
Fig	O
.	O

Three	O
hundred	O
and	O
eighty	O
three	O
antibodies	O
did	O
not	O
detect	O
bands	O
in	O
this	O
screen	O
,	O
indicating	O
lack	O
of	O
expression	O
,	O
or	O
possibly	O
technical	O
issues	O
with	O
detection	O
under	O
standard	O
conditions	O
(	O
Additional	O
File	O
1	O
)	O
.The	O
size	O
of	O
the	O
detected	O
proteins	O
ranged	O
from	O
15	O
kD	O
(	O
GS15	S-GP
)	O
to	O
280	O
kD	O
(	O
ABP-280	S-GP
)	O
.	O

Several	O
major	O
signal	O
pathways	O
that	O
have	O
been	O
suggested	O
to	O
be	O
involved	O
in	O
self-renewal	O
were	O
examined	O
to	O
test	O
this	O
approach	O
.	O

Immunofluorescence	O
was	O
used	O
to	O
examine	O
the	O
expression	O
of	O
TNIK	S-GP
and	O
p130	B-GP
Cas	E-GP
during	O
early	O
differentiation	O
of	O
hESCs	S-cell_type
.	O

(	O
E	O
)	O
Localized	O
expression	O
of	O
ERBB3	S-GP
,	O
in	O
the	O
same	O
field	O
of	O
view	O
as	O
(	O
B	O
)	O
.	O

In	O
summary	O
,	O
we	O
generated	O
a	O
focused	O
proteome	O
of	O
hESCs	S-cell_type
using	O
large-scale	O
western	O
blotting	O
and	O
sorted	O
the	O
detected	O
proteins	O
according	O
to	O
function	O
and	O
signaling	O
pathways	O
.	O

A	O
more	O
refined	O
understanding	O
of	O
the	O
biology	O
of	O
hESCs	O
has	O
contributed	O
the	O
development	O
of	O
a	O
defined	O
medium	O
utilizing	O
ligands	O
for	O
IGF1R	S-GP
and	O
ERBB2/3	S-GP
receptors	O
to	O
promote	O
in	O
self-renewal	O
(	O
TCS	O
and	O
AJR	O
,	O
submitted	O
)	O
.	O

1A–E	O
and	O
Additional	O
File	O
1	O
)	O
.	O

These	O
analyses	O
highlight	O
that	O
predictions	O
from	O
a	O
combination	O
of	O
transcriptional	O
and	O
proteomic	O
approaches	O
will	O
serve	O
to	O
focus	O
the	O
investigation	O
of	O
hESCs	S-cell_type
in	O
the	O
future	O
.	O

A	O
mix	O
of	O
1	O
to	O
8	O
mouse	O
monoclonal	O
primary	O
antibodies	O
was	O
added	O
to	O
each	O
lane	O
,	O
in	O
dilutions	O
and	O
combinations	O
that	O
had	O
been	O
predetermined	O
to	O
enable	O
accurate	O
identification	O
of	O
well-separated	O
proteins	O
.	O

Other	O
functional	O
classes	O
of	O
proteins	O
are	O
indicated	O
in	O
Additional	O
Table	O
2	O
.	O

value	O
,	O
antibody	O
dilution	O
,	O
outline	O
of	O
protein	O
function	O
,	O
Entrez	O
gene	O
and	O
SwissProt	O
identification	O
numbers	O
.	O

)	O
,	O
and	O
BiP	S-GP
(	O
74922	O
i.u	O
.	O

Scale	O
bar	O
for	O
A-L	O
:	O
(	O
A	O
,	O
L	O
)	O
200	O
μm	O
;	O
(	O
C	O
,	O
D	O
,	O
F	O
,	O
H	O
,	O
I	O
,	O
J	O
,	O
K	O
)	O
100	O
μm	O
;	O
(	O
B	O
,	O
E	O
,	O
G	O
)	O
50	O
μm	O
.	O

2A–D	O
,	O
Additional	O
File	O
1	O
)	O
.	O

The	O
following	O
antibodies	O
were	O
used	O
:	O
ABP-280	S-GP
(	O
1:250	O
,	O
BD	O
Biosciences	O
610798	O
)	O
,	O
CtBP1	S-GP
(	O
1:1000	O
,	O
BD	O
Biosciences	O
612042	O
)	O
,	O
CtBP2	S-GP
(	O
1:1000	O
,	O
BD	O
Biosciences	O
612044	O
)	O
,	O
GS-28	S-GP
(	O
1:2000	O
,	O
BD	O
Biosciences	O
611184	O
)	O
,	O
HDJ-2	S-GP
(	O
1:100	O
,	O
BD	O
Biosciences	O
611872	O
)	O
,	O
L-Caldesmon	S-GP
(	O
1:2000	O
,	O
BD	O
Biosciences	O
610660	O
)	O
,	O
Rabaptin-5	S-GP
(	O
1:500	O
,	O
BD	O
Biosciences	O
611080	O
)	O
,	O
phospho-p130	B-GP
Cas	E-GP
(	O
Tyr165	O
)	O
(	O
1:50	O
,	O
Cell	O
Signaling	O
Technology	O
4015	O
)	O
,	O
phospho-Ras-GAP	S-GP
(	O
pY460	O
)	O
(	O
1:250	O
,	O
BD	O
Biosciences	O
612736	O
)	O
,	O
Ras-GAP	S-GP
(	O
1:250	O
,	O
BD	O
Biosciences	O
610043	O
)	O
,	O
Shc-C	S-GP
(	O
1:1000	O
,	O
BD	O
Biosciences	O
610642	O
)	O
,	O
Oct-4	S-GP
(	O
Santa	O
Cruz	O
biotechnology	O
,	O
1:200	O
SC-8628	O
)	O
,	O
TNIK	S-GP
(	O
1:100	O
,	O
BD	O
Biosciences	O
,	O
612250	O
)	O
,	O
p130	B-GP
Cas	E-GP
(	O
1:100	O
,	O
BD	O
Biosciences	O
,	O
610272	O
)	O
,	O
ERBB2	S-GP
(	O
1:100	O
,	O
Lab	O
Vision	O
,	O
9G6.10	O
)	O
,	O
ERBB3	S-GP
(	O
1:100	O
,	O
R	O
&	O
D	O
Systems	O
,	O
MAB348	O
)	O
,	O
ZO1	S-GP
(	O
1:100	O
,	O
Invitrogen	O
,	O
61–7300	O
)	O
,	O
or	O
Occludin	S-GP
(	O
1:100	O
,	O
Invitrogen	O
,	O
71–1500	O
)	O
.	O

Averaged	O
transcript	O
expression	O
signals	O
from	O
the	O
BG01	S-cell_line
,	O
BG02	S-cell_line
and	O
BG03	S-cell_line
cell	O
lines	O
were	O
converted	O
to	O
a	O
+/-	O
format	O
,	O
based	O
on	O
the	O
following	O
criteria	O
:	O
A	O
mean	O
transcript	O
detection	O
level	O
of	O
>	O
5,000	O
was	O
designated	O
as	O
++++	O
;	O
1,000–5,000	O
as	O
+++	O
;	O
100–1,000	O
as	O
++	O
;	O
30–100	O
as	O
+	O
;	O
and	O
signals	O
<	O
30	O
was	O
represented	O
as	O
-	O
.	O

HPLC-tandem	O
mass	O
spectrometry	O
(	O
HPLC-MS/MS	O
)	O
based	O
technology	O
is	O
rapidly	O
evolving	O
and	O
has	O
recently	O
been	O
used	O
to	O
detect	O
protein	O
expression	O
in	O
multiple	O
cell	O
types	O
.	O

Proteins	O
known	O
to	O
be	O
expressed	O
by	O
hESCs	S-cell_type
and	O
also	O
identified	O
by	O
these	O
assays	O
,	O
included	O
Oct4	S-GP
,	O
E-CAD	S-GP
,	O
Connexin	B-GP
43	E-GP
and	O
Hsp70	S-GP
.	O

Such	O
a	O
comprehensive	O
definition	O
of	O
the	O
molecular	O
state	O
of	O
hESCs	S-cell_type
will	O
enable	O
more	O
accurate	O
prediction	O
and	O
testing	O
of	O
the	O
conditions	O
used	O
for	O
growth	O
and	O
differentiation	O
of	O
hESCs	S-cell_type
,	O
by	O
precise	O
genetic	O
modification	O
or	O
application	O
of	O
specific	O
growth	O
factor	O
cocktails	O
and	O
reagents	O
.	O

Unlike	O
2D	O
PAGE	O
and	O
HPLC-MS/MS	O
,	O
large-scale	O
western	O
blotting	O
only	O
identifies	O
proteins	O
for	O
which	O
antibodies	O
are	O
already	O
available	O
.	O

Before	O
these	O
cell	O
therapy	O
applications	O
are	O
developed	O
,	O
an	O
understanding	O
of	O
the	O
molecular	O
and	O
cellular	O
mechanisms	O
that	O
drive	O
self-renewal	O
and	O
differentiation	O
is	O
required	O
.	O

Each	O
lane	O
was	O
screened	O
with	O
1–8	O
antibodies	O
in	O
combinations	O
that	O
had	O
been	O
predetermined	O
to	O
enable	O
accurate	O
identification	O
of	O
well-separated	O
proteins	O
(	O
Fig	O
.	O

Finally	O
,	O
numerous	O
post-translational	O
modifications	O
are	O
known	O
to	O
regulate	O
protein	O
function	O
,	O
including	O
enzymatic	O
cleavage	O
,	O
covalent	O
coupling	O
to	O
other	O
molecules	O
,	O
glycosylation	O
,	O
phosphorylation	O
and	O
ubiquitination	O
.	O

An	O
enlargement	O
of	O
a	O
representative	O
lane	O
(	O
lane	O
24	O
of	O
Blot	O
C	O
)	O
alongside	O
protein	O
markers	O
is	O
shown	O
in	O
Fig	O
.	O

In	O
general	O
,	O
a	O
close	O
match	O
between	O
the	O
expression	O
level	O
of	O
transcript	O
and	O
protein	O
was	O
observed	O
:	O
transcripts	O
for	O
nearly	O
all	O
the	O
detected	O
proteins	O
were	O
also	O
identified	O
in	O
the	O
Illumina	O
analysis	O
,	O
and	O
most	O
proteins	O
expressed	O
at	O
high	O
levels	O
also	O
exhibited	O
high	O
mRNA	O
levels.We	O
reasoned	O
that	O
a	O
focused	O
comparison	O
of	O
specific	O
signaling	O
pathways	O
using	O
a	O
combination	O
of	O
proteomic	O
and	O
transcriptional	O
data	O
was	O
likely	O
to	O
be	O
much	O
more	O
informative	O
than	O
a	O
global	O
interrogation	O
of	O
hESCs	S-cell_type
.	O

)	O
,	O
whilst	O
the	O
proteins	O
with	O
the	O
lowest	O
intensity	O
that	O
could	O
be	O
verified	O
by	O
visual	O
inspection	O
were	O
Inhibitor	B-GP
2	E-GP
(	O
247	O
i.u	O
.	O

This	O
should	O
also	O
be	O
complemented	O
by	O
an	O
understanding	O
of	O
epigenetic	O
characteristics	O
of	O
pluripotency	O
,	O
including	O
methylation	O
,	O
imprinting	O
and	O
chromatin	S-cellcomponent
conformation	O
.	O

Sixty-four	O
antibodies	O
did	O
not	O
detect	O
their	O
corresponding	O
antigen	O
(	O
Additional	O
File	O
1	O
)	O
.Figure	O
2Kinexus	O
blots	O
of	O
undifferentiated	O
BG03	B-cell_type
cells	E-cell_type
.	O

BG01	S-cell_line
cultures	O
were	O
partially	O
differentiated	O
by	O
growth	O
in	O
serum	O
containing	O
media	O
for	O
3	O
days	O
.	O

In	O
particular	O
,	O
the	O
availability	O
of	O
antibodies	O
for	O
candidate	O
proteins	O
is	O
a	O
major	O
benefit	O
of	O
this	O
approach	O
compared	O
to	O
2D-gel	O
or	O
HPLC-MS/MS	O
based	O
proteomics	O
.	O

The	O
full	O
PowerBlot	O
screen	O
consisted	O
of	O
five	O
gels	O
,	O
which	O
were	O
blotted	O
and	O
probed	O
with	O
934	O
antibodies	O
,	O
and	O
was	O
performed	O
in	O
duplicate	O
with	O
the	O
same	O
cell	O
lysate	O
.	O

Hoechst	O
(	O
Invitrogen	O
)	O
or	O
DAPI	O
(	O
Sigma	O
)	O
were	O
used	O
to	O
identify	O
nuclei	S-cellcomponent
,	O
and	O
Triton	O
X-100	O
was	O
omitted	O
when	O
staining	O
for	O
extracellular	O
antigens	O
(	O
ZO1	S-GP
,	O
occludin	S-GP
,	O
ERBB2/3	S-GP
)	O
.	O

Twenty-two	O
phosphorylation	O
events	O
in	O
cell	O
signaling	O
molecules	O
,	O
as	O
well	O
as	O
potential	O
new	O
markers	O
of	O
undifferentiated	O
hESCs	S-cell_type
were	O
also	O
identified	O
.	O

These	O
values	O
represent	O
the	O
relative	O
signal	O
intensity	O
observed	O
for	O
each	O
identified	O
protein	O
band	O
,	O
rather	O
than	O
relative	O
expression	O
levels	O
of	O
different	O
proteins	O
,	O
due	O
to	O
differences	O
in	O
the	O
efficiencies	O
of	O
antibody	O
binding	O
and	O
dilution	O
of	O
the	O
primary	O
antibodies	O
used	O
.	O

(	O
F	O
)	O
A	O
representative	O
lane	O
(	O
gel	O
C	O
,	O
lane	O
24	O
)	O
aligned	O
with	O
protein	O
markers	O
used	O
for	O
band	O
identification	O
.	O

Tight	B-cellcomponent
junction	E-cellcomponent
s	O
are	O
apical	B-cellcomponent
cell-cell	I-cellcomponent
junctions	E-cellcomponent
found	O
in	O
epithelia	S-x
that	O
establish	O
a	O
barrier	S-cellcomponent
to	O
the	O
extracellular	S-cellcomponent
environment	O
and	O
a	O
border	S-cellcomponent
for	O
apical	S-cellcomponent
-	O
basolateral	S-cellcomponent
polarity	O
.	O

3C	O
,	O
top	O
panel	O
)	O
,	O
which	O
may	O
represent	O
known	O
glycosylation	O
variants	O
of	O
this	O
growth	O
factor	O
[	O
33	O
]	O
.	O

Epithelial	B-cell_type
cells	E-cell_type
are	O
known	O
to	O
localize	O
ERBB	B-GP
receptors	E-GP
to	O
the	O
basolateral	S-cellcomponent
side	O
of	O
tight	B-cellcomponent
junctions	E-cellcomponent
,	O
which	O
serves	O
to	O
functionally	O
separate	O
receptors	O
from	O
ligands	O
[	O
42,43	O
]	O
.	O

(	O
F	O
)	O
Higher	O
magnification	O
of	O
ERBB3	S-GP
localization	O
in	O
ZO1	S-GP
expressing	O
BG01	B-cell_type
cells	E-cell_type
,	O
5	O
days	O
after	O
plating	O
.	O

The	O
Kinexus	O
assays	O
contained	O
140	O
antibodies	O
to	O
these	O
related	O
classes	O
of	O
proteins	O
and	O
phospho-sites	O
.	O

After	O
incubation	O
with	O
the	O
primary	O
antibodies	O
,	O
the	O
membranes	O
were	O
removed	O
from	O
the	O
manifolds	O
,	O
washed	O
and	O
incubated	O
with	O
a	O
mix	O
of	O
the	O
appropriate	O
secondary	O
antibodies	O
.	O

p130	B-GP
Cas	E-GP
was	O
detected	O
in	O
a	O
membrane	S-cellcomponent
/	O
peripheral-cytoplasmic	S-cellcomponent
pattern	O
in	O
hESCs	S-cell_type
(	O
Fig	O
4O	O
)	O
.	O

These	O
analyses	O
are	O
only	O
partly	O
predictive	O
of	O
protein	O
expression	O
however	O
,	O
and	O
do	O
not	O
shed	O
light	O
on	O
post-translational	O
regulation	O
,	O
leaving	O
a	O
large	O
gap	O
in	O
our	O
knowledge	O
of	O
the	O
biology	O
of	O
pluripotent	B-cell_type
stem	I-cell_type
cells	E-cell_type
.ResultsHere	O
we	O
describe	O
the	O
use	O
of	O
two	O
large-scale	O
western	O
blot	O
assays	O
to	O
identify	O
over	O
600	O
proteins	O
expressed	O
in	O
undifferentiated	O
hESCs	S-cell_type
,	O
and	O
highlight	O
over	O
40	O
examples	O
of	O
multiple	O
gel	O
mobility	O
variants	O
,	O
which	O
are	O
suspected	O
protein	O
isoforms	O
and/or	O
post-translational	O
modifications	O
.	O

The	O
distribution	O
of	O
ZO1	S-GP
expression	O
changed	O
dramatically	O
as	O
hESCs	S-cell_type
proliferated	O
in	O
culture	O
.	O

Different	O
combinations	O
of	O
primary	O
antibodies	O
are	O
added	O
to	O
each	O
well	O
,	O
with	O
appropriate	O
dilutions	O
of	O
each	O
primary	O
antibody	O
so	O
that	O
expressed	O
proteins	O
are	O
detected	O
in	O
a	O
single	O
condition	O
.	O

The	O
distribution	O
of	O
p130Cas	S-GP
was	O
substantially	O
altered	O
in	O
differentiating	O
cells	O
with	O
a	O
flattened	O
morphology	O
,	O
exhibiting	O
a	O
general	O
cytoplasmic	S-cellcomponent
,	O
or	O
perinuclear	S-cellcomponent
profile	O
(	O
Fig	O
4R	O
)	O
.	O

Bands	O
with	O
>	O
800	O
i.u	O
.	O

While	O
these	O
conditions	O
have	O
been	O
associated	O
with	O
the	O
accumulation	O
of	O
trisomies	O
of	O
chromosome	S-cellcomponent
s	O
12	O
,	O
17	O
and	O
X	O
[	O
24	O
]	O
,	O
the	O
ease	O
of	O
use	O
of	O
these	O
cultures	O
and	O
similarity	O
in	O
gene	O
expression	O
and	O
differentiation	O
potential	O
to	O
karyotypically	O
normal	O
BG01	B-cell_type
hESCs	E-cell_type
[	O
11,24,25	O
]	O
make	O
them	O
suitable	O
for	O
such	O
large	O
scale	O
applications	O
.	O

Molecular	O
weight	O
standards	O
were	O
generated	O
by	O
adding	O
a	O
cocktail	O
of	O
antibodies	O
to	O
P190	S-GP
(	O
190	O
kD	O
)	O
,	O
Adaptin	B-GP
beta	E-GP
(	O
106	O
kD	O
)	O
,	O
STAT-3	S-GP
(	O
92	O
kD	O
)	O
,	O
PTP1D	S-GP
(	O
72	O
kD	O
)	O
,	O
Mek-2	S-GP
(	O
46	O
kD	O
)	O
,	O
RACK-1	S-GP
(	O
36	O
kD	O
)	O
,	O
GRB-2	S-GP
(	O
24	O
kD	O
)	O
and	O
Rap2	S-GP
(	O
21	O
kD	O
)	O
to	O
lane	O
40	O
of	O
gels	O
A-D.	O
Molecular	O
standards	O
for	O
gel	O
E	O
were	O
generated	O
by	O
adding	O
a	O
cocktail	O
of	O
antibodies	O
to	O
Exportin-1/CRM1	S-GP
(	O
112	O
kD	O
)	O
,	O
MCM	S-GP
(	O
83	O
kD	O
)	O
,	O
Nucleoporin	B-GP
p62	E-GP
(	O
62	O
kD	O
)	O
,	O
α-tubulin	S-GP
(	O
55	O
kD	O
)	O
,	O
Actin	S-GP
(	O
42	O
kD	O
)	O
,	O
KNP-1/HES1	S-GP
(	O
28	O
kD	O
)	O
and	O
NTF2	S-GP
(	O
15	O
kD	O
)	O
to	O
lane	O
16	O
,	O
and	O
antibodies	O
to	O
p190	S-GP
(	O
190	O
kD	O
)	O
,	O
Hip1R	S-GP
(	O
120	O
kD	O
)	O
,	O
Transportin	S-GP
(	O
101	O
kD	O
)	O
,	O
Calreticulin	S-GP
(	O
60	O
kD	O
)	O
,	O
Arp3	S-GP
(	O
50	O
kD	O
)	O
,	O
eIF-6	S-GP
(	O
27	O
kD	O
)	O
and	O
Rap2	S-GP
(	O
21	O
kD	O
)	O
to	O
lane	O
17.Bands	O
were	O
detected	O
and	O
raw	O
signal	O
intensity	O
captured	O
automatically	O
using	O
the	O
PDQuest	O
software	O
(	O
Bio-Rad	O
)	O
.	O

Another	O
functional	O
group	O
(	O
Cell	O
surface	O
)	O
consisted	O
of	O
20	O
transmembrane	O
or	O
cell	B-GP
surface	I-GP
proteins	E-GP
(	O
Additional	O
File	O
2	O
)	O
.	O

(	O
C	O
)	O
A	O
total	O
of	O
42	O
proteins	O
,	O
including	O
FGF2	S-GP
,	O
HSP70	S-GP
and	O
ERK1	S-GP
,	O
were	O
found	O
to	O
have	O
multiple	O
bands	O
in	O
either	O
the	O
PowerBlot	O
or	O
Kinexus	O
blots	O
.	O

This	O
suggested	O
that	O
this	O
approach	O
should	O
be	O
informative	O
when	O
comparing	O
hESCs	O
to	O
their	O
differentiated	O
derivatives	O
.	O

These	O
cultures	O
were	O
undifferentiated	O
and	O
retained	O
uniform	O
expression	O
of	O
Oct4	S-GP
protein	O
(	O
not	O
shown	O
)	O
.	O

Ras-GAP	S-GP
(	O
pY460	O
)	O
is	O
a	O
phosphorylated	O
form	O
of	O
Ras-GAP	S-GP
.	O

Culture	O
of	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
For	O
the	O
PowerBlot	O
analysis	O
,	O
enzymatically	O
passaged	O
BG01	B-cell_type
hESCs	E-cell_type
were	O
grown	O
as	O
described	O
previously	O
[	O
23	O
]	O
.	O

Nevertheless	O
,	O
cataloguing	O
the	O
cellular	O
transcriptome	O
is	O
only	O
predictive	O
of	O
protein	O
expression	O
and	O
typically	O
does	O
not	O
shed	O
light	O
on	O
post-transcriptional	O
regulation	O
.	O

ERBB2	S-GP
and	O
3	O
are	O
members	O
of	O
the	O
epidermal	S-x
growth	O
factor	O
(	O
EGF	S-GP
)	O
-receptor	O
family	O
,	O
which	O
regulate	O
epithelial	O
proliferation	O
via	O
EGF	S-GP
-family	O
ligands	O
.	O

This	O
could	O
indicate	O
an	O
alteration	O
in	O
the	O
function	O
of	O
p130	B-GP
Cas	E-GP
as	O
pluripotent	B-cell_type
cell	E-cell_type
s	O
differentiate	O
.	O

TNIK	S-GP
is	O
known	O
to	O
be	O
involved	O
in	O
the	O
inhibition	O
of	O
cell	O
spreading	O
via	O
disruption	O
of	O
F-actin	S-GP
[	O
34,35	O
]	O
.	O

Comparison	O
of	O
proteomic	O
and	O
transcriptional	O
profiles	O
of	O
hESCs	S-cell_type
We	O
have	O
previously	O
employed	O
the	O
Illumina	O
Bead	O
Array	O
system	O
for	O
the	O
large-scale	O
profiling	O
of	O
gene	O
expression	O
in	O
hESCs	S-cell_type
using	O
24,000	O
transcript	O
probes	O
[	O
11	O
]	O
.	O

A	O
20-lane	O
manifold	O
was	O
placed	O
over	O
the	O
membrane	O
and	O
a	O
different	O
mixture	O
of	O
up	O
to	O
3	O
primary	O
antibodies	O
was	O
added	O
to	O
each	O
well	O
.	O

(	O
N	O
)	O
TNIK	S-GP
expression	O
was	O
localized	O
to	O
the	O
cytoplasm	O
,	O
and	O
(	O
N	O
,	O
Q	O
)	O
expression	O
appeared	O
to	O
be	O
restricted	O
to	O
morphologically	O
undifferentiated	O
cells	O
(	O
arrowhead	O
)	O
.	O

The	O
Kinexus	O
expression	O
data	O
was	O
organized	O
separately	O
into	O
cell	O
signaling-related	O
functional	O
groups	O
(	O
Additional	O
File	O
1	O
)	O
.	O

The	O
detected	O
proteins	O
were	O
annotated	O
into	O
functional	O
classes	O
representing	O
diverse	O
cellular	O
processes	O
.	O

These	O
proteins	O
were	O
all	O
expressed	O
by	O
hESCs	S-cell_type
,	O
with	O
the	O
expected	O
subcellular	O
localization	O
(	O
Fig	O
.	O

The	O
predicted	O
sizes	O
of	O
detectable	O
proteins	O
in	O
the	O
blots	O
ranged	O
from	O
10–540	O
kD	O
,	O
and	O
the	O
dilutions	O
of	O
the	O
primary	O
antibodies	O
ranged	O
from	O
1:250	O
to	O
1:15,000.The	O
blots	O
were	O
removed	O
from	O
the	O
manifolds	O
,	O
washed	O
and	O
incubated	O
with	O
goat	O
anti-mouse	O
secondary	O
antibody	O
conjugated	O
to	O
the	O
Alexa680	O
fluorophore	O
(	O
Molecular	O
Probes	O
)	O
.	O

We	O
report	O
here	O
a	O
proteomic	O
analysis	O
of	O
pluripotent	O
hESCs	S-cell_type
by	O
using	O
two	O
large-scale	O
western	O
blotting	O
systems	O
and	O
highlight	O
post-translational	O
events	O
in	O
undifferentiated	O
hESCs	S-cell_type
.	O

To	O
further	O
annotate	O
these	O
data	O
,	O
the	O
detected	O
proteins	O
were	O
ordered	O
into	O
18	O
subgroups	O
based	O
on	O
protein	O
function	O
(	O
Additional	O
File	O
2	O
)	O
.	O

These	O
included	O
the	O
FGF	S-GP
,	O
TGFβ	S-GP
,	O
GSK3β	S-GP
/	O
Wnt	S-GP
/	O
β-catenin	S-GP
and	O
Jak	S-GP
/	O
Stat	S-GP
pathways	O
[	O
17,29,36-39	O
]	O
,	O
as	O
well	O
as	O
the	O
more	O
recently	O
suggested	O
MAPK	S-GP
/	O
ERK	S-GP
and	O
Gap	B-GP
junction	E-GP
pathways	O
[	O
32,40	O
]	O
.	O

These	O
tables	O
were	O
used	O
to	O
list	O
expressed	O
proteins	O
(	O
Additional	O
File	O
1	O
)	O
.	O

When	O
tight	O
junction	O
complexes	O
were	O
disrupted	O
by	O
disaggreagation	O
to	O
single	O
cells	O
,	O
only	O
a	O
subset	O
of	O
cells	O
showed	O
ZO1	S-GP
staining	O
4	O
days	O
after	O
plating	O
(	O
Fig	O
.	O

PowerBlot	O
analysis	O
of	O
hESCs	S-cell_type
We	O
first	O
employed	O
a	O
large-scale	O
western	O
blot	O
screen	O
,	O
the	O
PowerBlot	O
system	O
,	O
to	O
profile	O
protein	O
expression	O
in	O
undifferentiated	O
hESCs	S-cell_type
.	O

For	O
example	O
,	O
a	O
scalable	O
,	O
fully	O
defined	O
and	O
GMP-certified	O
culture	O
system	O
will	O
need	O
to	O
be	O
developed	O
for	O
the	O
eventual	O
development	O
of	O
hESC-based	O
cellular	O
therapies	O
.	O

Detected	O
proteins	O
were	O
verified	O
by	O
visual	O
inspection	O
.	O

The	O
expression	O
of	O
545	O
bands	O
was	O
detected	O
,	O
potentially	O
representing	O
529	O
proteins	O
,	O
or	O
their	O
migratory	O
isoforms	O
.	O

Other	O
studies	O
have	O
also	O
demonstrated	O
the	O
expression	O
of	O
several	O
of	O
the	O
proteins	O
we	O
detected	O
in	O
hESCs	S-cell_type
.	O

This	O
may	O
indicate	O
that	O
TNIK	S-GP
is	O
active	O
in	O
hESCs	S-cell_type
and	O
degraded	O
rapidly	O
upon	O
differentiation	O
.	O

We	O
correlated	O
the	O
expression	O
of	O
members	O
of	O
key	O
active	O
pathways	O
in	O
our	O
transcriptional	O
and	O
proteomic	O
databases	O
and	O
confirmed	O
the	O
validity	O
of	O
this	O
approach	O
.	O

1F	O
.	O

This	O
condition	O
generated	O
heterogeneous	O
populations	O
containing	O
Oct4+	B-cell_type
cell	E-cell_type
s	O
with	O
characteristic	O
hESC	O
morphology	O
and	O
less	O
tightly	O
packed	O
,	O
and	O
morphologically	O
differentiated	O
areas	O
,	O
lacking	O
expression	O
of	O
Oct4	S-GP
(	O
Fig	O
4M	O
,	O
P	O
)	O
.	O

One	O
potential	O
issue	O
with	O
this	O
approach	O
is	O
that	O
multiple	O
antibodies	O
are	O
included	O
in	O
each	O
lane	O
,	O
which	O
could	O
possibly	O
lead	O
to	O
misidentification	O
of	O
bands	O
.	O

Thirteen	O
proteins	O
including	O
AKT	S-GP
,	O
caveolin1	S-GP
and	O
ERK1	S-GP
were	O
detected	O
in	O
multiple	O
lanes	O
using	O
the	O
same	O
or	O
different	O
antibodies	O
.	O

Images	O
were	O
captured	O
on	O
an	O
Olympus	O
or	O
Nikon	O
fluorescence	O
microscope	O
.	O

More	O
recently	O
,	O
two	O
research	O
groups	O
have	O
conducted	O
proteomic	O
analyses	O
of	O
hESCs	S-cell_type
using	O
MS	O
[	O
19-22	O
]	O
.	O

The	O
same	O
antibodies	O
were	O
used	O
in	O
this	O
analysis	O
as	O
in	O
the	O
PowerBlot	O
assay	O
,	O
except	O
phospho-p130	B-GP
Cas	E-GP
(	O
Tyr165	O
)	O
.	O

The	O
secondary	O
antibodies	O
were	O
donkey	S-y
anti-	O
rabbit	S-y
(	O
at	O
1:5000	O
)	O
,	O
sheep	S-y
anti-	O
mouse	S-y
(	O
at	O
1:10,000	O
)	O
and	O
bovine	S-y
anti-	O
goat	S-y
(	O
at	O
1:10,000	O
)	O
,	O
all	O
conjugated	O
with	O
horse	B-GP
radish	I-GP
peroxidase	E-GP
.	O

However	O
,	O
we	O
did	O
examine	O
key	O
features	O
to	O
illustrate	O
the	O
power	O
of	O
this	O
methodology	O
.	O

While	O
this	O
is	O
not	O
an	O
appropriate	O
screen	O
for	O
identifying	O
uncharacterized	O
proteins	O
,	O
it	O
greatly	O
simplifies	O
the	O
verification	O
and	O
functional	O
analyses	O
of	O
proteins	O
that	O
are	O
detected	O
.	O

)	O
,	O
Caspase	B-GP
8	E-GP
(	O
201	O
i.u	O
.	O

This	O
provided	O
internal	O
,	O
or	O
independent	O
,	O
confirmation	O
of	O
expression	O
of	O
these	O
proteins	O
.	O

(	O
G	O
)	O
Scatter-plot	O
of	O
the	O
normalized	O
average	O
intensity	O
(	O
i.u	O
.	O
)	O

We	O
detected	O
42	O
proteins	O
with	O
multiple	O
closely	O
migrating	O
bands	O
(	O
Fig	O
.	O

Nuclei	S-cellcomponent
were	O
stained	O
with	O
DAPI	O
.	O

Karyotypically	O
normal	O
BG03	S-cell_line
hESCs	S-cell_type
grown	O
on	O
a	O
fibronectin	S-GP
matrix	O
in	O
MEF	S-cell_type
-CM	O
[	O
26	O
]	O
were	O
used	O
for	O
this	O
analysis	O
,	O
and	O
whole	O
cell	O
lysate	O
was	O
separated	O
on	O
four	O
12.5	O
%	O
gels	O
for	O
western	O
blotting	O
.	O

ERBB2	S-GP
and	O
3	O
transcripts	O
are	O
expressed	O
by	O
hESCs	S-cell_type
[	O
8	O
]	O
,	O
are	O
known	O
to	O
function	O
as	O
a	O
heterodimer	O
[	O
41	O
]	O
,	O
and	O
transmit	O
a	O
strong	O
proliferative	O
signal	O
for	O
hESCs	S-cell_type
by	O
Heregulin	B-GP
1β	E-GP
(	O
an	O
EGF	S-GP
-family	O
ligand	O
)	O
(	O
TCS	O
and	O
AJR	O
,	O
submitted	O
)	O
.	O

BG01	S-cell_line
hESCs	S-cell_type
were	O
disaggregated	O
to	O
single	O
cells	O
using	O
accutase	S-GP
[	O
52	O
]	O
and	O
cultured	O
in	O
defined	O
conditions	O
.	O

)	O
,	O
and	O
OXA1Hs	S-GP
(	O
195	O
i.u	O
.	O
)	O
.	O

An	O
alternate	O
approach	O
is	O
the	O
recent	O
large-scale	O
adaptation	O
of	O
standard	O
western	O
blotting	O
[	O
18	O
]	O
.	O

Four	O
blots	O
were	O
used	O
to	O
probe	O
BG03	S-cell_line
lysate	O
with	O
(	O
A	O
,	O
B	O
)	O
76	O
antibodies	O
for	O
protein	B-GP
kinases	E-GP
,	O
(	O
C	O
)	O
27	O
antibodies	O
for	O
phosphatases	S-GP
and	O
(	O
D	O
)	O
37	O
antibodies	O
for	O
phosphoylated	O
sites	O
in	O
cell	O
signaling	O
molecules	O
.	O

1A–E	O
)	O
.	O

This	O
characterization	O
provides	O
important	O
basic	O
information	O
on	O
expressed	O
proteins	O
,	O
their	O
isoforms	O
and	O
post-translational	O
modifications	O
,	O
and	O
tools	O
for	O
the	O
continued	O
investigation	O
of	O
the	O
underlying	O
molecular	O
characteristics	O
of	O
hESCs	S-cell_type
.	O

Kinexus	O
assaysPreparation	O
of	O
the	O
BG03	S-cell_line
cell	O
lysate	O
and	O
western	O
blotting	O
was	O
performed	O
according	O
to	O
published	O
protocols	O
[	O
50	O
]	O
.	O

The	O
gels	O
and	O
blots	O
were	O
performed	O
in	O
duplicate	O
and	O
expressed	O
proteins	O
were	O
identified	O
by	O
their	O
predicted	O
size	O
and	O
verified	O
by	O
visual	O
inspection.Figure	O
1PowerBlot	O
analysis	O
of	O
undifferentiated	O
BG01	B-cell_type
hESCs	E-cell_type
.	O

To	O
demonstrate	O
that	O
identified	O
proteins	O
were	O
expressed	O
in	O
hESCs	S-cell_type
,	O
the	O
same	O
antibodies	O
used	O
in	O
the	O
PowerBlot	O
assay	O
were	O
used	O
to	O
confirm	O
expression	O
of	O
10	O
representative	O
proteins	O
by	O
immunofluorescence	O
(	O
Fig	O
.	O

We	O
confirmed	O
the	O
expression	O
of	O
a	O
subset	O
of	O
the	O
identified	O
proteins	O
by	O
immunofluorescence	O
and	O
correlated	O
the	O
expression	O
of	O
transcript	O
and	O
protein	O
for	O
key	O
molecules	O
in	O
active	O
signaling	O
pathways	O
in	O
hESCs	S-cell_type
.	O

Fundamental	O
to	O
this	O
understanding	O
is	O
the	O
elucidation	O
of	O
the	O
transcriptome	O
and	O
proteome	O
of	O
hESCs	S-cell_type
,	O
using	O
approaches	O
that	O
lay	O
a	O
framework	O
for	O
functional	O
analyses	O
of	O
the	O
unique	O
properties	O
of	O
these	O
cells	O
.	O

Attempts	O
to	O
harness	O
the	O
potential	O
of	O
hESCs	S-cell_type
for	O
models	O
of	O
human	S-y
embryogenesis	O
and	O
cell	O
therapy	O
applications	O
will	O
be	O
greatly	O
enhanced	O
by	O
a	O
detailed	O
understanding	O
of	O
their	O
molecular	O
characteristics	O
.	O

For	O
example	O
,	O
while	O
tens	O
of	O
thousands	O
of	O
transcripts	O
can	O
be	O
followed	O
simultaneously	O
with	O
SAGE	O
,	O
microarrays	O
and	O
MPSS	O
,	O
these	O
methods	O
do	O
not	O
routinely	O
detect	O
differences	O
in	O
transcript	O
splice	O
variants	O
,	O
or	O
polyadenylation	O
status	O
.	O

This	O
included	O
several	O
receptors	O
for	O
peptides	O
and	O
growth	O
factors	O
,	O
such	O
as	O
neurotensin	B-GP
receptor	I-GP
3	E-GP
,	O
the	O
B2	B-GP
bradykinin	E-GP
,	O
endothelin	B-GP
1	E-GP
,	O
and	O
thrombin	S-GP
receptors	O
,	O
and	O
the	O
glial	B-GP
derived	I-GP
neurotrophic	I-GP
factor	I-GP
receptor	I-GP
α	E-GP
(	O
Fig	O
.	O

Two	O
candidate	O
proteins	O
,	O
TNIK	S-GP
and	O
p130	B-GP
Cas	E-GP
,	O
were	O
downregulated	O
,	O
or	O
exhibited	O
altered	O
localization	O
upon	O
spontaneous	O
differentiation	O
of	O
hESCs	S-cell_type
,	O
respectively	O
.	O

Although	O
these	O
western	O
blotting	O
approaches	O
are	O
currently	O
more	O
limited	O
in	O
scope	O
than	O
most	O
large-scale	O
cDNA	S-cellcomponent
based	O
assays	O
,	O
detecting	O
up	O
to	O
1000	O
proteins	O
compared	O
to	O
tens	O
of	O
thousands	O
of	O
transcripts	O
,	O
they	O
have	O
the	O
potential	O
to	O
highlight	O
translational	O
events	O
and	O
post-translational	O
modifications	O
.	O

Finally	O
,	O
the	O
consistency	O
of	O
this	O
assay	O
was	O
demonstrated	O
by	O
plotting	O
the	O
normalized	O
average	O
intensity	O
values	O
for	O
each	O
protein	O
,	O
which	O
revealed	O
a	O
linear	O
relationship	O
between	O
the	O
duplicate	O
samples	O
(	O
Fig	O
.	O

(	O
A	O
)	O
Proteins	O
with	O
known	O
or	O
suggested	O
roles	O
in	O
self-renewal	O
are	O
shown	O
,	O
including	O
Oct4	S-GP
,	O
STAT3	S-GP
,	O
Smad2/3	S-GP
and	O
FGF2	S-GP
(	O
Additional	O
Table	O
2	O
,	O
``	O
Pluripotency	O
''	O
)	O
.	O

The	O
Kinexus	O
assays	O
for	O
protein	B-GP
kinases	E-GP
(	O
KPKS-1.2A	O
and	O
B	O
[	O
76	O
antibodies	O
]	O
)	O
,	O
phosphatases	S-GP
(	O
KPPS-1.2	O
[	O
27	O
antibodies	O
]	O
)	O
and	O
phosporylated	O
sites	O
in	O
cell	O
signaling	O
molecules	O
(	O
KPSS-3.1	O
[	O
37	O
antibodies	O
]	O
)	O
were	O
performed	O
by	O
Kinexus	O
.	O

For	O
example	O
,	O
multiple	O
proteins	O
were	O
detected	O
that	O
have	O
been	O
suggested	O
to	O
regulate	O
the	O
pluirpotent	O
state	O
in	O
mouse	B-cell_type
ESCs	E-cell_type
or	O
hESCs	S-cell_type
.	O

Oct4	S-GP
was	O
used	O
as	O
a	O
positive	O
control	O
(	O
Fig	O
.	O

We	O
and	O
others	O
have	O
performed	O
transcriptional	O
analyses	O
of	O
hESCs	S-cell_type
,	O
using	O
cDNA	S-cellcomponent
and	O
oligonucleotide	O
microarrays	O
,	O
SAGE	O
,	O
MPSS	O
and	O
EST	O
enumeration	O
.	O

4	O
)	O
.	O

values	O
for	O
each	O
protein	O
indicating	O
a	O
linear	O
relationship	O
between	O
duplicate	O
blots	O
.	O

Human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hESCs	S-cell_type
)	O
are	O
pluripotent	O
cells	O
isolated	O
from	O
the	O
inner	B-x
cell	I-x
mass	E-x
of	O
the	O
blastocyst	S-x
[	O
1	O
]	O
.	O

These	O
bands	O
migrated	O
closely	O
but	O
were	O
sufficiently	O
separated	O
from	O
other	O
detected	O
proteins	O
.	O

could	O
typically	O
be	O
observed	O
without	O
additional	O
image	O
enhancement	O
.	O

Examination	O
of	O
the	O
blots	O
described	O
here	O
identified	O
42	O
examples	O
of	O
multiple	O
banding	O
for	O
a	O
single	O
target	O
antigen	O
(	O
Fig	O
.	O

In	O
addition	O
,	O
35	O
proteins	O
were	O
detected	O
by	O
both	O
the	O
PowerBlot	O
and	O
Kinexus	O
systems	O
(	O
Table	O
1	O
)	O
.Table	O
1Proteins	O
detected	O
by	O
both	O
PowerBlot	O
and	O
Kinexus	O
systemsProtein	O
nameSwiss	O
NrProtein	O
nameSwiss	O
NrBMX	S-GP
P51813	O
MEK2	S-GP
P36506	O
CaM	B-GP
Kinase	I-GP
Kinase	E-GP
Q64572	O
MKP2	S-GP
Q62767	O
Casein	B-GP
Kinase	I-GP
I	I-GP
epsilon	E-GP
P49674	O
p38	B-GP
alpha	E-GP
/	O
SAPK2a	S-GP
Q16539	O
Casein	B-GP
Kinase	I-GP
II	I-GP
alpha	E-GP
/CK2aP19139	O
Paxillin	S-GP
P49024	O
Cdk1	S-GP
/	O
Cdc2	S-GP
P06493	O
PKA	B-GP
C	E-GP
P17612	O
Cdk5	S-GP
Q00535	O
PKC	B-GP
beta	E-GP
P05771	O
Cdk7P	S-GP
50613	O
PKC	B-GP
delta	E-GP
Q05655	O
DAP	B-GP
Kinase	E-GP
P53355PP2A	O
Catalytic	O
alphaP05323	O
DAP3	S-GP
P51398	O
PP5/PPT	S-GP
P53042	O
ERK1	S-GP
Q63538	O
PTP1B	S-GP
P18031	O
ERK2	S-GP
P27703	O
PTP1C/SHP1	S-GP
P29350	O
FAK	S-GP
Q00944	O
PTP1D/SHP2	S-GP
Q06124	O
GSK-3	B-GP
beta	E-GP
P18266	O
RbP	S-GP
13405	O
I	B-GP
kappa	I-GP
B	I-GP
alpha	E-GP
P25963	O
Rsk	S-GP
Q15418	O
IKK	B-GP
beta	E-GP
O14920	O
Stat1	S-GP
A46159	O
JAK1	S-GP
P23458	O
Stat3	S-GP
P52631	O
JNK1	S-GP
P45983	O
VHR	S-GP
P51452	O
MEK1	S-GP
Q02750	O
Detection	O
of	O
protein	O
isoforms	O
or	O
post-translational	O
variantsUnlike	O
many	O
cDNA-based	O
gene	O
expression	O
assays	O
,	O
western	O
blotting	O
has	O
the	O
capacity	O
to	O
detect	O
multiple	O
protein	O
isoforms	O
due	O
to	O
translation	O
of	O
different	O
mRNA	O
splice	O
variants	O
,	O
as	O
well	O
as	O
post-translational	O
modifications	O
such	O
as	O
enzymatic	O
cleavage	O
,	O
glycosylation	O
,	O
or	O
phosphorylation	O
.	O

Thus	O
,	O
hESCs	S-cell_type
provide	O
a	O
unique	O
and	O
powerful	O
system	O
to	O
study	O
otherwise	O
intractable	O
aspects	O
of	O
human	S-y
development	O
.	O

These	O
include	O
Oct4	S-GP
,	O
a	O
key	O
marker	O
of	O
the	O
pluripotent	O
state	O
,	O
Connexin	B-GP
43	E-GP
and	O
GSK3β	S-GP
,	O
confirming	O
the	O
reliability	O
of	O
large-scale	O
western	O
blotting	O
.	O

While	O
hESCs	S-cell_type
grow	O
in	O
colonies	O
that	O
are	O
highly	O
reminiscent	O
of	O
epithelia	S-x
,	O
and	O
have	O
been	O
shown	O
to	O
be	O
coupled	O
by	O
gap	B-cellcomponent
junctions	E-cellcomponent
[	O
40	O
]	O
,	O
the	O
formation	O
of	O
tight	B-cellcomponent
junction	I-cellcomponent
complexes	E-cellcomponent
has	O
not	O
been	O
described	O
.	O

Potential	O
new	O
markers	O
for	O
hESCs	S-cell_type
were	O
identified	O
,	O
the	O
expression	O
and	O
activation	O
of	O
proteins	O
in	O
key	O
self-renewal	O
pathways	O
were	O
confirmed	O
,	O
and	O
a	O
diverse	O
range	O
of	O
proteins	O
were	O
detected	O
and	O
expression	O
correlated	O
with	O
transcriptional	O
analyses	O
.	O

3C	O
)	O
,	O
suggestive	O
of	O
closely	O
related	O
isoforms	O
or	O
post-translational	O
modifications	O
such	O
as	O
phosphorylation	O
.	O

While	O
these	O
efforts	O
have	O
been	O
highly	O
valuable	O
in	O
defining	O
the	O
transcriptional	O
profile	O
of	O
undifferentiated	O
hESCs	S-cell_type
,	O
they	O
are	O
only	O
predictive	O
of	O
translation	O
and	O
do	O
not	O
shed	O
light	O
on	O
post-translational	O
events	O
in	O
this	O
unique	O
cell	O
type	O
.	O

Proteins	O
were	O
identified	O
based	O
on	O
the	O
similarity	O
of	O
expected	O
and	O
observed	O
band	O
migration	O
profiles	O
and	O
bands	O
that	O
could	O
not	O
be	O
identified	O
were	O
excluded	O
from	O
the	O
analysis	O
.	O

These	O
issues	O
all	O
highlight	O
potential	O
shortfalls	O
in	O
our	O
understanding	O
of	O
the	O
hESC	O
proteome	O
.	O

3A	O
and	O
Additional	O
File	O
2	O
)	O
.	O

To	O
normalize	O
the	O
signal	O
intensities	O
,	O
the	O
total	O
raw	O
quantity	O
of	O
each	O
band	O
was	O
divided	O
by	O
the	O
average	O
intensity	O
value	O
of	O
the	O
molecular	O
standards	O
in	O
that	O
image	O
and	O
the	O
normalized	O
values	O
for	O
the	O
duplicate	O
samples	O
were	O
averaged	O
and	O
expressed	O
as	O
normalized	O
intensity	O
units	O
(	O
i.u	O
.	O
)	O
.	O

These	O
approaches	O
have	O
highlighted	O
an	O
expanded	O
set	O
of	O
transcripts	O
that	O
mark	O
the	O
pluripotent	O
state	O
[	O
4,13,14	O
]	O
,	O
cross-species	O
commonalities	O
in	O
the	O
molecular	O
profile	O
of	O
ESCs	S-cell_type
[	O
6,12,15	O
]	O
,	O
prominent	O
receptors	O
expressed	O
by	O
hESCs	S-cell_type
[	O
8	O
]	O
and	O
pathways	O
that	O
may	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
pluripotency	O
[	O
16,17	O
]	O
.	O

For	O
example	O
,	O
16	O
factors	O
with	O
known	O
or	O
implied	O
roles	O
in	O
the	O
regulation	O
of	O
self-renewal	O
or	O
pluripotency	O
of	O
mESCs	S-cell_type
or	O
hESCs	S-cell_type
,	O
such	O
as	O
Oct4	S-GP
[	O
27	O
]	O
,	O
STAT3	S-GP
[	O
28	O
]	O
,	O
members	O
of	O
the	O
FGF	S-GP
[	O
29	O
]	O
,	O
PI3	B-GP
kinase	E-GP
[	O
30	O
]	O
,	O
Src	S-GP
[	O
31	O
]	O
or	O
MAPK	S-GP
pathways	O
[	O
32	O
]	O
,	O
and	O
phosphorylated	O
isoforms	O
of	O
GSK3	S-GP
,	O
STAT3	S-GP
and	O
p38	B-GP
MAPK	E-GP
,	O
were	O
grouped	O
under	O
``	O
Pluripotency	O
''	O
(	O
Fig	O
.	O

5	O
)	O
.	O

To	O
verify	O
expression	O
using	O
a	O
complementary	O
approach	O
,	O
we	O
performed	O
immunoflurorescent	O
staining	O
for	O
10	O
proteins	O
not	O
previously	O
reported	O
to	O
be	O
expressed	O
in	O
hESCs	S-cell_type
by	O
immunocytochemistry	O
,	O
using	O
karyotypically	O
normal	O
BG01	S-cell_line
cultures	O
(	O
Fig	O
.	O

4L	O
)	O
.	O

(	O
L	O
)	O
Oct4	S-GP
was	O
used	O
as	O
a	O
positive	O
control	O
.	O

The	O
combinations	O
of	O
primary	O
antibodies	O
had	O
been	O
predetermined	O
to	O
detect	O
well-separated	O
proteins	O
,	O
avoiding	O
crossreaction	O
to	O
different	O
proteins	O
that	O
co-migrate	O
.	O

Verification	O
of	O
protein	O
expression	O
by	O
immunocytochemistryThe	O
PowerBlot	O
and	O
Kinexus	O
assays	O
identified	O
proteins	O
based	O
on	O
their	O
expected	O
and	O
observed	O
molecular	O
weight	O
,	O
using	O
combinations	O
of	O
antibodies	O
that	O
had	O
been	O
predetermined	O
to	O
detect	O
proteins	O
of	O
sufficiently	O
different	O
sizes	O
.	O

These	O
results	O
suggested	O
that	O
most	O
of	O
the	O
bands	O
in	O
the	O
PowerBlot	O
and	O
Kinexus	O
assays	O
were	O
likely	O
to	O
be	O
correctly	O
identified.Figure	O
4Verification	O
of	O
protein	O
expression	O
using	O
immunocytochemistry	O
.	O

The	O
scalability	O
of	O
the	O
system	O
depends	O
on	O
defining	O
suitable	O
combinations	O
of	O
primary	O
antibodies	O
,	O
with	O
up	O
to	O
1000	O
antibodies	O
in	O
200	O
lanes	O
being	O
used	O
in	O
the	O
largest	O
screens	O
thus	O
far	O
.	O

The	O
membranes	O
were	O
scanned	O
using	O
the	O
Odyssey	O
Imaging	O
System	O
(	O
LI-COR	O
)	O
.	O

(	O
O	O
)	O
p130	B-GP
Cas	E-GP
was	O
detected	O
in	O
a	O
membrane	S-cellcomponent
/	O
peripheral-cytoplasmic	S-cellcomponent
pattern	O
in	O
undifferentiated	O
cells	O
,	O
(	O
R	O
)	O
but	O
this	O
distribution	O
was	O
substantially	O
altered	O
in	O
differentiating	O
cells	O
with	O
a	O
flattened	O
morphology	O
,	O
which	O
exhibited	O
a	O
general	O
cytoplasmic	S-cellcomponent
,	O
or	O
perinuclear	S-cellcomponent
profile	O
.	O

These	O
staining	O
patterns	O
are	O
also	O
suggestive	O
of	O
basolateral	O
sorting	O
of	O
ERBB3	S-GP
in	O
hESCs	S-cell_type
.	O

Information	O
on	O
the	O
antibody	O
catalogue	O
number	O
and	O
dilution	O
,	O
band	O
intensity	O
for	O
each	O
repeat	O
and	O
the	O
averaged	O
value	O
,	O
description	O
of	O
protein	O
function	O
,	O
and	O
Entrez	O
gene	O
and	O
SwissProt	O
database	O
identification	O
numbers	O
is	O
shown	O
in	O
Additional	O
File	O
1	O
.	O

Defining	O
the	O
interplay	O
of	O
these	O
multiple	O
signaling	O
pathways	O
will	O
be	O
critical	O
in	O
understanding	O
the	O
self-renewal	O
versus	O
differentiation	O
decisions	O
of	O
hESCs	S-cell_type
.	O

The	O
gel	O
dimensions	O
were	O
130	O
×	O
100	O
×	O
0.5	O
mm	O
,	O
and	O
proteins	O
were	O
separated	O
at	O
150	O
volts	O
for	O
1.5	O
hours	O
,	O
and	O
transferred	O
to	O
an	O
Immobilon-P	O
membrane	O
(	O
Millipore	O
)	O
.	O

Examination	O
of	O
tight	B-GP
junction	I-GP
protein	E-GP
expression	O
indicated	O
that	O
undifferentiated	O
hESCs	S-cell_type
could	O
form	O
polarized	B-x
epithelia	E-x
,	O
which	O
has	O
also	O
been	O
recently	O
suggested	O
by	O
ultrastructural	O
analyses	O
[	O
49	O
]	O
.	O

The	O
average	O
intensity	O
of	O
the	O
detected	O
proteins	O
ranged	O
from	O
195	O
to	O
117926	O
normalized	O
intensity	O
units	O
(	O
i.u	O
.	O

These	O
cultures	O
were	O
karyotypically	S-cellcomponent
normal.To	O
partially	O
differentiate	O
hESC	O
cultures	O
for	O
immunostaining	O
analysis	O
,	O
karyotypically	S-cellcomponent
normal	O
BG01	B-cell_type
cells	E-cell_type
were	O
plated	O
on	O
matrigel	O
and	O
grown	O
for	O
three	O
days	O
in	O
DMEM/F12	O
containing	O
10	O
%	O
fetal	O
calf	O
serum	O
(	O
HyClone	O
)	O
,	O
1×	O
nonessential	O
amino	O
acids	O
,	O
20	O
mM	O
L-glutamine	O
,	O
50	O
U/ml	O
penicillin/streptomycin	O
,	O
and	O
0.1	O
mM	O
β-mecaptoethanol	O
.	O

Continued	O
proliferation	O
to	O
a	O
confluent	O
monolayer	O
on	O
day	O
7	O
was	O
accompanied	O
by	O
widespread	O
expression	O
of	O
ZO1	S-GP
,	O
suggesting	O
the	O
formation	O
of	O
a	O
general	O
tight	O
junction	O
barrier	O
.	O

In	O
this	O
procedure	O
,	O
a	O
large	O
well	O
is	O
used	O
to	O
separate	O
the	O
sample	O
by	O
PAGE	O
and	O
lanes	O
are	O
created	O
on	O
the	O
membrane	O
containing	O
immobilized	O
protein	O
with	O
the	O
use	O
of	O
a	O
manifold	O
.	O

ImmunocytochemistryImmunocytochemistry	O
and	O
staining	O
procedures	O
were	O
as	O
described	O
previously	O
[	O
51	O
]	O
.	O

(	O
A	O
)	O
ZO1	S-GP
expression	O
four	O
and	O
(	O
B	O
)	O
seven	O
days	O
after	O
plating	O
,	O
indicating	O
progressive	O
tight	O
junction	O
formation	O
.	O

This	O
system	O
used	O
934	O
antibodies	O
toward	O
proteins	O
representing	O
22	O
diverse	O
classes	O
of	O
function	O
,	O
such	O
as	O
transcription	O
factors	O
,	O
the	O
MAP	B-GP
kinase	E-GP
(	O
MAPK	S-GP
)	O
pathway	O
,	O
and	O
apoptosis	O
,	O
among	O
others	O
.	O

lllumina	O
data	O
and	O
comparison	O
to	O
proteomic	O
databaseExpression	O
levels	O
of	O
proteins	O
detected	O
by	O
the	O
PowerBlot	O
assay	O
were	O
compared	O
to	O
our	O
previous	O
published	O
database	O
of	O
multiple	O
hESC	O
lines	O
examined	O
using	O
the	O
Illumina	O
bead	O
array	O
platform	O
(	O
Liu	O
et	O
al.	O
,	O
2006	O
)	O
.	O

Progress	O
has	O
been	O
made	O
in	O
defining	O
growth	O
factor	O
conditions	O
that	O
support	O
self-renewal	O
[	O
44-46	O
]	O
,	O
and	O
hESC	O
lines	O
have	O
been	O
isolated	O
in	O
the	O
absence	O
of	O
mouse	B-cell_type
embryonic	I-cell_type
fibroblasts	E-cell_type
and	O
in	O
animal	O
protein	O
free	O
culture	O
conditions	O
[	O
47,48	O
]	O
.	O

Correlating	O
transcriptional	O
and	O
proteomic	O
data	O
provided	O
direct	O
confirmation	O
that	O
these	O
pathways	O
were	O
present	O
and	O
likely	O
functional	O
in	O
hESCs	S-cell_type
(	O
Table	O
2	O
)	O
.	O

Using	O
these	O
approaches	O
we	O
identified	O
new	O
markers	O
for	O
undifferentiated	O
hESCs	S-cell_type
and	O
highlighted	O
unrecognized	O
epithelial	O
characteristics	O
of	O
hESCs	S-cell_type
.	O

Microsoft	O
Excel	O
files	O
were	O
generated	O
that	O
contained	O
information	O
on	O
:	O
gel	O
number	O
,	O
lane	O
number	O
,	O
antibody	O
catalogue	O
number	O
(	O
BD	O
Biosciences	O
)	O
,	O
protein	O
name	O
,	O
expected	O
size	O
,	O
observed	O
size	O
,	O
repeat	O
1	O
i.u	O
.	O

Importantly	O
,	O
the	O
foundation	O
of	O
this	O
approach	O
is	O
the	O
large	O
amount	O
of	O
data	O
on	O
individual	O
antibodies	O
,	O
which	O
are	O
already	O
available	O
and	O
characterized	O
in	O
the	O
literature	O
.	O

For	O
example	O
,	O
FGF2	S-GP
protein	O
was	O
expressed	O
highly	O
in	O
hESCs	S-cell_type
and	O
expression	O
of	O
key	O
members	O
of	O
the	O
TGFβ	S-GP
,	O
Wnt	S-GP
,	O
Jak	S-GP
/	O
Stat	S-GP
and	O
Gap	B-cellcomponent
junction	E-cellcomponent
pathways	O
,	O
namely	O
Stat1	S-GP
,	O
SMADs	S-GP
,	O
GSK3β	S-GP
,	O
β-catenin	S-GP
and	O
Connexin	B-GP
43	E-GP
,	O
were	O
detected	O
in	O
both	O
transcriptional	O
and	O
proteomic	O
databases.Table	O
2Signal	O
pathways	O
that	O
may	O
be	O
active	O
in	O
hESCsNameProteinmRNA	O
TGF	B-GP
β	E-GP
Stat1	S-GP
++++++	O
PAI-1	S-GP
/	O
SERPINE1	S-GP
+++-	O
Smad2/3	S-GP
++++	O
Jun	S-GP
+++	O
Smad4	S-GP
/	O
DPC4	S-GP
+++	O
Endoglin	S-GP
+-	O
WntCtBP2	S-GP
+++++++	O
PP2A	B-GP
Catalytic	I-GP
alpha	E-GP
/	O
PPP2CA	S-GP
+++++++	O
EBP50	S-GP
/	O
SLC9A3R1	S-GP
++++++	O
beta-Catenin	S-GP
/	O
Ctnnb1	S-GP
++++	O
Cyclin	B-GP
D3	E-GP
/	O
CCND3	S-GP
++++	O
GSK-3	B-GP
beta	E-GP
++++	O
Jun	S-GP
+++	O
Casein	B-GP
Kinase	I-GP
II	I-GP
alpha	E-GP
/	O
CSNK2A1	S-GP
++++Jak-Stat	O
Stat1	S-GP
++++++	O
Crk	S-GP
++++	O
Stat3/2	S-GP
+++++	O
Stat6	S-GP
+++++	O
PTP1B	S-GP
+++++	O
JAK1	S-GP
++-Glucocorticoid	O
R/	O
NR3C1	S-GP
++-	O
Thrombin	B-GP
Receptor	E-GP
/	O
PAR1	S-GP
/	O
F2R	S-GP
+++	O
SHPS-1	S-GP
/	O
PTPNS1	S-GP
++++	O
MCM5	S-GP
+++++	O
Smad2/3	S-GP
++++	O
Tyk2	S-GP
++++	O
Jun	S-GP
+++	O
Bcl-x	S-GP
/	O
BCL2L1	S-GP
++++	O
Smad4	S-GP
/	O
DPC4	S-GP
+++	O
Stat5A	S-GP
++	O
GPCRB2	S-GP
Bradykinin	B-GP
Receptor	E-GP
/	O
BDKRB2	S-GP
++++-	O
Neurotensin	B-GP
Receptor	I-GP
3	E-GP
/	O
SORT1	S-GP
+++-	O
Endopeptidase	B-GP
3.4.24.16	E-GP
/	O
NLN	S-GP
++++	O
IP3R-3	S-GP
++++	O
SHC	S-GP
++++	O
Gap	B-cellcomponent
Junction	E-cellcomponent
Cdk1	S-GP
/	O
Cdc2	S-GP
++++++	O
GRB2	S-GP
++++++	O
MEK1	S-GP
/	O
MAP2K1	S-GP
++++++	O
PKA	B-GP
C	E-GP
++-	O
PKA	B-GP
RI	I-GP
alpha	E-GP
++-	O
PKC	B-GP
alpha	E-GP
++-	O
C-Raf	S-GP
/	O
RAF1	S-GP
++++	O
ZO-1	S-GP
/	O
TJP1	S-GP
+++++	O
Connexin-43	S-GP
/	O
GJA1	S-GP
++++	O
IGFPKC	B-GP
iota	E-GP
++++++	O
MEK1	S-GP
/	O
MAP2K1	S-GP
++++++	O
Rsk	S-GP
/	O
RPS6KA1	S-GP
+++++	O
GRB2	S-GP
++++++	O
MEK2	S-GP
/	O
MAP2K2	S-GP
++++++	O
PI3Kinase	S-GP
/	O
PIK3R1	S-GP
+++++pan	O
ERK/	O
MAPK1	S-GP
+++++	O
Crk	S-GP
++++	O
eIF-4E	S-GP
+++++	O
ShcC	S-GP
+++-	O
PAI-1	S-GP
/	O
SERPINE1	S-GP
+++-	O
C-Raf	S-GP
++++	O
SHC	S-GP
+++++	O
PKC	B-GP
beta	E-GP
/	O
PRKCB1	S-GP
++++	O
NCK	S-GP
++++	O
PKB	B-GP
alpha	E-GP
/Akt+++	O
GSK-3	B-GP
beta	E-GP
++++	O
Ercc-1	S-GP
++++	O
Fatty	B-GP
Acid	I-GP
Synthase	E-GP
/	O
FASN	S-GP
+++++	O
Jun	S-GP
+++	O
RAFT1	S-GP
/	O
FRAP	S-GP
++++	O
PTP1D	S-GP
/	O
SHP2	S-GP
/	O
PTPN11	S-GP
++++	O
SCAMP1	S-GP
++++	O
Bcl-x	S-GP
/	O
BCL2L1	S-GP
++++	O
p70s6k	S-GP
/	O
RPS6KB1	S-GP
+-	O
PI3-Kinase	B-GP
p170	E-GP
/	O
PIK3C2A	S-GP
++	O
PTP1B	S-GP
/	O
PTPN1	S-GP
+++	O
Dok1	S-GP
/	O
p62dok	S-GP
+++	O
PI3-Kinase	B-GP
p110	I-GP
alpha	E-GP
/	O
PIK3CA	S-GP
+-	O
ERBBEphA4	S-GP
/	O
Sek	S-GP
++++-	O
ShcC	S-GP
/	O
SHC3	S-GP
+++-	O
c-erb-B2	S-GP
/	O
ERBB2	S-GP
++++	O
C-Raf	S-GP
/	O
RAF1	S-GP
++++SHC/	O
SHC1	S-GP
+++++	O
GDNFI	B-GP
kappa	I-GP
B	E-GP
epsilon/	O
NFKBIE	S-GP
++++++	O
GRB2	S-GP
++++++	O
MEK2	S-GP
++++++	O
NCK	S-GP
+++++	O
C-Raf	S-GP
++++	O
Ras-GAP	S-GP
/	O
RASA1	S-GP
++++	O
SHC	S-GP
+++++	O
GDNFR-alpha	S-GP
/	O
Gfra1	S-GP
++-	O
Jun	S-GP
+++	O
IKK	B-GP
beta	E-GP
++++pan-JNK/	O
SAPK1	S-GP
/	O
MAPK10	S-GP
+++	O
NBS1	S-GP
/	O
ARTN	S-GP
++	O
Dok1	S-GP
/	O
p62dok	S-GP
+++	O
Tight	B-cellcomponent
Junction	E-cellcomponent
PTEN	S-GP
++++++	O
PP2A	B-GP
Catalytic	I-GP
alpha	E-GP
+++++++	O
PKC	B-GP
iota	E-GP
++++++Sec8/	O
SEC8L1	S-GP
+++++	O
beta-Catenin	S-GP
/	O
CTNNB1	S-GP
++++	O
CDC42	S-GP
+++++AF6/	O
MLLT4	S-GP
+++++	O
PKC	B-GP
alpha	E-GP
++-Yes++++	O
Rho	S-GP
/	O
ARHA	S-GP
+++++	O
ZO-1	S-GP
/	O
TJP1	S-GP
+++++	O
CASK	S-GP
+++	O
Symplekin	S-GP
/	O
SYMPK	S-GP
++-Ras/	O
NRAS	S-GP
++++	O
Casein	B-GP
Kinase	I-GP
II	I-GP
alpha	E-GP
/	O
CSNK2A1	S-GP
++++	O
VAP33	S-GP
/	O
VAPA	S-GP
+++	O
alpha-Catenin	S-GP
/	O
Ctnna1	S-GP
+++	O
MAPK	S-GP
pan	O
ERK++++++	O
MEK1	S-GP
++++++	O
Rsk	S-GP
++++++	O
ERK2	S-GP
++++++MEK2/	O
Map2k2	S-GP
++++++	O
MST3	S-GP
/	O
STK25	S-GP
++++++	O
ERK1	S-GP
+++++	O
CDC42	S-GP
+++++	O
C-Raf	S-GP
++++	O
p38	B-GP
alpha	E-GP
/	O
SAPK2a	S-GP
++-	O
G3BP	S-GP
+++++	O
TFII-I	S-GP
/	O
GTF2IRD1	S-GP
++++	O
MST1	S-GP
/	O
STK4	S-GP
++++	O
MKP2	S-GP
/	O
Dusp4	S-GP
++++	O
Ras	S-GP
++++Phospho-	O
p38MAPK	S-GP
(	O
T180/Y182	O
)	O
+++pan-JNK/	O
SAPK1	S-GP
+++	O
Inhibitor2	S-GP
/	O
PPP1R2	S-GP
++++	O
ABP-280	S-GP
++++++	O
14-3-3	B-GP
epsilon	E-GP
/	O
YWHAE	S-GP
++++	O
MAPKAPK-5	S-GP
+++	O
TAO1	S-GP
+*PBK+++	O
MKK3b	S-GP
/	O
Map2k3	S-GP
++Protein	O
expression	O
level	O
:	O
>	O
10,000	O
:	O
++++	O
;	O
5,000–10,000	O
:	O
+++	O
;	O
1,000–5,000	O
:	O
++	O
;	O
100–1,000	O
:	O
+	O
mRNA	O
gene	O
expression	O
level	O
:	O
>	O
5,000	O
:	O
++++	O
;	O
1,000–5,000	O
:	O
+++	O
;	O
100–1,000	O
:	O
++	O
;	O
30–100	O
:	O
+*	O
:	O
not	O
included	O
in	O
the	O
gene	O
expression	O
arrayThis	O
independent	O
confirmation	O
of	O
known	O
networks	O
led	O
us	O
to	O
examine	O
other	O
pathways	O
that	O
showed	O
a	O
similar	O
correlation	O
but	O
have	O
not	O
been	O
identified	O
as	O
key	O
regulators	O
of	O
either	O
self-renewal	O
or	O
differentiation	O
,	O
or	O
suggest	O
unappreciated	O
characteristics	O
of	O
hESCs	S-cell_type
.	O

(	O
M-R	O
)	O
Oct4	S-GP
,	O
TNIK	S-GP
and	O
p130	B-GP
Cas	E-GP
as	O
markers	O
of	O
undifferentiated	O
hESCs	S-cell_type
.	O

Datasets	O
for	O
this	O
analysis	O
are	O
in	O
Additional	O
Tables	O
1	O
and	O
2	O
.	O

By	O
comparison	O
,	O
SAGE	O
and	O
MPSS	O
are	O
limited	O
to	O
detecting	O
short	O
sequence	O
``	O
tags	O
''	O
adjacent	O
to	O
the	O
poly-A	O
tail	O
of	O
transcripts	O
,	O
and	O
may	O
not	O
distinguish	O
splice	O
variants	O
with	O
the	O
same	O
3	O
'	O
exon	O
.	O

Bands	O
predicted	O
to	O
be	O
isoforms	O
of	O
the	O
indicated	O
protein	O
are	O
highlighted	O
in	O
some	O
panels	O
(	O
*	O
)	O
.Other	O
functional	O
classification	O
of	O
the	O
proteins	O
detected	O
by	O
the	O
PowerBlot	O
screen	O
included	O
:	O
transcription	O
factors	O
(	O
71	O
proteins	O
)	O
,	O
nucleus	S-cellcomponent
and	O
nuclear	S-cellcomponent
transport	O
(	O
144	O
)	O
,	O
cytoskeleton	S-cellcomponent
(	O
75	O
)	O
,	O
cell	O
adhesion	O
(	O
45	O
)	O
,	O
MAP	B-GP
kinase	E-GP
pathway	O
(	O
24	O
)	O
,	O
protein	B-GP
kinase	I-GP
A	E-GP
(	O
13	O
)	O
,	O
protein	B-GP
kinase	I-GP
C	E-GP
(	O
20	O
)	O
,	O
tyrosine	B-GP
kinases	E-GP
(	O
15	O
)	O
,	O
adaptors	O
and	O
tyrosine	O
kinase	O
substrates	O
(	O
51	O
)	O
,	O
protein	B-GP
phosphatases	E-GP
(	O
17	O
)	O
,	O
GTPases	S-GP
and	O
regulators	O
(	O
42	O
)	O
,	O
calcium	O
signaling	O
(	O
23	O
)	O
,	O
cell	O
cycle	O
(	O
87	O
)	O
,	O
apoptosis	O
(	O
61	O
)	O
,	O
membrane	S-cellcomponent
research	O
(	O
62	O
)	O
,	O
and	O
other	O
functions	O
(	O
51	O
)	O
(	O
Additional	O
File	O
1	O
)	O
.	O

Briefly	O
,	O
cell	O
lysate	O
was	O
prepared	O
in	O
20	O
mM	O
MOPS	O
pH	O
7.0	O
,	O
2	O
mM	O
EGTA	O
,	O
5	O
mM	O
EDTA	O
,	O
30	O
mM	O
sodium	O
fluoride	O
,	O
40	O
mM	O
β-glycerolphosphate	O
pH	O
7.2	O
,	O
20	O
mM	O
sodium	O
pyrophosphate	O
,	O
1	O
mM	O
sodium	O
orthovanadate	O
,	O
1	O
mM	O
PMSF	O
,	O
3	O
mM	O
benzamidine	O
,	O
5	O
μM	O
pepstatin	O
,	O
10	O
μM	O
leupeptin	O
,	O
0.5	O
%	O
nonidet	O
P-40	O
,	O
with	O
the	O
final	O
pH	O
adjusted	O
to	O
7.2	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
used	O
two	O
large-scale	O
western	O
blot	O
systems	O
to	O
examine	O
the	O
expression	O
of	O
>	O
1000	O
proteins	O
in	O
hESCs	S-cell_type
and	O
detected	O
>	O
600	O
proteins	O
that	O
were	O
grouped	O
into	O
18	O
functional	O
classes	O
.	O

Other	O
known	O
examples	O
of	O
post-translational	O
modifications	O
included	O
those	O
of	O
HSP70	S-GP
,	O
IKKgamma	S-GP
and	O
ERK1	S-GP
.	O

To	O
compare	O
proteomic	O
and	O
transcriptional	O
analyses	O
of	O
hESCs	S-cell_type
,	O
the	O
levels	O
of	O
>	O
600	O
proteins	O
detected	O
using	O
large	O
scale	O
blotting	O
were	O
correlated	O
with	O
the	O
levels	O
of	O
transcripts	O
detected	O
with	O
the	O
Illumina	O
platform	O
(	O
Additional	O
File	O
3	O
)	O
.	O

PowerBlot	O
assays	O
BG01	S-cell_line
hESC	O
lysate	O
was	O
prepared	O
in	O
10	O
mM	O
Tris-HCl	O
pH	O
7.4	O
,	O
1	O
mM	O
sodium	O
orthovanadate	O
and	O
1	O
%	O
SDS	O
,	O
and	O
the	O
PowerBlot	O
assays	O
were	O
performed	O
by	O
BD	O
Biosciences	O
(	O
BD	O
Biosciences	O
)	O
.	O

value	O
,	O
averaged	O
i.u	O
.	O

It	O
is	O
impossible	O
in	O
an	O
initial	O
manuscript	O
to	O
analyze	O
and	O
rigorously	O
test	O
all	O
the	O
predictions	O
that	O
could	O
be	O
made	O
from	O
comparing	O
transcriptional	O
and	O
proteomic	O
data	O
sets	O
.	O

The	O
Bio-Rad	O
Mini-PROTEAN	O
3	O
electrophoresis	O
system	O
was	O
used	O
to	O
separate	O
proteins	O
by	O
SDS-PAGE	O
.	O

In	O
addition	O
,	O
this	O
approach	O
is	O
highly	O
flexible	O
,	O
and	O
if	O
desired	O
can	O
be	O
focused	O
to	O
particular	O
sets	O
of	O
proteins	O
or	O
protein	O
function	O
,	O
such	O
as	O
cell	O
signaling	O
molecules	O
.	O

Several	O
practical	O
approaches	O
for	O
proteomic	O
analyses	O
are	O
currently	O
available	O
,	O
the	O
most	O
established	O
of	O
which	O
is	O
the	O
2-dimensional	O
(	O
2D	O
)	O
separation	O
of	O
proteins	O
by	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
PAGE	O
)	O
.	O

The	O
membranes	O
were	O
washed	O
and	O
immunoreactive	O
bands	O
detected	O
by	O
enhanced	O
chemiluminescence	O
(	O
Amersham-Pharmacia	O
)	O
using	O
a	O
FluorS	O
Max	O
Multi-imager	O
(	O
Bio-Rad	O
)	O
.	O

They	O
can	O
be	O
maintained	O
for	O
prolonged	O
periods	O
in	O
culture	O
and	O
differentiate	O
to	O
representatives	O
of	O
the	O
three	O
germ	B-x
layers	E-x
as	O
well	O
as	O
trophoblasts	S-cell_type
and	O
germ	B-cell_type
cells	E-cell_type
.	O

These	O
focused	O
proteomic	O
approaches	O
are	O
therefore	O
likely	O
to	O
be	O
highly	O
complimentary	O
to	O
transcriptional	O
analyses	O
in	O
investigating	O
the	O
functional	O
expression	O
of	O
the	O
genome	O
in	O
hESCs	S-cell_type
and	O
during	O
cellular	O
differentiation	O
.	O

Furthermore	O
,	O
these	O
approaches	O
have	O
the	O
potential	O
to	O
provide	O
differentiated	O
cell	O
types	O
for	O
cell	O
replacement	O
therapies	O
of	O
degenerative	O
disorders	O
such	O
as	O
Parkinson	O
's	O
disease	O
and	O
Type	O
I	O
diabetes	O
[	O
2,3	O
]	O
.	O

3C	O
)	O
.	O

These	O
candidates	O
exhibited	O
closely	O
migrating	O
multiple	O
bands	O
,	O
which	O
were	O
close	O
to	O
their	O
predicted	O
size	O
but	O
were	O
sufficiently	O
separated	O
from	O
other	O
proteins	O
.	O

Cultures	O
were	O
passaged	O
using	O
Collagenase	B-GP
IV	E-GP
and	O
plated	O
on	O
growth	O
factor	O
depleted	O
Matrigel	O
(	O
BD	O
Biosciences	O
)	O
diluted	O
1:200	O
.	O

These	O
techniques	O
have	O
enabled	O
the	O
collation	O
and	O
comparison	O
of	O
transcriptional	O
profiles	O
from	O
multiple	O
hESC	O
lines	O
and	O
their	O
differentiated	O
derivatives	O
and	O
have	O
highlighted	O
an	O
expanded	O
set	O
of	O
hESC	O
specific	O
markers	O
and	O
signaling	O
pathways	O
that	O
may	O
regulate	O
self-renewal	O
or	O
differentiation	O
.	O

Eighty	O
five	O
immunoreactive	O
bands	O
were	O
identified	O
,	O
representing	O
38	O
protein	B-GP
kinases	E-GP
and	O
16	O
phosphatases	S-GP
,	O
their	O
isoforms	O
,	O
and	O
22	O
phosphorylated	O
sites	O
in	O
signaling	O
molecules	O
(	O
Fig	O
.	O

Isoforms	O
of	O
FGF2	S-GP
,	O
and	O
phospho-GSK3	S-GP
are	O
indicated	O
(	O
*	O
)	O
.	O

This	O
indicated	O
that	O
they	O
were	O
novel	O
markers	O
of	O
undifferentiated	O
cells	O
and	O
molecules	O
that	O
could	O
be	O
functionally	O
involved	O
with	O
self-renewal	O
.	O

Some	O
proteins	O
were	O
included	O
in	O
multiple	O
functional	O
categories	O
due	O
to	O
overlapping	O
properties	O
,	O
such	O
as	O
AIM-1	S-GP
,	O
which	O
was	O
included	O
in	O
the	O
cell	O
cycle	O
as	O
well	O
as	O
in	O
the	O
nucleus	S-cellcomponent
/nuclear	O
transport	O
categories	O
.	O

A	O
detailed	O
study	O
demonstrating	O
the	O
importance	O
of	O
the	O
IGF	S-GP
and	O
ERBB2	S-GP
pathways	O
in	O
hESC	O
self-renewal	O
has	O
been	O
performed	O
and	O
enabled	O
the	O
development	O
of	O
a	O
defined	O
medium	O
for	O
hESC	O
maintenance	O
(	O
TCS	O
and	O
AJR	O
,	O
submitted	O
)	O
.	O

BG01	S-cell_line
cultures	O
were	O
partially	O
differentiated	O
by	O
exposure	O
to	O
10	O
%	O
fetal	O
bovine	O
serum	O
for	O
3	O
days	O
.	O

Using	O
pathway	O
analysis	O
we	O
were	O
also	O
able	O
to	O
identify	O
key	O
pathways	O
that	O
are	O
active	O
in	O
ESCs	S-cell_type
(	O
reviewed	O
in	O
[	O
16	O
]	O
)	O
.	O

Briefly	O
,	O
200	O
μg	O
of	O
protein	O
lysate	O
was	O
loaded	O
in	O
a	O
single	O
,	O
gel-wide	O
well	O
,	O
on	O
a	O
SDS-4–15	O
%	O
gradient	O
polyacrylamide	O
gel	O
.	O

These	O
conditions	O
maintain	O
cell	O
populations	O
that	O
express	O
the	O
appropriate	O
markers	O
of	O
pluripotency	O
and	O
can	O
differentiate	O
to	O
representatives	O
of	O
all	O
three	O
germ	O
layers	O
,	O
but	O
may	O
lead	O
to	O
eventual	O
accumulation	O
of	O
trisomies	O
for	O
chromosome	S-cellcomponent
s	O
12	O
,	O
17	O
or	O
X	O
[	O
26	O
]	O
.	O

Finally	O
,	O
several	O
proteins	O
detected	O
by	O
our	O
assays	O
were	O
also	O
detected	O
in	O
hESCs	S-cell_type
by	O
MS	O
approaches	O
including	O
Karyopherin	B-GP
α	E-GP
[	O
19	O
]	O
.	O

Appropriately	O
coupled	O
secondary	O
antibodies	O
(	O
Molecular	O
Probes	O
)	O
were	O
used	O
for	O
single	O
and	O
double	O
labeling	O
.	O

Briefly	O
,	O
cells	O
were	O
fixed	O
with	O
4	O
%	O
paraformaldehyde	O
for	O
half	O
an	O
hour	O
,	O
blocked	O
in	O
blocking	O
buffer	O
(	O
5	O
%	O
goat	S-y
serum	O
,	O
1	O
%	O
BSA	O
,	O
0.1	O
%	O
Triton	O
X-100	O
)	O
for	O
1	O
hour	O
followed	O
by	O
incubation	O
with	O
the	O
primary	O
antibody	O
at	O
4°C	O
overnight	O
.	O

4A–K	O
)	O
.	O

)	O
,	O
with	O
an	O
average	O
of	O
5367	O
i.u	O
.	O

These	O
conditions	O
were	O
necessary	O
to	O
scale	O
up	O
the	O
culture	O
to	O
generate	O
the	O
milligram	O
amounts	O
of	O
protein	O
lysate	O
required	O
for	O
this	O
analysis	O
.	O

Identified	O
bands	O
are	O
indicated	O
(	O
*	O
)	O
.	O

These	O
included	O
ABP-280	S-GP
,	O
a	O
homodimeric	O
actin-binding	O
protein	O
often	O
associated	O
with	O
membrane	O
glycoproteins	O
;	O
CtBP1	S-GP
and	O
CtBP2	S-GP
,	O
two	O
C	O
terminal	O
binding	O
proteins	O
that	O
are	O
a	O
class	O
of	O
transcription	O
corepressors	O
;	O
GS-28	S-GP
,	O
a	O
golgi	S-cellcomponent
protein	O
;	O
HDJ-2	S-GP
,	O
a	O
member	O
of	O
the	O
DnaJ-related	O
Hsp40	S-GP
(	O
heat	B-GP
shock	I-GP
protein	I-GP
40	E-GP
)	O
subfamily	O
;	O
L-Caldesmon	S-GP
,	O
a	O
cytoplasmi	S-cellcomponent
c	O
actin-binding	O
protein	O
;	O
Rabaptin	S-GP
,	O
a	O
GTP-binding	O
protein	O
;	O
phosphorylated-p130	B-GP
Cas	E-GP
,	O
a	O
docking	O
protein	O
with	O
an	O
amino-terminal	O
SH3	O
domain	O
that	O
may	O
function	O
as	O
a	O
molecular	O
switch	O
that	O
regulates	O
CAS	O
(	O
Crk-associated	B-GP
substrate	E-GP
)	O
tyrosine	O
phosphorylation	O
;	O
Ras-GAP	S-GP
and	O
phosphorylated	B-GP
Ras-GAP	E-GP
(	O
p-Y460	O
)	O
,	O
a	O
protein	O
that	O
down-regulates	O
the	O
signal	O
transducer	O
p21ras	S-GP
;	O
and	O
ShcC	S-GP
,	O
a	O
protein	O
with	O
an	O
N-terminal	O
phosphotyrosine-binding	O
domain	O
.	O

(	O
C	O
)	O
Occludin	S-GP
expression	O
5	O
days	O
after	O
plating	O
.	O

Immunofluorescence	O
revealed	O
general	O
cell	O
surface	O
expression	O
of	O
ERBB2	S-GP
on	O
hESCs	S-cell_type
.	O

The	O
primary	O
antibodies	O
were	O
rabbit	S-y
and	O
goat	S-y
polyclonal	O
,	O
and	O
mouse	S-y
monoclonal	O
antibodies	O
,	O
diluted	O
1:1000	O
.	O

For	O
the	O
PowerBlot	O
screen	O
,	O
whole	O
cell	O
lysate	O
from	O
BG01	B-cell_type
hESCs	E-cell_type
was	O
separated	O
on	O
five	O
4–15	O
%	O
gradient	O
gels	O
.	O

This	O
includes	O
definition	O
of	O
the	O
transcripts	O
,	O
splice	O
variants	O
,	O
and	O
protein	O
isoforms	O
expressed	O
by	O
these	O
cells	O
.	O

This	O
large-scale	O
western	O
blot	O
consisted	O
of	O
five	O
gels	O
run	O
in	O
duplicate	O
and	O
probed	O
with	O
934	O
antibodies	O
.	O

Large-scale	O
gene	O
expression	O
analyses	O
such	O
as	O
microarray	O
,	O
massive	O
parallel	O
signature	O
sequencing	O
(	O
MPSS	O
)	O
,	O
expressed	O
sequenced	O
tag	O
(	O
EST	O
)	O
enumeration	O
,	O
and	O
serial	O
analysis	O
of	O
gene	O
expression	O
(	O
SAGE	O
)	O
have	O
been	O
used	O
to	O
compare	O
multiple	O
hESC	O
lines	O
[	O
4-7	O
]	O
;	O
hESCs	S-cell_type
to	O
germ	B-x
cell	I-x
tumors	E-x
[	O
8	O
]	O
;	O
or	O
to	O
differentiated	O
derivatives	O
in	O
embryoid	B-x
bodies	E-x
[	O
9-11	O
]	O
or	O
neural	B-cell_type
populations	E-cell_type
[	O
12	O
]	O
.	O

These	O
analyses	O
also	O
indicated	O
that	O
hESCs	S-cell_type
exhibit	O
several	O
features	O
of	O
polarized	O
epithelia	O
,	O
including	O
expression	O
of	O
tight	O
junction	O
proteins.ConclusionOur	O
approach	O
complements	O
proteomic	O
and	O
transcriptional	O
analysis	O
to	O
provide	O
unique	O
information	O
on	O
human	B-cell_type
pluripotent	I-cell_type
stem	I-cell_type
cells	E-cell_type
,	O
and	O
is	O
a	O
framework	O
for	O
the	O
continued	O
analyses	O
of	O
self-renewal	O
.	O

In	O
addition	O
,	O
one	O
hundred	O
and	O
forty	O
phospho-specific	O
antibodies	O
were	O
used	O
to	O
identify	O
85	O
different	O
phosphorylated	O
sites	O
,	O
on	O
76	O
proteins	O
in	O
these	O
cells	O
.	O

Furthermore	O
,	O
13	O
proteins	O
were	O
detected	O
with	O
multiple	O
different	O
antibodies	O
,	O
and	O
35	O
proteins	O
(	O
Table	O
1	O
)	O
were	O
detected	O
in	O
both	O
the	O
PowerBlot	O
and	O
Kinexus	O
assays	O
.	O

Discrete	O
localization	O
of	O
ERBB3	S-GP
may	O
also	O
suggest	O
basolateral	O
separation	O
of	O
this	O
receptor	O
from	O
soluble	O
ligand	O
.	O

Four	O
signaling	O
pathways	O
(	O
IGF	S-GP
,	O
ERBB2	S-GP
,	O
GPCR	S-GP
,	O
and	O
GDNF	S-GP
)	O
and	O
the	O
tight	B-cellcomponent
junction	I-cellcomponent
complex	E-cellcomponent
were	O
highlighted	O
by	O
this	O
analysis	O
(	O
Table	O
2	O
)	O
,	O
and	O
expression	O
of	O
key	O
proteins	O
in	O
these	O
pathways	O
was	O
confirmed	O
.	O

1G	O
)	O
.	O

Kinexus	O
analysis	O
of	O
hESCs	S-cell_type
A	O
more	O
focused	O
screen	O
was	O
used	O
to	O
profile	O
expression	O
of	O
protein	B-GP
kinases	E-GP
,	O
phosphatases	S-GP
and	O
phosphorylated	O
sites	O
in	O
cell	O
signaling	O
molecules	O
in	O
hESCs	S-cell_type
.	O

(	O
B	O
)	O
Cell	O
surface	O
proteins	O
are	O
shown	O
,	O
including	O
Connexin	B-GP
43	E-GP
,	O
E-Cad	S-GP
and	O
GDNFRα	S-GP
(	O
Additional	O
Table	O
2	O
,	O
``	O
Cell	O
Surface	O
''	O
)	O
.	O

The	O
proteins	O
with	O
the	O
highest	O
band	O
intensity	O
were	O
the	O
B2	B-GP
Bradykinin	I-GP
Receptor	E-GP
(	O
117926	O
i.u	O
.	O

This	O
is	O
a	O
basic	O
epithelial	S-cell_type
wound	O
healing	O
mechanism	O
,	O
whereby	O
disruption	O
of	O
the	O
tight	O
junction	O
barrier	O
by	O
injury	O
immediately	O
exposes	O
receptors	O
to	O
extracelluar	O
ligands	O
[	O
43	O
]	O
.	O

Briefly	O
,	O
the	O
media	O
consisted	O
of	O
DMEM/F12	O
(	O
Invitrogen	O
)	O
,	O
2	O
%	O
fatty	O
acid-free	O
Cohn	O
's	O
fraction	O
V	O
BSA	O
(	O
Serologicals	O
)	O
,	O
1×	O
nonessential	O
amino	O
acids	O
,	O
50	O
U/ml	O
penicillin/streptomycin	O
,	O
50	O
μg/ml	O
ascorbic	O
acid	O
,	O
10	O
μg/ml	O
bovin	S-y
e	O
transferrin	S-GP
,	O
0.1	O
mM	O
β-mecaptoethanol	O
(	O
all	O
from	O
Invitrogen	O
)	O
,	O
1×	O
Trace	O
Elements	O
A	O
,	O
B	O
&	O
C	O
(	O
Mediatech	O
)	O
,	O
10	O
ng/ml	O
hergulin1β	S-GP
(	O
Peprotech	O
)	O
,	O
10	O
ng/ml	O
activinA	S-GP
(	O
R	O
&	O
D	O
Systems	O
)	O
,	O
200	O
ng/ml	O
LR3-IGF1	S-GP
(	O
JRH	O
Biosciences	O
)	O
,	O
and	O
8	O
ng/ml	O
FGF2	S-GP
(	O
R	O
&	O
D	O
Systems	O
)	O
.	O

3B	O
)	O
.	O

Importantly	O
,	O
we	O
provide	O
a	O
list	O
of	O
tools	O
,	O
in	O
the	O
form	O
of	O
commercially	O
available	O
antibodies	O
,	O
which	O
can	O
be	O
used	O
to	O
interrogate	O
the	O
function	O
of	O
these	O
molecules	O
in	O
self-renewal	O
or	O
differentiation	O
.	O

These	O
molecules	O
may	O
be	O
useful	O
as	O
targets	O
for	O
cell	O
sorting	O
experiments	O
,	O
and	O
expression	O
of	O
these	O
receptors	O
could	O
identify	O
bioactive	O
peptides	O
or	O
growth	O
factors	O
that	O
may	O
influence	O
hESC	O
self-renewal	O
or	O
differentiation.Figure	O
3Functional	O
classification	O
and	O
mobility	O
variants	O
of	O
proteins	O
detected	O
in	O
hESCs	S-cell_type
.	O

Therefore	O
,	O
our	O
data	O
provide	O
a	O
powerful	O
framework	O
for	O
the	O
functional	O
analysis	O
of	O
specific	O
proteins	O
,	O
protein	O
classes	O
,	O
or	O
molecular	O
pathways	O
.	O

For	O
each	O
assay	O
,	O
250	O
μg	O
of	O
cell	O
lysate	O
was	O
loaded	O
in	O
a	O
single	O
well	O
spanning	O
the	O
width	O
of	O
the	O
stacking	O
gel	O
,	O
then	O
separated	O
through	O
a	O
12.5	O
%	O
SDS-Polyacrylamide	O
gel	O
and	O
transferred	O
to	O
a	O
PVDF	O
membrane	O
.	O

These	O
differences	O
may	O
have	O
profound	O
effects	O
on	O
translation	O
,	O
as	O
well	O
as	O
the	O
isoform	O
and	O
function	O
of	O
the	O
protein	O
produced	O
.	O

hESCs	S-cell_type
expressed	O
the	O
ZO1	S-GP
and	O
occludin	S-GP
tight	O
junction	O
proteins	O
along	O
cell	B-cellcomponent
borders	E-cellcomponent
as	O
expected	O
in	O
polarized	B-x
epithelia	E-x
.	O

>	O
10,000	O
as	O
++++	O
;	O
5,000–10,000	O
as	O
+++	O
;	O
1,000–5,000	O
as	O
++	O
;	O
100–1,000	O
as	O
+	O
.	O

Our	O
data	O
confirm	O
the	O
importance	O
of	O
proteomic	O
analyses	O
in	O
complementing	O
transcriptional	O
profiling	O
and	O
provide	O
a	O
framework	O
for	O
continued	O
analyses	O
of	O
the	O
molecular	O
and	O
cellular	O
biology	O
of	O
pluirpotent	O
hESCs	S-cell_type
.	O

BackgroundUsing	O
antibodies	O
to	O
specific	O
protein	O
antigens	O
is	O
the	O
method	O
of	O
choice	O
to	O
assign	O
and	O
identify	O
cell	O
lineage	O
through	O
simultaneous	O
analysis	O
of	O
surface	O
molecules	O
and	O
intracellular	O
markers	O
.	O

DPPA5	S-GP
(	O
developmental	B-GP
pluripotency	I-GP
associated	I-GP
5	E-GP
)	O
expression	O
was	O
also	O
observed	O
in	O
undifferentiated	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
(	O
data	O
not	O
shown	O
)	O
.	O

After	O
wash	O
,	O
cells	O
were	O
resuspend	O
in	O
400	O
μL	O
of	O
PBS	O
and	O
analyzed	O
on	O
a	O
FACScant	O
flow	O
cytometer	O
(	O
Becton-Dickinson	O
,	O
Mountain	O
View	O
,	O
CA	O
)	O
.	O

1–265	O
)	O
,	O
PDX-1	S-GP
(	O
aa	O
.	O

For	O
example	O
,	O
pluripotent	B-cell_type
ESC	E-cell_type
can	O
be	O
characterized	O
by	O
high	O
level	O
expression	O
of	O
Oct3/4	S-GP
(	O
POU	B-GP
domain	I-GP
,	I-GP
class	I-GP
5	I-GP
,	I-GP
transcription	I-GP
factor	I-GP
1	E-GP
,	O
Pou5f1	S-GP
)	O
and	O
Nanog	S-GP
,	O
which	O
are	O
a	O
member	O
of	O
POU	O
domain	O
and	O
homeobox	O
transcription	O
factors	O
respectively	O
.	O

3	O
)	O
.	O

Following	O
incubation	O
,	O
excess	O
antibody	O
was	O
removed	O
by	O
washing	O
cells	O
twice	O
with	O
FACS	O
buffer	O
(	O
2	O
%	O
FCS	O
and	O
0.1	O
%	O
sodium	O
azide	O
in	O
Hank	O
's	O
buffer	O
)	O
.	O

Minimal	O
or	O
no	O
expressions	O
of	O
Oct3/4	S-GP
,	O
E-Cadherin	S-GP
,	O
PODXL	S-GP
and	O
Nanog	S-GP
were	O
detected	O
in	O
the	O
differentiated	O
EBs	S-x
(	O
Fig	O
.	O

The	O
IgG	S-GP
fraction	O
of	O
the	O
culture	O
supernatant	O
was	O
purified	O
by	O
Protein	B-GP
G	E-GP
affinity	O
chromatography	O
(	O
Sigma	O
)	O
.	O

1–283	O
)	O
,	O
SOX2	S-GP
(	O
aa	O
.	O

The	O
differentiation	O
status	O
of	O
the	O
EB	O
used	O
here	O
was	O
detected	O
to	O
contain	O
all	O
germ	O
cell	O
markers	O
by	O
RT-PCR	O
(	O
Fig	O
.	O

Embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
ESC	O
)	O
,	O
derived	O
from	O
the	O
inner	B-x
cell	I-x
mass	E-x
of	O
pre-implantation	O
embryos	S-x
,	O
have	O
been	O
recognized	O
as	O
the	O
earliest	O
stem	O
cell	O
population	O
[	O
1,2	O
]	O
.	O

Gene	O
expression	O
of	O
undifferentiated	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
has	O
been	O
investigated	O
among	O
several	O
ES	O
cell	O
lines	O
by	O
a	O
variety	O
of	O
techniques	O
.	O

135–317	O
)	O
and	O
SOX17	S-GP
(	O
aa	O
.	O

These	O
results	O
are	O
summarized	O
in	O
Table	O
2.Table	O
2Summary	O
of	O
antibodies	O
detection	O
in	O
ES	S-cell_type
and	O
EB	O
samples.AntibodyESEBReactivity	O
to	O
mouse	S-y
Isotype	O
of	O
monoclonal	O
antibody	O
(	O
Clone	O
No	O
.	O

RT-PCRTotal	O
RNA	O
was	O
extracted	O
from	O
EBs	S-x
using	O
Trizol	O
LS	O
(	O
Invitrogen	O
)	O
.	O

No	O
single	O
marker	O
however	O
is	O
sufficient	O
or	O
unique	O
for	O
identifying	O
ESCs	S-cell_type
.	O

However	O
,	O
SOX2	S-GP
expression	O
is	O
persistent	O
in	O
subsets	O
of	O
EB	B-cell_type
cells	E-cell_type
.	O

Based	O
on	O
published	O
data	O
at	O
the	O
level	O
of	O
gene	O
expression	O
,	O
we	O
have	O
cloned	O
a	O
number	O
of	O
candidate	O
marker	O
genes	O
.	O

In	O
contrast	O
to	O
the	O
undifferentiated	O
ES	B-cell_type
cells	E-cell_type
,	O
subpopulations	O
of	O
SOX17	S-GP
-	O
,	O
GATA6	S-GP
-	O
,	O
Brachyury	S-GP
-	O
and	O
GATA1	S-GP
-positive	O
cells	O
were	O
observed	O
(	O
Fig	O
4	O
)	O
.	O

Selected	O
endoderm	S-x
markers	O
AFP	S-GP
,	O
FoxA2	S-GP
;	O
mesoderm	S-x
markers	O
Hand1	S-GP
,	O
MSX1	S-GP
and	O
ectoderm	S-x
marker	O
Msl1	S-GP
were	O
all	O
highly	O
expressed	O
in	O
the	O
EB	O
samples	O
while	O
their	O
expression	O
was	O
either	O
undetectable	O
or	O
at	O
low	O
level	O
in	O
the	O
ES	S-cell_type
samples	O
.	O

Human	S-y
peripheral	B-x
blood	E-x
platelets	S-cellcomponent
were	O
used	O
for	O
screening	O
mouse	S-y
anti-	O
human	S-y
CD9	S-GP
antibody	O
.	O

Following	O
incubation	O
,	O
cells	O
were	O
washed	O
once	O
with	O
FACS	O
buffer	O
,	O
once	O
with	O
PBS	O
.	O

All	O
polyclonal	O
antibodies	O
were	O
affinity-purified	O
using	O
recombinant	O
proteins	O
and	O
validated	O
by	O
direct	O
ELISAs	O
and	O
Western	O
.	O

Cells	O
or	O
sections	O
of	O
EBs	S-x
were	O
fixed	O
with	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
at	O
room	O
temperature	O
for	O
20	O
min	O
,	O
then	O
blocked	O
and	O
permeabilized	O
with	O
0.1	O
%	O
Triton	O
X-100	O
,	O
1	O
%	O
BSA	O
,	O
10	O
%	O
normal	O
donkey	S-y
serum	O
in	O
PBS	O
at	O
room	O
temperature	O
for	O
45	O
min	O
.	O

The	O
extracts	O
are	O
heated	O
in	O
a	O
boiling	O
water	O
bath	O
for	O
5	O
minutes	O
and	O
sonicated	O
with	O
a	O
probe	O
sonicator	O
with	O
3–4	O
bursts	O
of	O
5–10	O
seconds	O
each	O
.	O

Cells	O
were	O
cultured	O
according	O
to	O
the	O
ATCC	O
instructions	O
.	O

cDNA	O
was	O
synthesized	O
by	O
using	O
Superscript	O
II	O
reverse	O
transcriptase	O
(	O
Invitrogen	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
recommendations	O
.	O

Cross-reactivity	O
to	O
mouse	S-y
of	O
goat	O
anti-	O
Oct3/4	S-GP
,	O
goat	O
anti-	O
PDX-1	S-GP
,	O
goat	O
anti-	O
SOX17	S-GP
and	O
mouse	S-y
anti-	O
SOX2	S-GP
was	O
detected	O
.	O

Characterization	O
of	O
undifferentiated	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
and	O
differentiated	O
EBs	S-x
by	O
antibodiesAll	O
monoclonal	O
antibodies	O
were	O
initially	O
selected	O
for	O
their	O
abilities	O
to	O
recognize	O
recombinant	O
proteins	O
in	O
direct	O
ELISAs	O
.	O

Several	O
additional	O
antibodies	O
to	O
the	O
molecules	O
that	O
have	O
been	O
identified	O
as	O
potential	O
cell	O
lineage	O
markers	O
[	O
13	O
]	O
are	O
currently	O
under	O
development	O
using	O
the	O
same	O
approach	O
.	O


The	O
expression	O
patterns	O
detected	O
using	O
antibodies	O
developed	O
in	O
our	O
facility	O
are	O
consistent	O
with	O
data	O
reported	O
using	O
reverse	O
transcriptase-polymerase	O
chain	O
reaction	O
or	O
cDNA	O
microarrays	O
.	O

Each	O
panel	O
of	O
antibodies	O
was	O
screened	O
and	O
selected	O
for	O
their	O
abilities	O
to	O
detect	O
purified	O
recombinant	O
antigen	O
in	O
direct	O
ELISA	O
and	O
Western	O
blot	O
.	O

We	O
noted	O
that	O
a	O
subset	O
of	O
the	O
proteins	O
used	O
were	O
membrane	S-cellcomponent
bound	O
proteins	O
.	O

Five	O
thousand	O
events	O
were	O
collected	O
and	O
analyzed	O
using	O
CELL	O
Quest	O
software	O
.	O

4	O
)	O
.	O

(	O
B	O
)	O
Immunostaining	O
with	O
goat	O
anti-	O
human	S-y
GATA6	S-GP
(	O
Red	O
)	O
,	O
is	O
contrasted	O
with	O
DAPI	O
nuclear	S-cellcomponent
staining	O
(	O
Blue	O
)	O
.	O

In	O
order	O
to	O
examine	O
how	O
more	O
antibodies	O
can	O
be	O
used	O
for	O
characterization	O
of	O
early	O
differentiation	O
events	O
from	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
,	O
we	O
examined	O
the	O
expressions	O
of	O
endodermal	S-x
markers	O
,	O
SOX17	S-GP
,	O
GATA6	S-GP
and	O
PDX-1	S-GP
,	O
and	O
mesodermal	S-x
markers	O
,	O
Brachyury	S-GP
and	O
GATA1	S-GP
,	O
in	O
the	O
undifferentiated	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
and	O
differentiated	O
EBs	S-cell_type
.	O

However	O
,	O
SOX2	S-GP
expression	O
,	O
which	O
is	O
observed	O
in	O
neural	B-cell_type
progenitor	I-cell_type
cells	E-cell_type
,	O
is	O
persistent	O
in	O
subsets	O
of	O
EBs.Figure	O
1Western	O
blot	O
analysis	O
for	O
Gt	O
×	O
h	O
Oct3/4	S-GP
(	O
A	O
)	O
,	O
Gt	O
×	O
h	O
Nanog	S-GP
(	O
B	O
)	O
and	O
Ms	O
×	O
h	O
SOX2	S-GP
(	O
C	O
)	O
in	O
NTERA-2	B-cell_type
cell	E-cell_type
lysate	O
,	O
Ms	O
×	O
h	O
E-Cadherin	S-GP
(	O
D	O
)	O
in	O
MCF-7	B-cell_type
cell	E-cell_type
lysate	O
,	O
Ms	O
×	O
hCD9	S-GP
(	O
E	O
)	O
in	O
PBMC	S-cell_type
lysate	O
and	O
Ms	O
×	O
h	O
PDX-1	S-GP
(	O
F	O
)	O
in	O
β-TC-6	B-cell_type
cell	E-cell_type
lysate	O
.	O

Information	O
regarding	O
human	S-y
ES	B-cell_type
cel	E-cell_type
l	O
line	O
HSF-6	S-cell_line
(	O
NIH	O
code	O
UC06	S-cell_line
)	O
can	O
be	O
obtained	O
at	O
the	O
website	O
[	O
14	O
]	O
.	O

After	O
wash	O
,	O
cells	O
were	O
resuspend	O
in	O
200	O
μL	O
of	O
FACS	O
buffer	O
and	O
the	O
binding	O
of	O
unlabeled	O
monoclonal	O
antibodies	O
was	O
visualized	O
by	O
adding	O
10	O
μL	O
of	O
a	O
25	O
μg/mL	O
stock	O
solution	O
of	O
a	O
secondary	O
developing	O
reagent	O
such	O
as	O
goat	O
anti-	O
mouse	S-y
IgG	S-GP
conjugated	O
to	O
a	O
fluorochrome	O
for	O
20	O
min	O
at	O
2–8°C	O
.	O

MCF-7	S-cell_line
cells	O
were	O
used	O
for	O
screening	O
mouse	S-y
anti-	O
human	S-y
E-Cadherin	S-GP
and	O
PODXL	S-GP
(	O
podocalyxin-like	S-GP
)	O
antibodies	O
.	O

They	O
include	O
comparison	O
with	O
databases	O
,	O
reverse	O
transcriptase-polymerase	O
chain	O
reaction	O
,	O
focused	O
cDNA	O
microarrays	O
,	O
and	O
immunocytochemistry	O
.	O

While	O
stem	B-cell_type
cells	E-cell_type
can	O
be	O
best	O
defined	O
functionally	O
,	O
a	O
good	O
number	O
of	O
molecular	O
markers	O
have	O
been	O
used	O
to	O
prospectively	O
identify	O
various	O
stem	O
cell	O
populations	S-x
.	O

We	O
have	O
also	O
expressed	O
the	O
recombinant	O
protein	O
and	O
generated	O
a	O
panel	O
of	O
monoclonal	O
or	O
polyclonal	O
antibodies	O
to	O
these	O
proteins	O
.	O

Immunostaining	O
with	O
goat	O
anti-	O
human	S-y
Oct3/4	S-GP
(	O
Red	O
in	O
A	O
and	O
D	O
)	O
,	O
mouse	S-y
anti-	O
human	S-y
SOX2	S-GP
(	O
Green	O
in	O
A	O
and	O
D	O
)	O
,	O
goat	O
anti-	O
human	S-y
E-Cadherin	S-GP
(	O
Red	O
in	O
B	O
and	O
E	O
)	O
,	O
mouse	S-y
anti-	O
human	S-y
PODXL	S-GP
(	O
Green	O
in	O
B	O
and	O
E	O
)	O
,	O
and	O
goat	O
anti-	O
human	S-y
Nanog	S-GP
(	O
Red	O
in	O
C	O
and	O
F	O
)	O
,	O
are	O
contrasted	O
with	O
DAPI	O
nuclear	S-cellcomponent
staining	O
(	O
Blue	O
in	O
C-F	O
)	O
.	O

1	O
and	O
data	O
not	O
shown	O
)	O
,	O
they	O
were	O
used	O
to	O
examine	O
the	O
expression	O
of	O
individual	O
molecules	O
in	O
undifferentiated	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
and	O
differentiated	O
EBs	S-cell_type
.	O

This	O
pluripotent	B-x
population	E-x
can	O
differentiate	O
into	O
all	O
somatic	B-x
tissue	E-x
including	O
germ	B-cell_type
cells	E-cell_type
.	O

Embryonic	O
stem	O
cell	O
research	O
can	O
be	O
benefited	O
from	O
using	O
antibodies	O
specific	O
to	O
transcriptional	O
factors/markers	O
that	O
contribute	O
to	O
the	O
``	O
stemness	O
''	O
phenotype	O
or	O
critical	O
for	O
cell	O
lineage.ResultsIn	O
this	O
report	O
,	O
we	O
have	O
developed	O
and	O
validated	O
antibodies	O
(	O
either	O
monoclonal	O
or	O
polyclonal	O
)	O
specific	O
to	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cell	E-cell_type
antigens	O
and	O
early	O
differentiation	O
transcriptional	O
factors/markers	O
that	O
are	O
critical	O
for	O
cell	O
differentiation	O
into	O
definite	O
lineage.ConclusionThese	O
antibodies	O
enable	O
stem	O
cell	O
biologists	O
to	O
conveniently	O
identify	O
stem	O
cell	O
characteristics	O
and	O
to	O
quantitatively	O
assess	O
differentiation	O
.	O

All	O
proteins	O
were	O
purified	O
and	O
sequenced	O
before	O
they	O
were	O
used	O
as	O
antigens	O
for	O
immunizations	O
and	O
as	O
substrate	O
for	O
antibody	O
screening	O
and	O
subcloning	O
.	O

Caco-2	S-cell_line
cells	O
were	O
used	O
for	O
validation	O
of	O
goat	O
anti-	O
human	S-y
GATA6	S-GP
antibody	O
and	O
NTERA-2	S-cell_line
cells	O
were	O
used	O
for	O
validation	O
of	O
goat	O
anti-	O
human	S-y
Nanog	S-GP
and	O
anti-	O
human	S-y
Oct3/4	S-GP
antibodies	O
(	O
Summarized	O
in	O
Table	O
1	O
)	O
.Table	O
1Summary	O
list	O
of	O
antibody	O
verification	O
by	O
western	O
blot.AntibodySample	O
used	O
for	O
analysisMol	O
.	O

To	O
test	O
if	O
any	O
of	O
the	O
antibodies	O
generated	O
could	O
recognize	O
an	O
extracellular	B-cellcomponent
epitope	E-cellcomponent
and	O
thus	O
be	O
used	O
for	O
live	O
cell	O
sorting	O
,	O
we	O
repeated	O
staining	O
of	O
live	O
cells	O
as	O
previously	O
described	O
.	O

These	O
results	O
suggest	O
that	O
both	O
endodermal	S-x
and	O
mesodermal	B-cell_type
precursors	E-cell_type
exist	O
in	O
EBs	S-x
with	O
FGF	S-GP
withdrawal	O
for	O
8	O
days	O
.	O

Minimal	O
cross-reactivity	O
to	O
mouse	S-y
,	O
measured	O
by	O
10	O
%	O
intensity	O
to	O
human	S-y
by	O
higher	O
than	O
control	O
cells	O
,	O
was	O
observed	O
in	O
mouse	S-y
anti-	O
CD9	S-GP
and	O
mouse	S-y
anti-	O
E-cadherin	S-GP
antibodies	O
.	O

G3PDH	S-GP
was	O
a	O
positive	O
control	O
showing	O
similar	O
amount	O
of	O
RNA	O
samples	O
were	O
used	O
for	O
analysis	O
.	O

)	O
Gt	O
×	O
h	O
Brachyury	S-GP
NoYesNT*Ms	O
×	O
h	O
DPPA5	S-GP
YesNT*NT*ND*Gt	O
×	O
h	O
GATA6	S-GP
NoYesNT*Gt	O
×	O
h	O
Nanog	S-GP
YesDownNoGt	O
×	O
h	O
Oct	B-GP
3/4	E-GP
YesDownYesGt	O
×	O
h	O
PDX-1	S-GP
NoNoYesGt	O
×	O
h	O
SOX17	S-GP
NoYesYesMs	O
×	O
h	O
CD9	S-GP
YesNoMinimal	O
Mouse	B-GP
IgG2B	E-GP
(	O
clone	O
209306	O
)	O
Ms	O
×	O
h	O
E-cadherin	S-GP
YesNoMinimal	O
Mouse	B-GP
IgG2B	E-GP
(	O
clone	O
180224	O
)	O
Ms	O
×	O
h	O
GATA1	S-GP
NoYesNT*	O
Rat	B-GP
IgG2B	E-GP
(	O
clone	O
234732	O
)	O
Ms	O
×	O
h	O
PODXL	S-GP
YesNoNo	O
Mouse	B-GP
IgG2A	E-GP
(	O
clone	O
222328	O
)	O
Ms	O
×	O
h	O
SOX2	S-GP
YesYesYes	O
Mouse	B-GP
IgG2A	E-GP
(	O
clone	O
245610	O
)	O
*NT	O
,	O
Not	O
tested	O
;	O
ND	O
,	O
Not	O
determined	O
.	O

Samples	O
are	O
diluted	O
with	O
1×	O
SDS	O
sample	O
buffer	O
to	O
the	O
desired	O
loading	O
of	O
1–5	O
×	O
103	O
per	O
lane	O
.	O

Unless	O
otherwise	O
noted	O
,	O
EBs	S-x
derived	O
from	O
human	S-y
ES	O
cell	O
aggregates	S-x
were	O
cultured	O
for	O
8	O
days	O
in	O
ES	S-cell_type
culture	O
medium	O
deprived	O
of	O
bFGF	S-GP
and	O
used	O
for	O
analysis	O
by	O
immunohistochemistry	O
as	O
described	O
.	O

Likewise	O
,	O
Nanog	S-GP
has	O
been	O
shown	O
to	O
express	O
in	O
other	O
tissues	O
.	O

Oct3/4	S-GP
for	O
example	O
is	O
expressed	O
by	O
germ	B-cell_type
cells	E-cell_type
and	O
may	O
be	O
expressed	O
by	O
specific	O
populations	O
later	O
in	O
development	O
.	O

A	O
critical	O
amount	O
of	O
Oct3/4	S-GP
and	O
Nanog	S-GP
expression	O
is	O
required	O
to	O
sustain	O
stem-cell	O
pluripotency	O
and	O
both	O
of	O
these	O
markers	O
are	O
downregulated	O
as	O
cells	O
differentiate	O
in	O
vitro	O
and	O
in	O
vivo	O
[	O
4-9	O
]	O
.	O

(	O
C	O
)	O
Immunostaining	O
with	O
goat	O
anti-	O
human	S-y
brachyury	S-GP
(	O
Red	O
)	O
,	O
is	O
contrasted	O
with	O
DAPI	O
nuclear	S-cellcomponent
staining	O
(	O
Blue	O
)	O
.	O

Undifferentiated	O
human	S-y
ES	B-cell_type
cells	E-cell_type
were	O
cultured	O
according	O
to	O
the	O
protocol	O
provided	O
by	O
the	O
University	O
of	O
California	O
,	O
San	O
Francisco	O
in	O
human	S-y
ES	S-cell_type
culture	O
medium	O
[	O
DMEM	O
supplemented	O
with	O
20	O
%	O
KnockOut	O
Serum	O
Replacement	O
(	O
Invitrogen	O
)	O
and	O
5	O
ng/mL	O
of	O
bFGF	S-GP
(	O
R	O
&	O
D	O
Systems	O
)	O
]	O
.	O

Our	O
results	O
confirm	O
the	O
expression	O
pattern	O
and	O
timing	O
of	O
these	O
cell	O
markers	O
at	O
the	O
protein	O
level	O
,	O
whereas	O
previous	O
data	O
reported	O
at	O
the	O
level	O
of	O
gene	O
expression	O
.	O

MG-63	S-cell_line
cells	O
were	O
used	O
for	O
screening	O
mouse	S-y
anti-	O
human	S-y
GATA1	S-GP
(	O
GATA	B-GP
binding	I-GP
protein	I-GP
1	E-GP
)	O
antibody	O
.	O

All	O
polyclonal	O
antibodies	O
were	O
derived	O
from	O
sera	O
of	O
goats	S-y
which	O
had	O
been	O
immunized	O
and	O
boost	O
it	O
with	O
purified	O
antigen	O
.	O

In	O
the	O
case	O
of	O
human	S-y
ESC	O
,	O
they	O
can	O
differentiate	O
into	O
some	O
extra-embryonic	B-cell_type
derivatives	E-cell_type
as	O
well	O
.	O

Although	O
the	O
stem	O
cell	O
concept	O
was	O
introduced	O
decades	O
ago	O
,	O
to	O
date	O
,	O
stem	B-cell_type
cells	E-cell_type
can	O
only	O
be	O
defined	O
functionally	O
,	O
not	O
morphologically	O
or	O
phenotypically	O
.	O

Cloning	O
and	O
expression	O
of	O
Brachyury	S-GP
,	O
DPPA5	S-GP
,	O
CD9	S-GP
,	O
E-Cadherin	S-GP
,	O
GATA1	S-GP
,	O
GATA6	S-GP
,	O
Nanog	S-GP
,	O
Oct3/4	S-GP
,	O
PDX-1	S-GP
,	O
PODXL	S-GP
,	O
SOX2	S-GP
and	O
SOX17	S-GP
Brachyury	S-GP
(	O
aa	O
.	O

2D	O
,	O
2E	O
and	O
2F	O
)	O
.	O

Flow	O
cytometryAntibodies	O
were	O
prepared	O
at	O
the	O
concentration	O
of	O
0.1	O
mg/mL	O
.	O

We	O
and	O
other	O
have	O
noted	O
however	O
,	O
that	O
while	O
no	O
single	O
marker	O
is	O
sufficient	O
a	O
constellation	O
of	O
positive	O
and	O
negative	O
markers	O
can	O
in	O
concert	O
unambiguously	O
allow	O
one	O
to	O
define	O
the	O
state	O
of	O
ESC	O
cultures	O
and	O
that	O
surface	O
markers	O
in	O
combination	O
can	O
be	O
used	O
to	O
prospectively	O
sort	O
for	O
ESC	O
.	O

The	O
specific	O
staining	O
is	O
indicated	O
by	O
green	O
histogram	O
and	O
corresponding	O
isotype	O
control	O
is	O
indicated	O
by	O
black	O
histogram.Suspension	O
culture	O
with	O
FGF	S-GP
withdrawal	O
is	O
known	O
to	O
induce	O
differentiation	O
of	O
ES	B-cell_type
cells	E-cell_type
to	O
all	O
three	O
germ	B-cell_type
layer	I-cell_type
precursors	E-cell_type
[	O
12	O
]	O
.	O

Using	O
these	O
antibodies	O
we	O
have	O
confirmed	O
the	O
specificity	O
and	O
selectivity	O
of	O
these	O
antibodies	O
on	O
several	O
ESC	O
lines	O
and	O
established	O
their	O
utility	O
as	O
stem	O
cells	O
markers	O
.	O

ImmunohistochemistryAntibodies	O
were	O
used	O
with	O
the	O
appropriate	O
secondary	O
reagents	O
at	O
a	O
concentration	O
of	O
5	O
to	O
10	O
μg/ml	O
.	O

After	O
blocking	O
,	O
cells	O
were	O
incubated	O
with	O
diluted	O
primary	O
antibody	O
overnight	O
at	O
4°C	O
followed	O
by	O
coupled	O
anti-	O
mouse	S-y
or	O
anti-goat	O
IgG	S-GP
(	O
Molecular	O
Probes	O
)	O
at	O
room	O
temperature	O
in	O
the	O
dark	O
for	O
an	O
hour	O
.	O

Moreover	O
several	O
of	O
the	O
monoclonal	O
antibodies	O
have	O
differing	O
heavy	O
chain	O
subunits	O
allowing	O
double	O
labeling	O
using	O
subtype	O
specific	O
markers	O
to	O
be	O
performed	O
.	O

Secondly	O
they	O
can	O
differentiate	O
into	O
various	O
progenitor	B-cell_type
cells	E-cell_type
,	O
which	O
commit	O
to	O
further	O
maturation	O
along	O
a	O
specific	O
lineage	O
.	O

Lysates	O
were	O
resolved	O
by	O
SDS-PAGE	O
,	O
transferred	O
to	O
Immobilon-P	O
membrane	O
,	O
and	O
immunoblotted	O
with	O
0.5	O
μg/mL	O
primary	O
Abs	O
as	O
described	O
in	O
R	O
&	O
D	O
Systems	O
Website	O
[	O
15	O
]	O
.	O

However	O
,	O
no	O
PDX-1	S-GP
-positive	O
cells	O
were	O
seen	O
in	O
EBs	S-x
differentiated	O
with	O
the	O
same	O
treatment	O
(	O
data	O
not	O
shown	O
)	O
.Figure	O
4Differentiated	O
EBs	S-cell_type
were	O
analyzed	O
by	O
either	O
immunocytochemistry	O
or	O
RT-PCR	O
to	O
the	O
indicated	O
molecular	O
markers	O
.	O

A	O
subset	O
were	O
also	O
tested	O
by	O
Western	O
Blot	O
analysis	O
using	O
recombinant	O
proteins	O
and	O
cell	O
lysate	O
to	O
confirm	O
binding	O
to	O
a	O
single	O
epitope	O
.	O

Although	O
the	O
functional	O
importance	O
of	O
many	O
of	O
these	O
antigens	O
remains	O
unknown	O
,	O
their	O
unique	O
expression	O
pattern	O
and	O
timing	O
of	O
expression	O
provide	O
a	O
useful	O
tool	O
for	O
scientists	O
to	O
identify	O
as	O
well	O
as	O
isolate	O
stem	B-cell_type
cells	E-cell_type
.	O

When	O
examined	O
by	O
immunohistochemistry	O
,	O
high	O
level	O
of	O
expressions	O
of	O
Oct3/4	S-GP
,	O
SOX2	S-GP
,	O
E-Cadherin	S-GP
,	O
PODXL	S-GP
and	O
Nanog	S-GP
were	O
observed	O
in	O
undifferentiated	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
(	O
Fig	O
.	O

A	O
list	O
of	O
molecules	O
comprised	O
of	O
known	O
ES	S-cell_type
-specific	O
or	O
-highly	O
expressed	O
genes	O
and	O
candidates	O
that	O
can	O
serve	O
as	O
markers	O
for	O
human	B-cell_type
ESCs	E-cell_type
and	O
may	O
also	O
contribute	O
to	O
the	O
``	O
stemness	O
''	O
phenotype	O
has	O
been	O
established	O
[	O
3-11	O
]	O
.	O

Production	O
and	O
purification	O
of	O
antibodiesAll	O
monoclonal	O
antibodies	O
were	O
derived	O
from	O
fusions	O
of	O
mouse	B-x
myeloma	E-x
with	O
B	B-cell_type
cells	E-cell_type
obtained	O
from	O
BALB/c	B-y
mice	E-y
which	O
had	O
been	O
immunized	O
with	O
purified	O
antigen	O
.	O

(	O
D	O
)	O
Immunostaining	O
with	O
mouse	S-y
anti-	O
human	S-y
GATA1	S-GP
(	O
Red	O
)	O
.	O

DPPA5	S-GP
is	O
still	O
being	O
subcloned	O
.	O

Beta-TC6	S-cell_line
cells	O
were	O
used	O
for	O
screening	O
for	O
mouse	S-y
anti-	O
human	S-y
/	O
mouse	S-y
PDX-1	S-GP
(	O
pancreatic	B-GP
duodenal	I-GP
homeobox-1	E-GP
)	O
antibody	O
.	O

10	O
μL	O
of	O
the	O
stock	O
solution	O
was	O
added	O
to	O
1	O
–	O
2.5	O
×	O
105	O
cells	O
in	O
a	O
total	O
reaction	O
volume	O
not	O
exceeding	O
200	O
μL	O
.	O

Like	O
mouse	B-cell_type
ESC	E-cell_type
,	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
can	O
be	O
maintained	O
and	O
propagated	O
on	O
mouse	B-cell_type
fibroblast	E-cell_type
feeders	O
for	O
extended	O
periods	O
in	O
media	O
containing	O
basic	B-GP
fibroblast	I-GP
growth	I-GP
factor	E-GP
(	O
bFGF	S-GP
)	O
[	O
3	O
]	O
.	O

Goat	S-y
anti-	O
Nanog	S-GP
and	O
mouse	S-y
anti-	O
PODXL	S-GP
antibodies	O
appear	O
to	O
be	O
human	S-y
-specific	O
as	O
well	O
(	O
data	O
not	O
shown	O
)	O
.	O

Examination	O
of	O
cross-reactivity	O
of	O
antibodies	O
on	O
mouse	B-cell_type
ES	E-cell_type
and	O
differentiated	O
cellsWe	O
have	O
also	O
examined	O
the	O
cross-reactivities	O
of	O
these	O
antibodies	O
to	O
mouse	B-cell_type
ES	I-cell_type
cells	E-cell_type
using	O
mouse	B-cell_type
D3	I-cell_type
ES	I-cell_type
cell	E-cell_type
line	O
and	O
mouse	S-y
fetal	S-x
endodermal	S-x
tissue	O
.	O

Only	O
Elisa	O
verification	O
is	O
available.2	O
.	O

The	O
CD9	S-GP
,	O
E-Cadherin	S-GP
and	O
PODXL	S-GP
antibodies	O
recognized	O
an	O
extracellular	B-cellcomponent
epitope	E-cellcomponent
and	O
their	O
ability	O
to	O
select	O
cells	O
by	O
FACS	O
was	O
confirmed	O
(	O
Fig	O
.	O

Antibody	O
was	O
purified	O
from	O
the	O
sera	O
by	O
an	O
antigen-affinity	O
chromatography	O
.	O

(	O
A	O
)	O
Immunostaining	O
with	O
goat	O
anti-	O
human	S-y
SOX17	S-GP
(	O
Red	O
)	O
,	O
is	O
contrasted	O
with	O
Fluoro	O
Nissl	O
nuclear	S-cellcomponent
staining	O
(	O
Green	O
)	O
.	O

Note	O
that	O
each	O
antibody	O
recognizes	O
subsets	O
of	O
EB	B-cell_type
cells	E-cell_type
.	O

Western	O
blotCells	O
are	O
solubilized	O
in	O
hot	O
2×	O
SDS	O
gel	O
sample	O
buffer	O
(	O
20	O
mM	O
dithiothreitol	O
,	O
6	O
%	O
SDS	O
,	O
0.25	O
M	O
Tris	O
,	O
pH	O
6.8	O
,	O
10	O
%	O
glycerol	O
,	O
10	O
mM	O
NaF	O
and	O
bromophenyl	O
blue	O
)	O
at	O
2	O
×	O
106	O
per	O
mL	O
.	O

1–202	O
)	O
,	O
DPPA5	S-GP
(	O
a.a.	O
1–116	O
)	O
,	O
GATA1	S-GP
(	O
a.a.	O
1–413	O
)	O
,	O
GATA6	S-GP
(	O
aa	O
.	O

The	O
clone	O
for	O
GATA-1	S-GP
(	O
MAB1779	O
)	O
does	O
not	O
work	O
for	O
Western	O
blot	O
application	O
but	O
is	O
useful	O
for	O
IHC	O
,	O
The	O
clone	O
picked	O
for	O
Western	O
blot	O
analysis	O
does	O
not	O
work	O
for	O
IHC	O
(	O
MAB17791	O
,	O
see	O
data	O
in	O
)	O
.After	O
antibodies	O
were	O
validated	O
in	O
direct	O
ELISAs	O
,	O
Western	O
blot	O
or	O
cell	O
lines	O
(	O
Fig	O
.	O

Antibodies	O
to	O
Oct3/4	S-GP
which	O
cross	O
react	O
with	O
human	B-GP
Oct	I-GP
3/4	E-GP
have	O
been	O
widely	O
used	O
to	O
monitor	O
the	O
presence	O
of	O
undifferentiated	O
ESC	O
.	O

177–414	O
)	O
were	O
expressed	O
in	O
E.	O
Coli	O
and	O
extracellular	O
domains	O
of	O
CD9	S-GP
,	O
E-Cadherin	S-GP
,	O
PODXL	S-GP
were	O
expressed	O
in	O
mouse	B-cell_type
NSO	I-cell_type
cells	E-cell_type
.	O

Two	O
functions	O
define	O
stem	B-cell_type
cells	E-cell_type
.	O

Expressions	O
of	O
SOX17	S-GP
,	O
GATA6	S-GP
,	O
PDX-1	S-GP
,	O
Brachyury	S-GP
and	O
GATA1	S-GP
were	O
not	O
detected	O
in	O
undifferentiated	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
best	O
clone	O
was	O
later	O
screened	O
for	O
its	O
applications	O
for	O
immunocytochemistry	O
and	O
flow	O
cytometry	O
using	O
various	O
cell	O
lines	O
.	O

In	O
summary	O
,	O
we	O
have	O
developed	O
a	O
useful	O
collection	O
of	O
antibodies	O
that	O
would	O
be	O
useful	O
for	O
identification	O
of	O
stem	O
cell	O
characteristics	O
and	O
assessment	O
of	O
differentiation	O
.	O

Cells	O
and	O
cell	O
culture	O
Human	S-y
Caco-2	S-cell_line
,	O
MG-63	S-cell_line
,	O
MCF-7	S-cell_line
,	O
NTERA-2	S-cell_line
and	O
mouse	B-cell_type
D3	I-cell_type
cells	E-cell_type
were	O
purchased	O
from	O
American	O
Type	O
Culture	O
Collection	O
(	O
ATCC	O
)	O
.	O

Note	O
the	O
dramatic	O
downregulation	O
of	O
ESC	O
specific	O
markers	O
(	O
Oct3/4	S-GP
,	O
E-Cadherin	S-GP
,	O
PODXL	S-GP
,	O
and	O
Nanog	S-GP
)	O
in	O
EBs	S-x
.	O

Firstly	O
,	O
they	O
are	O
self-renewing	O
,	O
thus	O
able	O
to	O
propagate	O
to	O
generate	O
additional	O
stem	B-cell_type
cells	E-cell_type
.	O

NTERA-2	S-cell_line
cells	O
were	O
used	O
for	O
screening	O
mouse	S-y
anti-	O
human	S-y
Oct3/4	S-GP
and	O
SOX2	S-GP
(	O
sex-determining	B-GP
region	I-GP
Y-box	I-GP
2	E-GP
)	O
antibodies	O
.	O

Numbers	O
indicate	O
the	O
positions	O
of	O
molecular	O
weight	O
markers.Figure	O
2Undifferentiated	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
(	O
A	O
,	O
B	O
,	O
and	O
C	O
)	O
and	O
differentiated	O
EBs	S-x
(	O
D	O
,	O
E	O
and	O
F	O
)	O
were	O
analyzed	O
using	O
antibodies	O
to	O
indicated	O
molecular	O
markers	O
.	O

The	O
sample	O
was	O
then	O
incubated	O
for	O
20	O
min	O
at	O
2–8	O
°C	O
.	O

1–449	O
)	O
,	O
Nanog	S-GP
(	O
aa	O
.	O

The	O
subtypes	O
of	O
monoclonal	O
antibodies	O
were	O
also	O
identified	O
in	O
the	O
best	O
clones	O
.	O

(	O
E	O
)	O
The	O
differentiation	O
status	O
of	O
EB	O
is	O
detected	O
by	O
RT-PCR	O
using	O
different	O
germ	B-cell_type
layer	I-cell_type
cell	E-cell_type
markers	O
.	O

The	O
PCR	O
primers	O
are	O
available	O
upon	O
request	O
.	O

Wt	O
.	O

2A	O
,	O
2B	O
and	O
2C	O
)	O
.	O

(	O
KD	O
)	O
Gt	O
×	O
h	O
Brachyury	S-GP
mouse	B-cell_type
ES	E-cell_type
-derived	O
EB	O
lysate48Ms	O
×	O
h	O
DPPA5	S-GP
N/AN/AGt	O
×	O
h	O
GATA6	S-GP
Caco2	B-cell_line
cell	E-cell_line
lysate65Gt	O
×	O
h	O
Nanog	S-GP
NTERA-2	B-cell_type
cell	E-cell_type
lysate33Gt	O
×	O
h	O
Oct	B-GP
3/4	E-GP
NTERA-2	B-cell_type
cell	E-cell_type
lysate39Gt	O
×	O
hPDX1	O
beta-TC	B-cell_type
6	I-cell_type
cell	E-cell_type
lysate32Gt	O
×	O
h	O
SOX17	S-GP
mouse	B-cell_type
ES	E-cell_type
-derived	O
EB	O
lysate45Ms	O
×	O
h	O
CD9	S-GP
PBMC	S-cell_type
25Rt	O
×	O
h	O
GATA-1	S-GP
N/AN/AMs	O
×	O
h	O
E-Cadherin	S-GP
MCF-7	B-cell_type
cell	E-cell_type
lysate97Ms	O
×	O
h	O
PODXL	S-GP
MCF-7	B-cell_type
cell	E-cell_type
lysate57Ms	O
×	O
h	O
SOX2	S-GP
NTERA-2	B-cell_type
cell	E-cell_type
lysate36N/A	O
:	O
1	O
.	O

153–305	O
)	O
,	O
Oct3/4	S-GP
(	O
aa	O
.	O

Between	O
each	O
step	O
cells	O
were	O
washed	O
with	O
PBS	O
with	O
0.1	O
%	O
BSA	O
.	O

To	O
induce	O
formation	O
of	O
embryoid	B-x
bodies	E-x
(	O
EBs	S-x
)	O
,	O
ES	S-cell_type
colonies	S-x
were	O
harvested	O
,	O
separated	O
from	O
the	O
MEF	S-cell_type
feeder	B-cell_type
cells	E-cell_type
by	O
gravity	O
,	O
gently	O
resuspended	O
in	O
ES	S-cell_type
culture	S-x
medium	O
and	O
transferred	O
to	O
non-adherent	O
suspension	O
culture	S-x
dishes	O
(	O
Corning	O
)	O
.	O

This	O
work	O
uncovers	O
novel	O
mechanisms	O
of	O
aging	O
within	O
stem	B-x
cell	I-x
niches	E-x
that	O
are	O
evolutionarily	O
conserved	O
between	O
mice	S-y
and	O
humans	S-y
and	O
affect	O
both	O
embryonic	S-x
and	O
adult	B-cell_type
stem	I-cell_type
cells	E-cell_type
.	O

These	O
experiments	O
were	O
carried	O
out	O
in	O
GM	O
.	O

Hoechst	O
(	O
blue	O
)	O
labels	O
nuclei	S-cellcomponent
throughout	O
this	O
figure	O
.	O

4	O
are	O
summarized	O
and	O
presented	O
as	O
mean	O
percentages	O
from	O
experimental	O
replicates	O
±	O
SE	O
.	O

Similarly	O
,	O
hMSCs	S-cell_type
were	O
expanded	O
in	O
6-well	O
plates	O
,	O
lifted	O
with	O
Trypsin	S-GP
/EDTA	O
(	O
Invitrogen	O
)	O
,	O
washed	O
and	O
resuspended	O
in	O
100	O
µL	O
hESC	O
medium	O
.	O

Isolated	O
fibers	O
were	O
resuspended	O
in	O
GM	O
(	O
Ham	O
's	O
F10	O
nutrient	O
mixture	O
(	O
Mediatech	O
,	O
Inc.	O
,	O
Herndon	O
,	O
VA	O
,	O
USA	O
)	O
,	O
20	O
%	O
FBS	O
(	O
Mediatech	O
)	O
,	O
5	O
ng	O
mL−1	O
bFGF	S-GP
(	O
Chemicon	O
,	O
Temecula	O
,	O
CA	O
,	O
USA	O
)	O
and	O
1	O
%	O
Pen-Strep	O
,	O
and	O
cultured	O
on	O
ECM-coated	O
(	O
BD	O
Biosciences	O
,	O
San	O
Jose	O
,	O
CA	O
,	O
USA	O
)	O
plates	O
(	O
diluted	O
1	O
:	O
500	O
in	O
PBS	O
)	O
.	O

After	O
1–5	O
days	O
post-injection	O
,	O
injured	O
or	O
uninjured	O
muscle	O
tissue	O
was	O
dissected	O
out	O
.	O

Moreover	O
,	O
aged	O
systemic	O
milieu	O
had	O
similar	O
inhibitory	O
effects	O
on	O
proliferation	O
of	O
hESCs	S-cell_type
and	O
ASCs	S-cell_type
,	O
suggesting	O
that	O
not	O
only	O
the	O
regenerative	O
capacity	O
,	O
but	O
also	O
the	O
presence	O
and	O
expansion	O
of	O
stem	B-cell_type
cells	E-cell_type
will	O
be	O
significantly	O
restricted	O
in	O
aged	O
organs	O
.	O

Young	O
and	O
old	O
tibialis	B-x
anterior	E-x
and	O
gastrocnemius	S-x
muscles	S-x
were	O
injured	O
by	O
cardiotoxin	O
injection	O
.	O

Namely	O
,	O
while	O
the	O
regenerative	O
capacity	O
,	O
or	O
presence	O
,	O
of	O
hESCs	S-cell_type
is	O
greatly	O
restricted	O
in	O
aged	O
,	O
as	O
compared	O
to	O
young	O
skeletal	B-x
muscle	E-x
(	O
where	O
transplanted	O
cells	O
experience	O
both	O
old	O
systemic	O
and	O
local	O
environments	O
)	O
,	O
embryonic	B-cell_type
cells	E-cell_type
indirectly	O
enhance	O
and	O
rejuvenate	O
muscle	O
repair	O
when	O
introduced	O
at	O
the	O
time	O
of	O
muscle	O
stem	O
cell	O
activation	O
in	O
the	O
host	O
,	O
e.g.	O
,	O
at	O
Day	O
1	O
after	O
the	O
injury	O
(	O
Fig	O
.	O

Furthermore	O
,	O
colonies	O
of	O
hESCs	S-cell_type
in	O
co-cultures	O
with	O
aged	O
myofibers	S-cell_type
typically	O
differentiated	O
into	O
cells	O
with	O
fibroblast	S-cell_type
morphology	O
,	O
which	O
lacked	O
Oct4	S-GP
expression	O
(	O
not	O
shown	O
)	O
.	O

4B	O
)	O
,	O
1.0	O
µm	O
transwell	O
(	O
Corning	O
,	O
NY	O
,	O
USA	O
)	O
co-cultures	O
of	O
uninjured	O
explants	O
with	O
activated	B-cell_type
satellite	I-cell_type
cells	E-cell_type
were	O
established	O
.	O

1	O
)	O
.	O

In	O
contrast	O
,	O
hESC	O
proliferation	O
and	O
Oct4	S-GP
expression	O
are	O
inhibited	O
in	O
the	O
presence	O
of	O
old	O
mouse	S-y
serum	O
,	O
either	O
alone	O
or	O
when	O
mixed	O
with	O
young	O
serum	O
.	O

Myofiber	O
cultures	O
,	O
in	O
which	O
satellite	B-cell_type
cells	E-cell_type
have	O
been	O
activated	O
by	O
injury	O
in	O
vivo	O
,	O
were	O
established	O
from	O
young	O
(	O
2–3	O
months	O
)	O
and	O
old	O
(	O
22–24	O
months	O
)	O
C57-BL/6	O
male	O
mice	S-y
,	O
as	O
previously	O
described	O
(	O
Conboy	O
&	O
Rando	O
,	O
2002	O
;	O
Conboy	O
et	O
al.	O
,	O
2005	O
)	O
.	O

Myogenic	S-x
potential	O
was	O
determined	O
by	O
the	O
ability	O
of	O
satellite	B-cell_type
cells	E-cell_type
to	O
generate	O
proliferating	O
desmin+	O
myoblasts	S-cell_type
(	O
immunodetection	O
shown	O
in	O
green	O
)	O
and	O
by	O
rate	O
of	O
proliferation	O
(	O
2	O
h	O
BrdU	O
incorporation	O
;	O
immunodetection	O
shown	O
in	O
red	O
)	O
.	O

Mixtures	O
of	O
young	O
and	O
old	O
sera	O
were	O
made	O
1	O
:	O
1	O
.	O

hESCs	S-cell_type
were	O
distinguished	O
from	O
mouse	B-cell_type
cells	E-cell_type
by	O
using	O
a	O
species-specific	O
antibody	O
to	O
the	O
cell-surface	O
marker	O
M-cadherin	S-GP
for	O
murine	S-y
and	O
the	O
nuclear	O
marker	O
NuMA	S-GP
for	O
human	B-cell_type
cells	E-cell_type
.	O

3	O
)	O
,	O
suggesting	O
that	O
hESC-produced	O
factors	O
established	O
an	O
embryonic	B-x
microniche	E-x
that	O
may	O
provide	O
temporary	O
protection	O
from	O
the	O
aged	O
environment	O
.	O

Shown	O
are	O
myogenic	S-x
responses	O
of	O
mouse	B-cell_type
cells	E-cell_type
only	O
,	O
judged	O
by	O
lack	O
of	O
immunoreactivity	O
to	O
human-specific/hESC-specific	O
antigens	O
,	O
such	O
as	O
NuMA	S-GP
and	O
Oct4	S-GP
;	O
and	O
presence	O
of	O
mouse	S-y
-specific	O
immunoreactivity	O
,	O
e.g.	O
,	O
M-cadherin	S-GP
(	O
not	O
shown	O
)	O
.	O

Embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
ESCs	S-cell_type
)	O
are	O
distinguished	O
by	O
their	O
ability	O
to	O
self-renew	O
and	O
to	O
differentiate	O
into	O
any	O
other	O
cell	O
type	O
via	O
asymmetric	O
cell	O
divisions	O
,	O
in	O
which	O
one	O
daughter	O
cell	O
maintains	O
‘	O
stemness	O
’	O
while	O
the	O
other	O
daughter	O
cell	O
differentiates	O
into	O
a	O
particular	O
tissue	O
type	O
.	O

An	O
experimental	O
system	O
was	O
developed	O
that	O
(	O
i	O
)	O
provided	O
the	O
ability	O
to	O
study	O
the	O
regenerative	O
response	O
of	O
hESCs	S-cell_type
and	O
of	O
muscle	O
stem	B-cell_type
cells	E-cell_type
in	O
various	O
heterochronic	O
environments	O
in	O
vitro	O
;	O
and	O
(	O
ii	O
)	O
allowed	O
examination	O
of	O
the	O
effects	O
of	O
hESCs	S-cell_type
on	O
muscle	O
repair	O
,	O
in	O
vivo	O
,	O
after	O
transplantation	O
into	O
young	O
vs.	O
old	O
hosts	O
.	O

hMSCs	S-cell_type
were	O
maintained	O
in	O
mesenchymal	B-cell_type
stem	I-cell_type
cell	E-cell_type
GM	O
,	O
MSC-GM™	O
and	O
were	O
cultured	O
according	O
to	O
supplier	O
recommendations	O
(	O
Cambrex	O
Walkersville	O
,	O
MD	O
,	O
USA	O
)	O
.	O

Additionally	O
,	O
de	O
novo	O
myofibers	S-cell_type
in	O
the	O
damaged	O
area	O
appear	O
positive	O
for	O
eMyHC	S-GP
,	O
while	O
undamaged	O
myofibers	S-cell_type
remain	O
negative	O
.	O

In	O
select	O
cultures	O
,	O
10	O
µm	O
BrdU	O
was	O
added	O
for	O
2	O
h	O
prior	O
to	O
fixation	O
.	O

To	O
avoid	O
immune	O
response	O
against	O
hESC	O
antigens	O
,	O
mice	S-y
were	O
immunosuppressed	O
using	O
FK506	O
(	O
Ito	O
&	O
Tanaka	O
,	O
1997	O
;	O
Dumont	O
,	O
2000	O
)	O
.	O

Satellite	B-cell_type
cells	E-cell_type
were	O
cultured	O
for	O
72–96	O
h	O
in	O
the	O
presence	O
of	O
myofiber	S-x
explants	O
and	O
were	O
fixed	O
for	O
immunodetection	O
,	O
as	O
described	O
above	O
.	O

MCM	O
with	O
mouse	S-y
sera	O
at	O
5	O
%	O
gave	O
results	O
similar	O
to	O
those	O
observed	O
with	O
10	O
%	O
young	O
mouse	S-y
sera	O
or	O
in	O
control	O
media	O
(	O
Supplementary	O
Fig	O
.	O

Additionally	O
,	O
in	O
this	O
experimental	O
set-up	O
there	O
was	O
no	O
general	O
inhibitory	O
effect	O
of	O
sera	O
per	O
se	O
on	O
hESC	O
proliferation	O
and	O
Oct4	S-GP
expression	O
,	O
as	O
10	O
%	O
young	O
mouse	S-y
sera	O
(	O
young	O
)	O
and	O
10–20	O
%	O
of	O
FBS	O
(	O
growth	O
medium	O
and	O
DMEM/FBS	O
)	O
allowed	O
for	O
a	O
high	O
rate	O
of	O
cell	O
proliferation	O
and	O
for	O
uniformly	O
high	O
Oct4	S-GP
levels	O
(	O
Fig	O
.	O

To	O
prepare	O
muscle	O
supernatants	O
,	O
explants	O
were	O
cultured	O
for	O
24	O
h	O
in	O
GM	O
and	O
cellular	O
debris	O
was	O
removed	O
from	O
conditioned	O
media	O
by	O
multiple	O
rounds	O
of	O
centrifugation	O
.	O

(	O
D	O
)	O
Satellite	O
cell	O
regenerative	O
potential	O
was	O
quantified	O
as	O
percentage	O
of	O
desmin+/BrdU+	B-cell_type
cell	E-cell_type
s	O
for	O
transwell	O
co-cultures	O
with	O
young	O
or	O
old	O
uninjured	O
myofibers	S-cell_type
(	O
i.e.	O
,	O
RM	O
,	O
resting	O
muscle	O
)	O
.	O

Encouraged	O
by	O
these	O
data	O
,	O
we	O
analyzed	O
the	O
myogenic	S-x
potential	O
of	O
young	O
and	O
old	O
satellite	B-cell_type
cells	E-cell_type
co-cultured	O
with	O
hESCs	S-cell_type
for	O
48	O
h.	O
As	O
shown	O
in	O
Fig	O
.	O

(	O
A	O
)	O
1	O
×	O
105	O
hESCs	S-cell_type
or	O
control	O
hMSCs	S-cell_type
were	O
co-cultured	O
with	O
5	O
×	O
106	O
primary	O
mouse	B-cell_type
myoblasts	E-cell_type
.	O

Importantly	O
,	O
the	O
myogenic	S-x
differentiation	O
of	O
hESCs	S-cell_type
failed	O
in	O
the	O
aged	O
co-cultures	O
(	O
Fig	O
.	O

Similar	O
to	O
the	O
data	O
shown	O
for	O
adult	B-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
ASCs	S-cell_type
)	O
(	O
Fig	O
.	O

M-cadherin+/desmin+	B-cell_type
cell	E-cell_type
s	O
are	O
the	O
myogenic	B-cell_type
progeny	E-cell_type
of	O
mouse	B-cell_type
satellite	I-cell_type
cells	E-cell_type
(	O
yellow	O
arrows	O
)	O
.	O

No	O
such	O
NuMA+/desmin+	O
myofibers	S-cell_type
were	O
detected	O
in	O
aged	O
regenerated	O
muscle	O
(	O
not	O
shown	O
)	O
.In	O
agreement	O
with	O
the	O
in	O
vitro	O
data	O
,	O
establishing	O
that	O
aged	O
systemic	O
and	O
local	O
niches	O
inhibit	O
hESC	O
proliferation	O
and	O
Oct4	S-GP
expression	O
(	O
Figs	O
2	O
and	O
4	O
and	O
Supplementary	O
Fig	O
.	O

Poorly	O
regenerated	O
areas	O
lack	O
new	O
myofibers	S-cell_type
and	O
contain	O
areas	O
of	O
fibrosis	O
and	O
inflammation	O
.	O

Every	O
desmin+	B-cell_type
cell	E-cell_type
in	O
such	O
cultures	O
is	O
a	O
fusion-competent	O
myoblast	O
,	O
and	O
is	O
able	O
to	O
produce	O
multinucleated	B-cell_type
myotubes	E-cell_type
after	O
48	O
h	O
of	O
culture	O
in	O
differentiation-promoting	O
medium	O
[	O
Dulbecco	O
's	O
modified	O
Eagle	O
's	O
medium	O
(	O
DMEM	O
)	O
with	O
2	O
%	O
horse	O
serum	O
]	O
.	O

For	O
heterochronic	O
local	O
organ	O
niche	O
cultures	O
,	O
hESCs	S-cell_type
were	O
co-cultured	O
directly	O
with	O
myofiber	S-x
explants	O
for	O
48	O
h	O
in	O
GM	O
,	O
or	O
were	O
cultured	O
in	O
the	O
presence	O
of	O
supernatants	O
derived	O
from	O
cultured	O
myofiber	S-x
explants	O
for	O
48	O
h	O
(	O
Figs	O
4A	O
and	O
5	O
)	O
.	O

Hoechst	O
(	O
blue	O
)	O
labels	O
nuclei	S-cellcomponent
in	O
all	O
experiments	O
.	O

When	O
myofibers	S-cell_type
are	O
damaged	O
,	O
quiescent	B-cell_type
satellite	I-cell_type
cells	E-cell_type
are	O
activated	O
to	O
proliferate	O
and	O
then	O
differentiate	O
into	O
fusion-competent	B-cell_type
myoblasts	E-cell_type
that	O
continue	O
to	O
proliferate	O
and	O
can	O
form	O
primary	O
cultures	O
,	O
but	O
are	O
also	O
capable	O
of	O
producing	O
new	O
,	O
multinucleated	O
myofibers	S-cell_type
or	O
myotubes	S-cell_type
in	O
vitro	O
and	O
in	O
vivo	O
(	O
Morgan	O
et	O
al.	O
,	O
2002	O
;	O
Collins	O
et	O
al.	O
,	O
2005	O
;	O
Wagers	O
&	O
Conboy	O
,	O
2005	O
)	O
.	O

While	O
many	O
studies	O
have	O
focused	O
on	O
the	O
derivation	O
,	O
propagation	O
,	O
and	O
in	O
vitro	O
differentiation	O
of	O
hESCs	S-cell_type
(	O
reviewed	O
in	O
Hoffman	O
&	O
Carpenter	O
,	O
2005	O
;	O
Wobus	O
&	O
Boheler	O
,	O
2005	O
)	O
,	O
relatively	O
few	O
have	O
examined	O
the	O
properties	O
of	O
these	O
cells	O
and	O
their	O
more	O
differentiated	O
progeny	O
in	O
the	O
aged	O
,	O
as	O
opposed	O
to	O
the	O
young	O
,	O
systemic	O
and	O
local	O
organ	O
environments	O
.	O

WA07	S-cell_line
,	O
obtained	O
from	O
WiCell	O
Research	O
Institue	O
,	O
Madison	O
,	O
WI	O
,	O
USA	O
)	O
,	O
was	O
used	O
in	O
accordance	O
with	O
the	O
UC	O
Berkeley	O
and	O
UC	O
San	O
Francisco	O
Committee	O
on	O
Human	O
Research	O
guidelines	O
,	O
and	O
in	O
accordance	O
with	O
NIH	O
guidelines	O
.	O

Cells	O
were	O
analyzed	O
by	O
immunofluorescence	O
microscopy	O
,	O
using	O
anti-BrdU	O
(	O
red	O
)	O
,	O
anti	O
desmin	S-GP
(	O
green	O
)	O
or	O
anti-	O
Myf5	S-GP
antibodies	O
(	O
green	O
,	O
small	O
panels	O
)	O
.	O

Following	O
permeabilization	O
in	O
PBS	O
,	O
+1	O
%	O
FBS	O
,	O
+0.25	O
%	O
Triton	O
X-100	O
,	O
cells	O
were	O
incubated	O
with	O
primary	O
antibodies	O
(	O
concentration	O
determined	O
as	O
per	O
manufacturer	O
's	O
recommendations	O
)	O
for	O
1	O
h	O
at	O
room	O
temperature	O
in	O
PBS	O
,	O
+1	O
%	O
FBS	O
,	O
washed	O
several	O
times	O
,	O
and	O
then	O
incubated	O
with	O
fluorophore-conjugated	O
,	O
species-specific	O
secondary	O
antibodies	O
(	O
diluted	O
1	O
:	O
500	O
in	O
PBS	O
+	O
1	O
%	O
FBS	O
)	O
for	O
1	O
h	O
at	O
room	O
temperature	O
.	O

Antibody	O
to	O
M-cadherin	S-GP
(	O
clone	O
12G4	O
)	O
was	O
acquired	O
from	O
Upstate	O
Biotechnology	O
(	O
Lake	O
Placid	O
,	O
NY	O
,	O
USA	O
)	O
,	O
and	O
NuMA	S-GP
antibody	O
(	O
Catalog	O
number	O
NA09L	O
)	O
from	O
EMD	O
Biosciences	O
(	O
San	O
Diego	O
,	O
CA	O
,	O
USA	O
)	O
.	O

Multiple	O
,	O
10	O
µm	O
H	O
&	O
E	O
sections	O
were	O
examined	O
through	O
the	O
entire	O
volume	O
of	O
injury	O
in	O
multiple	O
,	O
independently	O
injured	O
muscles	S-x
.	O

For	O
example	O
,	O
in	O
5	O
%	O
+	O
5	O
%	O
conditions	O
,	O
50	O
µL	O
of	O
young	O
and	O
50	O
µL	O
old	O
serum	O
were	O
added	O
to	O
900	O
µL	O
of	O
culture	O
medium	O
(	O
Opti-MEM	O
or	O
MCM	O
,	O
see	O
co-culture	O
procedures	O
below	O
)	O
.	O

5	O
)	O
.	O

Cell	O
transplantation	O
hESCs	S-cell_type
were	O
grown	O
on	O
MEFs	S-cell_type
and	O
expanded	O
in	O
6-well	O
plates	O
.	O

Shown	O
are	O
identical	O
microscope	O
fields	O
at	O
×40	O
magnification	O
.	O

3	O
)	O
,	O
the	O
hESC-produced	O
factors	O
enhanced	O
myogenic	S-cell_type
capacity	O
of	O
even	O
old	O
mouse	S-y
satellite	B-cell_type
cells	E-cell_type
.Establishing	O
that	O
hESC-produced	O
factors	O
enhance	O
adult	O
myogenesis	O
and	O
rejuvenate	O
the	O
regenerative	O
capacity	O
of	O
even	O
aged	O
satellite	B-cell_type
cells	E-cell_type
in	O
vitro	O
prompted	O
us	O
to	O
examine	O
whether	O
the	O
regeneration	O
of	O
old	O
injured	O
muscle	O
will	O
be	O
improved	O
by	O
hESC	O
transplantation	O
in	O
vivo	O
.	O

Both	O
young	O
and	O
old	O
myofiber	S-x
associated	O
satellite	B-cell_type
cells	E-cell_type
exhibited	O
considerable	O
myogenic	S-x
improvement	O
over	O
control	O
conditions	O
.	O

Rate	O
of	O
proliferation	O
(	O
BrdU	O
)	O
and	O
myogenic	S-x
differentiation	O
(	O
desmin	S-GP
)	O
are	O
shown	O
for	O
both	O
ESCs	S-cell_type
and	O
ASCs	S-cell_type
,	O
in	O
the	O
presence	O
of	O
young	O
vs.	O
old	O
differentiated	O
muscle	O
environments	O
(	O
young	O
myofiber	S-x
or	O
old	O
myofiber	O
)	O
.	O

This	O
observation	O
suggests	O
that	O
satellite	B-cell_type
cells	E-cell_type
of	O
young	O
mice	S-y
engage	O
in	O
efficient	O
myogenic	S-x
responses	O
,	O
in	O
part	O
,	O
because	O
the	O
inhibitory	O
influence	O
of	O
old	O
circulatory	O
milieu	O
is	O
absent.These	O
data	O
reveal	O
that	O
the	O
regenerative	O
potential	O
of	O
young	O
muscle	B-cell_type
stem	I-cell_type
cells	E-cell_type
is	O
determined	O
by	O
the	O
age	O
of	O
the	O
systemic	O
milieu	O
,	O
prompting	O
us	O
to	O
investigate	O
whether	O
hESCs	S-cell_type
would	O
similarly	O
succumb	O
to	O
inhibitory	O
factors	O
present	O
in	O
the	O
aged	O
circulation.To	O
determine	O
the	O
effects	O
of	O
aged	O
serum	O
on	O
stem	O
cell	O
self-renewal/pluripotency	O
,	O
we	O
analyzed	O
hESC	O
expression	O
of	O
Oct4	S-GP
and	O
studied	O
the	O
rate	O
of	O
hESC	O
proliferation	O
,	O
by	O
assessing	O
BrdU	O
incorporation	O
(	O
Fig	O
.	O

To	O
mimic	O
the	O
local	O
organ	O
niche	O
for	O
satellite	O
cell	O
assays	O
(	O
Fig	O
.	O

However	O
,	O
while	O
satellite	B-cell_type
cells	E-cell_type
are	O
unable	O
to	O
deter	O
the	O
inhibitory	O
affects	O
of	O
aged	O
systemic	O
and	O
local	O
niches	O
,	O
hESCs	S-cell_type
are	O
capable	O
of	O
antagonizing	O
the	O
aged	O
environments	O
,	O
thereby	O
enhancing	O
the	O
regenerative	O
potential	O
of	O
both	O
young	O
and	O
old	O
muscle	B-cell_type
stem	I-cell_type
cells	E-cell_type
in	O
vitro	O
and	O
in	O
vivo	O
.	O

4A	O
,	O
B	O
)	O
.Interestingly	O
,	O
in	O
addition	O
to	O
the	O
rejuvenating	O
effects	O
of	O
direct	O
co-cultures	O
shown	O
in	O
Fig	O
.	O

The	O
resulting	O
data	O
demonstrate	O
that	O
the	O
composition	O
of	O
conserved	O
extrinsic	O
cues	O
,	O
regulating	O
stem	O
cell	O
responses	O
,	O
becomes	O
altered	O
with	O
age	O
in	O
ways	O
that	O
inhibit	O
both	O
hESCs	S-cell_type
and	O
adult	O
stem	O
cell	O
regenerative	O
potential	O
.	O

The	O
data	O
presented	O
here	O
establish	O
for	O
the	O
first	O
time	O
that	O
both	O
the	O
local	O
environment	O
of	O
old	O
differentiated	O
organ	O
,	O
e.g.	O
,	O
skeletal	B-x
muscle	E-x
and	O
the	O
systemic	O
milieu	O
dramatically	O
affect	O
the	O
regenerative	O
potential	O
of	O
both	O
hESCs	S-cell_type
and	O
mouse	S-y
post-natal	O
myogenic	B-cell_type
progenitor	I-cell_type
cells	E-cell_type
.	O

Specifically	O
,	O
the	O
myogenic	S-x
capacity	O
(	O
generation	O
of	O
desmin	S-GP
+	O
myoblasts	S-cell_type
)	O
was	O
inhibited	O
in	O
young	O
satellite	B-cell_type
cells	E-cell_type
co-cultured	O
in	O
a	O
transwell	O
system	O
with	O
aged	O
myofibers	S-cell_type
(	O
Fig	O
.	O

These	O
differentiated	O
cells	O
are	O
expected	O
to	O
replace	O
their	O
dysfunctional	O
counterparts	O
in	O
vivo	O
.	O

6C	O
)	O
.	O

Immunodetection	O
of	O
BrdU	O
and	O
Oct4	S-GP

Intriguingly	O
,	O
these	O
experiments	O
also	O
hinted	O
at	O
a	O
small	O
but	O
persistent	O
inhibitory	O
effect	O
of	O
the	O
aged	O
systemic	O
milieu	O
on	O
the	O
performance	O
of	O
young	O
stem	B-cell_type
cells	E-cell_type
.	O

Isolated	O
hESCs	S-cell_type
were	O
washed	O
several	O
times	O
and	O
resuspended	O
in	O
100	O
µL	O
hESC	O
medium	O
.	O

Antibodies	O
to	O
Oct4	S-GP
were	O
used	O
as	O
a	O
marker	O
of	O
hESC	O
self-renewal/pluripotency	O
.	O

(	O
B	O
)	O
Quantification	O
of	O
muscle	O
regeneration	O
was	O
performed	O
by	O
analyzing	O
the	O
density	O
of	O
newly	O
formed	O
myofibers	S-cell_type
per	O
mm2	O
of	O
injury	O
site	O
,	O
which	O
is	O
the	O
volume	O
that	O
typically	O
covers	O
the	O
whole	O
injured	O
area	O
.	O

hESCs	S-cell_type
or	O
hMSCs	S-cell_type
were	O
transplanted	O
at	O
the	O
site	O
of	O
injury	O
and	O
were	O
analyzed	O
by	O
cryosectioning	O
at	O
Day	O
5	O
after	O
injury	O
(	O
as	O
described	O
in	O
Experimental	O
procedures	O
)	O
.	O

Quantification	O
of	O
desmin	S-GP
+/BrdU+	O
hESCs	S-cell_type
in	O
direct	O
myofiber	S-x
cocultures	O
,	O
or	O
with	O
muscle	O
supernatants	O
,	O
is	O
shown	O
in	O
(	O
B	O
)	O
.	O

In	O
addition	O
,	O
hESC	O
and	O
ASC	O
proliferation	O
(	O
BrdU	O
incorporation	O
)	O
was	O
also	O
inhibited	O
by	O
aged	O
differentiated	O
muscle	O
(	O
Fig	O
.	O

Regenerative	S-cell_type
responses	O
of	O
adult	B-cell_type
muscle	I-cell_type
stem	I-cell_type
cells	E-cell_type
and	O
hESCs	S-cell_type
are	O
dominantly	O
inhibited	O
by	O
the	O
aged	O
systemic	O
milieuPrevious	O
work	O
established	O
that	O
the	O
upregulation	O
of	O
repair-specific	O
molecular	O
signaling	O
mechanisms	O
,	O
such	O
as	O
Notch	S-GP
,	O
and	O
successful	O
engagement	O
of	O
resident	O
muscle	B-cell_type
stem	I-cell_type
cells	E-cell_type
in	O
tissue	O
repair	O
are	O
largely	O
determined	O
by	O
the	O
age	O
of	O
the	O
systemic	O
milieu	O
,	O
rather	O
than	O
by	O
the	O
cell-autonomous	O
age	O
of	O
muscle	B-cell_type
cells	E-cell_type
,	O
or	O
by	O
the	O
differences	O
in	O
their	O
numbers	O
(	O
Conboy	O
&	O
Rando	O
,	O
2005	O
;	O
Conboy	O
et	O
al.	O
,	O
2005	O
)	O
.	O

Heterochronic	O
co-culture	O
systemsHeterochronic	O
systemic	O
cultures	O
were	O
established	O
by	O
culturing	O
myofiber	S-x
explants	O
(	O
in	O
GM	O
)	O
or	O
hESCs	S-cell_type
(	O
in	O
MCM	O
)	O
in	O
the	O
presence	O
of	O
young	O
,	O
old	O
or	O
young	O
+	O
old	O
sera	O
for	O
48	O
h	O
(	O
Figs	O
1	O
and	O
2	O
and	O
Supplementary	O
Figs	O
S1–3	O
)	O
.	O

Briefly	O
,	O
hESCs	S-cell_type
grown	O
on	O
MEFs	S-cell_type
were	O
cultured	O
in	O
standard	O
hESC	O
medium	O
[	O
Knockout™	O
DMEM	O
,	O
20	O
%	O
KSR	O
,	O
1	O
%	O
NEAA	O
,	O
1	O
mm	O
l-glutamine	O
(	O
Invitrogen	O
)	O
,	O
0.1	O
mmβ-mercaptoethanol	O
(	O
Sigma	O
)	O
]	O
and	O
were	O
supplemented	O
with	O
4	O
ng	O
mL−1	O
hbFGF	S-GP
(	O
Invitrogen	O
)	O
.	O

Most	O
cells	O
in	O
control	O
cultures	O
or	O
young	O
conditions	O
expressed	O
high	O
levels	O
of	O
this	O
marker	O
of	O
‘	O
stemness	O
’	O
,	O
and	O
maintained	O
their	O
normal	O
phenotype	O
and	O
morphology	O
throughout	O
the	O
various	O
co-culture	O
experiments	O
performed	O
in	O
this	O
study	O
(	O
see	O
below	O
)	O
.Fig	O
.	O

Myofibers	S-cell_type
with	O
associated	O
satellite	B-cell_type
cells	E-cell_type
were	O
isolated	O
from	O
young	O
and	O
old	O
injured	O
muscle	S-cell_type
,	O
and	O
were	O
directly	O
co-cultured	O
with	O
hESCs	S-cell_type
in	O
typical	O
hESC	O
differentiation	O
medium	O
(	O
DMEM/FBS	O
)	O
.	O

hESCs	S-cell_type
and	O
hMSCs	S-cell_type
were	O
typically	O
seeded	O
onto	O
chambered	O
slides	O
coated	O
with	O
a	O
3	O
%	O
GFR	O
Matrigel™	O
(	O
BD	O
Biosciences	O
)	O
substrate	O
in	O
PBS	O
.	O

In	O
summary	O
,	O
while	O
the	O
myogenic	S-x
potential	O
(	O
production	O
of	O
desmin	S-GP
+	O
fusion-competent	O
cells	O
)	O
was	O
more	O
pronounced	O
in	O
young	O
vs.	O
old	O
myofiber	S-x
-associated	O
satellite	B-cell_type
cells	E-cell_type
under	O
all	O
experimental	O
conditions	O
,	O
a	O
finding	O
that	O
is	O
consistent	O
with	O
previous	O
data	O
(	O
Conboy	O
et	O
al.	O
,	O
2003	O
)	O
,	O
a	O
clear	O
increase	O
in	O
myogenic	S-cell_type
potential	O
of	O
old	O
satellite	B-cell_type
cells	E-cell_type
was	O
noted	O
in	O
co-cultures	O
with	O
hESCs	S-cell_type
,	O
as	O
compared	O
to	O
control	O
cultures	O
devoid	O
of	O
hESCs	S-cell_type
(	O
Fig	O
.	O

This	O
finding	O
validates	O
several	O
technical	O
aspects	O
of	O
these	O
experiments	O
,	O
and	O
confirms	O
the	O
contrasting	O
effects	O
of	O
young	O
and	O
old	O
systemic	O
and	O
local	O
organ	O
niches	O
on	O
hESC	O
self-renewal.These	O
data	O
further	O
confirm	O
and	O
extrapolate	O
our	O
findings	O
and	O
demonstrate	O
that	O
when	O
exposed	O
to	O
both	O
aged	O
systemic	O
and	O
local	O
organ	O
niches	O
,	O
hESCs	S-cell_type
fail	O
to	O
persist	O
and	O
do	O
not	O
contribute	O
to	O
tissue	O
repair	O
directly	O
.	O

Therefore	O
,	O
despite	O
their	O
general	O
neoorganogenesis	O
potential	O
,	O
the	O
ability	O
of	O
hESCs	S-cell_type
,	O
and	O
the	O
more	O
differentiated	O
myogenic	B-cell_type
ASCs	E-cell_type
to	O
contribute	O
to	O
tissue	O
repair	O
in	O
the	O
old	O
will	O
be	O
greatly	O
restricted	O
due	O
to	O
the	O
conserved	O
inhibitory	O
influence	O
of	O
aged	O
differentiated	O
niches	O
.	O

Results	O
for	O
5	O
%	O
young	O
mouse	S-y
sera	O
are	O
very	O
similar	O
to	O
those	O
for	O
10	O
%	O
young	O
mouse	S-y
sera	O
and	O
are	O
shown	O
in	O
Fig	O
.	O

Approximately	O
5	O
×	O
105	O
hESCs	S-cell_type
or	O
hMSCs	S-cell_type
were	O
injected	O
into	O
24	O
h	O
post-injured	O
gastrocnemius	S-x
and	O
tibialis	O
anterior	O
muscles	S-x
of	O
young	O
and	O
old	O
mice	S-y
,	O
using	O
a	O
21-gauge	O
needle	O
.	O

At	O
least	O
three	O
independent	O
experiments	O
produced	O
similar	O
results	O
.	O

4A	O
,	O
white	O
arrow	O
in	O
old	O
)	O
.	O

hESCs	S-cell_type
expressing	O
Oct4	S-GP
(	O
immunodetection	O
shown	O
in	O
red	O
)	O
dramatically	O
enhanced	O
myotube	O
formation	O
of	O
co-cultured	O
mouse	B-cell_type
myoblasts	E-cell_type
(	O
immunodetection	O
of	O
eMyHC	S-GP
is	O
shown	O
in	O
green	O
)	O
,	O
as	O
compared	O
to	O
co-cultures	O
between	O
mouse	B-cell_type
myoblasts	E-cell_type
and	O
human	B-cell_type
mesenchymal	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
Mb	S-cell_type
+	O
hMSCs	S-cell_type
)	O
or	O
myoblasts	S-cell_type
alone	O
(	O
Mb	S-cell_type
alone	O
)	O
.	O

As	O
expected	O
,	O
the	O
young	O
mouse	B-cell_type
muscle	I-cell_type
progenitor	I-cell_type
cells	E-cell_type
(	O
M-cadherin	S-GP
+/	O
desmin	S-GP
+	O
)	O
were	O
more	O
advanced	O
in	O
their	O
degree	O
of	O
myogenic	S-x
differentiation	O
,	O
which	O
was	O
of	O
skeletal	B-x
muscle	I-x
lineage	E-x
,	O
as	O
judged	O
by	O
the	O
formation	O
of	O
large	O
,	O
multinucleated	B-cell_type
de	I-cell_type
novo	I-cell_type
myotubes	E-cell_type
(	O
yellow	O
arrow	O
in	O
young	O
)	O
.	O

Importantly	O
,	O
the	O
similar	O
inhibitory	O
effects	O
of	O
old	O
mouse	S-y
serum	O
and	O
old	O
myofibers	S-cell_type
on	O
satellite	O
cell	O
(	O
Figs	O
1	O
and	O
4C	O
)	O
and	O
hESC	O
(	O
Figs	O
2	O
and	O
4A	O
)	O
proliferation	O
and	O
regenerative	O
capacity	O
suggest	O
the	O
conservation	O
of	O
elements	O
in	O
age-specific	O
extrinsic	O
regulatory	O
mechanisms	O
between	O
evolutionarily	O
distinct	O
species	O
and	O
stem	B-cell_type
cel	E-cell_type
l	O
types	O
.	O

eMyHC	S-GP
immunodetection	O
is	O
specific	O
for	O
regenerating	O
areas	O
of	O
muscle	O
only	O
.	O

First	O
,	O
in	O
heterochronic	O
tissue-transplantation	O
studies	O
,	O
the	O
age	O
of	O
the	O
host	O
environment	O
determined	O
the	O
regenerative	O
outcome	O
,	O
as	O
both	O
young	O
and	O
old	O
skeletal	B-x
muscle	E-x
explants	O
containing	O
differentiated	O
and	O
precursor	B-cell_type
cells	E-cell_type
effectively	O
regenerated	O
in	O
young	O
,	O
but	O
not	O
in	O
old	O
animals	O
(	O
Zacks	O
&	O
Sheff	O
,	O
1982	O
;	O
Carlson	O
&	O
Faulkner	O
,	O
1989	O
)	O
.	O

Similar	O
data	O
was	O
obtained	O
by	O
using	O
another	O
myogenic	S-x
marker	O
,	O
Pax7	S-GP
(	O
Supplementary	O
Fig	O
.	O

4A	O
)	O
.	O

Thus	O
,	O
we	O
sought	O
to	O
determine	O
whether	O
key	O
molecular	O
identifiers	O
of	O
stem	O
cell	O
properties	O
,	O
the	O
rate	O
of	O
cell	O
proliferation	O
,	O
and	O
the	O
myogenic	S-x
capacity	O
would	O
be	O
influenced	O
by	O
the	O
age	O
of	O
extrinsic	O
milieu	O
,	O
regardless	O
of	O
whether	O
stem	B-cell_type
cells	E-cell_type
are	O
embryonic	S-x
or	O
the	O
more	O
differentiated	O
,	O
muscle-specific	B-cell_type
satellite	I-cell_type
cells	E-cell_type
.	O

Activated-by-injury	O
(	O
24	O
h	O
post-injury	O
)	O
satellite	B-cell_type
cells	E-cell_type
were	O
seeded	O
onto	O
ECM-coated	O
12-well	O
plates	O
in	O
Opti-MEM	O
(	O
Invitrogen	O
)	O
and	O
5	O
%	O
FBS	O
.	O

5	O
,	O
soluble	O
factors	O
present	O
in	O
hESC-conditioned	O
culture	O
supernatants	O
were	O
also	O
able	O
to	O
enhance	O
myogenesis	O
of	O
aged	O
satellite	B-cell_type
cells	E-cell_type
(	O
Supplementary	O
Fig	O
.	O

Quantification	O
of	O
multiple	O
independent	O
experiments	O
has	O
demonstrated	O
that	O
hESC	O
expression	O
of	O
Oct4	S-GP
and	O
BrdU	O
incorporation	O
have	O
been	O
reduced	O
by	O
two-	O
to	O
threefold	O
in	O
the	O
aged	O
milieu	O
(	O
Fig	O
.	O

Muscle	S-x
was	O
isolated	O
5	O
days	O
post-injury	O
,	O
when	O
nascent	O
differentiated	O
myofibers	S-cell_type
normally	O
replace	O
the	O
damaged	O
tissue	O
(	O
Conboy	O
et	O
al.	O
,	O
2003	O
)	O
,	O
and	O
10	O
µm	O
cryosections	O
were	O
analyzed	O
for	O
the	O
success	O
in	O
tissue	O
repair	O
using	O
hematoxylin	O
and	O
eosin	O
(	O
H	O
&	O
E	O
)	O
histochemistry	O
and	O
eMyHC	S-GP
immunodetection	O
.	O

Not	O
only	O
are	O
the	O
factors	O
promoting	O
myogenic	S-x
differentiation	O
and	O
proliferation	O
of	O
hESCs	S-cell_type
likely	O
to	O
become	O
depleted	O
with	O
age	O
,	O
but	O
the	O
aged	O
systemic	O
and	O
local	O
organ	O
niches	O
are	O
likely	O
to	O
contain	O
dominant	O
inhibitors	O
of	O
ASC	O
and	O
hESC	O
regenerative	O
potential	O
(	O
Figs	O
1	O
,	O
2	O
,	O
and	O
4	O
,	O
summarized	O
in	O
Tables	O
1	O
and	O
2	O
)	O
.	O

Specifically	O
,	O
we	O
have	O
examined	O
the	O
effects	O
of	O
aged	O
muscle	O
and	O
systemic	O
niches	O
on	O
key	O
molecular	O
identifiers	O
of	O
regenerative	O
potential	O
of	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hESCs	S-cell_type
)	O
and	O
post-natal	B-cell_type
muscle	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
satellite	B-cell_type
cells	E-cell_type
)	O
.	O

As	O
such	O
,	O
the	O
use	O
of	O
hESCs	S-cell_type
is	O
particularly	O
important	O
,	O
due	O
to	O
the	O
fact	O
that	O
adult	B-cell_type
organ	I-cell_type
stem	I-cell_type
cells	E-cell_type
are	O
often	O
limited	O
in	O
number	O
,	O
cell-fate	O
plasticity	O
,	O
expansion	O
capacity	O
,	O
telomere	S-cellcomponent
length	O
,	O
and	O
lifespan	O
(	O
Mayhall	O
et	O
al.	O
,	O
2004	O
)	O
.	O

Cell	O
commitment	O
to	O
this	O
differentiation	O
program	O
was	O
assessed	O
by	O
the	O
efficiency	O
of	O
myotube	O
formation	O
,	O
estimated	O
by	O
the	O
number	O
of	O
nuclei	S-cellcomponent
per	O
myotube	O
.	O

1The	O
age	O
of	O
sera	O
determined	O
the	O
regenerative	O
potential	O
of	O
satellite	B-cell_type
cells	E-cell_type
.	O

It	O
appears	O
that	O
satellite	B-cell_type
cells	E-cell_type
do	O
not	O
have	O
such	O
anti-aging	O
ability	O
,	O
because	O
despite	O
an	O
initial	O
activation	O
in	O
entirely	O
young	O
environments	O
,	O
e.g.	O
,	O
after	O
muscle	S-y
injury	O
to	O
young	O
muscle	O
,	O
isolated	O
satellite	B-cell_type
cells	E-cell_type
remain	O
susceptible	O
to	O
inhibition	O
by	O
the	O
old	O
mouse	S-y
serum	O
(	O
Figs	O
1	O
and	O
4C	O
)	O
.	O

5A	O
)	O
.	O

6A	O
and	O
quantified	O
in	O
6B	O
,	O
injection	O
of	O
hESCs	S-cell_type
significantly	O
enhanced	O
regeneration	O
of	O
skeletal	B-x
muscle	E-x
.	O

Again	O
,	O
the	O
inhibitory	O
factors	O
in	O
the	O
aged	O
milieu	O
were	O
dominant	O
over	O
the	O
young	O
,	O
as	O
evidenced	O
by	O
a	O
decline	O
in	O
Oct4	S-GP
expression	O
,	O
the	O
low	O
rate	O
of	O
BrdU	O
incorporation	O
,	O
and	O
Ki67	S-GP
expression	O
in	O
young	O
and	O
old	O
mixed	O
environments	O
(	O
5	O
%	O
young	O
+	O
5	O
%	O
old	O
sera	O
in	O
MCM	O
)	O
.	O

Control	O
co-cultures	O
of	O
these	O
satellite	B-cell_type
cells	E-cell_type
with	O
hMSCs	S-cell_type
displayed	O
no	O
enhanced	O
myogenicity	O
.	O

In	O
contrast	O
,	O
when	O
co-cultured	O
with	O
hMSCs	S-cell_type
,	O
myotube	O
formation	O
was	O
no	O
greater	O
than	O
in	O
myoblast	O
cultures	O
alone	O
(	O
Fig	O
.	O

4A	O
)	O
.	O

2	O
,	O
control	O
medium	O
)	O
.	O

The	O
scope	O
of	O
disorders	O
that	O
can	O
be	O
potentially	O
treated	O
with	O
a	O
neoorganogenesis	O
approach	O
is	O
large	O
and	O
includes	O
many	O
that	O
are	O
currently	O
incurable	O
,	O
such	O
as	O
muscle	S-y
atrophy	O
,	O
diabetes	O
,	O
Alzheimer	O
's	O
disease	O
,	O
Parkinson	O
's	O
disease	O
,	O
and	O
other	O
degenerative	O
diseases	O
that	O
often	O
accompany	O
huma	S-y
n	O
aging	O
(	O
McDonald	O
et	O
al.	O
,	O
1999	O
;	O
Liu	O
et	O
al.	O
,	O
2000	O
;	O
Hori	O
et	O
al.	O
,	O
2002	O
;	O
Kim	O
et	O
al.	O
,	O
2002	O
;	O
Blyszczuk	O
et	O
al.	O
,	O
2003	O
)	O
.	O

In	O
any	O
case	O
,	O
the	O
virtual	O
lack	O
of	O
hESC	O
and	O
hMSC	O
direct	O
contribution	O
to	O
the	O
newly	O
regenerated	O
skeletal	B-x
muscle	E-x
,	O
when	O
small	O
numbers	O
of	O
these	O
cells	O
were	O
injected	O
into	O
injured	O
tissue	O
,	O
is	O
completely	O
consistent	O
with	O
the	O
body	O
of	O
previous	O
data	O
demonstrating	O
that	O
myofiber	S-cellcomponent
-associated	O
satellite	B-cell_type
cells	E-cell_type
conduct	O
rapid	O
and	O
robust	O
muscle	O
repair	O
and	O
greatly	O
outnumber	O
injected	O
human	O
cells	O
(	O
Collins	O
et	O
al.	O
,	O
2005	O
;	O
Wagers	O
&	O
Conboy	O
,	O
2005	O
)	O
;	O
that	O
compared	O
to	O
muscle-specific	O
satellite	O
cells	O
,	O
the	O
myogenic	S-x
differentiation	O
of	O
hESCs	S-cell_type
in	O
vitro	O
remains	O
very	O
small	O
(	O
Fig	O
.	O

BrdU	O
was	O
added	O
for	O
the	O
last	O
2	O
h	O
of	O
culture	O
to	O
measure	O
the	O
rate	O
of	O
cell	O
proliferation	O
.	O

The	O
absence	O
of	O
cells	O
was	O
confirmed	O
by	O
microscopic	O
examination	O
.	O

Thus	O
,	O
the	O
indirect	O
beneficial	O
effects	O
of	O
hESCs	S-cell_type
on	O
tissue	O
repair	O
are	O
unlikely	O
to	O
be	O
compromised	O
by	O
the	O
oncogenic	S-x
properties	O
of	O
these	O
embryonic	B-cell_type
cells	E-cell_type
in	O
the	O
context	O
of	O
old	O
skeletal	B-x
muscle	E-x
.	O

The	O
effects	O
of	O
heterochronic	O
systemic	O
milieu	O
on	O
myogenic	S-x
potential	O
were	O
examined	O
as	O
generation	O
of	O
proliferating	O
myoblasts	S-cell_type
that	O
express	O
desmin	S-GP
and	O
Myf5	S-GP
,	O
and	O
that	O
spontaneously	O
form	O
multinucleated	B-cell_type
nascent	I-cell_type
myotubes	E-cell_type
.	O

Co-culture	O
with	O
hESCs	S-cell_type
(	O
myofiber	S-x
+	O
hESC	O
)	O
,	O
but	O
not	O
hMSCs	S-cell_type
(	O
myofiber	S-x
+	O
hMSC	O
)	O
or	O
control	O
medium	O
(	O
DMEM/FBS	O
)	O
,	O
greatly	O
enhanced	O
the	O
myogenic	S-x
potential	O
of	O
both	O
young	O
and	O
old	O
myofiber-associated	B-cell_type
satellite	I-cell_type
cells	E-cell_type
,	O
based	O
on	O
immunodetection	O
of	O
percentage	O
of	O
desmin	S-GP
+	O
de	O
novo	O
generated	O
myoblasts	S-cell_type
and	O
multinucleated	B-cell_type
myotubes	E-cell_type
.	O

2	O
)	O
and	O
Ki67	S-GP
expression	O
(	O
Supplementary	O
Fig	O
.	O

As	O
summarized	O
in	O
Table	O
1	O
,	O
aged	O
mouse	S-y
sera	O
similarly	O
affected	O
the	O
expression	O
of	O
key	O
molecular	O
identifiers	O
of	O
both	O
embryonic	S-x
and	O
adult	B-cell_type
stem	I-cell_type
cells	E-cell_type
,	O
e.g.	O
,	O
Oct4	S-GP
in	O
hESCs	S-cell_type
and	O
Myf5	S-GP
in	O
mouse	B-cell_type
ASCs	E-cell_type
.	O

To	O
propagate	O
hESCs	S-cell_type
,	O
routine	O
culturing	O
and	O
maintenance	O
was	O
performed	O
using	O
standard	O
in	O
vitro	O
conditions	O
for	O
both	O
feeder	S-cell_type
-dependent	O
and	O
feeder	S-cell_type
-free	O
cultures	O
(	O
Geron	O
Corporation	O
,	O
2002	O
)	O
.	O

(	O
A	O
)	O
As	O
opposed	O
to	O
immediate	O
exposure	O
to	O
old	O
mouse	S-y
serum	O
after	O
passaging	O
(	O
10	O
%	O
old	O
)	O
,	O
preculturing	O
of	O
hESCs	S-cell_type
for	O
24	O
h	O
in	O
feeder	S-cell_type
-free	O
conditions	O
,	O
e.g.	O
,	O
Matrigel™	O
+	O
MCM	O
,	O
prior	O
to	O
replacing	O
MCM	O
with	O
MCM	O
+	O
10	O
%	O
old	O
mouse	S-y
sera	O
,	O
resulted	O
in	O
continuously	O
high	O
BrdU	O
incorporation	O
and	O
Oct4	S-GP
expression	O
(	O
embryonic	B-x
microniche	E-x
+	O
10	O
%	O
old	O
)	O
.	O

(	O
*	O
)	O
indicates	O
P≤	O
0.001	O
as	O
compared	O
to	O
young	O
sera.Importantly	O
,	O
it	O
was	O
not	O
simply	O
the	O
dilution	O
of	O
young	O
serum	O
factors	O
that	O
resulted	O
in	O
diminished	O
myogenic	S-x
capacity	O
when	O
young	O
and	O
old	O
sera	O
were	O
mixed	O
,	O
because	O
young	O
sera	O
promoted	O
robust	O
myogenesis	S-x
both	O
at	O
10	O
%	O
and	O
5	O
%	O
.	O

Samples	O
were	O
analyzed	O
at	O
room	O
temperature	O
by	O
using	O
a	O
Zeiss	O
Axioscope	O
40	O
fluorescent	O
microscope	O
,	O
and	O
imaged	O
with	O
an	O
Axiocan	O
MRc	O
camera	O
and	O
AxioVision	O
software	O
.	O

Animal	O
strainsYoung	O
(	O
2–3	O
months	O
)	O
,	O
C57-BL/6	O
male	O
mice	S-y
were	O
obtained	O
from	O
pathogen-free	O
breeding	O
colonies	O
at	O
Jackson	O
Laboratories	O
(	O
Bar	O
Harbor	O
,	O
ME	O
,	O
USA	O
)	O
.	O

It	O
remains	O
to	O
be	O
determined	O
whether	O
the	O
percentage	O
of	O
hESCs	S-cell_type
direct	O
contribution	O
to	O
desmin	S-cellcomponent
+	O
myofibers	S-cell_type
in	O
young	O
muscle	O
will	O
be	O
increased	O
by	O
transplanting	O
these	O
cells	O
at	O
a	O
different	O
time-point	O
after	O
muscle	O
injury	O
,	O
e.g.	O
,	O
at	O
Days	O
3–5	O
(	O
as	O
in	O
co-cultures	O
with	O
myofibers	S-cell_type
pre-injured	O
for	O
3	O
days	O
,	O
Fig	O
.	O

Animals	O
were	O
maintained	O
in	O
the	O
North-West	O
Animal	O
Facility	O
of	O
the	O
University	O
of	O
California	O
,	O
Berkeley	O
,	O
CA	O
,	O
USA	O
,	O
and	O
handled	O
in	O
accordance	O
with	O
the	O
Administrative	O
Panel	O
on	O
Laboratory	O
Animal	O
Care	O
at	O
UC	O
Berkeley	O
.	O

Similar	O
results	O
are	O
shown	O
for	O
Pax7	S-GP
immunodetection	O
(	O
Supplementary	O
Fig	O
.	O

First	O
,	O
we	O
examined	O
the	O
effects	O
of	O
hESCs	S-cell_type
on	O
myotube	O
generation	O
by	O
co-culture	O
with	O
primary	O
myoblasts	S-cell_type
freshly	O
derived	O
from	O
activated-by-injury	O
satellite	B-cell_type
cells	E-cell_type
(	O
Conboy	O
et	O
al.	O
,	O
2003	O
)	O
.	O

S4	O
)	O
.In	O
contrast	O
,	O
when	O
co-cultured	O
with	O
the	O
aged	O
mouse	B-cell_type
myofibers	E-cell_type
,	O
only	O
mouse	B-cell_type
cells	E-cell_type
appeared	O
desmin	S-GP
+	O
(	O
Fig	O
.	O

The	O
myogenic	B-cell_type
progeny	E-cell_type
of	O
hESCs	S-cell_type
appears	O
M-cadherin	S-GP
−/	O
desmin	S-GP
+	O
(	O
white	O
arrow	O
in	O
young	O
)	O
,	O
as	O
opposed	O
to	O
M-cadherin	S-GP
−/	O
desmin	S-GP
−	O
hESCs	S-cell_type
that	O
lack	O
myogenic	S-x
commitment	O
(	O
white	O
arrow	O
in	O
old	O
)	O
.	O

Identification	O
of	O
these	O
embryonic	S-x
factors	O
would	O
allow	O
us	O
to	O
potentially	O
enrich	O
the	O
arsenal	O
of	O
therapeutic	O
tools	O
for	O
combating	O
age-specific	O
degenerative	O
disorders	O
.	O

Both	O
assays	O
showed	O
dramatic	O
enhancement	O
of	O
muscle	O
regeneration	O
in	O
‘	O
old	O
+	O
hESC	O
’	O
vs.	O
‘	O
old	O
+	O
hMSC	O
’	O
.	O

*	O
indicates	O
P≤	O
0.001	O
as	O
compared	O
to	O
young	O
.	O

(	O
B	O
)	O
Three	O
independent	O
experiments	O
yielded	O
similar	O
results	O
and	O
were	O
quantified	O
as	O
percentage	O
of	O
BrdU+/	O
Oct4	S-GP
+	O
for	O
each	O
condition	O
.	O

4B	O
)	O
.	O

Immunostaining	O
was	O
performed	O
in	O
the	O
manner	O
described	O
above	O
,	O
or	O
H	O
&	O
E	O
staining	O
of	O
cryosections	O
was	O
performed	O
.	O

To	O
test	O
these	O
hypotheses	O
,	O
we	O
injected	O
5	O
×	O
105	O
hESCs	S-cell_type
or	O
control	O
hMSCs	S-cell_type
into	O
the	O
tibialis	B-x
anterior	E-x
(	O
TA	S-x
)	O
and	O
gastrocnemius	B-x
muscles	E-x
of	O
young	O
and	O
old	O
mice	S-y
at	O
24	O
h	O
after	O
cardiotoxin-induced	O
injury	O
,	O
when	O
activation/proliferation	O
of	O
endogenous	O
satellite	B-cell_type
cells	E-cell_type
normally	O
begins	O
(	O
Conboy	O
et	O
al.	O
,	O
2003	O
,	O
2005	O
;	O
Wagers	O
&	O
Conboy	O
,	O
2005	O
)	O
.	O

Myofiber	S-x
explant	O
culturesExplant	O
and	O
primary	B-cell_type
cell	E-cell_type
cultures	O
were	O
generated	O
from	O
C57-BL/6	O
mice	S-y
,	O
as	O
previously	O
described	O
(	O
Conboy	O
&	O
Rando	O
,	O
2002	O
;	O
Conboy	O
et	O
al.	O
,	O
2003	O
)	O
.	O

S1	O
)	O
.	O

S2	O
)	O
.	O

2	O
)	O
.	O

1	O
(	O
ASCs	S-cell_type
)	O
and	O
Supplementary	O
Fig	O
.	O

Additionally	O
,	O
there	O
were	O
two	O
to	O
three	O
times	O
fewer	O
total	O
cells	O
generated	O
in	O
the	O
presence	O
of	O
aged	O
serum	O
(	O
not	O
shown	O
)	O
.Fig	O
.	O

Specifically	O
,	O
these	O
determinants	O
of	O
hESC	O
regenerative	O
potential	O
were	O
examined	O
in	O
the	O
presence	O
of	O
heterochronic	O
(	O
young	O
vs.	O
old	O
)	O
mouse	S-y
sera	O
added	O
to	O
typical	O
hESC	O
medium	O
,	O
e.g.	O
,	O
MEF-conditioned	O
medium	O
(	O
MCM	O
)	O
.	O

Hoechst	O
(	O
blue	O
)	O
labels	O
nuclei	S-cellcomponent
.Importantly	O
,	O
such	O
enhanced	O
and	O
rejuvenated	O
muscle	O
repair	O
stems	O
from	O
an	O
indirect	O
induction	O
,	O
as	O
hESCs	S-cell_type
themselves	O
(	O
or	O
control	O
hMSCs	S-cell_type
)	O
did	O
not	O
physically	O
contribute	O
to	O
the	O
mouse	B-cell_type
myofibers	E-cell_type
,	O
as	O
judged	O
by	O
near	O
absence	O
(	O
less	O
than	O
0.1	O
%	O
)	O
of	O
human-specific	O
NuMA	S-GP
+	O
nuclei	S-cellcomponent
in	O
de	O
novo	O
desmin+	O
myofibers	S-cell_type
,	O
analyzed	O
through	O
multiple	O
injury	O
sites	O
.	O

Cells	O
were	O
treated	O
with	O
1	O
mg	O
mL−1	O
Collagenase	B-GP
Type	I-GP
IV	E-GP
(	O
Invitrogen	O
)	O
for	O
5–10	O
min	O
,	O
were	O
washed	O
and	O
then	O
incubated	O
with	O
0.5	O
mg	O
mL−1	O
Dispase	S-GP
(	O
Invitrogen	O
)	O
to	O
lift	O
only	O
human	O
cell	O
colonies	O
.	O

While	O
desmin	S-GP
can	O
be	O
also	O
present	O
in	O
smooth	O
and	O
cardiac	B-cell_type
muscle	I-cell_type
cells	E-cell_type
,	O
the	O
isolation	O
of	O
hind	B-x
limb	E-x
skeletal	B-x
muscle	E-x
with	O
subsequent	O
purification	O
of	O
myofibers	S-cell_type
away	O
from	O
all	O
interstitial	B-cell_type
cells	E-cell_type
,	O
as	O
well	O
as	O
purification	O
of	O
associated	O
muscle	B-cell_type
stem	I-cell_type
cells	E-cell_type
results	O
in	O
primary	O
cultures	O
that	O
are	O
uniformly	O
of	O
skeletal	B-x
muscle	E-x
lineage	O
.	O

Antibody	O
to	O
developmental	O
eMyHC	S-GP
(	O
clone	O
RNMy2/9D2	O
)	O
was	O
acquired	O
from	O
Vector	O
Laboratories	O
(	O
Burlingame	O
,	O
CA	O
,	O
USA	O
)	O
.	O

Exploring	O
this	O
further	O
,	O
we	O
found	O
that	O
young	O
serum	O
permits	O
satellite	B-cell_type
cells	E-cell_type
to	O
be	O
myogenic	S-x
,	O
while	O
old	O
serum	O
inhibits	O
the	O
satellite	O
cell	O
regenerative	O
potential	O
not	O
only	O
alone	O
,	O
but	O
also	O
when	O
mixed	O
with	O
young	O
serum	O
,	O
suggesting	O
a	O
dominant	O
over-riding	O
of	O
‘	O
young	O
’	O
serum	O
factors	O
(	O
Fig	O
.	O

Intriguingly	O
,	O
prolonged	O
culturing	O
of	O
hESCs	S-cell_type
in	O
their	O
preferred	O
in	O
vitro	O
conditions	O
enables	O
generation	O
of	O
an	O
embryonic	B-x
microniche	E-x
that	O
antagonizes	O
the	O
inhibitory	O
influences	O
of	O
aged	O
circulatory	O
factors.Table	O
1Conservation	O
of	O
stem	O
cell	O
aging	O
in	O
the	O
systemic	O
environmentRate	O
of	O
proliferation	O
ESC/ASC	O
(	O
percentage	O
of	O
BrdU	O
)	O
Call-fate	O
identifier	O
ESC	O
(	O
percentage	O
of	O
Oct4	S-GP
)	O
/	O
ASC	O
(	O
percentage	O
of	O
Myf5	S-GP
)	O
10	O
%	O
young59.5	O
±	O
0.8	O
,	O
59.3	O
±	O
4.099.0	O
±	O
0.1	O
,	O
50.7	O
±	O
9.510	O
%	O
old32.7	O
±	O
2.1	O
,	O
27.3	O
±	O
3.517.6	O
±	O
3.2	O
,	O
18.1	O
±	O
5.95	O
%	O
young	O
+	O
5	O
%	O
old31.0	O
±	O
2.6	O
,	O
38.0	O
±	O
2.020.6	O
±	O
3.5	O
,	O
17.1	O
±	O
4.2Quantified	O
results	O
from	O
Figs	O
1	O
,	O
2	O
are	O
summarized	O
and	O
presented	O
as	O
mean	O
percentages	O
from	O
experimental	O
replicates	O
±	O
SE	O
.	O

5	O
,	O
Table	O
2	O
)	O
,	O
and	O
that	O
control	O
hMSCs	S-cell_type
are	O
not	O
normally	O
myogenic	S-x
unless	O
these	O
cells	O
overexpress	O
exogenous	O
constitutively	O
active	O
domain	O
of	O
Notch	S-GP
(	O
Dezawa	O
et	O
al.	O
,	O
2005	O
)	O
.	O

As	O
previously	O
shown	O
,	O
this	O
method	O
is	O
well	O
suited	O
for	O
the	O
assessment	O
of	O
satellite	O
cell	O
regenerative	O
myogenic	S-x
capacity	O
(	O
Conboy	O
&	O
Rando	O
,	O
2002	O
;	O
Wagers	O
&	O
Conboy	O
,	O
2005	O
)	O
.	O

As	O
compared	O
to	O
young	O
myofiber	S-x
-derived	O
supernatants	O
(	O
young	O
myofiber	S-x
supernant	O
)	O
,	O
exposure	O
to	O
old	O
myofiber	S-x
-derived	O
supernatants	O
(	O
old	O
myofiber	S-x
supernant	O
)	O
inhibited	O
hESCs	S-cell_type
proliferation	O
,	O
as	O
judged	O
by	O
BrdU	O
immunodetection	O
(	O
red	O
)	O
.	O

Humans	S-y
display	O
broad	O
genetic	O
polymorphisms	O
and	O
behavioral	O
variations	O
,	O
which	O
makes	O
the	O
identification	O
of	O
age-specific	O
molecular	O
changes	O
complicated	O
.	O

Combinations	O
of	O
antibodies	O
were	O
used	O
to	O
co-stain	O
cultures	O
and	O
histosections	O
,	O
in	O
order	O
to	O
determine	O
the	O
percentages	O
of	O
cells	O
that	O
proliferated	O
or	O
differentiated	O
and	O
to	O
distinguish	O
hESCs	S-cell_type
from	O
mouse	B-cell_type
cells	E-cell_type
.	O

(	O
A	O
)	O
Newly	O
regenerated	O
myofibers	S-cell_type
were	O
detected	O
using	O
eMyHC	S-GP
-specific	O
antibody	O
(	O
green	O
)	O
and	O
staining	O
with	O
H	O
&	O
E	O
.	O

Furthermore	O
,	O
at	O
least	O
two	O
lines	O
of	O
evidence	O
suggest	O
that	O
stem	O
cell-based	O
tissue-replacement	O
therapies	O
might	O
be	O
hindered	O
in	O
the	O
elderly	O
,	O
because	O
all	O
cells	O
along	O
the	O
developmental	O
lineage	O
(	O
e.g.	O
,	O
stem	B-cell_type
cells	E-cell_type
,	O
more	O
differentiated	O
progenitor	B-cell_type
cells	E-cell_type
or	O
even	O
tissues	O
containing	O
a	O
pool	O
of	O
precursors	S-cell_type
)	O
might	O
rapidly	O
‘	O
age	O
’	O
and	O
fail	O
to	O
contribute	O
to	O
organ	O
repair	O
when	O
introduced	O
into	O
the	O
old	O
organism	O
in	O
vivo	O
.	O

Specifically	O
,	O
1	O
×	O
105	O
hESCs	S-cell_type
or	O
control	O
hMSCs	S-cell_type
were	O
co-cultured	O
with	O
identical	O
volume	O
,	O
e.g.	O
,	O
100	O
µL	O
,	O
of	O
young	O
or	O
old	O
myofiber	S-x
fragments	O
with	O
their	O
associated	O
satellite	B-cell_type
cells	E-cell_type
(	O
Fig	O
.	O

(	O
C	O
)	O
Transwell	O
co-cultures	O
between	O
purified	O
young	O
satellite	B-cell_type
cells	E-cell_type
and	O
myofibers	S-cell_type
isolated	O
from	O
uninjured	O
young	O
(	O
young	O
myofiber	S-x
)	O
and	O
old	O
(	O
old	O
myofiber	S-x
)	O
muscle	O
demonstrated	O
that	O
satellite	O
cell	O
regenerative	O
myogenic	S-x
capacity	O
was	O
inhibited	O
by	O
the	O
aged	O
differentiated	O
muscle	O
.	O

Therefore	O
,	O
we	O
further	O
explored	O
the	O
enhancing	O
and	O
rejuvenating	O
effects	O
of	O
hESCs	S-cell_type
on	O
myogenic	S-x
potential	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
using	O
human	B-cell_type
mesenchymal	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hMSCs	S-cell_type
)	O
as	O
a	O
negative	O
control	O
.	O

S3	O
(	O
hESCs	S-cell_type
)	O
.	O

Immunodetection	O
assays	O
were	O
performed	O
for	O
BrdU	O
(	O
red	O
)	O
,	O
Oct4	S-GP
(	O
red	O
)	O
,	O
and	O
Ki67	S-GP
(	O
Supplementary	O
Fig	O
.	O

Remarkably	O
,	O
this	O
positive	O
embryonic	S-x
effect	O
was	O
especially	O
pronounced	O
in	O
old	O
tissue.Fig	O
.	O

5	O
)	O
,	O
and	O
also	O
significantly	O
improve	O
repair	O
of	O
young	O
and	O
old	O
injured	O
muscle	O
in	O
vivo	O
(	O
Fig	O
.	O

The	O
regenerative	O
potential	O
of	O
hESCs	S-cell_type
and	O
ASCs	S-cell_type
is	O
inhibited	O
by	O
aged	O
differentiated	O
muscleAfter	O
establishing	O
that	O
the	O
aged	O
systemic	O
niche	O
negatively	O
affects	O
the	O
regenerative	O
capacity	O
of	O
hESCs	S-cell_type
and	O
of	O
ASCs	S-cell_type
,	O
we	O
then	O
assessed	O
whether	O
myogenic	S-x
potential	O
and	O
the	O
rate	O
of	O
cell	O
proliferation	O
would	O
be	O
inhibited	O
in	O
hESCs	S-cell_type
and	O
ASCs	S-cell_type
by	O
the	O
aged	O
local	O
muscle	O
niche	O
.	O

Hoechst	O
(	O
blue	O
)	O
labeled	O
nuclei	S-cellcomponent
.	O

5A	O
,	O
Mb	S-cell_type
+	O
hMSC	O
and	O
Mb	S-cell_type
alone	O
)	O
.	O

6	O
)	O
.	O

Some	O
of	O
these	O
myogenic	B-cell_type
cells	E-cell_type
fuse	O
into	O
myotubes	S-cell_type
,	O
even	O
in	O
the	O
mitogen-rich	O
medium	O
[	O
(	O
Opti-MEM	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
,	O
USA	O
)	O
with	O
5–10	O
%	O
mouse	S-y
serum	O
or	O
DMEM	O
with	O
10	O
%	O
fetal	S-x
bovine	S-y
serum	O
,	O
FBS	O
]	O
(	O
Conboy	O
&	O
Rando	O
,	O
2002	O
;	O
Conboy	O
et	O
al.	O
,	O
2003	O
;	O
and	O
see	O
below	O
)	O
.	O

n	O
=	O
20	O
;	O
*	O
indicates	O
P	O
<	O
0.001	O
(	O
‘	O
old	O
+	O
hMSC	O
’	O
compared	O
to	O
young	O
+	O
hMSC	O
and	O
‘	O
old	O
+	O
hMSC	O
’	O
compared	O
to	O
‘	O
old	O
+	O
hESC	O
’	O
.	O

S3	O
)	O
.	O

Immunosuppression	O
of	O
animals	O
was	O
achieved	O
by	O
intraperitoneal	S-x
injection	O
of	O
1	O
mg	O
kg−1	O
FK506	O
(	O
Sigma	O
)	O
at	O
48	O
h	O
prior	O
to	O
cell	O
transplantation	O
,	O
and	O
on	O
each	O
day	O
following	O
transplantation	O
.	O

Specifically	O
,	O
molecular	O
markers	O
of	O
stem	O
cell	O
functionality	O
,	O
e.g	O
.	O

(	O
B	O
)	O
Three	O
independent	O
experiments	O
yielded	O
similar	O
results	O
and	O
were	O
quantified	O
as	O
percentage	O
of	O
BrdU+	O
and	O
Oct4+	B-cell_type
cell	E-cell_type
s	O
for	O
each	O
culture	O
condition	O
.	O

Similar	O
to	O
Fig	O
.	O

Statistical	O
analysesA	O
minimum	O
of	O
three	O
replicates	O
were	O
undertaken	O
for	O
each	O
experimental	O
condition	O
.	O

Cells	O
were	O
typically	O
incubated	O
for	O
48	O
h	O
at	O
37	O
°C	O
,	O
5	O
%	O
CO2	O
,	O
under	O
the	O
various	O
experimental	O
conditions	O
employed	O
,	O
then	O
were	O
fixed	O
with	O
70	O
%	O
EtOH/PBS	O
at	O
4	O
°C	O
.	O

S2	O
)	O
,	O
hESCs	S-cell_type
failed	O
to	O
expand	O
or	O
even	O
persist	O
in	O
old	O
muscle	O
,	O
as	O
judged	O
by	O
the	O
absence	O
of	O
NuMA	S-GP
+/	O
Oct4	S-GP
+	O
hESC-derived	O
cells	O
in	O
the	O
aged	O
tissue	O
.	O

ESCs	S-cell_type
,	O
including	O
those	O
of	O
human	O
origin	O
(	O
hESCs	S-cell_type
)	O
,	O
are	O
derived	O
from	O
the	O
blastocyst	S-x
and	O
can	O
be	O
propagated	O
in	O
vitro	O
(	O
Evans	O
&	O
Kaufman	O
,	O
1981	O
;	O
Thomson	O
et	O
al.	O
,	O
1998	O
;	O
Wobus	O
&	O
Boheler	O
,	O
2005	O
)	O
.	O

4A	O
,	O
hESCs	S-cell_type
underwent	O
myogenic	S-x
differentiation	O
in	O
co-cultures	O
with	O
young	O
myofibers	S-cell_type
(	O
M-cadherin−/desmin+	O
mononucleated	B-cell_type
cells	E-cell_type
,	O
white	O
arrow	O
in	O
young	O
)	O
.	O

Immunodetection	O
and	O
histological	O
analysisTo	O
assay	O
the	O
affects	O
of	O
heterochronic	O
local	O
and	O
systemic	O
environments	O
on	O
stem	O
cell	O
regenerative	O
potential	O
,	O
hESC	O
,	O
hMSC	O
,	O
and	O
myofiber-derived	B-cell_type
precursor	I-cell_type
cell	E-cell_type
cultures	O
were	O
fixed	O
with	O
70	O
%	O
EtOH/PBS	O
at	O
4	O
°C	O
,	O
and	O
were	O
analyzed	O
by	O
indirect	O
immunofluorescence	O
.	O

Ki67	S-GP
,	O
a	O
cell	O
cycle	O
related	O
nuclear	S-cellcomponent
protein	O
consistently	O
absent	O
in	O
quiescent	B-cell_type
cells	E-cell_type
,	O
was	O
used	O
as	O
a	O
marker	O
for	O
proliferation	O
.	O

(	O
B	O
)	O
Three	O
independent	O
experiments	O
were	O
quantified	O
[	O
300	O
young	O
myofibers	S-cell_type
per	O
experiment	O
]	O
as	O
percentage	O
of	O
desmin	S-GP
+/	O
Myf5	S-GP
+/BrdU+	O
de	O
novo	O
generated	O
cells	O
for	O
each	O
age	O
and	O
culture	O
condition	O
.	O

Regeneration	O
improvement	O
was	O
also	O
seen	O
in	O
young	O
+	O
hESC	O
,	O
as	O
compared	O
to	O
young	O
+	O
hMSC	O
.	O

(	O
B	O
)	O
1	O
×	O
105	O
hESCs	S-cell_type
or	O
control	O
hMSCs	S-cell_type
were	O
co-cultured	O
with	O
young	O
or	O
old	O
myofiber	S-x
-associated	O
satellite	B-cell_type
cells	E-cell_type
,	O
as	O
described	O
in	O
Experimental	O
procedures	O
.	O

1	O
,	O
the	O
myogenic	S-x
potential	O
in	O
these	O
co-cultures	O
was	O
assayed	O
by	O
the	O
expression	O
of	O
desmin	S-GP
,	O
which	O
is	O
present	O
in	O
both	O
fusion-competent	B-cell_type
myoblasts	E-cell_type
and	O
newly	O
formed	O
myotubes	S-cell_type
.	O

Once	O
isolated	O
,	O
whole	O
muscle	O
was	O
prepared	O
for	O
cryosectioning	O
(	O
see	O
below	O
)	O
or	O
myofiber	O
fragments	O
were	O
obtained	O
from	O
hind	B-x
limb	E-x
muscles	S-x
by	O
enzymatic	O
digestion	O
(	O
see	O
below	O
)	O
,	O
trituration	O
,	O
and	O
multiple	O
sedimentation	O
and	O
washing	O
procedures	O
.	O

(	O
C	O
)	O
H	O
&	O
E	O
and	O
immunofluoresence	O
staining	O
for	O
Oct4	S-GP
,	O
and	O
a	O
human-specific	O
antibody	O
to	O
NuMA	S-GP
,	O
revealed	O
the	O
failure	O
of	O
hESCs	S-cell_type
to	O
expand	O
or	O
persist	O
in	O
old	O
,	O
but	O
the	O
presence	O
of	O
hESCs	S-cell_type
in	O
young	O
muscle	O
at	O
5	O
days	O
post-transplantation	O
.	O

Significantly	O
,	O
these	O
experiments	O
have	O
also	O
revealed	O
that	O
not	O
only	O
are	O
hESCs	S-cell_type
able	O
to	O
protect	O
themselves	O
against	O
the	O
negative	O
influences	O
of	O
aged	O
mouse	S-y
sera	O
(	O
Fig	O
.	O

Additionally	O
,	O
a	O
similarity	O
in	O
the	O
inhibitory	O
properties	O
between	O
systemic	O
and	O
local	O
organ	O
niches	O
is	O
also	O
of	O
interest	O
and	O
may	O
indicate	O
that	O
molecules	O
produced	O
by	O
old	O
tissues	O
have	O
circulatory/endocrine	O
activity	O
;	O
and/or	O
that	O
age-specific	O
systemic	O
inhibitory	O
components	O
become	O
deposited	O
in	O
the	O
old	O
tissues	O
.	O

Our	O
results	O
reveal	O
that	O
aged	O
differentiated	O
niches	O
dominantly	O
inhibit	O
the	O
expression	O
of	O
Oct4	S-GP
in	O
hESCs	S-cell_type
and	O
Myf-5	S-GP
in	O
activated	O
satellite	B-cell_type
cells	E-cell_type
,	O
and	O
reduce	O
proliferation	O
and	O
myogenic	S-x
differentiation	O
of	O
both	O
embryonic	S-x
and	O
tissue-specific	O
adult	B-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
ASCs	S-cell_type
)	O
.	O

Comprehensively	O
,	O
this	O
work	O
points	O
toward	O
novel	O
venues	O
for	O
in	O
situ	O
restoration	O
of	O
tissue	O
repair	O
in	O
the	O
old	O
and	O
identifies	O
critical	O
determinants	O
of	O
successful	O
cell-replacement	O
therapies	O
for	O
aged	O
degenerating	O
organs	O
.	O

Briefly	O
,	O
mice	S-y
were	O
injured	O
by	O
direct	O
injection	O
with	O
5	O
ng	O
cardiotoxin	O
(	O
CTX-1	O
)	O
(	O
Sigma	O
,	O
St	O
Louis	O
,	O
MO	O
,	O
USA	O
)	O
into	O
the	O
tibialis	B-x
anterior	E-x
and	O
gastrocnemius	S-x
muscles	S-x
using	O
a	O
28-gauge	O
needle	O
.	O

Spontaneous	O
production	O
of	O
desmin	S-GP
+	O
myogenic	B-cell_type
cells	E-cell_type
in	O
control	O
hESC	O
cultures	O
without	O
myofibers	S-cell_type
,	O
or	O
with	O
young/old	O
mouse	S-y
sera	O
was	O
less	O
than	O
0.1	O
%	O
(	O
not	O
shown	O
)	O
.Fig	O
.	O

Quantified	O
data	O
are	O
presented	O
as	O
means	O
±	O
SE	O
.	O

Feeder	S-cell_type
-free	O
hESC	O
cultures	O
were	O
maintained	O
in	O
MEF-conditioned	O
hESC	O
medium	O
(	O
MCM	O
)	O
,	O
4	O
ng	O
mL−1	O
hbFGF	S-GP
.	O

These	O
aged	O
myogenic	B-cell_type
cells	E-cell_type
were	O
of	O
skeletal	B-x
muscle	I-x
lineage	E-x
,	O
based	O
on	O
spontaneous	O
generation	O
of	O
multinucleated	B-cell_type
myotubes	E-cell_type
(	O
see	O
Fig	O
.	O

2B	O
)	O
.As	O
expected	O
,	O
hESCs	S-cell_type
cultured	O
in	O
control	O
media	O
,	O
including	O
MCM	O
alone	O
that	O
does	O
not	O
contain	O
either	O
young	O
or	O
old	O
serum	O
,	O
also	O
displayed	O
a	O
high	O
rate	O
of	O
proliferation	O
and	O
Oct4	S-GP
expression	O
(	O
Fig	O
.	O

This	O
model	O
allowed	O
us	O
to	O
address	O
both	O
the	O
negative	O
effects	O
of	O
the	O
aged	O
niche	O
on	O
key	O
stem	O
cell	O
properties	O
and	O
the	O
positive	O
effects	O
of	O
hESCs	S-cell_type
on	O
the	O
aged	B-cell_type
muscle-specific	I-cell_type
organ	I-cell_type
progenitor	I-cell_type
cells	E-cell_type
in	O
vitro	O
,	O
and	O
on	O
the	O
regenerative	O
capacity	O
of	O
old	O
muscle	O
in	O
vivo	O
.	O

2	O
)	O
.When	O
instead	O
of	O
immediate	O
exposure	O
to	O
aged	O
mouse	S-y
serum	O
,	O
hESCs	S-cell_type
were	O
first	O
cultured	O
overnight	O
in	O
MCM	O
,	O
these	O
cells	O
were	O
no	O
longer	O
susceptible	O
to	O
the	O
negative	O
effects	O
of	O
old	O
systemic	O
milieu	O
(	O
Fig	O
.	O

Significance	O
testing	O
was	O
performed	O
using	O
one-way	O
analysis	O
of	O
variance	O
(	O
anova	O
)	O
to	O
compare	O
data	O
from	O
different	O
experimental	O
groups	O
.	O

Myoblast	S-cell_type
differentiation	O
medium	O
[	O
DMEM	O
,	O
supplemented	O
with	O
2	O
%	O
horse	S-y
serum	O
(	O
Mediatech	O
)	O
]	O
was	O
used	O
to	O
promote	O
rapid	O
formation	O
of	O
myotubes	S-cell_type
from	O
cultured	O
myoblasts	S-cell_type
(	O
Morgan	O
&	O
Partridge	O
,	O
2003	O
)	O
.	O

Cultures	O
of	O
primary	B-cell_type
myoblasts	E-cell_type
were	O
derived	O
from	O
isolated	O
fibers	O
,	O
through	O
repeated	O
passaging	O
,	O
and	O
were	O
maintained	O
in	O
GM	O
.	O

S4	O
and	O
see	O
below	O
)	O
.	O

*	O
indicates	O
P	O
<	O
0.001	O
as	O
compared	O
to	O
‘	O
old	O
+	O
MCM	O
’	O
.Fig	O
.	O

S6	O
.	O

Aged	O
22–24	O
months	O
C57-BL/6	O
male	O
mice	S-y
were	O
obtained	O
from	O
the	O
National	O
Institute	O
on	O
Aging	O
(	O
NIH	O
)	O
.	O

Thus	O
,	O
a	O
complex	O
interplay	O
between	O
negative	O
regulation	O
of	O
hESCs	S-cell_type
and	O
adult	B-cell_type
muscle	I-cell_type
stem	I-cell_type
cells	E-cell_type
by	O
the	O
aged	O
niche	O
,	O
and	O
positive	O
regulation	O
of	O
the	O
host	O
's	O
regenerative	O
responses	O
by	O
hESCs	S-cell_type
will	O
likely	O
determine	O
the	O
success	O
of	O
hESC-based	O
cell-replacement	O
therapies	O
in	O
the	O
old	O
.	O

2The	O
regenerative	O
potential	O
of	O
embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
was	O
negatively	O
affected	O
by	O
aged	O
mouse	S-y
sera	O
.	O

6	O
Skeletal	B-x
muscle	E-x
regeneration	O
following	O
hESC	O
transplantation	O
is	O
a	O
balance	O
between	O
the	O
inhibitory	O
influence	O
of	O
aged	O
niches	O
and	O
the	O
rejuvenating	O
effects	O
of	O
hESCs	S-cell_type
.	O

All	O
images	O
depict	O
identical	O
microscope	O
fields	O
at	O
×20	O
magnification	O
,	O
unless	O
otherwise	O
noted	O
.	O

Myf5	S-GP
(	O
GTX77876	O
)	O
and	O
Pax7	S-GP
(	O
GTX77888	O
)	O
antibodies	O
were	O
obtained	O
from	O
GeneTex	O
(	O
San	O
Antonio	O
,	O
TX	O
,	O
USA	O
)	O
.	O

For	O
histological	O
analysis	O
,	O
dissected	O
muscle	O
was	O
treated	O
in	O
a	O
25	O
%	O
sucrose/PBS	O
solution	O
,	O
frozen	O
in	O
OCT	O
compound	O
(	O
Tissue	O
Tek	O
)	O
and	O
cryosectioned	O
at	O
10	O
µm	O
.	O

Oct4	S-GP
(	O
in	O
hESCs	S-cell_type
)	O
and	O
Myf5	S-GP
(	O
in	O
muscle	B-cell_type
stem	I-cell_type
cells	E-cell_type
)	O
,	O
the	O
rate	O
of	O
cell	O
proliferation	O
,	O
and	O
the	O
capacity	O
for	O
myogenic	S-x
differentiation	O
are	O
all	O
dominantly	O
inhibited	O
by	O
the	O
aged	O
systemic	O
milieu	O
,	O
and	O
by	O
the	O
old	O
differentiated	O
muscle	O
tissue	O
.	O

In	O
H	O
&	O
E	O
staining	O
,	O
newly	O
regenerated	O
areas	O
contain	O
smaller	O
,	O
immature	O
myofibers	S-cell_type
with	O
centrally	O
located	O
nuclei	S-cellcomponent
.	O

3	O
Embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
produce	O
youthful	O
microniche	S-x
in	O
culture	O
.	O

Hoechst	O
(	O
blue	O
)	O
labels	O
nuclei	O
.	O

hESCs	S-cell_type
indirectly	O
enhance	O
and	O
rejuvenate	O
the	O
regeneration	O
of	O
skeletal	B-x
muscle	E-x
While	O
hESC	O
properties	O
were	O
inhibited	O
by	O
aged	O
differentiated	O
muscle	O
,	O
the	O
myogenic	S-x
potential	O
of	O
aged	O
satellite	B-cell_type
cells	E-cell_type
seemed	O
to	O
be	O
enhanced	O
by	O
co-cultures	O
with	O
hESCs	S-cell_type
(	O
Fig	O
.	O

Comprehensively	O
,	O
the	O
results	O
of	O
this	O
work	O
increase	O
our	O
understanding	O
of	O
aging	O
as	O
a	O
process	O
,	O
reveal	O
evolutionary	O
conserved	O
age-specific	O
interactions	O
between	O
stem	B-cell_type
cells	E-cell_type
and	O
their	O
differentiated	B-x
niches	E-x
,	O
and	O
suggest	O
novel	O
therapeutic	O
approaches	O
for	O
improving	O
the	O
regenerative	O
responses	O
of	O
endogenous	O
or	O
transplanted	O
stem	B-cell_type
cells	E-cell_type
in	O
old	O
individuals	O
.	O

The	O
interactions	O
between	O
hESCs	S-cell_type
and	O
heterochronic	B-x
differentiated	I-x
niches	E-x
,	O
initially	O
identified	O
in	O
vitro	O
,	O
have	O
been	O
confirmed	O
by	O
in	O
vivo	O
experiments	O
.	O

Intriguingly	O
,	O
the	O
failure	O
of	O
hESCs	S-cell_type
to	O
strive	O
in	O
old	O
skeletal	B-x
muscle	E-x
might	O
represent	O
a	O
therapeutically	O
desirable	O
outcome	O
.	O

4A	O
,	O
C	O
)	O
.	O

As	O
expected	O
,	O
adult	B-cell_type
mouse	I-cell_type
stem	I-cell_type
cells	E-cell_type
did	O
not	O
express	O
Oct4	S-GP
,	O
and	O
hESCs	S-cell_type
did	O
not	O
express	O
Myf5	S-GP
in	O
these	O
experimental	O
conditions	O
(	O
not	O
shown	O
)	O
.	O

n	O
=	O
3.In	O
concert	O
with	O
the	O
conservation	O
of	O
inhibitory	O
affects	O
of	O
aged	B-x
systemic	I-x
niche	E-x
,	O
the	O
negative	O
influence	O
of	O
local	B-x
muscle	I-x
niche	E-x
was	O
also	O
found	O
to	O
be	O
conserved	O
in	O
its	O
inhibition	O
of	O
hESC	O
and	O
ASC	O
regenerative	O
responses	O
.	O

The	O
general	O
goal	O
behind	O
most	O
cell-replacement	O
approaches	O
is	O
to	O
expand	O
and	O
then	O
differentiate	O
hESCs	S-cell_type
in	O
vitro	O
,	O
thus	O
producing	O
a	O
cell	O
type	O
of	O
interest	O
,	O
such	O
as	O
neuronal	S-x
,	O
blood	S-x
,	O
endothelial	S-x
,	O
pancreatic	S-x
,	O
bone	S-x
,	O
and	O
others	O
.	O

These	O
data	O
suggest	O
that	O
not	O
only	O
systemic	O
but	O
also	O
local	B-x
organ	I-x
niches	E-x
would	O
inhibit	O
key	O
stem	O
cell	O
properties	O
,	O
e.g.	O
,	O
myogenic	S-x
capacity	O
and	O
the	O
rate	O
of	O
proliferation	O
in	O
the	O
aged	O
organism	O
.	O

An	O
example	O
of	O
one	O
regenerated	O
myofiber	S-x
from	O
young	O
muscle	O
injected	O
with	O
hESCs	S-cell_type
,	O
with	O
NuMA	S-GP
+	O
nucleus	S-cellcomponent
in	O
a	O
field	O
of	O
NuMA	S-GP
−/	O
desmin	S-GP
+	O
mouse	S-y
myofibers	S-cell_type
,	O
is	O
shown	O
in	O
Supplementary	O
Fig	O
.	O

Briefly	O
,	O
blood	B-cell_type
cells	E-cell_type
were	O
coagulated	O
at	O
37	O
°C	O
for	O
15	O
’	O
and	O
then	O
were	O
centrifuged	O
repeatedly	O
at	O
5900	O
g	O
,	O
4	O
°C	O
in	O
a	O
microfuge	O
for	O
3	O
’	O
to	O
isolate	O
sera	O
.	O

3	O
)	O
.	O

Dissected	O
gastrocnemius	S-x
and	O
tibialis	O
anterior	O
muscles	S-x
underwent	O
enzymatic	O
digestion	O
at	O
37	O
°C	O
in	O
DMEM	O
(	O
Invitrogen	O
)	O
/Pen-Strep	O
(	O
Invitrogen	O
)	O
/0.2	O
%	O
Collagenase	B-GP
Type	I-GP
IIA	E-GP
(	O
Sigma	O
)	O
solution	O
.	O

BrdU-specific	O
immunostaining	O
required	O
nuclear	O
permeabilization	O
with	O
treatment	O
of	O
4N	O
HCl	O
.	O

Significantly	O
,	O
this	O
work	O
establishes	O
that	O
hESC-derived	O
factors	O
enhance	O
the	O
regenerative	O
potential	O
of	O
both	O
young	O
and	O
,	O
importantly	O
,	O
aged	O
muscle	B-cell_type
stem	I-cell_type
cells	E-cell_type
in	O
vitro	O
and	O
in	O
vivo	O
;	O
thus	O
,	O
suggesting	O
that	O
the	O
regenerative	O
outcome	O
of	O
stem	O
cell-based	O
replacement	O
therapies	O
will	O
be	O
determined	O
by	O
a	O
balance	O
between	O
negative	O
influences	O
of	O
aged	O
tissues	O
on	O
transplanted	O
cells	O
and	O
positive	O
effects	O
of	O
embryonic	B-cell_type
cells	E-cell_type
on	O
the	O
endogenous	O
regenerative	O
capacity	O
.	O

Human	O
embryonic	S-x
and	O
mesenchymal	B-cell_type
stem	I-cell_type
cell	E-cell_type
cultureThe	O
federally	O
approved	O
hESC	O
line	O
,	O
H7	S-cell_line
(	O
NIH	O
no	O
.	O

Recently	O
published	O
data	O
suggest	O
that	O
these	O
extrinsic	O
cues	O
become	O
altered	O
with	O
age	O
in	O
ways	O
that	O
preclude	O
activation	O
of	O
organ	B-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
such	O
as	O
satellite	B-cell_type
cells	E-cell_type
)	O
,	O
inhibit	O
repair-specific	O
molecular	O
signaling	O
(	O
such	O
as	O
delta-Notch	S-GP
)	O
,	O
and	O
interfere	O
with	O
productive	O
tissue	O
repair	O
(	O
Conboy	O
et	O
al.	O
,	O
2003	O
,	O
2005	O
;	O
Janzen	O
et	O
al.	O
,	O
2006	O
;	O
Krishnamurthy	O
et	O
al.	O
,	O
2006	O
;	O
Molofsky	O
et	O
al.	O
,	O
2006	O
)	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

5A	O
(	O
Mb	S-cell_type
+	O
hESC	O
)	O
,	O
primary	O
myoblasts	S-cell_type
underwent	O
very	O
rapid	O
and	O
robust	O
nascent	B-cell_type
myotube	E-cell_type
formation	O
,	O
when	O
co-cultured	O
with	O
hESCs	S-cell_type
for	O
48	O
h	O
in	O
myoblas	S-cell_type
t	O
differentiation	O
medium	O
.	O

Transwells	O
were	O
placed	O
over	O
satellite	B-cell_type
cells	E-cell_type
and	O
contained	O
isolated	O
myofiber	S-x
explants	O
from	O
uninjured	O
young	O
or	O
old	O
muscle	O
(	O
i.e.	O
,	O
resting	O
muscle	O
)	O
.	O

4	O
Aged	B-x
muscle	I-x
niche	E-x
inhibits	O
the	O
regenerative	O
potential	O
of	O
hESCs	S-cell_type
and	O
satellite	B-cell_type
cells	E-cell_type
.	O

In	O
contrast	O
,	O
laboratory	O
mice	S-y
are	O
genetically	O
and	O
environmentally	O
controlled	O
.	O

Nuclei	S-cellcomponent
were	O
visualized	O
by	O
Hoechst	O
staining	O
for	O
all	O
immunostains	O
.	O

Rate	O
of	O
proliferation	O
(	O
BrdU	O
)	O
and	O
cell-fate	O
identifier	O
(	O
Oct4	S-GP
or	O
Myf5	S-GP
)	O
are	O
shown	O
for	O
both	O
ESCs	S-cell_type
and	O
ASCs	S-cell_type
cultured	O
in	O
heterochronic	O
systemic	O
conditions	O
of	O
10	O
%	O
young	O
(	O
young	O
)	O
,	O
10	O
%	O
old	O
(	O
old	O
)	O
or	O
in	O
5	O
%	O
+	O
5	O
%	O
mouse	S-y
sera	O
combination	O
(	O
young	O
+	O
old	O
)	O
.	O

In	O
addition	O
to	O
the	O
myogenically	S-x
differentiated	O
human	B-cell_type
cells	E-cell_type
,	O
co-cultures	O
with	O
young	O
myofiber	S-x
explants	O
also	O
contained	O
some	O
small	O
undifferentiated	O
hESC	O
colonies	O
,	O
as	O
determined	O
by	O
immunoreactivity	O
to	O
a	O
human-specific	O
antibody	O
to	O
the	O
nuclear	B-GP
mitotic	I-GP
apparatus	I-GP
protein	E-GP
,	O
NuMA	S-GP
and	O
Oct4	S-GP
expression	O
(	O
Supplementary	O
Fig	O
.	O

4A	O
,	O
yellow	O
arrow	O
in	O
old	O
)	O
.	O

Isolated	O
myofiber	S-x
explants	O
with	O
associated	O
satellite	B-cell_type
cells	E-cell_type
were	O
cultured	O
overnight	O
in	O
the	O
presence	O
of	O
young	O
or	O
old	O
serum	O
(	O
alone	O
at	O
5	O
%	O
and	O
10	O
%	O
,	O
and	O
mixed	O
at	O
5	O
%	O
young	O
+	O
5	O
%	O
old	O
)	O
;	O
bromodeoxyuridine	O
(	O
BrdU	O
)	O
was	O
added	O
for	O
the	O
last	O
2	O
h	O
of	O
culture	O
to	O
measure	O
the	O
rate	O
of	O
cell	O
proliferation	O
.	O

S5	O
)	O
.	O

Activated	B-cell_type
satellite	I-cell_type
cells	E-cell_type
express	O
myogenic	O
markers	O
,	O
such	O
as	O
Myf5	S-GP
,	O
M-cadherin	S-GP
,	O
and	O
Paired	B-GP
box	I-GP
gene	I-GP
7	E-GP
(	O
Pax7	S-GP
)	O
;	O
fusion-competent	B-cell_type
myoblasts	E-cell_type
express	O
high	O
levels	O
of	O
desmin	S-GP
,	O
and	O
de	O
novo	O
generated	O
myofibers	S-cell_type
or	O
myotubes	S-cell_type
express	O
embryonic	B-GP
myosin	I-GP
heavy	I-GP
chain	E-GP
(	O
eMyHC	S-GP
)	O
and	O
continue	O
to	O
express	O
desmin	S-GP
(	O
Schultz	O
&	O
McCormick	O
,	O
1994	O
;	O
Wagers	O
&	O
Conboy	O
,	O
2005	O
)	O
.	O

A	O
high	O
rate	O
of	O
hESC	O
proliferation	O
and	O
Oct4	S-GP
expression	O
is	O
displayed	O
in	O
all	O
control	O
media	O
and	O
in	O
the	O
presence	O
of	O
young	O
mouse	S-y
serum	O
.	O

Thus	O
,	O
in	O
agreement	O
with	O
the	O
notion	O
that	O
an	O
established	O
embryonic	B-x
microniche	E-x
antagonizes	O
the	O
inhibitory	O
effects	O
of	O
the	O
aged	O
environment	O
on	O
stem	O
cell	O
responses	O
(	O
Fig	O
.	O

The	O
conserved	O
inhibitory	O
influences	O
of	O
the	O
differentiated	O
muscle	B-x
niche	E-x
on	O
hESC	O
and	O
ASC	O
regenerative	O
responses	O
are	O
summarized	O
in	O
Table	O
2.Table	O
2Conservation	O
of	O
stem	O
cell	O
aging	O
in	O
the	O
local	O
organ	O
nicheRate	O
of	O
proliferation	O
ESC/ASC	O
(	O
percentage	O
of	O
BrdU	O
)	O
Myogenic	S-x
differentiation	O
ESC/ASC	O
(	O
percentage	O
of	O
desmin	S-GP
)	O
Young	O
myofiber	S-x
60.2	O
±	O
2.5	O
,	O
40.5	O
±	O
2.67.4	O
±	O
0.9	O
,	O
47.6	O
±	O
5.0Old	O
myofiber30.1	O
±	O
4.3	O
,	O
21.5	O
±	O
4.11.3	O
±	O
0.7	O
,	O
19.7	O
±	O
4.7Quantified	O
results	O
from	O
Fig	O
.	O

Namely	O
,	O
remarkably	O
large	O
fused	B-cell_type
myotubes	E-cell_type
containing	O
approximately	O
50–70	O
nuclei	S-cellcomponent
formed	O
around	O
hESCs	S-cell_type
colonies	O
(	O
Fig	O
.	O

Muscle	S-x
injury	O
and	O
isolationMyofiber	O
cultures	O
,	O
in	O
which	O
satellite	B-cell_type
cells	E-cell_type
were	O
activated	O
by	O
in	O
vivo	O
injury	O
,	O
were	O
set	O
up	O
as	O
previously	O
described	O
(	O
Conboy	O
&	O
Rando	O
,	O
2002	O
;	O
Conboy	O
et	O
al.	O
,	O
2005	O
)	O
.	O

Additionally	O
,	O
based	O
on	O
the	O
data	O
shown	O
above	O
,	O
we	O
speculated	O
that	O
even	O
if	O
the	O
host	O
's	O
repair	O
capacity	O
is	O
improved	O
,	O
hESCs	S-cell_type
themselves	O
will	O
not	O
be	O
efficiently	O
maintained	O
or	O
expanded	O
in	O
the	O
context	O
of	O
old	O
systemic	O
and	O
local	O
organ	O
environments	O
,	O
and	O
will	O
not	O
directly	O
contribute	O
to	O
the	O
repair	O
of	O
aged	O
skeletal	B-x
muscle	E-x
.	O

(	O
A	O
)	O
Young	O
satellite	B-cell_type
cells	E-cell_type
were	O
cultured	O
either	O
in	O
5	O
%	O
or	O
10	O
%	O
young	O
(	O
Young	O
)	O
,	O
10	O
%	O
old	O
(	O
Old	O
)	O
,	O
or	O
in	O
a	O
5	O
%	O
+	O
5	O
%	O
mouse	O
sera	O
combination	O
(	O
young	O
+	O
old	O
)	O
.	O

Differentiation	O
medium	O
for	O
hESCs	S-cell_type
(	O
DMEM/FBS	O
)	O
was	O
made	O
by	O
replacing	O
KSR	O
with	O
20	O
%	O
FBS	O
(	O
Hyclone	O
,	O
Logan	O
,	O
UH	O
,	O
USA	O
)	O
.	O

Whereas	O
Ki67	S-GP
appears	O
in	O
all	O
active	O
phases	O
of	O
the	O
cell	O
cycle	O
,	O
BrdU	O
staining	O
allowed	O
exclusive	O
detection	O
of	O
cells	O
in	O
S-phase	O
,	O
thereby	O
enabling	O
accurate	O
quantification	O
of	O
DNA	S-cellcomponent
synthesis	O
.	O

Experiments	O
were	O
carried	O
out	O
in	O
myoblast	O
differentiation	O
medium	O
.	O

n	O
=	O
3	O
;	O
*	O
indicates	O
P≤	O
0.05	O
as	O
compared	O
to	O
young.Comprehensively	O
,	O
these	O
data	O
establish	O
that	O
the	O
inhibition	O
of	O
stem	O
cell	O
regenerative	O
potential	O
by	O
the	O
aged	O
systemic	O
milieu	O
is	O
conserved	O
between	O
species	O
(	O
mouse	S-y
vs.	O
human	O
)	O
and	O
cell	O
types	O
(	O
adult	O
vs	O
.	O
embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
)	O
.	O

S5	O
,	O
culture-conditioned	O
supernatant	O
produced	O
by	O
hESCs	S-cell_type
grown	O
in	O
MCM	O
was	O
used	O
as	O
a	O
medium	O
in	O
which	O
1	O
×	O
105	O
of	O
myofiber	S-x
-associated	O
young	O
or	O
old	O
satellite	B-cell_type
cells	E-cell_type
were	O
cultured	O
for	O
48	O
h.	O
In	O
direct	O
co-cultures	O
,	O
mouse	S-y
vs	O
.	O
huma	S-y
n	O
cells	O
were	O
distinguished	O
by	O
immunodetection	O
with	O
human-specific/hESC-specific	O
and	O
mouse	S-y
-specific	O
antibodies	O
(	O
Supplementary	O
Fig	O
.	O

H	O
&	O
E	O
analysis	O
reveals	O
newly	O
formed	O
myofibers	S-cell_type
,	O
based	O
on	O
their	O
smaller	O
size	O
and	O
centrally	O
located	O
nuclei	S-cellcomponent
.	O

Oct4	S-GP
is	O
expressed	O
by	O
self-renewing	O
,	O
pluripotent	B-cell_type
ESCs	E-cell_type
in	O
culture	O
,	O
by	O
the	O
totipotent	O
inner	B-x
cell	I-x
mass	E-x
of	O
the	O
blastocyst	S-x
and	O
by	O
the	O
germ	B-cell_type
cells	E-cell_type
(	O
Nichols	O
et	O
al.	O
,	O
1998	O
;	O
Pesce	O
et	O
al.	O
,	O
1999	O
)	O
.	O

1B	O
,	O
the	O
age	O
of	O
sera	O
clearly	O
determined	O
satellite	O
cell	O
regenerative	O
potential	O
and	O
old	O
serum	O
strongly	O
inhibited	O
the	O
myogenic	S-x
potential	O
of	O
young	O
satellite	B-cell_type
cells	E-cell_type
either	O
when	O
present	O
alone	O
,	O
or	O
when	O
mixed	O
with	O
young	O
sera	O
.	O

*	O
indicates	O
P	O
<	O
0.001	O
as	O
compared	O
to	O
young	O
serum.Importantly	O
,	O
at	O
10	O
%	O
aged	O
serum	O
dramatically	O
inhibited	O
the	O
self-renewal	O
and	O
proliferative	O
potential	O
of	O
hESCs	S-cell_type
,	O
as	O
judged	O
by	O
highly	O
diminished	O
Oct4	S-GP
expression	O
and	O
a	O
lack	O
of	O
BrdU	O
incorporation	O
.	O

Similarly	O
,	O
culturing	O
satellite	B-cell_type
cells	E-cell_type
isolated	O
from	O
noninjured	O
muscle	O
in	O
growth-promoting	O
medium	O
for	O
1–2	O
days	O
does	O
not	O
protect	O
against	O
the	O
inhibitory	O
affects	O
of	O
aged	O
systemic	O
milieu	O
(	O
not	O
shown	O
)	O
.Fig	O
.	O

In	O
contrast	O
,	O
colonies	O
of	O
Numa	S-GP
+/	O
Oct4	S-GP
+	O
hESC-derived	O
cells	O
that	O
did	O
not	O
undergo	O
myogenic	S-x
differentiation	O
were	O
easily	O
detected	O
in	O
young	O
regenerating	O
muscle	O
(	O
Fig	O
.	O

ReagentsAntibodies	O
to	O
Oct4	S-GP
(	O
ab18976	O
)	O
,	O
BrdU	S-GP
(	O
BU1/75	O
(	O
ICR1	O
)	O
,	O
and	O
Ki67	S-GP
(	O
ab15580	O
)	O
were	O
purchased	O
from	O
Abcam	O
(	O
Cambridge	O
,	O
MA	O
,	O
USA	O
)	O
.	O

(	O
A	O
)	O
hESCs	S-cell_type
were	O
cultured	O
in	O
MCM	O
with	O
10	O
%	O
young	O
(	O
young	O
)	O
or	O
old	O
(	O
old	O
)	O
mouse	S-y
serum	O
,	O
or	O
in	O
three	O
control	O
media	O
:	O
MCM	O
without	O
mouse	S-y
sera	O
;	O
GM	O
(	O
myoblast	O
medium	O
of	O
Ham	O
's	O
F10	O
with	O
20	O
%	O
FBS	O
)	O
and	O
DMEM/FBS	O
(	O
hESC	O
differentiation	O
medium	O
of	O
DMEM	O
with	O
10	O
%	O
FBS	O
)	O
.	O

These	O
myogenic	B-cell_type
progeny	E-cell_type
of	O
hESCs	S-cell_type
in	O
co-cultures	O
with	O
young	O
myofibers	S-cell_type
could	O
be	O
of	O
skeletal	S-x
,	O
smooth	O
or	O
cardiac	B-x
muscle	E-x
lineages	O
(	O
Debus	O
et	O
al.	O
,	O
1983	O
;	O
Fischman	O
&	O
Danto	O
,	O
1985	O
;	O
Schultz	O
&	O
McCormick	O
,	O
1994	O
)	O
.	O

Satellite	B-cell_type
cells	E-cell_type
are	O
muscle	B-cell_type
stem	I-cell_type
cells	E-cell_type
situated	O
in	O
direct	O
contact	O
with	O
myofibers	S-cell_type
,	O
the	O
differentiated	B-cell_type
muscle	I-cell_type
cells	E-cell_type
.	O

hESCs	S-cell_type
and	O
hMSCs	S-cell_type
were	O
analyzed	O
24–48	O
h	O
after	O
experimental	O
treatments	O
,	O
during	O
which	O
no	O
apoptosis-related	O
differences	O
in	O
cell	O
numbers	O
were	O
observed	O
.	O

Desmin	S-GP
antibodies	O
(	O
clone	O
DE-U-10	O
and	O
Catalog	O
number	O
D8281	O
)	O
,	O
BrdU	O
labeling	O
reagent	O
and	O
FK506	S-GP
(	O
Catalog	O
number	O
F4679	O
)	O
were	O
obtained	O
from	O
Sigma	O
.	O

5B	O
,	O
hESCs	S-cell_type
conferred	O
a	O
much-enhanced	O
myogenic	S-x
capacity	O
on	O
both	O
young	O
and	O
,	O
importantly	O
,	O
old	O
myofiber	S-x
-associated	O
satellite	B-cell_type
cells	E-cell_type
(	O
rapid	O
formation	O
of	O
desmin	S-GP
+	O
myogenic	B-cell_type
cells	E-cell_type
,	O
many	O
of	O
which	O
formed	O
de	O
novo	O
multinucleated	O
myotubes	S-cell_type
)	O
.	O

Antibodies	O
to	O
the	O
myogenic	S-x
transcription	O
factors	O
,	O
Myf5	S-GP
/	O
Pax7	S-GP
,	O
the	O
intermediate	O
filament	O
protein	O
,	O
desmin	S-GP
,	O
and	O
the	O
marker	O
of	O
newly	O
formed	O
myotubes	O
,	O
eMyHC	S-GP
,	O
were	O
used	O
to	O
reveal	O
commitment	O
to	O
myogenic	O
differentiation	O
.	O

Thus	O
,	O
old	O
serum	O
factors	O
dominantly	O
inhibited	O
the	O
myogenic	S-x
capacity	O
of	O
young	O
satellite	O
cells	O
even	O
in	O
the	O
presence	O
of	O
young	O
serum	O
.	O

In	O
contrast	O
,	O
preculturing	O
of	O
hESCs	S-cell_type
for	O
24	O
h	O
in	O
MCM	O
,	O
prior	O
to	O
replacing	O
MCM	O
with	O
MCM	O
+	O
10	O
%	O
old	O
mouse	O
sera	O
was	O
done	O
for	O
embryonic	B-x
microniche	E-x
experiments	O
(	O
Fig	O
.	O

5B	O
)	O
and	O
based	O
on	O
induced	O
differentiation	O
into	O
myotubes	S-cell_type
in	O
DMEM	O
+	O
2	O
%	O
horse	S-y
serum	O
(	O
not	O
shown	O
)	O
.	O

1A	O
and	O
quantified	O
in	O
Fig	O
.	O

In	O
experiments	O
shown	O
in	O
Supplementary	O
Fig	O
.	O

Second	O
,	O
using	O
parabiotically	O
paired	O
young	O
and	O
old	O
mice	O
,	O
the	O
regenerative	O
potential	O
of	O
muscle	O
and	O
liver	S-x
was	O
shown	O
to	O
be	O
influenced	O
by	O
the	O
age	O
of	O
the	O
systemic	O
environment	O
(	O
Conboy	O
et	O
al.	O
,	O
2005	O
)	O
.	O

P	O
values	O
of	O
<	O
0.05	O
were	O
considered	O
as	O
statistically	O
significant	O
.	O

Uninjured	O
myofibers	S-cell_type
are	O
much	O
larger	O
,	O
by	O
comparison	O
,	O
with	O
peripherally	O
restricted	O
nuclei	S-cellcomponent
.	O

To	O
assess	O
the	O
effects	O
of	O
secreted	O
factors	O
produced	O
by	O
young	O
vs.	O
old	O
myofibers	S-cell_type
on	O
the	O
rate	O
of	O
hESC	O
proliferation	O
,	O
transient	O
,	O
2	O
h	O
BrdU	O
incorporation	O
was	O
examined	O
in	O
hESCs	S-cell_type
cultured	O
for	O
48	O
h	O
with	O
supernatants	O
produced	O
by	O
heterochronic	O
myofiber	S-x
explants	O
(	O
See	O
Experimental	O
procedures	O
for	O
details	O
)	O
.	O

As	O
expected	O
,	O
the	O
rate	O
of	O
hESCs	S-cell_type
proliferation	O
was	O
high	O
in	O
control	O
media	O
(	O
shown	O
in	O
Fig	O
.	O

At	O
the	O
same	O
time	O
,	O
these	O
embryonic	B-cell_type
cells	E-cell_type
indirectly	O
but	O
significantly	O
improve	O
the	O
repair	O
of	O
aged	O
injured	O
muscle	O
in	O
vivo	O
.	O

3	O
)	O
,	O
but	O
these	O
cells	O
also	O
produce	O
factors	O
that	O
dramatically	O
enhance	O
the	O
myogenic	S-x
capacity	O
of	O
primary	O
myoblasts	S-cell_type
and	O
young	O
and	O
old	O
satellite	B-cell_type
cells	E-cell_type
(	O
Fig	O
.	O

1	O
)	O
,	O
it	O
was	O
not	O
simply	O
a	O
dilution	O
of	O
young	O
serum	O
factors	O
as	O
hESCs	S-cell_type
robustly	O
proliferated	O
and	O
expressed	O
high	O
levels	O
of	O
Oct4	S-GP
when	O
cultured	O
with	O
5	O
%	O
young	O
sera	O
in	O
MCM	O
(	O
Supplementary	O
Fig	O
.	O

Establishing	O
that	O
age-specific	O
signals	O
,	O
regulating	O
stem	O
cell	O
responses	O
,	O
are	O
evolutionarily	O
conserved	O
and	O
soluble	O
enables	O
the	O
formation	O
of	O
rational	O
approaches	O
for	O
the	O
identification	O
and	O
characterization	O
of	O
the	O
inhibitors	O
involved	O
,	O
and	O
for	O
revealing	O
the	O
precise	O
timing	O
of	O
their	O
first	O
appearance	O
in	O
serum	O
and	O
differentiated	O
tissues	O
with	O
advancing	O
age	O
.	O

To	O
analyze	O
whether	O
hESCs	S-cell_type
,	O
mouse	B-cell_type
myogenic	I-cell_type
progenitor	I-cell_type
cells	E-cell_type
or	O
both	O
could	O
express	O
desmin	S-GP
in	O
direct	O
co-cultures	O
,	O
we	O
costained	O
these	O
cells	O
with	O
a	O
mouse	S-y
-specific	O
antibody	O
to	O
a	O
myogenic	O
marker	O
,	O
M-cadherin	S-GP
,	O
which	O
does	O
not	O
react	O
with	O
human	O
protein	O
,	O
and	O
a	O
desmin	S-GP
-specific	O
antibody	O
that	O
recognizes	O
both	O
mouse	S-y
and	O
human	O
proteins	O
.	O

Additionally	O
,	O
blood	S-x
was	O
collected	O
from	O
mice	S-y
for	O
the	O
isolation	O
of	O
sera	O
.	O

Their	O
tremendous	O
potential	O
for	O
organogenesis	O
has	O
created	O
a	O
great	O
interest	O
in	O
using	O
hESCs	S-cell_type
for	O
replacing	O
tissues	O
and	O
organs	O
lost	O
to	O
disease	O
,	O
or	O
old	O
age	O
(	O
reviewed	O
in	O
Wobus	O
&	O
Boheler	O
,	O
2005	O
)	O
.	O

(	O
A	O
)	O
Immunodetection	O
of	O
a	O
mouse	S-y
-specific	O
M-cadherin	S-GP
(	O
green	O
)	O
or	O
desmin	S-GP
(	O
red	O
;	O
both	O
human	O
and	O
mouse	S-y
proteins	O
are	O
detected	O
)	O
revealed	O
that	O
hESCs	S-cell_type
underwent	O
muscle	O
lineage	O
differentiation	O
when	O
co-cultured	O
with	O
young	O
,	O
but	O
not	O
old	O
myofibers	S-cell_type
.	O

5In	O
vitro	O
co-culture	O
with	O
hESCs	S-cell_type
enhanced	O
myogenesis	O
of	O
mouse	B-cell_type
cells	E-cell_type
.	O

In	O
such	O
cultures	O
,	O
hESCs	S-cell_type
were	O
passaged	O
immediately	O
prior	O
to	O
sera	O
exposure	O
.	O

Fluorophore-conjugated	O
secondary	O
antibodies	O
(	O
Alexa	O
Fluor	O
)	O
were	O
obtained	O
from	O
Molecular	O
Probes	O
(	O
Eugene	O
,	O
OR	O
,	O
USA	O
)	O
.	O

For	O
example	O
,	O
while	O
in	O
young	O
tissue	O
hESC	O
derivatives	O
putatively	O
would	O
go	O
on	O
to	O
produce	O
teratomas	S-x
,	O
it	O
is	O
unlikely	O
that	O
teratoma	O
formation	O
would	O
occur	O
after	O
hESC	O
transplantation	O
into	O
aged	O
skeletal	B-x
muscle	E-x
.	O

On	O
average	O
,	O
two	O
to	O
three	O
fewer	O
cells	O
were	O
generated	O
when	O
cultured	O
in	O
the	O
presence	O
of	O
old	O
.	O

BackgroundIn	O
order	O
to	O
compare	O
the	O
gene	O
expression	O
profiles	O
of	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cell	E-cell_type
(	O
hESC	O
)	O
lines	O
and	O
their	O
differentiated	O
progeny	O
and	O
to	O
monitor	O
feeder	O
contaminations	O
,	O
we	O
have	O
examined	O
gene	O
expression	O
in	O
seven	O
hESC	O
lines	O
and	O
human	B-cell_type
fibroblast	I-cell_type
feeder	I-cell_type
cells	E-cell_type
using	O
Illumina®	O
bead	O
arrays	O
that	O
contain	O
probes	O
for	O
24,131	O
transcript	O
probes.ResultsA	O
total	O
of	O
48	O
different	O
samples	O
(	O
including	O
duplicates	O
)	O
grown	O
in	O
multiple	O
laboratories	O
under	O
different	O
conditions	O
were	O
analyzed	O
and	O
pairwise	O
comparisons	O
were	O
performed	O
in	O
all	O
groups	O
.	O

Quantitative	O
real	O
time	O
PCR	O
gene	O
specific	O
primer	O
pairs	O
and	O
probes	O
were	O
purchased	O
from	O
Applied	O
Biosystems	O
(	O
Foster	O
City	O
,	O
CA	O
)	O
for	O
the	O
following	O
genes	O
:	O
MMP3	O
(	O
Hs00233962_m1	O
)	O
,	O
TFRSF11B	O
(	O
Hs00171068_m1	O
)	O
,	O
THBS1	O
(	O
Hs00170236_m1	O
)	O
,	O
KRTHA4	O
(	O
Hs00606019_gH	O
)	O
,	O
and	O
for	O
internal	O
control	O
β-actin	O
(	O
ACTB	O
,	O
Hs99999903_m1	O
)	O
.	O

It	O
can	O
provide	O
a	O
list	O
of	O
significant	O
genes	O
whose	O
expression	O
characterizes	O
each	O
diagnostic	O
class	O
.	O

Human	B-cell_type
ES	I-cell_type
cells	E-cell_type
(	O
hESCs	S-cell_type
)	O
can	O
be	O
maintained	O
and	O
propagated	O
on	O
mouse	S-y
or	O
human	B-cell_type
fibroblast	I-cell_type
feeders	E-cell_type
for	O
extended	O
periods	O
in	O
media	O
containing	O
basic	B-GP
fibroblast	I-GP
growth	I-GP
factor	E-GP
(	O
bFGF	S-GP
)	O
[	O
1-4	O
]	O
while	O
retaining	O
the	O
ability	O
to	O
differentiate	O
into	O
ectoderm	S-x
,	O
endoderm	S-x
and	O
mesoderm	S-x
as	O
well	O
as	O
trophoectoderm	S-x
and	O
germ	B-cell_type
cells	E-cell_type
.	O

Comparisons	O
of	O
all	O
three	O
lines	O
were	O
made	O
and	O
lists	O
of	O
selected	O
genes	O
that	O
were	O
specifically	O
expressed	O
in	O
BG01	S-cell_line
(	O
A	O
)	O
,	O
BG02	S-cell_line
(	O
C	O
)	O
and	O
BG03	S-cell_line
(	O
F	O
)	O
are	O
shown	O
.	O

Hierarchical	O
clustering	O
showed	O
that	O
blinded	O
duplicates	O
were	O
correctly	O
identified	O
as	O
the	O
closest	O
related	O
samples	O
.	O

We	O
have	O
confirmed	O
the	O
utility	O
of	O
previously	O
identified	O
markers	O
for	O
use	O
in	O
this	O
platform	O
as	O
well	O
as	O
identified	O
an	O
additional	O
set	O
of	O
markers	O
that	O
can	O
serve	O
as	O
biomarkers	O
to	O
distinguish	O
between	O
the	O
hESC	O
and	O
EB	O
states	O
.	O

The	O
entire	O
set	O
of	O
differentially	O
expressed	O
genes	O
is	O
provided	O
in	O
Additional	O
file	O
3	O
.	O

Duplicates	O
using	O
100	O
ng	O
of	O
RNA	S-cellcomponent
were	O
run	O
and	O
results	O
obtained	O
forty-eight	O
hours	O
later	O
.	O

Based	O
on	O
their	O
properties	O
,	O
we	O
classified	O
some	O
of	O
our	O
samples	O
into	O
four	O
groups	O
,	O
(	O
A	O
)	O
undifferentiated	O
hESCs	S-cell_type
(	O
including	O
a	O
sample	O
from	O
karyotypically	O
abnormal	O
variant	O
,	O
designated	O
as	O
``	O
ES	S-cell_type
``	O
,	O
n	O
=	O
11	O
)	O
;	O
(	O
B	O
)	O
differentiated	O
ES	B-cell_type
cells	E-cell_type
and	O
EBs	S-x
(	O
designated	O
as	O
``	O
EB	O
''	O
,	O
n	O
=	O
6	O
)	O
;	O
(	O
C	O
)	O
hESC	O
derived	O
neural	B-cell_type
cells	E-cell_type
(	O
designated	O
as	O
``	O
NS	S-cell_type
``	O
,	O
n	O
=	O
3	O
)	O
;	O
and	O
(	O
D	O
)	O
hESC	O
derived	O
mesenchyme	S-x
and	O
human	B-cell_type
fibroblast	I-cell_type
feeder	I-cell_type
cells	E-cell_type
(	O
designated	O
as	O
``	O
FB	S-cell_type
``	O
,	O
n	O
=	O
5	O
)	O
and	O
these	O
groups	O
were	O
shown	O
in	O
the	O
heat-map	O
.	O

The	O
number	O
of	O
genes	O
detected	O
by	O
each	O
method	O
and	O
the	O
degree	O
of	O
overlap	O
is	O
summarized	O
.	O

As	O
a	O
test	O
we	O
looked	O
for	O
differences	O
between	O
BG01	S-cell_line
,	O
BG02	S-cell_line
and	O
BG03	S-cell_line
,	O
which	O
were	O
grown	O
in	O
the	O
same	O
laboratory	O
under	O
the	O
same	O
conditions	O
.	O

Samples	O
included	O
7	O
hESC	O
lines	O
BG01	S-cell_line
,	O
BG02	S-cell_line
,	O
BG03	S-cell_line
,	O
I6	S-cell_line
,	O
H1	S-cell_line
,	O
H7	S-cell_line
and	O
H9	S-cell_line
,	O
EBs	S-x
that	O
were	O
differentiated	O
from	O
hESCs	S-cell_type
of	O
the	O
three	O
BG	O
lines	O
,	O
human	S-y
fibroblast	O
feeder	O
HS27	S-cell_line
(	O
ATCC	O
)	O
,	O
hESC-derived	O
fibroblasts	S-cell_type
,	O
karyotypically	O
abnormal	O
hESC	O
line	O
BG01	B-cell_line
Variant	E-cell_line
(	O
BG01V	S-cell_line
)	O
[	O
13	O
]	O
and	O
EC	S-x
line	O
NTera2	S-cell_line
[	O
14	O
]	O
.	O

We	O
are	O
in	O
progress	O
of	O
redesigning	O
appropriate	O
probes	O
for	O
these	O
genes	O
.	O

The	O
global	O
pairwise	O
comparison	O
clearly	O
showed	O
that	O
human	B-cell_type
feeders	E-cell_type
were	O
far	O
more	O
dissimilar	O
to	O
hESCs	S-cell_type
than	O
hESCs	S-cell_type
grown	O
in	O
different	O
laboratories	O
,	O
hESCs	S-cell_type
compared	O
to	O
their	O
differentiated	O
EBs	S-x
that	O
contained	O
mesodermal	S-x
tissue	O
,	O
and	O
hESCs	S-cell_type
compared	O
to	O
the	O
karyotypically	O
variant	O
hESC	O
line	O
BG01V	S-cell_line
.	O

These	O
genes	O
were	O
similar	O
in	O
most	O
samples	O
though	O
relative	O
levels	O
varied.Table	O
1Correlation	O
coefficients	O
of	O
paired	O
samples	O
in	O
this	O
bead	O
array	O
In	O
order	O
to	O
test	O
the	O
reproducibility	O
and	O
reliability	O
of	O
the	O
bead	O
array	O
,	O
duplicate	O
samples	O
of	O
hESC	O
lines	O
H9	S-cell_line
,	O
I6	S-cell_line
,	O
and	O
EC	S-cell_type
line	O
NTera2	S-cell_line
and	O
human	B-cell_type
fibroblast	I-cell_type
feeders	E-cell_type
(	O
HS27	S-cell_line
)	O
were	O
run	O
at	O
the	O
same	O
time	O
and	O
correlation	O
coefficients	O
(	O
R2	O
)	O
of	O
duplicates	O
were	O
generated	O
using	O
the	O
entire	O
data	O
of	O
all	O
genes	O
with	O
expression	O
level	O
>	O
0	O
(	O
§	O
)	O
,	O
or	O
genes	O
with	O
detection	O
confidence	O
>	O
0.99	O
(	O
*	O
)	O
,	O
or	O
genes	O
with	O
detection	O
confidence	O
>	O
0.99	O
and	O
expression	O
level	O
>	O
100	O
arbitrary	O
units	O
(	O
#	O
)	O
.	O

The	O
complete	O
comparison	O
of	O
gene	O
expression	O
is	O
shown	O
in	O
Additional	O
file	O
2	O
and	O
is	O
summarized	O
in	O
Tables	O
3	O
and	O
Table	O
4	O
.	O

cDNA	S-cellcomponent
was	O
synthesized	O
using	O
2.5	O
μg	O
total	O
RNA	S-cellcomponent
in	O
a	O
20-μl	O
reaction	O
with	O
Superscript	O
II	O
(	O
Invitrogen	O
)	O
and	O
oligo	O
(	O
dT	O
)	O
12–18	O
(	O
Promega	O
;	O
Madison	O
,	O
WI	O
)	O
.	O

Although	O
the	O
sensitivity	O
of	O
the	O
array	O
has	O
been	O
reported	O
to	O
be	O
high	O
,	O
in	O
the	O
present	O
report	O
we	O
have	O
restricted	O
our	O
analysis	O
to	O
expression	O
of	O
at	O
least	O
100	O
units	O
in	O
any	O
one	O
sample	O
.	O

While	O
we	O
have	O
listed	O
19	O
potential	O
markers	O
(	O
Figure	O
3	O
)	O
and	O
identified	O
several	O
hundred	O
potential	O
markers	O
as	O
shown	O
in	O
Additional	O
file	O
5	O
,	O
we	O
suggest	O
that	O
as	O
few	O
as	O
3–4	O
genes	O
may	O
be	O
sufficient	O
.	O

Several	O
markers	O
such	O
as	O
MMP3	S-GP
and	O
TNFRSF11B	S-GP
have	O
commercially	O
available	O
antibodies	O
(	O
R	O
&	O
D	O
systems	O
)	O
that	O
may	O
be	O
used	O
to	O
further	O
confirm	O
contamination	O
of	O
feeder	B-cell_type
cells	E-cell_type
by	O
immunocytochemistry	O
.	O

of	O
genes	O
detected	O
at	O
>	O
0.99	O
confidence13,72615,81414,04314,76013,95014,6219,85716,888One	O
of	O
the	O
advantages	O
of	O
the	O
Illumina	O
arrays	O
is	O
the	O
ability	O
of	O
running	O
multiple	O
samples	O
simultaneously	O
thus	O
allowing	O
multiple	O
pairwise	O
comparisons	O
to	O
be	O
performed	O
readily	O
.	O

As	O
one	O
of	O
our	O
purposes	O
of	O
this	O
study	O
was	O
to	O
distinguish	O
between	O
human	B-cell_type
fibroblast	I-cell_type
feeders	I-cell_type
cells	E-cell_type
and	O
hESCs	S-cell_type
and	O
hEBs	S-x
,	O
wishing	O
to	O
readily	O
detect	O
feeder	O
contamination	O
in	O
hESCs	S-cell_type
,	O
we	O
included	O
one	O
of	O
the	O
human	B-cell_type
feeder	I-cell_type
cells	E-cell_type
HS27	S-cell_line
(	O
ATCC	O
)	O
in	O
this	O
study	O
.	O

Our	O
strategy	O
was	O
to	O
compare	O
a	O
variety	O
of	O
different	O
hESC	O
lines	O
that	O
were	O
derived	O
and	O
expanded	O
by	O
three	O
different	O
institutions	O
(	O
WiCell	O
Research	O
Institute	O
,	O
BresaGen	O
,	O
Inc.	O
,	O
and	O
Technion-Israel	O
Institute	O
of	O
Technology	O
)	O
,	O
and	O
cultured	O
in	O
two	O
separate	O
laboratories	O
(	O
Burnham	O
Institute	O
and	O
NIA	O
)	O
to	O
a	O
baseline	O
set	O
of	O
data	O
against	O
which	O
cell	O
samples	O
can	O
be	O
compared	O
.	O

Culture	O
medium	O
for	O
all	O
cultures	O
was	O
composed	O
of	O
DMEM/F12-Glutamax	O
1:1	O
,	O
20	O
%	O
Knockout	O
Serum	O
Replacement	O
,	O
2	O
mM	O
nonessential	O
amino	O
acids	O
,	O
100	O
μM	O
beta-mercaptoethanol	O
,	O
50	O
μg/ml	O
Pen-Strep	O
(	O
all	O
from	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
)	O
,	O
and	O
4	O
ng/ml	O
human	S-y
recombinant	O
basic	B-GP
fibroblast	I-GP
growth	I-GP
factor	E-GP
(	O
bFGF	S-GP
/	O
FGF2	S-GP
;	O
PeproTech	O
Inc.	O
,	O
Rocky	O
Hill	O
,	O
NJ	O
.	O
)	O

For	O
example	O
BG01V	S-cell_line
,	O
while	O
much	O
more	O
similar	O
to	O
BG01	S-cell_line
than	O
to	O
any	O
other	O
cell	O
type	O
,	O
could	O
still	O
be	O
distinguished	O
from	O
a	O
biological	O
replicate	O
of	O
BG01	S-cell_line
by	O
the	O
expression	O
of	O
a	O
particular	O
subset	O
of	O
differentiation	O
markers	O
(	O
Figure	O
6	O
)	O
.	O

Black	O
dots	O
represent	O
genes	O
that	O
were	O
detected	O
at	O
>	O
0	O
expression	O
level	O
,	O
blue	O
dots	O
represent	O
genes	O
that	O
were	O
detected	O
both	O
at	O
>	O
0	O
expression	O
level	O
and	O
at	O
>	O
0.99	O
confidence	O
.	O

As	O
discussed	O
above	O
,	O
most	O
hESC	O
markers	O
identified	O
by	O
MPSS	O
have	O
been	O
detected	O
in	O
the	O
present	O
bead	O
array	O
analysis	O
(	O
Table	O
3	O
)	O
,	O
confirming	O
the	O
utility	O
of	O
these	O
previously	O
identified	O
markers	O
for	O
use	O
in	O
assessing	O
undifferentiated	O
status	O
of	O
hESCs	S-cell_type
.	O

By	O
comparing	O
across	O
many	O
samples	O
,	O
a	O
procedure	O
previously	O
expensive	O
and	O
difficult	O
in	O
terms	O
of	O
the	O
RNA	O
and	O
replicate	O
requirement	O
,	O
one	O
can	O
rapidly	O
identify	O
key	O
regulatory	O
pathways.To	O
test	O
whether	O
we	O
could	O
use	O
such	O
multiple	O
pairwise	O
comparisons	O
to	O
elucidate	O
the	O
major	O
regulatory	O
pathways	O
that	O
may	O
be	O
required	O
for	O
hESC	O
self-renewal	O
,	O
we	O
examined	O
several	O
metabolic	O
pathways	O
.	O

In	O
summary	O
,	O
the	O
Illumina	O
bead	O
array	O
has	O
several	O
key	O
strengths	O
including	O
high	O
throughput	O
,	O
low	O
cost	O
and	O
high	O
sensitivity	O
.	O

Undifferentiated	O
hESCs	S-cell_type
have	O
been	O
analyzed	O
by	O
EST	O
scan	O
,	O
MPSS	O
,	O
SAGE	O
and	O
microarray	O
[	O
5,10,16	O
]	O
.	O

PAM	O
is	O
a	O
class	O
prediction	O
method	O
for	O
expression	O
data	O
mining	O
.	O

Markers	O
for	O
hESCs	S-cell_type
that	O
may	O
also	O
contribute	O
to	O
the	O
``	O
stemness	O
''	O
phenotype	O
have	O
been	O
established	O
and	O
markers	O
that	O
distinguish	O
ESCs	S-cell_type
from	O
embryoid	B-cell_type
bodies	E-cell_type
(	O
EB	O
)	O
have	O
been	O
developed	O
.	O

*	O
:	O
represents	O
the	O
gene	O
expression	O
level	O
is	O
detected	O
at	O
<	O
0.99	O
confidence.In	O
summary	O
,	O
our	O
data	O
suggest	O
that	O
the	O
bead	O
array	O
format	O
is	O
sufficiently	O
sensitive	O
and	O
global	O
that	O
it	O
can	O
distinguish	O
one	O
cell	O
line	O
from	O
another	O
even	O
if	O
those	O
two	O
cell	O
lines	O
are	O
grown	O
in	O
the	O
same	O
laboratory	O
under	O
virtually	O
identical	O
conditions	O
.	O

The	O
genes	O
with	O
nonzero	O
components	O
in	O
each	O
class	O
were	O
almost	O
mutually	O
exclusive	O
and	O
were	O
the	O
candidate	O
molecular	O
markers	O
for	O
the	O
diagnosis	O
of	O
the	O
four	O
groups	O
of	O
cell	O
populations	O
,	O
including	O
,	O
(	O
from	O
left	O
to	O
right	O
)	O
hESC	O
derived	O
mesenchyme	S-cell_type
and	O
human	B-cell_type
fibroblast	I-cell_type
feeder	I-cell_type
cells	E-cell_type
(	O
``	O
FB	S-cell_type
``	O
,	O
n	O
=	O
5	O
)	O
,	O
undifferentiated	O
hESCs	S-cell_type
(	O
``	O
ES	S-cell_type
``	O
,	O
n	O
=	O
11	O
)	O
,	O
hESC	O
derived	O
neural	B-cell_type
cells	E-cell_type
(	O
``	O
NS	O
''	O
,	O
n	O
=	O
3	O
)	O
,	O
and	O
differentiated	O
ES	B-cell_type
cells	E-cell_type
and	O
EB	O
,	O
(	O
``	O
EB	O
''	O
,	O
n	O
=	O
6	O
)	O
.	O

The	O
resulting	O
graph	O
(	O
Figure	O
7	O
)	O
showed	O
the	O
shrunken	O
class	O
centroids	O
for	O
genes	O
that	O
had	O
at	O
least	O
one	O
nonzero	O
difference	O
in	O
each	O
diagnostic	O
class	O
.	O

Our	O
future	O
efforts	O
will	O
focus	O
on	O
data	O
mining	O
and	O
developing	O
better	O
cross	O
platform	O
comparison	O
tools	O
and	O
generating	O
focused	O
high	O
throughput	O
arrays	O
for	O
quality	O
control	O
in	O
clinical	O
and	O
research	O
settings	O
.	O

Thus	O
,	O
the	O
bead	O
array	O
format	O
,	O
which	O
allows	O
multiple	O
pairwise	O
comparisons	O
,	O
can	O
be	O
used	O
to	O
identify	O
genes	O
that	O
are	O
expressed	O
by	O
all	O
differentiating	O
EB	O
samples	O
in	O
the	O
present	O
study	O
.	O

Amplified	O
RNA	S-cellcomponent
synthesized	O
from	O
limited	O
quantities	O
of	O
heterogenous	O
cDNA	S-cellcomponent
[	O
30	O
]	O
was	O
performed	O
using	O
the	O
Illumina	O
RNA	S-cellcomponent
Amplification	O
kit	O
(	O
Ambion	O
,	O
Inc.	O
,	O
Austin	O
,	O
TX	O
)	O
following	O
the	O
Manufacturer	O
instructions	O
.	O

Note	O
much	O
higher	O
degree	O
of	O
overlap	O
when	O
the	O
top	O
2000	O
hits	O
were	O
compared	O
.	O

High	O
expressions	O
relative	O
to	O
mean	O
are	O
colored	O
red	O
.	O

The	O
current	O
analysis	O
confirms	O
that	O
comparison	O
across	O
platforms	O
is	O
difficult	O
and	O
that	O
only	O
positive	O
results	O
can	O
be	O
treated	O
with	O
any	O
reliability	O
.	O

We	O
show	O
that	O
the	O
Illumina	O
bead	O
based	O
array	O
correctly	O
identified	O
blinded	O
duplicates	O
as	O
the	O
closest	O
related	O
samples	O
and	O
readily	O
distinguished	O
between	O
hESC	O
lines	O
,	O
as	O
well	O
as	O
between	O
ESCs	S-cell_type
and	O
EBs	S-cell_type
derived	O
from	O
them	O
.	O

Bead	O
array	O
identified	O
lists	O
of	O
genes	O
that	O
were	O
uniquely	O
expressed	O
in	O
human	B-cell_type
fibroblast	I-cell_type
feeders	E-cell_type
as	O
compared	O
to	O
hESCs	S-cell_type
(	O
A	O
)	O
and	O
hEBs	S-x
(	O
B	O
)	O
.	O

Multiple	O
hESC	O
lines	O
can	O
be	O
assessed	O
by	O
Illumina	O
bead	O
arrayForty-eight	O
samples	O
were	O
selected	O
from	O
multiple	O
laboratories	O
and	O
gene	O
expression	O
profiles	O
were	O
examined	O
using	O
a	O
bead	O
array	O
containing	O
24,131	O
transcripts	O
derived	O
from	O
the	O
Human	S-y
RefSeq	O
database	O
that	O
included	O
full	O
length	O
and	O
splice	O
variants	O
.	O

This	O
is	O
consistent	O
with	O
the	O
postulated	O
role	O
of	O
this	O
pathway	O
in	O
germ	O
cell	O
differentiation	O
[	O
22,23	O
]	O
and	O
suggests	O
that	O
TGFβ	S-GP
pathway	O
can	O
not	O
be	O
reliably	O
tested	O
using	O
NTera2	S-cell_line
as	O
a	O
model	O
for	O
hESC.The	O
BG01V	S-cell_line
showed	O
clear	O
differences	O
from	O
its	O
normal	O
counterpart	O
and	O
some	O
major	O
changes	O
are	O
summarized	O
in	O
Figure	O
6D	O
and	O
6F	O
.	O

H	O
lines	O
were	O
grown	O
on	O
Matrigel	O
coated	O
dishes	O
,	O
while	O
BG	O
lines	O
on	O
fibronectin	S-GP
treated	O
dishes	O
.	O

Note	O
that	O
the	O
correlation	O
coefficients	O
are	O
in	O
the	O
range	O
of	O
0.9382–0.9761	O
and	O
the	O
number	O
of	O
genes	O
was	O
in	O
the	O
range	O
of	O
10,000–14,000.Duplicate	O
SamplesNo	O
.	O


Further	O
,	O
by	O
comparing	O
embryonal	B-cell_type
carcinoma	I-cell_type
cell	E-cell_type
(	O
EC	S-x
)	O
and	O
karyotypically	S-cellcomponent
variant	O
lines	O
with	O
hESC	O
,	O
we	O
would	O
be	O
able	O
to	O
directly	O
assess	O
their	O
utility	O
as	O
surrogates	O
(	O
for	O
quality	O
control	O
purposes	O
)	O
for	O
hESC	O
.	O

Our	O
data	O
suggested	O
that	O
a	O
core	O
set	O
of	O
limited	O
markers	O
might	O
be	O
sufficient	O
to	O
monitor	O
the	O
process	O
of	O
differentiation	O
.	O

Intensity	O
results	O
are	O
reported	O
in	O
arbitrary	O
units	O
and	O
ranged	O
from	O
10	O
to	O
20,000	O
(	O
a	O
two	O
thousand	O
fold	O
range	O
)	O
.	O

By	O
using	O
this	O
array	O
,	O
we	O
can	O
readily	O
detect	O
contaminating	O
feeders	S-cell_type
and	O
spontaneous	O
differentiation	O
,	O
differentiate	O
male	S-x
and	O
female	S-x
lines	O
and	O
distinguish	O
between	O
one	O
undifferentiated	O
population	O
and	O
another	O
.	O

Global	O
arrays	O
provide	O
a	O
snapshot	O
of	O
the	O
state	O
of	O
the	O
cells	O
and	O
identify	O
core	O
self-renewal	O
pathwaysWe	O
have	O
utilized	O
a	O
small	O
fraction	O
of	O
the	O
data	O
to	O
demonstrate	O
the	O
overall	O
utility	O
of	O
this	O
approach	O
and	O
its	O
sensitivity	O
in	O
identifying	O
small	O
differences	O
in	O
cell	O
populations	O
.	O

In	O
particular	O
,	O
the	O
Wnt	S-GP
pathway	O
and	O
the	O
TGFβ	S-GP
signaling	O
pathway	O
(	O
Figure	O
6D	O
)	O
,	O
both	O
of	O
which	O
involved	O
in	O
the	O
early	O
process	O
of	O
differentiation	O
[	O
24,25	O
]	O
,	O
appeared	O
to	O
be	O
activated	O
(	O
Additional	O
file	O
4	O
)	O
,	O
suggesting	O
that	O
the	O
role	O
of	O
growth	O
factors	O
and	O
signaling	O
in	O
these	O
early	O
events	O
can	O
not	O
be	O
readily	O
studied	O
in	O
this	O
cell	O
line.In	O
summary	O
,	O
the	O
analysis	O
highlighted	O
the	O
utility	O
of	O
the	O
potential	O
reference	O
standards	O
NTera2	S-cell_line
and	O
BG01V	S-cell_line
,	O
demonstrated	O
their	O
general	O
similarity	O
and	O
provided	O
detail	O
on	O
potential	O
caveats	O
to	O
their	O
application	O
.	O

Unsupervised	O
hierarchical	O
clustering	O
analysis	O
and	O
principal	O
component	O
analysis	O
(	O
PCA	O
)	O
were	O
conducted	O
using	O
software	O
Pcluster	O
[	O
31	O
]	O
and	O
TreeView	O
[	O
18	O
]	O
.Identification	O
of	O
diagnostic	O
markersPAM	O
(	O
prediction	O
analysis	O
of	O
microarray	O
)	O
was	O
employed	O
for	O
the	O
identification	O
of	O
diagnostic	O
markers	O
from	O
insulin	S-GP
pathway	O
genes	O
by	O
using	O
the	O
software	O
package	O
bioconductor	O
[	O
17	O
]	O
.	O

The	O
average	O
gene	O
expression	O
level	O
in	O
multiple	O
classes	O
,	O
such	O
as	O
ES	S-cell_type
,	O
EB	O
,	O
NS	S-cell_type
,	O
and	O
FB	S-cell_type
,	O
was	O
divided	O
by	O
the	O
within-class	O
standard	O
deviation	O
for	O
that	O
gene	O
.	O

hESCs	S-cell_type
clustered	O
together	O
and	O
BG	O
lines	O
cultured	O
in	O
the	O
same	O
laboratory	O
shared	O
the	O
largest	O
similarities	O
.	O

Caution	O
should	O
be	O
observed	O
in	O
comparing	O
different	O
samples	O
run	O
on	O
different	O
platforms	O
,	O
especially	O
when	O
there	O
has	O
not	O
been	O
rigorous	O
bioinformatic	O
matching	O
of	O
the	O
source	O
sequences	O
used	O
to	O
identify	O
genes	O
in	O
the	O
platforms	O
.	O

To	O
make	O
such	O
analysis	O
more	O
readily	O
available	O
,	O
we	O
utilized	O
several	O
software	O
tools	O
including	O
the	O
software	O
package	O
available	O
through	O
Illumina	O
.	O

We	O
believe	O
that	O
a	O
partial	O
explanation	O
for	O
the	O
variability	O
in	O
Nanog	S-GP
expression	O
is	O
due	O
to	O
the	O
lack	O
of	O
sensitivity	O
to	O
this	O
gene	O
.	O

Overall	O
,	O
concordance	O
in	O
Illumina	O
array	O
was	O
better	O
than	O
that	O
evident	O
between	O
EST	O
scan	O
and	O
MPSS	O
datasets	O
[	O
9	O
]	O
,	O
but	O
clearly	O
showed	O
much	O
wider	O
differences	O
than	O
that	O
seen	O
with	O
running	O
duplicates	O
in	O
the	O
same	O
assay	O
format	O
.	O

Labeled	O
,	O
amplified	O
material	O
(	O
700	O
ng	O
per	O
array	O
)	O
was	O
hybridized	O
to	O
a	O
pilot	O
version	O
of	O
the	O
Illumina	O
Human	S-y
Ref-8	O
BeadChip	O
according	O
to	O
the	O
Manufacturer	O
's	O
instructions	O
(	O
Illumina	O
,	O
Inc.	O
,	O
San	O
Diego	O
,	O
CA	O
)	O
.	O

Several	O
ESC-specific	O
gene	O
,	O
including	O
Lin41	S-GP
,	O
Sox2	S-GP
and	O
FoxD3	S-GP
,	O
were	O
not	O
detected	O
in	O
the	O
array	O
either	O
(	O
Table	O
3	O
)	O
.	O

However	O
,	O
immunocytochemistry	O
while	O
not	O
strictly	O
quantitative	O
shows	O
similar	O
variability	O
when	O
used	O
to	O
assess	O
Nanog	S-GP
expression	O
in	O
different	O
cell	O
lines	O
[	O
9,27,28	O
]	O
.	O

Low	O
expressions	O
are	O
colored	O
green	O
.	O

hESCs	S-cell_type
and	O
EBs	S-x
can	O
be	O
distinguished	O
from	O
each	O
otherIllumina	O
bead	O
array	O
analysis	O
confirmed	O
that	O
hESCs	S-cell_type
could	O
be	O
readily	O
distinguished	O
from	O
EBs	S-x
by	O
global	O
analysis	O
.	O

Comparison	O
between	O
the	O
two	O
methodologies	O
indicated	O
that	O
while	O
there	O
is	O
good	O
concordance	O
for	O
genes	O
expressed	O
at	O
high	O
levels	O
,	O
this	O
does	O
not	O
hold	O
for	O
genes	O
expressed	O
at	O
lower	O
levels	O
.	O

The	O
limited	O
concordance	O
at	O
low	O
levels	O
raises	O
a	O
question	O
as	O
to	O
how	O
many	O
genes	O
are	O
actually	O
expressed	O
by	O
any	O
one	O
cell	O
line	O
and	O
whether	O
the	O
cutoff	O
of	O
3	O
tpm	O
used	O
for	O
MPSS	O
or	O
100	O
intensity	O
units	O
for	O
bead	O
arrays	O
is	O
a	O
reasonable	O
cutoff	O
.	O

Each	O
of	O
these	O
methods	O
has	O
its	O
advantages	O
and	O
disadvantages	O
.	O

We	O
used	O
100	O
units	O
for	O
our	O
analysis	O
and	O
we	O
would	O
suggest	O
that	O
readers	O
exercise	O
similar	O
caution	O
.	O

The	O
goal	O
of	O
these	O
experiments	O
including	O
our	O
own	O
is	O
to	O
develop	O
a	O
low	O
cost	O
reliable	O
method	O
to	O
assess	O
multiple	O
samples	O
to	O
generate	O
a	O
global	O
database	O
of	O
markers	O
and	O
to	O
provide	O
a	O
method	O
of	O
identifying	O
core	O
measures	O
of	O
similarities	O
and	O
differences	O
across	O
multiple	O
laboratories	O
.	O

A	O
complete	O
list	O
of	O
genes	O
expressed	O
at	O
least	O
ten-fold	O
higher	O
in	O
human	B-cell_type
feeders	E-cell_type
is	O
provided	O
in	O
Figure	O
3	O
.	O

The	O
comparison	O
across	O
multiple	O
samples	O
will	O
allow	O
a	O
set	O
of	O
core	O
stem	O
cell	O
markers	O
to	O
be	O
identified	O
.	O

The	O
most	O
robust	O
were	O
RPS4Y	S-GP
,	O
RPS4Y2	S-GP
,	O
and	O
EIF1AY	S-GP
(	O
Figure	O
5	O
)	O
.	O

*	O
:	O
Most	O
of	O
the	O
genes	O
detected	O
by	O
MPSS	O
were	O
novel	O
genes	O
not	O
included	O
in	O
the	O
bead	O
array.ESNo.	O
%	O
Common	O
in	O
both	O
(	O
Top	O
2000	O
hits	O
)	O
1,62281.1Common	O
in	O
both	O
(	O
All	O
hits	O
)	O
5,07146.0By	O
bead	O
array	O
only3,46231.4By	O
MPSS	O
only	O
*2,50422.7Total11,037100EBNo.	O
%	O
Common	O
in	O
both	O
(	O
All	O
hits	O
)	O
5,16843.1By	O
bead	O
array	O
only4,13134.4By	O
MPSS	O
only	O
*2,69422.5Total11,993100	O
Human	B-cell_type
feeders	E-cell_type
and	O
hESCs	S-cell_type
can	O
be	O
readily	O
distinguished	O
and	O
contamination	O
can	O
be	O
readily	O
assessedFor	O
all	O
samples	O
,	O
we	O
conducted	O
an	O
unsupervised	O
one-way	O
hierarchical	O
clustering	O
analysis	O
.	O

It	O
will	O
be	O
necessary	O
to	O
develop	O
methods	O
to	O
monitor	O
and	O
assess	O
hESC	O
and	O
their	O
derivatives	O
on	O
a	O
routine	O
basis	O
.	O

One	O
microliter	O
RNase	B-GP
H	E-GP
(	O
Invitrogen	O
)	O
was	O
added	O
to	O
each	O
tube	O
and	O
incubated	O
for	O
20	O
minutes	O
at	O
37°C	O
before	O
proceeding	O
to	O
the	O
RT-PCR	O
analysis	O
.	O

The	O
clustering	O
analysis	O
was	O
based	O
on	O
the	O
average	O
linkage	O
and	O
Euclidean	O
distances	O
as	O
the	O
similarity	O
metric	O
using	O
differentially	O
expressed	O
genes	O
identified	O
by	O
ANOVA	O
(	O
P	O
<	O
0.05	O
)	O
.	O

Given	O
the	O
sensitivity	O
of	O
the	O
bead	O
array	O
analysis	O
,	O
we	O
tested	O
its	O
ability	O
to	O
detect	O
the	O
overall	O
similarities	O
and	O
differences	O
between	O
NTera2	S-cell_line
and	O
a	O
pooled	O
ESC	O
sample	O
or	O
between	O
the	O
karyotypically	O
abnormal	O
BG01V	S-cell_line
and	O
its	O
normal	O
parent	O
line	O
(	O
Figure	O
6	O
)	O
.Figure	O
6Diploid	O
pluripotent	O
EC	O
cell	O
line	O
NTera2	S-cell_line
and	O
karyotypically	O
abnormal	O
hESC	O
line	O
BG01V	S-cell_line
can	O
be	O
distinguished	O
from	O
normal	O
hESCs	S-cell_type
using	O
Illumina	O
array	O
.	O

Results	O
from	O
the	O
entire	O
sample	O
set	O
are	O
available	O
for	O
download	O
as	O
an	O
excel	O
spreadsheet	O
(	O
Additional	O
file	O
1	O
)	O
and	O
a	O
CD	O
of	O
the	O
results	O
is	O
available	O
upon	O
request	O
.	O

Black	O
represents	O
no	O
significant	O
change	O
in	O
expression	O
level	O
between	O
mean	O
and	O
sample	O
.	O

HS27	B-cell_type
embryonic	I-cell_type
human	I-cell_type
newborn	I-cell_type
foreskin	I-cell_type
cells	E-cell_type
(	O
ATCC	O
CRL-1634	O
)	O
were	O
grown	O
in	O
DMEM	O
with	O
10	O
%	O
FBS.All	O
samples	O
included	O
in	O
this	O
study	O
can	O
be	O
found	O
in	O
Additional	O
file	O
6.Bead	O
array	O
gene	O
expression	O
analysis	O
RNA	S-cellcomponent
was	O
isolated	O
from	O
cultured	O
cells	O
using	O
the	O
Qiagen	O
RNEasy	O
kit	O
(	O
Qiagen	O
,	O
Inc	O
,	O
Valencia	O
,	O
CA	O
)	O
.	O

More	O
recently	O
we	O
have	O
identified	O
BG01V	S-cell_line
as	O
a	O
karyotypically	O
abnormal	O
variant	O
that	O
behaves	O
much	O
like	O
its	O
normal	O
counterpart	O
BG01	S-cell_line
,	O
but	O
is	O
not	O
subject	O
to	O
the	O
same	O
constraints	O
of	O
use	O
as	O
karyotypically	O
normal	O
hESCs	S-cell_type
[	O
13	O
]	O
.	O

Arrays	O
were	O
scanned	O
with	O
an	O
Illumina	O
Bead	O
array	O
Reader	O
confocal	O
scanner	O
according	O
to	O
the	O
Manufacturer	O
's	O
instructions	O
.	O

Several	O
germ	O
cell	O
markers	O
such	O
as	O
GAGE2	S-GP
,	O
GAGE7	S-GP
and	O
GAGE8	S-GP
were	O
highly	O
expressed	O
in	O
NTera2	S-cell_line
but	O
were	O
absent	O
(	O
or	O
present	O
at	O
low	O
levels	O
)	O
in	O
any	O
of	O
the	O
hESC	O
lines	O
examined	O
(	O
See	O
Figure	O
6C	O
and	O
Additional	O
file	O
1	O
.	O

Since	O
differentiated	O
cells	O
are	O
often	O
scattered	O
within	O
or	O
at	O
the	O
edge	O
of	O
colonies	O
[	O
11	O
]	O
and	O
the	O
differentiation	O
is	O
so	O
subtle	O
that	O
morphological	O
characteristics	O
and	O
even	O
immunohistochemistry	O
are	O
insufficient	O
to	O
detect	O
it	O
,	O
larger	O
scale	O
methods	O
of	O
analysis	O
need	O
to	O
be	O
developed	O
.	O

hESCs	O
could	O
be	O
readily	O
distinguished	O
from	O
embryoid	B-x
bodies	E-x
(	O
EB	O
)	O
differentiated	O
from	O
them	O
and	O
the	O
karyotypically	O
abnormal	O
hESC	O
line	O
BG01V	S-cell_line
.	O

Using	O
this	O
cutoff	O
,	O
on	O
average	O
cells	O
expressed	O
approximately	O
8,000	O
transcripts	O
(	O
Table	O
1	O
,	O
2	O
)	O
,	O
a	O
number	O
similar	O
to	O
the	O
number	O
detected	O
by	O
SAGE	O
,	O
MPSS	O
and	O
EST	O
analysis	O
[	O
5-7,10,15,16	O
]	O
.	O

Five	O
potential	O
genes	O
RPS4Y	S-GP
,	O
RPS4Y2	S-GP
,	O
EIF1AY	S-GP
,	O
VCY	S-GP
,	O
and	O
AMELY	S-GP
are	O
located	O
in	O
the	O
Y	B-cellcomponent
chromosome	E-cellcomponent
.	O

The	O
BeadStudio	O
software	O
provided	O
with	O
the	O
BeadLab	O
and	O
BeadStudio	O
genetic	O
analysis	O
systems	O
for	O
use	O
with	O
the	O
bead	O
array	O
datasets	O
provides	O
a	O
useful	O
set	O
of	O
analytical	O
and	O
presentation	O
tools	O
that	O
allow	O
straightforward	O
comparisons	O
,	O
which	O
are	O
sufficient	O
for	O
average	O
users	O
.	O

For	O
cross-validation	O
of	O
prediction	O
results	O
,	O
multiple	O
classification	O
processes	O
were	O
performed	O
on	O
two	O
data	O
sets	O
randomly	O
constructed	O
each	O
time	O
from	O
the	O
entire	O
gene	O
expression	O
dataset	O
.	O

The	O
present	O
results	O
suggest	O
that	O
the	O
global	O
Illumina	O
bead	O
array	O
retains	O
the	O
advantages	O
of	O
low	O
cost	O
per	O
sample	O
associated	O
with	O
focused	O
arrays	O
yet	O
still	O
has	O
the	O
strength	O
of	O
the	O
global	O
attributes	O
of	O
MPSS	O
or	O
EST	O
scan	O
while	O
requiring	O
much	O
less	O
RNA	O
and	O
turnaround	O
time	O
.	O

Previously	O
we	O
found	O
that	O
as	O
few	O
as	O
four	O
were	O
satisfactory	O
to	O
distinguish	O
between	O
hESCs	S-cell_type
and	O
hEBs	S-x
,	O
which	O
are	O
two	O
much	O
more	O
closely	O
related	O
samples	O
[	O
9	O
]	O
.	O

hESC	O
cultureThe	O
hESC	O
lines	O
H1	S-cell_line
,	O
H7	S-cell_line
and	O
H9	S-cell_line
(	O
WiCell	O
,	O
Madison	O
,	O
WI	O
)	O
were	O
cultured	O
on	O
feeder	O
layers	O
derived	O
from	O
mitotically	O
inactivated	O
HS27	S-cell_line
human	B-cell_type
fibroblast	E-cell_type
cells	O
(	O
HS27	S-cell_line
,	O
ATCC	O
)	O
,	O
or	O
mouse	B-cell_type
embryonic	I-cell_type
fibroblsts	E-cell_type
or	O
under	O
feeder-free	O
conditions	O
on	O
Matrigel	O
(	O
BD	O
,	O
Franklin	O
Lakes	O
,	O
NJ	O
)	O
coated	O
plates	O
for	O
at	O
least	O
10	O
passages	O
.	O

The	O
genes	O
with	O
nonzero	O
components	O
in	O
each	O
class	O
were	O
almost	O
mutually	O
exclusive	O
and	O
represented	O
candidate	O
biomarkers	O
for	O
the	O
diagnosis	O
of	O
each	O
class	O
.	O

To	O
confirm	O
that	O
these	O
were	O
useful	O
markers	O
,	O
we	O
designed	O
RT-PCR	O
primers	O
and	O
tested	O
their	O
expression	O
in	O
a	O
male	S-x
(	O
BG01	S-cell_line
)	O
and	O
a	O
female	S-x
(	O
BG03	S-cell_line
)	O
line	O
(	O
Figure	O
5B	O
)	O
.	O

This	O
raised	O
the	O
possibility	O
that	O
this	O
microarray	O
strategy	O
may	O
be	O
sufficiently	O
sensitive	O
to	O
identify	O
relatively	O
cell	O
type	O
specific	O
candidate	O
genes	O
that	O
could	O
be	O
used	O
to	O
distinguish	O
one	O
hESC	O
population	O
from	O
another	O
or	O
to	O
identify	O
differences	O
that	O
were	O
due	O
to	O
varied	O
isolation	O
and	O
growth	O
conditions	O
.	O

An	O
additional	O
potential	O
application	O
of	O
such	O
an	O
analysis	O
is	O
the	O
ability	O
to	O
examine	O
the	O
general	O
state	O
of	O
a	O
particular	O
signaling	O
pathway	O
and	O
determine	O
whether	O
it	O
is	O
active	O
.	O

Amersham	O
fluorolink	O
streptavidin	S-GP
-Cy3	O
(	O
GE	O
Healthcare	O
Bio-Sciences	O
,	O
Little	O
Chalfont	O
,	O
UK	O
)	O
following	O
the	O
BeadChip	O
manual	O
.	O

In	O
particular	O
,	O
genes	O
expressed	O
at	O
low	O
levels	O
(	O
greater	O
than	O
70	O
%	O
of	O
all	O
genes	O
detected	O
)	O
should	O
not	O
be	O
assessed	O
in	O
cross	O
platform	O
comparisons	O
.	O

In	O
addition	O
,	O
we	O
have	O
generated	O
a	O
list	O
of	O
genes	O
differentially	O
expressed	O
at	O
higher	O
level	O
in	O
EBs	S-x
than	O
in	O
hESCs	S-cell_type
,	O
a	O
subset	O
of	O
which	O
is	O
shown	O
in	O
Table	O
5	O
.	O

The	O
four	O
genes	O
whose	O
expression	O
was	O
confirmed	O
by	O
qPCR	O
(	O
C	O
)	O
were	O
in	O
bold	O
.	O

None	O
of	O
these	O
were	O
present	O
in	O
BG01V	S-cell_line
,	O
indicating	O
that	O
the	O
karyotypically	O
abnormal	O
variant	O
is	O
not	O
the	O
equivalent	O
of	O
a	O
teratocarcinoma	S-x
line	O
such	O
as	O
NTera2	S-cell_line
.	O

EBs	S-x
were	O
separated	O
from	O
hESCs	S-cell_type
from	O
which	O
they	O
were	O
derived	O
.	O

We	O
examined	O
the	O
data	O
to	O
develop	O
a	O
list	O
of	O
genes	O
that	O
had	O
high	O
levels	O
of	O
expression	O
in	O
human	B-cell_type
feeder	I-cell_type
cells	E-cell_type
maintained	O
in	O
hESC	O
medium	O
but	O
whose	O
expression	O
was	O
low	O
or	O
absent	O
in	O
either	O
ESCs	S-cell_type
or	O
EBs	S-x
.	O

In	O
this	O
study	O
we	O
have	O
confirmed	O
by	O
qPCR	O
the	O
differential	O
expression	O
of	O
four	O
genes	O
,	O
THBS1	S-GP
,	O
MMP3	S-GP
,	O
TNFRSF11B	S-GP
and	O
KRTH4	S-GP
,	O
to	O
separate	O
human	B-cell_type
fibroblast	I-cell_type
feeders	E-cell_type
and	O
hESCs	S-cell_type
(	O
Figure	O
3	O
)	O
.	O

The	O
absence	O
of	O
expression	O
can	O
not	O
be	O
readily	O
interpreted	O
.	O

The	O
resolution	O
was	O
sufficient	O
that	O
ESC	O
samples	O
could	O
be	O
distinguished	O
from	O
one	O
another	O
and	O
a	O
variant	O
karyotypically	S-x
abnormal	O
subclone	O
could	O
be	O
distinguished	O
from	O
the	O
parent	S-x
population	O
(	O
correlation	O
coefficient	O
=	O
0.9043	O
)	O
.	O

Novel	O
stage-specific	O
genes	O
that	O
distinguish	O
between	O
hESCs	S-cell_type
and	O
EBs	S-x
have	O
been	O
identified	O
and	O
allelic	S-cellcomponent
differences	O
between	O
ESC	O
have	O
begun	O
to	O
be	O
recognized	O
[	O
8-10	O
]	O
.	O

In	O
PAM	O
,	O
a	O
list	O
of	O
significant	O
IGF	S-GP
pathway	O
genes	O
whose	O
expression	O
characterizes	O
each	O
diagnostic	O
class	O
was	O
obtained	O
.	O

Nevertheless	O
even	O
at	O
this	O
higher	O
cutoff	O
the	O
arrays	O
were	O
remarkably	O
sensitive	O
and	O
allowed	O
us	O
to	O
readily	O
distinguish	O
between	O
samples	O
including	O
cells	O
grown	O
in	O
the	O
same	O
laboratory	O
.	O

We	O
believe	O
that	O
the	O
problem	O
with	O
Lin	B-GP
41	E-GP
,	O
Sox2	S-GP
and	O
FoxD3	S-GP
is	O
a	O
technical	O
one	O
as	O
we	O
were	O
able	O
to	O
confirm	O
expression	O
using	O
alternate	O
methods	O
.	O

Labeling	O
was	O
achieved	O
by	O
use	O
of	O
the	O
incorporation	O
of	O
biotin-16-UTP	S-GP
(	O
Perkin	O
Elmer	O
Life	O
and	O
Analytical	O
Sciences	O
,	O
Boston	O
,	O
MA	O
)	O
present	O
at	O
a	O
ratio	O
of	O
1:1	O
with	O
unlabeled	O
UTP	S-GP
.	O

These	O
coating	O
substrata	O
supported	O
the	O
growth	O
of	O
hESCs	S-cell_type
similarly	O
,	O
as	O
evaluated	O
by	O
colony	O
morphology	O
,	O
immunocytochemistry	O
and	O
proliferation	O
rate	O
(	O
data	O
not	O
shown	O
)	O
.	O
Embryoid	B-x
bodies	E-x
(	O
EBs	S-x
)	O
were	O
prepared	O
from	O
BG	O
lines	O
as	O
described	O
in	O
[	O
5	O
]	O
.	O

of	O
all	O
genes	O
(	O
expr.	O
>	O
0	O
)	O
§R2of	O
all	O
genes	O
(	O
expr	O
.	O

Quantitative	O
RT-PCR	O
(	O
qPCR	O
)	O
was	O
used	O
to	O
verify	O
the	O
fold	O
change	O
of	O
the	O
expression	O
of	O
4	O
genes	O
,	O
including	O
THBS1	S-GP
,	O
MMP3	S-GP
,	O
TNFRSF11B	S-GP
and	O
KRTHA4	S-GP
(	O
Figure	O
3C	O
)	O
.	O

Each	O
row	O
represents	O
the	O
relative	O
levels	O
of	O
expression	O
of	O
a	O
single	O
gene	O
.	O

In	O
subsequent	O
sections	O
we	O
have	O
performed	O
such	O
analysis	O
.	O

Samples	O
cluster	O
closer	O
within	O
their	O
own	O
group	O
than	O
samples	O
from	O
other	O
groups.Figure	O
2Dendrogram	O
of	O
unsupervised	O
one-way	O
hierarchical	O
clustering	O
analysis	O
of	O
relative	O
expression	O
of	O
genes	O
in	O
selected	O
samples	O
.	O

EC	B-cell_type
cells	E-cell_type
such	O
as	O
NTera2	S-cell_line
could	O
be	O
distinguished	O
from	O
hESCs	S-cell_type
by	O
the	O
expression	O
of	O
germ	O
cell	O
markers	O
and	O
the	O
presence	O
of	O
a	O
partially	O
inactivated	O
TGFβ	S-GP
(	O
BMP	S-GP
)	O
signaling	O
pathway	O
(	O
Figure	O
6	O
)	O
.	O

For	O
detailed	O
analysis	O
we	O
recommend	O
using	O
more	O
specific	O
commercial	O
tools	O
or	O
software	O
packages	O
developed	O
by	O
NCBI	O
.	O

Pairwise	O
comparisons	O
of	O
human	B-cell_type
feeders	E-cell_type
with	O
hESCs	S-cell_type
resulted	O
in	O
a	O
correlation	O
coefficient	O
of	O
0.66	O
,	O
which	O
was	O
less	O
than	O
the	O
correlation	O
coefficient	O
of	O
0.71–0.74	O
observed	O
between	O
hESCs	S-cell_type
and	O
their	O
corresponding	O
EBs	S-x
.	O

We	O
have	O
been	O
using	O
HS27	S-cell_line
as	O
feeder	B-cell_type
cells	E-cell_type
for	O
H9	S-cell_line
hESCs	S-cell_type
for	O
more	O
than	O
two	O
years	O
and	O
all	O
hESCs	S-cell_type
grown	O
on	O
HS27	S-cell_line
had	O
normal	O
karyotype	S-cellcomponent
,	O
expressed	O
all	O
undifferentiated	O
markers	O
,	O
and	O
made	O
teratomas	S-x
with	O
all	O
germ	B-x
layers	E-x
(	O
data	O
not	O
show	O
)	O
.	O

The	O
first	O
dataset	O
,	O
consisting	O
of	O
70	O
%	O
of	O
the	O
total	O
data	O
,	O
was	O
used	O
as	O
the	O
training	O
dataset	O
,	O
and	O
the	O
other	O
dataset	O
,	O
containing	O
the	O
remaining	O
30	O
%	O
of	O
data	O
,	O
was	O
used	O
for	O
the	O
data	O
prediction	O
and	O
verification	O
process	O
.	O

Several	O
such	O
candidate	O
genes	O
were	O
identified	O
.	O

The	O
nearest	O
centroid	O
classification	O
computed	O
by	O
PAM	O
takes	O
the	O
protein	O
expression	O
profile	O
from	O
a	O
new	O
sample	O
,	O
and	O
compares	O
it	O
to	O
each	O
of	O
these	O
class	O
centroids	O
[	O
26	O
]	O
.RT-PCR	O
and	O
quantitative	O
real-time	O
PCR	O
analysisTotal	O
RNA	S-cellcomponent
was	O
isolated	O
with	O
TRIzol	O
(	O
Invitrogen	O
.	O

G3PDH	S-GP
was	O
used	O
as	O
an	O
internal	O
control	O
.	O

To	O
show	O
the	O
similarity	O
of	O
relative	O
gene	O
expression	O
between	O
samples	O
,	O
we	O
have	O
used	O
Illumina	O
Beadstudio	O
and	O
clustering	O
software	O
packages	O
Pcluster	O
[	O
17	O
]	O
and	O
TreeView	O
[	O
18	O
]	O
to	O
generate	O
a	O
heat-map	O
(	O
Figure	O
1	O
)	O
and	O
a	O
dendrogram	O
(	O
Figure	O
2	O
)	O
.	O

Gene	O
expression	O
in	O
hESC	O
has	O
been	O
investigated	O
by	O
a	O
variety	O
of	O
techniques	O
including	O
massively	O
parallel	O
signature	O
sequencing	O
(	O
MPSS	O
)	O
,	O
serial	O
analysis	O
of	O
gene	O
expression	O
(	O
SAGE	O
)	O
,	O
expressed	O
sequence	O
tag	O
(	O
EST	O
)	O
scan	O
,	O
large	O
scale	O
microarrays	O
,	O
focused	O
cDNA	S-cellcomponent
microarrays	O
,	O
and	O
immunocytochemistry	O
[	O
5-7	O
]	O
.	O

Comparison	O
of	O
NTera2	S-cell_line
and	O
pooled	O
hESC	O
sample	O
resulted	O
a	O
correlation	O
coefficient	O
of	O
0.8997	O
.	O

Samples	O
were	O
blinded	O
and	O
biological	O
and	O
technical	O
repeats	O
were	O
examined	O
at	O
the	O
same	O
time	O
.	O

EC	S-x
line	O
NTera2	S-cell_line
and	O
feeder	B-cell_type
cells	E-cell_type
can	O
be	O
distinguished	O
from	O
hESCs	S-cell_type
respectively.The	O
global	O
analysis	O
suggested	O
that	O
the	O
bead	O
arrays	O
used	O
were	O
sufficiently	O
sensitive	O
such	O
that	O
individual	O
subsets	O
of	O
genes	O
could	O
be	O
analyzed	O
,	O
different	O
populations	O
of	O
cells	O
could	O
be	O
readily	O
distinguished	O
and	O
that	O
a	O
subset	O
of	O
candidate	O
genes	O
could	O
be	O
sufficient	O
to	O
distinguish	O
between	O
groups	O
of	O
cells	O
.	O

While	O
we	O
have	O
focused	O
on	O
the	O
immediate	O
utility	O
of	O
the	O
Illumina	O
array	O
platform	O
,	O
it	O
is	O
important	O
to	O
remember	O
that	O
this	O
array	O
provides	O
a	O
global	O
snapshot	O
of	O
cell	O
state	O
and	O
the	O
data	O
obtained	O
can	O
be	O
readily	O
compared	O
in	O
order	O
to	O
determine	O
key	O
signaling	O
pathways	O
.	O

By	O
comparing	O
the	O
expression	O
level	O
of	O
these	O
genes	O
in	O
all	O
hESC	O
lines	O
,	O
we	O
have	O
found	O
that	O
3	O
out	O
of	O
5	O
were	O
specifically	O
expressed	O
in	O
male	S-x
hESC	O
lines	O
I6	S-cell_line
,	O
BG01	S-cell_line
and	O
BG02	S-cell_line
(	O
A	O
)	O
and	O
this	O
was	O
verified	O
by	O
RT-PCR	O
in	O
male	S-x
line	O
BG01	S-cell_line
and	O
female	O
line	O
BG03	S-cell_line
(	O
B	O
)	O
.	O

>	O
0	O
)	O
No	O
.	O

The	O
PCR	O
primers	O
are	O
:	O
RPS4Y	S-GP
-forward	O
:	O
5	O
'	O
AGATTCTCTTCCGTCGCAG	O
3	O
'	O
,	O
RPS4Y	S-GP
-reverse	O
,	O
5	O
'	O
CTCCACCAATCACCATACAC	O
3	O
'	O
;	O
EIFAY	S-GP
-forward	O
,	O
5	O
'	O
CTGCTGCATCTTAGTTCAGTC	O
3	O
'	O
;	O
EIFAY	S-GP
-reverse	O
5	O
'	O
CTTCCAATCGTCCATTTCCC	O
3	O
'	O
.	O

In	O
the	O
graph	O
(	O
C	O
)	O
,	O
gene	O
expression	O
of	O
each	O
gene	O
in	O
feeder	B-cell_type
cells	E-cell_type
was	O
designated	O
as	O
1	O
fold	O
and	O
the	O
bars	O
represented	O
fold	O
decrease	O
for	O
each	O
gene.Thus	O
this	O
comparison	O
allowed	O
us	O
to	O
distinguish	O
between	O
hESCs	S-cell_type
and	O
human	B-cell_type
feeders	E-cell_type
and	O
identify	O
candidate	O
markers	O
that	O
could	O
detect	O
feeder	O
cell	O
contamination	O
should	O
human	B-cell_type
feeders	E-cell_type
be	O
used	O
in	O
the	O
propagation	O
of	O
hESCs	S-cell_type
.	O

This	O
raised	O
the	O
possibility	O
that	O
specific	O
subsets	O
of	O
markers	O
could	O
be	O
identified	O
.	O

This	O
array	O
allowed	O
us	O
to	O
estimate	O
the	O
degree	O
of	O
feeder	O
contamination	O
present	O
in	O
the	O
cultures	O
.	O

of	O
genes	O
(	O
>	O
0.99	O
)	O
*R2	O
of	O
genes	O
(	O
>	O
0.99	O
)	O
*No	O
.	O

We	O
employed	O
a	O
pre-commercial	O
prototype	O
of	O
the	O
Illumina	O
Human	S-y
Ref-8	O
BeadChip	O
[	O
12	O
]	O
,	O
a	O
genome-scale	O
bead	O
based	O
array	O
technology	O
that	O
combines	O
the	O
sensitivity	O
and	O
low	O
cost	O
of	O
a	O
focused	O
array	O
with	O
the	O
coverage	O
of	O
a	O
large	O
scale	O
array	O
,	O
while	O
requiring	O
much	O
smaller	O
sample	O
sizes	O
than	O
MPSS	O
,	O
EST	O
scan	O
or	O
SAGE	O
.	O

Most	O
of	O
the	O
genes	O
were	O
also	O
identified	O
using	O
Illumina	O
bead	O
array	O
in	O
all	O
8	O
hESC	O
populations	O
in	O
this	O
study	O
(	O
1*	O
)	O
,	O
the	O
gene	O
CER1	S-GP
was	O
detected	O
in	O
all	O
except	O
one	O
duplicate	O
of	O
H9	S-cell_line
(	O
2*	O
)	O
,	O
Nanog	S-GP
was	O
not	O
detected	O
in	O
all	O
populations	O
(	O
3*	O
)	O
and	O
Sox2	S-GP
,	O
Lin41	S-GP
,	O
NR6A1	S-GP
and	O
FoxD3	S-GP
were	O
not	O
detected	O
in	O
the	O
array	O
although	O
they	O
were	O
present	O
in	O
the	O
chips	O
for	O
hybridization	O
(	O
4*	O
)	O
.AccessionSymbolPooled	O
ES	S-cell_type
(	O
H1	S-cell_line
,	O
7	S-cell_line
,	O
9	S-cell_line
)	O
CommentsNM_003641.1IFITM188441*NM_020997.2LEFTB6579.61*NM_024674.3LIN283944.11*NM_175849.1DNMT3B33911*NM_003212.1TDGF131691*NM_001769.2CD92930.81*NM_000165.2GJA12404.41*NM_021195.2CLDN62247.21*NM_004360.2CDH11972.91*NM_021127.1PMAIP11601.51*NM_032805.1ZNF2061504.51*NM_003577.1UTF11444.11*XM_050625.2SFRP21353.91*NM_006548.3IMP-212061*NM_152312.2GYLTL1B1066.61*NM_015973.2GAL1043.31*NM_003240.2EBAF944.11*NM_054023.2SCGB3A2890.51*NM_020990.2CKMT1742.41*NM_033668.1ITGB1694.71*NM_003744.3NUMB618.31*NM_007015.1LECT1597.41*NM_021912.2GABRB3482.71*NM_006729.2DIAPH2467.11*NM_000222.1KIT188.91*NM_005454.1CER1151.52*NM_024865.1NANOG56.93*NM_002701.1POU5F1694.41*NM_003106SOX2ND4*NM_006458.2LIN41ND4*NM_001489.3NR6A1ND4*NM_012183FOXD3ND4*Table	O
4Comparison	O
of	O
MPSS	O
and	O
Illumina	O
bead	O
array	O
results	O
The	O
samples	O
were	O
analyzed	O
by	O
MPSS	O
and	O
bead	O
array	O
.	O

Readers	O
are	O
urged	O
to	O
analyze	O
the	O
expression	O
of	O
desired	O
genes	O
directly	O
as	O
it	O
is	O
impossible	O
to	O
test	O
every	O
gene	O
given	O
the	O
large	O
body	O
of	O
data	O
generated	O
.	O

Two	O
lists	O
of	O
genes	O
,	O
which	O
were	O
specifically	O
expressed	O
in	O
NTera2	S-cell_line
(	O
C	O
)	O
or	O
in	O
hESCs	S-cell_type
(	O
E	O
)	O
were	O
identified	O
.	O

As	O
a	O
test	O
of	O
the	O
quality	O
of	O
the	O
data	O
generated	O
in	O
these	O
experiments	O
and	O
to	O
evaluate	O
whether	O
comparisons	O
can	O
be	O
made	O
across	O
different	O
methodologies	O
,	O
we	O
re-ran	O
the	O
identical	O
samples	O
on	O
the	O
bead	O
array	O
platform	O
.	O

Genes	O
plotted	O
outside	O
the	O
two	O
thin	O
red	O
lines	O
were	O
detected	O
at	O
>	O
2.5-	O
fold	O
difference.Our	O
results	O
showed	O
that	O
,	O
while	O
NTera2	S-cell_line
shared	O
a	O
high	O
similarity	O
with	O
hESCs	S-cell_type
[	O
21	O
]	O
,	O
it	O
did	O
have	O
important	O
differences	O
with	O
hESC	O
lines	O
.	O

Each	O
column	O
represents	O
a	O
sample	O
.	O

The	O
total	O
number	O
of	O
genes	O
identified	O
as	O
expressed	O
at	O
>	O
0.99	O
confidence	O
is	O
summarized	O
in	O
Table	O
1	O
.	O

The	O
embryonal	B-x
carcinoma	E-x
(	O
EC	S-cell_type
)	O
line	O
NTera2	S-cell_line
is	O
a	O
useful	O
model	O
for	O
evaluating	O
characteristics	O
of	O
hESCs	S-cell_type
.	O

These	O
markers	O
were	O
common	O
to	O
all	O
EB	O
samples	O
tested	O
and	O
included	O
genes	O
known	O
to	O
be	O
expressed	O
in	O
ectoderm	S-x
,	O
endoderm	S-x
and	O
mesoderm	S-x
.	O

Embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
ESCs	S-cell_type
)	O
,	O
derived	O
from	O
the	O
inner	B-x
cell	I-x
mass	E-x
of	O
pre-implantation	B-x
embryos	E-x
,	O
have	O
been	O
recognized	O
as	O
the	O
most	O
p	O
luripotent	B-x
stem	I-x
cell	I-x
population	E-x
.	O

The	O
analysis	O
revealed	O
the	O
underlying	O
features	O
and	O
variation	O
patterns	O
of	O
gene	O
expression	O
in	O
each	O
cell	O
types	O
.	O

A	O
subset	O
of	O
these	O
markers	O
have	O
been	O
used	O
to	O
develop	O
a	O
qPCR	O
assay	O
that	O
shows	O
such	O
a	O
high	O
sensitivity	O
that	O
changes	O
in	O
cell	O
behavior	O
can	O
be	O
detected	O
after	O
as	O
little	O
as	O
twenty-four	O
hours	O
and	O
the	O
development	O
of	O
EBs	S-x
can	O
be	O
reliably	O
staged	O
[	O
10,20	O
]	O
.	O

Correlation	O
coefficients	O
(	O
R2	O
)	O
were	O
generated	O
using	O
all	O
genes	O
with	O
expression	O
level	O
>	O
0	O
(	O
black	O
and	O
blue	O
dots	O
)	O
,	O
or	O
all	O
genes	O
with	O
detection	O
confidence	O
>	O
0.99	O
(	O
blue	O
dots	O
)	O
.	O

Examining	O
these	O
differences	O
(	O
summarized	O
in	O
Figure	O
6C	O
and	O
6E	O
)	O
,	O
we	O
noted	O
that	O
some	O
reflected	O
the	O
origin	O
of	O
the	O
tumor	B-cell_type
cells	E-cell_type
from	O
which	O
this	O
line	O
was	O
derived	O
[	O
14	O
]	O
.	O

The	O
numbers	O
are	O
similar	O
to	O
results	O
obtained	O
by	O
other	O
large	O
scale	O
analysis	O
such	O
as	O
MPSS.Abundance	O
(	O
relative	O
detection	O
levels	O
)	O
H9	S-cell_line
H9	S-cell_line
on	O
human	B-cell_type
feeders	E-cell_type
I6	S-cell_line
BG01	S-cell_line
BG02	S-cell_line
BG03	S-cell_line
BG01V	S-cell_line
Pooled	O
(	O
H1	S-cell_line
,	O
H7	S-cell_line
,	O
H9	S-cell_line
)	O
No.	O
%	O
No.	O
%	O
No.	O
%	O
No.	O
%	O
No.	O
%	O
No.	O
%	O
No.	O
%	O
No.	O
%	O
<	O
502,90921.26,06738.43,55925.34,52830.74,25630.54,70632.24194.35,80334.4	O
>	O
5010,81778.89,74761.610,48474.710,23269.39,69469.59,91567.89,43895.711,08565.6	O
>	O
1008,12659.27,53947.77,40952.87,70352.27,49653.77,43050.87,23073.38,21748.7	O
>	O
5003,07722.42,94718.62,62618.73,06520.82,95021.12,85219.52,85128.92,94117.4	O
>	O
10001,62911.91,62510.31,49010.61,63811.11,58911.41,51710.41,56615.91,5549.2	O
>	O
50002481.82571.62561.82561.72631.92621.82752.82511.5	O
>	O
10000900.7940.61120.8920.61000.71070.71011.0940.6Total	O
No	O
.	O

(	O
>	O
0.99	O
,	O
level	O
>	O
100	O
)	O
#	O
H9	S-cell_line
18,8990.868113,6720.97087,408I619,1390.866312,5700.97616,826	O
NTera2	S-cell_line
19,1620.874114,0360.93827,147	O
Feeder	S-cell_type
18,1570.872410,6060.97517,021Table	O
2Distribution	O
of	O
genes	O
with	O
expression	O
levels	O
<	O
50	O
and	O
>	O
50–10,000	O
as	O
detected	O
by	O
Illumina	O
bead	O
array	O
in	O
8	O
hESC	O
populations	O
All	O
human	B-cell_type
ESC	E-cell_type
samples	O
were	O
hybridized	O
in	O
one	O
experiment	O
and	O
the	O
relative	O
detection	O
levels	O
of	O
genes	O
were	O
binned	O
to	O
obtain	O
a	O
global	O
overview	O
of	O
transcription	O
,	O
approximately	O
8	O
,	O
000	O
genes	O
(	O
~50	O
%	O
)	O
were	O
greater	O
than	O
100	O
arbitrary	O
units	O
.	O

Often	O
genes	O
called	O
by	O
the	O
same	O
symbol	O
originate	O
from	O
different	O
database	O
records	O
,	O
which	O
may	O
originate	O
from	O
different	O
splice	O
variants	O
or	O
contain	O
sequence	O
differences	O
due	O
to	O
polymorphisms	O
or	O
outright	O
error	O
[	O
19	O
]	O
.Table	O
3Expression	O
of	O
hESC	O
specific	O
markers	O
in	O
pooled	O
hESC	O
sample	O
as	O
detected	O
by	O
Illumina	O
bead	O
array	O
The	O
expression	O
of	O
previously	O
identified	O
hESC	O
markers	O
was	O
examined	O
in	O
all	O
hESC	O
samples	O
(	O
the	O
values	O
displayed	O
represent	O
the	O
expression	O
level	O
of	O
pooled	O
H1	S-cell_line
,	O
H7	S-cell_line
and	O
H9	S-cell_line
)	O
.	O

Culture	O
medium	O
was	O
DMEM/F12	O
,	O
1:1	O
supplemented	O
with	O
20	O
%	O
Knockout	O
Serum	O
Replacement	O
,	O
2	O
mM	O
non-essential	O
amino	O
acids	O
,	O
2	O
mM	O
L-glutamine	O
,	O
50	O
μg/ml	O
Pen-Strep	O
,	O
100	O
μM	O
beta-mercaptoethanol	O
,	O
and	O
4	O
ng/ml	O
of	O
bFGF	S-GP
.Different	O
hESC	O
lines	O
were	O
grown	O
in	O
slightly	O
different	O
culture	O
conditions	O
as	O
described	O
above	O
.	O

Nevertheless	O
,	O
this	O
comparison	O
provides	O
an	O
independent	O
verification	O
of	O
the	O
data	O
and	O
suggests	O
that	O
if	O
a	O
sample	O
is	O
detected	O
in	O
more	O
than	O
one	O
large-scale	O
analysis	O
,	O
the	O
reliability	O
of	O
the	O
gene	O
expression	O
detection	O
is	O
high	O
,	O
which	O
also	O
reduces	O
the	O
number	O
of	O
individual	O
genes	O
needed	O
to	O
be	O
verified	O
.	O

The	O
average	O
gene	O
expression	O
level	O
in	O
each	O
class	O
was	O
divided	O
by	O
the	O
within-class	O
standard	O
deviation	O
.	O

Efforts	O
to	O
identify	O
other	O
useful	O
antibodies	O
based	O
on	O
these	O
results	O
continue	O
[	O
29	O
]	O
.	O

The	O
samples	O
include	O
four	O
groups	O
of	O
cells	O
,	O
ES	S-cell_type
designates	O
11	O
samples	O
of	O
hESCs	S-cell_type
,	O
EB	O
contains	O
6	O
samples	O
of	O
differentiated	O
ESCs	S-cell_type
and	O
EBs	S-x
,	O
NS	S-cell_type
consists	O
of	O
3	O
hESC	O
derived	O
neural	B-cell_type
cells	E-cell_type
and	O
FB	S-cell_type
is	O
a	O
collection	O
of	O
hESC	O
derived	O
mesenchyme	S-x
and	O
fibroblasts	S-cell_type
.	O

These	O
three	O
hESC	O
lines	O
share	O
high	O
similarities	O
as	O
shown	O
by	O
the	O
scatterplots	O
of	O
BG01	S-cell_line
vs	O
BG02	S-cell_line
(	O
B	O
)	O
,	O
BG01	S-cell_line
vs	O
BG03	S-cell_line
(	O
D	O
)	O
and	O
BG02	S-cell_line
vs	O
BG03	S-cell_line
(	O
F	O
)	O
.	O

All	O
data	O
analyses	O
were	O
performed	O
using	O
the	O
bioconductor	O
package	O
[	O
17	O
]	O
.Figure	O
7Identification	O
of	O
diagnostic	O
markers	O
by	O
PAM	O
.	O

Array	O
data	O
processing	O
and	O
analysis	O
was	O
performed	O
using	O
Illumina	O
BeadStudio	O
software.Identification	O
of	O
differentially	O
expressed	O
genes	O
and	O
clustering	O
analysisDifferentially	O
expressed	O
genes	O
between	O
ES	S-cell_type
and	O
EB	O
were	O
identified	O
by	O
ANOVA	O
at	O
p	O
value	O
0.05	O
using	O
bioconductor	O
[	O
17	O
]	O
.	O

We	O
noted	O
that	O
several	O
of	O
these	O
continued	O
to	O
be	O
expressed	O
at	O
high	O
levels	O
as	O
ESCs	S-cell_type
differentiated	O
to	O
form	O
EBs	S-cell_type
and	O
upon	O
further	O
differentiation	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
these	O
markers	O
might	O
be	O
used	O
in	O
adult	B-cell_type
stem	I-cell_type
cell	E-cell_type
and	O
germ	O
cell	O
populations	O
as	O
well.Figure	O
5	O
Male	S-x
and	O
female	S-x
hESC	O
lines	O
can	O
be	O
distinguished	O
by	O
genes	O
identified	O
by	O
bead	O
array	O
.	O

By	O
suitable	O
selection	O
of	O
different	O
germ	B-x
cell	I-x
layer	E-x
specific	O
markers	O
one	O
may	O
also	O
assess	O
the	O
overall	O
quality	O
of	O
differentiation	O
toward	O
germ	B-cell_type
cells	E-cell_type
.Table	O
5Genes	O
which	O
are	O
differentially	O
expressed	O
at	O
higher	O
levels	O
in	O
EBs	S-x
than	O
in	O
hESCs	S-cell_type
SymbolAll	O
EBAll	O
ESEB/ESRELN11120.52224.0SST1394.25.5253.5SLC40A11210.19.1133.0IGF24896.938.4127.5SLN2017.817118.7DCN7588.176.299.6ANXA84048.941.996.6AQP11665.420.581.2APOB1256.415.879.5AHSG1414.320.868.0NID21476.731.447.0FGB221052.442.2LUM8439.4205.441.1MGP2772.469.839.7THBD1206.434.435.1SERPINA11255.643.728.7HAND112294437.428.1HBE11106.542.626.0TTR7661.2347.122.1HBG21601.185.618.7COL2A11636.291.817.8KIAA09771370.87817.6AFP8941552.316.2COL3A11355796714.0IGFBP38446.3603.414.0PAX61577.8118.213.3APOA19398.1709.813.2FRZB3523.7315.711.2SPON21548.7159.49.7CEBPD1100.2122.79.0DLK13355.8374.89.0RDC11589.7192.18.3BMP41851.5227.38.1PITX21057.9131.28.1ACTA25045629.88.0GAS11215.61547.9AGTRL11053.8135.17.8COL5A15876.4765.47.7CDKN1C3134.1412.97.6CXCL142220.5312.67.1DOK41011.1145.27.0ARHGDIB1635.3246.56.6FLRT21879.5314.36.0MSX12771.8499.75.5	O
Smaller	O
but	O
distinct	O
differences	O
among	O
undifferentiated	O
hESC	O
linesOur	O
cluster	O
analysis	O
indicated	O
that	O
BG01	S-cell_line
,	O
BG02	S-cell_line
and	O
BG03	S-cell_line
cell	O
lines	O
were	O
overall	O
more	O
similar	O
to	O
each	O
other	O
than	O
to	O
other	O
lines	O
(	O
Figure	O
1	O
and	O
2	O
)	O
,	O
but	O
nevertheless	O
showed	O
additional	O
differences	O
than	O
technical	O
or	O
biological	O
repeats	O
of	O
the	O
same	O
sample	O
.	O

A	O
single	O
slide	O
contained	O
eight	O
replicates	O
and	O
six	O
such	O
slides	O
were	O
used	O
for	O
the	O
present	O
set	O
of	O
samples	O
.	O

The	O
ability	O
to	O
compare	O
multiple	O
samples	O
in	O
one	O
run	O
enhances	O
data	O
selectivity	O
and	O
reliability	O
.	O

As	O
with	O
other	O
analysis	O
,	O
genes	O
with	O
the	O
highest	O
abundance	O
were	O
housekeeping	O
genes	O
,	O
ribosomal	O
genes	O
and	O
structural	O
genes	O
(	O
Table	O
2	O
and	O
Additional	O
file	O
1	O
)	O
.	O

Bead	O
array	O
can	O
also	O
be	O
used	O
to	O
distinguish	O
between	O
male	S-x
and	O
female	O
lines	O
.	O

In	O
addition	O
to	O
the	O
expression	O
of	O
germ	O
cell	O
markers	O
,	O
we	O
noticed	O
a	O
significant	O
difference	O
in	O
the	O
expression	O
of	O
genes	O
in	O
the	O
TGFβ	S-GP
pathway	O
,	O
such	O
as	O
GDF3	S-GP
(	O
Figure	O
6C	O
)	O
,	O
TGFBI	S-GP
,	O
CDKN1A	S-GP
,	O
IGFBP7	S-GP
,	O
IGFBP3	S-GP
,	O
NODAL	S-GP
,	O
CER1	S-GP
and	O
BMP2	S-GP
(	O
Figure	O
6E	O
)	O
.	O

We	O
and	O
others	O
have	O
used	O
MPSS	O
and	O
EST	O
scan	O
and	O
generated	O
array	O
data	O
to	O
make	O
lists	O
of	O
hESC-specific	O
genes	O
[	O
5,9,10,20	O
]	O
.	O

By	O
using	O
cells	O
grown	O
in	O
different	O
conditions	O
we	O
expected	O
to	O
be	O
able	O
to	O
identify	O
core	O
commonalities	O
and	O
by	O
comparing	O
feeders	S-cell_type
and	O
embryoid	B-x
bodies	E-x
(	O
EB	O
)	O
with	O
hESC	O
identify	O
measures	O
of	O
contamination	O
and	O
early	O
markers	O
of	O
differentiation	O
.	O

Note	O
that	O
the	O
GAGE	S-GP
genes	O
are	O
highly	O
similar	O
in	O
sequence	O
,	O
making	O
it	O
difficult	O
to	O
distinguish	O
one	O
family	O
member	O
from	O
another	O
through	O
hybridization	O
;	O
thus	O
,	O
while	O
all	O
of	O
these	O
GAGE	O
gene	O
probes	O
gave	O
positive	O
signal	O
,	O
it	O
is	O
difficult	O
to	O
say	O
if	O
the	O
signal	O
came	O
from	O
the	O
specific	O
gene	O
itself	O
or	O
from	O
cross-hybridization	O
from	O
one	O
of	O
the	O
other	O
family	O
members	O
)	O
.	O

Each	O
gene	O
was	O
represented	O
by	O
sequences	O
containing	O
an	O
average	O
of	O
thirty	O
beads	O
to	O
provide	O
an	O
internal	O
measure	O
of	O
reliability	O
.	O

As	O
the	O
potential	O
of	O
hESCs	S-cell_type
and	O
their	O
derivatives	O
for	O
regenerative	O
medicine	O
is	O
being	O
evaluated	O
,	O
it	O
has	O
become	O
clear	O
that	O
the	O
overall	O
state	O
of	O
the	O
cells	O
,	O
degree	O
of	O
contamination	O
and	O
comparisons	O
of	O
the	O
more	O
than	O
a	O
hundred	O
different	O
newly	O
derived	O
lines	O
will	O
need	O
to	O
be	O
performed	O
.	O

Genes	O
outside	O
the	O
two	O
thin	O
red	O
lines	O
were	O
detected	O
at	O
>	O
2.5-	O
fold	O
difference.We	O
reasoned	O
as	O
well	O
that	O
such	O
a	O
global	O
comparison	O
should	O
allow	O
us	O
to	O
distinguish	O
between	O
male	S-x
and	O
female	S-x
lines	O
if	O
genes	O
present	O
on	O
the	O
Y	O
chromosome	O
were	O
expressed	O
at	O
high	O
levels	O
in	O
the	O
undifferentiated	O
state	O
and	O
were	O
detected	O
by	O
the	O
bead	O
array	O
.	O

Similarities	O
and	O
differences	O
between	O
EC	S-cell_type
line	O
NTera2	S-cell_line
and	O
hESC	O
lines	O
could	O
be	O
determined	O
and	O
verified	O
,	O
and	O
the	O
database	O
comparisons	O
allowed	O
us	O
to	O
identify	O
core	O
self-renewal	O
pathways	O
that	O
regulate	O
hESC	O
propagation	O
.	O

Further	O
confirmation	O
can	O
also	O
be	O
done	O
using	O
immunocytochemistry	O
,	O
as	O
antibodies	O
against	O
these	O
genes	O
are	O
commercially	O
available.Figure	O
3	O
Human	B-cell_type
fibroblast	I-cell_type
feeder	I-cell_type
cells	E-cell_type
can	O
be	O
distinguished	O
from	O
hESCs	S-cell_type
and	O
EBs	S-x
.	O

Early	O
markers	O
of	O
differentiation	O
appeared	O
to	O
be	O
present	O
at	O
higher	O
levels	O
in	O
BG01V	S-cell_line
as	O
compared	O
to	O
any	O
of	O
the	O
hESC	O
lines	O
examined	O
,	O
although	O
hESC	O
specific	O
genes	O
continued	O
to	O
be	O
expressed	O
at	O
high	O
levels	O
(	O
see	O
Additional	O
file	O
4	O
)	O
.	O

This	O
large	O
comparison	O
between	O
samples	O
allowed	O
us	O
to	O
identify	O
markers	O
that	O
distinguish	O
human	B-cell_type
feeder	I-cell_type
cells	E-cell_type
from	O
hESC	O
.	O

Lists	O
of	O
candidate	O
genes	O
are	O
shown	O
in	O
Figure	O
4A	O
,	O
C	O
and	O
4E	O
and	O
the	O
comparison	O
of	O
these	O
three	O
lines	O
are	O
shown	O
in	O
scatter	O
plots	O
in	O
Figure	O
4B	O
,	O
D	O
and	O
4F.Figure	O
4BG	O
lines	O
show	O
small	O
but	O
distinct	O
differences	O
as	O
assessed	O
by	O
bead	O
array	O
.	O

The	O
basis	O
of	O
the	O
sensitivity	O
could	O
be	O
attributed	O
to	O
a	O
limited	O
set	O
of	O
genes	O
and	O
those	O
genes	O
could	O
be	O
identified	O
for	O
future	O
use	O
.	O

We	O
and	O
others	O
have	O
proposed	O
three	O
alternative	O
methods	O
of	O
assessment	O
:	O
Quantitative	O
RT-PCR	O
[	O
9,20	O
]	O
,	O
focused	O
arrays	O
[	O
27	O
]	O
or	O
a	O
large	O
scale	O
array	O
with	O
bioinformatics	O
tools	O
being	O
utilized	O
to	O
focus	O
on	O
appropriate	O
subsets	O
of	O
genes	O
[	O
5,7,15,16,28	O
]	O
.	O

The	O
results	O
of	O
the	O
analysis	O
of	O
the	O
insulin	S-GP
/	O
insulin-like	B-GP
growth	I-GP
factor	E-GP
(	O
IGF	S-GP
)	O
signaling	O
pathway	O
are	O
shown	O
in	O
Figure	O
7	O
.	O

The	O
absence	O
of	O
expression	O
in	O
EBs	S-x
was	O
used	O
as	O
a	O
control	O
for	O
spontaneous	O
differentiation	O
of	O
ESC	B-x
colonies	E-x
(	O
including	O
mesodermal	S-x
differentiation	O
)	O
which	O
may	O
occur	O
and	O
the	O
markers	O
selected	O
should	O
be	O
able	O
to	O
distinguish	O
between	O
these	O
two	O
events	O
.	O

The	O
nearest	O
centroid	O
classification	O
computed	O
took	O
the	O
gene	O
expression	O
profile	O
from	O
a	O
new	O
sample	O
and	O
compared	O
it	O
to	O
each	O
of	O
these	O
class	O
centroids	O
.	O

Expression	O
of	O
subsets	O
of	O
individual	O
genes	O
was	O
validated	O
by	O
comparing	O
with	O
published	O
databases	O
,	O
MPSS	O
(	O
Massively	O
Parallel	O
Signature	O
Sequencing	O
)	O
libraries	O
,	O
and	O
parallel	O
analysis	O
by	O
microarray	O
and	O
RT-PCR.Conclusionwe	O
show	O
that	O
Illumina	O
's	O
bead	O
array	O
platform	O
is	O
a	O
reliable	O
,	O
reproducible	O
and	O
robust	O
method	O
for	O
developing	O
base	O
global	O
profiles	O
of	O
cells	O
and	O
identifying	O
similarities	O
and	O
differences	O
in	O
large	O
number	O
of	O
samples	O
.	O

Using	O
the	O
same	O
4	O
groups	O
of	O
samples	O
as	O
in	O
Figure	O
1	O
,	O
we	O
conducted	O
PAM	O
(	O
Prediction	O
Analysis	O
of	O
Microarray	O
)	O
[	O
26	O
]	O
,	O
in	O
search	O
for	O
biomarkers	O
used	O
in	O
diagnostic	O
identification	O
of	O
these	O
four	O
groups	O
,	O
ES	S-cell_type
,	O
EB	O
,	O
NS	S-cell_type
,	O
and	O
FB	S-cell_type
.	O

Distinguishing	O
ESCs	S-cell_type
from	O
EBs	S-x
was	O
relatively	O
straightforward	O
.	O

Figure	O
2	O
shows	O
results	O
of	O
the	O
cluster	O
analysis	O
of	O
relative	O
gene	O
expression	O
in	O
selected	O
samples	O
.	O

Comparison	O
of	O
diploid	O
pluripotent	O
cells	O
with	O
NTera2	S-cell_line
and	O
BG01	B-cell_line
variant	E-cell_line
Our	O
previous	O
results	O
have	O
suggested	O
that	O
EC	S-cell_type
lines	O
share	O
many	O
of	O
the	O
properties	O
of	O
hESCs	S-cell_type
and	O
can	O
be	O
used	O
as	O
a	O
useful	O
model	O
for	O
initial	O
testing	O
of	O
biological	O
questions	O
[	O
21	O
]	O
.	O

The	O
identified	O
biomarkers	O
can	O
be	O
used	O
to	O
distinguish	O
the	O
four	O
groups	O
of	O
cell	O
populations	O
.	O

During	O
the	O
identification	O
of	O
ES	S-cell_type
and	O
EB	O
specific	O
markers	O
,	O
we	O
have	O
noticed	O
that	O
some	O
known	O
hESC	O
markers	O
,	O
such	O
as	O
Nanog	S-GP
,	O
was	O
not	O
detected	O
in	O
all	O
populations	O
of	O
hESCs	S-cell_type
that	O
were	O
included	O
in	O
this	O
analysis	O
.	O

In	O
the	O
case	O
of	O
the	O
gene	O
Nanog	S-GP
,	O
there	O
are	O
several	O
pseudo	O
genes	O
in	O
the	O
genome	O
for	O
Nanog	S-GP
and	O
it	O
has	O
been	O
a	O
major	O
technical	O
challenge	O
designing	O
primers	O
or	O
probes	O
that	O
are	O
specific	O
and	O
sensitive	O
.	O

Comparing	O
the	O
overall	O
pattern	O
of	O
expression	O
,	O
we	O
made	O
several	O
important	O
observations	O
:	O
1	O
)	O
Duplicates	O
clustered	O
close	O
to	O
each	O
other	O
and	O
were	O
more	O
related	O
to	O
each	O
other	O
than	O
to	O
any	O
other	O
sample	O
;	O
2	O
)	O
ESCs	S-cell_type
appeared	O
more	O
similar	O
to	O
each	O
other	O
than	O
to	O
EBs	S-x
;	O
3	O
)	O
NTera2	B-cell_type
cells	E-cell_type
appeared	O
more	O
similar	O
to	O
ESCs	S-cell_type
while	O
differentiated	O
NTera2	S-cell_line
and	O
EBs	S-x
can	O
be	O
readily	O
distinguished	O
from	O
their	O
parent	O
populations	O
(	O
Figure	O
2	O
)	O
;	O
4	O
)	O
BG01V	S-cell_line
appeared	O
similar	O
to	O
undifferentiated	O
BG01	S-cell_line
cells	O
;	O
5	O
)	O
In	O
general	O
ESC	O
lines	O
grown	O
in	O
one	O
laboratory	O
appeared	O
more	O
similar	O
than	O
samples	O
grown	O
in	O
other	O
laboratories	O
,	O
suggesting	O
that	O
culture	O
conditions	O
affected	O
gene	O
expression	O
but	O
that	O
this	O
effect	O
was	O
much	O
smaller	O
than	O
the	O
effect	O
of	O
differentiation.Figure	O
1Unsupervised	O
two-way	O
hierarchical	O
cluster	O
analysis	O
of	O
differentially	O
expressed	O
genes	O
illustrated	O
in	O
a	O
heat-map	O
.	O

Aliquots	O
of	O
the	O
pooled	O
ES	S-cell_type
and	O
pooled	O
EB	O
samples	O
,	O
which	O
we	O
had	O
prepared	O
for	O
MPSS	O
,	O
were	O
included	O
in	O
this	O
run	O
to	O
compare	O
these	O
two	O
methods	O
directly	O
.	O

Such	O
a	O
global	O
analysis	O
allows	O
us	O
to	O
assess	O
context	O
dependent	O
signaling	O
and	O
identify	O
biomarkers	O
of	O
particular	O
states	O
of	O
cells	O
.	O

Comparison	O
between	O
MPSS	O
and	O
Illumina	O
bead	O
array	O
resultsWe	O
have	O
previously	O
used	O
EST	O
scan	O
and	O
MPSS	O
to	O
analyze	O
pooled	O
samples	O
of	O
ESCs	S-cell_type
and	O
EBs	S-x
from	O
three	O
different	O
WiCell	O
lines	O
(	O
H1	S-cell_line
,	O
H7	S-cell_line
and	O
H9	S-cell_line
)	O
[	O
5	O
]	O
.	O

The	O
clustering	O
analysis	O
was	O
based	O
on	O
the	O
average	O
linkage	O
and	O
Euclidean	O
distances	O
as	O
the	O
similarity	O
metric	O
using	O
differentially	O
expressed	O
genes	O
identified	O
by	O
ANOVA	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Sample	O
amplification	O
was	O
performed	O
using	O
100	O
ng	O
of	O
total	O
RNA	S-cellcomponent
as	O
input	O
material	O
by	O
the	O
method	O
of	O
Van	O
Gelder	O
et	O
al	O
[	O
30	O
]	O
.	O

To	O
test	O
this	O
array	O
format	O
we	O
examined	O
samples	O
from	O
a	O
variety	O
of	O
laboratories	O
in	O
a	O
blinded	O
fashion	O
to	O
determine	O
whether	O
the	O
array	O
was	O
sufficiently	O
sensitive	O
and	O
rapid	O
for	O
routine	O
assessment	O
.	O

Likewise	O
,	O
while	O
sharing	O
similarities	O
with	O
BG01	S-cell_line
(	O
B	O
,	O
correlation	O
coefficient=	O
0.9043	O
)	O
,	O
BG01V	S-cell_line
was	O
different	O
from	O
BG01	S-cell_line
in	O
expression	O
for	O
many	O
genes	O
,	O
particularly	O
genes	O
from	O
the	O
TGFβ	S-GP
pathway	O
(	O
D	O
,	O
F	O
)	O
.	O

The	O
large	O
difference	O
between	O
human	B-cell_type
feeders	E-cell_type
and	O
hESCs	S-cell_type
suggested	O
that	O
it	O
would	O
be	O
possible	O
to	O
identify	O
markers	O
that	O
were	O
robust	O
and	O
reliable	O
in	O
distinguishing	O
the	O
two	O
populations	O
,	O
and	O
these	O
markers	O
would	O
be	O
sufficiently	O
sensitive	O
in	O
detecting	O
contamination	O
of	O
feeders	S-cell_type
.	O

Results	O
were	O
normalized	O
to	O
average	O
following	O
Illumina	O
Beadstudio	O
manual	O
and	O
the	O
quality	O
of	O
each	O
sample	O
was	O
assessed	O
by	O
immunocytochemitsry	O
and	O
RT-PCR	O
prior	O
to	O
subjecting	O
them	O
for	O
analysis	O
(	O
data	O
not	O
shown	O
)	O
.	O

Cells	O
were	O
aggregated	O
and	O
cultured	O
on	O
non-adherent	O
substrata	O
for	O
fourteen	O
days.Other	O
cells	O
NTera2	B-cell_type
cells	E-cell_type
were	O
purchased	O
from	O
ATCC	O
and	O
cultured	O
in	O
parallel	O
with	O
hESCs	S-cell_type
samples	O
using	O
protocols	O
described	O
previously	O
[	O
21	O
]	O
.	O

The	O
final	O
biomarkers	O
were	O
determined	O
in	O
such	O
a	O
way	O
that	O
the	O
misclassification	O
error	O
rate	O
was	O
minimal	O
.	O

Feeder	S-cell_type
-free	O
cultures	O
were	O
prepared	O
for	O
gene	O
expression	O
analysis	O
by	O
manually	O
harvesting	O
individual	O
colonies	O
with	O
uniform	O
typical	O
undifferentiated	O
ESC	O
morphology	O
.	O
BG01	S-cell_line
(	O
46	O
,	O
XY	O
)	O
,	O
BG02	S-cell_line
(	O
46	O
,	O
XY	O
)	O
,	O
BG03	S-cell_line
(	O
46	O
,	O
XX	O
)	O
,	O
I6	S-cell_line
(	O
46	O
,	O
XY	O
)	O
and	O
BG01V	S-cell_line
(	O
BG01	S-cell_line
karyotypic	O
variant	O
:	O
49	O
,	O
XXY	O
,	O
+12	O
,	O
+17	O
)	O
:	O
Cells	O
were	O
maintained	O
for	O
3	O
(	O
BG01V	S-cell_line
)	O
,	O
7	O
(	O
BG02	S-cell_line
)	O
,	O
8	O
(	O
BG01	S-cell_line
)	O
,	O
or	O
21	O
(	O
BG03	S-cell_line
)	O
passages	O
under	O
feeder-free	O
condition	O
on	O
fibronectin	S-GP
-coated	O
plates	O
in	O
medium	O
that	O
had	O
been	O
conditioned	O
by	O
mouse	B-cell_type
embryonic	I-cell_type
fibroblasts	E-cell_type
for	O
24	O
hours	O
.	O

The	O
shrunken	O
class	O
centroids	O
for	O
genes	O
which	O
have	O
at	O
least	O
one	O
nonzero	O
difference	O
are	O
shown	O
.	O

Mapping	O
sites	O
within	O
the	O
genome	O
that	O
are	O
hypersensitive	O
to	O
digestion	O
with	O
DNaseI	S-GP
is	O
an	O
important	O
method	O
for	O
identifying	O
DNA	S-cellcomponent
elements	O
that	O
regulate	O
transcription	O
.	O

It	O
will	O
have	O
potential	O
use	O
for	O
researchers	O
across	O
a	O
broad	O
spectrum	O
of	O
biology	O
for	O
the	O
study	O
of	O
transcriptional	O
regulation	O
in	O
both	O
healthy	O
and	O
diseased	O
tissues	O
.	O

The	O
black	O
bar	O
denotes	O
the	O
location	O
of	O
the	O
‘	O
core	O
’	O
hypersensitive	O
site	O
as	O
defined	O
by	O
Southern	O
blotting	O
.	O

K562	B-cell_type
cells	E-cell_type
are	O
relatively	O
undifferentiated	O
,	O
although	O
they	O
have	O
a	O
partial	O
erythroid	S-cell_type
phenotype	O
.	O

Dorscher	O
et	O
al	O
.	O

Figure	O
4B	O
shows	O
the	O
mean	O
±	O
SD	O
ratio	O
(	O
DNaseI	S-GP
-treated	O
enrichment/	O
DNaseI	S-GP
-untreated	O
enrichment	O
)	O
of	O
quantitative	O
enrichments	O
from	O
two	O
independent	O
hES	O
cell	O
biological	O
replicates	O
and	O
two	O
independent	O
K562	S-cell_line
biological	O
replicates	O
,	O
using	O
primer	O
sets	O
from	O
different	O
locations	O
as	O
indicated	O
in	O
the	O
figure	O
.	O

Glycogen	O
carrier	O
(	O
5	O
μg	O
)	O
was	O
used	O
at	O
this	O
stage	O
,	O
and	O
the	O
pellet	O
resuspended	O
in	O
80	O
μl	O
water.The	O
blunt-ended	O
DNA	S-cellcomponent
was	O
then	O
ligated	O
to	O
the	O
LP21–25	O
linker	O
.	O

Advantages	O
of	O
the	O
technique	O
reported	O
here	O
include	O
the	O
small	O
cell	O
numbers	O
required	O
for	O
each	O
analysis	O
,	O
rapid	O
,	O
relatively	O
low-cost	O
experiments	O
with	O
minimal	O
need	O
for	O
specialist	O
equipment	O
.	O

This	O
reveals	O
a	O
central	O
DHS	O
∼500	O
bp	O
wide	O
,	O
with	O
a	O
suggestion	O
of	O
weaker	O
hypersensitivity	O
for	O
a	O
few	O
hundred	O
base	O
pairs	O
5′	O
and	O
3′	O
to	O
the	O
central	O
region	O
.	O

While	O
these	O
approaches	O
have	O
the	O
advantage	O
of	O
covering	O
large	O
genomic	O
regions	O
with	O
a	O
limited	O
number	O
of	O
experiments	O
,	O
they	O
are	O
inherently	O
costly	O
and	O
less	O
applicable	O
to	O
the	O
rapid	O
DHS	O
mapping	O
of	O
specific	O
genomic	O
sites	O
in	O
a	O
range	O
of	O
cell	O
types	O
.	O

Quantification	O
of	O
DHS	O
across	O
the	O
TAL1	S-GP
locus	O
in	O
hES	S-cell_type
and	O
K562	B-cell_type
cells	E-cell_type
As	O
examples	O
of	O
relative	O
enrichments	O
at	O
different	O
regulatory	O
elements	O
,	O
we	O
present	O
a	O
comparison	O
of	O
enrichments	O
across	O
the	O
extended	O
TAL1	S-GP
locus	O
from	O
human	O
embryonic	B-cell_type
stem	I-cell_type
(	I-cell_type
hES	I-cell_type
)	I-cell_type
cell	E-cell_type
s	O
and	O
K562	B-cell_type
cells	E-cell_type
in	O
Figure	O
4B	O
.	O

quantify	O
the	O
DHS	O
through	O
the	O
loss	O
of	O
PCR	O
signal	O
obtained	O
from	O
DHS	O
when	O
DNA	S-cellcomponent
is	O
digested	O
,	O
whereas	O
our	O
approach	O
uses	O
real-time	O
PCR	O
to	O
quantify	O
a	O
gain	O
of	O
signal	O
observed	O
from	O
DHS	O
.	O

All	O
four	O
regions	O
showed	O
no	O
enrichments	O
between	O
DNaseI	S-GP
-treated	O
and	O
-untreated	O
samples	O
in	O
either	O
the	O
hES	B-cell_type
cells	E-cell_type
or	O
K562	B-cell_type
cells	E-cell_type
.	O

Although	O
there	O
is	O
enrichment	O
at	O
the	O
+50	O
enhancer	O
,	O
there	O
is	O
minimal	O
enrichment	O
at	O
the	O
−4	O
,	O
promoter	O
1A	O
and	O
+19	O
elements	O
.	O

Generating	O
a	O
library	O
of	O
DHSsThe	O
basic	O
protocol	O
is	O
outlined	O
in	O
Figure	O
1	O
.	O

Care	O
was	O
taken	O
to	O
use	O
cut-off	O
tips	O
and	O
very	O
gentle	O
pipetting	O
to	O
reduce	O
non-specific	O
DNA	S-cellcomponent
sheering	O
.	O

The	O
left-hand	O
panels	O
of	O
Figure	O
2A	O
show	O
the	O
Sybr-green	O
real-time	O
fluorescence	O
profiles	O
using	O
serial	O
5-fold	O
dilutions	O
of	O
quantified	O
mouse	S-y
genomic	O
DNA	O
standards	O
with	O
primers	O
A	O
and	O
B	O
.	O

Primers	O
indicated	O
in	O
red	O
correspond	O
to	O
known	O
regulatory	O
elements	O
.	O

After	O
5	O
min	O
,	O
the	O
lysed	O
cells	O
were	O
spun	O
at	O
500	O
g	O
for	O
5	O
min	O
at	O
4°C	O
with	O
brakes	O
off	O
.	O

Post	O
embryogenesis	S-x
,	O
TAL1	S-GP
expression	O
is	O
maintained	O
in	O
the	O
non-lymphoid	B-x
haematopoietic	I-x
system	E-x
,	O
although	O
in	O
addition	O
,	O
expression	O
is	O
observed	O
in	O
a	O
range	O
of	O
non-haematopoietic	O
tissues	O
,	O
including	O
endothelium	S-x
and	O
brain	S-x
(	O
16–18	O
)	O
.	O

Major	O
disadvantages	O
of	O
these	O
approaches	O
include	O
cost	O
and	O
lack	O
of	O
focus	O
.	O

0	O
,	O
20	O
,	O
60	O
,	O
120	O
units	O
DNaseI	S-GP
)	O
,	O
the	O
nuclei	O
were	O
resuspended	O
in	O
120	O
μl	O
of	O
reaction	O
buffer	O
.	O

Agarose	O
gel	O
electrophoresis	O
of	O
the	O
DNA	O
recovered	O
from	O
the	O
beads	O
confirms	O
that	O
the	O
vast	O
majority	O
of	O
these	O
products	O
are	O
between	O
300	O
and	O
500	O
base	O
pairs	O
in	O
length	O
(	O
Figure	O
1B	O
)	O
.	O

Human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hES	S-cell_type
)	O
were	O
grown	O
in	O
chemically	O
defined	O
media	O
in	O
the	O
presence	O
of	O
Activin	S-GP
and	O
FGF2	S-GP
,	O
as	O
detailed	O
previously	O
(	O
33	O
)	O
.	O

The	O
reaction	O
was	O
stopped	O
with	O
excess	O
EDTA	O
(	O
4	O
μl	O
0.5	O
M	O
)	O
followed	O
by	O
75°C	O
for	O
10	O
min	O
.	O

These	O
include	O
transcriptional	O
enhancers	O
(	O
1,2	O
)	O
and	O
repressors	O
(	O
3,4	O
)	O
as	O
well	O
as	O
chromatin	S-cellcomponent
insulators	O
and	O
barrier	O
elements	O
(	O
5,6	O
)	O
.	O

The	O
HMBS	O
primers	O
are	O
:	O
human	S-y
—Forward	O
;	O
ATGCTGCCTATTTCAAGGTTGT	O
,	O
Reverse	O
;	O
GAATT	O
GGAACATTGCGACAGT	O
,	O
and	O
mouse	S-y
—Forward	O
;	O
CGGAGTCATGTCCGGTAAC	O
,	O
Reverse	O
;	O
CGACCAA	O
TAGACGACGAGAA	O
.	O

In	O
the	O
experiment	O
shown	O
,	O
maximal	O
enrichment	O
at	O
a	O
known	O
control	O
DHS	O
was	O
seen	O
with	O
40	O
units	O
DNaseI	S-GP
(	O
real-time	O
PCR	O
quantification	O
shown	O
in	O
Figure	O
2B	O
)	O
.	O

This	O
stock	O
was	O
used	O
as	O
5	O
μl	O
per	O
real-time	O
PCR	O
reaction	O
,	O
and	O
following	O
amplification	O
,	O
quantified	O
relative	O
to	O
the	O
genomic	O
DNA	S-cellcomponent
standard	O
curve	O
,	O
for	O
each	O
primer	O
set	O
.	O

The	O
technique	O
is	O
highly	O
reproducible	O
,	O
with	O
relatively	O
little	O
variation	O
in	O
quantifiable	O
enrichments	O
observed	O
between	O
different	O
biological	O
replicates	O
.	O

We	O
feel	O
our	O
technique	O
can	O
deliver	O
acceptable	O
specificity	O
and	O
sensitivity	O
for	O
DHS	O
mapping	O
with	O
small	O
numbers	O
of	O
cells	O
,	O
and	O
will	O
therefore	O
be	O
of	O
use	O
to	O
those	O
researchers	O
working	O
with	O
limited	O
numbers	O
of	O
primary	O
cells	O
.	O

This	O
potentially	O
explains	O
the	O
marked	O
enrichment	O
seen	O
at	O
the	O
+19	B-GP
stem	I-GP
cell	I-GP
enhancer	E-GP
and	O
the	O
+50	B-GP
erythroid	I-GP
enhancer	E-GP
.	O

Nuclei	S-cellcomponent
are	O
extracted	O
from	O
living	O
cells	O
,	O
then	O
digested	O
on	O
ice	O
for	O
1	O
h	O
with	O
a	O
range	O
of	O
DNaseI	S-GP
concentrations	O
,	O
as	O
detailed	O
in	O
the	O
‘	O
Materials	O
and	O
methods	O
’	O
sections	O
.	O

The	O
hES	O
cell	O
cultures	O
were	O
maintained	O
as	O
detailed	O
in	O
methods	O
.	O

There	O
is	O
good	O
correlation	O
between	O
the	O
location	O
of	O
the	O
DHS	O
between	O
the	O
two	O
techniques	O
.	O

Following	O
precipitation	O
,	O
DNA	S-cellcomponent
was	O
resuspended	O
in	O
200	O
μl	O
of	O
0.1	O
TE	O
and	O
quantified	O
using	O
spectophotometry	O
.	O

This	O
approach	O
has	O
been	O
reported	O
as	O
showing	O
good	O
sensitivity	O
,	O
but	O
a	O
limitation	O
is	O
the	O
large	O
number	O
of	O
PCR	O
reactions	O
required	O
to	O
quantify	O
the	O
calculated	O
loss	O
of	O
signal	O
with	O
significant	O
certainty	O
.	O

After	O
careful	O
removal	O
of	O
supernatant	O
,	O
the	O
nuclei	O
were	O
gently	O
resuspended	O
in	O
200	O
μl	O
of	O
ice-cold	O
reaction	O
buffer	O
(	O
20	O
μl	O
10×	O
DNaseI	S-GP
buffer	O
,	O
4	O
μl	O
glycerol	O
,	O
176	O
μl	O
water	O
)	O
using	O
pipette	O
tips	O
with	O
cut	O
off	O
ends	O
.	O

The	O
location	O
of	O
the	O
STIL	S-GP
promoter	O
has	O
been	O
previously	O
mapped	O
(	O
14	O
)	O
,	O
although	O
no	O
other	O
STIL	S-GP
regulatory	O
elements	O
have	O
yet	O
been	O
identified	O
.	O

This	O
makes	O
them	O
less	O
suitable	O
for	O
many	O
laboratories	O
that	O
want	O
to	O
assess	O
the	O
chromatin	S-cellcomponent
accessibility	O
of	O
a	O
number	O
of	O
defined	O
or	O
presumed	O
regulatory	O
elements	O
in	O
a	O
range	O
of	O
cell	O
types	O
.	O

This	O
was	O
mixed	O
well	O
with	O
a	O
pipette	O
and	O
left	O
at	O
16°C	O
overnight.Following	O
ligation	O
,	O
the	O
DNA	S-cellcomponent
was	O
precipitated	O
with	O
ethanol	O
,	O
and	O
resuspended	O
in	O
42	O
μl	O
water	O
.	O

After	O
the	O
last	O
wash	O
,	O
each	O
sample	O
was	O
resuspended	O
in	O
30	O
μl	O
0.1	O
TE	O
.	O

The	O
comparison	O
of	O
the	O
thymocytes	S-cell_type
with	O
the	O
BW5147	B-cell_type
cells	E-cell_type
illustrates	O
another	O
common	O
finding	O
that	O
,	O
in	O
our	O
experience	O
of	O
primary	O
cell	O
experiments	O
,	O
maximal	O
enrichment	O
is	O
often	O
obtained	O
using	O
lower	O
amounts	O
of	O
DNaseI	S-GP
compared	O
with	O
cell	O
lines	O
.	O

This	O
equates	O
to	O
greater	O
than	O
40-fold	O
enrichment	O
at	O
the	O
Stil	S-GP
promoter	O
compared	O
with	O
no	O
observed	O
enrichment	O
downstream	O
of	O
the	O
promoter	O
.	O

DNA	S-cellcomponent
was	O
then	O
extracted	O
using	O
standard	O
phenol–chloroform	O
techniques	O
.	O

It	O
also	O
provides	O
flexibility	O
,	O
as	O
any	O
genomic	O
region	O
can	O
be	O
analysed	O
from	O
the	O
DNA	S-cellcomponent
library	O
derived	O
from	O
the	O
DNaseI	S-GP
-treated	O
samples	O
by	O
designing	O
further	O
real-time	O
PCR	O
primer	O
sets	O
.	O

The	O
sample	O
was	O
amplified	O
using	O
Vent	B-GP
exo-polymerase	E-GP
and	O
a	O
biotinylated	O
LP25	O
primer	O
.	O

Reduced/absent	O
accessibility	O
of	O
regulatory	O
elements	O
to	O
DNaseI	S-GP
digestion	O
is	O
consistent	O
with	O
the	O
lack	O
of	O
expression	O
of	O
TAL1	S-GP
in	O
hES	B-cell_type
cells	E-cell_type
(	O
Figure	O
4A	O
)	O
.	O

The	O
development	O
of	O
techniques	O
that	O
permit	O
the	O
rapid	O
comparative	O
mapping	O
of	O
DHS	O
between	O
different	O
cell	O
types	O
will	O
greatly	O
facilitate	O
the	O
study	O
of	O
transcriptional	O
regulation	O
in	O
both	O
normal	O
and	O
diseased	O
cells	O
.	O

The	O
most	O
striking	O
differences	O
between	O
hES	B-cell_type
cells	E-cell_type
and	O
K562	B-cell_type
cells	E-cell_type
were	O
found	O
at	O
the	O
TAL1	S-GP
regulatory	O
elements	O
.	O

As	O
has	O
been	O
previously	O
reasoned	O
(	O
13	O
)	O
,	O
one	O
double	O
strand	O
of	O
DNA	O
in	O
a	O
region	O
of	O
DNaseI	S-GP
hypersensitivity	O
is	O
more	O
likely	O
to	O
be	O
digested	O
twice	O
within	O
a	O
short	O
distance	O
than	O
non-hypersensitive	O
DNA	O
.	O

Cell	O
cultureCell	O
lines	O
were	O
maintained	O
in	O
culture	O
as	O
previously	O
described	O
(	O
11	O
)	O
.	O

The	O
standard	O
approach	O
to	O
locating	O
these	O
DNaseI	S-GP
-hypersensitive	O
sites	O
(	O
DHSs	O
)	O
has	O
been	O
to	O
use	O
Southern	O
blotting	O
techniques	O
,	O
although	O
we	O
,	O
and	O
others	O
,	O
have	O
recently	O
published	O
alternative	O
methods	O
using	O
a	O
range	O
of	O
technologies	O
including	O
high-throughput	O
sequencing	O
and	O
genomic	O
array	O
tiling	O
paths	O
.	O

Both	O
cell	O
types	O
show	O
significant	O
enrichment	O
at	O
the	O
STIL	S-GP
promoter	O
.	O

A	O
stock	O
of	O
linker	O
was	O
prepared	O
by	O
mixing	O
80	O
μl	O
LP21	O
(	O
100	O
μM	O
:	O
GAATTCAGATCTCCCGGGTCA	O
)	O
with	O
80	O
μl	O
LP25	O
(	O
100	O
μM	O
:	O
GCGGTGACCCGGGAGATCTG	O
AATTC	O
)	O
and	O
240	O
μl	O
water	O
.	O

The	O
lower	O
panel	O
shows	O
real-time	O
PCR	O
data	O
from	O
K562	S-cell_line
material	O
using	O
10	O
primer	O
sets	O
,	O
each	O
generating	O
an	O
amplicon	O
∼120	O
bp	O
long	O
.	O

While	O
there	O
is	O
no	O
difference	O
in	O
amplification	O
between	O
the	O
samples	O
using	O
primer	O
pair	O
B	O
,	O
with	O
primer	O
pair	O
A	O
,	O
the	O
40	O
units	O
DNaseI	S-GP
sample	O
amplifies	O
∼5.5	O
PCR	O
cycles	O
before	O
the	O
0	O
units	O
sample	O
.	O

There	O
is	O
also	O
potential	O
for	O
signal	O
to	O
be	O
lost	O
at	O
the	O
most	O
‘	O
open	O
’	O
stretch	O
of	O
DNA	O
,	O
due	O
to	O
over-digestion	O
with	O
DNaseI	S-GP
.	O

DNA	S-cellcomponent
library	O
preparationFollowing	O
quantification	O
,	O
7.5	O
μg	O
of	O
DNA	S-cellcomponent
was	O
taken	O
for	O
each	O
sample	O
condition	O
.	O

For	O
each	O
sample	O
,	O
30	O
μl	O
of	O
beads	O
(	O
Dyabeads	O
M-270	O
;	O
Dynal	O
biotech	O
)	O
were	O
washed	O
twice	O
in	O
2×	O
binding	O
buffer	O
(	O
10	O
mM	O
Tris	O
HCL	O
pH7.5	O
,	O
1	O
mM	O
EDTA	O
,	O
2	O
M	O
NaCl	O
)	O
using	O
a	O
magnet	O
,	O
and	O
then	O
resuspended	O
in	O
50	O
μl	O
of	O
2×	O
binding	O
buffer/sample	O
.	O

The	O
5′	O
extension	O
of	O
enrichment	O
seen	O
in	O
the	O
lower	O
panel	O
appears	O
to	O
reflect	O
the	O
weaker	O
5′	O
extension	O
seen	O
in	O
the	O
Southern	O
blot	O
in	O
the	O
upper	O
panel	O
.	O

In	O
these	O
conditions	O
,	O
hES	B-cell_type
cells	E-cell_type
remain	O
homogenously	O
undifferentiated	O
.	O

The	O
paired	O
samples	O
that	O
were	O
split	O
before	O
ligation	O
were	O
then	O
pooled	O
,	O
making	O
a	O
60	O
μl	O
final	O
aliquot	O
.	O

A	O
number	O
of	O
techniques	O
have	O
been	O
published	O
recently	O
that	O
permit	O
the	O
mapping	O
of	O
DHSs	O
without	O
the	O
need	O
for	O
Southern	O
blotting	O
(	O
7–13	O
)	O
.	O

We	O
have	O
used	O
a	O
range	O
of	O
primer	O
sets	O
.	O

Presented	O
examples	O
include	O
comparative	O
DHS	O
mapping	O
of	O
known	O
TAL1/SCL	S-GP
regulatory	O
elements	O
between	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
and	O
K562	B-cell_type
cells	E-cell_type
.	O

A	O
calculated	O
standard	O
curve	O
then	O
permits	O
the	O
quantification	O
of	O
DNA	O
from	O
this	O
sequence	O
in	O
library	O
samples	O
.	O

This	O
is	O
similar	O
to	O
data	O
obtained	O
from	O
primary	O
mouse	B-cell_type
erythroid	I-cell_type
cells	E-cell_type
(	O
day	O
14.5	O
foetal	B-x
liver	E-x
)	O
,	O
which	O
show	O
the	O
highest	O
enrichments	O
at	O
the	O
mouse	B-GP
+40	I-GP
enhancer	E-GP
(	O
homologous	O
to	O
the	O
human	S-y
+50	O
)	O
(	O
data	O
not	O
shown	O
)	O
.	O

report	O
excellent	O
sensitivity	O
using	O
their	O
approach	O
to	O
map	O
DHS	O
.	O

Real-time	O
PCR	O
quantification	O
of	O
DNA	O
within	O
the	O
DHS	O
libraryFigure	O
2	O
documents	O
the	O
quantification	O
of	O
specific	O
DNA	O
sites	O
from	O
different	O
mouse	S-y
-cell-derived	O
DNA	O
libraries	O
.	O

The	O
DNA	O
is	O
then	O
blunt-ended	O
using	O
T4	B-GP
polymerase	E-GP
(	O
Figure	O
1B	O
)	O
and	O
ligated	O
with	O
an	O
asymmetric	O
double-stranded	O
linker	O
.	O

Here	O
,	O
we	O
detail	O
the	O
laboratory	O
protocol	O
that	O
permits	O
the	O
rapid	O
comparative	O
mapping	O
of	O
known	O
and	O
candidate	O
DHS	O
between	O
different	O
cell	O
types	O
using	O
real-time	O
PCR	O
.	O

Four	O
control	O
regions	O
were	O
selected	O
:	O
−16	O
kb	O
,	O
upstream	O
of	O
TAL1	S-GP
;	O
+5	O
and	O
+22	O
kb	O
,	O
within	O
the	O
TAL1	S-GP
locus	O
;	O
+70	O
kb	O
,	O
downstream	O
of	O
TAL1	S-GP
.	O

Primers	O
from	O
the	O
TAL1	S-GP
locus	O
(	O
human	S-y
and	O
mouse	S-y
)	O
are	O
available	O
on	O
request.Amplification	O
conditions	O
and	O
PCR	O
mixes	O
were	O
as	O
recommended	O
by	O
Stratagene	O
.	O

Moreover	O
,	O
we	O
demonstrate	O
tissue	O
specificity	O
,	O
with	O
variable	O
enrichment	O
at	O
known	O
regulatory	O
elements	O
between	O
different	O
cell	O
types	O
.	O

The	O
quantifications	O
shown	O
in	O
Figure	O
3	O
represent	O
the	O
absolute	O
quantification	O
of	O
DNA	O
at	O
each	O
primer	O
set	O
for	O
the	O
5	O
μl	O
PCR	O
sample.The	O
mRNA	O
expression	O
levels	O
of	O
TAL1	O
and	O
STIL	O
in	O
Figure	O
4A	O
were	O
normalised	O
relative	O
to	O
β-actin	O
and	O
plotted	O
relative	O
to	O
mRNA	O
expression	O
from	O
normal	O
human	O
donor	O
CD34	O
+	O
cells	O
,	O
as	O
described	O
previously	O
(	O
11	O
)	O
.	O

This	O
made	O
a	O
final	O
digestion	O
volume	O
of	O
100	O
μl	O
for	O
each	O
sample	O
,	O
which	O
was	O
left	O
to	O
incubate	O
for	O
1	O
h	O
on	O
ice	O
in	O
the	O
cold	O
room	O
.	O

After	O
1	O
h	O
,	O
700	O
μl	O
of	O
nuclei	S-cellcomponent
lysis	O
buffer	O
(	O
100	O
mM	O
tris	O
HCL	O
pH	O
8	O
,	O
5	O
mM	O
EDTA	O
pH	O
8	O
,	O
200	O
mM	O
NaCl	O
,	O
0.2	O
%	O
SDS	O
)	O
was	O
added	O
to	O
each	O
sample	O
with	O
50	O
μg	O
proteinase	B-GP
K	E-GP
.	O
Following	O
gentle	O
mixing	O
with	O
inversion	O
,	O
the	O
lysed	O
samples	O
were	O
incubated	O
at	O
55°C	O
for	O
1	O
h	O
.	O
RNaseA	S-GP
(	O
10	O
μg	O
(	O
Ambion	O
)	O
)	O
was	O
then	O
added	O
to	O
each	O
sample	O
and	O
further	O
incubated	O
at	O
37°C	O
for	O
30	O
min	O
.	O

With	O
K562	B-cell_type
cells	E-cell_type
,	O
there	O
is	O
prominent	O
enrichment	O
at	O
the	O
TAL1	S-GP
promoter	O
1a	O
,	O
and	O
the	O
−4	O
,	O
+19	O
and	O
+50	O
enhancers	O
.	O

An	O
alternative	O
approach	O
that	O
does	O
permit	O
the	O
targeted	O
semi-quantitative	O
DHS	O
mapping	O
of	O
specific	O
loci	O
has	O
used	O
quantitative	O
real-time	O
PCR	O
to	O
map	O
sites	O
from	O
digested	O
DNA	S-cellcomponent
(	O
10	O
)	O
.	O

Over	O
the	O
past	O
10	O
years	O
,	O
we	O
and	O
others	O
have	O
dissected	O
the	O
regulatory	O
elements	O
that	O
direct	O
the	O
expression	O
of	O
TAL1	S-GP
to	O
different	O
tissues	O
(	O
11,19–31	O
)	O
.	O

Nuclei	S-cellcomponent
preparationUp	O
to	O
3	O
×	O
107	O
cells	O
were	O
washed	O
in	O
ice-cold	O
PBS	O
and	O
resuspended	O
in	O
2	O
ml	O
of	O
ice-cold	O
cell	O
lysis	O
buffer	O
[	O
300	O
mM	O
sucrose	O
,	O
10	O
mM	O
Tris	O
pH	O
7.4	O
,	O
15	O
mM	O
NaCl	O
,	O
5	O
mM	O
MgCl	O
,	O
0.1	O
mM	O
EGTA	O
,	O
60	O
mM	O
KCl	O
,	O
0.2	O
%	O
NP-40	O
,	O
0.5	O
mM	O
DTT	O
,	O
0.5	O
μM	O
spermidine	O
,	O
1×	O
protease	S-GP
inhibitor	O
(	O
complete	O
,	O
Roche	O
)	O
]	O
.	O

Following	O
RNaseA	S-GP
and	O
proteinaseK	S-GP
treatment	O
,	O
the	O
DNA	O
is	O
extracted	O
and	O
run	O
on	O
a	O
1	O
%	O
agarose	O
gel	O
to	O
check	O
for	O
the	O
size	O
of	O
digested	O
DNA	O
.	O

Figure	O
2B	O
shows	O
the	O
quantifiable	O
differences	O
in	O
enrichment	O
at	O
the	O
porphobilinogen	B-GP
deaminase	E-GP
(	O
Hmbs	S-GP
)	O
promoter	O
between	O
primary	O
mouse	B-cell_type
thymocytes	E-cell_type
and	O
the	O
mouse	B-cell_type
T-cell	E-cell_type
line	O
BW5147	S-cell_line
.	O

This	O
was	O
blunt-ended	O
using	O
T4	B-GP
polymerase	E-GP
(	O
10	O
μl	O
10×	O
buffer	O
,	O
0.5	O
μl	O
25	O
mM	O
dNTP	O
,	O
3	O
μl	O
BSA	O
,	O
1	O
μl	O
T4	B-GP
polymerase	E-GP
(	O
3	O
U/μl	O
NE	O
Biolabs	O
)	O
,	O
85.5	O
μl	O
of	O
water/	O
DNA	S-cellcomponent
in	O
0.1	O
TE	O
)	O
.	O

However	O
,	O
the	O
technique	O
depends	O
on	O
large	O
numbers	O
of	O
comparative	O
quantitative	O
real-time	O
PCR	O
reactions	O
across	O
a	O
region	O
in	O
both	O
digested	O
and	O
undigested	O
material	O
,	O
in	O
order	O
to	O
quantify	O
the	O
loss	O
of	O
enrichment	O
.	O

As	O
examples	O
,	O
we	O
include	O
comparative	O
DHS	O
mapping	O
of	O
regulatory	O
elements	O
located	O
across	O
the	O
extended	O
TAL1	S-GP
(	O
T-cell	B-GP
acute	I-GP
lymphocytic	I-GP
leukaemia-1	E-GP
,	O
also	O
known	O
as	O
SCL	S-GP
(	O
stem	B-GP
cell	I-GP
leukaemia	E-GP
)	O
)	O
locus	O
in	O
human	S-y
embryonic	B-cell_type
stem	I-cell_type
(	I-cell_type
hES	I-cell_type
)	I-cell_type
cell	E-cell_type
s	O
and	O
the	O
leukaemia	B-cell_type
cell	E-cell_type
line	O
K562	S-cell_line
.	O

In	O
this	O
article	O
,	O
we	O
present	O
an	O
alternative	O
method	O
to	O
identify	O
DHS	O
using	O
real-time	O
PCR	O
by	O
adapting	O
the	O
protocol	O
we	O
have	O
used	O
to	O
map	O
DHS	O
using	O
genomic	O
tiling	O
path	O
arrays	O
(	O
11	O
)	O
.	O

This	O
permits	O
the	O
quantification	O
of	O
enrichments	O
over	O
1200	O
bp	O
,	O
centred	O
around	O
the	O
STIL	S-GP
transcription	O
start	O
site	O
.	O

The	O
samples	O
were	O
mixed	O
gently	O
on	O
ice	O
,	O
then	O
put	O
at	O
12°C	O
for	O
16	O
min	O
.	O

This	O
was	O
heated	O
at	O
95°C	O
for	O
10	O
min	O
to	O
free	O
the	O
DNA	S-cellcomponent
from	O
the	O
beads	O
,	O
and	O
then	O
stored	O
at	O
4°C	O
.	O

These	O
issues	O
are	O
addressed	O
in	O
Figure	O
3	O
.	O

As	O
ES	B-cell_type
cells	E-cell_type
differentiate	O
to	O
form	O
embryoid	B-x
bodies	E-x
,	O
expression	O
of	O
TAL1	S-GP
is	O
rapidly	O
switched	O
on	O
,	O
appearing	O
from	O
day	O
3	O
of	O
mouse	B-cell_type
ES	I-cell_type
cell	E-cell_type
differentiation	O
(	O
32	O
)	O
.	O

Relative	O
quantification	O
of	O
mRNA	O
expression	O
using	O
real-time	O
PCR	O
shows	O
that	O
both	O
of	O
these	O
cell	O
types	O
express	O
STIL	S-GP
,	O
but	O
only	O
K562	B-cell_type
cells	E-cell_type
express	O
TAL1	S-GP
(	O
Figure	O
4A	O
)	O
.	O

A	O
real-time-PCR-based	O
approach	O
to	O
DHS	O
mapping	O
has	O
,	O
therefore	O
,	O
a	O
number	O
of	O
potential	O
advantages	O
for	O
researchers	O
interested	O
in	O
specific	O
regulatory	O
questions	O
at	O
defined	O
loci	O
.	O

We	O
have	O
previously	O
shown	O
that	O
our	O
basic	O
technique	O
for	O
amplifying	O
a	O
library	O
of	O
DHS	O
generates	O
a	O
template	O
representative	O
of	O
known	O
DHS	O
with	O
excellent	O
sensitivity	O
and	O
specificity	O
(	O
11	O
)	O
.	O

The	O
right-hand	O
panels	O
of	O
Figure	O
2A	O
show	O
the	O
quantification	O
of	O
samples	O
from	O
0	O
and	O
40	O
units	O
DNaseI	S-GP
-treated	O
material	O
using	O
primers	O
A	O
and	O
B	O
.	O

The	O
mix	O
was	O
then	O
placed	O
on	O
a	O
95°C	O
hot	O
block	O
and	O
the	O
power	O
supply	O
turned	O
off	O
.	O

The	O
nuclei	S-cellcomponent
were	O
spun	O
again	O
at	O
500	O
g	O
for	O
5	O
min	O
at	O
4°C	O
and	O
,	O
following	O
supernatant	O
removal	O
,	O
were	O
resuspended	O
in	O
30	O
μl	O
of	O
reaction	O
buffer	O
per	O
DNaseI	S-GP
condition	O
.	O

These	O
include	O
high-throughput	O
sequencing	O
of	O
cloned	O
DNA	S-cellcomponent
libraries	O
derived	O
from	O
DNaseI	S-GP
-digested	O
chromatin	S-cellcomponent
(	O
8,9	O
)	O
,	O
and	O
a	O
number	O
of	O
different	O
approaches	O
that	O
use	O
genomic	O
tiling	O
path	O
arrays	O
to	O
map	O
DHSs	O
(	O
7,11,13	O
)	O
.	O

Separate	O
30	O
μl	O
aliquots	O
were	O
then	O
taken	O
and	O
gently	O
mixed	O
with	O
70	O
μl	O
of	O
DNaseI	S-GP
mix	O
(	O
see	O
Table	O
1	O
)	O
on	O
ice	O
.	O

The	O
upper	O
panel	O
shows	O
a	O
Southern	O
blot	O
of	O
the	O
human	O
STIL	S-GP
(	O
SCL	S-GP
/	O
TAL1	S-GP
interrupting	O
locus	O
)	O
promoter	O
in	O
K562	B-cell_type
cells	E-cell_type
.	O

A	O
dip	O
in	O
enrichment	O
is	O
observed	O
in	O
the	O
lower	O
panel	O
over	O
the	O
previously	O
mapped	O
transcription-factor-binding	O
sites	O
(	O
14	O
)	O
,	O
which	O
may	O
represent	O
over-digestion	O
of	O
the	O
most	O
accessible	O
core	O
region	O
of	O
the	O
DHS	O
.	O

Mapping	O
the	O
location	O
of	O
DNaseI	S-GP
-hypersensitive	O
sites	O
(	O
DHSs	O
)	O
remains	O
central	O
to	O
developing	O
our	O
understanding	O
of	O
transcriptional	O
regulation	O
.	O

This	O
will	O
lead	O
to	O
the	O
preferential	O
amplification	O
of	O
DNA	O
from	O
regions	O
of	O
DHS	O
.	O

Recently	O
published	O
high-throughput	O
techniques	O
that	O
map	O
DHS	O
sites	O
using	O
high-throughput	O
sequencing	O
(	O
8,9	O
)	O
and	O
genomic	O
array	O
tiling	O
paths	O
(	O
7,11,13	O
)	O
have	O
clear	O
advantages	O
of	O
scale	O
over	O
more	O
targeted	O
approaches	O
.	O

These	O
sequences	O
were	O
chosen	O
as	O
control	O
regions	O
as	O
they	O
show	O
limited	O
homology	O
between	O
a	O
number	O
of	O
species	O
(	O
26	O
)	O
and	O
were	O
considered	O
highly	O
unlikely	O
to	O
represent	O
regulatory	O
elements	O
.	O

The	O
mix	O
(	O
5	O
μl	O
ThermoPol	O
10×	O
buffer	O
,	O
0.5	O
μl	O
B-LP25	O
(	O
200	O
μM	O
)	O
,	O
2	O
μl	O
Vent	O
exo-	O
(	O
NE	O
Biolabs	O
2	O
U/μl	O
)	O
,	O
1	O
μl	O
dNTP	O
(	O
25	O
mM	O
)	O
and	O
41.5	O
μl	O
DNA	S-cellcomponent
)	O
was	O
amplified	O
with	O
the	O
following	O
thermal	O
cycle	O
:	O
(	O
95°C	O
3	O
min	O
,	O
95°C	O
30	O
s	O
,	O
61°C	O
30	O
s	O
,	O
72°C	O
30	O
s	O
)	O
×	O
35	O
cycles.Following	O
amplification	O
,	O
the	O
biotinylated	O
products	O
were	O
extracted	O
using	O
Dynal	O
streptavidin	O
beads	O
.	O

These	O
cells	O
express	O
high	O
levels	O
of	O
TAL1	S-GP
transcripts	O
,	O
and	O
were	O
originally	O
derived	O
from	O
a	O
patient	O
with	O
blastic	S-cell_type
transformation	O
of	O
chronic	O
myeloid	S-x
leukaemia	O
.	O

Comparison	O
of	O
real-time	O
PCR	O
DHS	O
with	O
Southern	O
blottingAs	O
the	O
protocol	O
generates	O
template	O
by	O
primer	O
extending	O
away	O
from	O
a	O
DNaseI	S-GP
-digestion	O
site	O
,	O
as	O
well	O
as	O
PCR	O
amplification	O
between	O
DNaseI	S-GP
-digestion	O
sites	O
,	O
there	O
is	O
the	O
potential	O
for	O
the	O
genomic	O
size	O
of	O
the	O
real-time	O
DHS	O
to	O
be	O
larger	O
than	O
sites	O
revealed	O
by	O
Southern	O
blotting	O
.	O

The	O
technique	O
published	O
here	O
permits	O
the	O
rapid	O
comparative	O
analysis	O
of	O
DHS	O
between	O
different	O
cell	O
types	O
from	O
relatively	O
small	O
numbers	O
of	O
cells	O
.	O

The	O
primary	O
thymocytes	S-cell_type
used	O
for	O
Figure	O
2	O
were	O
prepared	O
by	O
gentle	O
physical	O
disassociation	O
of	O
a	O
whole	O
thymus	B-x
gland	E-x
into	O
PBS	O
supplemented	O
with	O
2	O
%	O
FCS	O
.	O

Genomic	O
standard	O
curves	O
were	O
calculated	O
for	O
each	O
primer	O
using	O
serial	O
5-fold	O
dilutions	O
from	O
50	O
ng	O
genomic	O
DNA	S-cellcomponent
/PCR	O
reaction	O
.	O

Real-time	O
PCR	O
quantificationWe	O
have	O
used	O
Stratagene	O
Brilliant	O
SYBR	O
Green	O
QPCR	O
Master	O
Mix	O
as	O
our	O
standard	O
kit	O
for	O
quantification	O
of	O
genomic	O
controls	O
and	O
samples	O
.	O

Figure	O
2A	O
shows	O
the	O
quantification	O
of	O
material	O
from	O
two	O
primer	O
sets	O
,	O
which	O
are	O
within	O
(	O
primer	O
pair	O
A	O
)	O
and	O
3′	O
(	O
primer	O
pair	O
B	O
)	O
to	O
the	O
mouse	S-y
Stil	S-GP
promoter	O
.	O

An	O
alternative	O
approach	O
using	O
real-time	O
PCR	O
to	O
define	O
DHS	O
has	O
been	O
previously	O
published	O
(	O
10	O
)	O
.	O

The	O
gel	O
in	O
Figure	O
1A	O
shows	O
the	O
DNA	O
from	O
mouse	S-y
thymocyte	O
nuclei	S-cellcomponent
digested	O
with	O
0	O
,	O
40	O
and	O
120	O
units	O
of	O
DNaseI	S-GP
.	O

When	O
the	O
block	O
had	O
cooled	O
to	O
room	O
temperature	O
,	O
the	O
LP21–25	O
linker	O
was	O
aliquoted	O
and	O
frozen	O
.	O

The	O
lower	O
panel	O
represents	O
the	O
mean	O
±	O
SD	O
enrichment	O
from	O
three	O
independent	O
biological	O
replicates	O
from	O
K562	B-cell_type
cells	E-cell_type
.	O

These	O
include	O
the	O
3′	O
haematopoietic	B-GP
stem	I-GP
cell	I-GP
enhancer	E-GP
(	O
+19	O
)	O
(	O
24,30	O
)	O
,	O
the	O
5′	O
endothelial-haematopoietic	B-GP
enhancer	E-GP
(	O
−4	O
)	O
(	O
31	O
)	O
,	O
the	O
3′	O
erythroid	B-GP
enhancer	E-GP
(	O
+40	O
in	O
mouse	S-y
,	O
+50	O
in	O
human	S-y
)	O
(	O
28	O
)	O
,	O
and	O
a	O
number	O
of	O
neuronal	S-x
elements	O
(	O
25,26	O
)	O
.	O

Each	O
post	O
amplification	O
sample	O
(	O
50	O
μl	O
)	O
was	O
then	O
mixed	O
with	O
50	O
μl	O
of	O
resuspended	O
beads	O
and	O
incubated	O
at	O
room	O
temperature	O
on	O
a	O
rotator	O
for	O
1	O
h.	O
After	O
binding	O
,	O
the	O
samples	O
were	O
washed	O
twice	O
with	O
2×	O
binding	O
buffer	O
,	O
then	O
once	O
with	O
1×	O
TE	O
.	O

Care	O
was	O
taken	O
to	O
ensure	O
maximum	O
viability	O
of	O
cells	O
when	O
taken	O
for	O
experiments	O
.	O

In	O
contrast	O
,	O
the	O
hES	B-cell_type
cells	E-cell_type
show	O
markedly	O
reduced	O
enrichment	O
at	O
the	O
TAL1	S-GP
regulatory	O
elements	O
when	O
compared	O
with	O
K562	B-cell_type
cells	E-cell_type
.	O

The	O
amplified	O
DNA	O
is	O
then	O
extracted	O
using	O
para-magnetic	O
streptavidin	O
beads	O
,	O
which	O
provides	O
a	O
DNA	O
library	O
representative	O
of	O
whole-genome	O
DHS	O
.	O

This	O
technique	O
depends	O
on	O
the	O
quantification	O
of	O
relative	O
loss	O
of	O
PCR	O
signal	O
observed	O
when	O
PCR	O
primers	O
amplify	O
across	O
regions	O
of	O
digested	O
DNA	S-cellcomponent
compared	O
with	O
amplification	O
of	O
undigested	O
DNA	S-cellcomponent
.	O

This	O
representative	O
primary	O
mouse	S-y
cell	O
experiment	O
was	O
performed	O
with	O
the	O
DNA	O
shown	O
in	O
Figure	O
1A	O
,	O
which	O
confirms	O
that	O
with	O
these	O
cells	O
,	O
maximal	O
enrichment	O
is	O
observed	O
from	O
DNA	O
that	O
is	O
not	O
over-digested	O
.	O

The	O
DNA	S-cellcomponent
was	O
further	O
extracted	O
using	O
phenol–chloroform	O
and	O
precipitated	O
with	O
ethanol	O
.	O

The	O
BglII	S-GP
restricted	O
fragment	O
is	O
probed	O
from	O
the	O
3′	O
end	O
,	O
as	O
shown	O
in	O
the	O
upper	O
panel	O
.	O

The	O
relative	O
accessibility	O
of	O
the	O
+50	O
enhancer	O
may	O
reflect	O
a	O
poised	O
chromatin	S-cellcomponent
state	O
in	O
hES	B-cell_type
cells	E-cell_type
,	O
which	O
permits	O
a	O
rapid	O
response	O
to	O
the	O
changing	O
transcription	O
factor	O
environment	O
that	O
accompanies	O
differentiation	O
.	O

In	O
this	O
article	O
,	O
we	O
describe	O
a	O
novel	O
protocol	O
to	O
use	O
real-time	O
PCR	O
to	O
map	O
DHS	O
.	O

TAL1	S-GP
expression	O
is	O
critical	O
to	O
the	O
establishment	O
of	O
haematopoiesis	S-x
in	O
a	O
developing	O
embryo	S-x
(	O
15	O
)	O
.	O

Samples	O
(	O
1	O
μg	O
)	O
were	O
analysed	O
using	O
gel-electrophoresis	O
,	O
as	O
shown	O
in	O
Figure	O
1A	O
.	O

Cells	O
were	O
filtered	O
to	O
ensure	O
that	O
a	O
single-cell	O
suspension	O
was	O
taken	O
forward	O
for	O
nuclei	S-cellcomponent
isolation	O
.	O

Real-time	O
PCR	O
is	O
relatively	O
inexpensive	O
compared	O
with	O
the	O
large-scale	O
techniques	O
,	O
and	O
permits	O
a	O
rapid	O
,	O
focused	O
DHS	O
analysis	O
of	O
defined	O
regions	O
of	O
DNA	S-cellcomponent
from	O
multiple	O
cell	O
types	O
.	O

We	O
have	O
previously	O
demonstrated	O
the	O
high	O
sensitivity	O
and	O
specificity	O
of	O
the	O
basic	O
protocol	O
with	O
regard	O
to	O
identifying	O
DHS	O
across	O
large	O
genomic	O
regions	O
(	O
11	O
)	O
.	O

Elements	O
with	O
a	O
range	O
of	O
transcriptional	O
regulatory	O
functions	O
have	O
been	O
identified	O
initially	O
as	O
DHSs	O
.	O

For	O
example	O
,	O
if	O
2	O
×	O
107	O
cells	O
were	O
taken	O
to	O
look	O
at	O
four	O
different	O
conditions	O
(	O
e.g	O
.	O

One	O
advantage	O
of	O
our	O
technique	O
published	O
here	O
is	O
that	O
data	O
can	O
be	O
obtained	O
using	O
far	O
fewer	O
quantitative	O
PCR	O
reactions	O
.	O

The	O
two	O
approaches	O
differ	O
in	O
that	O
Dorscher	O
et	O
al	O
.	O

The	O
80	O
μl	O
DNA	S-cellcomponent
sample	O
was	O
split	O
into	O
two	O
samples	O
for	O
ligation	O
(	O
5	O
μl	O
10×	O
buffer	O
,	O
3	O
μl	O
LP21–25	O
linker	O
,	O
3	O
μl	O
ligase	O
(	O
NE	O
biolabs	O
400	O
U/μl	O
and	O
39	O
μl	O
DNA	S-cellcomponent
)	O
.	O

Although	O
the	O
experiments	O
presented	O
in	O
this	O
paper	O
were	O
each	O
performed	O
using	O
5	O
million	O
cells/digestion	O
condition	O
,	O
we	O
have	O
obtained	O
reproducible	O
data	O
using	O
5-fold	O
fewer	O
cells	O
as	O
starting	O
material	O
.	O

As	O
the	O
linker	O
will	O
ligate	O
to	O
both	O
ends	O
of	O
digested	O
DNA	O
,	O
the	O
amplification	O
will	O
represent	O
a	O
mix	O
of	O
primer	O
extension	O
and	O
PCR	O
,	O
depending	O
on	O
the	O
length	O
of	O
DNA	O
amplified	O
.	O

Maximal	O
enrichment	O
at	O
DHS	O
is	O
usually	O
observed	O
with	O
samples	O
that	O
are	O
not	O
over-digested	O
.	O

For	O
each	O
sample	O
PCR	O
,	O
a	O
45	O
μl	O
stock	O
was	O
made	O
using	O
1.3	O
μl	O
of	O
sample	O
DNA	S-cellcomponent
+	O
43.7	O
μl	O
water	O
.	O

After	O
extraction	O
,	O
DNA	O
is	O
amplified	O
using	O
a	O
biotinylated	O
linker-specific	O
primer	O
and	O
35	O
thermal	O
polymerase	S-GP
cycles	O
,	O
as	O
detailed	O
in	O
‘	O
Materials	O
and	O
methods	O
’	O
section	O
.	O

Background	O
Human	B-cell_type
stem	I-cell_type
cells	E-cell_type
are	O
viewed	O
as	O
a	O
possible	O
source	O
of	O
neurons	S-cell_type
for	O
a	O
cell-based	O
therapy	O
of	O
neurodegenerative	O
disorders	O
,	O
such	O
as	O
Parkinson	O
's	O
disease	O
.	O

Genome-scale	O
microarrays	O
(	O
cDNA	S-cellcomponent
-	O
or	O
oligonucleotide-based	O
)	O
are	O
most	O
valuable	O
when	O
screening	O
populations	O
of	O
cells	O
for	O
the	O
novel	O
genes	O
reflecting	O
potential	O
diagnostic	O
and	O
prognostic	O
markers	O
or	O
for	O
an	O
identification	O
of	O
novel	O
therapeutic	O
targets	O
.	O

A	O
wider	O
application	O
of	O
neural	S-x
transplantation	O
in	O
PD	O
is	O
,	O
however	O
,	O
currently	O
not	O
feasible	O
due	O
to	O
the	O
unpredictable	O
and	O
variable	O
outcome	O
,	O
the	O
risks	O
of	O
unwanted	O
side-effects	O
(	O
dyskinesias	O
)	O
[	O
9,10	O
]	O
and	O
ethical	O
and	O
practical	O
problems	O
associated	O
with	O
using	O
donor	O
cells	O
obtained	O
from	O
aborted	O
embryos	S-x
and	O
fetuses	S-x
[	O
11,12	O
]	O
.	O

For	O
example	O
,	O
the	O
expression	O
of	O
Nanog	S-GP
,	O
DNA	B-GP
(	I-GP
cytosine-5-	I-GP
)	I-GP
-methyltransferase	I-GP
3α	E-GP
(	O
Dnmt3a	S-GP
)	O
,	O
MutS	B-GP
homolog	I-GP
2	I-GP
,	I-GP
colon	I-GP
cancer	I-GP
,	I-GP
nonpolyposis	I-GP
type	I-GP
1	I-GP
(	I-GP
E.	I-GP
coli	I-GP
)	E-GP
(	O
Msh2	S-GP
)	O
,	O
Thy-1	B-GP
cell	I-GP
surface	I-GP
antigen	E-GP
(	O
Thy1	S-GP
)	O
,	O
high-mobility	B-GP
group	I-GP
box	I-GP
2	E-GP
(	O
Hmgb2	S-GP
)	O
,	O
transcription	B-GP
factor	I-GP
3	E-GP
(	O
Tcf3	S-GP
)	O
,	O
Nanos	B-GP
homolog	I-GP
1	E-GP
(	O
Nanos1	S-GP
)	O
,	O
MyoD	B-GP
family	I-GP
inhibitor	E-GP
(	O
Mdfi	S-GP
)	O
,	O
Calumenin	S-GP
(	O
Calu	S-GP
)	O
and	O
soluble	B-GP
thymidine	I-GP
kinase	I-GP
1	E-GP
(	O
Tk1	S-GP
)	O
was	O
detected	O
in	O
hES	S-cell_type
SA02	S-cell_line
cells	O
with	O
Log2	O
ratio	O
value	O
<	O
1	O
.	O

We	O
believe	O
it	O
has	O
the	O
potential	O
to	O
become	O
an	O
important	O
screening	O
tool	O
in	O
the	O
expanding	O
field	O
of	O
hSC	O
studies	O
in	O
application	O
to	O
neurological	S-x
/	O
neurodegenerative	S-x
disorders	O
.	O

NeuroStem	O
Chip	O
is	O
comparable	O
to	O
other	O
stem	O
cell-related	O
focused	O
microarray	O
platforms	O
in	O
regards	O
to	O
manufacturing	O
costs	O
and	O
technical	O
simplicity	O
of	O
the	O
recommended	O
hybridization	O
protocols	O
.	O

Coverslips	O
were	O
mounted	O
onto	O
glass	O
slides	O
with	O
PVA	O
mounting	O
medium	O
containing	O
anti-fading	O
reagent	O
DABCO	O
.	O

The	O
intron-spanning	O
primers	O
for	O
RT-PCR	O
were	O
selected	O
from	O
published	O
works	O
or	O
designed	O
using	O
Oligo	O
4.0	O
software	O
(	O
Molecular	O
Biology	O
Insight	O
)	O
or	O
Clone	O
Manager	O
Suite	O
7.1	O
(	O
Sci	O
Ed	O
Software	O
,	O
NC	O
,	O
USA	O
)	O
and	O
ordered	O
from	O
TAG	O
Copenhagen	O
A/S	O
,	O
Denmark	O
,	O
as	O
the	O
following	O
:	O
Sox2	S-GP
,	O
SRY-box	B-GP
2	E-GP
:	O
5'-TAC	O
CTC	O
TTC	O
CTC	O
CC	O
CTC	O
CA-3	O
'	O
,	O
5'-ACT	O
CTC	O
CTC	O
TTT	O
TGC	O
ACC	O
CC-3	O
'	O
;	O
En1	S-GP
,	O
Engrailed	B-GP
1	E-GP
:	O
5'-AAG	O
GGA	O
CGA	O
AAC	O
TGC	O
GAA	O
CTC	O
C-3	O
'	O
,	O
5'-GAC	O
ACG	O
AAA	O
GGA	O
AAC	O
ACA	O
CAC	O
TCT	O
CG-3	O
'	O
[	O
47	O
]	O
;	O
Nanog	S-GP
:	O
5'-TGC	O
TTA	O
TTC	O
AGG	O
ACA	O
GCC	O
T-3	O
'	O
,	O
5'-TCT	O
GGT	O
CTT	O
CTG	O
TTT	O
CTT	O
GAC	O
T-3	O
'	O
[	O
48	O
]	O
;	O
Gapdh	S-GP
,	O
glyceraldehydes-3-phosphate	B-GP
dehydrogenase	E-GP
:	O
5'-GGA	O
AGG	O
TGA	O
AGG	O
TCG	O
GAG	O
TCA	O
A-3	O
'	O
,	O
5'-GAT	O
CTC	O
GCT	O
CCT	O
GGA	O
AGA	O
TGG	O
T-3	O
'	O
;	O
Aldh1A1	S-GP
,	O
aldehyde	B-GP
dehydrogenase	I-GP
1	I-GP
family	I-GP
,	I-GP
member	I-GP
A1	E-GP
:	O
5'-GGG	O
CAG	O
CCA	O
TTT	O
CTT	O
CTC	O
AC-3	O
'	O
,	O
5'-CTT	O
CTT	O
AGC	O
CCG	O
CTC	O
AAC	O
AC-3	O
'	O
[	O
49	O
]	O
;	O
Sdha	S-GP
,	O
succinate	B-GP
dehydrogenase	E-GP
:	O
5'-TGG	O
GAA	O
CAA	O
GAG	O
GGC	O
ATC	O
TG-3	O
'	O
,	O
5'-CCA	O
CCA	O
CTG	O
CAT	O
CAA	O
ATT	O
CAT	O
G-3	O
'	O
[	O
50	O
]	O
;	O
Tubb	S-GP
,	O
β-tubulin	S-GP
:	O
5'-CTC	O
ACA	O
AGT	O
ACG	O
TGC	O
CTC	O
GAG-3	O
'	O
,	O
5'-GCA	O
CGA	O
CGC	O
TGA	O
AGG	O
TGT	O
TCA-3	O
'	O
;	O
Nestin	S-GP
:	O
5'-AGA	O
GGG	O
GAA	O
TTC	O
CTG	O
CT	O
GAG-3	O
'	O
,	O
5'-CTG	O
AGG	O
ACC	O
AGG	O
ACT	O
CTC	O
TA-3	O
'	O
[	O
47	O
]	O
;	O
Actb	S-GP
,	O
β-actin	S-GP
:	O
5'-CAT	O
CGA	O
GCA	O
CGG	O
CAT	O
CGT	O
CA-3	O
'	O
,	O
5'-TAG	O
CAC	O
AGC	O
CTG	O
GAT	O
AGC	O
AAC-3	O
'	O
[	O
51	O
]	O
;	O
Th	S-GP
,	O
Tyrosine	B-GP
hydroxylase	E-GP
:	O
5'-CGA	O
GCT	O
GTG	O
AAG	O
GTG	O
TTT	O
G-3	O
'	O
,	O
5'-TTG	O
GTG	O
ACC	O
AGG	O
TGA	O
TGA	O
C-3	O
'	O
;	O
Msx1	S-GP
,	O
homolog	B-GP
of	I-GP
Drosophila	I-GP
muscle	I-GP
segment	I-GP
homolog	I-GP
1	E-GP
:	O
5'-CTC	O
AAG	O
CTG	O
CCA	O
GAA	O
GAT	O
GC-3	O
'	O
,	O
5'-TCC	O
AGC	O
TCT	O
GCC	O
TCT	O
TGT	O
AG-3	O
'	O
;	O
Pitx2	S-GP
,	O
paired-like	B-GP
homeodomain	I-GP
transcription	I-GP
factor	I-GP
2	E-GP
:	O
5'-ACC	O
TTA	O
CGG	O
AAG	O
CCC	O
GAG	O
TC-3	O
'	O
,	O
5'-TGG	O
ATA	O
GGG	O
AGG	O
CGG	O
ATG	O
TA-3	O
'	O
[	O
49	O
]	O
.	O

The	O
optimal	O
number	O
of	O
clusters	O
was	O
determined	O
empirically	O
to	O
produce	O
the	O
most	O
balanced	O
ratio	O
of	O
entries	O
to	O
cluster	O
of	O
highly	O
expressed	O
genes	O
.	O

Among	O
these	O
,	O
entries	O
related	O
to	O
Dickkopf	S-GP
gene	O
family	O
,	O
galanin-	B-GP
,	I-GP
melatonin-	I-GP
,	I-GP
vasoactive	I-GP
intestinal	I-GP
peptide	E-GP
(	O
VIP	S-GP
)	O
-	O
,	O
cAMP	B-GP
response	I-GP
element-binding	I-GP
protein	E-GP
(	O
CREB	S-GP
)	O
-	O
and	O
B	B-GP
cell	I-GP
leukemia	I-GP
2	E-GP
(	O
Bcl2	S-GP
)	O
oncogene-related	O
are	O
present	O
.	O

Diversity	O
of	O
NeuroStem	O
Chip	O
entries	O
responsive	O
to	O
hESC	O
commitment	O
toward	O
neuronal	S-x
/	O
dopaminergic	S-x
differentiation	O
pathway	O
clearly	O
illustrates	O
the	O
complexity	O
of	O
that	O
pathway	O
.	O

Cells	O
were	O
pre-incubated	O
with	O
blocking	O
solution	O
containing	O
PBS	O
,	O
0.5	O
%	O
Triton	O
X-100	O
and	O
5	O
%	O
of	O
donkey	S-y
serum	O
.	O

Co-culturing	O
of	O
ESCs	S-cell_type
with	O
murine	B-cell_type
stromal	I-cell_type
cells	E-cell_type
(	O
including	O
PA6	S-cell_line
cell	O
line	O
)	O
rapidly	O
generates	O
dopaminergic	B-cell_type
neurons	E-cell_type
from	O
ESCs	S-cell_type
by	O
an	O
unexplained	O
mechanism	O
termed	O
stromal	B-GP
cell-derived	I-GP
inducing	I-GP
activity	E-GP
(	O
SDIA	S-GP
;	O
[	O
28,29	O
]	O
)	O
.	O

To	O
illustrate	O
the	O
utility	O
of	O
NeuroStem	O
Chip	O
platform	O
,	O
we	O
have	O
characterized	O
an	O
undifferentiated	O
population	O
of	O
pluripotent	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hESCs	S-cell_type
,	O
cell	O
line	O
SA02	S-cell_line
)	O
.	O

We	O
believe	O
that	O
those	O
findings	O
could	O
be	O
explained	O
by	O
cellular	O
composition	O
of	O
human	O
universal	O
reference	O
RNA	O
sample	O
[	O
42	O
]	O
,	O
which	O
includes	O
pooled	O
RNA	O
samples	O
from	O
proliferating	O
cells	O
(	O
e.g.	O
,	O
skin	S-x
and	O
testis	B-cell_type
cell	E-cell_type
lines	O
)	O
.	O

It	O
would	O
be	O
therefore	O
impossible	O
to	O
apply	O
the	O
platform	O
to	O
identify	O
novel	O
genes	O
associated	O
with	O
the	O
process	O
of	O
differentiation	O
;	O
for	O
that	O
application	O
,	O
the	O
genome-scale	O
microarray	O
platforms	O
(	O
e.g.	O
,	O
Affymetrix	O
)	O
are	O
clearly	O
superior	O
.	O

The	O
outer	O
rings	O
of	O
the	O
IVF	O
dishes	O
were	O
filled	O
with	O
Dulbecco	O
's	O
modified	O
Eagle	O
medium	O
(	O
DMEM	O
)	O
supplemented	O
with	O
0.5	O
%	O
Penicillin/Streptomycin	O
mix	O
.	O

Affymetrix	O
Human	S-y
Genome	O
platforms	O
)	O
,	O
they	O
have	O
a	O
clear	O
advantage	O
in	O
routine	O
work	O
involving	O
samples	O
from	O
,	O
e.g.	O
,	O
multiple	O
cell	O
culture	O
conditions	O
.	O

and	O
Yang	O
et	O
al.	O
,	O
who	O
designed	O
small-to-moderate	O
scale	O
custom	O
microarray	O
platforms	O
(	O
281	O
and	O
755	O
gene	O
targets	O
,	O
respectively	O
)	O
[	O
17,18	O
]	O
.	O

The	O
final	O
extension	O
was	O
5	O
min	O
at	O
72°C	O
.	O

We	O
therefore	O
incorporated	O
gene	O
markers	O
of	O
development	O
and	O
differentiation	O
in	O
general	O
,	O
and	O
that	O
of	O
neuronal	S-x
and	O
dopaminergic	S-x
differentiation	O
in	O
particular	O
,	O
into	O
the	O
NeuroStem	O
Chip	O
.	O

Considering	O
the	O
complexity	O
of	O
the	O
processes	O
involved	O
,	O
stemness	O
can	O
hardly	O
be	O
ensured	O
by	O
co-operation	O
of	O
just	O
a	O
few	O
genes	O
.	O

Thereby	O
,	O
it	O
is	O
possible	O
to	O
employ	O
it	O
to	O
monitor	O
the	O
relative	O
expression	O
levels	O
of	O
numerous	O
known	O
and	O
candidate	O
stemness	O
genes	O
in	O
a	O
single	O
experiment	O
.	O

Amplified	O
fluorescent	O
cRNA	S-cellcomponent
samples	O
were	O
purified	O
using	O
RNeasy	O
mini-columns	O
(	O
Quiagen	O
)	O
,	O
and	O
fluorescence	O
of	O
the	O
eluted	O
products	O
was	O
measured	O
using	O
ND-1000	O
specrophotometer	O
(	O
NanoDrop	O
)	O
.	O

The	O
microarray	O
format	O
we	O
selected	O
relies	O
on	O
long	O
oligonucleotide	O
molecules	O
(	O
69–71	O
nucleotides	O
)	O
printed	O
over	O
a	O
solid	O
surface	O
.	O

This	O
is	O
well	O
illustrated	O
by	O
multiple	O
studies	O
on	O
substantia	B-cell_type
nigra	I-cell_type
dopaminergic	I-cell_type
neurons	E-cell_type
,	O
which	O
degenerate	O
in	O
Parkinson	O
's	O
disease	O
(	O
PD	O
)	O
[	O
1-5	O
]	O
.	O

We	O
performed	O
two-color	O
hybridizations	O
(	O
e.g	O
.	O

Microarray	O
slides	O
were	O
UV-cross-linked	O
(	O
800	O
mJ/cm2	O
)	O
,	O
pre-hybridizedwith	O
fluorescently	O
labeled	O
samples	O
using	O
the	O
Pronto	O
!	O

At	O
the	O
same	O
time	O
,	O
genes	O
listed	O
in	O
Table	O
4	O
represent	O
the	O
most	O
highly	O
up-regulated	O
entries	O
in	O
a	O
relatively	O
limited	O
group	O
of	O
genes	O
(	O
Figure	O
5C	O
)	O
.	O

Notably	O
,	O
comparison	O
of	O
expression	O
profiles	O
of	O
undifferentiated	O
hESCs	S-cell_type
and	O
hESC-derived	O
cells	O
committed	O
toward	O
dopaminergic	S-x
differentiation	O
pathway	O
by	O
co-culturing	O
with	O
SDIA	S-GP
for	O
16	O
days	O
have	O
revealed	O
that	O
many	O
of	O
the	O
stem	O
cell	O
marker	O
genes	O
mentioned	O
above	O
were	O
down-regulated	O
in	O
differentiation	O
(	O
Table	O
5	O
)	O
.	O

hematopoietic	S-x
and	O
pancreatic	S-x
)	O
and	O
cell	O
types	O
(	O
e.g	O
.	O

Twenty	O
μl	O
volumes	O
of	O
RT-PCR	O
products	O
were	O
analyzed	O
by	O
electrophoresis	O
at	O
1	O
%	O
agarose	O
gels	O
and	O
visualized	O
by	O
ethidium	O
bromide	O
staining	O
.	O
RNA	S-cellcomponent
purification	O
and	O
fluorescent	O
dye	O
incorporationFor	O
RNA	O
purification	O
of	O
undifferentiated	O
hESCs	S-cell_type
,	O
the	O
latter	O
were	O
mechanically	O
separated	O
from	O
hFCs	S-cell_type
,	O
collected	O
in	O
a	O
500	O
μl	O
volume	O
of	O
VitroHES	O
media	O
,	O
rinsed	O
in	O
PBS	O
buffer	O
and	O
spun	O
down	O
at	O
300	O
rcf	O
for	O
5	O
min	O
.	O

At	O
the	O
same	O
time	O
,	O
it	O
currently	O
implies	O
an	O
advantage	O
in	O
both	O
the	O
scale	O
and	O
the	O
spectrum	O
of	O
pre-selected	O
,	O
specific	O
gene	O
targets	O
assayed	O
.	O

Universal	O
Microarray	O
Hybridization	O
Kit	O
(	O
Corning	O
)	O
and	O
subsequently	O
hybridized	O
with	O
test	O
(	O
Cy3-labeled	O
)	O
/reference	O
(	O
Cy5-labeled	O
)	O
RNA	O
samples	O
(	O
or	O
in	O
reverse	O
dye-labeling	O
order	O
)	O
at	O
42°C	O
for	O
17	O
h	O
using	O
a	O
MAUI	O
hybridization	O
station	O
(	O
BioMicro	O
Systems	O
Inc.	O
,	O
USA	O
)	O
and	O
the	O
Pronto	O
!	O

Table	O
1	O
lists	O
24	O
dopaminergic	B-x
system	E-x
-related	O
entries	O
(	O
e.g.	O
,	O
Ptx3	S-GP
,	O
Th	S-GP
,	O
Lhx1	S-GP
)	O
with	O
gene	O
expression	O
up-regulated	O
by	O
Day	O
16	O
of	O
hESC	O
differentiation	O
protocol	O
;	O
few	O
more	O
genes	O
have	O
demonstrated	O
less	O
prominent	O
up-regulation	O
(	O
Log2	O
ratio	O
values	O
in	O
the	O
range	O
of	O
0.7/0.97–1.0	O
)	O
.	O

In	O
many	O
published	O
studies	O
,	O
the	O
expression	O
of	O
only	O
a	O
single	O
(	O
tyrosine	B-GP
hydroxylase	E-GP
,	O
TH	S-GP
)	O
or	O
2–3	O
markers	O
for	O
dopaminergic	B-cell_type
neurons	E-cell_type
(	O
e.g	O
.	O

Some	O
of	O
the	O
housekeeping	O
genes	O
(	O
Gapdh	S-GP
,	O
Sdha	S-GP
,	O
Tubb	S-GP
,	O
Actb	S-GP
)	O
have	O
somewhat	O
different	O
expression	O
in	O
undifferentiated	O
vs.	O
differentiated	O
cells	O
,	O
consistent	O
with	O
previous	O
reports	O
on	O
certain	O
established	O
housekeeping	O
genes	O
(	O
including	O
Gapdh	S-GP
)	O
being	O
variable	O
in	O
human	S-y
samples	O
[	O
45	O
]	O
.	O

The	O
following	O
primary	O
antibodies	O
were	O
used	O
:	O
mouse	B-GP
anti-Oct3/4	E-GP
(	O
1:500	O
,	O
Santa	O
Cruz	O
Biotechnology	O
Inc.	O
)	O
;	O
rabbit	B-GP
anti-Ki67	E-GP
(	O
1:200	O
,	O
Novocastra	O
Ltd.	O
)	O
;	O
rabbit	B-GP
anti-TH	E-GP
(	O
1:500	O
,	O
Chemicon	O
)	O
.	O

To	O
detect	O
genes	O
with	O
high	O
expression	O
levels	O
in	O
hESC	O
samples	O
,	O
we	O
filtered	O
data	O
for	O
intensity	O
values	O
>	O
100	O
in	O
the	O
hESC	O
sample	O
and	O
performed	O
clustering	O
analysis	O
using	O
the	O
TIGR	O
MultiExperiment	O
Viewer	O
(	O
MEV	O
;	O
[	O
34	O
]	O
)	O
.	O

for	O
the	O
experiment	O
vs.	O
reference	O
)	O
following	O
an	O
established	O
protocol	O
[	O
31	O
]	O
,	O
and	O
included	O
dye-flip	O
technical	O
replicates	O
in	O
the	O
analysis	O
(	O
Figure	O
4	O
)	O
.	O

Those	O
entries	O
encompass	O
recognized	O
and	O
candidate	O
markers	O
for	O
dopaminergic	B-cell_type
neurons	E-cell_type
(	O
mature	O
and	O
early	O
)	O
and	O
progenitors	S-cell_type
,	O
as	O
well	O
as	O
markers	O
for	O
the	O
maturation	O
and	O
differentiation	O
of	O
the	O
latter	O
(	O
Table	O
1	O
)	O
.	O

genes	O
for	O
KIAA1573	B-GP
protein	E-GP
,	O
forkhead	B-GP
box	I-GP
O1A	E-GP
(	O
Foxo1a	S-GP
)	O
,	O
high-mobility	B-GP
group	I-GP
box	I-GP
1	E-GP
(	O
Hmgb1	S-GP
)	O
,	O
C-terminal	B-GP
binding	I-GP
protein	I-GP
2	E-GP
(	O
Ctbp2	S-GP
)	O
and	O
left-right	B-GP
determination	I-GP
factor	I-GP
1	E-GP
(	O
Lefty1	S-GP
)	O
,	O
as	O
well	O
as	O
others	O
.	O

In	O
addition	O
SuperArray	O
Bioscience	O
Corporation	O
(	O
Frederick	O
,	O
MD	O
,	O
USA	O
)	O
have	O
manufactured	O
a	O
range	O
of	O
small-scale	O
arrays	O
(	O
263	O
gene	O
targets	O
for	O
human	O
array	O
;	O
[	O
19	O
]	O
)	O
.	O

RT-PCR	O
analyses	O
have	O
validated	O
the	O
overall	O
reliability	O
of	O
NeuroStem	O
microarray	O
platform	O
:	O
all	O
of	O
the	O
entries	O
detected	O
in	O
the	O
hybridization	O
experiments	O
have	O
demonstrated	O
similar	O
trends	O
when	O
analyzed	O
by	O
RT-PCR	O
means	O
(	O
Figure	O
3	O
)	O
.	O

Highly	O
expressed	O
in	O
pluripotent	B-cell_type
ESCs	E-cell_type
,	O
Hesx1	S-GP
expression	O
is	O
down-regulated	O
upon	O
embryonic	B-cell_type
stem	I-cell_type
cell	E-cell_type
differentiation	O
[	O
35,36	O
]	O
,	O
as	O
also	O
clearly	O
seen	O
in	O
differentiation	O
experiment	O
of	O
our	O
own	O
(	O
Table	O
4	O
)	O
.	O

They	O
were	O
then	O
incubated	O
with	O
primary	O
antibodies	O
in	O
blocking	O
solution	O
overnight	O
at	O
room	O
temperature	O
.	O

We	O
have	O
selected	O
genes	O
that	O
are	O
relevant	O
to	O
cells	O
(	O
i	O
)	O
being	O
stem	B-cell_type
cells	E-cell_type
,	O
(	O
ii	O
)	O
becoming	O
neurons	S-cell_type
,	O
and	O
(	O
iii	O
)	O
being	O
neurons	S-cell_type
.	O

cancer	S-x
subtypes	O
and	O
a	O
range	O
of	O
normal	O
cell	O
types	O
)	O
to	O
serve	O
as	O
essential	O
controls	O
.	O

Commitment	O
of	O
hESCs	S-cell_type
towards	O
neuronal	S-x
/dopaminergic	O
differentiation	O
pathwayCo-culturing	O
with	O
the	O
PA6	S-cell_line
stromal	O
cell	O
line	O
(	O
MC3T3-G2/Pa6	O
,	O
from	O
RIKEN	O
Cell	O
Bank	O
Japan	O
(	O
RCB	O
1127	O
)	O
,	O
derived	O
from	O
newborn	O
mouse	S-y
calvaria	S-x
rapidly	O
generates	O
high	O
numbers	O
of	O
DA	O
neurons	S-cell_type
from	O
mouse	S-y
and	O
monkey	S-y
ESCs	S-cell_type
by	O
an	O
unknown	O
mechanism	O
named	O
stromal-derived	B-GP
inducing	I-GP
activity	E-GP
(	O
SDIA	S-GP
;	O
[	O
28,29	O
]	O
)	O
.	O

Printing	O
was	O
performed	O
in	O
a	O
temperature-	O
(	O
18–20°C	O
)	O
and	O
humidity-	O
(	O
44–49	O
%	O
RH	O
)	O
controlled	O
area	O
on	O
Corning	O
UltraGAPS	O
aminosilane	O
slides	O
(	O
Corning	O
Inc.	O
,	O
USA	O
)	O
with	O
140	O
μm	O
spot-to-spot	O
centerdistance	O
and	O
90–110	O
μm	O
average	O
spot	O
size	O
.	O

The	O
molecular	O
mechanisms	O
that	O
govern	O
development	O
of	O
cultured	O
hESCs	S-cell_type
into	O
specific	O
types	O
of	O
neural	B-cell_type
cells	E-cell_type
are	O
not	O
fully	O
understood	O
.	O

All	O
normalizations	O
,	O
filtering	O
,	O
merging	O
of	O
technical	O
replicates	O
and	O
analyses	O
were	O
performed	O
in	O
the	O
BioArray	O
Software	O
Environment	O
database	O
[	O
32	O
]	O
.	O

Several	O
protocols	O
that	O
generate	O
different	O
types	O
of	O
neurons	S-cell_type
from	O
human	B-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hSCs	S-cell_type
)	O
have	O
been	O
developed	O
.	O

We	O
have	O
aimed	O
to	O
embrace	O
the	O
most	O
comprehensive	O
set	O
of	O
those	O
genes	O
into	O
a	O
solitary	O
array	O
,	O
the	O
NeuroStem	O
Chip	O
.	O

A	O
cluster	O
of	O
101	O
genes	O
up-regulated	O
in	O
the	O
hESC	O
sample	O
[	O
see	O
Additional	O
file	O
1	O
]	O
,	O
was	O
plotted	O
in	O
a	O
centroid	O
graph	O
(	O
Figure	O
5C	O
)	O
;	O
the	O
variation	O
across	O
technical	O
replicates	O
was	O
low	O
.	O

Recent	O
technological	O
advances	O
have	O
led	O
to	O
DNA	S-cellcomponent
microarrays	O
which	O
contain	O
over	O
hundred	O
thousand	O
of	O
spots	O
of	O
DNA	S-cellcomponent
material	O
,	O
reaching	O
a	O
truly	O
genomic	O
scale	O
.	O

One	O
day	O
prior	O
to	O
hESC	O
plating	O
,	O
hFC	O
medium	O
was	O
washed	O
away	O
from	O
the	O
hFCs	S-cell_type
,	O
the	O
latter	O
were	O
resuspended	O
in	O
a	O
hESC	O
proliferation	O
medium	O
(	O
VitroHES	O
media	O
(	O
Vitrolife	O
AB	O
,	O
Sweden	O
)	O
supplemented	O
with	O
4	O
ng/ml	O
human	B-GP
recombinant	I-GP
basic	I-GP
FGF	E-GP
(	O
hrbFGF	S-GP
,	O
Biosource	O
International	O
,	O
USA	O
)	O
and	O
plated	O
in	O
a	O
central	O
ring	O
of	O
gelatinized	O
in	O
vitro	O
fertilization	O
(	O
IVF	O
)	O
dishes	O
with	O
a	O
cell	O
density	O
of	O
120,000	O
cells/dish	O
.	O

Human	S-y
embryonic	S-x
stem	O
cell	O
(	O
hESC	O
)	O
culturesUndifferentiated	O
hESCs	S-cell_type
of	O
SA02	S-cell_line
(	O
Sahlgrenska	B-cell_line
2	E-cell_line
)	O
line	O
(	O
Cellartis	O
AB	O
,	O
Göteborg	O
,	O
Sweden	O
;	O
see	O
NIH	O
Human	O
Embryonic	O
Stem	O
Cell	O
Registry	O
at	O
[	O
46	O
]	O
)	O
were	O
maintained	O
over	O
a	O
monolayer	O
of	O
human	S-y
``	O
feeder	B-cell_type
cells	E-cell_type
``	O
(	O
hFCs	S-cell_type
;	O
human	B-cell_type
foreskin	I-cell_type
fibroblasts	E-cell_type
,	O
ATCC	O
;	O
cell	O
line	O
CCD-1112Sk	S-cell_line
)	O
.	O

Here	O
we	O
introduce	O
the	O
platform	O
and	O
the	O
advantages	O
it	O
can	O
offers	O
to	O
neuroscientists	O
and	O
stem	O
cell	O
biologists	O
:	O
particularly	O
,	O
in	O
the	O
niche	O
of	O
gene	O
expression-oriented	O
characterization	O
of	O
the	O
samples	O
using	O
an	O
assay	O
of	O
pre-selected	O
,	O
already	O
established	O
gene	O
targets	O
.	O

Characterization	O
of	O
hESCs	S-cell_type
and	O
hESC-derived	O
cells	O
by	O
immunocytochemistry	O
(	O
ICC	O
)	O
and	O
RT-PCRIVF	O
dishes	O
with	O
hESCs	S-cell_type
grown	O
atop	O
hFCs	S-cell_type
and	O
4-well	O
plate	O
dishes	O
with	O
hESCs	S-cell_type
growing	O
atop	O
PA6	B-cell_type
cells	E-cell_type
were	O
fixed	O
with	O
4	O
%	O
paraformaldehyde	O
(	O
PFA	O
)	O
for	O
15	O
minutes	O
at	O
the	O
day	O
of	O
passage/harvest	O
(	O
Day	O
6	O
of	O
hESC/hFC	O
co-culturing	O
)	O
and	O
Day	O
16	O
of	O
co-culturing	O
with	O
PA6	B-cell_type
cells	E-cell_type
,	O
respectively	O
.	O

We	O
performed	O
the	O
analysis	O
of	O
microarray	O
data	O
,	O
as	O
described	O
in	O
the	O
Methods	O
,	O
and	O
spot	O
error	O
values	O
were	O
generally	O
in	O
the	O
lower	O
range	O
,	O
indicating	O
high	O
stringency	O
of	O
the	O
signals	O
and	O
low	O
variance	O
.	O

Nevertheless	O
,	O
three	O
stemness	O
genes	O
(	O
namely	O
,	O
Oct3/4	S-GP
,	O
Stat3	S-GP
and	O
Nanog	S-GP
)	O
are	O
considered	O
``	O
master	O
''	O
-genes	O
that	O
control	O
the	O
self-renewing	O
process	O
[	O
23,24	O
]	O
.	O

For	O
the	O
first	O
of	O
these	O
,	O
we	O
used	O
total	O
RNA	O
sample	O
purified	O
from	O
hESC	O
colonies	O
that	O
exhibited	O
morphology	O
consistent	O
with	O
cell	O
proliferation	O
and	O
the	O
absence	O
of	O
spontaneous	O
differentiation	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
cell	O
population	O
obtained	O
after	O
16	O
day	O
exposure	O
to	O
SDIA	O
is	O
highly	O
heterogeneous	O
.	O

We	O
spotted	O
the	O
synthesized	O
oligonucleotides	O
(	O
Operon	O
Biotechnologies	O
)	O
with	O
a	O
constant	O
concentration	O
across	O
the	O
slides	O
,	O
and	O
evaluated	O
the	O
quality	O
and	O
consistency	O
of	O
spotting	O
in	O
a	O
series	O
of	O
control	O
experiments	O
.	O

While	O
there	O
is	O
a	O
risk	O
that	O
one	O
will	O
miss	O
out	O
on	O
changes	O
in	O
genes	O
previously	O
not	O
believed	O
to	O
be	O
relevant	O
to	O
neural	S-x
differentiation	O
,	O
the	O
restricted	O
number	O
of	O
genes	O
in	O
the	O
NeuroStem	O
Chip	O
also	O
simplifies	O
analysis	O
and	O
adds	O
power	O
.	O

Data	O
normalization	O
was	O
performed	O
per	O
array	O
subgrid	O
using	O
LOWESS	O
curve	O
fitting	O
with	O
a	O
smoothing	O
factor	O
of	O
0.33	O
[	O
52,53	O
]	O
.	O

At	O
the	O
same	O
time	O
,	O
hundreds	O
of	O
genes	O
are	O
suggested	O
as	O
candidate	O
markers	O
for	O
``	O
stemness	O
''	O
,	O
but	O
their	O
coupling	O
to	O
the	O
undifferentiated	B-cell_type
stem	I-cell_type
cell	E-cell_type
state	O
is	O
not	O
yet	O
fully	O
verified	O
[	O
21	O
]	O
.	O

Following	O
initial	O
denaturation	O
for	O
5	O
min	O
at	O
95°C	O
,	O
DNA	O
amplifications	O
were	O
performed	O
for	O
35	O
(	O
En1	S-GP
,	O
Nanog	S-GP
,	O
Aldh1a1	S-GP
)	O
,	O
33	O
(	O
Sox2	S-GP
,	O
Nestin	S-GP
,	O
Th	S-GP
,	O
Msx1	S-GP
)	O
,	O
32	O
(	O
Tubb	S-GP
,	O
Pitx2	S-GP
)	O
,	O
27	O
(	O
Sdha	S-GP
)	O
,	O
25	O
(	O
Actb	S-GP
)	O
or	O
22	O
(	O
Gapdh	S-GP
)	O
cycles	O
of	O
1	O
min	O
at	O
95°C	O
,	O
1	O
min	O
at	O
55°C	O
(	O
En1	S-GP
,	O
Pitx2	S-GP
)	O
,	O
57°C	O
(	O
Sox2	S-GP
,	O
Nanog	S-GP
,	O
Sdha	S-GP
,	O
Nestin	S-GP
)	O
,	O
58°C	O
(	O
Tubb	S-GP
)	O
,	O
58.5°C	O
(	O
Aldh1a1	S-GP
,	O
Th	S-GP
)	O
or	O
59°C	O
(	O
Gapdh	S-GP
,	O
Actb	S-GP
,	O
Msx1	S-GP
)	O
,	O
and	O
1	O
min	O
at	O
72°C	O
.	O

In	O
addition	O
,	O
the	O
NeuroStem	O
Chip	O
can	O
be	O
used	O
to	O
characterize	O
gene	O
changes	O
in	O
intracerebral	S-x
grafts	O
of	O
human	S-y
cells	O
,	O
even	O
when	O
they	O
are	O
transplanted	O
into	O
experimental	O
animals	S-x
.	O

In	O
addition	O
,	O
we	O
have	O
performed	O
a	O
comparative	O
gene	O
expression	O
analysis	O
of	O
those	O
cells	O
versus	O
a	O
heterogeneous	O
population	O
of	O
hESC-derived	O
cells	O
committed	O
towards	O
neuronal	S-x
/dopaminergic	O
differentiation	O
pathway	O
by	O
co-culturing	O
with	O
PA6	B-cell_type
stromal	I-cell_type
cells	E-cell_type
for	O
16	O
days	O
and	O
containing	O
a	O
few	O
tyrosine	B-GP
hydroxylase	E-GP
-positive	O
dopaminergic	B-cell_type
neurons	E-cell_type
.ConclusionWe	O
characterized	O
the	O
gene	O
expression	O
profiles	O
of	O
undifferentiated	O
and	O
dopaminergic	O
lineage-committed	O
hESC-derived	O
cells	O
using	O
a	O
highly	O
focused	O
custom	O
microarray	O
platform	O
(	O
NeuroStem	O
Chip	O
)	O
that	O
can	O
become	O
an	O
important	O
research	O
tool	O
in	O
human	S-y
stem	O
cell	O
biology	O
.	O

The	O
shortcomings	O
of	O
pharmacological	O
therapies	O
in	O
PD	O
have	O
stimulated	O
a	O
search	O
for	O
alternative	O
treatment	O
strategies	O
.	O

Taken	O
together	O
,	O
we	O
believe	O
that	O
in	O
its	O
present	O
form	O
NeuroStem	O
Chip	O
represents	O
currently	O
most	O
comprehensive	O
gene	O
expression	O
platform	O
for	O
studies	O
on	O
stem	B-cell_type
cells	E-cell_type
,	O
neural	S-x
/	O
neuronal	S-x
differentiation	O
,	O
human	S-y
neurodegeneration	O
and	O
neuronal	S-x
survival	O
,	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

Many	O
other	O
genes	O
involved	O
in	O
maintenance	O
of	O
ESC	O
phenotype	O
(	O
i.e	O
.	O

The	O
expression	O
of	O
fibroblast	B-GP
growth	I-GP
factor	I-GP
receptor	I-GP
2	E-GP
(	O
Fgfr2	S-GP
)	O
is	O
of	O
particular	O
interest	O
.	O

Some	O
suggested	O
areas	O
of	O
application	O
for	O
NeuroStem	O
microarray	O
platform	O
could	O
be	O
the	O
following	O
:	O
(	O
i	O
)	O
characterization	O
of	O
the	O
expression	O
of	O
established	O
,	O
pre-selected	O
gene	O
targets	O
in	O
human	S-y
stem	O
cell	O
(	O
hSC	O
)	O
lines	O
,	O
including	O
newly	O
derived	O
ones	O
,	O
(	O
ii	O
)	O
longitudinal	O
quality	O
control	O
for	O
maintained	O
hSC	O
populations	O
,	O
(	O
iii	O
)	O
following	O
gene	O
expression	O
changes	O
during	O
differentiation	O
under	O
defined	O
cell	O
culture	O
conditions	O
,	O
and	O
(	O
iv	O
)	O
confirming	O
the	O
success	O
of	O
differentiation	O
into	O
specific	O
neuronal	S-x
subtypes	O
.	O

Many	O
of	O
them	O
play	O
potentially	O
important	O
,	O
yet	O
undefined	O
,	O
roles	O
in	O
the	O
biology	O
of	O
stem	B-cell_type
cells	E-cell_type
.	O

amino	B-GP
acid	I-GP
decarboxylase	E-GP
(	O
AADC	S-GP
)	O
,	O
dopamine	B-GP
transporter	E-GP
(	O
DAT	S-GP
)	O
,	O
vesicular	B-GP
monoamine	I-GP
transporter	I-GP
2	E-GP
(	O
VMAT2	S-GP
)	O
)	O
have	O
been	O
used	O
to	O
indicate	O
dopaminergic	S-x
identity	O
of	O
neurons	S-cell_type
.	O

We	O
therefore	O
committed	O
hESCs	S-cell_type
toward	O
the	O
neuronal	S-x
/	O
dopaminergic	S-x
differentiation	O
pathway	O
by	O
co-culturing	O
with	O
PA6	B-cell_type
cells	E-cell_type
for	O
16	O
days	O
,	O
resulting	O
in	O
appearance	O
of	O
cells	O
positive	O
for	O
early	O
and	O
late	O
neuronal	S-x
markers	O
,	O
including	O
nestin	S-GP
,	O
β-III-tubulin	S-GP
,	O
and	O
TH	S-GP
,	O
the	O
established	O
marker	O
of	O
dopaminergic	B-cell_type
neurons	E-cell_type
(	O
Figure	O
2	O
)	O
.	O

Examples	O
include	O
markers	O
for	O
the	O
processes	O
of	O
neuronal	S-x
maturation	O
,	O
axonal	S-x
branching	O
,	O
neural	S-x
/	O
neuronal	S-x
survival	O
,	O
etc	O
.	O

The	O
cells	O
were	O
maintained	O
at	O
37°C	O
,	O
5	O
%	O
CO2	O
,	O
95	O
%	O
humidity	O
settings	O
.	O

Microarray	O
technologyLong	O
oligonucleotide	O
probes	O
(	O
69–71	O
nucleotides	O
)	O
matching	O
gene	O
targets	O
of	O
interest	O
were	O
selected	O
from	O
Operon	O
V2	O
and	O
V3	O
human	O
AROS	O
sets	O
(	O
Operon	O
Biotechnologies	O
Inc.	O
,	O
USA	O
)	O
.	O

Thus	O
,	O
the	O
relative	O
difference	O
between	O
gene	O
expression	O
of	O
certain	O
markers	O
of	O
stem	B-cell_type
cells	E-cell_type
in	O
undifferentiated	B-cell_type
hESCs	E-cell_type
and	O
universal	O
reference	O
RNA	O
is	O
naturally	O
decreased	O
.	O

The	O
NeuroStem	O
Chip	O
has	O
over	O
1,300	O
pre-selected	O
gene	O
targets	O
and	O
multiple	O
controls	O
spotted	O
in	O
quadruplicates	O
(	O
~46,000	O
spots	O
total	O
)	O
.	O

Nevertheless	O
,	O
the	O
cellular	O
mechanisms	O
that	O
underlie	O
the	O
development	O
of	O
neurons	S-cell_type
in	O
vitro	O
as	O
they	O
are	O
subjected	O
to	O
the	O
specific	O
differentiation	O
protocols	O
are	O
often	O
poorly	O
understood.ResultsWe	O
have	O
designed	O
a	O
focused	O
DNA	O
(	O
oligonucleotide-based	O
)	O
large-scale	O
microarray	O
platform	O
(	O
named	O
``	O
NeuroStem	O
Chip	O
''	O
)	O
and	O
used	O
it	O
to	O
study	O
gene	O
expression	O
patterns	O
in	O
hSCs	S-cell_type
as	O
they	O
differentiate	O
into	O
neurons	S-cell_type
.	O

Modern	O
DNA	S-cellcomponent
microarrays	O
permit	O
a	O
comprehensive	O
analysis	O
of	O
quantitative	O
and	O
qualitative	O
changes	O
in	O
RNA	S-cellcomponent
transcript	O
abundance	O
,	O
outlining	O
the	O
cross-sections	O
of	O
gene	O
expression	O
and	O
alterations	O
of	O
these	O
in	O
response	O
to	O
genetic	O
or	O
environmental	O
stimuli	O
.	O

Stem	B-cell_type
cells	E-cell_type
have	O
unique	O
biological	O
characteristics	O
,	O
but	O
only	O
a	O
limited	O
number	O
of	O
genes	O
are	O
currently	O
recognized	O
as	O
established	O
stem	O
cell	O
markers	O
.	O

To	O
verify	O
the	O
expression	O
of	O
some	O
key	O
stem	O
cell-	O
and	O
neural	S-x
phenotype-associated	O
genes	O
we	O
performed	O
RT-PCR	O
comparing	O
RNA	O
samples	O
from	O
the	O
undifferentiated	O
hESCs	S-cell_type
with	O
hESCs	S-cell_type
of	O
the	O
same	O
line	O
differentiated	O
toward	O
neuronal	S-cell_type
/dopaminergic	O
pathway	O
,	O
as	O
described	O
above	O
.	O

Using	O
the	O
online	O
software	O
program	O
BASE	O
[	O
32	O
]	O
we	O
sequentially	O
filtered	O
the	O
data	O
by	O
background	O
subtraction	O
,	O
negative	O
flagging	O
,	O
negative	O
intensities	O
and	O
for	O
inconsistent	O
data	O
amongst	O
replicates	O
[	O
33	O
]	O
.	O

Nevertheless	O
,	O
being	O
based	O
upon	O
a	O
moderate	O
assay	O
of	O
pre-selected	O
specific	O
gene	O
targets	O
,	O
the	O
comparative	O
analysis	O
of	O
microarray	O
data	O
derived	O
from	O
undifferentiated	O
and	O
dopaminergic	S-x
differentiate	O
pathway-committed	O
hESCs	S-cell_type
provides	O
a	O
valuable	O
cross-cut	O
of	O
complex	O
relationship	O
between	O
factors	O
driving	O
or	O
indicative	O
to	O
neuronal	S-x
/	O
dopaminergic	S-x
differentiation	O
[	O
see	O
Additional	O
file	O
2	O
]	O
.	O

To	O
promote	O
our	O
understanding	O
of	O
such	O
mechanisms	O
,	O
it	O
would	O
be	O
valuable	O
to	O
have	O
tools	O
that	O
readily	O
and	O
reproducibly	O
can	O
help	O
to	O
characterize	O
the	O
cells	O
as	O
they	O
differentiate	O
from	O
pluripotent	B-cell_type
stem	I-cell_type
cells	E-cell_type
into	O
post-mitotic	B-cell_type
neurons	E-cell_type
.	O

Immunostained	O
cell	O
cultures	O
were	O
visualized	O
using	O
a	O
Zeiss	O
fluorescent	O
microscope	O
attached	O
to	O
a	O
Nikon	O
digital	O
camera.Using	O
RT-PCR	O
,	O
all	O
RNA	O
samples	O
used	O
in	O
this	O
study	O
were	O
tested	O
negative	O
for	O
the	O
presence	O
of	O
gDNA	O
(	O
data	O
not	O
shown	O
)	O
.	O

Only	O
around	O
0.2	O
%	O
of	O
the	O
cells	O
are	O
TH	S-GP
-positive	O
cells	O
(	O
Figure	O
2	O
)	O
.	O

We	O
specifically	O
wish	O
to	O
stress	O
that	O
we	O
are	O
about	O
to	O
make	O
the	O
NeuroStem	O
Chip	O
available	O
at	O
a	O
non-profit	O
cost	O
to	O
the	O
research	O
community	O
.	O

established	O
or	O
candidate	O
markers	O
of	O
stem	B-cell_type
cells	E-cell_type
)	O
have	O
lower	O
levels	O
of	O
expression	O
(	O
Table	O
5	O
)	O
.	O

To	O
visualize	O
sample-dependent	O
variation	O
of	O
spot	O
intensities	O
,	O
data	O
was	O
uploaded	O
to	O
the	O
TIGR	O
MultiExperiment	O
Viewer	O
(	O
MEV	O
;	O
[	O
34	O
]	O
)	O
.	O

We	O
propose	O
that	O
the	O
areas	O
of	O
application	O
for	O
NeuroStem	O
microarray	O
platform	O
could	O
be	O
the	O
following	O
:	O
(	O
i	O
)	O
characterization	O
of	O
the	O
expression	O
of	O
established	O
,	O
pre-selected	O
gene	O
targets	O
in	O
hSC	O
lines	O
,	O
including	O
newly	O
derived	O
ones	O
,	O
(	O
ii	O
)	O
longitudinal	O
quality	O
control	O
for	O
maintained	O
hSC	O
populations	O
,	O
(	O
iii	O
)	O
following	O
gene	O
expression	O
changes	O
during	O
differentiation	O
under	O
defined	O
cell	O
culture	O
conditions	O
,	O
and	O
(	O
iv	O
)	O
confirming	O
the	O
success	O
of	O
differentiation	O
into	O
specific	O
neuronal	S-cell_type
subtypes	O
.	O

One	O
half	O
of	O
the	O
co-culture	O
medium	O
was	O
replaced	O
every	O
other	O
day	O
for	O
first	O
10	O
days	O
,	O
and	O
daily	O
onwards	O
.	O

Results	O
obtained	O
revealed	O
that	O
data	O
were	O
consistent	O
across	O
technical	O
replicates	O
(	O
dye-swap	O
and	O
amount	O
of	O
loaded	O
material	O
)	O
,	O
showing	O
general	O
high	O
reproducibility	O
:	O
e.g.	O
,	O
correlation	O
coefficients	O
were	O
greater	O
than	O
0.96	O
for	O
technical	O
replicates	O
and	O
0.78	O
for	O
dye-swapping	O
samples	O
in	O
hESCs	S-cell_type
vs.	O
universal	O
reference	O
hybridizations	O
(	O
Table	O
3	O
)	O
.	O

The	O
expression	O
profile	O
outlined	O
by	O
RT-PCR	O
confirmed	O
the	O
identity	O
of	O
the	O
sample	O
used	O
(	O
Figure	O
3	O
)	O
.	O

Using	O
GenePix	O
Pro	O
(	O
Molecular	O
Devices	O
Corp.	O
USA	O
)	O
flags	O
for	O
artifactual	O
spots	O
were	O
annotated	O
for	O
each	O
spot	O
.	O

Human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hESCs	S-cell_type
)	O
are	O
considered	O
a	O
promising	O
future	O
source	O
of	O
cells	O
for	O
cell	O
replacement	O
therapy	O
in	O
PD	O
and	O
other	O
neurological	O
conditions	O
[	O
13	O
]	O
.	O

Highly	O
specialized	O
DNA	S-cellcomponent
microarrays	O
of	O
smaller	O
scale	O
(	O
e.g	O
.	O

Every	O
6	O
days	O
,	O
fragments	O
of	O
the	O
hESC	O
colonies	O
(	O
around	O
10–14	O
colonies	O
per	O
dish	O
,	O
measuring	O
around	O
0.015	O
×	O
0.015	O
mm	O
)	O
that	O
had	O
an	O
unaltered	O
morphology	O
(	O
indicating	O
lack	O
of	O
spontaneous	O
differentiation	O
)	O
were	O
mechanically	O
cut	O
from	O
dishes	O
using	O
stem	O
cell	O
knives/transfer	O
pipettes	O
(	O
SweMed	O
Lab	O
International	O
AB	O
,	O
Sweden	O
)	O
and	O
then	O
plated	O
on	O
fresh	O
hFCs	S-cell_type
.	O

Basic	B-GP
fibroblast	I-GP
growth	I-GP
factor	E-GP
(	O
FGF2	S-GP
,	O
bFGF	S-GP
)	O
supports	O
hESC	O
proliferation	O
and	O
their	O
ability	O
to	O
maintain	O
undifferentiated	O
phenotype	O
when	O
cultured	O
in	O
vitro	O
[	O
38,39	O
]	O
.	O

For	O
numerous	O
established	O
or	O
candidate	O
markers	O
of	O
stem	B-cell_type
cells	E-cell_type
the	O
expression	O
levels	O
were	O
not	O
considerably	O
higher	O
(	O
Log2	O
ratio	O
<	O
1	O
)	O
in	O
the	O
hESC	O
sample	O
compared	O
to	O
the	O
universal	O
reference	O
RNA	O
.	O

Table	O
2	O
represents	O
conditional	O
functional	O
breakdown	O
of	O
genes	O
targeted	O
by	O
the	O
NeuroStem	O
microarray	O
platform	O
.	O

Additionally	O
,	O
we	O
included	O
some	O
genes	O
implicated	O
in	O
disease	O
mechanisms	O
of	O
neurodegenerative	O
disorders	O
(	O
most	O
importantly	O
,	O
Parkinson	O
's	O
disease	O
and	O
Alzheimer	O
's	O
disease	O
)	O
in	O
the	O
chip	O
.	O

Alternatively	O
,	O
PA6	B-cell_type
cells	E-cell_type
were	O
plated	O
over	O
Type	B-GP
I	I-GP
collagen	E-GP
-coated	O
glass	O
cover-slips	O
placed	O
in	O
wells	O
of	O
4-well-plates	O
(	O
50,000	O
cells/well	O
,	O
for	O
immunocytochemical	O
(	O
ICC	O
)	O
analysis	O
)	O
.	O

Similarly	O
,	O
Gremlin	B-GP
1	I-GP
homolog	I-GP
,	I-GP
cysteine	I-GP
knot	I-GP
superfamily	I-GP
gene	E-GP
(	O
Grem1	S-GP
,	O
also	O
known	O
as	O
Cktsf1b1	S-GP
and	O
Dand2	S-GP
)	O
is	O
a	O
recognized	O
factor	O
of	O
cell-fate	O
determination	O
of	O
ESCs	S-cell_type
[	O
37	O
]	O
.	O

In	O
successful	O
cases	O
,	O
transplants	O
of	O
human	B-cell_type
embryonic	I-cell_type
mesencephalic	I-cell_type
dopaminergic	I-cell_type
neurons	E-cell_type
can	O
both	O
restore	O
dopaminergic	O
neurotransmission	O
and	O
provide	O
some	O
symptomatic	O
relief	O
[	O
6-8	O
]	O
.	O

We	O
merged	O
technical	O
replicates	O
to	O
generate	O
a	O
list	O
of	O
the	O
most	O
up-regulated	O
genes	O
expressed	O
in	O
the	O
hESC	O
sample	O
compared	O
to	O
the	O
universal	O
reference	O
RNA	S-cellcomponent
(	O
Table	O
4	O
)	O
.	O

Various	O
types	O
of	O
stem	B-cell_type
cells	E-cell_type
,	O
such	O
as	O
hematopoietic	S-x
,	O
mesenchymal	S-x
and	O
neural	S-x
(	O
HSCs	S-cell_type
,	O
MSCs	S-cell_type
and	O
NSCs	S-cell_type
,	O
respectively	O
)	O
,	O
embryonic	S-x
germ	S-x
and	O
embryonic	B-cell_type
carcinoma	I-cell_type
cells	E-cell_type
(	O
EGCs	S-cell_type
and	O
ECCs	S-cell_type
,	O
respectively	O
)	O
are	O
all	O
characterized	O
by	O
variations	O
in	O
gene	O
expression	O
profiles	O
,	O
and	O
only	O
a	O
few	O
gene	O
markers	O
are	O
associated	O
with	O
all	O
these	O
cell	O
types	O
[	O
25,26	O
]	O
.	O

After	O
image	O
formatting	O
by	O
Tiff	O
Image	O
Channel	O
Splitter	O
Utility	O
(	O
Agilent	O
Technologies	O
)	O
and	O
grid	O
annotation	O
,	O
a	O
complete	O
set	O
of	O
spots	O
was	O
visually	O
inspected	O
for	O
each	O
slide	O
.	O

This	O
heterogeneity	O
,	O
with	O
an	O
apparent	O
presence	O
of	O
residual	O
pluripotent	O
cells	O
explains	O
the	O
presence	O
of	O
stem	O
cell	O
marker	O
genes	O
,	O
including	O
homeobox	B-GP
transcription	I-GP
factor	E-GP
Nanog	S-GP
,	O
as	O
revealed	O
by	O
RT-PCR	O
data	O
(	O
Figure	O
3	O
)	O
.	O

Fragments	O
of	O
hESC	O
colonies	O
(	O
80–90	O
per	O
flask	O
;	O
4–5	O
per	O
well	O
of	O
4-well-plate	O
)	O
presenting	O
undifferentiated	O
morphology	O
were	O
manually	O
passaged	O
onto	O
the	O
confluent	O
PA6	S-cell_line
monolayer	O
and	O
cell	O
co-cultures	O
were	O
maintained	O
at	O
37°C	O
,	O
5	O
%	O
CO2	O
,	O
95	O
%	O
humidity	O
settings	O
.	O

We	O
sought	O
to	O
create	O
an	O
improved	O
and	O
updated	O
microarray	O
platform	O
for	O
hESC/	O
neuronal	S-x
differentiation-oriented	O
gene	O
expression	O
studies	O
.	O

Similarly	O
,	O
24	O
nmols	O
of	O
the	O
Cyanine	O
5-CTP	O
(	O
Cy5	O
;	O
PerkinElmer	O
)	O
fluorescent	O
label	O
were	O
incorporated	O
to	O
400	O
ng	O
sample	O
of	O
Human	S-y
Universal	O
Reference	O
RNA	S-cellcomponent
(	O
Stratagene	O
,	O
USA	O
)	O
;	O
in	O
addition	O
,	O
dye-swap	O
replicate	O
amplification	O
were	O
performed	O
.	O

Those	O
entries	O
include	O
Sox2	S-GP
,	O
En1	S-GP
and	O
Nanog	S-GP
(	O
ratio	O
of	O
differentiated/undifferentiated	O
hESC	O
sample	O
normalized	O
spot	O
intensity	O
<	O
0.75	O
,	O
down-regulated	O
)	O
,	O
Gadph	S-GP
,	O
Aldh1a1	S-GP
,	O
Sdha	S-GP
,	O
Tubb	S-GP
and	O
Nestin	S-GP
(	O
ratio	O
.1.0	O
,	O
unchanged	O
)	O
,	O
Actb	S-GP
,	O
Th	S-GP
,	O
Msx1	S-GP
and	O
Pitx2	S-GP
(	O
ratio	O
>	O
1.25	O
,	O
up-regulated	O
)	O
.	O

Finally	O
,	O
we	O
ensured	O
that	O
known	O
markers	O
for	O
specific	O
types	O
of	O
neurons	S-cell_type
,	O
allowing	O
identification	O
of	O
individual	O
cell	O
types	O
,	O
were	O
present	O
on	O
the	O
chip	O
.	O

The	O
gene	O
expression	O
profiles	O
generated	O
are	O
therefore	O
consistent	O
with	O
the	O
results	O
of	O
earlier	O
studies	O
utilizing	O
hSC-derived	O
samples	O
with	O
similar	O
characteristics	O
[	O
43,44	O
]	O
.	O

Following	O
printing	O
,	O
arrays	O
were	O
dried	O
for	O
48	O
hours	O
andstored	O
in	O
a	O
dessicator	O
until	O
used	O
.	O

the	O
NeuroStem	O
Chip	O
)	O
still	O
have	O
an	O
important	O
role	O
in	O
the	O
directed	O
studies	O
in	O
particular	O
fields	O
.	O

As	O
seen	O
in	O
Table	O
4	O
and	O
Table	O
5	O
,	O
the	O
NeuroStem	O
Chip	O
identified	O
numerous	O
genes	O
associated	O
with	O
stem	O
cells	O
.	O

Importantly	O
,	O
all	O
the	O
observed	O
gene	O
expression	O
trends	O
were	O
similar	O
in	O
both	O
microarray	O
and	O
RT-PCR	O
.	O

The	O
concept	O
of	O
``	O
stemness	O
''	O
(	O
term	O
introduced	O
in	O
1986	O
by	O
Grossman	O
&	O
Levine	O
)	O
is	O
defined	O
as	O
``	O
core	O
stem	O
cell	O
properties	O
that	O
underlie	O
self-renewal	O
and	O
the	O
ability	O
to	O
generate	O
differentiated	O
progeny	O
''	O
[	O
22	O
]	O
.	O

Examples	O
include	O
undifferentiated	B-GP
embryonic	I-GP
cell	I-GP
transcription	I-GP
factor	I-GP
1	E-GP
(	O
Utf1	S-GP
)	O
,	O
DNA	B-GP
methyltransferase	I-GP
3B	E-GP
(	O
Dnmt3b	S-GP
)	O
,	O
developmental	B-GP
pluripotency	I-GP
associated	I-GP
4	E-GP
(	O
Dppa4	S-GP
,	O
a	O
newly	O
established	O
pluripotency	O
marker	O
[	O
41	O
]	O
)	O
and	O
numerous	O
candidate	O
markers	O
of	O
``	O
stemness	O
''	O
:	O
e.g	O
.	O

Universal	O
reference	O
RNA	O
has	O
been	O
previously	O
established	O
as	O
a	O
standard	O
reference	O
material	O
for	O
microarray	O
experiments	O
,	O
proving	O
an	O
ability	O
to	O
effectively	O
hybridize	O
to	O
a	O
large	O
fraction	O
of	O
microarray	O
spots	O
[	O
30	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
present	O
the	O
NeuroStem	O
Chip	O
in	O
detail	O
and	O
describe	O
the	O
special	O
advantages	O
it	O
offers	O
to	O
the	O
fields	O
of	O
experimental	O
neurology	O
and	O
stem	O
cell	O
biology	O
.	O

Expectedly	O
,	O
Hesx1	S-GP
,	O
Grem1	S-GP
,	O
Dnmt3b	S-GP
,	O
Utf1	S-GP
and	O
Nanog	S-GP
could	O
be	O
listed	O
among	O
these	O
.	O

We	O
also	O
evaluated	O
the	O
expression	O
of	O
the	O
cell	O
cycle	O
marker	O
Ki67	S-GP
and	O
the	O
pluripotency	O
marker	O
OCT3/4	S-GP
in	O
the	O
sample	O
by	O
immunocytochemistry	O
(	O
Figure	O
1B–E	O
)	O
.	O

After	O
performing	O
RNA	O
integrity	O
tests	O
,	O
we	O
incorporated	O
fluorescent	O
labels	O
to	O
the	O
amplified	O
RNA	O
samples	O
from	O
hESCs	S-cell_type
(	O
Cyanine	O
3-CTP	O
(	O
Cy3	O
)	O
and	O
Cyanine	O
5-CTP	O
(	O
Cy5	O
)	O
)	O
,	O
hESC-derived	O
cells	O
containing	O
TH-positive	O
neurons	S-cell_type
(	O
Cy3	O
and	O
Cy5	O
)	O
and	O
human	O
universal	O
reference	O
RNA	O
(	O
Cy5	O
)	O
,	O
and	O
hybridized	O
aliquots	O
with	O
NeuroStem	O
microarray	O
slides	O
using	O
the	O
following	O
conditions	O
:	O
hESC	O
vs.	O
reference	O
,	O
Cy3	O
:	O
Cy5	O
=	O
(	O
i	O
)	O
20:10	O
pmol	O
,	O
and	O
(	O
ii	O
)	O
10:5	O
pmol	O
;	O
and	O
hESC	O
vs.	O
hESC-derived	O
cells	O
,	O
Cy3	O
:	O
Cy5	O
=	O
(	O
iii	O
)	O
30:20	O
pmol	O
,	O
respectively	O
.	O

In	O
contrast	O
,	O
the	O
NeuroStem	O
Chip	O
includes	O
oligonucleotide	O
probes	O
for	O
88	O
genes	O
related	O
to	O
dopaminergic	B-cell_type
neurons	E-cell_type
,	O
thus	O
being	O
more	O
comprehensive	O
in	O
this	O
sense	O
,	O
compared	O
to	O
other	O
existing	O
microarray	O
platforms	O
,	O
including	O
focused	O
ones	O
[	O
17,18	O
]	O
.	O

Cells	O
were	O
then	O
washed	O
once	O
with	O
PBS	O
,	O
incubated	O
with	O
1:1000	O
DAPI	O
in	O
PBS	O
for	O
10	O
minutes	O
,	O
followed	O
by	O
another	O
wash	O
with	O
PBS	O
.	O

We	O
then	O
illustrated	O
the	O
utility	O
and	O
technical	O
reliability	O
of	O
the	O
NeuroStem	O
Chip	O
by	O
characterizing	O
the	O
gene	O
expression	O
profile	O
of	O
commonly	O
utilized	O
hESC	O
line	O
SA02	S-cell_line
(	O
Sahlgrenska	B-cell_line
2	E-cell_line
;	O
[	O
27	O
]	O
)	O
,	O
including	O
(	O
i	O
)	O
undifferentiated	O
cells	O
and	O
(	O
ii	O
)	O
cells	O
committed	O
towards	O
neuronal	S-x
/	O
dopaminergic	S-x
differentiation	O
pathway	O
.	O

cDNA	S-cellcomponent
was	O
synthesized	O
from	O
1	O
mg	O
of	O
total	O
RNA	S-cellcomponent
using	O
SuperScript	O
II	O
(	O
Invitrogen	O
)	O
,	O
and	O
RT-PCR	O
amplifications	O
were	O
performed	O
using	O
the	O
MiniOpticon	O
system	O
(	O
Bio-Rad	O
)	O
with	O
REDTaq	O
Polymerase	O
(	O
Sigma-Aldrich	O
)	O
essentially	O
as	O
described	O
by	O
the	O
manufacturer	O
.	O

Examples	O
include	O
POU	B-GP
domain	I-GP
,	I-GP
class	I-GP
5	I-GP
,	I-GP
transcription	I-GP
factor	I-GP
1	E-GP
(	O
Oct3/4	S-GP
)	O
,	O
signal	B-GP
transducer	I-GP
and	I-GP
activator	I-GP
of	I-GP
transcription	I-GP
3	E-GP
(	O
Stat3	S-GP
)	O
,	O
teratocarcinoma-derived	B-GP
growth	I-GP
factor	E-GP
(	O
Tdgf1	S-GP
)	O
,	O
Enk-pending	S-GP
(	O
Nanog	S-GP
)	O
,	O
undifferentiated	B-GP
embryonic	I-GP
cell	I-GP
transcription	I-GP
factor	I-GP
1	E-GP
(	O
Utf1	S-GP
)	O
and	O
DNA	B-GP
methyltransferase	I-GP
3B	E-GP
(	O
Dnmt3b	S-GP
)	O
[	O
20	O
]	O
.	O

Median	O
pixel	O
intensity	O
minus	O
the	O
median	O
local	O
background	O
for	O
both	O
dyes	O
was	O
used	O
to	O
obtain	O
a	O
test	O
over	O
reference	O
intensity	O
ratio	O
.	O

Similar	O
to	O
the	O
genetic	O
bases	O
underlying	O
stemness	O
,	O
cell	O
differentiation	O
is	O
associated	O
with	O
altered	O
expression	O
levels	O
of	O
certain	O
recognized	O
or	O
candidate	O
genes	O
[	O
25	O
]	O
.	O

After	O
three	O
washes	O
with	O
PBS	O
,	O
cells	O
were	O
incubated	O
with	O
the	O
donkey	B-GP
anti-rabbit	I-GP
IgG	E-GP
conjugated	O
with	O
FITC	O
or	O
anti-	O
mouse	S-y
Cy3	O
(	O
1:200	O
,	O
Jackson	O
ImmunoResearch	O
Laboratories	O
)	O
.	O

The	O
resulting	O
cell	O
pellets	O
were	O
resuspended	O
in	O
RLT	O
buffer	O
(	O
Qiagen	O
,	O
USA	O
)	O
,	O
passed	O
through	O
the	O
shredder	O
column	O
(	O
Qiagen	O
)	O
and	O
stored	O
at	O
-80°C	O
until	O
the	O
RNA	O
sample	O
was	O
purified	O
following	O
the	O
RNeasy	O
Micro	O
Kit	O
(	O
Qiagen	O
)	O
protocol	O
(	O
without	O
carrier	O
RNA	O
)	O
;	O
with	O
DNase	B-GP
I	E-GP
(	O
Quiagen	O
)	O
treatment	O
incorporated	O
to	O
the	O
latter	O
.	O

Taken	O
together	O
,	O
the	O
gene	O
expression	O
signature	O
of	O
hES	S-cell_type
SA02	S-cell_line
cell	O
line	O
profiled	O
by	O
NeuroStem	O
Chip	O
is	O
indeed	O
characteristic	O
for	O
pluripotent	O
stem	B-cell_type
cells	E-cell_type
,	O
providing	O
proof-of-concept	O
.	O

Expression	O
levels	O
of	O
those	O
genes	O
range	O
from	O
being	O
inconsiderably	O
higher	O
to	O
nearly	O
equal	O
to	O
that	O
in	O
universal	O
reference	O
RNA	O
sample	O
.	O

On	O
the	O
other	O
hand	O
,	O
custom	O
microarray	O
platforms	O
that	O
focus	O
on	O
specific	O
pre-selected	O
subset	O
of	O
genes	O
relevant	O
to	O
a	O
particular	O
field	O
of	O
investigation	O
can	O
be	O
less	O
costly	O
and	O
more	O
suitable	O
for	O
detection	O
of	O
smaller	O
gene	O
expression	O
changes	O
.	O

A	O
number	O
of	O
important	O
gene	O
groups	O
that	O
are	O
included	O
in	O
the	O
chip	O
are	O
not	O
mentioned	O
in	O
Table	O
2	O
.	O

One	O
half	O
of	O
the	O
culture	O
medium	O
was	O
replaced	O
every	O
other	O
day	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
use	O
the	O
NeuroStem	O
Chip	O
to	O
characterize	O
an	O
undifferentiated	O
population	O
of	O
pluripotent	B-cell_type
hESCs	E-cell_type
(	O
cell	O
line	O
SA02	S-cell_line
,	O
Cellartis	O
AB	O
,	O
Göteborg	O
,	O
Sweden	O
)	O
and	O
compare	O
the	O
gene	O
expression	O
in	O
those	O
cells	O
with	O
that	O
of	O
a	O
hESC-derived	O
cell	O
population	O
rich	O
in	O
neurons	S-cell_type
,	O
including	O
tyrosine	B-cell_type
hydroxylase-positive	I-cell_type
dopaminergic	I-cell_type
neurons	E-cell_type
.	O

Arrays	O
were	O
produced	O
by	O
the	O
SweGene	O
DNA	O
Microarray	O
Resource	O
Centre	O
,	O
Department	O
of	O
Oncology	O
at	O
Lund	O
University	O
(	O
Sweden	O
)	O
using	O
a	O
MicroGrid	O
II	O
600R	O
arrayer	O
fitted	O
with	O
MicroSpot	O
10	O
K	O
pins	O
(	O
Harvard	O
BioRobotics	O
,	O
USA	O
)	O
.	O

RNA	S-cellcomponent
integrity	O
was	O
tested	O
using	O
both	O
ND-1000	O
specrophotometer	O
(	O
NanoDrop	O
,	O
USA	O
)	O
and	O
RNA	S-cellcomponent
Nano	O
LabChip/2100	O
Bioanalyzer	O
system	O
(	O
Agilent	O
Technologies	O
,	O
USA	O
)	O
.Fluorescent	O
label	O
(	O
24	O
nmol	O
of	O
the	O
Cyanine	O
3-CTP	O
(	O
Cy3	O
)	O
;	O
PerkinElmer	O
,	O
USA	O
)	O
was	O
incorporated	O
to	O
350–500	O
ng	O
of	O
total	O
RNA	S-cellcomponent
amplified	O
using	O
Low	O
RNA	O
Input	O
Fluorescent	O
Linear	O
Amplification	O
Kit	O
(	O
Agilent	O
Technologies	O
)	O
,	O
generally	O
following	O
the	O
kit	O
manufacturer	O
's	O
protocol	O
.	O

To	O
visualize	O
variations	O
of	O
spot/reporter	O
per	O
technical	O
replicate	O
,	O
hierarchical	O
clustering	O
was	O
performed	O
by	O
K-means	O
classifier	O
based	O
on	O
the	O
linear-correlation-based	O
distance	O
(	O
Pearson	O
,	O
centred	O
)	O
method	O
.	O

Since	O
the	O
reproducibility	O
of	O
two-color	O
microarray	O
gene	O
expression	O
data	O
is	O
critically	O
important	O
,	O
we	O
calculated	O
Pearson	O
correlation	O
coefficients	O
of	O
the	O
reporters	O
present	O
in	O
the	O
filtered	O
database	O
comparing	O
the	O
average	O
expression	O
ratios	O
(	O
7005	O
for	O
hESCs	S-cell_type
vs.	O
universal	O
reference	O
;	O
6947	O
for	O
undifferentiated	O
vs.	O
neuronal/dopaminergic	O
lineage-committed	O
hESCs	S-cell_type
)	O
.	O

Data	O
acquisition	O
and	O
statistical	O
analysisImmediately	O
following	O
the	O
washing	O
steps	O
,	O
the	O
fluorescence	O
intensities	O
were	O
measured	O
using	O
a	O
confocal	O
laser	O
scanner	O
(	O
G2505B	O
,	O
Agilent	O
Technologies	O
)	O
.	O

Figure	O
5A	O
shows	O
a	O
comparison	O
of	O
the	O
spot	O
intensities	O
prior	O
to	O
normalization	O
(	O
M	O
versus	O
A	O
plot	O
)	O
,	O
with	O
the	O
Log2	O
of	O
the	O
expression	O
ratio	O
between	O
Cy3/Cy5	O
being	O
plotted	O
as	O
a	O
function	O
of	O
the	O
log10	O
of	O
the	O
mean	O
of	O
the	O
total	O
expression	O
intensities	O
for	O
Cy3	O
and	O
Cy5	O
channels	O
.	O

Since	O
they	O
are	O
significantly	O
less	O
expensive	O
,	O
compared	O
to	O
many	O
recognized	O
large-scale	O
platforms	O
(	O
e.g	O
.	O

At	O
the	O
same	O
time	O
,	O
numerous	O
other	O
genes	O
,	O
including	O
Pitx2	S-GP
,	O
Dlk1	S-GP
and	O
Msx1	S-GP
were	O
up-regulated	O
in	O
the	O
latter	O
sample	O
(	O
[	O
see	O
Additional	O
file	O
2	O
]	O
,	O
Figure	O
3	O
)	O
.	O

They	O
could	O
constitute	O
a	O
virtually	O
infinite	O
source	O
of	O
self-renewing	O
cells	O
that	O
can	O
be	O
persuaded	O
to	O
differentiate	O
into	O
specific	O
types	O
of	O
neural	B-cell_type
cells	E-cell_type
,	O
including	O
dopaminergic	B-cell_type
neurons	E-cell_type
[	O
14-16	O
]	O
.	O

Microarray	O
technology	O
has	O
added	O
important	O
information	O
on	O
both	O
normal	O
development	O
and	O
pathological	O
changes	O
in	O
neurons	S-cell_type
.	O

Feeder	B-cell_type
cells	E-cell_type
were	O
grown	O
in	O
hFC	O
medium	O
(	O
Iscove	O
's	O
modified	O
Dulbecco	O
's	O
medium	O
(	O
IMDM	O
)	O
supplemented	O
with	O
10	O
%	O
heat-inactivated	O
FCS	O
(	O
Stem	O
Cell	O
Technologies	O
,	O
USA	O
)	O
and	O
0.5	O
%	O
Penicillin/Streptomycin	O
mix	O
)	O
for	O
11	O
passages	O
.	O

Our	O
experiment	O
therefore	O
confirms	O
that	O
the	O
NeuroStem	O
Chip	O
microarray	O
platform	O
can	O
still	O
identify	O
gene	O
expression	O
changes	O
related	O
to	O
early	O
stages	O
of	O
differentiation	O
of	O
hESC	O
into	O
dopaminergic	B-cell_type
neurons	E-cell_type
.	O

Therefore	O
,	O
we	O
generated	O
a	O
specialized	O
large-scale	O
DNA	S-cellcomponent
microarray	O
platform	O
(	O
the	O
``	O
NeuroStem	O
Chip	O
''	O
)	O
that	O
has	O
over	O
1,300	O
pre-selected	O
gene	O
targets	O
and	O
multiple	O
controls	O
spotted	O
in	O
quadruplicates	O
(	O
~46,000	O
spots	O
total	O
)	O
.	O

For	O
differentiation	O
experiments	O
,	O
PA6	B-cell_type
cells	E-cell_type
were	O
plated	O
on	O
gelatine-coated	O
T25	O
flasks	O
at	O
16	O
×	O
103	O
cells/cm2	O
(	O
400,000	O
cells/flask	O
)	O
density	O
2	O
days	O
prior	O
to	O
introducing	O
hESCs	S-cell_type
into	O
the	O
co-culture	O
and	O
cultured	O
at	O
PA6	S-cell_line
culturing	O
media	O
(	O
containing	O
minimum	O
essential	O
medium	O
alpha	O
(	O
α-MEM	O
)	O
supplemented	O
with	O
10	O
%	O
FCS	O
and	O
0.5	O
%	O
Penicillin/Streptomycin	O
)	O
.	O

In	O
particular	O
,	O
homeo	B-GP
box	I-GP
expressed	I-GP
in	I-GP
ES	I-GP
cells	I-GP
1	E-GP
(	O
Hesx1	S-GP
)	O
gene	O
was	O
identified	O
as	O
the	O
most	O
up-regulated	O
in	O
the	O
ES	B-cell_type
cell	E-cell_type
preparation	O
,	O
compared	O
to	O
universal	O
reference	O
RNA	O
.	O

Moreover	O
,	O
in	O
some	O
hESC	O
lines	O
a	O
very	O
high	O
concentration	O
of	O
FGF2	S-GP
could	O
substitute	O
for	O
the	O
need	O
of	O
feeder	B-cell_type
cells	E-cell_type
[	O
40	O
]	O
.	O

hESC-derived	O
cells	O
grown	O
atop	O
PA6	B-cell_type
cells	E-cell_type
were	O
harvested	O
using	O
a	O
papain	S-GP
dissociation	O
kit	O
(	O
Worthington	O
Biochemical	O
Corporation	O
)	O
,	O
rinsed	O
in	O
PBS	O
buffer	O
and	O
spun	O
down	O
as	O
described	O
above	O
.	O

The	O
deviation	O
of	O
the	O
line	O
from	O
zero	O
revealed	O
a	O
need	O
for	O
normalization	O
,	O
so	O
prior	O
to	O
data	O
analyses	O
we	O
normalized	O
signals	O
using	O
a	O
locally	O
weighted	O
scatterplot-smoothing	O
regression	O
(	O
LOWESS	O
)	O
algorithm	O
(	O
Figure	O
5A–B	O
;	O
fitted	O
line	O
)	O
implemented	O
in	O
BASE	O
.	O

The	O
complete	O
layout	O
of	O
NeuroStem	O
Chip	O
will	O
be	O
disclosed	O
to	O
the	O
academic	O
community	O
,	O
upon	O
request	O
.	O

Standard	O
error	O
of	O
the	O
mean	O
expressed	O
as	O
percentage	O
was	O
calculated	O
for	O
the	O
4	O
technical	O
replicates	O
,	O
and	O
was	O
6.7	O
%	O
for	O
the	O
top	O
25	O
genes	O
up-regulated	O
in	O
hESC	O
samples	O
,	O
compared	O
to	O
universal	O
reference	O
RNA	O
.	O

Many	O
more	O
genes	O
highly	O
up-regulated	O
in	O
the	O
hESC	O
sample	O
in	O
comparison	O
with	O
universal	O
reference	O
RNA	O
are	O
associated	O
with	O
stem	B-cell_type
cells	E-cell_type
:	O
further	O
examples	O
include	O
Gap	B-GP
junction	I-GP
protein	I-GP
α1	E-GP
(	O
Gja1	S-GP
)	O
and	O
Zic	B-GP
family	I-GP
member	I-GP
3	I-GP
heterotaxy	I-GP
1	E-GP
(	O
Zic3	S-GP
)	O
(	O
Table	O
4	O
)	O
[	O
20	O
]	O
.	O

Universal	O
Microarray	O
Hybridization	O
Kit	O
,	O
generally	O
following	O
manufacturer	O
's	O
instructions	O
,	O
with	O
several	O
minor	O
adaptations	O
[	O
31	O
]	O
.	O

This	O
important	O
issue	O
was	O
addressed	O
in	O
earlier	O
studies	O
by	O
Luo	O
et	O
al	O
.	O

We	O
paid	O
special	O
attention	O
to	O
genes	O
associated	O
with	O
the	O
differentiation	O
and	O
maturation	O
of	O
dopaminergic	B-cell_type
neurons	E-cell_type
.	O

Three	O
hours	O
prior	O
to	O
initiation	O
of	O
co-culture	O
,	O
PA6	B-cell_type
cells	E-cell_type
were	O
rinsed	O
3	O
times	O
with	O
PBS	O
and	O
media	O
was	O
replaced	O
with	O
co-culture	O
media	O
(	O
Glasgow	O
's	O
modified	O
Eagle	O
's	O
media	O
(	O
G-MEM	O
)	O
supplemented	O
with	O
8	O
%	O
knock-out	O
serum	O
replacement	O
(	O
KSR	O
)	O
,	O
2	O
mM	O
glutamine	O
,	O
0.1	O
mM	O
non-essential	O
amino-acids	O
(	O
NEAA	O
)	O
,	O
1	O
mM	O
pyruvate	O
,	O
0.1	O
mM	O
β-mercaptoethanol	O
(	O
βME	O
)	O
and	O
4	O
ng/μl	O
bFGF	S-GP
)	O
.	O

Furthermore	O
,	O
we	O
incorporated	O
a	O
number	O
of	O
markers	O
for	O
distinct	O
differentiation	O
pathways	O
(	O
e.g	O
.	O

BackgroundMany	O
novel	O
studies	O
and	O
therapies	O
are	O
possible	O
with	O
the	O
use	O
of	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hES	B-cell_type
cells	E-cell_type
)	O
and	O
their	O
differentiated	O
cell	B-cell_type
progeny	E-cell_type
.	O

As	O
these	O
cells	O
possess	O
the	O
ability	O
to	O
self	O
renew	O
,	O
they	O
have	O
the	O
potential	O
to	O
continually	O
produce	O
HIV	S-y
resistant	O
T	B-cell_type
cells	E-cell_type
and	O
macrophages	S-cell_type
in	O
the	O
body	O
thus	O
providing	O
long	O
term	O
immune	O
reconstitution	O
.	O

Nontransduced	O
(	O
94.6	O
%	O
)	O
as	O
well	O
as	O
lentiviral	S-y
vector	O
transduced	O
(	O
98.7	O
%	O
)	O
hES	B-cell_type
cel	E-cell_type
l	O
derived	O
macrophages	S-cell_type
were	O
found	O
to	O
be	O
capable	O
of	O
phagocytosing	O
the	O
Bioparticles®	O
in	O
comparison	O
to	O
fetal	B-x
liver	E-x
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
(	O
95.8	O
%	O
)	O
(	O
Fig	O
3B	O
)	O
.	O

EGFP	S-GP
expression	O
was	O
also	O
analyzed	O
to	O
determine	O
the	O
levels	O
of	O
transduction	O
and	O
any	O
transgene	O
silencing	O
that	O
may	O
occur	O
during	O
differentiation	O
.	O

Although	O
there	O
are	O
advantages	O
of	O
using	O
hES	O
cell	O
derived	O
CD34	B-cell_type
cells	E-cell_type
for	O
potential	O
cellular	O
therapies	O
,	O
transplantation	O
of	O
these	O
cells	O
constitutes	O
an	O
allogenic	O
source	O
with	O
immune	O
rejection	O
as	O
a	O
major	O
issue	O
.	O

Lentiviral	S-y
vector	O
transduced	O
Magi-CXCR4	B-cell_type
cells	E-cell_type
,	O
a	O
HeLa	B-cell_line
cell	E-cell_line
derivative	O
with	O
no	O
phagocytic	O
capacity	O
,	O
were	O
used	O
as	O
non-phagocytic	O
cell	O
controls	O
and	O
similarly	O
exposed	O
to	O
E.	B-y
coli	E-y
Bioparticles®	O
Human	B-cell_type
ES	I-cell_type
cell	E-cell_type
derived	O
macrophages	S-cell_type
were	O
also	O
analyzed	O
for	O
their	O
ability	O
to	O
secrete	O
two	O
major	O
cytokines	O
,	O
IL-1	S-GP
and	O
TNF-α	S-GP
,	O
upon	O
external	O
stimulation	O
.	O

The	O
transgene	O
GFP	S-GP
expression	O
was	O
also	O
maintained	O
during	O
the	O
differentiation	O
of	O
hES	B-cell_type
cells	E-cell_type
into	O
mature	O
macrophages	S-cell_type
.	O

FACS	O
analysis	O
was	O
performed	O
on	O
a	O
Beckman-Coulter	O
EPICS	O
®	O
XL-MCL	O
flow	O
cytometer	O
with	O
data	O
analysis	O
using	O
EXPO32	O
ADC	O
software	O
(	O
Coulter	O
Corporation	O
,	O
Miami	O
,	O
FL	O
)	O
.	O

Transduced	O
cells	O
gave	O
rise	O
to	O
cystic	B-x
bodies	E-x
with	O
similar	O
CD34	S-GP
cell	O
content	O
and	O
profiles	O
upon	O
development	O
.	O

Our	O
results	O
showing	O
that	O
both	O
normal	O
and	O
transgenic	O
derivative	O
macrophages	S-cell_type
support	O
HIV-1	S-y
infection	O
points	O
out	O
to	O
their	O
utility	O
for	O
testing	O
anti-HIV	S-y
constructs	O
transduced	O
into	O
hES-CD34	B-cell_type
cells	E-cell_type
and	O
pave	O
the	O
way	O
for	O
their	O
application	O
in	O
stem	O
cell	O
based	O
HIV	S-y
gene	O
therapy	O
.	O

The	O
lack	O
of	O
vector	O
toxicity	O
on	O
cellular	O
maturation	O
is	O
encouraging	O
for	O
future	O
work	O
with	O
transduced	O
hES-CD34	B-cell_type
cells	E-cell_type
to	O
derive	O
other	O
important	O
differentiated	O
cells	O
like	O
T	B-cell_type
cells	E-cell_type
and	O
dendritic	B-cell_type
cells	E-cell_type
relevant	O
for	O
HIV	S-y
studies	O
.	O

Myeloid	B-x
colonies	E-x
were	O
allowed	O
to	O
develop	O
for	O
12–15	O
days	O
.	O

Therefore	O
we	O
analyzed	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
for	O
the	O
presence	O
of	O
characteristic	O
cell	O
surface	O
markers	O
and	O
compared	O
these	O
to	O
the	O
phenotypic	O
profile	O
displayed	O
on	O
fetal	B-cell_type
CD34	I-cell_type
cell	E-cell_type
derived	O
macrophages	S-cell_type
.	O

B	O
)	O
Representative	O
FACS	O
profile	O
of	O
hES	B-cell_type
cell	I-cell_type
derived	I-cell_type
CD34	I-cell_type
cells	E-cell_type
stained	O
with	O
PE	O
conjugated	O
antibodies	O
.	O

Since	O
these	O
cells	O
are	O
susceptible	O
to	O
HIV-1	S-y
infection	O
,	O
they	O
provide	O
a	O
uniform	O
source	O
of	O
macrophages	S-cell_type
for	O
viral	S-y
infection	O
studies	O
.	O

Several	O
pluripotent	O
hES	O
cell	O
lines	O
have	O
so	O
far	O
been	O
derived	O
from	O
the	O
inner	B-x
cell	I-x
mass	E-x
of	O
human	S-y
blastocysts	S-x
and	O
can	O
be	O
cultured	O
indefinitely	O
in	O
an	O
undifferentiated	O
state	O
[	O
5-7	O
]	O
.	O

HIV-1	S-y
infection	O
of	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
To	O
determine	O
if	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
can	O
be	O
infected	O
with	O
HIV-1	S-y
and	O
support	O
viral	O
replication	O
,	O
cells	O
were	O
challenged	O
with	O
a	O
macrophage	B-y
R5-tropic	I-y
BaL-1	I-y
strain	I-y
of	I-y
HIV-1	E-y
.	O

The	O
CD34	B-cell_type
cells	E-cell_type
currently	O
used	O
for	O
many	O
therapies	O
are	O
primarily	O
obtained	O
from	O
bone	B-x
marrow	E-x
or	O
mobilized	O
peripheral	B-x
blood	E-x
[	O
1,19	O
]	O
.	O

Percent	O
positive	O
cells	O
are	O
displayed	O
in	O
the	O
plots	O
for	O
each	O
respective	O
cell	O
surface	O
marker	O
staining	O
.	O

For	O
vector	O
transduction	O
,	O
the	O
undifferentiated	O
hES	B-cell_type
cells	E-cell_type
were	O
prepared	O
into	O
small	O
clumps	S-x
of	O
50–100	O
cells	O
with	O
enzyme	O
digestion	O
as	O
done	O
for	O
routine	O
passaging	O
of	O
cells	O
.	O

Similarly	O
,	O
nontransduced	O
and	O
transduced	O
hES	S-cell_type
cell	O
derived	O
macrophages	S-cell_type
were	O
also	O
capable	O
of	O
TNF-α	S-GP
secretion	O
upon	O
LPS	S-GP
stimulation	O
.	O

Twenty	O
four	O
hours	O
post-addition	O
,	O
cells	O
were	O
analyzed	O
by	O
FACS	O
.	O

Growth	O
,	O
propagation	O
and	O
lentiviral	O
transduction	O
of	O
hES	B-cell_type
cells	E-cell_type
The	O
NIH	O
approved	O
human	S-y
ES	O
H1	S-cell_line
cell	O
line	O
was	O
obtained	O
from	O
WiCell	O
(	O
Madison	O
,	O
Wisconsin	O
)	O
.	O

To	O
quantify	O
viral	O
p24	O
levels	O
,	O
a	O
Coulter-p24	O
kit	O
(	O
Beckman	O
Coulter	O
,	O
Fullerton	O
,	O
CA	O
)	O
was	O
used	O
.	O

HIV	S-y
mainly	O
targets	O
cells	O
of	O
the	O
hematopoietic	B-x
system	E-x
,	O
namely	O
,	O
T	B-cell_type
cells	E-cell_type
,	O
macrophages	S-cell_type
,	O
and	O
dendritic	B-cell_type
cells	E-cell_type
[	O
15	O
]	O
.	O

These	O
results	O
are	O
consistent	O
with	O
those	O
of	O
others	O
that	O
showed	O
normal	O
differentiation	O
of	O
hES	B-cell_type
cells	E-cell_type
to	O
other	O
cell	O
types	O
following	O
lentiviral	S-y
transduction	O
[	O
32	O
]	O
.	O

Its	O
expression	O
is	O
elevated	O
upon	O
activation	O
with	O
certain	O
stimuli	O
such	O
as	O
LPS	O
.	O

Different	O
methods	O
currently	O
exist	O
to	O
derive	O
CD34	B-cell_type
cells	E-cell_type
from	O
hES	B-cell_type
cells	E-cell_type
with	O
varying	O
efficiencies	O
[	O
20-27	O
]	O
.	O

Based	O
on	O
these	O
considerations	O
,	O
both	O
non-	O
transduced	O
and	O
lentiviral	O
vector	O
transduced	O
hES	B-cell_type
cells	E-cell_type
were	O
evaluated	O
for	O
their	O
capacity	O
to	O
give	O
rise	O
to	O
CD34	B-cell_type
progenitor	I-cell_type
cells	E-cell_type
.	O

By	O
4–5	O
days	O
,	O
cells	O
developed	O
into	O
mature	O
macrophages	S-cell_type
which	O
were	O
used	O
for	O
subsequent	O
phenotypic	O
and	O
functional	O
characterization	O
.	O

The	O
capacity	O
to	O
generate	O
T	B-cell_type
cells	E-cell_type
remains	O
to	O
be	O
evaluated	O
.	O

On	O
days	O
1	O
,	O
2	O
,	O
and	O
3	O
post-stimulation	O
,	O
supernatants	O
were	O
collected	O
and	O
assayed	O
by	O
ELISA	O
for	O
(	O
A	O
)	O
IL-1	S-GP
and	O
(	O
B	O
)	O
TNFα	S-GP
.	O

Tests	O
evaluating	O
phagocytosis	O
,	O
upregulation	O
of	O
the	O
costimulatory	O
molecule	O
B7.1	S-GP
,	O
and	O
cytokine	O
secretion	O
in	O
response	O
to	O
LPS	O
stimulation	O
showed	O
that	O
these	O
macrophages	S-cell_type
are	O
also	O
functionally	O
normal	O
.	O

This	O
may	O
be	O
due	O
to	O
inherent	O
differences	O
in	O
the	O
cell	O
types	O
and/or	O
due	O
to	O
their	O
physiological	O
state	O
at	O
the	O
time	O
of	O
harvest	O
[	O
35	O
]	O
.	O

To	O
assess	O
the	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
'	O
phagocytic	O
function	O
,	O
5	O
ug/ml	O
of	O
fluorescently	O
labeled	O
E.	B-y
coli	E-y
Bioparticles®	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
)	O
were	O
added	O
directly	O
to	O
the	O
cell	O
culture	O
medium	O
.	O

Both	O
non	O
transduced	O
and	O
lentiviral	S-y
vector	O
transduced	O
hES	B-cell_type
cells	E-cell_type
were	O
found	O
to	O
be	O
capable	O
of	O
generating	O
CD34	B-cell_type
cells	E-cell_type
that	O
give	O
rise	O
to	O
macrophages	S-cell_type
which	O
could	O
support	O
productive	O
HIV-1	O
infection	O
.	O

Cells	O
were	O
scraped	O
from	O
their	O
wells	O
,	O
washed	O
two	O
times	O
with	O
PBS	O
,	O
and	O
stained	O
with	O
the	O
following	O
antibodies	O
:	O
PE-CD14	S-GP
,	O
PE-HLA-DR	S-GP
,	O
PECY5-CD4	S-GP
,	O
PECY5-CCR5	S-GP
,	O
PECY5-CXCR4	S-GP
(	O
BD	O
Biosciences	O
,	O
San	O
Jose	O
,	O
CA	O
)	O
.	O

In	O
addition	O
to	O
providing	O
for	O
potential	O
cellular	O
replacement	O
therapies	O
,	O
opportunities	O
exist	O
in	O
programming	O
hES	B-cell_type
cells	E-cell_type
to	O
correct	O
a	O
genetic	O
defect	O
and/or	O
to	O
express	O
a	O
therapeutic	O
transgene	O
of	O
interest	O
.	O

We	O
wanted	O
to	O
determine	O
if	O
hES	B-cell_type
cel	E-cell_type
l	O
derived	O
macrophages	S-cell_type
were	O
susceptible	O
to	O
HIV-1	S-y
infection	O
compared	O
to	O
standard	O
macrophages	S-cell_type
.	O

Our	O
current	O
results	O
established	O
that	O
physiologically	O
normal	O
macrophages	S-cell_type
could	O
be	O
derived	O
from	O
hES	B-cell_type
cells	E-cell_type
and	O
that	O
these	O
cells	O
have	O
the	O
potential	O
for	O
use	O
in	O
cellular	O
and	O
gene	O
therapies	O
.	O

Furthermore	O
,	O
the	O
hES	S-cell_type
-	O
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
also	O
showed	O
a	O
normal	O
capacity	O
to	O
ingest	O
foreign	O
particles	O
in	O
phagocytosis	O
assays	O
using	O
E.coli	S-y
Bioparticles®	O
.	O

Demonstration	O
of	O
HIV-1	S-y
productive	O
infection	O
in	O
these	O
cells	O
will	O
permit	O
future	O
efficacy	O
evaluations	O
of	O
anti-HIV	S-y
genes	O
in	O
this	O
system	O
.	O

Isotype	O
controls	O
for	O
both	O
PE	O
and	O
PECY5	S-GP
stains	O
are	O
shown	O
in	O
Fig	O
2B	O
.	O

Similar	O
to	O
that	O
of	O
fetal	B-cell_type
liver	I-cell_type
CD34	I-cell_type
cell	I-cell_type
derived	I-cell_type
cells	E-cell_type
,	O
the	O
hES	S-cell_type
-	O
CD34	S-GP
macrophages	S-cell_type
also	O
supported	O
HIV-1	S-y
infection	O
although	O
the	O
levels	O
of	O
viral	S-y
yield	O
differed	O
somewhat	O
.	O

Mature	O
colonies	S-x
were	O
subcultured	O
weekly	O
by	O
digesting	O
with	O
collagenase	B-GP
IV	E-GP
as	O
previously	O
described	O
[	O
5	O
]	O
.	O

The	O
transduced	O
colonies	O
were	O
cultured	O
on	O
MEF	S-cell_type
like	O
above	O
.	O

Percent	O
positive	O
cells	O
are	O
displayed	O
in	O
the	O
plots	O
for	O
each	O
experiment	O
.	O

Cells	O
were	O
washed	O
twice	O
with	O
PBS	O
and	O
filtered	O
through	O
a	O
70	O
uM	O
cell	O
strainer	O
to	O
obtain	O
a	O
single	O
cell	O
suspension	O
.	O

Functional	O
analysis	O
of	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
Physiological	O
roles	O
of	O
macrophages	S-cell_type
include	O
phagocytic	O
and	O
immune	O
related	O
functions	O
.	O

At	O
higher	O
magnification	O
,	O
the	O
macrophages	S-cell_type
displayed	O
flat	O
projecting	O
cellular	O
borders	O
with	O
fried	O
egg	O
appearance	O
with	O
distinct	O
refractory	O
lysosomal	B-cellcomponent
granules	E-cellcomponent
in	O
the	O
cytoplasm	S-cellcomponent
(	O
data	O
not	O
shown	O
)	O
.	O

For	O
comparative	O
experiments	O
,	O
human	B-cell_type
CD34	I-cell_type
hematopoietic	I-cell_type
progenitor	I-cell_type
cells	E-cell_type
were	O
also	O
purified	O
from	O
fetal	B-x
liver	E-x
tissue	S-x
as	O
described	O
above	O
.	O

To	O
purify	O
the	O
CD34	B-cell_type
cells	E-cell_type
,	O
Direct	O
CD34	B-cell_type
Progenitor	I-cell_type
Cell	E-cell_type
Isolation	O
Kit	O
(	O
Miltenyi	O
Biotech	O
,	O
Auburn	O
,	O
CA	O
)	O
was	O
used	O
following	O
the	O
manufacturer	O
's	O
protocol	O
.	O

For	O
comparison	O
,	O
fetal	B-x
liver	E-x
derived	O
CD34	B-cell_type
cells	E-cell_type
were	O
cultured	O
similarly	O
to	O
derive	O
macrophages	S-cell_type
.	O

Accordingly	O
,	O
fetal	B-cell_type
liver	I-cell_type
CD34	E-cell_type
,	O
nontransduced	O
hES	S-cell_type
,	O
and	O
GFP	S-GP
-alone	O
transduced	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
were	O
stimulated	O
by	O
the	O
addition	O
of	O
LPS	S-GP
(	O
5	O
ug/ml	O
)	O
to	O
the	O
cell	O
culture	O
medium	O
.	O

However	O
,	O
the	O
levels	O
of	O
viral	S-y
yield	O
were	O
found	O
to	O
be	O
slightly	O
lower	O
for	O
the	O
ES	B-cell_type
cell	E-cell_type
derived	O
macrophages	S-cell_type
.	O

When	O
exposed	O
to	O
LPS	S-GP
,	O
the	O
hES	S-cell_type
-	O
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
secreted	O
two	O
important	O
cytokines	O
IL-1	S-GP
and	O
TNF-α	S-GP
similar	O
to	O
that	O
of	O
fetal	S-x
liver	S-x
derived	O
cells	O
.	O

Percent	O
positive	O
CD34	B-cell_type
cells	E-cell_type
are	O
shown	O
with	O
isotype	O
control	O
shown	O
in	O
the	O
left	O
panel.Figure	O
2Phenotypic	O
FACS	O
analysis	O
of	O
hES	O
cell	O
derived	S-GP
macrophages	S-cell_type
.	O

GFP	S-GP
expression	O
in	O
cystic	B-x
body	E-x
derived	O
CD34	B-cell_type
cells	E-cell_type
was	O
around	O
80	O
%	O
(	O
data	O
not	O
shown	O
)	O
with	O
similar	O
levels	O
seen	O
in	O
differentiated	O
macrophages	S-cell_type
(	O
Fig	O
2	O
)	O
.Figure	O
1Derivation	O
of	O
macrophages	S-cell_type
from	O
lentiviral	S-y
vector	O
transduced	O
and	O
normal	O
hES	B-cell_type
cells	E-cell_type
.	O

Thus	O
,	O
CD34	B-cell_type
progenitor	I-cell_type
cells	E-cell_type
are	O
an	O
essential	O
ingredient	O
for	O
HIV	S-y
gene	O
therapy	O
.	O

With	O
this	O
background	O
,	O
as	O
a	O
first	O
step	O
,	O
our	O
primary	O
goal	O
in	O
these	O
studies	O
is	O
to	O
examine	O
the	O
capacity	O
of	O
hES-CD34	B-cell_type
cells	E-cell_type
to	O
give	O
rise	O
to	O
phenotypically	O
and	O
functionally	O
normal	O
macrophages	S-cell_type
and	O
whether	O
such	O
cells	O
are	O
susceptible	O
to	O
productive	O
HIV	S-y
infection	O
.	O

FACS	O
analysis	O
of	O
single	O
cell	O
suspensions	O
of	O
the	O
cystic	B-x
bodies	E-x
showed	O
levels	O
of	O
CD34	B-cell_type
cells	E-cell_type
which	O
ranged	O
from	O
7–15	O
%	O
.	O

Accordingly	O
,	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
were	O
evaluated	O
to	O
determine	O
if	O
they	O
met	O
these	O
criteria	O
.	O

Activated	O
macrophages	S-cell_type
secrete	O
various	O
cytokines	O
,	O
two	O
of	O
the	O
major	O
ones	O
being	O
IL-1	S-GP
and	O
TNF-α	S-GP
.	O

Our	O
results	O
of	O
LPS	S-GP
stimulation	O
of	O
respective	O
macrophages	S-cell_type
have	O
shown	O
upregulation	O
of	O
B7.1	S-GP
with	O
values	O
for	O
fetal	B-x
liver	E-x
CD34	S-GP
cell	O
(	O
CD34	O
)	O
(	O
27.9	O
%	O
to	O
75.4	O
%	O
)	O
nontransduced	O
(	O
ES	O
)	O
(	O
17.8	O
%	O
to	O
49.4	O
%	O
)	O
and	O
transduced	O
(	O
GFP	O
ES	O
)	O
(	O
35.6	O
%	O
to	O
65.7	O
%	O
)	O
hES	B-cell_type
cell	I-cell_type
derived	I-cell_type
macrophages	E-cell_type
(	O
Fig	O
3A	O
)	O
.	O

Dot	O
plots	O
are	O
representative	O
of	O
triplicate	O
experiments	O
.	O

Moreover	O
,	O
multiple	O
novel	O
strategies	O
to	O
avoid	O
immune-mediated	O
rejection	O
of	O
hES	B-cell_type
cell-derived	I-cell_type
cells	E-cell_type
have	O
been	O
proposed	O
[	O
56,57	O
]	O
.	O

CD4	S-GP
levels	O
were	O
comparable	O
for	O
all	O
stem	B-cell_type
cell	I-cell_type
derived	I-cell_type
macrophages	E-cell_type
(	O
99.2	O
%	O
,	O
83.3	O
%	O
,	O
and	O
88.7	O
%	O
,	O
respectively	O
)	O
(	O
Fig	O
2A	O
)	O
.	O

Upon	O
stimulation	O
with	O
LPS	S-GP
,	O
hES-	O
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
had	O
shown	O
upregulation	O
of	O
the	O
costimulatory	O
molecule	O
B7.1	S-GP
similar	O
to	O
cells	O
derived	O
from	O
fetal	S-x
liver	S-x
.	O

The	O
hES	B-cell_type
cel	E-cell_type
l	O
derived	O
CD34	B-cell_type
hematopoietic	I-cell_type
stem	I-cell_type
cells	E-cell_type
can	O
be	O
potentially	O
used	O
for	O
many	O
gene	O
therapy	O
applications	O
.	O

HIV	S-y
continues	O
to	O
be	O
a	O
major	O
global	O
public	O
health	O
problem	O
with	O
infections	O
increasing	O
at	O
an	O
alarming	O
rate	O
[	O
10,11	O
]	O
.	O

Pooled	O
colonies	O
were	O
cultured	O
in	O
liquid	O
cytokine	O
media	O
supplemented	O
with	O
GM-CSF	S-GP
and	O
M-CSF	S-GP
to	O
promote	O
macrophage	O
growth	O
.	O

HLA-DR	S-GP
,	O
CD4	S-GP
,	O
and	O
CCR5	S-GP
expression	O
profiles	O
were	O
comparable	O
between	O
all	O
cell	O
types	O
analyzed	O
.	O

The	O
ability	O
to	O
obtain	O
phenotypically	O
normal	O
and	O
functionally	O
competent	O
macrophages	S-cell_type
from	O
hES	B-cell_type
cells	E-cell_type
is	O
important	O
to	O
evaluate	O
their	O
potential	O
therapeutic	O
utilities	O
in	O
the	O
future	O
.	O

Based	O
on	O
these	O
results	O
,	O
it	O
is	O
also	O
now	O
feasible	O
to	O
transduce	O
hES-CD34	B-cell_type
cells	E-cell_type
with	O
anti-HIV	B-GP
genes	E-GP
such	O
as	O
inhibitory	O
siRNAs	S-GP
and	O
test	O
their	O
antiviral	S-y
efficacy	O
in	O
down	O
stream	O
differentiated	O
cells	O
such	O
as	O
macrophages	S-cell_type
which	O
are	O
among	O
the	O
primary	B-cell_type
cells	E-cell_type
that	O
need	O
to	O
be	O
protected	O
against	O
HIV-1	S-y
infection	O
.	O

Recent	O
evidence	O
has	O
shown	O
that	O
hES-CD34	B-cell_type
cells	E-cell_type
can	O
give	O
rise	O
to	O
myelomonocytic	B-cell_type
cells	E-cell_type
[	O
21	O
]	O
.	O

Thus	O
,	O
the	O
potential	O
utility	O
of	O
hES	S-cell_type
derived	O
CD34	B-cell_type
hematopoietic	I-cell_type
cells	E-cell_type
for	O
HIV-1	S-x
gene	O
therapy	O
can	O
be	O
evaluated	O
.	O

The	O
differentiated	O
CD34	B-cell_type
cells	E-cell_type
isolated	O
from	O
cystic	B-x
bodies	E-x
were	O
further	O
cultured	O
in	O
cytokine	O
media	O
to	O
derive	O
macrophages	S-cell_type
.	O

As	O
infection	O
progresses	O
,	O
the	O
immune	B-x
system	E-x
is	O
rendered	O
defenseless	O
against	O
other	O
invading	O
pathogens	O
and	O
succumbs	O
to	O
opportunistic	O
infections	O
.	O

The	O
above	O
phenotypic	O
data	O
are	O
representative	O
of	O
triplicate	O
experiments	O
.	O

When	O
pooled	O
colonies	O
were	O
cultured	O
further	O
in	O
liquid	O
cytokine	O
media	O
for	O
12–15	O
days	O
for	O
differentiation	O
,	O
the	O
cells	O
developed	O
into	O
morphologically	O
distinct	O
macrophages	S-cell_type
(	O
Fig	O
1A	O
)	O
.	O

However	O
,	O
levels	O
of	O
the	O
respective	O
cytokines	O
detected	O
were	O
slightly	O
lower	O
than	O
those	O
from	O
fetal	B-x
liver	E-x
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
(	O
Fig	O
4B	O
)	O
.	O

Recent	O
reports	O
have	O
indicated	O
the	O
capacity	O
of	O
hES	O
cell	O
derived	O
CD34	B-cell_type
cells	E-cell_type
to	O
give	O
rise	O
to	O
lymphoid	S-x
and	O
myeloid	B-cell_type
lineages	E-cell_type
thus	O
paving	O
the	O
way	O
for	O
utilization	O
of	O
these	O
cells	O
for	O
hematopoietic	S-x
cell	O
therapy	O
[	O
20,27-29	O
]	O
.	O

hES	O
cell	O
colonies	S-x
were	O
cultured	O
on	O
mouse	B-cell_type
embryonic	I-cell_type
fibroblasts	E-cell_type
(	O
MEF	S-cell_type
)	O
(	O
Chemicon	O
,	O
Temecula	O
,	O
CA	O
)	O
in	O
the	O
presence	O
of	O
DMEM-F12	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
)	O
supplemented	O
with	O
20	O
%	O
KNOCKOUT	O
serum	O
replacement	O
with	O
1	O
mM	O
L-glutamine	O
,	O
1	O
%	O
Nonessential	O
Amino	O
Acids	O
,	O
0.1	O
mM	O
β-mercaptoethanol	O
,	O
0.5	O
%	O
penicillin/streptomycin	O
,	O
and	O
4	O
ng/ml	O
human	B-GP
basic	I-GP
fibroblast	I-GP
growth	I-GP
factor	E-GP
.	O

Phenotypically	O
normal	O
and	O
functionally	O
competent	O
macrophages	S-cell_type
could	O
be	O
derived	O
from	O
hES-CD34	B-cell_type
cells	E-cell_type
.	O

A	O
minimum	O
of	O
8,000	O
cells	O
were	O
analyzed	O
in	O
each	O
FACS	O
evaluation	O
.	O

These	O
data	O
are	O
representative	O
of	O
triplicate	O
experiments.Another	O
important	O
function	O
of	O
macrophages	S-cell_type
is	O
their	O
ability	O
to	O
phagocytose	S-cell_type
foreign	O
material	O
and	O
present	O
antigenic	O
peptides	O
on	O
their	O
cell	B-cellcomponent
surface	E-cellcomponent
.	O

To	O
assess	O
the	O
levels	O
of	O
CD34	B-cell_type
cells	E-cell_type
in	O
the	O
bulk	O
cell	O
suspension	O
,	O
cells	O
were	O
labeled	O
with	O
PE	O
conjugated	O
anti-	O
CD34	S-GP
antibody	O
(	O
BD	O
Biosciences	O
,	O
San	O
Jose	O
,	O
CA	O
)	O
and	O
analyzed	O
by	O
FACS	O
.	O

However	O
this	O
should	O
not	O
be	O
a	O
major	O
concern	O
for	O
testing	O
anti-HIV	S-y
genes	O
in	O
these	O
cells	O
.	O

Experiments	O
were	O
done	O
in	O
triplicate	O
.	O

The	O
hES	O
cell	O
clusters	S-x
were	O
then	O
transferred	O
to	O
irradiated	O
(	O
35	O
Gy	O
)	O
S17	B-cell_line
cell	E-cell_line
layers	S-x
and	O
cultured	O
with	O
RPMI	O
differentiation	O
medium	O
containing	O
15	O
%	O
FBS	O
(	O
HyClone	O
,	O
Logan	O
,	O
UT	O
)	O
,	O
2	O
mM	O
L-glutamine	O
,	O
0.1	O
mM	O
β-mercaptoethanol	O
,	O
1	O
%	O
MEM-nonessential	O
amino	O
acids	O
,	O
and	O
1	O
%	O
penicillin/streptomycin	O
.	O

Activated	O
macrophages	S-cell_type
upregulate	O
the	O
expression	O
of	O
B7.1	S-GP
upon	O
activation	O
with	O
various	O
stimuli	O
.	O

hES	B-cell_type
cell	I-cell_type
derived	I-cell_type
macrophages	E-cell_type
display	O
a	O
normal	O
phenotypic	O
profile	O
Macrophages	S-cell_type
play	O
a	O
critical	O
role	O
in	O
immune	O
system	O
function	O
and	O
are	O
also	O
major	O
target	O
cells	O
for	O
many	O
viral	S-y
infections	O
including	O
HIV-1	S-y
.	O

These	O
approaches	O
use	O
CD34	S-GP
hematopoietic	B-cell_type
stem	I-cell_type
cells	E-cell_type
for	O
anti-HIV	S-y
gene	O
transduction	O
via	O
integrating	O
viral	S-y
vectors	O
such	O
as	O
lentiviral	S-y
vectors	O
[	O
16-18	O
]	O
.	O

Phenotypic	O
analysis	O
of	O
hES	B-cell_type
cel	E-cell_type
l	O
derived	O
macrophagesTo	S-cell_type
determine	O
if	O
nontransduced	O
and	O
lentiviral	S-y
vector	O
transduced	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
display	O
normal	O
macrophage	O
surface	O
markers	O
,	O
FACS	O
analysis	O
was	O
performed	O
using	O
respective	O
fluorochrome	O
conjugated	O
antibodies	O
.	O

Thus	O
,	O
these	O
cells	O
provide	O
a	O
renewable	O
source	O
of	O
pluripotent	O
stem	B-cell_type
cells	E-cell_type
from	O
which	O
many	O
types	O
of	O
differentiated	O
cells	O
could	O
be	O
produced	O
for	O
experimental	O
and	O
therapeutic	O
purposes	O
.	O

Additional	O
hES	O
cell	O
lines	O
need	O
to	O
be	O
evaluated	O
in	O
the	O
future	O
to	O
establish	O
if	O
these	O
differences	O
are	O
consistent	O
.	O

The	O
cell	B-x
clumps	E-x
were	O
incubated	O
with	O
the	O
vector	O
for	O
2	O
hrs	O
in	O
the	O
presence	O
of	O
polybrene	O
6	O
ug/ml	O
.	O

In	O
view	O
of	O
the	O
need	O
for	O
CD34	B-cell_type
cells	E-cell_type
for	O
HIV	S-y
gene	O
therapy	O
as	O
well	O
as	O
for	O
other	O
hematopoietic	S-x
disorders	O
,	O
if	O
one	O
can	O
produce	O
these	O
cells	O
in	O
unlimited	O
quantities	O
from	O
a	O
renewable	O
source	O
,	O
it	O
will	O
overcome	O
the	O
limitations	O
of	O
securing	O
large	O
numbers	O
of	O
CD34	B-cell_type
cells	E-cell_type
for	O
therapeutic	O
purposes	O
.	O

In	O
all	O
the	O
above	O
experiments	O
,	O
the	O
vector	O
transduced	O
transgenic	O
macrophages	S-cell_type
also	O
behaved	O
similarly	O
to	O
that	O
of	O
nontransduced	O
cells	O
showing	O
that	O
they	O
were	O
also	O
physiologically	O
normal	O
.	O

Twenty-four	O
hours	O
post-stimulation	O
,	O
macrophages	S-cell_type
were	O
labeled	O
with	O
a	O
PE-CY5	O
conjugated	O
anti-	O
B7.1	S-GP
antibody	O
and	O
analyzed	O
by	O
FACS	O
.	O

However	O
,	O
a	O
recent	O
study	O
using	O
human	B-y
leukocyte	I-y
reconstituted	I-y
mice	E-y
suggested	O
that	O
hESCs	S-cell_type
and	O
their	O
derivative	O
cell	O
types	O
were	O
less	O
prone	O
to	O
invoking	O
an	O
allogeneic	O
response	O
[	O
53	O
]	O
.	O

At	O
two	O
and	O
four	O
days	O
post-harvest	O
,	O
medium	O
was	O
replaced	O
with	O
fresh	O
complete	O
DMEM	O
supplemented	O
with	O
10	O
ng/ml	O
GM-CSF	S-GP
and	O
M-CSF	S-GP
.	O

Both	O
nontransduced	O
(	O
denoted	O
as	O
ES	O
in	O
figures	O
)	O
and	O
vector	O
transduced	O
(	O
denoted	O
as	O
GFP	S-GP
ES	O
in	O
figures	O
)	O
hES	B-cell_type
cell	I-cell_type
derived	I-cell_type
CD34	I-cell_type
cells	E-cell_type
gave	O
rise	O
to	O
normal	O
myelomonocytic	B-x
colonies	E-x
similar	O
to	O
human	B-x
fetal	I-x
liver	E-x
derived	O
CD34	B-cell_type
cells	E-cell_type
(	O
denoted	O
as	O
CD34	S-GP
in	O
figures	O
)	O
(	O
Fig	O
1A	O
)	O
.	O

Upon	O
differentiation	O
and	O
proliferation	O
,	O
myelomonocytic	B-x
colonies	E-x
were	O
harvested	O
by	O
the	O
addition	O
of	O
5	O
ml	O
DMEM	O
containing	O
10	O
%	O
FBS	O
,	O
10	O
ng/ml	O
each	O
GM-CSF	S-GP
and	O
M-CSF	S-GP
.	O

Accordingly	O
,	O
macrophages	S-cell_type
were	O
stimulated	O
with	O
5	O
ug/ml	O
of	O
LPS	O
during	O
culture	O
.	O

The	O
surface	O
markers	O
analyzed	O
were	O
CD14	S-GP
,	O
a	O
monocyte	S-cell_type
/macrophage	O
specific	O
marker	O
,	O
HLA-DR	S-GP
(	O
a	O
class	B-GP
II	I-GP
MHC	I-GP
molecule	E-GP
found	O
on	O
antigen	O
presenting	O
cells	O
)	O
,	O
CD4	S-GP
,	O
the	O
major	O
receptor	O
for	O
HIV-1	S-y
infection	O
,	O
and	O
CCR5	S-GP
and	O
CXCR4	S-GP
,	O
chemokine	O
receptors	O
which	O
are	O
critical	O
coreceptors	O
essential	O
for	O
HIV-1	S-y
entry	O
.	O

In	O
the	O
case	O
of	O
GFP	S-GP
-	O
ES	S-cell_type
macrophages	S-cell_type
,	O
there	O
was	O
a	O
decline	O
in	O
viral	S-y
titer	O
.	O

Here	O
we	O
show	O
that	O
normal	O
and	O
lentiviral	S-y
vector	O
transduced	O
hES-CD34	B-cell_type
cells	E-cell_type
can	O
give	O
rise	O
to	O
phenotypically	O
and	O
functionally	O
normal	O
macrophages	S-cell_type
that	O
support	O
HIV	S-y
infection	O
thus	O
paving	O
the	O
way	O
for	O
many	O
novel	O
approaches	O
to	O
evaluate	O
their	O
potential	O
for	O
HIV	S-y
gene	O
therapy	O
.	O

The	O
above	O
data	O
has	O
established	O
that	O
phenotypically	O
and	O
functionally	O
normal	O
macrophages	S-cell_type
could	O
be	O
derived	O
from	O
hES-CD34	B-cell_type
cells	E-cell_type
.	O

A	O
VSV-G	O
pseudotyped	O
lentiviral	S-y
vector	O
(	O
SINF-EF1a-	O
GFP	S-GP
)	O
containing	O
a	O
GFP	O
reporter	O
gene	O
(	O
kindly	O
supplied	O
by	O
R.	O
Hawley	O
,	O
George	O
Washington	O
University	O
)	O
was	O
used	O
for	O
hES	O
cell	O
transductions	O
as	O
previously	O
described	O
(	O
30	O
,	O
58	O
)	O
.	O

Macrophages	S-cell_type
display	O
distinct	O
cell	O
surface	O
markers	O
upon	O
end	O
stage	O
differentiation	O
.	O

Transgenic	O
hES	B-cell_type
cell	I-cell_type
derived	I-cell_type
macrophages	E-cell_type
are	O
functionally	O
normalThe	O
antigen	O
presenting	O
cell	O
surface	O
specific	O
marker	O
HLA-DR	S-GP
(	O
MHC	B-GP
II	E-GP
)	O
on	O
normal	O
macrophages	S-cell_type
is	O
critical	O
for	O
presenting	O
antigen	O
to	O
CD4	S-GP
T	B-cell_type
cells	E-cell_type
.	O

Similarly	O
,	O
lentiviral	S-y
vector	O
transduced	O
hES	O
cell	O
colonies	S-x
,	O
also	O
displayed	O
normal	O
morphology	O
and	O
growth	O
characteristics	O
(	O
Fig	O
1A	O
)	O
.	O

These	O
values	O
are	O
representative	O
of	O
triplicate	O
experiments	O
.	O

Although	O
there	O
are	O
numerous	O
studies	O
on	O
hES	O
cell	O
differentiation	O
into	O
many	O
important	O
end	B-cell_type
stage	I-cell_type
mature	I-cell_type
cells	E-cell_type
,	O
systematic	O
work	O
on	O
hES	O
cell	O
hematopoietic	S-x
differentiation	O
and	O
thorough	O
characterization	O
of	O
end	B-cell_type
stage	I-cell_type
mature	I-cell_type
cells	E-cell_type
that	O
participate	O
in	O
critical	O
immune	O
responses	O
has	O
just	O
begun	O
[	O
21,27-29	O
]	O
.	O

Even	O
though	O
all	O
cell	O
types	O
analyzed	O
stained	O
positive	O
for	O
CD14	S-GP
,	O
relative	O
expression	O
of	O
CD14	S-GP
was	O
slightly	O
lower	O
on	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
compared	O
to	O
fetal	B-x
liver	E-x
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
.	O

Since	O
these	O
cells	S-x
are	O
susceptible	O
to	O
HIV-1	S-x
infection	O
,	O
they	O
provide	O
a	O
uniform	O
source	O
of	O
macrophages	S-cell_type
for	O
viral	S-x
infection	O
studies	O
.	O

Figure	O
1B	O
displays	O
a	O
representative	O
FACS	O
profile	O
of	O
hES-CD34	B-cell_type
cells	E-cell_type
.	O

However	O
,	O
thorough	O
phenotypic	O
or	O
functional	O
characterization	O
of	O
these	O
cells	O
is	O
lacking	O
.	O

To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
demonstration	O
that	O
hES	B-cell_type
cell	I-cell_type
derivatives	E-cell_type
can	O
be	O
used	O
for	O
infectious	O
disease	O
research	O
.	O

Here	O
we	O
evaluated	O
the	O
capacity	O
of	O
hES	O
cell	O
derived	O
CD34	B-cell_type
cells	E-cell_type
to	O
give	O
rise	O
to	O
normal	O
macrophages	S-cell_type
as	O
a	O
first	O
step	O
towards	O
using	O
these	O
cells	O
in	O
viral	O
infection	O
studies	O
and	O
in	O
developing	O
novel	O
stem	O
cell	O
based	O
gene	O
therapy	O
strategies	O
for	O
AIDS.ResultsUndifferentiated	O
normal	O
and	O
lentiviral	O
vector	O
transduced	O
hES	B-cell_type
cells	E-cell_type
were	O
cultured	O
on	O
S17	S-cell_line
mouse	S-y
bone	B-x
marrow	E-x
stromal	S-x
cell	O
layers	S-x
to	O
derive	O
CD34	B-cell_type
hematopoietic	I-cell_type
progenitor	I-cell_type
cells	E-cell_type
.	O

CCR5	S-GP
and	O
CXCR4	S-GP
cell	O
surface	O
expression	O
was	O
also	O
observed	O
for	O
fetal	B-x
liver	E-x
CD34	S-GP
cell	O
(	O
99.6	O
%	O
and	O
99.3	O
%	O
)	O
,	O
nontransduced	O
hES	B-cell_type
cel	E-cell_type
l	O
(	O
91.9	O
%	O
and	O
92.6	O
%	O
)	O
,	O
and	O
transduced	O
hES	O
cell	O
(	O
98.9	O
%	O
and	O
99.3	O
%	O
)	O
derived	O
macrophages	S-cell_type
(	O
Fig	O
2A	O
)	O
.	O

Culture	O
medium	O
was	O
replaced	O
daily	O
with	O
fresh	O
complete	O
DMEM-F12	O
.	O

Given	O
the	O
present	O
lack	O
of	O
effective	O
vaccines	O
and	O
the	O
ineffectiveness	O
of	O
drug	O
based	O
therapies	O
for	O
a	O
complete	O
cure	O
,	O
new	O
and	O
innovative	O
approaches	O
are	O
essential	O
.	O

In	O
these	O
studies	O
,	O
we	O
only	O
used	O
an	O
R5-tropic	O
strain	O
of	O
HIV-1	S-y
since	O
macrophages	S-cell_type
are	O
natural	O
targets	O
for	O
this	O
virus	S-y
.	O

It	O
is	O
not	O
too	O
far	O
in	O
the	O
future	O
that	O
even	O
autologous	B-cell_type
hES	I-cell_type
cells	E-cell_type
may	O
be	O
derived	O
from	O
specific	O
individuals	O
for	O
deriving	O
CD34	B-cell_type
cells	E-cell_type
which	O
can	O
be	O
used	O
for	O
cell	O
replacement	O
therapy	O
.	O

Human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hES	B-cell_type
cells	E-cell_type
)	O
show	O
great	O
promise	O
for	O
many	O
novel	O
cellular	O
therapies	O
due	O
to	O
their	O
pluripotent	O
nature	O
[	O
1	O
]	O
.	O

of	O
0.01	O
in	O
the	O
presence	O
of	O
4	O
ug/ml	O
polybrene	O
was	O
used	O
.	O

The	O
transduced	O
hES-CD34	B-cell_type
cells	E-cell_type
also	O
gave	O
rise	O
to	O
apparently	O
normal	O
macrophages	S-cell_type
that	O
expressed	O
the	O
transgene	O
as	O
shown	O
by	O
GFP	S-GP
expression	O
.	O

When	O
infected	O
with	O
HIV-1	S-x
,	O
the	O
differentiated	O
macrophages	S-cell_type

Current	O
sources	O
of	O
CD34	B-cell_type
cells	E-cell_type
consist	O
of	O
human	S-y
bone	B-x
marrow	E-x
,	O
cytokine	O
mobilized	B-x
peripheral	I-x
blood	E-x
,	O
fetal	S-x
liver	S-x
,	O
and	O
cord	B-x
blood	E-x
[	O
34	O
]	O
.	O

A	O
)	O
Macrophages	S-cell_type
derived	O
from	O
transduced	O
and	O
nontransduced	O
hES	B-cell_type
CD34	E-cell_type
and	O
fetal	B-cell_type
liver	I-cell_type
CD34	I-cell_type
cells	E-cell_type
were	O
stained	O
with	O
antibodies	O
to	O
CD14	S-GP
,	O
HLA-DR	S-GP
,	O
CD4	S-GP
,	O
CCR5	S-GP
,	O
and	O
CXCR4	S-GP
and	O
the	O
expression	O
of	O
these	O
surface	O
markers	O
was	O
analyzed	O
by	O
FACS	O
.	O

A	O
blocking	O
step	O
was	O
first	O
performed	O
by	O
incubating	O
the	O
cells	O
with	O
the	O
respective	O
isotype	O
control	O
for	O
30	O
minutes	O
at	O
4C	O
before	O
staining	O
with	O
the	O
respective	O
cell	O
surface	O
marker	O
antibodies	O
.	O

For	O
the	O
effective	O
utilization	O
of	O
hES-CD34	B-cell_type
cells	E-cell_type
for	O
HIV	S-y
gene	O
therapy	O
,	O
a	O
number	O
of	O
parameters	O
need	O
to	O
be	O
examined	O
.	O

Using	O
such	O
approaches	O
,	O
many	O
possibilities	O
exist	O
for	O
treating	O
a	O
number	O
of	O
genetic	O
and	O
immune	B-x
system	E-x
disorders	O
[	O
1	O
]	O
.	O

Phenotypic	O
and	O
functional	O
analyses	O
were	O
carried	O
out	O
to	O
compare	O
these	O
with	O
that	O
of	O
fetal	S-x
liver	S-x
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
.	O

So	O
far	O
a	O
number	O
of	O
studies	O
including	O
our	O
own	O
have	O
tested	O
many	O
gene	O
therapeutic	O
constructs	O
in	O
CD34	S-GP
cells	O
from	O
conventional	O
sources	O
.	O

Some	O
of	O
these	O
approaches	O
have	O
progressed	O
into	O
clinical	O
evaluations	O
as	O
well	O
[	O
14,51,52	O
]	O
.	O

hES	O
cell	O
cultures	O
were	O
treated	O
with	O
collagenase	B-GP
IV	E-GP
(	O
1	O
mg/ml	O
)	O
for	O
10	O
minutes	O
at	O
37°C	O
and	O
subsequently	O
detached	O
from	O
the	O
plate	O
by	O
gentle	O
scraping	O
of	O
the	O
colonies	S-x
.	O

A	O
secondary	O
cycle	O
of	O
transduction	O
was	O
done	O
by	O
adding	O
fresh	O
vector	O
and	O
incubating	O
for	O
another	O
2	O
hrs	O
.	O

Magi-CXCR4	B-cell_type
cells	E-cell_type
with	O
no	O
phagocytic	S-cell_type
capacity	O
were	O
used	O
as	O
non-	O
phagocytic	B-cell_type
cell	E-cell_type
controls	O
and	O
similarly	O
exposed	O
to	O
E.	B-y
coli	E-y
Bioparticles®	O
(	O
Fig	O
3B	O
)	O
.	O

This	O
could	O
be	O
due	O
to	O
possible	O
lower	O
numbers	O
of	O
cells	O
present	O
in	O
the	O
initial	O
cultures	O
.	O

Lentiviral	S-y
vector	O
transduced	O
hES	B-cell_type
cells	E-cell_type
also	O
did	O
not	O
display	O
any	O
abnormal	O
growth	O
or	O
differentiation	O
characteristics	O
as	O
compared	O
to	O
nontransduced	O
hES-CD34	B-cell_type
cells	E-cell_type
indicating	O
no	O
adverse	O
effects	O
due	O
to	O
vector	O
integration	O
and	O
expression	O
.	O

On	O
days	O
1	O
,	O
2	O
,	O
and	O
3	O
post-stimulation	O
,	O
cell	O
culture	O
supernatant	O
samples	O
were	O
collected	O
and	O
analyzed	O
by	O
a	O
Quantikine®	O
ELISA	O
kit	O
(	O
R	O
&	O
D	O
Systems	O
,	O
Minneapolis	O
,	O
MN	O
)	O
.	O

Twenty-four	O
hours	O
post-stimulation	O
,	O
cells	O
were	O
stained	O
with	O
an	O
anti-B7.1	B-GP
antibody	E-GP
labeled	O
with	O
PE-Cy5	O
(	O
BD	O
Biosciences	O
,	O
San	O
Jose	O
,	O
CA	O
)	O
and	O
analyzed	O
by	O
FACS	O
.	O

There	O
is	O
a	O
great	O
deal	O
of	O
progress	O
in	O
the	O
area	O
of	O
stem	O
cell	O
gene	O
therapy	O
for	O
AIDS	O
[	O
12	O
]	O
.	O

The	O
values	O
of	O
cytokine	O
secretion	O
levels	O
represent	O
triplicate	O
experiments.Figure	O
4Cytokine	O
IL-1	S-GP
and	O
TNFα	S-GP
secretion	O
by	O
stimulated	O
hES	B-cell_type
cel	E-cell_type
l	O
derived	O
macrophages	S-cell_type
:	O
Macrophages	S-cell_type
derived	O
from	O
transduced	O
and	O
nontransduced	O
hES	S-cell_type
and	O
fetal	B-x
liver	E-x
CD34	B-cell_type
cells	E-cell_type
were	O
stimulated	O
with	O
5	O
μg/ml	O
LPS	S-GP
.	O

An	O
m.o.i	O
.	O

Purified	O
CD34	B-cell_type
cells	E-cell_type
were	O
later	O
cultured	O
in	O
semi-solid	O
methylcellulose	O
medium	O
to	O
derive	O
myeloid	B-x
colonies	E-x
.	O

A	O
major	O
functional	O
role	O
of	O
macrophages	S-cell_type
in	O
vivo	O
is	O
their	O
ability	O
to	O
serve	O
as	O
professional	O
antigen	B-cell_type
presenting	I-cell_type
cells	E-cell_type
.	O

Media	O
was	O
changed	O
every	O
2	O
to	O
3	O
days	O
during	O
14–17	O
days	O
of	O
culture	O
on	O
S17	B-cell_type
cells	E-cell_type
[	O
20	O
]	O
.After	O
allowing	O
adequate	O
time	O
for	O
differentiation	O
,	O
hES	S-cell_type
cystic	B-x
bodies	E-x
were	O
harvested	O
and	O
processed	O
into	O
a	O
single	O
cell	O
suspension	O
by	O
collagenase	B-GP
IV	E-GP
treatment	O
followed	O
by	O
digestion	O
with	O
trypsin	S-GP
/EDTA	O
supplemented	O
with	O
2	O
%	O
chick	S-y
serum	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
)	O
for	O
20	O
minutes	O
at	O
37°C	O
.	O

At	O
different	O
days	O
post-infection	O
,	O
culture	O
supernatants	O
were	O
collected	O
and	O
assayed	O
for	O
p24	O
antigen	O
by	O
ELISA	O
.	O

Our	O
results	O
from	O
challenge	O
studies	O
of	O
these	O
cells	O
clearly	O
indicated	O
the	O
capacity	O
of	O
hES	B-cell_type
cel	E-cell_type
l	O
derived	O
macrophages	S-cell_type
in	O
supporting	O
a	O
productive	O
infection	O
.	O

Twenty-four	O
hours	O
later	O
,	O
cells	O
were	O
analyzed	O
by	O
FACS	O
for	O
the	O
presence	O
of	O
ingested	O
Bioparticles®	O
which	O
can	O
be	O
detected	O
in	O
the	O
PE	O
(	O
FL2	O
)	O
channel	O
.	O

On	O
days	O
1	O
,	O
2	O
,	O
and	O
3	O
post-stimulation	O
,	O
culture	O
supernatants	O
were	O
analyzed	O
by	O
ELISA	O
to	O
detect	O
IL-1	S-GP
and	O
TNF-α	S-GP
.	O

Additionally	O
,	O
testing	O
of	O
transgenic	O
hES	B-cell_type
cells	E-cell_type
derived	O
via	O
lentiviral	S-y
vector	O
gene	O
transduction	O
is	O
also	O
helpful	O
to	O
determine	O
the	O
stability	O
of	O
the	O
transgene	O
expression	O
and	O
their	O
capacity	O
for	O
differentiation	O
into	O
end	B-cell_type
stage	I-cell_type
mature	I-cell_type
cells	E-cell_type
such	O
as	O
macrophages	S-cell_type
.	O

It	O
is	O
also	O
not	O
clear	O
if	O
these	O
cells	O
are	O
susceptible	O
to	O
HIV	S-y
infection	O
.	O

Distinct	O
surface	O
phenotypic	O
markers	O
exist	O
on	O
these	O
cells	O
and	O
,	O
thus	O
far	O
,	O
there	O
has	O
been	O
no	O
thorough	O
evaluation	O
of	O
hES	B-cell_type
cell	I-cell_type
derived	I-cell_type
macrophages	E-cell_type
.	O

B7.1	S-GP
upregulation	O
data	O
are	O
representative	O
of	O
triplicate	O
experiments	O
.	O

When	O
compared	O
,	O
the	O
morphology	O
of	O
macrophages	S-cell_type
derived	O
from	O
all	O
stem	B-cell_type
cell	I-cell_type
progenitor	E-cell_type
populations	O
appeared	O
similar	O
.	O

Lentiviral	S-y
vectors	O
have	O
several	O
advantages	O
over	O
conventional	O
retroviral	O
vectors	O
since	O
higher	O
transduction	O
efficiencies	O
can	O
be	O
obtained	O
and	O
there	O
is	O
less	O
gene	O
silencing	O
.	O

However	O
,	O
the	O
mean	O
fluorescent	O
intensity	O
(	O
MFI	O
)	O
was	O
found	O
to	O
be	O
lower	O
on	O
hES	B-cell_type
cell	I-cell_type
derived	I-cell_type
macrophages	E-cell_type
.	O

Macrophages	S-cell_type
in	O
addition	O
to	O
playing	O
important	O
physiological	O
roles	O
are	O
also	O
major	O
cell	O
targets	O
for	O
certain	O
viral	S-y
infections	O
,	O
particularly	O
HIV-1	S-y
.	O

hES	B-cell_type
cel	E-cell_type
l	O
derived	O
macrophages	S-cell_type
support	O
productive	O
HIV-1	S-y
infectionThe	O
above	O
data	O
have	O
shown	O
that	O
hES	S-cell_type
cell	O
derived	O
macrophages	S-cell_type
are	O
very	O
similar	O
to	O
normal	O
human	B-cell_type
macrophages	E-cell_type
based	O
on	O
phenotypic	O
and	O
functional	O
analysis	O
.	O

Four	O
hours	O
later	O
,	O
macrophages	S-cell_type
were	O
washed	O
six	O
times	O
with	O
PBS	O
and	O
fresh	O
medium	O
with	O
10	O
ng/ml	O
GM-CSF	S-GP
and	O
M-CSF	S-GP
was	O
added	O
.	O

A	O
)	O
Transduced	O
and	O
non-transduced	O
H1	B-cell_type
hES	I-cell_type
cells	E-cell_type
were	O
cultured	O
on	O
mouse	B-cell_type
S17	I-cell_type
bone	I-cell_type
marrow	I-cell_type
stromal	I-cell_type
cell	E-cell_type
layers	S-x
to	O
derive	O
cystic	B-x
bodies	E-x
.	O

Thus	O
,	O
uptake	O
of	O
E.	B-y
coli	E-y
Bioparticles®	O
by	O
macrophages	S-cell_type
is	O
indicative	O
of	O
active	O
ingestion	O
.	O
Macrophages	S-cell_type
,	O
as	O
effector	B-cell_type
cells	E-cell_type
,	O
play	O
a	O
key	O
role	O
in	O
the	O
inflammatory	O
response	O
.	O

Representative	O
ES	B-cell_type
cell	E-cell_type
colonies	O
,	O
cystic	B-x
bodies	E-x
,	O
methocult	O
colonies	O
,	O
and	O
derivative	O
macrophages	S-cell_type
are	O
shown	O
with	O
GFP	S-GP
expressing	O
cells	O
fluorescing	O
green	O
under	O
UV	O
illumination	O
.	O

Lentiviral	O
vector	S-x
transduced	O
hES	B-cell_type
cells	E-cell_type
expressing	O
the	O
transgene	O
GFP	S-GP
were	O
evaluated	O
similarly	O
like	O
above	O
.	O

As	O
expected	O
,	O
the	O
vector	B-x
transduced	I-x
colonies	E-x
displayed	O
green	O
fluorescence	O
due	O
to	O
the	O
presence	O
of	O
the	O
GFP	S-GP
reporter	O
gene	O
.	O

To	O
determine	O
if	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
were	O
functionally	O
normal	O
,	O
a	O
stimulation	O
assay	O
to	O
determine	O
upregulation	O
of	O
the	O
costimulatory	B-GP
molecule	I-GP
B7.1	E-GP
was	O
performed	O
.	O

Based	O
on	O
these	O
results	O
,	O
it	O
is	O
also	O
now	O
feasible	O
to	O
transduce	O
hES	S-cell_type
-	O
CD34	B-cell_type
cells	E-cell_type
with	O
anti-HIV	S-x
genes	O
such	O
as	O
inhibitory	O
siRNAs	S-GP
and	O
test	O
their	O
antiviral	S-x
efficacy	O
in	O
down	O
stream	O
differentiated	O
cells	O
such	O
as	O
macrophages	S-cell_type
which	O
are	O
among	O
the	O
primary	B-cell_type
cells	E-cell_type
that	O
need	O
to	O
be	O
protected	O
against	O
HIV-1	S-x
infection	O
.	O

To	O
determine	O
if	O
hES	S-cell_type
cell	O
derived	O
macrophages	S-cell_type
have	O
such	O
a	O
capacity	O
,	O
cells	O
were	O
stimulated	O
with	O
LPS	S-GP
.	O

To	O
evaluate	O
phagocytic	S-cell_type
function	O
,	O
fluorescently	O
labeled	O
E.	B-y
coli	E-y
Bioparticles®	O
were	O
added	O
to	O
macrophage	O
cultures	O
followed	O
by	O
FACS	O
analysis	O
.	O

Based	O
on	O
our	O
current	O
results	O
,	O
many	O
of	O
these	O
novel	O
anti-HIV	S-y
constructs	O
can	O
also	O
be	O
tested	O
in	O
hES-CD34	B-cell_type
cells	E-cell_type
for	O
their	O
potential	O
application	O
.	O

To	O
determine	O
whether	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
display	O
these	O
surface	O
markers	O
,	O
FACS	O
analysis	O
was	O
performed	O
to	O
detect	O
the	O
presence	O
of	O
CD14	S-GP
,	O
HLA-DR	S-GP
(	O
MHCII	S-GP
)	O
,	O
CD4	S-GP
,	O
CCR5	S-GP
,	O
and	O
CXCR4	S-GP
.	O

Cells	O
(	O
~106	O
)	O
were	O
placed	O
in	O
a	O
35	O
mm	O
well	O
and	O
allowed	O
to	O
adhere	O
for	O
48	O
hours	O
.	O

Cell	O
differentiation	O
protocols	O
currently	O
exist	O
for	O
the	O
derivation	O
of	O
neurons	S-cell_type
,	O
cardiomyocytes	S-cell_type
,	O
endothelial	B-cell_type
cells	E-cell_type
,	O
hematopoietic	B-cell_type
progenitor	I-cell_type
cells	E-cell_type
,	O
keratinocytes	S-cell_type
,	O
osteoblasts	S-cell_type
,	O
and	O
hepatocytes	S-cell_type
to	O
name	O
a	O
few	O
[	O
2,3,8,9	O
]	O
.	O

Since	O
lentiviral	S-y
vectors	O
have	O
been	O
shown	O
to	O
successfully	O
transduce	O
hES	B-cell_type
cells	E-cell_type
[	O
30-33	O
]	O
,	O
we	O
further	O
investigated	O
the	O
ability	O
of	O
transduced	O
hES	B-cell_type
cells	E-cell_type
to	O
differentiate	O
into	O
transgenic	O
macrophages	S-cell_type
that	O
can	O
support	O
HIV-1	S-y
infection	O
.	O

Fetal	B-x
liver	E-x
(	O
CD34	S-GP
)	O
,	O
nontransduced	O
(	O
ES	S-cell_type
)	O
,	O
and	O
vector	O
transduced	O
(	O
GFP	S-GP
ES	O
)	O
hES	B-cell_type
cell	I-cell_type
derived	I-cell_type
macrophages	E-cell_type
were	O
all	O
positive	O
for	O
the	O
monocyte/macrophage	O
marker	O
CD14	S-GP
(	O
99.3	O
%	O
,	O
88.7	O
%	O
,	O
and	O
99.2	O
%	O
,	O
respectively	O
)	O
(	O
Fig	O
2A	O
)	O
.	O

Other	O
recent	O
studies	O
demonstrated	O
successful	O
engraftment	O
of	O
primary	O
and	O
secondary	O
recipients	O
with	O
hES	O
cell	O
derived	O
hematopoietic	B-cell_type
cells	E-cell_type
in	O
both	O
immunodeficient	O
mice	S-y
and	O
in	O
vivo	O
fetal	S-x
sheep	S-y
models	O
adding	O
further	O
support	O
that	O
any	O
obstacles	O
could	O
be	O
overcome	O
[	O
23,54,55	O
]	O
.	O

A	O
primary	O
goal	O
of	O
many	O
ongoing	O
studies	O
is	O
to	O
introduce	O
an	O
effective	O
anti-HIV	S-y
gene	O
into	O
hematopoietic	B-cell_type
stem	I-cell_type
cells	E-cell_type
[	O
16-18	O
]	O
.	O

These	O
cells	O
have	O
the	O
capacity	O
to	O
give	O
rise	O
to	O
mature	O
cells	O
and	O
tissues	O
that	O
arise	O
from	O
all	O
three	O
germ	B-x
layers	E-x
during	O
embryonic	S-x
development	O
[	O
2-4	O
]	O
.	O

Many	O
novel	O
applications	O
can	O
be	O
foreseen	O
for	O
hES	B-cell_type
cells	E-cell_type
in	O
infectious	O
disease	O
research	O
.	O

The	O
general	O
vector	O
titers	O
were	O
1	O
×	O
107	O
and	O
the	O
multiplicity	O
of	O
infection	O
was	O
10	O
.	O

However	O
,	O
the	O
number	O
of	O
cells	O
that	O
can	O
be	O
obtained	O
for	O
manipulations	O
is	O
not	O
unlimited	O
.	O

These	O
values	O
represent	O
a	O
significant	O
upregulation	O
of	O
B7.1	S-GP
for	O
all	O
three	O
macrophage	O
populations.Figure	O
3Functional	O
analysis	O
of	O
hES	B-cell_type
cell	I-cell_type
derived	I-cell_type
macrophages	E-cell_type
for	O
B7.1	S-GP
costimulatory	O
molecule	O
upregulation	O
and	O
phagocytosis	O
of	O
E.	B-y
coli	E-y
particles	O
:	O
A	O
)	O
Mature	O
macrophages	S-cell_type
were	O
stimulated	O
with	O
LPS	S-GP
to	O
determine	O
B7.1	S-GP
upregulation	O
.	O

Similarly	O
,	O
although	O
the	O
hES-CD34	B-cell_type
cells	E-cell_type
were	O
shown	O
to	O
have	O
lymphoid	B-cell_type
progenitor	E-cell_type
capacity	O
,	O
only	O
B	B-cell_type
cell	E-cell_type
and	O
natural	B-cell_type
killer	I-cell_type
(	I-cell_type
NK	I-cell_type
)	I-cell_type
cel	E-cell_type
l	O
differentiation	O
has	O
been	O
examined	O
so	O
far	O
[	O
21,28	O
]	O
.	O

Isotype	O
control	O
is	O
shown	O
in	O
the	O
left	O
panel	O
.	O

As	O
assessed	O
by	O
FACS	O
analysis	O
,	O
the	O
hES	S-cell_type
-	O
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
displayed	O
characteristic	O
cell	O
surface	O
markers	O
CD14	S-GP
,	O
CD4	S-GP
,	O
CCR5	S-GP
,	O
CXCR4	S-GP
,	O
and	O
HLA-DR	S-GP
suggesting	O
a	O
normal	O
phenotype	O
.	O

In	O
addition	O
,	O
a	O
number	O
of	O
cellular	O
molecules	O
that	O
aid	O
in	O
HIV-1	S-y
infection	O
such	O
as	O
cellular	O
receptors	O
and	O
coreceptors	O
CD4	S-GP
,	O
CCR5	S-GP
and	O
CXCR4	S-GP
have	O
also	O
been	O
successfully	O
tested	O
in	O
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
and	O
T	B-cell_type
cells	E-cell_type
[	O
16,18,38	O
]	O
.	O

These	O
constructs	O
include	O
anti-HIV	B-GP
ribozymes	E-GP
,	O
RNA	O
decoys	O
,	O
transdominant	O
proteins	O
,	O
bacterial	O
toxins	O
,	O
anti-sense	O
nucleic	O
acids	O
,	O
and	O
most	O
recently	O
siRNAs	O
[	O
36-50	O
]	O
.	O

A	O
requirement	O
for	O
successful	O
cellular	O
and	O
HIV-1	S-y
gene	O
therapy	O
is	O
that	O
mature	B-cell_type
end	I-cell_type
stage	I-cell_type
cells	E-cell_type
derived	O
from	O
CD34	B-cell_type
progenitor	I-cell_type
cells	E-cell_type
be	O
phenotypically	O
and	O
functionally	O
normal	O
to	O
maintain	O
and	O
restore	O
the	O
body	O
's	O
immunological	O
function	O
.	O

Gene	O
therapy	O
through	O
intracellular	O
immunization	O
offers	O
a	O
promising	O
alternative	O
approach	O
and	O
possible	O
supplement	O
to	O
current	O
HAART	O
therapy	O
[	O
12-14	O
]	O
.	O

Generation	O
of	O
the	O
pseudotyped	O
vector	O
in	O
293T	B-cell_type
cells	E-cell_type
and	O
its	O
concentration	O
by	O
ultracentrifugation	O
were	O
described	O
previously	O
[	O
30,48	O
]	O
.	O

When	O
subsequently	O
cultured	O
in	O
cytokine	O
media	O
that	O
promotes	O
macrophage	O
differentiation	O
,	O
morphologically	O
normal	O
macrophages	S-cell_type
were	O
obtained	O
with	O
hES-CD34	B-cell_type
cells	E-cell_type
similar	O
to	O
that	O
of	O
fetal	B-cell_type
liver	I-cell_type
CD34	I-cell_type
cells	E-cell_type
.	O

In	O
addition	O
to	O
antigen	O
presentation	O
and	O
phagocytosis	O
,	O
macrophages	S-cell_type
also	O
play	O
a	O
critical	O
role	O
in	O
inflammation	O
and	O
secrete	O
cytokines	O
in	O
response	O
to	O
external	O
stimuli	O
.	O

In	O
colony	O
forming	O
assays	O
using	O
semisolid	O
methylcellulose	O
medium	O
,	O
the	O
morphology	O
of	O
myelomonocytic	S-cell_type
colonies	O
derived	O
from	O
hES	B-cell_type
CD34	I-cell_type
cells	E-cell_type
appeared	O
similar	O
to	O
that	O
of	O
fetal	B-cell_type
liver	I-cell_type
CD34	I-cell_type
cells	E-cell_type
.	O

During	O
this	O
process	O
macrophages	S-cell_type
present	O
antigen	O
peptide	O
fragments	O
complexed	O
with	O
both	O
classes	O
of	O
MHC	B-GP
molecules	E-GP
and	O
deliver	O
a	O
costimulatory	O
signal	O
through	O
the	O
expression	O
of	O
B7	B-GP
molecule	E-GP
s	O
.	O

As	O
seen	O
in	O
figure	O
4A	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
IL-1	S-GP
secretion	O
between	O
the	O
three	O
sets	O
of	O
macrophages	S-cell_type
.	O

In	O
addition	O
to	O
being	O
important	O
cells	O
of	O
the	O
immune	B-x
system	E-x
,	O
macrophages	S-cell_type
are	O
among	O
the	O
major	O
target	O
cells	O
for	O
certain	O
viral	S-y
infections	O
,	O
particularly	O
for	O
HIV-1	S-y
.	O

On	O
the	O
contrary	O
,	O
the	O
levels	O
of	O
CXCR4	S-GP
,	O
a	O
chemokine	O
receptor	O
involved	O
in	O
cellular	O
homing	O
,	O
were	O
found	O
to	O
be	O
higher	O
on	O
hES	S-cell_type
-	O
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
.	O

A	O
second	O
co-stimulatory	O
molecule	O
,	O
B7.1	S-GP
is	O
present	O
at	O
low	O
basal	O
levels	O
on	O
resting	O
macrophages	S-cell_type
and	O
is	O
necessary	O
to	O
activate	O
T	B-cell_type
cells	E-cell_type
.	O

No	O
uptake	O
of	O
the	O
bacteria	O
could	O
be	O
seen	O
.	O

Derivation	O
and	O
purification	O
of	O
CD34	B-cell_type
cells	E-cell_type
from	O
hES	B-cell_type
cells	E-cell_type
Undifferentiated	O
hES	B-cell_type
cells	E-cell_type
were	O
cultured	O
on	O
S17	S-cell_line
mouse	S-y
bone	B-x
marrow	E-x
stromal	S-x
cell	O
monolayers	S-x
to	O
derive	O
cystic	B-x
bodies	E-x
containing	O
CD34+	B-cell_type
hematopoietic	I-cell_type
progenitor	I-cell_type
stem	I-cell_type
cells	E-cell_type
.	O

B	O
)	O
To	O
assess	O
phagocytic	S-cell_type
function	O
,	O
E.	B-y
coli	E-y
Bioparticles®	O
were	O
added	O
directly	O
to	O
the	O
cultured	O
macrophages	S-cell_type
.	O

As	O
a	O
first	O
step	O
towards	O
the	O
use	O
of	O
hES	B-cell_type
cells	E-cell_type
for	O
hematopoietic	S-x
stem	O
cell	O
and	O
HIV	O
gene	O
therapies	O
,	O
we	O
have	O
shown	O
here	O
that	O
phenotypically	O
and	O
functionally	O
normal	O
macrophages	S-cell_type
could	O
be	O
derived	O
from	O
hES-CD34	B-cell_type
cells	E-cell_type
.	O

Thus	O
,	O
the	O
potential	O
utility	O
of	O
hES	B-cell_type
derived	I-cell_type
CD34	I-cell_type
hematopoietic	I-cell_type
cells	E-cell_type
for	O
HIV-1	S-y
gene	O
therapy	O
can	O
be	O
evaluated	O
.	O

Surface	O
expression	O
of	O
HLA-DR	S-GP
was	O
observed	O
at	O
similar	O
levels	O
between	O
macrophages	S-cell_type
derived	O
from	O
fetal	B-cell_type
liver	I-cell_type
CD34	I-cell_type
cells	E-cell_type
(	O
99.6	O
%	O
)	O
,	O
nontransduced	O
hES	B-cell_type
cells	E-cell_type
(	O
92.8	O
%	O
)	O
,	O
and	O
transduced	O
hES	B-cell_type
cells	E-cell_type
(	O
98.2	O
%	O
)	O
(	O
Fig	O
2A	O
)	O
.	O

These	O
results	O
were	O
found	O
to	O
be	O
consistent	O
in	O
replicative	O
experiments	O
.	O

Due	O
to	O
the	O
extensive	O
ability	O
for	O
hES	B-cell_type
cells	E-cell_type
to	O
self-renew	O
,	O
large	O
numbers	O
of	O
differentiated	O
cells	O
can	O
be	O
derived	O
so	O
that	O
infection	O
studies	O
and	O
evaluation	O
tests	O
can	O
be	O
carried	O
out	O
in	O
a	O
more	O
standardized	O
way	O
.	O

Non-stimulated	O
supernatants	O
were	O
also	O
analyzed	O
for	O
basal	O
levels	O
of	O
cytokine	O
secretion	O
.	O

Isotype	O
control	O
staining	O
was	O
used	O
to	O
determine	O
background	O
levels	O
.	O

Fetal	B-x
liver	E-x
derived	O
CD34+	B-cell_type
cells	E-cell_type
as	O
well	O
as	O
nontransduced	O
and	O
transduced	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
were	O
evaluated	O
in	O
parallel	O
.	O

The	O
transgenic	O
hES	B-cell_type
cells	E-cell_type
also	O
gave	O
rise	O
to	O
macrophages	S-cell_type
with	O
normal	O
phenotypic	O
and	O
functional	O
characteristics	O
indicating	O
no	O
vector	O
mediated	O
adverse	O
effects	O
during	O
differentiation.ConclusionPhenotypically	O
normal	O
and	O
functionally	O
competent	O
macrophages	S-cell_type
could	O
be	O
derived	O
from	O
hES	S-cell_type
-	O
CD34	B-cell_type
cells	E-cell_type
.	O

As	O
compared	O
to	O
fetal	B-cell_type
liver	I-cell_type
CD34	I-cell_type
cell	I-cell_type
derived	I-cell_type
macrophages	E-cell_type
,	O
hES	B-cell_type
cell	I-cell_type
derived	I-cell_type
macrophages	E-cell_type
displayed	O
a	O
higher	O
level	O
of	O
expression	O
of	O
CXCR4	S-GP
.	O

Levels	O
of	O
virus	S-y
increased	O
up	O
to	O
15	O
days	O
similar	O
to	O
non-	O
hES	S-cell_type
derived	O
macrophages	S-cell_type
showing	O
that	O
the	O
initial	O
viral	S-y
input	O
was	O
amplified	O
in	O
productive	O
viral	S-y
infection	O
.	O

The	O
transduction	O
efficiency	O
was	O
about	O
50	O
%	O
.	O

AIDS	O
is	O
a	O
potential	O
disease	O
that	O
can	O
benefit	O
from	O
exploiting	O
hES	B-cell_type
cells	E-cell_type
for	O
cell	O
replacement	O
therapy	O
as	O
they	O
have	O
the	O
capacity	O
to	O
differentiate	O
into	O
various	O
hematopoietic	B-cell_type
cells	E-cell_type
.	O

Derivation	O
of	O
macrophages	S-cell_type
from	O
hES	O
cell	O
derived	O
and	O
human	B-cell_type
fetal	I-cell_type
CD34	I-cell_type
cells	E-cell_type
CD34	B-cell_type
cells	E-cell_type
were	O
cultured	O
initially	O
in	O
semisolid	O
media	O
to	O
derive	O
myelomonocytic	B-x
colonies	E-x
followed	O
by	O
liquid	O
culture	O
in	O
cytokine	O
supplemented	O
media	O
as	O
described	O
below	O
.	O

When	O
cultured	O
on	O
irradiated	O
S17	B-cell_type
mouse	I-cell_type
bone	I-cell_type
marrow	I-cell_type
stromal	I-cell_type
cells	E-cell_type
,	O
both	O
nontransduced	O
and	O
transduced	O
hES	B-cell_type
cells	E-cell_type
developed	O
into	O
embryonic	B-x
cystic	I-x
bodies	E-x
(	O
Fig	O
1A	O
)	O
.	O

Purified	O
CD34+	B-cell_type
progenitor	I-cell_type
cells	E-cell_type
(	O
~2.5	O
×	O
105	O
to	O
4.0	O
×	O
105	O
)	O
were	O
placed	O
directly	O
into	O
Methocult	O
semisolid	O
medium	O
(	O
Stem	O
Cell	O
Technologies	O
,	O
Vancouver	O
,	O
BC	O
)	O
,	O
mixed	O
,	O
and	O
cultured	O
in	O
35	O
mm	O
plates	O
.	O

In	O
this	O
regard	O
,	O
progress	O
has	O
been	O
made	O
in	O
deriving	O
CD34	B-cell_type
cells	E-cell_type
from	O
hES	B-cell_type
cells	E-cell_type
(	O
hES-CD34	S-cell_type
)	O
.	O

Therefore	O
,	O
deriving	O
CD34	B-cell_type
cells	E-cell_type
for	O
therapeutic	O
and	O
investigative	O
purposes	O
from	O
hES	B-cell_type
cells	E-cell_type
with	O
unlimited	O
growth	O
potential	O
has	O
the	O
advantage	O
of	O
a	O
consistent	O
and	O
uniform	O
source	O
.	O

Cystic	B-x
body	E-x
derived	O
CD34	B-cell_type
cells	E-cell_type
were	O
purified	O
by	O
positive	O
selection	O
with	O
antibody	O
conjugated	O
magnetic	O
beads	O
and	O
placed	O
in	O
methocult	O
media	O
to	O
obtain	O
myelomonocytic	B-x
colonies	E-x
.	O

Derivation	O
of	O
macrophages	S-cell_type
from	O
hES	B-cell_type
cells	E-cell_type
Undifferentiated	O
hES	O
cell	O
colonies	S-x
grown	O
in	O
media	O
supplemented	O
with	O
4	O
ng/ml	O
bFGF	S-GP
displayed	O
normal	O
morphology	O
of	O
pluripotent	O
human	S-y
embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
with	O
tight	O
and	O
discreet	O
borders	O
on	O
the	O
MEF	S-cell_type
feeder	B-x
layers	E-x
(	O
Fig	O
1A	O
)	O
.	O

As	O
observed	O
in	O
Fig	O
2A	O
,	O
both	O
nontransduced	O
and	O
transduced	O
hES	O
cell	O
derived	O
macrophages	S-cell_type
expressed	O
all	O
of	O
these	O
markers	O
with	O
some	O
differences	O
in	O
their	O
levels	O
of	O
expression	O
.	O

First	O
,	O
one	O
has	O
to	O
demonstrate	O
that	O
hES-CD34	B-cell_type
cells	E-cell_type
can	O
give	O
rise	O
to	O
macrophages	S-cell_type
and	O
helper	B-cell_type
T	I-cell_type
cells	E-cell_type
which	O
are	O
the	O
main	O
cells	O
that	O
need	O
to	O
be	O
protected	O
against	O
HIV	S-y
infection	O
.	O

Here	O
we	O
evaluated	O
the	O
susceptibility	O
of	O
hES	S-cell_type
-	O
CD34	S-GP
cell	O
derived	O
macrophages	S-cell_type
to	O
be	O
productively	O
infected	O
with	O
HIV-1	S-y
.	O

B	O
)	O
Isotype	O
controls	O
for	O
PE	O
and	O
PE-CY5	O
antibodies	O
.	O

Isolated	O
CD34	B-cell_type
hematopoietic	I-cell_type
progenitor	I-cell_type
stem	I-cell_type
cells	E-cell_type
were	O
then	O
analyzed	O
by	O
FACS	O
as	O
mentioned	O
above	O
to	O
determine	O
cell	O
purity	O
.	O

Background	O
Human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
provide	O
access	O
to	O
the	O
earliest	O
stages	O
of	O
human	S-y
development	O
and	O
may	O
serve	O
as	O
a	O
source	O
of	O
specialized	O
cells	O
for	O
regenerative	O
medicine	O
.	O

After	O
40	O
d	O
of	O
coculture	O
,	O
cells	O
were	O
harvested	O
and	O
sorted	O
by	O
FACS	O
for	O
CD73	S-GP
,	O
a	O
surface	S-cellcomponent
marker	O
expressed	O
in	O
adult	O
MSCs	S-cell_type
[	O
5	O
]	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
high	O
purity	O
,	O
unlimited	O
availability	O
,	O
and	O
multipotentiality	O
of	O
hESMPCs	S-cell_type
will	O
provide	O
the	O
basis	O
for	O
future	O
therapeutic	O
efforts	O
using	O
these	O
cells	O
in	O
preclinical	O
animal	O
models	O
of	O
disease	O
.	O

After	O
28	O
d	O
in	O
culture	O
,	O
more	O
than	O
50	O
%	O
of	O
all	O
cells	O
exhibited	O
robust	O
staining	O
for	O
Alcian	O
Blue	O
,	O
a	O
marker	O
specific	O
for	O
extracellular	B-GP
matrix	I-GP
proteoglycans	E-GP
.	O

Previous	O
studies	O
have	O
demonstrated	O
the	O
derivation	O
of	O
neural	B-cell_type
cells	E-cell_type
[	O
1–3	O
]	O
,	O
hematopoietic	S-x
[	O
17	O
]	O
and	O
endothelial	S-x
lineages	O
[	O
18	O
]	O
,	O
and	O
cardiomyocytes	S-cell_type
[	O
19	O
]	O
from	O
hESCs	S-cell_type
.	O

All	O
other	O
immunocytochemical	O
analyses	O
were	O
performed	O
after	O
fixation	O
in	O
4	O
%	O
paraformaldehyde	O
and	O
0.15	O
%	O
picric	O
acid	O
,	O
followed	O
by	O
permeabilization	O
in	O
0.3	O
%	O
Triton	O
X100	O
.	O

Although	O
generation	O
of	O
skeletal	B-cell_type
muscle	I-cell_type
cells	E-cell_type
from	O
adult	O
MSCs	S-cell_type
remains	O
controversial	O
,	O
we	O
tested	O
whether	O
hESMPCs	S-cell_type
exhibit	O
this	O
potential	O
.	O

Chondrocytic	S-cell_type
DifferentiationDifferentiation	O
of	O
hESMPCs	S-cell_type
was	O
induced	O
in	O
pellet	O
culture	O
[	O
5	O
]	O
by	O
exposure	O
to	O
10	O
ng/ml	O
TGF-β3	S-GP
(	O
R	O
&	O
D	O
Systems	O
,	O
Minneapolis	O
,	O
Minnesota	O
,	O
United	O
States	O
)	O
and	O
200	O
μM	O
ascorbic	O
acid	O
(	O
Sigma	O
)	O
in	O
alpha	O
MEM	O
medium	O
containing	O
10	O
%	O
FBS	O
for	O
3–4	O
wk	O
.	O

Mesenchymal	S-x
differentiation	O
was	O
induced	O
by	O
plating	O
10	O
×	O
103	O
to	O
25	O
×	O
103	O
cells/cm2	O
on	O
a	O
monolayer	O
of	O
OP9	B-cell_line
cell	E-cell_line
s	O
in	O
the	O
presence	O
of	O
20	O
%	O
heat-inactivated	O
FBS	O
in	O
alpha	O
MEM	O
medium	O
.	O

More	O
rapid	O
myogenic	S-x
differentiation	O
was	O
obtained	O
in	O
the	O
presence	O
of	O
24-h-conditioned	O
medium	O
from	O
the	O
murine	B-cell_type
myoblastic	I-cell_type
cell	E-cell_type
line	O
C2C12	S-cell_line
previously	O
induced	O
to	O
form	O
myotubes	S-cellcomponent
[	O
14	O
]	O
.	O

A	O
Venn	O
diagram	O
was	O
generated	O
to	O
visualize	O
overlap	O
in	O
gene	O
expression	O
.	O

Adipocytic	S-cell_type
differentiation	O
of	O
hESMPCs	S-cell_type
was	O
induced	O
under	O
conditions	O
described	O
previously	O
for	O
primary	O
adult	O
MSCs	S-cell_type
[	O
5	O
]	O
.	O

Data	O
were	O
confirmed	O
in	O
hESMPC-H1.3	S-cell_line
,	O
-	O
H1.4	S-cell_line
,	O
and	O
-	O
H9.1	S-cell_line
(	O
hESMPC-H1.1	S-cell_line
and	O
-	O
H1.2	S-cell_line
were	O
not	O
tested	O
)	O
.	O

In	O
contrast	O
,	O
hESCs	S-cell_type
could	O
provide	O
an	O
unlimited	O
number	O
of	O
specialized	O
cells	O
.	O

PCR	O
conditions	O
were	O
optimized	O
and	O
linear	O
amplification	O
range	O
was	O
determined	O
for	O
each	O
primer	O
by	O
varying	O
annealing	O
temperature	O
and	O
cycle	O
number	O
.	O

Chondrocytic	S-cell_type
differentiation	O
was	O
achieved	O
using	O
the	O
pellet	O
culture	O
system	O
[	O
5	O
]	O
.	O

Human	S-y
cell	O
contribution	O
to	O
myotubes	S-cellcomponent
in	O
coculture	O
was	O
confirmed	O
by	O
expression	O
of	O
human	S-y
muscle	S-x
-specific	O
transcripts	O
such	O
as	O
MyoD	S-GP
,	O
myosin	B-GP
heavy	I-GP
chain	I-GP
IIa	E-GP
,	O
and	O
myogenin	S-GP
(	O
data	O
not	O
shown	O
)	O
.	O

Such	O
in	O
vivo	O
studies	O
will	O
also	O
be	O
required	O
to	O
properly	O
assess	O
the	O
safety	O
profile	O
of	O
these	O
cells	O
.	O

Cell	O
Culture	O
and	O
FACSUndifferentiated	O
hESCs	S-cell_type
,	O
H1	S-cell_line
(	O
WA-01	S-cell_line
,	O
XY	O
,	O
passages	O
40–65	O
)	O
and	O
H9	S-cell_line
(	O
WA-09	S-cell_line
,	O
XX	O
,	O
passages	O
35–45	O
)	O
,	O
were	O
cultured	O
on	O
mitotically	O
inactivated	O
mouse	B-cell_type
embryonic	I-cell_type
fibroblasts	E-cell_type
(	O
Specialty	O
Media	O
,	O
Phillipsburg	O
,	O
New	O
Jersey	O
,	O
United	O
States	O
)	O
and	O
maintained	O
under	O
growth	O
conditions	O
and	O
passaging	O
techniques	O
described	O
previously	O
[	O
3	O
]	O
.	O

Further	O
statistical	O
analyses	O
were	O
performed	O
as	O
described	O
below	O
.	O

However	O
,	O
some	O
of	O
the	O
lines	O
(	O
e.g.	O
,	O
hESMPC9.1	S-cell_line
)	O
exhibited	O
a	O
tendency	O
of	O
spontaneous	O
osteogenic	S-x
differentiation	O
after	O
long-term	O
propagation	O
.	O

We	O
used	O
a	O
Bayesian	O
extension	O
to	O
the	O
standard	O
t-test	O
[	O
12	O
]	O
to	O
assess	O
this	O
difference	O
.	O

Numerous	O
known	O
MSC	O
markers	O
were	O
included	O
in	O
the	O
list	O
of	O
412	O
genes	O
,	O
such	O
as	O
the	O
mesenchymal	B-cell_type
stem	I-cell_type
cell	E-cell_type
protein	O
DSC54	S-GP
(	O
13.9-fold	O
increase	O
,	O
p	O
<	O
0.001	O
)	O
,	O
neuropilin	B-GP
1	E-GP
(	O
30.4-fold	O
increase	O
,	O
p	O
<	O
0.001	O
)	O
,	O
hepatocyte	B-GP
growth	I-GP
factor	E-GP
(	O
48.1-fold	O
increase	O
,	O
p	O
<	O
0.001	O
)	O
,	O
forkhead	B-GP
box	I-GP
D1	E-GP
(	O
14.8-fold	O
increase	O
,	O
p	O
<	O
0.001	O
)	O
,	O
and	O
notch	B-GP
homolog	I-GP
2	E-GP
(	O
2.9-fold	O
increase	O
,	O
p	O
<	O
0.001	O
)	O
.	O

An	O
average	O
of	O
5	O
%	O
CD73+	B-cell_type
cell	E-cell_type
s	O
was	O
obtained	O
from	O
the	O
mixed	O
culture	O
of	O
OP9	S-cell_line
and	O
differentiated	O
hESC	O
progeny	O
.	O

Known	O
markers	O
of	O
MSCs	S-cell_type
,	O
such	O
as	O
mesenchymal	B-cell_type
stem	I-cell_type
cell	E-cell_type
protein	O
DSC54	S-GP
,	O
were	O
all	O
included	O
within	O
the	O
579	O
shared	O
transcripts	O
.	O

In	O
this	O
study	O
,	O
we	O
present	O
techniques	O
for	O
the	O
generation	O
and	O
purification	O
of	O
mesenchymal	B-cell_type
precursors	E-cell_type
from	O
hESCs	S-cell_type
and	O
their	O
directed	O
differentiation	O
in	O
vitro	O
into	O
various	O
mesenchymal	B-cell_type
derivatives	E-cell_type
,	O
including	O
skeletal	B-cell_type
myoblasts	E-cell_type
.	O

Based	O
on	O
this	O
analysis	O
,	O
1,280	O
transcripts	O
were	O
selectively	O
expressed	O
in	O
hESMPC-H1.2	S-cell_line
,	O
932	O
transcripts	O
in	O
hESMPC-H9.1	S-cell_line
,	O
and	O
1,218	O
transcripts	O
in	O
primary	O
adult	O
MSCs	S-cell_type
.	O

The	O
successful	O
isolation	O
of	O
human	B-cell_type
ES	I-cell_type
cells	E-cell_type
(	O
hESCs	S-cell_type
)	O
has	O
raised	O
the	O
hope	O
that	O
these	O
cells	O
may	O
provide	O
a	O
universal	O
tissue	O
source	O
to	O
treat	O
many	O
human	S-y
diseases	O
.	O

Chondrocytic	S-cell_type
differentiation	O
was	O
confirmed	O
by	O
the	O
gene	O
expression	O
of	O
collagen	B-GP
II	E-GP
and	O
aggrecan	S-GP
,	O
two	O
components	O
of	O
extracellular	B-cellcomponent
matrix	E-cellcomponent
selectively	O
expressed	O
by	O
chondrocytes	S-cell_type
,	O
using	O
RT-PCR	O
(	O
Figure	O
2B	O
)	O
.	O

CytochemistryImmunocytochemistry	O
for	O
all	O
surface	O
markers	O
was	O
performed	O
on	O
live	O
cells	O
.	O

We	O
did	O
not	O
detect	O
markers	O
of	O
undifferentiated	O
hESCs	S-cell_type
,	O
such	O
as	O
Nanog	S-GP
[	O
15	O
]	O
or	O
Oct-4	S-GP
[	O
16	O
]	O
,	O
in	O
any	O
of	O
the	O
hESMPCs	S-cell_type
by	O
RT-PCR	O
(	O
see	O
Figure	O
2D	O
)	O
and	O
immunocytochemistry	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
the	O
lack	O
of	O
any	O
undifferentiated	O
ES	B-cell_type
cells	E-cell_type
in	O
hESMPC	O
cultures	O
.	O

This	O
study	O
presents	O
the	O
induction	O
of	O
paraxial	B-x
mesoderm	E-x
with	O
the	O
generation	O
of	O
multipotent	O
mesenchymal	B-cell_type
precursors	E-cell_type
.	O

Fat	B-x
granules	E-x
were	O
visualized	O
by	O
Oil	O
Red	O
O	O
staining	O
solution	O
(	O
Sigma	O
)	O
.	O

Mesenchymal	S-x
differentiation	O
of	O
hESCs	S-cell_type
(	O
lines	O
H1	S-cell_line
[	O
WA-01	S-cell_line
]	O
and	O
H9	S-cell_line
[	O
WA-09	S-cell_line
]	O
)	O
[	O
9	O
]	O
was	O
induced	O
by	O
plating	O
undifferentiated	O
hESCs	S-cell_type
on	O
a	O
monolayer	O
of	O
murine	B-cell_type
OP9	I-cell_type
stromal	I-cell_type
cells	E-cell_type
[	O
10	O
]	O
,	O
in	O
the	O
presence	O
of	O
20	O
%	O
heat-inactivated	O
FBS	O
in	O
alpha	O
MEM	O
medium	O
.	O

Mesenchymal	B-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
MSCs	S-cell_type
)	O
have	O
been	O
isolated	O
from	O
the	O
adult	O
bone	B-x
marrow	E-x
[	O
5	O
]	O
,	O
adipose	B-x
tissue	E-x
[	O
6	O
]	O
,	O
and	O
dermis	S-x
and	O
other	O
connective	B-x
tissues	E-x
[	O
7	O
]	O
.	O

Polyclonal	O
antibodies	O
used	O
were	O
MyoD	S-GP
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Santa	O
Cruz	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
nestin	S-GP
(	O
gift	O
from	O
R.	O
McKay	O
)	O
;	O
monoclonal	O
antibodies	O
were	O
vimentin	S-GP
,	O
alpha	B-GP
smooth	I-GP
muscle	I-GP
actin	E-GP
,	O
fast-switch	B-GP
myosin	E-GP
,	O
pan-cytokeratin	S-GP
(	O
all	O
from	O
Sigma	O
)	O
,	O
and	O
human	B-GP
nuclear	I-GP
antigen	E-GP
(	O
Chemicon	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O
Alkaline	B-GP
phosphatase	E-GP
reaction	O
was	O
performed	O
using	O
a	O
commercially	O
available	O
kit	O
(	O
Kit-86	O
;	O
Sigma	O
)	O
and	O
the	O
mineral	O
was	O
stained	O
with	O
silver	O
nitrate	O
according	O
to	O
the	O
von	O
Kossa	O
method	O
.	O

Appearance	O
of	O
cells	O
harboring	O
fat	B-cellcomponent
granules	E-cellcomponent
was	O
observed	O
after	O
10–14	O
d	O
in	O
culture	O
.	O

Our	O
isolation	O
method	O
for	O
mesenchymal	B-cell_type
precursors	E-cell_type
is	O
the	O
first	O
example	O
,	O
to	O
our	O
knowledge	O
,	O
of	O
efficiently	O
deriving	O
structures	O
of	O
the	O
paraxial	B-x
mesoderm	E-x
from	O
ES	B-cell_type
cells	E-cell_type
,	O
and	O
further	O
highlights	O
the	O
potential	O
of	O
hESCs	S-cell_type
for	O
basic	O
biology	O
and	O
regenerative	O
medicine	O
.	O

Furthermore	O
,	O
our	O
system	O
also	O
offers	O
a	O
novel	O
platform	O
to	O
study	O
basic	O
mechanisms	O
of	O
mesodermal	O
induction	O
and	O
differentiation	O
during	O
early	O
human	O
development	O
.	O

At	O
day	O
28	O
,	O
Alizarin	O
Red	O
staining	O
was	O
detected	O
in	O
approximately	O
70	O
%	O
of	O
all	O
cells	O
.	O

Adipocytic	S-cell_type
Differentiation	O
hESMPCs	S-cell_type
are	O
grown	O
to	O
confluence	O
followed	O
by	O
exposure	O
to	O
1	O
mM	O
dexamethasone	O
,	O
10	O
μg/ml	O
insulin	O
,	O
and	O
0.5	O
mM	O
isobutylxanthine	O
(	O
all	O
from	O
Sigma	O
,	O
St.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
in	O
alpha	O
MEM	O
medium	O
containing	O
10	O
%	O
FBS	O
for	O
2–4	O
wk	O
.	O

Of	O
the	O
579	O
genes	O
,	O
412	O
of	O
them	O
were	O
significantly	O
different	O
,	O
at	O
a	O
false	O
discovery	O
rate	O
cutoff	O
of	O
0.05	O
.	O

Flow-activated	O
cell	O
sorting	O
(	O
FACS	O
)	O
(	O
CD73	S-GP
-PE	O
;	O
PharMingen	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
was	O
performed	O
on	O
a	O
MoFlo	O
(	O
Cytomation	O
,	O
Fort	O
Collins	O
,	O
Colorado	O
,	O
United	O
States	O
)	O
.	O

Direct	O
coculture	O
of	O
hESMPCs	S-cell_type
with	O
C2C12	B-cell_line
cells	E-cell_line
led	O
to	O
the	O
formation	O
of	O
hESMPC-derived	O
myotubes	S-cell_type
,	O
as	O
visualized	O
by	O
expression	O
of	O
human	B-GP
nuclear	I-GP
antigen	E-GP
(	O
Figure	O
3B	O
)	O
,	O
similar	O
to	O
those	O
formed	O
by	O
host	O
C2C12	B-cell_line
cells	E-cell_line
.	O

To	O
further	O
characterize	O
hESMPCs	S-cell_type
,	O
we	O
performed	O
genome-wide	O
expression	O
analysis	O
using	O
oligonucleotide	O
arrays	O
(	O
Affymetrix	O
U133A	O
)	O
.	O

CD73+	B-cell_type
cell	E-cell_type
s	O
were	O
replated	O
in	O
the	O
absence	O
of	O
stromal	B-cell_type
feeders	E-cell_type
on	O
tissue	O
culture	O
plates	O
and	O
expanded	O
in	O
alpha	O
MEM	O
medium	O
with	O
20	O
%	O
FBS	O
for	O
7–14	O
d.	O
We	O
next	O
established	O
the	O
membrane	S-cellcomponent
antigen	O
profile	O
of	O
the	O
resulting	O
population	O
of	O
flat	O
spindle-like	O
cells	O
.	O

Data	O
were	O
analyzed	O
using	O
MAS5.0	O
(	O
Affymetrix	O
)	O
software	O
.	O

PCR	O
products	O
were	O
identified	O
by	O
size	O
,	O
and	O
identity	O
was	O
confirmed	O
by	O
DNA	O
sequencing	O
.	O

Alcian	O
Blue	O
(	O
Sigma	O
)	O
was	O
used	O
to	O
detect	O
extracellular	B-GP
matrix	I-GP
proteoglycans	E-GP
in	O
chondrogenic	S-x
cultures	O
.	O

The	O
cells	O
were	O
negative	O
for	O
hematopoietic	S-x
markers	O
such	O
as	O
CD34	S-GP
,	O
CD45	S-GP
,	O
and	O
CD14	S-GP
.	O

One	O
concern	O
for	O
the	O
clinical	O
application	O
of	O
hESC-derived	O
progeny	S-cell_type
in	O
regenerative	O
medicine	O
is	O
the	O
risk	O
of	O
teratoma	S-x
formation	O
due	O
to	O
the	O
presence	O
of	O
residual	O
undifferentiated	O
ES	B-cell_type
cells	E-cell_type
among	O
the	O
differentiated	O
progeny	S-cell_type
.	O

Monoclonal	O
antibodies	O
VCAM	S-GP
,	O
STRO-1	S-GP
,	O
ICAM-1	S-GP
(	O
CD54	S-GP
)	O
,	O
CD105	S-GP
,	O
CD29	S-GP
,	O
and	O
MF20	S-GP
were	O
from	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
(	O
University	O
of	O
Iowa	O
,	O
Iowa	O
City	O
,	O
Iowa	O
,	O
United	O
States	O
)	O
;	O
CD73	S-GP
,	O
CD44	S-GP
,	O
and	O
ALCAM	S-GP
(	O
CD166	S-GP
)	O
were	O
from	O
BD	O
Biosciences	O
Pharmingen	O
(	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Directed	O
differentiation	O
of	O
hESCs	S-cell_type
into	O
somatic	B-cell_type
stem-cell-like	I-cell_type
precursors	E-cell_type
represents	O
a	O
substantial	O
advancement	O
in	O
harnessing	O
the	O
developmental	O
potential	O
of	O
hESCs	S-cell_type
.	O

These	O
findings	O
support	O
the	O
immunocytochemical	O
data	O
and	O
suggest	O
that	O
hESMPCs	S-cell_type
and	O
primary	O
MSCs	S-cell_type
are	O
highly	O
related	O
.	O

After	O
3	O
wk	O
of	O
induction	O
,	O
more	O
than	O
70	O
%	O
of	O
the	O
cells	O
displayed	O
Oil	O
Red	O
O+	O
fat	B-cellcomponent
granules	E-cellcomponent
,	O
and	O
PPARγ	S-GP
,	O
a	O
marker	O
of	O
adipocytic	S-x
differentiation	O
,	O
was	O
detected	O
by	O
RT-PCR	O
.	O

Throughout	O
these	O
studies	O
,	O
human	B-cell_type
adult	I-cell_type
MSCs	E-cell_type
and	O
foreskin	B-cell_type
fibroblasts	E-cell_type
were	O
used	O
as	O
positive	O
and	O
negative	O
controls	O
,	O
respectively	O
.	O

These	O
data	O
demonstrate	O
that	O
hESMPCs	S-cell_type
can	O
give	O
rise	O
to	O
mesenchymal	B-cell_type
derivatives	E-cell_type
typically	O
obtained	O
from	O
primary	O
adult	O
MSCs	S-cell_type
,	O
as	O
well	O
as	O
to	O
cells	O
expressing	O
markers	O
of	O
skeletal	B-x
muscle	E-x
.	O

We	O
calculate	O
that	O
under	O
these	O
conditions	O
a	O
single	O
undifferentiated	O
hESC	O
yields	O
an	O
average	O
of	O
one	O
CD73+	B-cell_type
cel	E-cell_type
l	O
at	O
day	O
40	O
of	O
differentiation	O
,	O
suggesting	O
a	O
balance	O
between	O
cell	O
proliferation	O
and	O
cell	O
selection	O
.	O

Data	O
were	O
confirmed	O
in	O
hESMPC-H1.1	S-cell_line
,	O
-	O
H1.3	S-cell_line
,	O
and	O
-	O
H9.1	S-cell_line
(	O
hESMPC-H1.2	S-cell_line
and	O
-	O
H1.4	S-cell_line
were	O
not	O
tested	O
)	O
.	O

Transcripts	O
selectively	O
expressed	O
in	O
each	O
of	O
the	O
mesenchymal	S-x
cell	O
populations	O
(	O
MSC	O
,	O
hESMPC-H9.1	S-cell_line
,	O
and	O
hESMPC-H1.2	S-cell_line
)	O
were	O
defined	O
as	O
those	O
called	O
“	O
increased	O
”	O
by	O
the	O
MAS5.0	O
algorithm	O
in	O
each	O
of	O
three	O
comparisons	O
with	O
independent	O
samples	O
of	O
undifferentiated	O
hESCs	S-cell_type
.	O

However	O
,	O
directed	O
differentiation	O
of	O
hESCs	S-cell_type
into	O
specific	O
tissue	O
types	O
poses	O
a	O
formidable	O
challenge	O
.	O

A	O
remarkable	O
overlap	O
of	O
579	O
transcripts	O
shared	O
among	O
the	O
three	O
mesenchymal	S-x
populations	O
was	O
observed	O
(	O
Figure	O
1D	O
)	O
.	O

The	O
relative	O
fold	O
changes	O
were	O
also	O
extremely	O
large	O
in	O
many	O
of	O
the	O
cases	O
.	O

Harvesting	O
MSCs	S-cell_type
from	O
any	O
of	O
these	O
sources	O
requires	O
invasive	O
procedures	O
and	O
the	O
availability	O
of	O
a	O
suitable	O
donor	O
.	O

Primer	O
sequences	O
,	O
cycle	O
numbers	O
,	O
and	O
annealing	O
temperatures	O
are	O
provided	O
in	O
Table	O
S1.Affymetrix	O
analysisTotal	O
RNA	O
(	O
5	O
μg	O
)	O
from	O
primary	O
MSCs	S-cell_type
,	O
from	O
hESMPC-H9.1	S-cell_line
,	O
hESMPC-H1.2	S-cell_line
,	O
and	O
three	O
samples	O
of	O
undifferentiated	O
hESCs	S-cell_type
(	O
H1	S-cell_line
;	O
passages	O
42–46	O
)	O
,	O
were	O
processed	O
by	O
the	O
Memorial	O
Sloan-Kettering	O
Cancer	O
Center	O
Genomics	O
Core	O
Facility	O
and	O
hybridized	O
on	O
Affymetrix	O
(	O
Santa	O
Clara	O
,	O
California	O
,	O
United	O
States	O
)	O
U133A	O
human	S-y
oligonucleotide	O
arrays	O
.	O

They	O
were	O
also	O
negative	O
for	O
neuroectodermal	S-x
,	O
epithelial	S-x
,	O
and	O
muscle	S-x
cell	O
markers	O
including	O
nestin	S-GP
,	O
pancytokeratin	S-GP
,	O
and	O
desmin	S-GP
(	O
data	O
not	O
shown	O
)	O
.	O

Gene-Expression	O
AnalysesRT-PCR	O
analysisTotal	O
RNA	O
was	O
extracted	O
by	O
using	O
the	O
RNeasy	O
kit	O
and	O
DNase	O
I	O
treatment	O
(	O
Qiagen	O
,	O
Valencia	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

However	O
,	O
when	O
confluent	O
cells	O
were	O
maintained	O
in	O
culture	O
in	O
the	O
presence	O
or	O
absence	O
of	O
5-AzaC	O
without	O
passage	O
for	O
more	O
than	O
21	O
d	O
,	O
expression	O
of	O
specific	O
skeletal	B-x
muscle	E-x
markers	O
such	O
as	O
MyoD	S-GP
and	O
fast-switch	B-GP
myosin	E-GP
was	O
observed	O
(	O
Figure	O
3A	O
)	O
.	O

The	O
expression	O
profiles	O
of	O
hESMPC-H1.2	S-cell_line
and	O
hESMPC-H9.1	S-cell_line
were	O
compared	O
with	O
that	O
of	O
human	B-cell_type
primary	I-cell_type
adult	I-cell_type
MSCs	E-cell_type
.	O

Osteogenic	S-x
differentiation	O
was	O
induced	O
in	O
the	O
presence	O
of	O
β-glycerolphosphate	S-GP
[	O
5	O
]	O
.	O

More	O
rapid	O
induction	O
was	O
observed	O
in	O
the	O
presence	O
of	O
medium	O
conditioned	O
for	O
24	O
h	O
by	O
differentiated	O
C2C12	B-cell_type
cells	E-cell_type
.	O

MSCs	S-cell_type
are	O
characterized	O
functionally	O
by	O
their	O
ability	O
to	O
differentiate	O
into	O
mesenchymal	B-x
tissues	E-x
,	O
such	O
as	O
fat	S-x
,	O
cartilage	S-x
,	O
and	O
bone	S-x
.	O

All	O
human	S-y
ES	O
cell–derived	O
mesenchymal	B-cell_type
precursor	I-cell_type
cell	E-cell_type
(	O
hESMPC	O
)	O
lines	O
in	O
this	O
study	O
are	O
of	O
polyclonal	O
origin	O
.	O

We	O
also	O
looked	O
at	O
the	O
variance	O
of	O
the	O
expression	O
levels	O
within	O
the	O
cell	O
types	O
.	O

Osteogenic	S-x
Differentiation	O
hESMPCs	S-cell_type

In	O
addition	O
to	O
adipocytic	S-cell_type
,	O
chondrocytic	S-cell_type
,	O
and	O
osteogenic	S-cell_type
differentiation	O
,	O
reports	O
suggested	O
that	O
adult	O
MSCs	S-cell_type
can	O
form	O
skeletal	B-x
muscle	E-x
[	O
13	O
]	O
.	O

Protocols	O
are	O
currently	O
available	O
for	O
only	O
a	O
few	O
cell	O
types	O
,	O
mostly	O
of	O
neural	S-x
identity	O
[	O
1–3	O
]	O
,	O
and	O
differentiation	O
into	O
many	O
of	O
the	O
cell	O
types	O
derived	O
from	O
the	O
paraxial	B-x
mesoderm	E-x
has	O
not	O
been	O
reported	O
,	O
with	O
the	O
exception	O
of	O
a	O
recent	O
study	O
indicating	O
osteoblastic	S-x
differentiation	O
[	O
4	O
]	O
.	O

OP9	B-cell_type
cells	E-cell_type
have	O
been	O
previously	O
shown	O
to	O
induce	O
blood	B-cell_type
cel	E-cell_type
l	O
differentiation	O
from	O
mouse	B-cell_type
ES	I-cell_type
cells	E-cell_type
[	O
11	O
]	O
.	O

However	O
,	O
future	O
in	O
vivo	O
studies	O
are	O
required	O
to	O
rule	O
out	O
the	O
potential	O
of	O
these	O
cells	O
for	O
teratoma	S-x
formation	O
.	O

After	O
1	O
wk	O
of	O
coculture	O
,	O
myotubes	S-cell_type
composed	O
of	O
human	S-y
nuclei	S-cellcomponent
accounted	O
for	O
more	O
than	O
10	O
%	O
of	O
the	O
total	O
number	O
of	O
human	S-y
cells	O
present	O
,	O
and	O
each	O
human	B-cell_type
myotube	E-cell_type
was	O
composed	O
of	O
up	O
to	O
ten	O
human	S-y
nuclei	S-cellcomponent
.	O

Using	O
the	O
genes	O
that	O
were	O
selected	O
in	O
the	O
initial	O
filter	O
,	O
we	O
performed	O
a	O
statistical	O
analysis	O
on	O
the	O
expression	O
levels	O
to	O
determine	O
whether	O
the	O
genes	O
were	O
expressed	O
significantly	O
differently	O
in	O
the	O
two	O
cell	O
types	O
.	O

(	O
Figure	O
2A	O
)	O
.	O

The	O
number	O
of	O
MSCs	S-cell_type
that	O
can	O
be	O
obtained	O
from	O
a	O
single	O
donor	O
is	O
limited	O
,	O
and	O
the	O
capacity	O
of	O
these	O
cells	O
for	O
long-term	O
proliferation	O
is	O
rather	O
poor	O
.	O

Osteogenesis	S-x
was	O
demonstrated	O
by	O
specific	O
staining	O
for	O
calcium	O
deposition	O
in	O
the	O
matrix	S-cellcomponent
(	O
von	O
Kossa	O
,	O
Figure	O
2C	O
;	O
or	O
Alizarin	O
Red	O
,	O
Figure	O
S2A	O
)	O
and	O
increased	O
expression	O
of	O
bone-specific	B-GP
alkaline	I-GP
phosphatase	E-GP
and	O
bone	B-GP
sialoprotein	E-GP
at	O
day	O
28	O
of	O
treatment	O
(	O
Figures	O
2C	O
and	O
S2B	O
)	O
.	O

OP9	B-cell_line
cell	E-cell_line
s	O
were	O
maintained	O
in	O
alpha	O
MEM	O
medium	O
containing	O
20	O
%	O
fetal	S-x
bovine	S-y
serum	O
(	O
FBS	O
)	O
and	O
2	O
mM	O
L-glutamine	O
.	O

Data	O
were	O
confirmed	O
in	O
hESMPC-H1.1	S-cell_line
,	O
-	O
H1.2	S-cell_line
,	O
-	O
H1.3	S-cell_line
,	O
and	O
-	O
H9.1	S-cell_line
(	O
hESMPC-H1.4	S-cell_line
was	O
not	O
tested	O
)	O
.	O

Embryonic	B-cell_type
stem	I-cell_type
(	I-cell_type
ES	I-cell_type
)	I-cell_type
cells	E-cell_type
are	O
pluripotent	B-cell_type
cells	E-cell_type
derived	O
from	O
the	O
inner	B-x
cell	I-x
mass	E-x
of	O
the	O
blastocyst	S-x
that	O
can	O
be	O
maintained	O
in	O
culture	O
for	O
an	O
extended	O
period	O
of	O
time	O
without	O
losing	O
differentiation	O
potential	O
.	O

Housekeeping	B-GP
genes	E-GP
for	O
each	O
of	O
the	O
mesenchymal	S-x
cell	O
populations	O
were	O
eliminated	O
by	O
subtracting	O
those	O
transcripts	O
also	O
expressed	O
in	O
at	O
least	O
one	O
of	O
three	O
independent	O
samples	O
of	O
undifferentiated	O
hESCs	S-cell_type
.	O

For	O
the	O
MSCs	S-cell_type
,	O
94	O
%	O
had	O
a	O
coefficient	O
of	O
variation	O
less	O
than	O
20	O
%	O
for	O
the	O
expression	O
(	O
log	O
transformed	O
)	O
;	O
for	O
the	O
ES	S-cell_type
-derived	O
cells	O
,	O
72	O
%	O
had	O
a	O
coefficient	O
of	O
variation	O
less	O
than	O
20	O
%	O
.	O

The	O
human	S-y
identity	O
of	O
these	O
presumed	O
mesenchymal	B-cell_type
cells	E-cell_type
(	O
termed	O
hESMPC-H1.1	S-cell_line
,	O
-	O
H1.2	S-cell_line
,	O
-	O
H1.3	S-cell_line
,	O
-	O
H1.4	S-cell_line
,	O
and	O
-	O
H9.1	S-cell_line
)	O
was	O
confirmed	O
for	O
all	O
experiments	O
by	O
immunocytochemistry	O
for	O
human	B-GP
nuclear	I-GP
antigen	E-GP
to	O
rule	O
out	O
the	O
possibility	O
of	O
contamination	O
with	O
OP9	B-cell_line
cell	E-cell_line
s	O
(	O
Figure	O
S1	O
)	O
.	O

Coculture	O
of	O
hESMPCs	S-cell_type
and	O
C2C12	B-cell_type
cells	E-cell_type
was	O
carried	O
out	O
in	O
alpha	O
MEM	O
with	O
3	O
%	O
horse	S-y
serum	O
and	O
1	O
%	O
FBS	O
[	O
8	O
]	O
.	O

Table	O
S2	O
lists	O
the	O
p-values	O
from	O
the	O
test	O
,	O
the	O
mean	O
and	O
standard	O
deviation	O
of	O
the	O
expression	O
levels	O
,	O
and	O
the	O
relative	O
fold	O
change	O
of	O
all	O
412	O
genes	O
between	O
the	O
two	O
types	O
.	O

The	O
H1	S-cell_line
-	O
and	O
H9	S-cell_line
-derived	O
CD73+	B-cell_type
cell	E-cell_type
s	O
expressed	O
a	O
comprehensive	O
set	O
of	O
markers	O
that	O
are	O
considered	O
to	O
define	O
adult	O
MSCs	S-cell_type
,	O
including	O
CD105	S-GP
(	O
SH2	S-GP
)	O
,	O
STRO-1	S-GP
,	O
VCAM	S-GP
(	O
CD106	S-GP
)	O
,	O
CD29	S-GP
(	O
integrin	B-GP
β1	E-GP
)	O
,	O
CD44	S-GP
,	O
ICAM	B-GP
-1	E-GP
(	O
CD54	S-GP
)	O
,	O
ALCAM	S-GP
(	O
CD166	S-GP
)	O
,	O
vimentin	S-GP
,	O
and	O
alpha	B-GP
smooth	I-GP
muscle	I-GP
actin	E-GP
(	O
Figure	O
1B	O
and	O
1C	O
)	O
.	O

Primary	O
human	B-x
bone	I-x
marrow	E-x
–derived	O
MSCs	S-cell_type
and	O
primary	O
human	B-cell_type
foreskin	I-cell_type
fibroblasts	E-cell_type
(	O
both	O
from	O
Poietics	O
,	O
Cambrex	O
,	O
East	O
Rutherford	O
,	O
New	O
Jersey	O
,	O
United	O
States	O
)	O
were	O
grown	O
in	O
alpha	O
MEM	O
medium	O
containing	O
10	O
%	O
FBS	O
and	O
2	O
mM	O
L-glutamine	O
.	O

There	O
were	O
no	O
obvious	O
differences	O
in	O
marker	O
and	O
gene-expression	O
profile	O
or	O
in	O
differentiation	O
behavior	O
among	O
the	O
five	O
hESMPC	O
lines	O
generated	O
.	O

Myogenic	S-x
DifferentiationConfluent	O
hESMPCs	S-cell_type
were	O
maintained	O
for	O
2–3	O
wk	O
in	O
alpha	O
MEM	O
medium	O
with	O
20	O
%	O
heat-inactivated	O
FBS	O
.	O

Thus	O
,	O
it	O
becomes	O
crucial	O
to	O
develop	O
protocols	O
for	O
the	O
directed	O
differentiation	O
of	O
embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
into	O
tissue-restricted	B-cell_type
precursors	E-cell_type
.Methods	O
and	O
FindingsHere	O
,	O
we	O
present	O
culture	O
conditions	O
for	O
the	O
derivation	O
of	O
unlimited	O
numbers	O
of	O
pure	O
mesenchymal	B-cell_type
precursors	E-cell_type
from	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
and	O
demonstrate	O
multilineage	O
differentiation	O
into	O
fat	S-x
,	O
cartilage	S-x
,	O
bone	S-x
,	O
and	O
skeletal	B-cell_type
muscle	I-cell_type
cells	E-cell_type
.ConclusionOur	O
findings	O
will	O
help	O
to	O
elucidate	O
the	O
mechanism	O
of	O
mesoderm	S-x
specification	O
during	O
embryonic	S-x
stem	O
cell	O
differentiation	O
and	O
provide	O
a	O
platform	O
to	O
efficiently	O
generate	O
specialized	O
human	B-cell_type
mesenchymal	I-cell_type
cell	E-cell_type
types	O
for	O
future	O
clinical	O
applications.Lorenz	O
Studer	O
and	O
colleagues	O
describe	O
the	O
use	O
of	O
embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
to	O
derive	O
mesenchymal	B-cell_type
precursors	E-cell_type
and	O
then	O
fat	S-x
,	O
cartilage	S-x
,	O
bone	S-x
,	O
and	O
skeletal	B-cell_type
muscle	I-cell_type
cells	E-cell_type
.	O

Total	O
RNA	O
(	O
2	O
μg	O
each	O
)	O
was	O
reverse	O
transcribed	O
(	O
SuperScript	O
;	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Under	O
the	O
conditions	O
previously	O
described	O
[	O
13	O
]	O
,	O
hESMPC-H1.1	S-cell_line
and	O
-	O
H9.1	S-cell_line
did	O
not	O
yield	O
significant	O
numbers	O
of	O
MyoD+	B-cell_type
cell	E-cell_type
s	O
after	O
15–20	O
d	O
in	O
culture	O
.	O

Therefore	O
,	O
we	O
tested	O
whether	O
hESMPCs	S-cell_type
have	O
the	O
same	O
potential	O
(	O
Figure	O
2	O
)	O
.	O

Background	O
Human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hESCs	S-cell_type
)	O
offer	O
a	O
virtually	O
unlimited	O
source	O
of	O
neural	B-cell_type
cells	E-cell_type

As	O
a	O
control	O
group	O
,	O
we	O
used	O
rats	S-y
subjected	O
to	O
ischemia	O
and	O
injected	O
with	O
the	O
vehicle	O
(	O
n	O
=	O
7	O
)	O
.	O

The	O
double	O
labeling	O
was	O
always	O
confirmed	O
in	O
x-z	O
and	O
y-z	O
cross-sections	O
produced	O
by	O
the	O
orthogonal	O
projections	O
of	O
z-series	O
.	O

Statistical	O
analysisOutcome	O
measurement	O
for	O
each	O
experiment	O
was	O
reported	O
as	O
mean±SEM	O
.	O

PCR	O
amplification	O
was	O
performed	O
using	O
standard	O
procedure	O
with	O
Taq	O
Polymerase	O
.	O

Dissociated	O
hNSCs	S-cell_type
were	O
plated	O
at	O
a	O
density	O
of	O
100,000	O
cell/ml	O
in	O
Corning	O
T75	O
(	O
Invitrogen	O
)	O
culture	O
flasks	O
in	O
the	O
defined	O
media	O
together	O
with	O
the	O
growth	O
factors	O
.	O

To	O
promote	O
neuralization	O
,	O
ESCs	S-cell_type
were	O
cultured	O
in	O
a	O
defined	O
media	O
supplemented	O
with	O
morphogens	O
or	O
growth	O
factors	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
or	O
cultured	O
under	O
conditions	O
that	O
promote	O
“	O
rosettes	S-x
”	O
,	O
structures	O
morphologically	O
similar	O
to	O
the	O
developing	O
neural	B-x
tube	E-x
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

Interestingly	O
,	O
nearly	O
all	O
viable	O
cells	O
expressed	O
nestin	S-GP
,	O
the	O
early	O
neural	O
fate	O
marker	O
Sox1	S-GP
,	O
and	O
the	O
pluripotency	O
marker	O
Oct4	S-GP
.	O

The	O
self-renewal	O
property	O
of	O
the	O
hNSCs	S-cell_type
was	O
characterized	O
by	O
a	O
predominant	O
symmetrical	O
mode	O
of	O
cell	O
division	O
.	O

The	O
in	O
vitro	O
analysis	O
of	O
BrdU	O
incorporation	O
and	O
nestin	O
expression	O
indicated	O
that	O
our	O
hNSCs	S-cell_type
divide	O
predominantly	O
symmetrically	O
.	O

To	O
establish	O
the	O
baseline	O
of	O
the	O
stroke-induced	O
sensorimotor	O
deficit	O
,	O
spontaneous	O
behavior	O
of	O
rats	S-y
in	O
a	O
transparent	O
cylinder	O
was	O
videotaped	O
one	O
week	O
after	O
stroke	O
(	O
pre-transplant	O
,	O
Figure	O
4	O
)	O
.	O

The	O
population	O
doubling	O
at	O
each	O
passage	O
averaged	O
at	O
1.4±0.1	O
(	O
Figure	O
1H	O
)	O
.	O

The	O
cylinder	O
encourages	O
use	O
of	O
the	O
forelimbs	S-x
for	O
vertical	O
exploration	O
.	O

Immunostaining	O
with	O
the	O
blood	S-x
vessel	O
marker	O
,	O
GluT1	S-GP
,	O
revealed	O
dilated	O
vessels	O
in	O
the	O
infarcted	O
striatum	S-x
and	O
a	O
close	O
association	O
between	O
vessels	S-x
and	O
the	O
grafted	O
hNSCs	S-cell_type
(	O
Figure	O
3B	O
,	O
3C	O
)	O
.	O

The	O
majority	O
of	O
grafted	O
cells	O
(	O
61.2±4.7	O
%	O
)	O
migrated	O
at	O
least	O
200	O
µm	O
away	O
from	O
the	O
injection	O
site	O
and	O
penetrated	O
an	O
average	O
distance	O
of	O
806.4±49.3	O
µm	O
into	O
the	O
stroke-damaged	O
tissue	O
(	O
Figure	O
3A–C	O
)	O
.	O

These	O
2°	O
spheres	O
were	O
then	O
passaged	O
using	O
a	O
single	O
cell	O
dissociation	O
protocol	O
(	O
F	O
)	O
.	O

In	O
the	O
adult	O
lesioned	O
brain	O
,	O
the	O
grafted	O
hESC-derived	O
neural	B-cell_type
cells	E-cell_type
proliferated	O
and	O
formed	O
rosettes	S-x
[	O
14	O
]	O
,	O
teratomas	S-x
[	O
12	O
]	O
,	O
[	O
15	O
]	O
or	O
a	O
cellular	O
mass	O
that	O
induced	O
a	O
gliotic	O
host	O
response	O
whereby	O
local	O
astrocytes	S-cell_type
demarcated	O
the	O
grafts	O
[	O
16	O
]	O
.	O

Thereafter	O
oral	O
cyclosporine	O
was	O
used	O
at	O
210	O
µg/ml	O
in	O
drinking	O
water	O
until	O
euthanasia	O
.	O

BrdU	O
labeling	O
demonstrated	O
that	O
it	O
was	O
rare	O
for	O
only	O
one	O
daughter	O
cell	O
to	O
inherit	O
the	O
BrdU	O
and	O
thus	O
had	O
undergone	O
asymmetric	O
segregation	O
of	O
the	O
chromatid	S-cellcomponent
s	O
(	O
Figure	O
S2	O
)	O
.	O

Immunostaining	O
for	O
GAD	S-GP
demonstrated	O
that	O
25.1±2.3	O
%	O
of	O
grafted	O
hNSCs	S-cell_type
differentiated	O
into	O
GABAergic	B-cell_type
neurons	E-cell_type
while	O
less	O
than	O
2	O
%	O
were	O
positive	O
for	O
glutamate	S-GP
(	O
Figure	O
3J	O
,	O
K	O
)	O
.10.1371/journal.pone.0001644.g003Figure	O
3Dispersion	O
,	O
engraftment	O
and	O
differentiation	O
of	O
the	O
hNSCs	S-cell_type
in	O
stroke-lesioned	O
animals	O
.	O

(	O
E	O
)	O
Examples	O
of	O
grafted	O
SD56	B-cell_type
hNSCs	E-cell_type
showing	O
co-expression	O
of	O
hNuc	S-GP
(	O
green	O
)	O
and	O
nestin	S-GP
(	O
red	O
)	O
.	O

Therefore	O
,	O
the	O
first	O
critical	O
step	O
toward	O
developing	O
therapeutic	O
hNSCs	S-cell_type
is	O
to	O
verify	O
that	O
they	O
are	O
non-tumorigenic	O
.	O

Secondary	O
antibodies	O
raised	O
in	O
the	O
appropriate	O
hosts	O
and	O
conjugated	O
to	O
FITC	O
,	O
RITC	O
,	O
AMCA	O
,	O
CY3	O
or	O
CY5	O
chromogenes	O
(	O
Jackson	O
ImmunoResearch	O
)	O
were	O
used	O
.	O

Twenty	O
metaphase	O
cells	O
were	O
completely	O
analyzed	O
and	O
a	O
normal	O
female	S-x
chromosome	O
complement	O
was	O
found	O
(	O
46	O
,	O
XX	O
)	O
.	O

Animals	O
were	O
euthanized	O
two	O
months	O
later	O
and	O
the	O
brains	S-x
processed	O
for	O
histo-pathology	O
and	O
immunocytochemistry	O
.	O

Dissociated	O
hNSCs	S-cell_type
were	O
plated	O
at	O
a	O
density	O
of	O
106	O
cells/ml	O
in	O
control	O
(	O
media/hormone	O
mix	O
)	O
medium	O
devoid	O
of	O
any	O
growth	O
factors	O
and	O
supplemented	O
with	O
1	O
%	O
fetal	S-x
bovine	S-y
serum	O
(	O
FBS	O
)	O
on	O
poly-L-ornithine-coated	O
(	O
15	O
mg/ml	O
;	O
Sigma	O
)	O
glass	O
coverslips	O
in	O
24-well	O
Nunclon	O
culture	O
dishes	O
with	O
0.5	O
ml/well	O
.	O

The	O
cell	O
dispersion	O
was	O
measured	O
by	O
counting	O
the	O
number	O
of	O
cells	O
within	O
200	O
µm	O
distance	O
from	O
the	O
graft	O
site	O
.	O

The	O
cultures	O
were	O
then	O
passaged	O
by	O
collagenase	S-GP
cell	O
dissociation	O
every	O
7	O
DIV	O
for	O
an	O
additional	O
4	O
passages	O
(	O
Figure	O
S1	O
)	O
.	O

Positive	O
and	O
negative	O
controls	O
were	O
included	O
in	O
each	O
run	O
.	O

After	O
2	O
DIV	O
,	O
hNSCs	S-cell_type
expressed	O
transcripts	O
for	O
the	O
neural	S-x
-specific	O
genes	O
nestin	S-GP
,	O
Notch1	S-GP
and	O
neural	B-GP
cell	I-GP
adhesion	I-GP
molecule	E-GP
(	O
N-CAM	S-GP
)	O
(	O
Figure	O
2A	O
)	O
and	O
for	O
the	O
lineage	O
specific	O
markers	O
β-tubulin	B-GP
class	I-GP
III	E-GP
,	O
medium-size	B-GP
neurofilament	E-GP
(	O
NF-M	S-GP
)	O
and	O
microtubule-associated	B-GP
protein	I-GP
2	E-GP
(	O
MAP-2	S-GP
)	O
for	O
neurons	S-cell_type
,	O
GFAP	S-GP
for	O
astrocytes	S-cell_type
and	O
myelin	B-GP
basic	I-GP
protein	E-GP
(	O
MBP	S-GP
)	O
for	O
oligodendrocytes	S-cell_type
(	O
Figure	O
2A	O
)	O
.	O

*P	O
<	O
0.05	O
vs	O
pre-transplant	O
group	O
;	O
#	O
P	O
<	O
0.05	O
vs	O
vehicle	O
groups	O
.	O

To	O
determine	O
if	O
the	O
hNSCs	S-cell_type
divide	O
symmetrically	O
,	O
we	O
pulsed	O
cultures	O
with	O
the	O
thymidine	O
analog	O
,	O
bromodeoxyuridine	O
(	O
BrdU	O
)	O
,	O
after	O
plating	O
and	O
looked	O
for	O
the	O
expression	O
of	O
nestin	S-GP
in	O
the	O
progeny	S-cell_type
.	O

(	O
E	O
)	O
Photo	O
showing	O
cultures	O
double-immunostained	O
for	O
TuJ1	S-GP
(	O
green	O
)	O
and	O
nestin	S-GP
(	O
red	O
)	O
(	O
DAPI	O
,	O
blue	O
)	O
.	O

The	O
rostral	S-x
and	O
caudal	S-x
limits	O
of	O
the	O
reference	O
volume	O
were	O
determined	O
by	O
first	O
and	O
last	O
frontal	O
sections	O
containing	O
grafted	O
cells	O
.	O

Tissue	O
specific	O
stem	B-cell_type
cells	E-cell_type
,	O
however	O
,	O
self-renew	O
in	O
a	O
predominant	O
asymmetric	O
mode	O
to	O
maintain	O
them	O
selves	O
and	O
compensate	O
for	O
the	O
loss	O
of	O
differentiated	O
cells	O
due	O
to	O
disease	O
or	O
injury	O
.	O

Grafted	O
NSCs	S-cell_type
expressed	O
the	O
GABAergic	S-cell_type
marker	O
GAD65/67	S-GP
(	O
J	O
)	O
and	O
rarely	O
expressed	O
glutamate	S-GP
(	O
K	O
)	O
.	O

Enriched	O
neural	S-x
cultures	O
derived	O
from	O
mouse	S-y
[	O
42	O
]	O
and	O
monkey	S-y
ESCs	S-cell_type
[	O
43	O
]	O
have	O
produced	O
behavioral	O
improvements	O
when	O
transplanted	O
into	O
animal	O
models	O
of	O
stroke	O
and	O
brain	O
injury	O
.	O

The	O
inner	O
cores	O
of	O
these	O
grafts	O
contained	O
tumorigenic	B-cell_type
precursor	I-cell_type
cells	E-cell_type
(	O
reviewed	O
in	O
[	O
17	O
]	O
)	O
.	O

Transplantation	O
of	O
SD56	B-cell_type
hNSCs	E-cell_type
significantly	O
enhanced	O
the	O
independent	O
use	O
of	O
the	O
impaired	O
contralateral	S-x
forelimb	O
4	O
weeks	O
post	O
transplantation	O
(	O
P	O
<	O
0.05	O
vs	O
pre-transplant	O
)	O
.	O

Metaphase	O
chromosomes	S-cellcomponent
were	O
obtained	O
by	O
standard	O
chromosome	O
harvest	O
methods	O
by	O
exposure	O
to	O
Colcemid	O
at	O
0.1	O
µg/ml	O
for	O
1	O
hour	O
at	O
37°C	O
,	O
a	O
2-minute	O
exposure	O
to	O
trypsin	S-GP
/EDTA	O
,	O
hypotonized	O
with	O
0.057	O
M	O
KCl	O
and	O
fixed	O
with	O
3∶1	O
methanol	O
:	O
acetic	O
acid	O
.	O

Differences	O
between	O
the	O
groups	O
were	O
determined	O
using	O
Bonferroni	O
's	O
post	O
hoc	O
test	O
.	O

Furthermore	O
,	O
hNSCs	S-cell_type
isolated	O
under	O
these	O
conditions	O
migrated	O
toward	O
the	O
ischemia-injured	O
adult	O
brain	B-x
parenchyma	E-x
and	O
improved	O
the	O
independent	O
use	O
of	O
the	O
stroke-impaired	O
forelimb	O
two	O
months	O
post-transplantation.Conclusions/SignificanceThe	O
SD56	B-cell_type
human	I-cell_type
neural	I-cell_type
stem	I-cell_type
cells	E-cell_type
derived	O
under	O
the	O
reported	O
conditions	O
are	O
stable	O
,	O
do	O
not	O
form	O
tumors	S-x
in	O
vivo	O
and	O
enable	O
functional	O
recovery	O
after	O
stroke	O
.	O

ESCs	S-cell_type
plated	O
at	O
low	O
density	O
acquire	O
neural	O
identity	O
within	O
few	O
hours	O
after	O
plating	O
[	O
47	O
]	O
.	O

No	O
surviving	O
SD56	B-cell_type
hNSCs	E-cell_type
were	O
detected	O
in	O
the	O
flank	O
of	O
the	O
transplanted	O
animals	O
suggesting	O
that	O
the	O
grafted	O
cells	O
are	O
not	O
tumorigenic	S-x
.	O

(	O
I	O
)	O
RT-PCR	O
analysis	O
showing	O
the	O
down	O
regulation	O
of	O
the	O
pluripotency	O
transcripts	O
Oct4	S-GP
and	O
Nanog	S-GP
in	O
secondary	O
neurospheres	S-x
and	O
in	O
expanded	O
hNSCs	S-cell_type
at	O
passage	O
8	O
(	O
P8	O
)	O
.	O

Single	O
(	O
N	O
)	O
,	O
two-cell	O
stage	O
(	O
O	O
)	O
and	O
four-cell	O
stage	O
(	O
P	O
)	O
of	O
a	O
hNSC	O
proliferating	O
over	O
a	O
3-day	O
culture	O
period	O
.	O

This	O
is	O
the	O
first	O
report	O
demonstrating	O
that	O
the	O
transplantation	O
of	O
hNSCs	S-cell_type
derived	O
from	O
hESCs	S-cell_type
can	O
improve	O
neurologic	O
behavior	O
after	O
experimental	O
stroke	O
.	O

injections	O
of	O
cyclosporine	O
A	O
(	O
20	O
mg/ml	O
,	O
Sandimmune	O
,	O
Novartis	O
Pharmaceuticals	O
)	O
.	O

(	O
A	O
)	O
Differentiated	O
hNSCs	S-cell_type
expressed	O
the	O
neural	S-x
-specific	O
transcripts	O
nestin	S-GP
and	O
Notch1	S-GP
as	O
well	O
as	O
transcripts	O
:	O
for	O
neurons	S-cell_type
(	O
β-tubulin	B-GP
class	I-GP
III	E-GP
,	O
MAP-2	S-GP
,	O
NCAM	S-GP
and	O
medium-size	B-GP
neurofilament	E-GP
,	O
NF-M	S-GP
)	O
,	O
for	O
astrocytes	S-cell_type
(	O
GFAP	S-GP
)	O
and	O
for	O
oligodendrocytes	S-cell_type
(	O
MBP	S-GP
)	O
.	O

A	O
mirror	O
was	O
placed	O
behind	O
the	O
cylinder	O
so	O
that	O
the	O
forelimbs	S-x
could	O
be	O
viewed	O
at	O
all	O
times	O
.	O

The	O
viability	O
of	O
hNSCs	S-cell_type
at	O
each	O
passage	O
was	O
consistent	O
at	O
the	O
approximate	O
value	O
of	O
98	O
%	O
.	O

The	O
self-renewal	O
property	O
of	O
the	O
hNSCs	S-cell_type
was	O
characterized	O
by	O
a	O
predominant	O
symmetrical	O
mode	O
of	O
cell	O
division	O
.	O

1	O
.	O

In	O
an	O
independent	O
study	O
and	O
using	O
the	O
same	O
MCAO	O
rat	O
animal	O
model	O
,	O
we	O
found	O
that	O
transplantation	O
of	O
dermal	B-x
fibroblasts	E-x
did	O
not	O
improve	O
the	O
stroke-induced	O
motor	O
deficits	O
(	O
unpublished	O
data	O
)	O
.10.1371/journal.pone.0001644.g004Figure	O
4Transplantation	O
of	O
NSCs	S-cell_type
improves	O
sensorimotor	O
function	O
of	O
the	O
stroke-disabled	O
forelimb	O
.	O
Forelimb	S-x
use	O
during	O
spontaneous	O
lateral	O
exploration	O
was	O
measured	O
in	O
the	O
cylinder	O
test	O
(	O
see	O
Method	O
and	O
Results	O
sections	O
for	O
details	O
)	O
.	O

These	O
primary	O
spheres	O
were	O
harvested	O
and	O
replated	O
in	O
fresh	O
media	O
.	O

(	O
N-P	O
)	O
Clonal	O
self-renewal	O
ability	O
of	O
the	O
isolated	O
hNSCs	O
through	O
symmetrical	O
cell	O
division	O
.	O

Arrow	O
in	O
F	O
shows	O
an	O
example	O
of	O
a	O
focus	O
of	O
proliferating	O
cells	O
.	O

This	O
directed	O
migration	O
by	O
the	O
majority	O
of	O
the	O
grafted	O
cells	O
could	O
be	O
due	O
to	O
their	O
uniform	O
cellular	O
composition	O
,	O
which	O
results	O
in	O
an	O
equal	O
response	O
to	O
the	O
host	O
microenvironment	O
.	O

Our	O
results	O
indicate	O
that	O
a	O
self-renewable	O
and	O
homogenous	O
population	O
of	O
hNSCs	S-cell_type
,	O
SD56	S-cell_line
,	O
was	O
derived	O
from	O
hESCs	S-cell_type
using	O
defined	O
media	O
supplemented	O
with	O
a	O
specific	O
combination	O
of	O
growth	O
factors	O
.	O

A	O
subset	O
(	O
9.8±1.6	O
%	O
)	O
of	O
the	O
GFAP	S-GP
+	O
astrocytes	S-cell_type
co-expressed	O
nestin	S-GP
.10.1371/journal.pone.0001644.g002Figure	O
2hESC-derived	O
hNSCs	S-cell_type
spontaneously	O
differentiated	O
into	O
the	O
3	O
principal	O
central	B-cell_type
nervous	I-cell_type
system	I-cell_type
cell	E-cell_type
types.Dissociated	O
hNSCs	S-cell_type
were	O
washed	O
free	O
of	O
growth	O
factors	O
and	O
plated	O
on	O
poly-L-onithine	O
coated	O
glass	O
coverslips	O
.	O

For	O
clonal	O
analysis	O
,	O
single	O
spheres	O
or	O
confluent	O
hNSC	O
cultures	O
were	O
single	O
cell	O
dissociated	O
and	O
serially	O
diluted	O
to	O
yield	O
1–2	O
cell/10	O
µl	O
.	O

Sprague	B-y
Dawley	I-y
adult	I-y
male	I-y
rats	E-y
(	O
n	O
=	O
17	O
,	O
275g–310g	O
,	O
Charles	O
River	O
Laboratories	O
,	O
Wilmington	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
were	O
subjected	O
to	O
one	O
and	O
a	O
half	O
hour	O
suture	O
occlusion	O
of	O
the	O
middle	B-x
cerebral	I-x
artery	E-x
(	O
MCAO	S-x
)	O
,	O
as	O
previously	O
described	O
[	O
49	O
]	O
and	O
immunosuppressed	O
2	O
days	O
before	O
cell	O
transplantation	O
and	O
daily	O
thereafter	O
for	O
one	O
week	O
with	O
i.p	O
.	O

Under	O
these	O
culture	O
conditions	O
,	O
it	O
is	O
noteworthy	O
that	O
we	O
did	O
not	O
observe	O
the	O
formation	O
of	O
rosettes	S-x
which	O
has	O
been	O
previously	O
reported	O
to	O
occur	O
under	O
certain	O
conditions	O
during	O
neuralization	O
of	O
hESCs	S-cell_type
[	O
8	O
]	O
,	O
[	O
20	O
]	O
,	O
[	O
21	O
]	O
.	O

The	O
animals	O
were	O
tested	O
as	O
described	O
in	O
Method	O
section	O
.	O

Transcripts	O
for	O
the	O
GABAergic	B-cell_type
cell	E-cell_type
marker	O
glutamic	B-GP
acid	I-GP
decarboxylase	E-GP
(	O
GAD	S-GP
)	O
were	O
expressed	O
,	O
but	O
transcripts	O
for	O
the	O
tyrosine	B-GP
hydroxylase	E-GP
(	O
TH	S-GP
)	O
,	O
a	O
marker	O
for	O
dopaminergic	B-cell_type
neurons	E-cell_type
,	O
were	O
undetectable	O
.	O

(	O
F	O
)	O
Confocal	O
3D	O
reconstructed	O
orthogonal	O
images	O
of	O
the	O
hNuc	S-GP
+	O
(	O
green	O
)	O
/	O
DCX	S-GP
+	O
(	O
red	O
)	O
NSCs	S-cell_type
(	O
arrowheads	O
)	O
viewed	O
in	O
the	O
x-z	O
plan	O
on	O
the	O
top	O
and	O
y-z	O
plan	O
on	O
the	O
right	O
.	O

A	O
computer-assisted	O
image	O
analysis	O
system	O
was	O
performed	O
using	O
Stereo	O
Investigator	O
software	O
(	O
MicroBrightField	O
,	O
Inc.	O
)	O
.	O


The	O
products	O
were	O
visualized	O
through	O
a	O
UV	O
transilluminator	O
,	O
captured	O
in	O
a	O
digital	O
format	O
using	O
Quantify	O
One	O
Gel	O
Analysis	O
software	O
(	O
Bio-Rad	O
Laboratories	O
)	O
on	O
a	O
Macintosh	O
G4	O
computer.The	O
PCR	O
primers	O
specific	O
to	O
each	O
transcript	O
were	O
as	O
follows	O
:	O
GFAP	S-GP
,	O
forward	O
(	O
F	O
)	O
,	O
5′-TCATCGCTCAGGAGGTCCTT–3′	O
Reverse	O
(	O
R	O
)	O
,	O
5′-CTG	O
TTGCCAGAGATGGAGGTT–3′	O
;	O
MAP2	S-GP
(	O
F	O
)	O
5′-GAAGACTCGCATCCGAATGG–3′	O
,	O
(	O
R	O
)	O
5′-CGCAGGATAGGAGGAAGAGACT–3′	O
;	O
MBP	S-GP
(	O
F	O
)	O
5′-TTAGCTGAATTC	O
GCGTGTGG–3′	O
,	O
(	O
R	O
)	O
5′-GAGGAAGTGAATGAGCCGGTTA-3′	O
were	O
deigned	O
using	O
the	O
Primer	O
Designer	O
software	O
,	O
Version	O
2.0	O
(	O
Scientific	O
and	O
Educational	O
Software	O
)	O
[	O
48	O
]	O
.	O

To	O
date	O
there	O
have	O
been	O
no	O
effective	O
treatments	O
for	O
improving	O
residual	O
structural	O
and	O
functional	O
deficits	O
resulting	O
from	O
stroke	O
.	O

In	O
vitro	O
isolation	O
,	O
growth	O
and	O
differentiation	O
of	O
hESC-derived	O
hNSCs	S-cell_type
The	O
hESCs	S-cell_type
were	O
maintained	O
and	O
expanded	O
on	O
mouse	S-y
feeder	O
layer	O
in	O
media	O
supplemented	O
with	O
bFGF	S-GP
(	O
Figure	O
1A	O
)	O
.	O

As	O
such	O
,	O
they	O
constitute	O
an	O
ideal	O
source	O
of	O
cells	O
for	O
regenerative	O
medicine	O
.	O

The	O
animals	O
were	O
kept	O
for	O
a	O
two-month	O
post-transplant	O
survival	O
period	O
.	O

Induction	O
of	O
Focal	O
Ischemia	O
and	O
Cell	O
TransplantationAll	O
animal	O
experimentations	O
were	O
conducted	O
according	O
to	O
the	O
National	O
Institute	O
of	O
Health	O
(	O
NIH	O
)	O
guidelines	O
and	O
approved	O
by	O
the	O
IACUC	O
.	O

Both	O
cells	O
and	O
brain	O
sections	O
were	O
rinsed	O
in	O
PBS	O
for	O
3×5	O
min	O
then	O
incubated	O
for	O
2	O
hrs	O
(	O
cultures	O
)	O
or	O
overnight	O
(	O
brain	O
sections	O
)	O
with	O
the	O
appropriate	O
primary	O
antibodies	O
for	O
multiple	O
labeling	O
.	O

The	O
cell	O
culture	O
media	O
consisted	O
of	O
a	O
1∶1	O
mixture	O
of	O
Dulbecco	O
's	O
modified	O
Eagle	O
's	O
medium	O
(	O
DMEM	O
)	O
and	O
F12	O
nutrient	O
,	O
20	O
%	O
serum	O
replacement	O
(	O
Invitrogen	O
)	O
,	O
0.1	O
mM	O
β-mercaptoethanol	O
,	O
2	O
µg/ml	O
heparin	S-GP
and	O
4	O
ng/ml	O
bFGF	S-GP
(	O
R	O
&	O
D	O
Systems	O
)	O
.	O

Tumorigenicity	O
in	O
nude	O
rats	S-y
All	O
animal	O
experiments	O
were	O
conducted	O
according	O
to	O
the	O
National	O
Institute	O
of	O
Health	O
(	O
NIH	O
)	O
guidelines	O
and	O
approved	O
by	O
the	O
IACUC	O
.	O

Immunostained	O
sections	O
were	O
coverslipped	O
using	O
fluorsave	O
(	O
Calbiochem	O
)	O
as	O
the	O
mounting	O
medium	O
.	O

The	O
monolayer	O
culture	O
of	O
SD56	B-cell_type
hNSCs	E-cell_type
clearly	O
demonstrated	O
contact	O
inhibition	O
of	O
growth	O
,	O
a	O
normal	O
karyotype	O
and	O
did	O
not	O
express	O
the	O
pluripotency	O
transcripts	O
Oct-4	S-GP
and	O
Nanog	S-GP
.	O

Grafted	O
SD56	B-cell_type
hNSCs	E-cell_type
,	O
identified	O
with	O
hNuc	S-GP
,	O
demonstrated	O
a	O
37.0±15.8	O
%	O
survival	O
rate	O
and	O
a	O
remarkable	O
dispersion	O
toward	O
the	O
stroke-damaged	O
tissue	O
with	O
no	O
sign	O
of	O
overgrowth	O
or	O
tumorigenesis	O
.	O

The	O
number	O
and	O
distance	O
in	O
µm	O
of	O
cells	O
dispersed	O
beyond	O
200	O
µm	O
was	O
also	O
measured	O
.	O

Neural	O
cells	O
can	O
be	O
derived	O
from	O
hESCs	S-cell_type
either	O
by	O
direct	O
enrichment	O
,	O
or	O
by	O
isolating	O
specific	O
growth	O
factor-responsive	O
and	O
expandable	O
populations	O
of	O
human	B-cell_type
neural	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hNSCs	S-cell_type
)	O
.	O

To	O
label	O
mitotically	O
active	O
cells	O
in	O
vivo	O
during	O
S-phase	O
,	O
the	O
rats	S-y
were	O
injected	O
IP	O
with	O
the	O
BrdU	O
(	O
50	O
mg/kg	O
,	O
Sigma	O
)	O
every	O
8	O
hours	O
during	O
the	O
last	O
24	O
hours	O
before	O
euthanasia	O
.	O

A	O
P-value	O
of	O
less	O
than	O
0.05	O
was	O
considered	O
to	O
be	O
statistically	O
significant	O
.	O

(	O
F	O
)	O
Quantitative	O
analysis	O
of	O
immunostained	O
10	O
day-old	O
cultures	O
for	O
the	O
3	O
neural	S-x
cell	O
types	O
.	O

These	O
findings	O
suggest	O
that	O
neural	B-cell_type
cells	E-cell_type
generated	O
by	O
acute	O
exposure	O
to	O
growth	O
factors	O
and/or	O
morphogens	O
may	O
still	O
be	O
heterogeneous	O
and	O
potentially	O
tumorigenic	O
.	O

Wells	O
containing	O
one	O
viable	O
cell	O
were	O
marked	O
the	O
next	O
day	O
and	O
re-scored	O
5	O
to	O
7	O
days	O
later	O
for	O
cell	O
proliferation	O
.	O

After	O
5–7	O
DIV	O
,	O
the	O
adherent	O
culture	O
was	O
incubated	O
in	O
0.025	O
%	O
trypsin	S-GP
/0.01	O
%	O
EDTA	O
(	O
w/v	O
)	O
for	O
1	O
min	O
followed	O
by	O
the	O
addition	O
of	O
trypsin	S-GP
inhibitor	O
(	O
Invitrogen	O
)	O
then	O
gently	O
triturated	O
to	O
achieve	O
single	O
cell	O
suspension	O
.	O

At	O
the	O
5th	O
and	O
6th	O
passages	O
,	O
spheres	O
were	O
dissociated	O
into	O
a	O
single-cell	O
suspension	O
using	O
trypsin	S-GP
-EDTA	O
.	O

During	O
the	O
following	O
week	O
,	O
the	O
spheres	O
attached	O
to	O
the	O
flask	O
and	O
a	O
fibroblast-like	O
cell	O
population	O
began	O
to	O
migrate	O
out	O
(	O
Figure	O
1C	O
)	O
.	O

(	O
G	O
,	O
H	O
)	O
The	O
hNSCs	S-cell_type
were	O
passaged	O
every	O
5–7	O
days	O
,	O
as	O
described	O
in	O
the	O
Methods	O
section	O
.	O

Rats	S-y
were	O
placed	O
in	O
a	O
transparent	O
acrylic	O
cylinder	O
(	O
20	O
cm	O
diameter	O
)	O
for	O
5	O
minutes	O
.	O

Note	O
the	O
significant	O
increase	O
in	O
the	O
independent	O
use	O
of	O
the	O
impaired	O
contralateral	S-x
forelimb	O
at	O
4	O
and	O
8	O
weeks	O
post	O
transplantation	O
(	O
P	O
<	O
0.05	O
vs	O
pre-transplant	O
group	O
)	O
.	O

In	O
the	O
present	O
study	O
,	O
SD56	S-cell_line
hNSC-transplanted	O
animals	O
demonstrated	O
a	O
stable	O
improvement	O
in	O
the	O
sensorimotor	O
function	O
when	O
evaluated	O
for	O
spontaneous	O
exploratory	O
activity	O
in	O
the	O
cylinder	O
test	O
that	O
detects	O
long-lasting	O
deficits	O
in	O
forelimb	O
use	O
in	O
the	O
experimental	O
models	O
of	O
stroke	O
[	O
22	O
]	O
.	O

The	O
projected	O
cumulative	O
cell	O
numbers	O
demonstrated	O
that	O
trillions	O
of	O
cells	O
could	O
be	O
generated	O
over	O
a	O
period	O
of	O
5	O
months	O
(	O
Figure	O
1G	O
)	O
.	O

Testing	O
sessions	O
were	O
videotaped	O
and	O
forelimb	O
use	O
was	O
scored	O
by	O
a	O
blinded	O
operator	O
.	O

Cells	O
and	O
sections	O
were	O
counterstained	O
with	O
the	O
nuclear	O
marker	O
4′,6-diamidine-2′-phenylindole	O
dihydrochloride	O
(	O
DAPI	O
)	O
.	O

The	O
optical	O
fractionator	O
probe	O
was	O
selected	O
to	O
perform	O
systematic	O
sampling	O
of	O
the	O
immunoreactive	O
cell	O
population	O
distributed	O
within	O
the	O
serial	O
sections	O
to	O
estimate	O
the	O
population	O
number	O
in	O
the	O
volume	O
of	O
tissue	O
.	O

Fluorescence	O
was	O
detected	O
,	O
analyzed	O
and	O
photographed	O
with	O
a	O
Zeiss	O
LSM550	O
laser	O
scanning	O
confocal	O
photomicroscope	O
.	O

The	O
clone	O
of	O
cells	O
continued	O
to	O
grow	O
over	O
the	O
3	O
DIV	O
and	O
all	O
the	O
progeny	S-cell_type
expressed	O
nestin	S-GP
.	O

To	O
label	O
mitotically	O
active	O
cells	O
in	O
vivo	O
during	O
S-phase	O
,	O
the	O
rats	S-y
were	O
injected	O
IP	O
with	O
BrdU	O
(	O
50	O
mg/kg	O
)	O
every	O
8	O
hours	O
during	O
the	O
last	O
24	O
hours	O
before	O
euthanasia	O
.	O

However	O
,	O
the	O
normal	O
human-derived	B-cell_type
somatic	I-cell_type
stem	I-cell_type
cells	E-cell_type
used	O
in	O
these	O
studies	O
have	O
a	O
limited	O
capacity	O
to	O
differentiate	O
into	O
the	O
diverse	O
neural	S-x
cell	O
types	O
optimal	O
for	O
structural	O
and	O
physiological	O
tissue	O
repair	O
and	O
are	O
not	O
amenable	O
for	O
large-scale	O
cell	O
production	O
.	O

The	O
striatum	S-x
and	O
cortex	S-x
were	O
accurately	O
outlined	O
at	O
low	O
magnification	O
(	O
2.5×	O
objective	O
)	O
.	O

The	O
brains	O
were	O
cryoprotected	O
in	O
an	O
increasing	O
gradient	O
of	O
10	O
,	O
20	O
and	O
30	O
%	O
sucrose	O
solution	O
and	O
cryostat	O
sectioned	O
at	O
40	O
µm	O
and	O
processed	O
for	O
immunocytochemistry	O
.	O

G-band	O
karyotyping	O
of	O
these	O
hNSCs	S-cell_type
confirmed	O
the	O
normal	O
,	O
non-transformed	O
nature	O
of	O
cells	O
after	O
12	O
passages	O
(	O
Figure	O
1J	O
)	O
.	O

Bars	O
:	O
(	O
B	O
,	O
C	O
)	O
100	O
µm	O
;	O
(	O
D	O
,	O
F	O
)	O
20	O
µm	O
;	O
(	O
E	O
,	O
G–K	O
)	O
10	O
µm	O
.	O

The	O
grafted	O
cells	O
rarely	O
expressed	O
the	O
proliferation	O
marker	O
Ki67	S-GP
(	O
Figure	O
3D	O
)	O
,	O
29.8±4.4	O
%	O
expressed	O
nestin	S-GP
(	O
Figure	O
3E	O
)	O
,	O
6.5±0.9	O
%	O
expressed	O
doublecortin	S-GP
(	O
DCX	S-GP
)	O
and	O
60.8±8.1	O
%	O
were	O
TuJ1	S-GP
+	O
(	O
Figure	O
3F	O
,	O
G	O
)	O
.	O

The	O
SD56	B-cell_type
hNSCs	E-cell_type
differentiated	O
into	O
neurons	S-cell_type
,	O
astrocytes	S-cell_type
and	O
oligodendrocytes	S-cell_type
throughout	O
multiple	O
passages	O
in	O
vitro	O
,	O
as	O
well	O
as	O
after	O
transplantation	O
.	O

The	O
successful	O
derivation	O
of	O
hESC	O
lines	O
from	O
the	O
inner	B-x
cell	I-x
mass	E-x
of	O
preimplantation	O
embryos	S-x
and	O
their	O
long-term	O
maintenance	O
in	O
vitro	O
over	O
multiple	O
passages	O
has	O
been	O
demonstrated	O
[	O
4	O
]	O
and	O
standardized	O
.	O

However	O
,	O
the	O
SD56	S-cell_line
hNSC	O
line	O
described	O
here	O
required	O
the	O
combination	O
of	O
EGF	S-GP
,	O
bFGF	S-GP
and	O
LIF	S-GP
for	O
self-maintenance	O
.	O

C	O
:	O
higher	O
magnification	O
of	O
the	O
inset	O
in	O
B	O
.	O

3	O
.	O

The	O
sample	O
sites	O
were	O
systematically	O
and	O
automatically	O
generated	O
by	O
the	O
computer	O
and	O
examined	O
using	O
a	O
60×	O
objective	O
of	O
a	O
Nikon	O
Eclipse	O
TE	O
300	O
microscope	O
.	O

Undifferentiated	O
hNSCs	S-cell_type
from	O
passage	O
9	O
were	O
single	O
cell	O
dissociated	O
using	O
trypsin	S-GP
-EDTA	O
and	O
suspended	O
at	O
the	O
concentration	O
of	O
125,000	O
cell/µl	O
in	O
preparation	O
for	O
cell	O
transplantation	O
.	O

Transplanted	O
cells	O
survived	O
,	O
migrated	O
toward	O
and	O
engrafted	O
into	O
the	O
stroke-damaged	O
host	O
tissueTo	O
investigate	O
the	O
survival	O
and	O
functional	O
engraftment	O
in	O
an	O
injury	O
environment	O
,	O
hNSCs	S-cell_type
(	O
4×105	O
)	O
were	O
transplanted	O
into	O
the	O
ischemic	O
boundary	O
zone	O
in	O
the	O
rat	O
striatum	S-x
one	O
week	O
after	O
the	O
middle	B-x
cerebral	I-x
artery	E-x
occlusion	O
(	O
MCAO	O
)	O
was	O
performed	O
.	O

A	O
combination	O
of	O
EGF	S-GP
and	O
FGF2	S-GP
was	O
sufficient	O
to	O
propagate	O
these	O
NSCs	S-cell_type
as	O
an	O
adherent	O
monolayer	O
.	O

A	O
defined	O
hormone	O
mix	O
and	O
salt	O
mixture	O
(	O
Sigma	O
)	O
,	O
including	O
insulin	S-GP
(	O
25	O
mg/ml	O
)	O
,	O
transferrin	S-GP
(	O
100	O
mg/ml	O
)	O
,	O
progesterone	O
(	O
20	O
nM	O
)	O
,	O
putrescine	O
(	O
60	O
mM	O
)	O
,	O
and	O
selenium	O
chloride	O
(	O
30	O
nM	O
)	O
was	O
used	O
in	O
place	O
of	O
serum	O
.	O

The	O
contralateral	S-x
forelimb	O
remained	O
impaired	O
in	O
the	O
vehicle	O
treated	O
group	O
at	O
4	O
and	O
8	O
weeks	O
post-injection	O
.	O

The	O
transplantation	O
of	O
hNSCs	S-cell_type
significantly	O
enhanced	O
the	O
independent	O
use	O
of	O
the	O
impaired	O
contralateral	O
forelimb	O
8	O
weeks	O
post	O
transplantation	O
.	O

For	O
the	O
flank	O
tumor	O
assay	O
,	O
2×106	O
cells	O
(	O
125,000	O
cell/µl	O
)	O
were	O
injected	O
subcutaneously	S-x
to	O
the	O
side	O
of	O
the	O
adult	O
nude	O
rats	S-y
.	O

They	O
exhibited	O
no	O
chromosom	S-cellcomponent
al	O
abnormalities	O
and	O
demonstrated	O
non-tumorigenic	O
properties	O
after	O
implantation	O
into	O
ischemic	O
brains	S-y
and	O
into	O
naïve	O
nude	O
rat	O
brains	S-x
and	O
flanks	S-x
.	O

Eight	O
weeks	O
after	O
transplantation	O
the	O
improvement	O
in	O
the	O
use	O
of	O
the	O
impaired	O
forelimb	O
was	O
stable	O
and	O
significant	O
when	O
compared	O
to	O
the	O
pre-transplant	O
group	O
and	O
significantly	O
improved	O
in	O
comparison	O
to	O
vehicle	O
treated	O
group	O
at	O
8	O
weeks	O
(	O
Figure	O
4	O
)	O
.	O

Primary	O
neurospheres	S-x
(	O
B	O
)	O
were	O
isolated	O
and	O
replated	O
to	O
eliminate	O
other	O
non-	O
neural	B-cell_type
cells	E-cell_type
.	O

Cultures	O
were	O
fixed	O
after	O
1	O
,	O
2	O
or	O
3	O
DIV	O
(	O
Figure	O
1N–P	O
)	O
.	O

Groups	O
of	O
vehicle	O
injected	O
(	O
n	O
=	O
7	O
)	O
and	O
hNSCs	S-cell_type
(	O
n	O
=	O
10	O
)	O
transplanted	O
are	O
represented	O
.	O

(	O
J	O
)	O
Cytogenetic	O
evaluation	O
of	O
the	O
SD56	S-cell_line
hNSCs	S-cell_type
line	O
at	O
passage	O
12	O
by	O
standard	O
G-banding	O
was	O
performed	O
.	O

Results	O
are	O
mean±s.e.m	O
.	O

This	O
type	O
of	O
growth	O
pattern	O
is	O
characteristic	O
of	O
primitive	O
normal	O
stem	O
cells	O
undergoing	O
mostly	O
symmetric	O
cell	O
division	O
to	O
increase	O
the	O
stem	O
cell	O
pool	O
at	O
the	O
early	O
stage	O
of	O
development	O
or	O
during	O
tissue	O
regeneration	O
after	O
injury	O
[	O
23	O
]	O
.	O

A	O
10-µl-cell	O
suspension	O
was	O
then	O
added	O
to	O
each	O
of	O
96	O
or	O
24	O
well	O
plates	O
containing	O
200–300	O
µl	O
of	O
growth	O
media	O
.	O

Starting	O
from	O
an	O
initial	O
population	O
of	O
1	O
million	O
cells	O
,	O
the	O
cumulative	O
cell	O
number	O
was	O
calculated	O
at	O
each	O
passage	O
as	O
the	O
fold	O
of	O
increase×the	O
total	O
cell	O
number	O
and	O
plotted	O
as	O
logarithm	O
with	O
base	O
2	O
in	O
function	O
of	O
time	O
(	O
G	O
)	O
.	O

In	O
vitro	O
,	O
defined	O
growth	O
factors	O
and	O
extracellular	B-cellcomponent
matrices	E-cellcomponent
support	O
stem	O
cell	O
self-renewal	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
.	O

Transplanted	O
cells	O
improve	O
sensorimotor	O
function	O
of	O
the	O
stroke-disabled	O
forelimbWe	O
asked	O
whether	O
transplanted	O
SD56	B-cell_type
hNSCs	E-cell_type
could	O
enhance	O
the	O
recovery	O
of	O
sensorimotor	O
function	O
that	O
is	O
compromised	O
in	O
the	O
stroke-injured	O
rats	S-y
.	O

Current	O
therapeutic	O
approaches	O
,	O
such	O
as	O
the	O
use	O
of	O
thrombolytics	O
,	O
benefit	O
only	O
1	O
to	O
4	O
%	O
of	O
patients	O
[	O
1	O
]	O
.	O

This	O
neuralization	O
process	O
has	O
proven	O
invaluable	O
in	O
understanding	O
the	O
specification	O
of	O
hESC-derived	O
neural	B-x
tissue	E-x
[	O
10	O
]	O
,	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
.	O

Oct4	S-GP
,	O
Nanog	S-GP
primers	O
[	O
11	O
]	O
.	O

(	O
D–I	O
)	O
Photos	O
taken	O
from	O
frontal	O
sections	O
through	O
the	O
graft	O
in	O
the	O
striatum	S-x
double	O
immunoprocessed	O
for	O
cell	O
proliferation	O
and	O
neural	S-x
lineage	O
markers	O
.	O

One	O
week	O
after	O
the	O
stroke	O
lesion	O
,	O
2	O
µl	O
of	O
the	O
hNSCs	S-cell_type
,	O
at	O
a	O
concentration	O
of	O
50,000	O
cell/µl	O
,	O
were	O
stereotaxically	O
transplanted	O
into	O
4	O
sites	O
within	O
the	O
lesioned	O
striatum	O
(	O
n	O
=	O
10	O
)	O
at	O
the	O
following	O
coordinates	O
:	O
AP	O
:	O
+1.0	O
mm	O
,	O
ML	O
:	O
+3.2	O
mm	O
,	O
DV	O
:	O
−5.0	O
;	O
AP	O
:	O
+0.5	O
mm	O
,	O
ML	O
:	O
+3.0	O
mm	O
,	O
DV	O
:	O
−5.0	O
;	O
AP	O
:	O
−0.5	O
mm	O
,	O
ML	O
:	O
+3.0	O
mm	O
,	O
DV	O
:	O
−5.0	O
;	O
AP	O
:	O
−1.0	O
mm	O
,	O
ML	O
:	O
+3.5	O
mm	O
,	O
DV	O
:	O
−5.0	O
mm	O
with	O
the	O
incisor	O
bar	O
set	O
at	O
3.4	O
mm	O
.	O

Movements	O
scored	O
were	O
the	O
independent	O
use	O
of	O
the	O
left	O
or	O
right	O
forelimb	O
or	O
simultaneous	O
use	O
of	O
both	O
the	O
left	O
and	O
right	O
forelimb	O
to	O
contact	O
the	O
wall	O
of	O
the	O
cylinder	O
during	O
a	O
full	O
rear	O
,	O
to	O
initiate	O
a	O
weight-shifting	O
movement	O
,	O
or	O
to	O
regain	O
center	O
of	O
gravity	O
while	O
moving	O
laterally	O
in	O
a	O
vertical	O
posture	O
along	O
the	O
wall	O
.	O

At	O
this	O
stage	O
there	O
was	O
a	O
change	O
in	O
the	O
hNSCs	S-cell_type
'	O
adherent	O
properties	O
,	O
and	O
the	O
cells	O
began	O
to	O
grow	O
as	O
a	O
monolayer	O
with	O
multiple	O
foci	O
of	O
cells	O
throughout	O
the	O
culture	O
(	O
Figure	O
1F	O
)	O
.	O

Tests	O
were	O
then	O
conducted	O
4	O
and	O
8	O
weeks	O
after	O
vehicle	O
and	O
SD56	B-cell_type
hNSCs	E-cell_type
transplantation	O
.	O

of	O
three	O
independent	O
experiments	O
,	O
each	O
performed	O
in	O
duplicate	O
.	O

After	O
cell	O
dissociation	O
,	O
a	O
portion	O
of	O
the	O
hESCs	S-cell_type
was	O
cultured	O
in	O
serum	O
free	O
medium	O
containing	O
EGF	S-GP
,	O
bFGF	S-GP
and	O
LIF	S-GP
.	O

Two	O
µl	O
of	O
the	O
cell	O
suspension	O
were	O
stereotaxically	O
transplanted	O
into	O
4	O
sites	O
within	O
the	O
striatum	O
at	O
the	O
following	O
coordinates	O
:	O
AP	O
:	O
+1.0	O
mm	O
,	O
ML	O
:	O
+3.2	O
mm	O
,	O
DV	O
:	O
−5.0	O
;	O
AP	O
:	O
+0.5	O
mm	O
,	O
ML	O
:	O
+3.0	O
mm	O
,	O
DV	O
:	O
−5.0	O
;	O
AP	O
:	O
−0.5	O
mm	O
,	O
ML	O
:	O
+3.0	O
mm	O
,	O
DV	O
:	O
−5.0	O
;	O
AP	O
:	O
−1.0	O
mm	O
,	O
ML	O
:	O
+3.5	O
mm	O
,	O
DV	O
:	O
−5.0	O
mm	O
with	O
the	O
incisor	O
bar	O
set	O
at	O
3.4	O
mm	O
.	O

(	O
G	O
)	O
Examples	O
show	O
the	O
majority	O
of	O
grafted	O
NSC	O
progeny	O
co-expressing	O
hNuc	S-GP
(	O
red	O
)	O
and	O
the	O
neuronal	S-x
marker	O
TuJ1	S-GP
(	O
green	O
)	O
.	O

ImmunocytochemistryCultures	O
were	O
fixed	O
with	O
4	O
%	O
paraformaldehyde	O
for	O
15	O
min	O
.	O

Double	O
labeling	O
was	O
determined	O
using	O
the	O
confocal	O
laser	O
scanning	O
microscope	O
by	O
random	O
sampling	O
of	O
100	O
or	O
more	O
cells	O
per	O
marker	O
for	O
each	O
animal	O
,	O
scoring	O
first	O
for	O
hNuc+	O
,	O
followed	O
by	O
DAPI+	O
nuclei	S-cellcomponent
and	O
then	O
the	O
marker	O
of	O
choice	O
.	O

In	O
previous	O
studies	O
,	O
subpopulations	O
of	O
transplanted	O
hESCs	S-cell_type
that	O
were	O
enriched	O
in	O
neural	B-cell_type
cells	E-cell_type
migrated	O
in	O
host	O
microenvironments	O
conducive	O
to	O
cell	O
migration	O
,	O
such	O
as	O
the	O
developing	O
brain	O
or	O
in	O
structures	O
such	O
as	O
the	O
rostral	B-x
migratory	I-x
stream	E-x
[	O
13	O
]	O
,	O
[	O
20	O
]	O
.	O

FOXa2	S-GP
(	O
HNF3B	S-GP
)	O
,	O
Brachyury	S-GP
primers	O
[	O
52	O
]	O
.	O

These	O
hNSCs	S-cell_type
grew	O
as	O
an	O
adherent	O
monolayer	O
culture	O
.	O

Furthermore	O
,	O
the	O
transplanted	O
SD56	B-cell_type
hNSCs	E-cell_type
migrated	O
toward	O
the	O
stroke-damaged	O
adult	O
brain	B-x
parenchyma	E-x
,	O
engrafted	O
and	O
improved	O
the	O
independent	O
use	O
of	O
the	O
stroke-impaired	O
forelimb	O
.	O

Together	O
,	O
these	O
studies	O
are	O
seminal	O
and	O
suggest	O
that	O
complete	O
neuralization	O
may	O
not	O
be	O
achieved	O
through	O
certain	O
enrichment	O
processes	O
,	O
consequently	O
the	O
neural	B-cell_type
cells	E-cell_type
could	O
revert	O
to	O
a	O
pluripotent	O
stage	O
[	O
17	O
]	O
.	O

After	O
2	O
days	O
,	O
plated	O
single	O
cells	O
first	O
underwent	O
a	O
symmetric	O
cell	O
division	O
and	O
gave	O
rise	O
to	O
daughter	O
cells	O
that	O
were	O
both	O
positive	O
for	O
BrdU	O
and	O
nestin	S-GP
.	O

In	O
vivo	O
,	O
a	O
complex	O
cellular	O
micro-environment	O
or	O
niche	O
ensures	O
the	O
self-maintenance	O
property	O
of	O
NSCs	S-cell_type
[	O
24	O
]	O
,	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
.	O

Secondary	O
spheres	O
(	O
2°	O
spheres	O
)	O
were	O
generated	O
from	O
these	O
cultures	O
and	O
lifted	O
off	O
by	O
the	O
end	O
of	O
the	O
week	O
leaving	O
a	O
hollow	O
in	O
the	O
middle	O
of	O
the	O
attached	O
cells	O
(	O
Figure	O
1D	O
)	O
.	O

Note	O
the	O
symmetrical	O
segregation	O
of	O
BrdU	O
and	O
nestin	S-GP
in	O
the	O
progeny	O
.	O

Normal	O
adult	O
NIH-Nude	O
rats	S-y
(	O
n	O
=	O
5	O
,	O
8	O
week-old	O
,	O
Taconic	O
,	O
Germantown	O
,	O
New	O
York	O
,	O
United	O
States	O
)	O
were	O
used	O
to	O
test	O
the	O
tumorigenic	O
potential	O
of	O
the	O
SD56	S-cell_line
hNSCs	S-cell_type
.	O

These	O
hNSCs	S-cell_type
did	O
not	O
express	O
the	O
pluripotency	O
markers	O
Oct4	S-GP
or	O
Nanog	S-GP
,	O
nor	O
did	O
they	O
express	O
markers	O
for	O
the	O
mesoderm	S-x
or	O
endoderm	S-x
lineages	O
.	O

For	O
each	O
animal	O
,	O
quantitative	O
estimates	O
of	O
the	O
total	O
number	O
of	O
grafted	O
cells	O
were	O
stereologically	O
determined	O
using	O
the	O
optical	O
fractionator	O
procedure	O
[	O
50	O
]	O
.	O

Reverse	O
Transcription-	O
Polymerase	S-GP
Chain	O
Reaction	O
(	O
RT-PCR	O
)	O
analysisTotal	O
RNA	O
was	O
extracted	O
from	O
cultured	O
cells	O
using	O
RNAeasy	O
kit	O
(	O
Quiagen	O
)	O
.	O

Slide	O
preparations	O
were	O
made	O
by	O
dropping	O
the	O
fixed	O
cell	O
pellet	O
onto	O
cold	O
,	O
wet	O
slides	O
and	O
air-dried	O
.	O

PCR	O
was	O
performed	O
using	O
the	O
following	O
thermal	O
profile	O
:	O
4	O
min	O
at	O
94°C	O
;	O
1	O
min	O
at	O
94°C	O
,	O
1	O
min	O
at	O
60°C	O
,	O
1.5	O
min	O
at	O
72°C	O
,	O
for	O
30–40	O
cycles	O
;	O
7	O
min	O
at	O
72°C	O
,	O
and	O
finally	O
a	O
soak	O
at	O
4°C	O
overnight	O
.	O

We	O
expanded	O
the	O
isolated	O
hNSCs	S-cell_type
lines	O
for	O
over	O
20	O
passages	O
with	O
a	O
stable	O
phenotype	O
.	O

Furthermore	O
,	O
the	O
SD56	B-cell_type
hNSCs	E-cell_type
described	O
here	O
exhibited	O
the	O
multipotential	O
characteristic	O
to	O
differentiate	O
into	O
neurons	S-cell_type
,	O
astrocytes	S-cell_type
and	O
oligodendrocytes	S-cell_type
both	O
in	O
vitro	O
and	O
upon	O
transplantation	O
.	O

Immunocytochemical	O
analysis	O
(	O
Figure	O
2B–F	O
)	O
of	O
10	O
day-old	O
cultures	O
demonstrated	O
that	O
the	O
proportion	O
of	O
nestin+	B-cell_type
cell	E-cell_type
s	O
was	O
36.6±2.7	O
%	O
,	O
62.5±2.8	O
%	O
expressed	O
the	O
neuronal	S-cell_type
marker	O
TuJ1	S-GP
,	O
1.9±0.3	O
%	O
expressed	O
the	O
astrocytic	S-cell_type
marker	O
GFAP	S-GP
and	O
7.1±0.4	O
%	O
were	O
oligodendrocytes	S-cell_type
and	O
expressed	O
galactocerebrocide	S-GP
(	O
GC	S-GP
)	O
(	O
Figure	O
2F	O
)	O
.	O

We	O
report	O
an	O
alternative	O
method	O
for	O
the	O
isolation	O
and	O
the	O
perpetuation	O
of	O
a	O
multipotent	O
hNSC	O
line	O
from	O
the	O
hESCs	S-cell_type
with	O
a	O
primitive	O
mode	O
of	O
self-renewal	O
.	O

Removal	O
of	O
mitogenic	O
factors	O
and	O
continued	O
culture	O
on	O
plastic	O
resulted	O
in	O
cell	O
senescence	O
that	O
is	O
characteristic	O
of	O
non-transformed	O
cells	O
.	O

Although	O
there	O
are	O
morphological	O
and	O
molecular	O
similarities	O
between	O
our	O
hNSCs	S-cell_type
and	O
the	O
NSCs	S-cell_type
previously	O
described	O
[	O
21	O
]	O
,	O
the	O
methods	O
of	O
isolation	O
and	O
growth	O
are	O
different	O
.	O

(	O
A	O
)	O
Schematic	O
drawing	O
of	O
a	O
frontal	O
section	O
through	O
the	O
striatum	S-x
illustrating	O
the	O
dispersion	O
of	O
grafted	O
hNSCs	S-cell_type
in	O
the	O
focal	O
ischemia-lesioned	O
parenchyma	S-x
(	O
shaded	O
area	O
)	O
.	O

After	O
2-month	O
survival	O
time	O
,	O
rats	S-y
were	O
euthanized	O
and	O
a	O
postmortem	O
examination	O
for	O
tumor	O
formation	O
was	O
performed	O
.	O

The	O
selectively	O
harvested	O
secondary	O
neurospheres	S-x
(	O
arrow	O
in	O
C	O
)	O
,	O
left	O
behind	O
hollow	O
cores	O
in	O
the	O
surface	O
area	O
(	O
star	O
in	O
D	O
)	O
where	O
they	O
attached	O
earlier	O
.	O

After	O
2	O
,	O
7–15	O
DIV	O
cultures	O
were	O
fixed	O
and	O
processed	O
for	O
immunocytochemistry	O
or	O
used	O
for	O
RT-PCR	O
analysis	O
.	O

RT-PCR	O
analysis	O
confirmed	O
that	O
these	O
hNSCs	S-cell_type
did	O
not	O
express	O
the	O
pluripotency	O
transcripts	O
Oct-4	S-GP
and	O
Nanog	S-GP
(	O
Figure	O
1I	O
)	O
.	O

Studies	O
have	O
indicated	O
that	O
the	O
direct	O
enrichment	O
method	O
generates	O
a	O
heterogeneous	O
population	O
of	O
cells	O
that	O
may	O
contain	O
residual	O
undifferentiated	O
stem	B-cell_type
cells	E-cell_type
that	O
could	O
lead	O
to	O
tumor	O
formation	O
in	O
vivo.Methods/Principal	O
FindingsWe	O
isolated	O
an	O
expandable	O
and	O
homogenous	O
population	O
of	O
hNSCs	S-cell_type
(	O
named	O
SD56	S-cell_line
)	O
from	O
hESCs	S-cell_type
using	O
a	O
defined	O
media	O
supplemented	O
with	O
epidermal	B-GP
growth	I-GP
factor	E-GP
(	O
EGF	S-GP
)	O
,	O
basic	B-GP
fibroblast	I-GP
growth	I-GP
factor	E-GP
(	O
bFGF	S-GP
)	O
and	O
leukemia	B-GP
inhibitory	I-GP
growth	I-GP
factor	E-GP
(	O
LIF	S-GP
)	O
.	O

Bars	O
:	O
(	O
c	O
)	O
20	O
µm	O
;	O
(	O
d	O
,	O
e	O
)	O
10	O
µm	O
.	O

The	O
hNSCs	S-cell_type
expressed	O
transcripts	O
for	O
GAD	S-GP
,	O
but	O
not	O
for	O
TH	S-GP
.	O

They	O
were	O
fully	O
neuralized	O
and	O
uniformly	O
expressed	O
molecular	O
features	O
of	O
NSCs	S-cell_type
,	O
including	O
nestin	S-GP
,	O
vimentin	S-GP
and	O
radial	O
glial	S-cell_type
markers	O
.	O

Undifferentiated	O
SD56	S-cell_line
hNSCs	S-cell_type
from	O
passages	O
between	O
P9	O
and	O
P13	O
were	O
single	O
cell	O
dissociated	O
using	O
trypsin	S-GP
-EDTA	O
in	O
preparation	O
for	O
cell	O
transplantation	O
.	O

All	O
animals	O
underwent	O
baseline	O
motor	O
behavioral	O
assessment	O
before	O
and	O
after	O
the	O
ischemic	O
lesion	O
,	O
and	O
4	O
&	O
8	O
weeks	O
after	O
cell	O
transplantation	O
.	O

In	O
addition	O
to	O
their	O
therapeutic	O
application	O
,	O
the	O
hNSCs	S-cell_type
isolated	O
under	O
the	O
reported	O
conditions	O
offer	O
a	O
means	O
to	O
interrogate	O
host	O
environments	O
and	O
unravel	O
mechanistic	O
features	O
of	O
self-renewal	O
,	O
non-tumorigenicity	O
and	O
functional	O
engraftability	O
in	O
animal	O
models	O
of	O
neurological	O
disorders	O
.	O

Twenty	O
metaphase	O
cells	O
were	O
analyzed	O
and	O
showed	O
a	O
normal	O
female	S-x
chromosome	O
complement	O
(	O
46	O
,	O
XX	O
)	O
.	O

These	O
properties	O
indicate	O
that	O
this	O
hNSC	O
line	O
may	O
offer	O
a	O
renewable	O
,	O
homogenous	O
source	O
of	O
neural	B-cell_type
cells	E-cell_type
that	O
will	O
be	O
valuable	O
for	O
basic	O
and	O
translational	O
research	O
.	O

Together	O
,	O
these	O
criteria	O
confirm	O
the	O
definitive	O
NSC	O
identity	O
of	O
the	O
SD56	S-cell_line
cell	O
line	O
.	O

The	O
transit	B-cell_type
amplifying	I-cell_type
endogenous	I-cell_type
precursors	E-cell_type
located	O
in	O
the	O
subventricular	B-x
zone	E-x
(	O
SVZ	S-x
)	O
were	O
labeled	O
(	O
Figure	O
S3	O
)	O
;	O
however	O
,	O
we	O
were	O
unable	O
to	O
detect	O
grafted	O
SD56	B-cell_type
hNSCs	E-cell_type
co-localizing	O
the	O
human	S-y
-specific	O
nuclear	S-cellcomponent
marker	O
hNuc	S-GP
and	O
BrdU	O
(	O
Figure	O
S3	O
)	O
.	O

The	O
embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
can	O
propagate	O
in	O
a	O
predominantly	O
proliferative	O
symmetrical	O
mode	O
,	O
leading	O
to	O
homogeneous	O
cell	O
cultures	O
growing	O
relatively	O
quickly	O
with	O
minimal	O
cell	O
differentiation	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
,	O
[	O
32	O
]	O
,	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

Stable	O
asymmetry	O
in	O
forelimb	O
use	O
was	O
observed	O
7	O
days	O
post-stroke	O
(	O
pre-transplant	O
,	O
Figure	O
4	O
)	O
.	O

The	O
animals	O
were	O
killed	O
after	O
2-month	O
survival	O
time	O
by	O
transcardial	O
perfusion	O
with	O
phosphate	O
buffered	O
saline	O
(	O
PBS	O
)	O
followed	O
by	O
4	O
%	O
paraformaldehyde	O
.	O

Consequently	O
,	O
the	O
majority	O
of	O
stroke	O
patients	O
experience	O
progression	O
of	O
ischemia	O
associated	O
with	O
debilitating	O
neurological	O
deficits	O
.	O

Bars	O
:	O
(	O
A	O
,	O
B	O
,	O
C	O
,	O
D	O
)	O
200	O
µm	O
;	O
(	O
E	O
,	O
F	O
)	O
100	O
µm	O
;	O
(	O
K–M	O
)	O
20	O
µm	O
;	O
(	O
N–P	O
)	O
10	O
µm.To	O
ascertain	O
self-renewal	O
ability	O
under	O
clonal	O
conditions	O
,	O
a	O
single	O
cell	O
suspension	O
was	O
plated	O
at	O
clonal	O
density	O
(	O
1–2	O
cell/10	O
µl	O
)	O
.	O

The	O
isolated	O
hNSCs	S-cell_type
are	O
normal	O
and	O
do	O
not	O
form	O
tumors	S-x
in	O
normal	O
nude	O
rats	S-y
The	O
self-renewal	O
and	O
pluripotent	O
abilities	O
of	O
the	O
hESCs	S-cell_type
are	O
also	O
associated	O
with	O
tumorigenic	O
properties	O
.	O

The	O
counting	O
frame	O
displayed	O
inclusion	O
and	O
exclusion	O
lines	O
and	O
only	O
immunoreactive	O
cell	O
bodies	O
falling	O
within	O
the	O
counting	O
frame	O
with	O
no	O
contact	O
with	O
the	O
exclusion	O
lines	O
were	O
counted	O
.	O

The	O
cells	O
were	O
then	O
washed	O
twice	O
with	O
fresh	O
medium	O
and	O
reseeded	O
in	O
fresh	O
growth	O
factor-containing	O
media	O
at	O
100,000	O
cells/ml	O
.	O

All	O
data	O
were	O
analyzed	O
using	O
SPSS	O
11	O
for	O
Mac	O
OS	O
X	O
(	O
SPSS	O
Inc.	O
)	O
.	O

To	O
generate	O
the	O
NSCs	S-cell_type
,	O
dissociated	O
hESCs	S-cell_type
were	O
cultured	O
in	O
a	O
chemically	O
defined	O
medium	O
composed	O
of	O
DMEM/F12	O
(	O
1∶1	O
)	O
including	O
glucose	O
(	O
0.6	O
%	O
)	O
,	O
glutamine	O
(	O
2	O
mM	O
)	O
,	O
sodium	O
bicarbonate	O
(	O
3	O
mM	O
)	O
,	O
and	O
HEPES	O
buffer	O
(	O
5	O
mM	O
)	O
[	O
all	O
from	O
Sigma	O
except	O
glutamine	O
(	O
Invitrogen	O
)	O
]	O
.	O

These	O
factors	O
are	O
known	O
to	O
stimulate	O
the	O
proliferation	O
of	O
human	B-cell_type
fetal-derived	I-cell_type
NSCs	E-cell_type
[	O
18	O
]	O
,	O
[	O
19	O
]	O
.	O

The	O
SD56	B-cell_type
hNSCs	E-cell_type
grew	O
as	O
an	O
adherent	O
monolayer	O
culture	O
,	O
uniformly	O
expressed	O
molecular	O
features	O
of	O
hNSCs	S-cell_type
including	O
nestin	S-GP
,	O
vimentin	S-GP
and	O
the	O
radial	B-cell_type
glial	E-cell_type
marker	O
3CB2	S-GP
,	O
and	O
did	O
not	O
express	O
the	O
pluripotency	O
markers	O
Oct4	S-GP
or	O
Nanog	S-GP
.	O

However	O
,	O
the	O
enriched	O
neural	B-cell_type
progeny	E-cell_type
derived	O
displayed	O
overgrowth	O
and	O
limited	O
migration	O
after	O
grafting	O
into	O
normal	O
newborn	O
mice	S-y
[	O
13	O
]	O
and	O
lesioned	O
adult	O
rat	B-x
striatum	E-x
[	O
12	O
]	O
,	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
,	O
[	O
16	O
]	O
.	O

B	O
,	O
C	O
&	O
D	O
,	O
morphology	O
of	O
NSC-derived	B-cell_type
progeny	E-cell_type
differentiated	O
into	O
GFAP	S-GP
+	O
astrocytes	S-cell_type
(	O
B	O
)	O
,	O
GC	S-GP
-expressing	O
oligodendrocytes	S-cell_type
(	O
C	O
)	O
and	O
TuJ1	S-GP
+	O
neurons	S-cell_type
(	O
D	O
)	O
,	O
DAPI	O
(	O
blue	O
)	O
show	O
life	O
cell	O
nuclei	S-cellcomponent
.	O

An	O
initial	O
cell	O
bank	O
of	O
75	O
vials	O
containing	O
2	O
to	O
5	O
million	O
cells	O
each	O
was	O
generated	O
and	O
cryopreserved.Upon	O
removal	O
of	O
the	O
mitogenic	O
factors	O
and	O
plating	O
on	O
a	O
coverslip	O
pre-coated	O
with	O
poly-L-ornithine	O
(	O
PLO	O
)	O
substrate	O
,	O
the	O
hNSCs	S-cell_type
spontaneously	O
differentiated	O
into	O
neurons	S-cell_type
,	O
astrocytes	S-cell_type
and	O
oligodendrocytes	S-cell_type
,	O
a	O
property	O
that	O
is	O
consistent	O
with	O
normal	O
multipotent	O
hNSCs	S-cell_type
(	O
Figure	O
2	O
)	O
.	O

Grafted	O
NSCs	S-cell_type
rarely	O
differentiate	O
into	O
GFAP	S-GP
+	O
astrocytes	S-cell_type
(	O
H	O
)	O
.	O

Grafted	O
cells	O
rarely	O
co-expressed	O
the	O
astroglial	S-cell_type
marker	O
GFAP	S-GP
(	O
Figure	O
3H	O
)	O
or	O
differentiated	O
into	O
CNPase	S-GP
-expressing	O
oligodendrocytes	S-cell_type
(	O
Figure	O
3I	O
)	O
.	O

We	O
named	O
the	O
derived	O
hNSCs	S-cell_type
SD56	S-cell_line
(	O
intermittently	O
referred	O
to	O
as	O
SD56	S-cell_line
hNSCs	S-cell_type
or	O
hNSCs	S-cell_type
)	O
.Under	O
these	O
defined	O
growth	O
conditions	O
,	O
the	O
hNSCs	S-cell_type
showed	O
stable	O
growth	O
with	O
a	O
2.7±0.2	O
fold	O
increase	O
every	O
5	O
to	O
7	O
days	O
(	O
Figure	O
1G	O
)	O
.	O

(	O
D	O
)	O
Note	O
the	O
endogenous	O
Ki67	S-GP
+	O
cells	O
(	O
red	O
cells	O
,	O
arrow	O
)	O
in	O
the	O
stroke	O
damaged	O
area	O
and	O
the	O
hNuc	S-GP
+	O
(	O
green	O
)	O
/	O
Ki67	S-GP
-	O
grafted	O
hNSCs	S-cell_type
(	O
arrowheads	O
)	O
.	O

Differentiation	O
and	O
enrichment	O
processes	O
that	O
direct	O
hESCs	S-cell_type
towards	O
a	O
neural	B-x
lineage	E-x
have	O
also	O
been	O
achieved	O
.	O

After	O
incubating	O
the	O
slides	O
at	O
90°C	O
for	O
30	O
minutes	O
,	O
chromosomes	S-cellcomponent
were	O
trypsin	S-GP
banded	O
and	O
then	O
Wright/Giemsa	O
stained	O
for	O
G-banding	O
analysis	O
.	O

The	O
following	O
day	O
,	O
10	O
µl	O
aliquots	O
of	O
the	O
amplified	O
products	O
were	O
run	O
on	O
a	O
2	O
%	O
agarose	O
Tris–acetate	O
gel	O
containing	O
0.5	O
mg/ml	O
ethidium	O
bromide	O
.	O

Significance	O
of	O
inter-group	O
differences	O
was	O
performed	O
by	O
applying	O
Student	O
's	O
t-test	O
where	O
appropriate	O
.	O

An	O
average	O
of	O
2,000	O
cells	O
was	O
counted	O
per	O
animal	O
.	O

The	O
One-Way	O
ANOVA	O
analysis	O
was	O
used	O
to	O
compare	O
group	O
differences	O
for	O
the	O
forelimb	O
use	O
as	O
the	O
dependant	O
variable	O
and	O
groups	O
as	O
the	O
single	O
independent	O
factor	O
variable	O
.	O

The	O
counting	O
frame	O
of	O
the	O
optical	O
fractionator	O
was	O
defined	O
at	O
50×50	O
µm	O
squares	O
and	O
the	O
systematic	O
sampling	O
was	O
performed	O
by	O
translating	O
a	O
grid	O
with	O
200×200	O
µm	O
squares	O
onto	O
the	O
sections	O
of	O
interest	O
using	O
the	O
Stereo	O
Investigator	O
software	O
.	O

Differentiated	O
cultures	O
were	O
either	O
harvested	O
after	O
2	O
DIV	O
for	O
total	O
RNA	O
extraction	O
and	O
RT-PCR	O
analysis	O
or	O
fixed	O
after	O
10	O
DIV	O
and	O
processed	O
for	O
indirect	O
immunocytochemistry	O
.	O

The	O
medium	O
was	O
supplemented	O
with	O
EGF	S-GP
(	O
20	O
ng/ml	O
)	O
,	O
bFGF	S-GP
(	O
10	O
ng/ml	O
)	O
and	O
LIF	S-GP
(	O
10	O
ng/ml	O
)	O
.	O

Together	O
these	O
findings	O
suggest	O
that	O
the	O
hNSC	O
line	O
we	O
isolated	O
are	O
appropriately	O
programmed	O
and	O
share	O
similar	O
characteristics	O
with	O
the	O
definitive	O
NSCs	S-cell_type
of	O
the	O
developing	O
brain	O
.	O

However	O
,	O
in	O
these	O
cases	O
,	O
the	O
transplanted	O
non-human	S-y
ESCs	S-cell_type
also	O
formed	O
a	O
mass	O
with	O
signs	O
of	O
overgrowth	O
in	O
the	O
core	O
,	O
as	O
well	O
as	O
deformations	O
[	O
44	O
]	O
,	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

The	O
injection	O
rate	O
was	O
1	O
µl/min	O
,	O
and	O
the	O
cannula	O
was	O
left	O
in	O
place	O
for	O
an	O
additional	O
5	O
min	O
before	O
retraction	O
.	O

Karyotype	O
analysisLong-term	O
cultures	O
of	O
hNSCs	S-cell_type
were	O
incubated	O
at	O
37°C	O
and	O
harvested	O
for	O
metaphase	O
chromosomes	O
when	O
the	O
cultures	O
were	O
75	O
%	O
confluent	O
.	O

Importantly	O
,	O
they	O
exhibited	O
no	O
chromosome	O
abnormalities	O
and	O
did	O
not	O
form	O
tumors	O
after	O
implantation	O
into	O
rat	O
ischemic	O
brains	S-x
and	O
into	O
naïve	O
nude	O
rat	O
brains	O
and	O
flanks	S-x
.	O

18S	O
,	O
β-tubulin	B-GP
class	I-GP
III	E-GP
,	O
N-CAM	S-GP
,	O
Nestin	S-GP
,	O
NF-M	S-GP
,	O
Notch-1	S-GP
primers	O
[	O
51	O
]	O
.	O

The	O
adherent	O
hNSC	O
culture	O
stained	O
uniformly	O
for	O
nestin	S-GP
(	O
Figure	O
1K	O
)	O
,	O
vimentin	S-GP
(	O
Figure	O
1L	O
)	O
and	O
with	O
the	O
radial	B-cell_type
glial	E-cell_type
marker	O
3CB2	S-GP
(	O
Figure	O
1M	O
)	O
indicating	O
their	O
homogeneity	O
and	O
NSC	O
identity	O
.	O

Isolated	O
and	O
expanded	O
hNSCs	S-cell_type
expressed	O
the	O
neural	B-cell_type
precursor	I-cell_type
cell	E-cell_type
markers	O
nestin	S-GP
(	O
K	O
)	O
,	O
Vimentin	S-GP
(	O
L	O
)	O
and	O
the	O
radial	B-cell_type
glial	I-cell_type
cell	E-cell_type
marker	O
3CB2	S-GP
(	O
M	O
)	O
in	O
virtually	O
all	O
the	O
progeny	O
.	O

Bars	O
represent	O
percentages±s.e.m	O
.	O

Furthermore	O
,	O
the	O
hNSCs	S-cell_type
did	O
not	O
express	O
transcripts	O
for	O
brachyury	S-GP
and	O
foxa2	S-GP
,	O
marker	O
genes	O
for	O
mesoderm	S-x
and	O
endoderm	S-x
respectively	O
(	O
negative	O
result	O
,	O
data	O
not	O
shown	O
)	O
.10.1371/journal.pone.0001644.g001Figure	O
1Isolation	O
and	O
purification	O
of	O
hNSCs	O
from	O
the	O
hESCs.The	O
hESCs	O
were	O
grown	O
on	O
a	O
mouse	O
feeder	O
layer	O
(	O
A	O
)	O
.	O

Behavioral	O
testsThe	O
cylinder	O
test	O
was	O
used	O
to	O
assess	O
the	O
spontaneous	O
forelimb	O
use	O
during	O
lateral	O
exploration	O
movement	O
[	O
22	O
]	O
.	O

Ischemic	O
rats	S-y
used	O
their	O
impaired	O
forelimbs	S-x
(	O
contralateral	O
to	O
lesion	O
)	O
during	O
lateral	O
exploration	O
less	O
than	O
they	O
did	O
before	O
stroke	O
.	O

Unlike	O
other	O
sources	O
of	O
stem	O
cells	O
,	O
hESC	O
lines	O
possess	O
a	O
nearly	O
unlimited	O
self-renewal	O
capacity	O
and	O
the	O
developmental	O
potential	O
to	O
differentiate	O
into	O
virtually	O
any	O
cell	O
type	O
of	O
the	O
organism	O
.	O

The	O
following	O
antibodies	O
were	O
used	O
:	O
Anti-human	B-GP
Nuclei	E-GP
(	O
hNuc	S-GP
,	O
monoclonal	O
1∶100	O
,	O
Chemicon	O
)	O
,	O
Anti-TuJ1	S-GP
(	O
monoclonal	O
1∶100	O
,	O
Covance	O
;	O
Polyclonal	O
1∶200	O
,	O
Aves	O
Labs	O
)	O
;	O
anti-GAD65/67	S-GP
(	O
polyclonal	O
1∶1000	O
,	O
Chemicon	O
)	O
;	O
Anti-glial	B-GP
fibrillary	I-GP
acidic	I-GP
protein	E-GP
(	O
GFAP	S-GP
,	O
monoclonal	O
1∶1000	O
,	O
Chemicon	O
;	O
polyclonal	O
1∶200	O
,	O
Aves	O
Labs	O
)	O
;	O
Anti-galactocerebrocide	S-GP
(	O
GC	S-GP
,	O
monoclonal	O
1∶250	O
,	O
Chemicon	O
)	O
;	O
Anti-CNPase	S-GP
(	O
polyclonal	O
1∶200	O
,	O
Aves	O
Labs	O
)	O
;	O
Anti-Glucose	B-GP
Transporter	I-GP
type	I-GP
1	E-GP
(	O
Glut-1	S-GP
polyclonal	O
,	O
1∶500	O
,	O
Chemicon	O
)	O
;	O
Anti-Nestin	S-GP
(	O
polyclonal	O
1∶1000	O
,	O
Chemicon	O
)	O
;	O
Anti-vimentin	S-GP
(	O
monoclonal	O
1∶500	O
,	O
Calbiochem	O
)	O
;	O
Anti-3CB2	S-GP
(	O
monoclonal	O
1∶500	O
,	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
)	O
;	O
Anti-doublecortin	S-GP
(	O
DCX	S-GP
,	O
polyclonal	O
1∶250	O
,	O
SantaCruz	O
Biotechnology	O
)	O
;	O
Anti-Ki67	S-GP
(	O
polyclonal	O
1∶250	O
,	O
SantaCruz	O
Biotechnology	O
)	O
.	O

A	O
recent	O
study	O
has	O
reported	O
that	O
a	O
murine	B-cell_type
ESC	E-cell_type
-derived	O
NSC	O
line	O
(	O
LC1	S-cell_line
)	O
is	O
propagated	O
as	O
an	O
adherent	O
homogenous	O
culture	O
with	O
a	O
dominant	O
mode	O
of	O
symmetrical	O
self-renewal	O
[	O
21	O
]	O
.	O

In	O
I	O
,	O
rare	O
example	O
of	O
grafted	O
NSC	O
progeny	O
becoming	O
an	O
oligodendrocyte	O
identified	O
by	O
the	O
expression	O
of	O
CNPase	S-GP
(	O
green	O
)	O
.	O

To	O
determine	O
whether	O
SD56	B-cell_type
hNSCs	E-cell_type
form	O
tumors	S-x
in	O
vivo	O
,	O
we	O
transplanted	O
them	O
at	O
high	O
density	O
(	O
see	O
Methods	O
)	O
into	O
the	O
forebrain	S-x
and	O
subcutaneously	S-x
into	O
the	O
flank	O
of	O
nude	O
rats	S-y
.	O

Animals	O
were	O
tested	O
for	O
their	O
baselines	O
after	O
stroke	O
and	O
4	O
and	O
8	O
weeks	O
after	O
cell	O
transplantation	O
.	O

The	O
dispersion	O
of	O
the	O
grafted	O
hNSCs	S-cell_type
within	O
host	O
parenchyma	S-x
may	O
allow	O
for	O
more	O
graft-host	O
interactions	O
that	O
could	O
stabilize	O
differentiation	O
,	O
inhibit	O
growth	O
and	O
prevent	O
gliotic	O
host	O
response	O
.	O

Maintenance	O
of	O
stem	O
cells	O
requires	O
symmetrical	O
and	O
asymmetrical	O
cell	O
divisions	O
to	O
both	O
expand	O
and	O
to	O
give	O
rise	O
to	O
specialized	O
progeny	S-cell_type
of	O
a	O
specific	O
tissue	O
(	O
reviewed	O
in	O
[	O
23	O
]	O
)	O
.	O

The	O
floating	O
2°	O
spheres	O
were	O
collected	O
and	O
replated	O
in	O
fresh	O
growth	O
medium	O
for	O
2	O
weeks	O
.	O

We	O
also	O
demonstrate	O
their	O
long-term	O
expansion	O
,	O
non-tumorigenic	O
properties	O
and	O
functional	O
engraftability	O
in	O
an	O
experimental	O
model	O
of	O
stroke	O
.	O

(	O
Abbreviations	O
:	O
Cx	O
:	O
cortex	S-x
,	O
Str	O
:	O
striatum	S-x
)	O
.	O

The	O
cell	O
perpetuation	O
(	O
G	O
)	O
and	O
population	O
doubling	O
(	O
H	O
)	O
analysis	O
demonstrated	O
the	O
continuous	O
and	O
stable	O
growth	O
of	O
the	O
hNSCs	S-cell_type
.	O

The	O
differentiation	O
of	O
the	O
hNSCs	S-cell_type
was	O
performed	O
as	O
previously	O
described	O
[	O
48	O
]	O
.	O

We	O
used	O
the	O
cylinder	O
test	O
to	O
measure	O
the	O
sensorimotor	O
asymmetry	O
in	O
forelimb	O
use	O
during	O
spontaneous	O
exploration	O
[	O
22	O
]	O
.	O

2	O
.	O

They	O
were	O
perpetuated	O
for	O
an	O
additional	O
5	O
passages	O
(	O
E	O
)	O
.	O

of	O
steps	O
taken	O
by	O
the	O
ipsilateral	S-x
,	O
contralateral	S-x
and	O
both	O
forelimbs	S-x
simultaneously	O
.	O

After	O
3	O
days	O
in	O
vitro	O
(	O
DIV	O
)	O
,	O
there	O
was	O
selective	O
survival	O
and	O
growth	O
of	O
cells	O
that	O
aggregated	O
in	O
clusters	O
or	O
spheres	O
(	O
Figure	O
1B	O
)	O
.	O

In	O
the	O
vehicle	O
treated	O
group	O
,	O
the	O
independent	O
use	O
of	O
the	O
contralateral	S-x
forelimb	O
remained	O
impaired	O
4	O
and	O
8	O
weeks	O
post-injection	O
.	O

RT-PCR	O
and	O
immunocytochemistry	O
analysis	O
demonstrated	O
that	O
these	O
undifferentiated	O
SD56	B-cell_type
cells	E-cell_type
did	O
not	O
express	O
any	O
pluripotency	O
,	O
endodermal	S-x
or	O
mesodermal	S-x
markers	O
.	O

hESC	O
and	O
NSC	O
CulturesThe	O
hESC	O
line	O
H9	S-cell_line
(	O
WiCell	O
Research	O
Institute	O
)	O
was	O
propagated	O
every	O
5	O
to	O
7	O
days	O
on	O
irradiated	O
mouse	S-y
embryonic	S-x
fibroblasts	O
.	O

Thus	O
,	O
NSCs	S-cell_type
isolated	O
from	O
developing	O
or	O
adult	O
brain	O
grow	O
as	O
a	O
mixture	O
of	O
undifferentiated	O
and	O
differentiated	O
cells	O
due	O
the	O
predominant	O
asymmetrical	O
mode	O
of	O
cell	O
division	O
[	O
35	O
]	O
,	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
,	O
[	O
41	O
]	O
.	O

Together	O
,	O
these	O
findings	O
are	O
encouraging	O
and	O
suggest	O
that	O
these	O
cells	O
are	O
promising	O
for	O
future	O
development	O
.	O

(	O
B	O
,	O
C	O
)	O
Photos	O
show	O
frontal	O
sections	O
through	O
the	O
graft	O
in	O
the	O
striatum	S-x
immunostained	O
with	O
the	O
human	S-y
specific	O
antibodies	O
:	O
anti-	O
hNuc	S-GP
(	O
green	O
in	O
B	O
&	O
C	O
)	O
and	O
anti-	O
GluT1	S-GP
(	O
red	O
,	O
B	O
&	O
C	O
)	O
showing	O
blood	B-x
vessels	E-x
and	O
dispersed	O
hNSCs	S-cell_type
in	O
the	O
graft	O
zone	O
.	O

In	O
addition	O
to	O
the	O
different	O
combination	O
of	O
growth	O
factors	O
used	O
,	O
the	O
hNSC	O
line	O
we	O
have	O
isolated	O
did	O
not	O
go	O
through	O
the	O
rosette-structure	O
stage	O
.	O

Recent	O
evidence	O
has	O
suggested	O
that	O
the	O
transplantation	O
of	O
cells	O
derived	O
from	O
cord	B-x
blood	E-x
,	O
bone	B-x
marrow	E-x
or	O
brain	O
tissue	O
(	O
fetal	S-x
and	O
adult	O
)	O
enhances	O
sensorimotor	O
function	O
in	O
experimental	O
models	O
of	O
stroke	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
.	O

The	O
SD56	B-cell_type
hNSCs	E-cell_type
demonstrated	O
a	O
remarkable	O
ability	O
to	O
migrate	O
toward	O
the	O
stroke-damaged	O
parenchyma	S-x
of	O
the	O
adult	O
rat	O
brain	O
.	O

This	O
procedure	O
was	O
performed	O
for	O
21	O
passages	O
and	O
the	O
fold	O
of	O
increase	O
and	O
population	O
doubling	O
were	O
calculated	O
at	O
each	O
passage	O
.	O

Aliquots	O
(	O
1	O
µg	O
)	O
of	O
total	O
RNA	O
from	O
the	O
cells	O
were	O
reverse	O
transcribed	O
in	O
the	O
presence	O
of	O
50	O
mM	O
Tris-HCl	O
,	O
pH	O
8.3	O
,	O
75	O
mM	O
KCl	O
,	O
3	O
mM	O
MgCl2	O
,	O
10	O
mM	O
DTT	O
,	O
0.5	O
µM	O
dNTPs	O
,	O
and	O
0.5	O
µg	O
oligo-dT	O
(	O
12–18	O
)	O
with	O
200	O
U	O
Superscript	O
RNase	S-GP
H-Reverse	O
Transcriptase	S-GP
(	O
Invitrogen	O
)	O
.	O

Aliquots	O
of	O
cDNA	O
equivalent	O
to	O
50	O
ng	O
of	O
total	O
RNA	O
were	O
amplified	O
in	O
25	O
µl	O
reactions	O
containing	O
10	O
mM	O
Tris-HCl	O
,	O
pH	O
8.3	O
,	O
50	O
mM	O
KCl	O
,	O
1.5	O
mM	O
MgCl2	O
,	O
50	O
pmol	O
of	O
each	O
primer	O
,	O
400	O
µM	O
dNTPs	O
,	O
and	O
0.5	O
U	O
AmpliTaq	O
DNA	O
polymerase	S-GP
(	O
Perkin-Elmer	O
)	O
.	O

Human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hESCs	S-cell_type
)	O
and	O
neural	O
progenitor	O
(	O
NP	O
)	O
cells	O
are	O
excellent	O
models	O
for	O
recapitulating	O
early	O
neuronal	O
development	O
in	O
vitro	O
,	O
and	O
are	O
key	O
to	O
establishing	O
strategies	O
for	O
the	O
treatment	O
of	O
degenerative	O
disorders	O
.	O

Here	O
,	O
we	O
compared	O
REAP	O
predictions	O
to	O
both	O
approaches	O
.	O

Finally	O
,	O
using	O
analysis	O
of	O
the	O
sequences	O
flanking	O
REAP-identified	O
alternative	O
exons	O
,	O
we	O
were	O
able	O
to	O
discover	O
known	O
and	O
novel	O
cis-regulatory	O
elements	O
that	O
potentially	O
regulate	O
these	O
AS	O
events	O
.	O

We	O
identified	O
a	O
motif	O
CUCAU	O
resembling	O
the	O
Nova	S-GP
binding	O
site	O
YCAY	O
[	O
74	O
]	O
,	O
and	O
a	O
G-rich	O
motif	O
(	O
AGGGG	O
,	O
GGGGA	O
,	O
GGGGC	O
,	O
GGGGG	O
,	O
GGGGU	O
)	O
enriched	O
in	O
the	O
introns	O
downstream	O
of	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
.	O

However	O
,	O
as	O
with	O
hESCs	S-cell_type
,	O
the	O
focus	O
thus	O
far	O
has	O
been	O
primarily	O
on	O
transcriptional	O
differences	O
,	O
which	O
ignores	O
differential	O
RNA	S-cellcomponent
processing	O
such	O
as	O
AS	O
,	O
polyadenylation	O
,	O
degradation	O
,	O
or	O
promoter	O
usage	O
.	O

Cyt-NP	O
,	O
HUES6-NP	O
,	O
and	O
hCNS-SCns	S-cell_type
cells	O
were	O
Nestin	S-GP
and	O
Sox1	S-GP
positive	O
.	O

The	O
negative	O
slope	O
revealed	O
that	O
probesets	O
enriched	O
in	O
hESCs	S-cell_type
versus	O
hCNS-SCns	S-cell_type
(	O
positive	O
valued	O
)	O
,	O
were	O
expectedly	O
depleted	O
when	O
hCNS-SCns	S-cell_type
was	O
compared	O
to	O
hESCs	S-cell_type
(	O
negative	O
valued	O
;	O
Figure	O
3F	O
)	O
.	O

In	O
comparison	O
,	O
the	O
shuffled	O
probesets	O
at	O
the	O
same	O
requirements	O
remained	O
at	O
∼4	O
%	O
.	O

The	O
commercial	O
availability	O
of	O
Affymetrix	O
exon	O
arrays	O
provides	O
an	O
alternative	O
approach	O
to	O
interrogate	O
the	O
expression	O
of	O
every	O
known	O
and	O
predicted	O
exon	O
in	O
the	O
human	S-y
genome	O
.	O

These	O
pieces	O
were	O
transferred	O
to	O
a	O
T75	O
flask	O
with	O
hESCs	S-cell_type
differentiation	O
media	O
(	O
same	O
hESC	O
medium	O
but	O
10	O
%	O
KSR	S-GP
and	O
no	O
FGF-2	S-GP
)	O
.	O

If	O
we	O
had	O
N	O
replicates	O
in	O
one	O
condition	O
and	O
M	O
replicates	O
in	O
the	O
other	O
,	O
we	O
could	O
consider	O
N*M	O
points	O
if	O
we	O
analyzed	O
every	O
possible	O
pairing	O
.	O

Similar	O
analysis	O
of	O
the	O
enriched	O
genes	O
in	O
NPs	S-cell_type
revealed	O
an	O
overrepresentation	O
in	O
molecular	O
functional	O
categories	O
,	O
such	O
as	O
“	O
calcium	O
ion	O
binding	O
”	O
(	O
p-value	O
<	O
10−8	O
)	O
and	O
“	O
structural	O
molecule	O
activity	O
”	O
(	O
p-value	O
<	O
10−5	O
)	O
,	O
and	O
in	O
biological	O
processes	O
involved	O
with	O
“	O
neurogenesis	O
”	O
(	O
p-value	O
<	O
10−38	O
)	O
,	O
“	O
cell	O
adhesion	O
”	O
(	O
p-value	O
<	O
10−13	O
)	O
,	O
“	O
cell	O
motility	O
”	O
(	O
p-value	O
<	O
10−4	O
)	O
,	O
“	O
development	O
”	O
(	O
p-value	O
<	O
10−6	O
)	O
,	O
“	O
neuropeptide	O
signaling	O
pathway	O
”	O
(	O
p-value	O
<	O
10−4	O
)	O
,	O
and	O
“	O
endocytosis	O
”	O
(	O
p-value	O
<	O
10−4	O
)	O
(	O
Figure	O
2B	O
)	O
.	O

Hybridization	O
was	O
performed	O
for	O
16	O
hours	O
using	O
the	O
Fluidics	O
450	O
station	O
.	O

White-filled	O
triangles	O
represented	O
similarly	O
computed	O
fractions	O
with	O
permuted	O
probeset	O
to	O
exon	O
mappings.Next	O
,	O
we	O
compared	O
REAP	O
predictions	O
to	O
a	O
computational	O
approach	O
of	O
identifying	O
exons	O
with	O
AS	O
conserved	O
in	O
human	S-y
and	O
mouse	S-y
,	O
ACEScan	O
[	O
55	O
]	O
.	O

Arrows	O
indicate	O
the	O
larger	O
(	O
exon-included	O
)	O
isoforms	O
and	O
smaller	O
(	O
exon-skipped	O
)	O
isoforms.First	O
,	O
given	O
three	O
independent	O
samples	O
each	O
from	O
two	O
conditions	O
,	O
we	O
concluded	O
that	O
REAP	O
was	O
able	O
to	O
identify	O
AS	O
events	O
with	O
high	O
specificity	O
but	O
with	O
moderate	O
sensitivity	O
.	O

Thus	O
,	O
robust	O
regression	O
would	O
find	O
the	O
line	O
that	O
was	O
least	O
dependent	O
on	O
outliers	O
,	O
which	O
would	O
be	O
potential	O
AS	O
exons	O
.	O

Examples	O
of	O
splicing	O
regulators	O
that	O
are	O
enriched	O
and	O
function	O
specifically	O
in	O
neuronal	B-cell_type
cells	E-cell_type
include	O
the	O
brain-specific	B-GP
splicing	I-GP
factor	I-GP
Nova	E-GP
[	O
43,44	O
]	O
and	O
neural-specific	B-GP
polypyrimidine	I-GP
tract	I-GP
binding	I-GP
protein	E-GP
(	O
nPTB	S-GP
)	O
,	O
which	O
antagonizes	O
its	O
paralogous	O
PTB	O
to	O
regulate	O
exon	O
exclusion	O
in	O
neuronal	B-cell_type
cells	E-cell_type
[	O
45–47	O
]	O
.	O

Briefly	O
,	O
DABG	O
compared	O
the	O
signal	O
for	O
each	O
probe	O
to	O
a	O
background	O
distribution	O
of	O
signals	O
from	O
anti-genomic	O
probes	O
with	O
the	O
same	O
GC	O
content	O
.	O

We	O
hypothesized	O
that	O
a	O
linear	O
regression	O
to	O
determine	O
if	O
some	O
probesets	O
behaved	O
unexpectedly	O
in	O
one	O
cell	O
type	O
compared	O
to	O
the	O
other	O
might	O
be	O
a	O
reasonable	O
approach	O
to	O
identify	O
AS	O
exons.Figure	O
3Description	O
of	O
the	O
REAP	O
Algorithm	O
Comparing	O
Exon	O
Array	O
Signal	O
Estimates	O
from	O
hCNS-SCns	S-cell_type
and	O
Cyt-ES	S-cell_line
(	O
A	O
)	O
Histogram	O
of	O
Pearson	O
correlation	O
coefficients	O
computed	O
from	O
median	O
signal	O
estimates	O
for	O
probesets	O
between	O
Cyt-ES	S-cell_line
versus	O
hCNS-SCns	S-cell_type
for	O
genes	O
(	O
blue	O
bars	O
)	O
.	O

The	O
patterns	O
of	O
AS	O
in	O
hESCs	O
were	O
similar	O
in	O
both	O
Cyt-ES	S-cell_line
and	O
HUES6-ES	S-cell_line
for	O
all	O
AS	O
events	O
validated	O
,	O
but	O
the	O
NPs	S-cell_type
(	O
Cyt-NP	O
,	O
HUES6	S-cell_line
-NP	O
,	O
and	O
hCNS-SCns	S-cell_type
)	O
had	O
more	O
varied	O
AS	O
.	O

Human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hESCs	S-cell_type
)	O
are	O
pluripotent	B-cell_type
cell	E-cell_type
s	O
that	O
propagate	O
perpetually	O
in	O
culture	O
as	O
undifferentiated	O
cells	O
and	O
can	O
be	O
induced	O
to	O
differentiate	O
into	O
a	O
multitude	O
of	O
cell	O
types	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
[	O
3	O
]	O
.	O

Nuclei	S-cellcomponent
stained	O
positive	O
for	O
Dapi	O
.	O

Exons	O
with	O
canonical	O
splice	O
signals	O
(	O
GT-AG	O
,	O
AT-AC	O
,	O
GC-AG	O
)	O
were	O
retained	O
,	O
resulting	O
in	O
a	O
total	O
of	O
213,736	O
exons	O
.	O

Of	O
the	O
six	O
5-mers	O
that	O
were	O
enriched	O
upstream	O
of	O
both	O
REAP	O
[	O
+	O
]	O
NP	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
,	O
we	O
identified	O
GCAUG	O
,	O
which	O
was	O
previously	O
shown	O
to	O
be	O
an	O
intronic	O
splicing	O
cis-element	O
for	O
the	O
mammalian	S-x
fibronectin	S-GP
and	O
calcitonin/CGRP	S-GP
genes	O
[	O
70–72	O
]	O
.	O

Similar	O
overall	O
trends	O
were	O
observed	O
with	O
hCNS-SCns	S-cell_type
versus	O
HUES6-ES	S-cell_line
and	O
the	O
derived	O
NPs	S-cell_type
versus	O
hESCs	S-cell_type
(	O
Figure	O
6B	O
)	O
.	O

REAP	O
was	O
based	O
on	O
the	O
assumptions	O
that	O
most	O
exons	O
in	O
the	O
gene	O
of	O
interest	O
and	O
in	O
the	O
genome	O
are	O
constitutively	O
spliced	O
and	O
that	O
outliers	O
in	O
a	O
linear	O
pairwise	O
comparison	O
of	O
the	O
signal	O
estimates	O
for	O
probesets	O
in	O
a	O
gene	O
could	O
be	O
detected	O
using	O
a	O
robust	O
regression-based	O
approach	O
.	O

Cells	O
could	O
be	O
grown	O
as	O
a	O
monolayer	O
for	O
up	O
to	O
at	O
least	O
ten	O
passages	O
.	O

Using	O
the	O
above-mentioned	O
groupings	O
of	O
hESCs	S-cell_type
(	O
Cyt-ES	S-cell_line
,	O
HUES6-ES	S-cell_line
)	O
and	O
NPs	S-cell_type
(	O
Cyt-NP	O
,	O
HUES6	S-cell_line
-NP	O
,	O
and	O
hCNS-SCns	S-cell_type
)	O
,	O
2,945	O
genes	O
were	O
enriched	O
in	O
hESCs	S-cell_type
relative	O
to	O
NPs	S-cell_type
;	O
and	O
552	O
genes	O
were	O
enriched	O
in	O
the	O
NPs	S-cell_type
relative	O
to	O
hESCs	S-cell_type
,	O
at	O
a	O
p-value	O
significance	O
cutoff	O
of	O
0.01	O
(	O
correcting	O
for	O
multiple	O
hypothesis	O
testing	O
using	O
the	O
Benjamini-Hochberg	O
method	O
)	O
.	O

White	O
horizontal	O
bar	O
indicated	O
15	O
μm	O
.	O

Arrays	O
were	O
scanned	O
using	O
the	O
Affymetrix	O
3000	O
7G	O
scanner	O
and	O
GeneChip	O
Operating	O
Software	O
version	O
1.4	O
to	O
produce	O
.CEL	O
intensity	O
files	O
.	O

In	O
addition	O
,	O
we	O
validated	O
nine	O
novel	O
AS	O
events	O
that	O
distinguish	O
hESCs	S-cell_type
and	O
NPs	S-cell_type
.	O

As	O
a	O
natural	O
benchmark	O
for	O
the	O
derived	O
NPs	S-cell_type
,	O
we	O
utilized	O
hCNS-SCns	S-cell_type
,	O
which	O
were	O
previously	O
isolated	O
from	O
fresh	O
human	B-x
fetal	I-x
brain	E-x
tissues	O
using	O
antibodies	O
to	O
cell-surface	S-cellcomponent
markers	O
and	O
fluorescence-activated	O
cell	O
sorting	O
[	O
12,23	O
]	O
.	O

This	O
assumption	O
was	O
substantiated	O
by	O
our	O
observation	O
that	O
,	O
using	O
publicly	O
available	O
ESTs	O
and	O
mRNAs	O
,	O
a	O
minority	O
of	O
human	S-y
exons	O
(	O
7	O
%	O
)	O
have	O
evidence	O
for	O
exon-skipping	O
,	O
the	O
most	O
common	O
form	O
of	O
AS	O
.	O

(	O
B	O
)	O
Gene-level	O
signal	O
estimates	O
of	O
marker	O
genes	O
(	O
GAPDH	S-GP
,	O
Oct4	S-GP
,	O
Nanog	S-GP
,	O
Nestin	S-GP
,	O
Notch1	S-GP
,	O
DNER	S-GP
,	O
and	O
Sox1	S-GP
)	O
from	O
Affymetrix	O
exon	O
array	O
analysis	O
.	O

Medium	O
was	O
changed	O
the	O
next	O
day	O
by	O
transferring	O
the	O
floating	O
hESC	O
aggregates	O
to	O
a	O
new	O
flask	O
.	O

13,934	O
exons	O
with	O
evidence	O
for	O
exon-skipping	O
and/or	O
inclusion	O
(	O
EST-SE	O
for	O
EST-verified	O
skipped	O
exons	O
)	O
were	O
generated	O
,	O
comprising	O
∼7	O
%	O
of	O
all	O
internal	O
exons	O
.	O

We	O
identified	O
68	O
conserved	O
5-mers	O
enriched	O
upstream	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
exons	O
;	O
and	O
34	O
5-mers	O
enriched	O
upstream	O
of	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
(	O
Figure	O
9C	O
;	O
Table	O
S4	O
)	O
.	O

Cells	O
were	O
Sox1	S-GP
and	O
nestin	S-GP
positive	O
and	O
readily	O
differentiated	O
into	O
neurons	O
upon	O
withdrawal	O
of	O
FGF-2	S-GP
.	O

Here	O
,	O
n	O
referred	O
to	O
the	O
number	O
of	O
points	O
(	O
generated	O
for	O
each	O
gene	O
)	O
,	O
and	O
p	O
referred	O
to	O
the	O
number	O
of	O
independent	O
variables	O
(	O
p	O
=	O
2	O
in	O
our	O
method	O
)	O
;	O
and	O
μx	O
=	O
Σxi2/n	O
;	O
sx2	O
=	O
n−1	O
Σ	O
(	O
xi	O
−	O
μx	O
)	O
2	O
.	O

For	O
instance	O
,	O
three	O
replicate	O
signal	O
estimates	O
for	O
every	O
probeset	O
per	O
cell	O
line	O
,	O
such	O
as	O
signal	O
estimates	O
a	O
,	O
b	O
,	O
and	O
c	O
in	O
hESCs	S-cell_type
and	O
d	O
,	O
e	O
,	O
and	O
f	O
in	O
hCNS-SCns	S-cell_type
,	O
would	O
translate	O
to	O
pairing	O
every	O
signal	O
(	O
d	O
,	O
a	O
)	O
,	O
(	O
d	O
,	O
b	O
)	O
,	O
(	O
d	O
,	O
c	O
)	O
…	O
(	O
f	O
,	O
a	O
)	O
,	O
(	O
f	O
,	O
b	O
)	O
,	O
(	O
f	O
,	O
c	O
)	O
for	O
linear	O
regression	O
(	O
Figure	O
3B	O
)	O
.	O

G-rich	O
motifs	O
had	O
previously	O
been	O
shown	O
to	O
be	O
part	O
of	O
a	O
bipartite	O
signal	O
that	O
silences	O
AS	O
exons	O
[	O
75	O
]	O
.	O

Of	O
these	O
,	O
197,262	O
(	O
92	O
%	O
of	O
all	O
exons	O
)	O
were	O
constitutive	O
exons	O
,	O
13,934	O
exons	O
(	O
7	O
%	O
)	O
had	O
evidence	O
of	O
exon-skipping	O
,	O
1,615	O
(	O
1	O
%	O
)	O
exons	O
were	O
mutually	O
exclusive	O
alternative	O
events	O
,	O
5,930	O
(	O
3	O
%	O
)	O
exons	O
had	O
alternative	O
3′	O
splice	O
sites	O
,	O
5,181	O
(	O
2	O
%	O
)	O
exons	O
had	O
alternative	O
5′	O
splice	O
sites	O
,	O
and	O
175	O
(	O
<	O
1	O
%	O
)	O
exons	O
overlapped	O
another	O
exon	O
,	O
but	O
did	O
not	O
fall	O
into	O
the	O
above	O
classifications	O
.	O

The	O
DABG	O
algorithm	O
generated	O
a	O
p-value	O
representing	O
the	O
probability	O
that	O
the	O
signal	O
intensity	O
of	O
a	O
given	O
probe	O
was	O
part	O
of	O
the	O
background	O
distribution	O
.	O

Derivation	O
of	O
Neural	B-cell_type
Progenitors	E-cell_type
from	O
Embryonic	B-cell_type
Stem	I-cell_type
Cells	E-cell_type
NPs	S-cell_type
were	O
independently	O
derived	O
from	O
two	O
hESC	O
lines	O
,	O
and	O
RNA	O
extracted	O
from	O
the	O
cell	O
lines	O
was	O
processed	O
and	O
hybridized	O
onto	O
Affymetrix	O
Human	S-y
1.0	O
ST	O
exon	O
arrays	O
.	O

As	O
our	O
method	O
for	O
predicting	O
candidate	O
alternative	O
exons	O
was	O
based	O
on	O
identification	O
of	O
outliers	O
using	O
robust	O
regression	O
,	O
we	O
named	O
the	O
method	O
REAP	O
.	O

AS	O
is	O
frequently	O
used	O
to	O
regulate	O
gene	O
expression	O
and	O
to	O
generate	O
tissue-specific	O
mRNA	O
and	O
protein	O
isoforms	O
[	O
36–39	O
]	O
.	O

We	O
postulated	O
that	O
AS	O
events	O
may	O
serve	O
also	O
to	O
bias	O
the	O
differentiation	O
spectrum	O
of	O
the	O
cells	O
,	O
an	O
important	O
avenue	O
for	O
future	O
work	O
.	O

Following	O
Belsley	O
et	O
al	O
.	O

In	O
total	O
,	O
7.5	O
%	O
(	O
131	O
of	O
1,737	O
)	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
designated	O
as	O
ACEScan	O
[	O
+	O
]	O
compared	O
to	O
2.4	O
%	O
(	O
2,328	O
of	O
97,437	O
)	O
of	O
REAP	O
[	O
−	O
]	O
exons	O
.	O

The	O
pattern	O
of	O
AS	O
in	O
the	O
REAP	O
[	O
+	O
]	O
exons	O
in	O
the	O
SLK	S-GP
(	O
serine/threonine	B-GP
kinase	I-GP
2	E-GP
)	O
and	O
POT1	S-GP
(	O
protection	B-GP
of	I-GP
telomeres	I-GP
1	E-GP
)	O
genes	O
showed	O
remarkable	O
agreement	O
within	O
derived	O
NPs	S-cell_type
and	O
hCNS-SCns	S-cell_type
(	O
Figure	O
7B	O
)	O
.	O

While	O
much	O
effort	O
had	O
been	O
undertaken	O
to	O
analyze	O
transcriptional	O
and	O
epigenetic	O
differences	O
during	O
the	O
transition	O
of	O
hESC	O
to	O
NP	O
,	O
very	O
little	O
work	O
has	O
been	O
performed	O
to	O
understand	O
post-transcriptional	O
changes	O
during	O
neuronal	O
differentiation	O
.	O

Exons	O
that	O
were	O
orthologous	O
across	O
human	S-y
,	O
dog	S-y
,	O
rat	S-y
,	O
and	O
mouse	S-y
were	O
obtained	O
and	O
the	O
flanking	O
intronic	O
regions	O
were	O
aligned	O
(	O
400	O
bases	O
upstream	O
and	O
downstream	O
separately	O
;	O
Figure	O
9A	O
)	O
.	O

EBs	S-x
were	O
plated	O
on	O
a	O
coated	O
10-cm	O
dish	O
in	O
hESC	O
differentiation	O
media	O
.	O

These	O
percentages	O
were	O
not	O
significantly	O
different	O
from	O
the	O
2.7	O
%	O
observed	O
from	O
all	O
exons	O
(	O
4,487	O
of	O
the	O
162,000	O
exons	O
that	O
were	O
scored	O
by	O
ACEScan	O
)	O
.	O

After	O
culturing	O
for	O
a	O
week	O
,	O
the	O
hESC	O
cell	O
aggregates	O
formed	O
mature	O
embroid	B-x
bodies	E-x
(	O
EBs	S-x
;	O
∼10	O
um	O
round	O
clusters	O
with	O
dark	O
centers	O
)	O
.	O

Detection	O
of	O
AS	O
by	O
RT-PCR	O
.	O
cDNAs	S-cellcomponent
were	O
generated	O
from	O
total	O
RNA	S-cellcomponent
with	O
Superscript	O
III	O
reverse	B-GP
transcriptase	E-GP
(	O
Invitrogen	O
)	O
.	O

Comparing	O
the	O
significant	O
probesets	O
between	O
hCNS-SCns	S-cell_type
versus	O
Cyt-ES	S-cell_line
and	O
hCNS-SCns	S-cell_type
versus	O
HUES6-ES	S-cell_line
revealed	O
672	O
significant	O
probesets	O
(	O
N	O
≥	O
2	O
)	O
,	O
whereas	O
if	O
we	O
shuffled	O
the	O
associations	O
between	O
probeset	O
identity	O
and	O
significant	O
outliers	O
,	O
only	O
four	O
significant	O
probesets	O
(	O
N	O
≥	O
2	O
)	O
were	O
identified—a	O
168-fold	O
enrichment	O
(	O
Figure	O
5B	O
,	O
Table	O
S1	O
)	O
.	O

Cells	O
grown	O
on	O
matrigel	O
were	O
grown	O
in	O
MEF-conditioned	O
medium	O
and	O
FGF-2	S-GP
was	O
used	O
at	O
20	O
ng/mL	O
instead	O
of	O
10	O
ng/mL	O
for	O
cells	O
grown	O
on	O
MEFs	O
.	O

Description	O
of	O
the	O
Regression-Based	O
Exon	O
Array	O
ProtocolConvinced	O
that	O
the	O
signal	O
estimates	O
from	O
the	O
exon	O
arrays	O
reflected	O
expected	O
molecular	O
and	O
biological	O
differences	O
between	O
hESCs	S-cell_type
and	O
NPs	S-cell_type
,	O
we	O
sought	O
to	O
identify	O
AS	O
events	O
.	O

RT-PCR	O
of	O
Oct4	S-GP
and	O
Nanog	S-GP
mRNA	O
levels	O
accurately	O
reflected	O
the	O
signal	O
estimates	O
from	O
the	O
array	O
(	O
Figure	O
1C	O
)	O
.	O

In	O
terms	O
of	O
GO	O
biological	O
process	O
categories	O
,	O
REAP	O
[	O
+	O
]	O
genes	O
were	O
more	O
frequently	O
involved	O
in	O
“	O
ubiquitin	S-GP
cycle.	O
”	O
Similar	O
results	O
were	O
obtained	O
when	O
we	O
compared	O
REAP	O
[	O
+	O
]	O
genes	O
to	O
all	O
human	S-y
genes	O
that	O
did	O
not	O
contain	O
REAP	O
[	O
+	O
]	O
exons	O
(	O
Table	O
1	O
)	O
[	O
55	O
]	O
.Table	O
1Significantly	O
Enriched	O
Gene	O
Ontology	O
Terms	O
in	O
REAP	O
[	O
+	O
]	O
Genes	O
(	O
Cutoff	O
of	O
Two	O
Significant	O
“	O
Outliers	O
”	O
per	O
Probeset	O
)	O
Next	O
we	O
asked	O
if	O
REAP	O
[	O
+	O
]	O
genes	O
are	O
differentially	O
expressed	O
in	O
hESCs	S-cell_type
compared	O
to	O
NPs	S-cell_type
and	O
vice	O
versa	O
.	O

ACEScan	O
receives	O
as	O
input	O
orthologous	O
human	S-y
–	O
mouse	S-y
exon	O
pairs	O
and	O
flanking	O
intronic	O
regions	O
and	O
computes	O
sequence	O
features	O
and	O
integrates	O
the	O
features	O
into	O
a	O
machine-learning	O
algorithm	O
to	O
assign	O
a	O
real-valued	O
score	O
to	O
the	O
exon	O
.	O

Vertical	O
bars	O
indicated	O
average	O
log2	O
normalized	O
signal	O
estimates	O
,	O
and	O
error	O
bars	O
represented	O
standard	O
deviations	O
from	O
three	O
independent	O
replicate	O
experiments	O
per	O
cell	O
type	O
.	O

Of	O
the	O
five	O
5-mers	O
that	O
were	O
enriched	O
downstream	O
of	O
both	O
REAP	O
[	O
+	O
]	O
NP	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
,	O
GCAUG	O
and	O
a	O
U-rich	O
motif	O
(	O
UUUUU	O
)	O
were	O
identified	O
.	O

During	O
alternative	O
RNA	S-cellcomponent
splicing	O
(	O
AS	O
)	O
,	O
noncoding	O
sequences	O
(	O
introns	O
)	O
in	O
a	O
pre-mRNA	S-cellcomponent
are	O
differentially	O
removed	O
in	O
different	O
cell	O
types	O
and	O
tissues	O
,	O
and	O
the	O
remaining	O
sequences	O
(	O
exons	O
)	O
are	O
joined	O
to	O
form	O
multiple	O
forms	O
of	O
mature	O
RNA	S-cellcomponent
,	O
playing	O
an	O
important	O
role	O
in	O
cellular	O
diversity	O
.	O

In	O
agreement	O
,	O
GO	O
analysis	O
suggested	O
that	O
genes	O
containing	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
enriched	O
in	O
serine/threonine	B-GP
kinase	E-GP
activity	O
,	O
of	O
which	O
SLK	S-GP
is	O
a	O
family	O
member	O
.	O

Second	O
,	O
AS	O
events	O
in	O
hESCs	S-cell_type
were	O
more	O
similar	O
,	O
whereas	O
the	O
AS	O
events	O
in	O
derived	O
NPs	S-cell_type
were	O
consistent	O
with	O
or	O
intermediate	O
to	O
the	O
benchmark	O
hCNS-SCns	S-cell_type
,	O
likely	O
reflecting	O
differences	O
in	O
the	O
cell	O
lines	O
and/or	O
differentiation	O
protocols	O
.	O

Points	O
per	O
probeset	O
should	O
be	O
correlated	O
;	O
in	O
other	O
words	O
,	O
if	O
one	O
point	O
was	O
a	O
significant	O
outlier	O
,	O
the	O
other	O
points	O
were	O
expected	O
to	O
be	O
outliers	O
as	O
well	O
.	O

Using	O
robust	O
regression	O
,	O
the	O
regression	O
line	O
for	O
Cyt-ESC	S-cell_line
versus	O
hCNS-SCns	S-cell_type
in	O
the	O
EHBP1	S-GP
gene	O
is	O
illustrated	O
in	O
Figure	O
3C	O
.	O

First	O
we	O
analyzed	O
Cyt-ES	S-cell_line
versus	O
hCNS-SCns	S-cell_type
.	O

Recent	O
studies	O
using	O
splicing-sensitive	O
microarrays	O
suggested	O
that	O
up	O
to	O
75	O
%	O
of	O
human	S-y
genes	O
undergo	O
AS	O
,	O
where	O
multiple	O
isoforms	O
are	O
derived	O
from	O
the	O
same	O
genetic	O
loci	O
[	O
40	O
]	O
.	O

More	O
recently	O
,	O
both	O
mammalian	S-x
Fox1	B-GP
and	I-GP
2	E-GP
have	O
been	O
demonstrated	O
to	O
regulate	O
alternatively	O
spliced	O
exons	O
via	O
UGCAUG	O
binding	O
sites	O
in	O
neighboring	O
introns	O
in	O
neuronal	S-x
cell	O
cultures	O
[	O
73	O
]	O
.Figure	O
9Conserved	O
Intronic	O
cis-Elements	O
Enriched	O
Proximal	O
to	O
REAP	O
[	O
+	O
]	O
Alternative	O
Exons	O
(	O
A	O
)	O
Schematic	O
describing	O
the	O
enumeration	O
of	O
intronic	O
elements	O
across	O
400	O
bases	O
of	O
flanking	O
mammalian	S-x
introns	O
(	O
human	S-y
,	O
dog	S-y
,	O
rat	S-y
,	O
and	O
mouse	S-y
)	O
.	O

Here	O
we	O
considered	O
a	O
point	O
to	O
have	O
high	O
leverage	O
if	O
hi	O
>	O
3p/n	O
.	O

In	O
the	O
first	O
comparison	O
,	O
publicly	O
available	O
ESTs	O
and	O
mRNA	O
transcripts	O
were	O
aligned	O
to	O
the	O
human	S-y
genome	O
sequence	O
.	O

Experimental	O
validation	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
suggested	O
a	O
high	O
specificity	O
at	O
the	O
expense	O
of	O
relatively	O
moderate	O
sensitivity	O
.	O

This	O
result	O
suggested	O
that	O
a	O
small	O
but	O
significantly	O
enriched	O
fraction	O
of	O
AS	O
events	O
in	O
hESCs	S-cell_type
versus	O
NPs	S-cell_type
was	O
likely	O
to	O
be	O
evolutionarily	O
conserved	O
in	O
human	S-y
and	O
mouse	S-y
.	O

We	O
considered	O
a	O
probeset	O
with	O
a	O
DABG	O
p-value	O
lower	O
than	O
0.05	O
as	O
detected	O
above	O
background	O
.	O

Identification	O
and	O
Removal	O
of	O
False	O
PositivesIn	O
the	O
process	O
of	O
experimentally	O
validating	O
our	O
predictions	O
,	O
we	O
encountered	O
three	O
main	O
sources	O
of	O
false	O
positives	O
(	O
FP	O
)	O
from	O
robust	O
regression	O
.	O

Genes	O
on	O
the	O
right	O
of	O
the	O
vertical	O
line	O
at	O
5	O
were	O
designated	O
enriched	O
in	O
hESC	O
and	O
genes	O
on	O
the	O
left	O
of	O
the	O
vertical	O
line	O
at	O
−5	O
were	O
designated	O
enriched	O
in	O
NP	O
;	O
genes	O
in	O
between	O
−5	O
and	O
5	O
were	O
designated	O
as	O
“	O
unchanged	O
”	O
or	O
expressed	O
similarly	O
in	O
hESC	O
and	O
NP	O
.	O

If	O
we	O
required	O
that	O
none	O
of	O
the	O
points	O
per	O
probeset	O
(	O
exon	O
)	O
was	O
significant	O
,	O
6	O
%	O
(	O
4,402	O
of	O
71,731	O
)	O
of	O
exons	O
(	O
after	O
probeset	O
mapping	O
)	O
had	O
evidence	O
for	O
EST-SE	O
(	O
Figure	O
6A	O
)	O
.	O

Points	O
that	O
resembled	O
boxed	O
point	O
“	O
a	O
”	O
were	O
designated	O
as	O
potential	O
AS	O
events	O
.	O

PCR	O
reactions	O
were	O
performed	O
with	O
primer	O
pairs	O
designed	O
for	O
AS	O
targets	O
(	O
annealing	O
at	O
58	O
°C	O
and	O
amplification	O
for	O
30	O
or	O
35	O
cycles	O
)	O
.	O

Closer	O
inspection	O
of	O
the	O
REAP	O
[	O
+	O
]	O
-validated	O
AS	O
exon	O
in	O
the	O
SLK	S-GP
gene	O
revealed	O
strong	O
conservation	O
in	O
the	O
intronic	O
region	O
flanking	O
the	O
exon	O
,	O
a	O
hallmark	O
feature	O
of	O
evolutionarily	O
conserved	O
AS	O
exons	O
[	O
55,77,78	O
]	O
.	O

REAP	O
predictions	O
were	O
found	O
to	O
correlate	O
well	O
with	O
transcript-based	O
methods	O
for	O
identifying	O
alternative	O
exons	O
,	O
which	O
interestingly	O
suggested	O
that	O
current	O
databases	O
of	O
transcript	O
information	O
,	O
albeit	O
not	O
specifically	O
enriched	O
for	O
hESC	O
or	O
NPs	S-cell_type
,	O
in	O
aggregate	O
are	O
nevertheless	O
predictive	O
of	O
AS	O
events	O
in	O
hESC	O
and	O
NP	O
.	O

Interestingly	O
,	O
Nestin	S-GP
was	O
not	O
significantly	O
higher	O
in	O
NPs	S-cell_type
as	O
compared	O
to	O
the	O
hESC	O
from	O
the	O
gene-level	O
estimates	O
(	O
p-value	O
0.065	O
)	O
,	O
which	O
was	O
further	O
confirmed	O
by	O
RT-PCR	O
(	O
Figure	O
1C	O
)	O
.	O

Next	O
,	O
we	O
calculated	O
the	O
covariance	O
ratio	O
,	O
covi	O
=	O
(	O
si2/sr2	O
)	O
p/	O
(	O
1	O
−	O
hi	O
)	O
,	O
which	O
is	O
the	O
ratio	O
of	O
the	O
determinant	O
of	O
the	O
covariance	O
matrix	O
after	O
deleting	O
the	O
ith	O
observation	O
to	O
the	O
determinant	O
of	O
the	O
covariance	O
matrix	O
with	O
the	O
entire	O
sample	O
.	O

We	O
enumerated	O
k-mers	O
that	O
were	O
perfectly	O
conserved	O
across	O
all	O
four	O
genomes	O
in	O
the	O
upstream	O
(	O
and	O
downstream	O
)	O
intronic	O
regions	O
.	O

Immunohistochemical	O
and	O
reverse-	O
transcriptase	S-GP
polymerase	S-GP
chain	O
reaction	O
(	O
RT-PCR	O
)	O
analyses	O
demonstrated	O
that	O
the	O
hESCs	S-cell_type
expressed	O
pluripotent	O
marker	O
genes	O
,	O
and	O
the	O
derived	O
NPs	S-cell_type
expressed	O
multipotent	O
and	O
neurogenic	S-x
markers	O
similar	O
to	O
hCNS-SCns	S-cell_type
.	O

The	O
AS	O
exon	O
in	O
SLK	S-GP
was	O
observed	O
to	O
be	O
included	O
in	O
hESCs	S-cell_type
and	O
completely	O
excluded	O
in	O
NPs	S-cell_type
;	O
the	O
AS	O
exon	O
in	O
the	O
POT1	S-GP
gene	O
was	O
included	O
more	O
in	O
hESCs	S-cell_type
and	O
a	O
smaller	O
isoform	O
persisted	O
in	O
NPs	S-cell_type
.	O

In	O
conclusion	O
,	O
our	O
introduction	O
of	O
REAP	O
and	O
its	O
application	O
to	O
identifying	O
AS	O
events	O
has	O
revealed	O
new	O
and	O
unanticipated	O
insights	O
into	O
hESC	O
biology	O
and	O
their	O
transition	O
to	O
NP	B-cell_type
cells	E-cell_type
.	O

We	O
concluded	O
that	O
potential	O
ISREs	O
were	O
enriched	O
proximal	O
to	O
a	O
subset	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
;	O
in	O
particular	O
,	O
the	O
Fox1/2	S-GP
binding	O
site	O
GCUAG	O
may	O
play	O
a	O
regulatory	O
role	O
in	O
controlling	O
AS	O
events	O
in	O
hESCs	S-cell_type
and	O
NPs	S-cell_type
.	O

The	O
cells	O
were	O
cultured	O
in	O
medium	O
consisting	O
of	O
Ex	O
Vivo	O
15	O
(	O
BioWhittaker	O
)	O
medium	O
with	O
N2	O
supplement	O
(	O
GIBCO	O
)	O
,	O
FGF2	S-GP
(	O
20	O
ng/mL	O
)	O
,	O
epidermal	B-GP
growth	I-GP
factor	E-GP
(	O
20	O
ng/mL	O
)	O
,	O
lymphocyte	B-GP
inhibitory	I-GP
factor	E-GP
(	O
10	O
ng/mL	O
)	O
,	O
0.2	O
mg/ml	O
heparin	O
,	O
and	O
60	O
ug/mL	O
N-acetylcysteine	O
.	O

The	O
boxed	O
points	O
belonged	O
to	O
a	O
probeset	O
that	O
was	O
enriched	O
in	O
hESCs	S-cell_type
but	O
depleted	O
in	O
hCNS-SCns	S-cell_type
,	O
which	O
was	O
suspected	O
to	O
be	O
due	O
to	O
AS	O
.	O

The	O
statistic	O
t	O
hCNS-SC	S-cell_type
ns	O
,	O
ESC	O
=	O
(	O
μ	O
hCNS-SC	S-cell_type
ns	O
−	O
μESC	O
)	O
/	O
sqrt	O
(	O
(	O
(	O
n	O
hCNS-SC	S-cell_type
ns	O
−	O
1	O
)	O
σ2	O
hCNS-SC	S-cell_type
ns	O
+	O
(	O
nESC	O
−	O
1	O
)	O
σ2ESC	O
)	O
(	O
n	O
hCNS-SC	S-cell_type
ns	O
+	O
nESC	O
)	O
)	O
/	O
(	O
(	O
n	O
hCNS-SC	S-cell_type
nsnESC	O
)	O
(	O
n	O
hCNS-SC	S-cell_type
ns	O
+	O
nESC	O
−	O
2	O
)	O
)	O
)	O
,	O
where	O
nh	O
CNS-SC	S-cell_type
ns	O
and	O
nESC	O
were	O
the	O
number	O
of	O
replicates	O
,	O
μ	O
hCNS-SC	S-cell_type
ns	O
and	O
μESC	O
were	O
the	O
mean	O
,	O
and	O
σ2	O
hCNS-SC	S-cell_type
ns	O
and	O
σ2ESC	O
were	O
the	O
variances	O
of	O
the	O
expression	O
values	O
for	O
the	O
two	O
datasets	O
used	O
to	O
represent	O
the	O
differential	O
enrichment	O
of	O
a	O
gene	O
using	O
gene-level	O
estimates	O
in	O
hCNS-SCns	S-cell_type
relative	O
to	O
hESCs	S-cell_type
.	O

The	O
15	O
most	O
enriched	O
genes	O
in	O
hESCs	S-cell_type
included	O
genes	O
such	O
as	O
teratocarcinoma-derived	B-GP
growth	I-GP
factor	I-GP
1	E-GP
(	O
TDGF1/cripto	S-GP
;	O
p-value	O
<	O
10−12	O
)	O
,	O
zinc	B-GP
finger	I-GP
protein	I-GP
42	E-GP
(	O
Zfp42/Rex1	S-GP
;	O
p-value	O
<	O
10−12	O
)	O
,	O
Oct4	S-GP
(	O
p-value	O
<	O
10−12	O
)	O
,	O
Nanog	S-GP
(	O
p-value	O
<	O
10−10	O
)	O
,	O
lin-28	B-GP
homolog	E-GP
(	O
p-value	O
<	O
10−10	O
)	O
,	O
cadherin	B-GP
1	I-GP
preprotein	E-GP
(	O
p-value	O
<	O
10−10	O
)	O
,	O
claudin	B-GP
6	E-GP
(	O
p-value	O
<	O
10−9	O
)	O
,	O
ephrin	O
receptor	O
EphA1	S-GP
(	O
p-value	O
<	O
10−9	O
)	O
,	O
and	O
erbB3	S-GP
(	O
p-value	O
<	O
10−9	O
)	O
.	O

For	O
example	O
,	O
four	O
of	O
the	O
five	O
boxed	O
points	O
in	O
Figure	O
3C	O
were	O
“	O
outliers	O
,	O
”	O
and	O
RT-PCR	O
validation	O
indicated	O
that	O
the	O
exon	O
represented	O
by	O
the	O
probeset	O
was	O
indeed	O
skipped	O
in	O
hCNS-SCns	S-cell_type
(	O
EHBP1	O
,	O
Figure	O
7B	O
)	O
.	O

The	O
next	O
day	O
,	O
the	O
medium	O
was	O
changed	O
to	O
DMEM/F12	O
supplemented	O
with	O
ITS	S-GP
and	O
fibronectin	S-GP
.	O

In	O
addition	O
,	O
the	O
hESCs	S-cell_type
are	O
a	O
nearly	O
infinite	O
source	O
for	O
generating	O
specialized	O
cells	O
such	O
as	O
neurons	S-cell_type
and	O
glia	S-cell_type
for	O
potential	O
therapeutic	O
purposes	O
[	O
4,5	O
]	O
.	O

Future	O
work	O
will	O
be	O
required	O
to	O
study	O
the	O
impact	O
of	O
AS	O
in	O
these	O
genes	O
in	O
hESCs	S-cell_type
and	O
NPs	S-cell_type
.	O

Instead	O
,	O
pairing	O
the	O
signal	O
estimates	O
of	O
all	O
replicates	O
in	O
one	O
condition	O
to	O
the	O
median	O
of	O
the	O
other	O
would	O
only	O
require	O
N	O
+	O
M	O
−	O
1	O
points	O
and	O
would	O
capture	O
the	O
variation	O
of	O
the	O
signal	O
estimates	O
of	O
each	O
probeset	O
.	O

Our	O
goal	O
was	O
to	O
identify	O
and	O
characterize	O
AS	O
events	O
that	O
distinguish	O
pluripotent	O
hESCs	S-cell_type
from	O
multipotent	O
NPs	S-cell_type
,	O
paving	O
the	O
way	O
for	O
future	O
candidate	O
gene	O
approaches	O
to	O
study	O
the	O
impact	O
of	O
AS	O
in	O
hESCs	O
and	O
NPs	O
.	O

We	O
believe	O
that	O
the	O
high	O
FP	O
rates	O
may	O
arise	O
from	O
cross-hybridization	O
effects	O
that	O
remained	O
unaccounted	O
for	O
.	O

To	O
ensure	O
that	O
this	O
was	O
the	O
case	O
,	O
we	O
counted	O
the	O
number	O
of	O
probesets	O
with	O
N	O
significant	O
outliers	O
,	O
where	O
N	O
was	O
varied	O
from	O
0	O
to	O
5	O
.	O

Alternative	O
RNA	S-cellcomponent
splicing	O
(	O
AS	O
)	O
,	O
a	O
major	O
form	O
of	O
post-transcriptional	O
gene	O
regulation	O
,	O
is	O
important	O
in	O
mammalian	S-x
development	O
and	O
neuronal	S-x

These	O
studies	O
have	O
largely	O
ignored	O
intermediate	O
RNA	S-cellcomponent
processing	O
events	O
prior	O
to	O
and	O
during	O
translation	O
.	O

The	O
shared	O
events	O
between	O
pairs	O
of	O
comparisons	O
made	O
up	O
a	O
minority	O
of	O
the	O
total	O
number	O
identified	O
:	O
102	O
REAP	O
[	O
+	O
]	O
events	O
were	O
found	O
to	O
be	O
in	O
common	O
between	O
hCNS-SCns	S-cell_type
versus	O
Cyt-ES	S-cell_line
and	O
hCNS-SCns	S-cell_type
versus	O
HUES6-ES	S-cell_line
;	O
48	O
between	O
hCNS-SCns	S-cell_type
versus	O
HUES6-ES	S-cell_line
and	O
HUES6	S-cell_line
-NP	O
versus	O
HUES6-ES	S-cell_line
;	O
and	O
only	O
17	O
between	O
hCNS-SCns	S-cell_type
versus	O
Cyt-ES	S-cell_line
and	O
Cyt-NP	O
versus	O
Cyt-ES	S-cell_line
(	O
Table	O
S2	O
)	O
.	O

This	O
functional	O
complexity	O
underscores	O
the	O
challenge	O
and	O
importance	O
of	O
elucidating	O
AS	O
regulation	O
.	O

We	O
compared	O
Cyt-ES	S-cell_line
to	O
hCNS-SCns	S-cell_type
to	O
illustrate	O
our	O
approach	O
.	O

PCR	O
products	O
were	O
resolved	O
on	O
either	O
1.5	O
%	O
or	O
3	O
%	O
agarose	O
gel	O
in	O
TBE	O
.	O

Genes	O
were	O
required	O
to	O
have	O
more	O
than	O
five	O
probesets	O
localized	O
within	O
the	O
exons	O
in	O
the	O
gene	O
.	O

In	O
conclusion	O
,	O
our	O
results	O
suggested	O
that	O
REAP	O
predictions	O
were	O
congruent	O
with	O
predictions	O
from	O
two	O
independent	O
,	O
orthogonal	O
methods	O
.	O

A	O
positive	O
score	O
indicated	O
a	O
higher	O
likelihood	O
of	O
being	O
AS	O
in	O
both	O
human	S-y
and	O
mouse	S-y
.	O

Considering	O
that	O
these	O
were	O
the	O
only	O
categories	O
that	O
were	O
significantly	O
enriched	O
out	O
of	O
more	O
than	O
18,000	O
GO	O
terms	O
,	O
and	O
that	O
randomly	O
selected	O
sets	O
of	O
similar	O
numbers	O
of	O
genes	O
did	O
not	O
reveal	O
statistical	O
differences	O
in	O
GO	O
categories	O
,	O
our	O
results	O
confirmed	O
that	O
the	O
global	O
molecular	O
profiles	O
derived	O
from	O
exon	O
array	O
analysis	O
were	O
consistent	O
with	O
known	O
differences	O
between	O
hESCs	S-cell_type
and	O
NPs	S-cell_type
.Figure	O
2Gene	O
Ontology	O
AnalysisDifferential	O
gene	O
expression	O
of	O
hESCs	S-cell_type
(	O
Cyt-ES	S-cell_line
and	O
HUES6-ES	S-cell_line
)	O
and	O
NPs	S-cell_type
(	O
Cyt-NP	O
,	O
HUES6	S-cell_line
-NP	O
,	O
and	O
hCNS-SCns	S-cell_type
)	O
was	O
computed	O
from	O
gene-level	O
signal	O
estimates	O
.	O

Shuffling	O
the	O
mapping	O
between	O
these	O
probesets	O
and	O
exons	O
resulted	O
in	O
8	O
%	O
(	O
5,777	O
of	O
71,731	O
)	O
of	O
exons	O
with	O
evidence	O
for	O
EST-SE	O
(	O
Figure	O
6A	O
)	O
.	O

Medium	O
was	O
changed	O
every	O
other	O
day	O
for	O
a	O
week	O
or	O
until	O
the	O
cells	O
formed	O
rosette-like	B-x
columnar	I-x
structures	E-x
that	O
were	O
isolated	O
manually	O
.	O

Each	O
conserved	O
k-mer	O
was	O
attributed	O
a	O
χ	O
score	O
representing	O
its	O
enrichment	O
in	O
a	O
set	O
of	O
exons	O
relative	O
to	O
another	O
set	O
of	O
exons	O
.	O

First	O
,	O
we	O
identified	O
genes	O
with	O
probeset	O
signal	O
estimates	O
that	O
were	O
poorly	O
correlated	O
and	O
were	O
not	O
amenable	O
to	O
our	O
method	O
.	O

In	O
addition	O
,	O
we	O
tested	O
the	O
AS	O
patterns	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
from	O
EHBP1	S-GP
,	O
SLK	S-GP
,	O
and	O
RAI14	S-GP
in	O
a	O
panel	O
of	O
differentiated	O
human	S-y
tissues	O
(	O
Figure	O
7C	O
)	O
.	O

First	O
we	O
normalized	O
the	O
data	O
and	O
generated	O
signal	O
estimates	O
with	O
Robust	O
Multichip	O
Analysis	O
(	O
RMA	O
)	O
and	O
estimated	O
the	O
probability	O
that	O
each	O
probeset	O
was	O
detected	O
above	O
background	O
(	O
DABG	O
)	O
using	O
publicly	O
available	O
Affymetrix	O
Power	O
Tools	O
(	O
APT	O
)	O
.	O

A	O
total	O
of	O
324,139	O
probesets	O
from	O
the	O
Affymetrix	O
Human	S-y
Exon	O
1.0	O
ST	O
array	O
were	O
mapped	O
to	O
208,422	O
human	S-y
exons	O
,	O
representing	O
17,431	O
genes	O
.	O

Notch	S-GP
was	O
recently	O
identified	O
to	O
be	O
important	O
in	O
promoting	O
the	O
neural	B-x
lineage	E-x
entry	O
in	O
mouse	B-cell_type
ESCs	E-cell_type
[	O
57	O
]	O
and	O
was	O
shown	O
to	O
regulate	O
stem	B-cell_type
cell	E-cell_type
proliferation	O
in	O
somatic	O
mouse	S-y
and	O
hESC	O
[	O
58	O
]	O
.	O

The	O
difference	O
between	O
the	O
actual	O
and	O
regression-based	O
predicted	O
value	O
,	O
normalized	O
by	O
the	O
estimate	O
of	O
its	O
standard	O
deviation	O
,	O
is	O
called	O
the	O
studentized	O
residuals	O
.	O

However	O
,	O
our	O
specificity	O
of	O
77	O
%	O
at	O
the	O
cutoff	O
of	O
two	O
significant	O
outliers	O
per	O
probeset	O
allowed	O
us	O
to	O
estimate	O
that	O
at	O
least	O
1,336	O
of	O
1,737	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
true	O
AS	O
events	O
that	O
changed	O
during	O
neuronal	O
differentiation	O
of	O
hESC	O
cells	O
,	O
and/or	O
were	O
different	O
between	O
endogeneous	O
NPs	S-cell_type
and	O
hESC	O
.	O

The	O
Ethidium	O
Bromide-stained	O
gels	O
were	O
scanned	O
with	O
Typhoon	O
8600	O
scanner	O
(	O
Molecular	O
Dynamics	O
)	O
for	O
quantification	O
.	O

The	O
authors	O
utilized	O
Affymetrix	O
exon	O
arrays	O
with	O
probes	O
targeting	O
hundreds	O
of	O
thousands	O
of	O
exons	O
to	O
study	O
AS	O
comparing	O
human	B-cell_type
ES	E-cell_type
to	O
NP	O
.	O

AS	O
appears	O
to	O
play	O
a	O
dominant	O
role	O
in	O
regulating	O
neuronal	O
gene	O
expression	O
and	O
function	O
[	O
41,42	O
]	O
.	O

Next	O
,	O
the	O
identity	O
of	O
the	O
probesets	O
and	O
points	O
derived	O
from	O
them	O
were	O
exchanged	O
with	O
other	O
probesets	O
,	O
keeping	O
constant	O
the	O
total	O
number	O
of	O
points	O
that	O
were	O
considered	O
significant	O
outliers	O
.	O

Red	O
bars	O
represented	O
Pearson	O
correlation	O
coefficients	O
computed	O
from	O
exons	O
with	O
shuffled	O
signal	O
estimates	O
.	O

ACEScan	O
was	O
updated	O
in	O
the	O
following	O
ways	O
.	O

In	O
recent	O
years	O
,	O
methods	O
have	O
been	O
introduced	O
to	O
induce	O
hESCs	S-cell_type
to	O
differentiate	O
into	O
neural	B-cell_type
progenitors	E-cell_type
(	O
NPs	S-cell_type
)	O
[	O
6,7	O
]	O
and	O
neuronal	S-cell_type
and	O
glial	B-cell_type
subtypes	E-cell_type
[	O
8–12	O
]	O
.	O

The	O
AS	O
patterns	O
of	O
the	O
other	O
verified	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
consistently	O
similar	O
in	O
hESCs	S-cell_type
but	O
were	O
more	O
varied	O
in	O
the	O
NP	O
.	O

Human	O
ESC	O
,	O
hESC-derived	O
NP	O
,	O
and	O
human	B-cell_type
central	I-cell_type
nervous	I-cell_type
system	I-cell_type
stem	I-cell_type
cells	E-cell_type
were	O
compared	O
using	O
Affymetrix	O
exon	O
arrays	O
.	O

(	O
B	O
)	O
Vertical	O
bars	O
representing	O
the	O
percentage	O
of	O
REAP	O
[	O
+	O
]	O
genes	O
out	O
of	O
all	O
genes	O
in	O
the	O
different	O
classifications	O
(	O
dashed	O
bar	O
:	O
“	O
enriched	O
in	O
hESC	O
”	O
;	O
black	O
filled	O
bar	O
:	O
“	O
unchanged	O
”	O
;	O
white	O
filled	O
bar	O
:	O
“	O
enriched	O
in	O
NP	O
”	O
)	O
,	O
at	O
different	O
cutoffs	O
of	O
1	O
to	O
5	O
.	O

We	O
considered	O
a	O
point	O
to	O
have	O
high	O
influence	O
if	O
|covi	O
−	O
1|	O
>	O
3p/n	O
.	O

The	O
ability	O
of	O
ESCs	S-cell_type
to	O
generate	O
all	O
three	O
embryonic	B-x
germ	I-x
layers	E-x
has	O
raised	O
the	O
exciting	O
possibility	O
that	O
hESCs	S-cell_type
may	O
become	O
an	O
unlimited	O
source	O
of	O
cells	O
for	O
transplantation	O
therapies	O
involving	O
organs	O
or	O
tissues	O
such	O
as	O
the	O
liver	S-x
,	O
pancreas	S-x
,	O
blood	S-x
,	O
and	O
nervous	B-x
system	E-x
,	O
and	O
become	O
tools	O
to	O
explore	O
the	O
molecular	O
mechanisms	O
of	O
human	S-y
development	O
.	O

Firstly	O
,	O
instead	O
of	O
relying	O
on	O
orthology	O
information	O
by	O
Ensembl	O
,	O
and	O
then	O
aligning	O
flanking	O
introns	O
in	O
“	O
orthologous	O
”	O
exons	O
,	O
conserved	O
exonic	O
and	O
intronic	O
regions	O
in	O
human	S-y
and	O
mouse	S-y
from	O
genome-wide	O
multiple	O
alignments	O
were	O
extracted	O
.	O

Points	O
that	O
were	O
“	O
high-leverage	O
,	O
”	O
such	O
as	O
the	O
five	O
points	O
in	O
the	O
CLCN2	S-GP
gene	O
,	O
were	O
experimentally	O
verified	O
to	O
be	O
a	O
FP	O
(	O
Figure	O
4C	O
;	O
unpublished	O
data	O
)	O
.	O

Undifferentiated	O
Cythera	S-cell_line
(	O
Cyt-ES	S-cell_line
)	O
and	O
HUES6	S-cell_line
(	O
HUES6-ES	S-cell_line
)	O
hESC	O
lines	O
were	O
maintained	O
in	O
culture	O
as	O
previously	O
described	O
[	O
12,23,56	O
]	O
.	O

As	O
an	O
example	O
,	O
the	O
median	O
probeset	O
signal	O
estimates	O
in	O
hESCs	S-cell_type
and	O
hCNS-SCns	S-cell_type
of	O
the	O
FIP1L1	S-GP
gene	O
(	O
gene	O
identifiers	O
BC011543	O
,	O
AL136910	O
)	O
had	O
a	O
Pearson	O
correlation	O
coefficient	O
of	O
0.38	O
,	O
and	O
the	O
distribution	O
of	O
points	O
was	O
not	O
amenable	O
to	O
robust	O
regression	O
(	O
Figure	O
4A	O
)	O
.	O

However	O
,	O
as	O
different	O
hESC	O
lines	O
were	O
established	O
under	O
different	O
culture	O
conditions	O
from	O
embryos	S-x
with	O
unique	O
genetic	O
backgrounds	O
,	O
we	O
expected	O
that	O
hESCs	S-cell_type
and	O
their	O
derived	O
NPs	S-cell_type
might	O
have	O
distinct	O
epigenetic	O
and	O
molecular	O
signatures	O
[	O
54	O
]	O
.	O

The	O
higher	O
the	O
score	O
,	O
the	O
more	O
frequent	O
the	O
conserved	O
k-mer	O
was	O
in	O
the	O
first	O
set	O
relative	O
to	O
the	O
second	O
set	O
.	O

These	O
percentages	O
were	O
not	O
significantly	O
different	O
from	O
the	O
7	O
%	O
of	O
exons	O
with	O
EST	O
evidence	O
for	O
AS	O
observed	O
from	O
using	O
all	O
exons	O
.	O

These	O
structures	O
were	O
then	O
transferred	O
to	O
coated	O
dishes	O
in	O
neural	S-x
induction	O
medium	O
(	O
DMEM/F12	O
supplemented	O
with	O
N2	O
and	O
FGF-2	S-GP
)	O
for	O
a	O
week	O
.	O

The	O
REAP	O
[	O
+	O
]	O
alternative	O
exon	O
in	O
the	O
RAI14	S-GP
(	O
retinoic	B-GP
acid	I-GP
induced	I-GP
14	E-GP
)	O
gene	O
was	O
observed	O
to	O
have	O
the	O
same	O
AS	O
pattern	O
in	O
NPs	S-cell_type
as	O
in	O
frontal	S-x
and	O
temporal	B-x
cortex	E-x
and	O
in	O
several	O
other	O
,	O
non-	O
brain	S-x
adult	O
tissues	O
,	O
such	O
as	O
heart	S-x
and	O
spleen	S-x
.	O

The	O
number	O
of	O
true	O
positives	O
(	O
TP	O
;	O
false	O
negatives	O
,	O
FN	O
)	O
was	O
computed	O
as	O
the	O
number	O
of	O
REAP	O
[	O
+	O
]	O
(	O
REAP	O
[	O
−	O
]	O
)	O
exons	O
that	O
were	O
validated	O
by	O
RT-PCR	O
as	O
AS	O
.	O

Cultures	O
were	O
fed	O
weekly	O
and	O
passaged	O
at	O
∼two	O
to	O
three	O
weeks	O
using	O
collagenases	S-GP
(	O
Roche	O
)	O
.	O

In	O
addition	O
,	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
also	O
enriched	O
for	O
ACEScan-predicted	O
evolutionarily	O
conserved	O
exons	O
[	O
55	O
]	O
.	O

Lastly	O
,	O
we	O
computed	O
the	O
studentized	O
residuals	O
,	O
rstudenti	O
=	O
ei	O
/	O
(	O
s	O
(	O
i	O
)	O
2	O
(	O
1	O
−	O
hi	O
)	O
0.5	O
)	O
,	O
where	O
s	O
(	O
i	O
)	O
2	O
=	O
(	O
n-p	O
)	O
se2	O
/	O
(	O
n-p-1	O
)	O
–	O
ei2	O
/	O
(	O
n-p-1	O
)	O
(	O
1	O
−	O
hi	O
)	O
,	O
the	O
error	O
term	O
variance	O
after	O
deleting	O
the	O
ith	O
point	O
.	O

These	O
probesets	O
were	O
used	O
to	O
derive	O
gene	O
and	O
exon-level	O
signal	O
estimates	O
from	O
the	O
CEL	O
files	O
.	O

Total	O
RNA	O
was	O
extracted	O
,	O
and	O
labeled	O
cDNA	O
targets	O
were	O
generated	O
from	O
three	O
independent	O
preparations	O
of	O
each	O
cell	O
type	O
,	O
namely	O
Cyt-ES	S-cell_line
,	O
HUES6-ES	S-cell_line
,	O
Cyt-NP	O
,	O
HUES6-NP	O
,	O
and	O
hCNS-SCns	S-cell_type
.	O

(	O
B	O
)	O
Each	O
probeset	O
contained	O
probeset-level	O
estimates	O
from	O
three	O
replicates	O
each	O
,	O
(	O
a	O
,	O
b	O
,	O
c	O
)	O
in	O
Cyt-ES	S-cell_line
and	O
(	O
d	O
,	O
e	O
,	O
f	O
)	O
in	O
hCNS-SCns	S-cell_type
.	O

To	O
accomplish	O
this	O
,	O
a	O
novel	O
computational	O
method	O
,	O
REAP	O
(	O
Regression-based	O
Exon	O
Array	O
Protocol	O
)	O
,	O
is	O
introduced	O
to	O
analyze	O
the	O
exon	O
array	O
data	O
.	O

Interestingly	O
,	O
the	O
patterns	O
of	O
AS	O
in	O
the	O
derived	O
NPs	S-cell_type
(	O
Cyt-NP	O
and	O
HUES6	S-cell_line
-NP	O
)	O
were	O
not	O
always	O
identical	O
to	O
those	O
of	O
hCNS-SCns	S-cell_type
.	O

(	O
C	O
)	O
RT-PCR	O
of	O
marker	O
genes	O
(	O
GAPDH	S-GP
,	O
Oct4	S-GP
,	O
Nanog	S-GP
,	O
Nestin	S-GP
,	O
Notch1	S-GP
,	O
DNER	S-GP
,	O
and	O
Sox1	S-GP
)	O
.Here	O
,	O
known	O
molecular	O
markers	O
were	O
subjected	O
to	O
RT-PCR	O
measurements	O
,	O
which	O
were	O
compared	O
to	O
gene-level	O
signal	O
estimates	O
generated	O
from	O
the	O
exon	O
array	O
data	O
.	O

We	O
introduced	O
an	O
outlier	O
detection	O
approach	O
,	O
REAP	O
(	O
Regression-based	O
Exon	O
Array	O
Protocol	O
)	O
,	O
to	O
identify	O
1,737	O
internal	O
exons	O
that	O
are	O
predicted	O
to	O
undergo	O
AS	O
in	O
NP	O
compared	O
to	O
hESC	O
.	O

Studentized	O
residuals	O
were	O
computed	O
for	O
all	O
probeset	O
pairs	O
in	O
EHBP1	S-GP
,	O
and	O
the	O
histogram	O
depicting	O
their	O
distribution	O
is	O
illustrated	O
in	O
Figure	O
3D	O
.	O

Red	O
and	O
green	O
horizontal	O
bars	O
represent	O
conserved	O
intronic	O
elements	O
and	O
nonconserved	O
elements	O
,	O
respectively	O
.	O

For	O
this	O
analysis	O
,	O
the	O
t-statistics	O
computed	O
above	O
measuring	O
the	O
enrichment	O
of	O
a	O
gene	O
in	O
hESCs	S-cell_type
relative	O
to	O
NPs	S-cell_type
was	O
utilized	O
for	O
only	O
REAP-analyzed	O
genes	O
.	O

Gene-level	O
signal	O
estimates	O
suggested	O
that	O
Notch	S-GP
was	O
significantly	O
higher	O
in	O
hCNS-SCns	S-cell_type
relative	O
to	O
hESCs	S-cell_type
,	O
but	O
levels	O
of	O
Notch	S-GP
were	O
not	O
significantly	O
different	O
in	O
the	O
derived	O
NPs	S-cell_type
compared	O
to	O
hESCs	S-cell_type
.	O

The	O
therapeutic	O
interest	O
in	O
understanding	O
the	O
molecular	O
basis	O
of	O
pluripotency	O
and	O
differentiation	O
has	O
led	O
to	O
many	O
studies	O
comparing	O
transcriptional	O
profiles	O
in	O
different	O
hESC	O
lines	O
and	O
the	O
study	O
of	O
expression	O
changes	O
during	O
the	O
differentiation	O
of	O
hESCs	S-cell_type
to	O
various	O
lineages	O
[	O
13–17	O
]	O
.	O

REAP	O
[	O
+	O
]	O
exons	O
were	O
underrepresented	O
in	O
genes	O
that	O
were	O
differentially	O
transcriptionally	O
regulated	O
in	O
hESCs	S-cell_type
and	O
NPs	S-cell_type
.	O

The	O
following	O
antibodies	O
and	O
corresponding	O
dilutions	O
were	O
utilized	O
for	O
the	O
immunohistochemical	O
analysis	O
of	O
marker	O
genes	O
in	O
Cyt-ES	S-cell_line
and	O
HUES6-ES	S-cell_line
:	O
Sox2	S-GP
(	O
Chemicon	O
,	O
1:500	O
)	O
,	O
Oct4	S-GP
(	O
Santa	O
Cruz	O
,	O
1:500	O
)	O
,	O
Sox1	S-GP
(	O
Chemicon	O
,	O
1:500	O
)	O
,	O
Nestin	S-GP
(	O
Pharmingen	O
,	O
1:250	O
)	O
;	O
hCNS-SCns	S-cell_type
:	O
Sox2	S-GP
(	O
Chemicon	O
,	O
1:200	O
)	O
,	O
Nestin	S-GP
(	O
Chemicon	O
,	O
1:200	O
)	O
.	O

As	O
a	O
negative	O
control	O
,	O
the	O
associations	O
between	O
REAP	O
scores	O
and	O
exons	O
were	O
shuffled	O
.	O

At	O
N	O
=	O
0	O
,	O
we	O
observed	O
approximately	O
equal	O
numbers	O
of	O
probesets	O
in	O
the	O
actual	O
versus	O
shuffled	O
controls	O
.	O

Utilizing	O
specific	O
antibodies	O
,	O
we	O
observed	O
that	O
undifferentiated	O
Cyt-ES	S-cell_line
and	O
HUES6-	O
ES	B-cell_type
cell	E-cell_type
s	O
were	O
positive	O
for	O
the	O
pluripotent	O
markers	O
Oct4	S-GP
,	O
SSEA-4	S-GP
,	O
and	O
Tra-1–80	S-GP
(	O
unpublished	O
data	O
)	O
.	O

The	O
four-way	O
mammalian	S-x
(	O
four-mammal	O
)	O
whole-genome	O
alignment	O
(	O
hg17	O
,	O
canFam1	O
,	O
mm5	O
,	O
rn3	O
)	O
was	O
extracted	O
from	O
the	O
eight-way	O
vertebrate	S-x
MULTIZ	O
alignments	O
(	O
hg17	O
,	O
panTrol1	O
,	O
mm5	O
,	O
rn3	O
,	O
canFam1	O
,	O
galGal2	O
,	O
fr1	O
,	O
danRer1	O
)	O
obtained	O
from	O
the	O
UCSC	O
Genome	O
Browser	O
.	O

To	O
validate	O
REAP	O
[	O
+	O
]	O
alternative	O
exons	O
,	O
RT-PCR	O
primers	O
were	O
designed	O
in	O
the	O
flanking	O
exons	O
to	O
amplify	O
both	O
isoforms	O
.	O

Points	O
that	O
were	O
“	O
high-influence	O
,	O
”	O
such	O
as	O
the	O
four	O
of	O
five	O
boxed	O
points	O
in	O
the	O
ABCA3	S-GP
gene	O
were	O
also	O
experimentally	O
verified	O
to	O
be	O
a	O
FP	O
(	O
Figure	O
4D	O
;	O
unpublished	O
data	O
)	O
.	O

As	O
ACEScan	O
utilized	O
a	O
different	O
set	O
of	O
information	O
from	O
REAP	O
,	O
the	O
agreement	O
between	O
both	O
algorithms	O
served	O
to	O
further	O
validate	O
the	O
predicted	O
alternative	O
exons	O
.	O

We	O
analyzed	O
probesets	O
that	O
(	O
i	O
)	O
comprised	O
three	O
or	O
more	O
individual	O
probes	O
;	O
(	O
ii	O
)	O
were	O
localized	O
within	O
the	O
exons	O
of	O
our	O
gene	O
models	O
with	O
evidence	O
from	O
at	O
least	O
three	O
sources	O
(	O
mRNA	O
,	O
EST	O
,	O
or	O
full-length	O
cDNA	O
)	O
;	O
and	O
(	O
iii	O
)	O
were	O
detected	O
above	O
background	O
in	O
at	O
least	O
one	O
of	O
the	O
cell	O
lines	O
.	O

By	O
raising	O
the	O
requirement	O
that	O
probesets	O
had	O
to	O
contain	O
at	O
least	O
one	O
significant	O
point	O
to	O
five	O
significant	O
points	O
,	O
the	O
percentage	O
of	O
EST-SE	O
increased	O
dramatically	O
from	O
11	O
%	O
(	O
531	O
of	O
4,898	O
exons	O
)	O
to	O
26	O
%	O
(	O
33	O
of	O
126	O
)	O
.	O

Elongated	O
single	O
cells	O
were	O
separated	O
from	O
leftover	O
aggregates	O
using	O
non-enzymatic	O
dissociation	O
.	O

The	O
number	O
of	O
true	O
negatives	O
(	O
TN	O
;	O
or	O
FPs	O
)	O
was	O
computed	O
as	O
the	O
number	O
of	O
REAP	O
[	O
−	O
]	O
(	O
REAP	O
[	O
+	O
]	O
)	O
exons	O
that	O
were	O
validated	O
by	O
RT-PCR	O
as	O
constitutively	O
spliced	O
.	O

The	O
five	O
points	O
summarizing	O
the	O
log2	O
probeset-level	O
estimates	O
are	O
indicated	O
by	O
black	O
filled	O
circles	O
.	O

After	O
hybridization	O
,	O
scanning	O
,	O
and	O
extraction	O
of	O
signal	O
estimates	O
for	O
each	O
probeset	O
on	O
the	O
exon	O
arrays	O
,	O
gene-level	O
estimates	O
were	O
computed	O
based	O
on	O
our	O
gene	O
models	O
using	O
available	O
normalization	O
and	O
signal	O
estimation	O
software	O
from	O
Affymetrix	O
.	O

Internal	O
exons	O
were	O
divided	O
into	O
REAP	O
[	O
+	O
]	O
NP	O
,	O
REAP	O
[	O
+	O
]	O
ES	O
,	O
and	O
REAP	O
[	O
−	O
]	O
exons	O
.	O

A	O
scatter	O
plot	O
of	O
all	O
probesets	O
of	O
the	O
EHBP1	S-GP
(	O
EH	B-GP
domain	I-GP
binding	I-GP
protein	E-GP
,	O
RefSeq	O
identifier	O
NM_015252	O
)	O
is	O
shown	O
in	O
Figure	O
3C	O
in	O
the	O
format	O
described	O
.	O

The	O
authors	O
showed	O
that	O
REAP	O
candidates	O
are	O
consistent	O
with	O
other	O
types	O
of	O
methods	O
for	O
discovering	O
alternative	O
exons	O
.	O

TDGF1/cripto	S-GP
was	O
first	O
shown	O
to	O
stimulate	O
DNA	O
synthesis	O
and	O
cell	O
proliferation	O
of	O
both	O
undifferentiated	O
and	O
differentiated	O
embryonic	B-cell_type
carcinoma	I-cell_type
cells	E-cell_type
[	O
61	O
]	O
and	O
was	O
later	O
shown	O
to	O
be	O
important	O
for	O
cardiomyocyte	S-cell_type
formation	O
from	O
mouse	S-y
ESC	O
[	O
62	O
]	O
.	O

Initially	O
,	O
5-mers	O
that	O
were	O
significantly	O
enriched	O
between	O
the	O
upstream	O
and	O
downstream	O
intronic	O
regions	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
relative	O
to	O
REAP	O
[	O
−	O
]	O
exons	O
were	O
enumerated	O
.	O

At	O
any	O
of	O
these	O
two	O
stages	O
,	O
pan-neuronal	S-x
differentiation	O
can	O
be	O
achieved	O
after	O
three	O
to	O
four	O
weeks	O
.	O

On	O
average	O
,	O
7	O
%	O
of	O
all	O
human	S-y
exons	O
have	O
been	O
estimated	O
by	O
transcript	O
data	O
to	O
undergo	O
AS	O
;	O
thus	O
REAP	O
's	O
validation	O
rate	O
of	O
60	O
%	O
at	O
the	O
cutoff	O
of	O
two	O
is	O
73-fold	O
(	O
60/7	O
)	O
higher	O
than	O
expected	O
.	O

The	O
enrichment	O
scores	O
for	O
all	O
downstream	O
intronic	O
5-mers	O
for	O
shuffled	O
REAP	O
[	O
+	O
]	O
NP	O
versus	O
set	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
x-axis	O
)	O
,	O
and	O
for	O
shuffled	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
versus	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
y-axis	O
)	O
were	O
displayed	O
(	O
Figure	O
9B	O
)	O
.	O

(	O
C	O
)	O
Set	O
of	O
genes	O
where	O
REAP	O
[	O
+	O
]	O
designation	O
was	O
randomly	O
chosen	O
.	O

Secondly	O
,	O
whereas	O
in	O
our	O
previous	O
analysis	O
exons	O
from	O
the	O
longest	O
transcript	O
in	O
Ensembl	O
were	O
utilized	O
,	O
now	O
we	O
collapsed	O
all	O
the	O
transcripts	O
available	O
at	O
the	O
UCSC	O
genome	O
browser	O
and	O
analyzed	O
all	O
exons	O
in	O
the	O
entire	O
gene	O
loci	O
.	O

As	O
expected	O
,	O
the	O
mean	O
of	O
the	O
distribution	O
was	O
close	O
to	O
zero	O
,	O
and	O
the	O
distribution	O
was	O
approximated	O
by	O
a	O
t-distribution	O
with	O
n-p-1	O
degrees	O
of	O
freedom	O
,	O
where	O
n	O
was	O
the	O
number	O
of	O
points	O
on	O
the	O
scatter	O
plot	O
,	O
and	O
the	O
number	O
of	O
parameters	O
p	O
was	O
2	O
.	O

Our	O
results	O
act	O
as	O
a	O
reminder	O
that	O
focusing	O
only	O
on	O
genes	O
that	O
are	O
differentially	O
expressed	O
will	O
overlook	O
RNA	S-cellcomponent
processing	O
events	O
that	O
may	O
be	O
biologically	O
relevant	O
to	O
the	O
system	O
of	O
interest	O
.	O

In	O
contrast	O
,	O
we	O
observed	O
that	O
there	O
were	O
1.5	O
times	O
more	O
probesets	O
with	O
N	O
=	O
2	O
significant	O
outliers	O
relative	O
to	O
shuffled	O
controls	O
;	O
12–31	O
times	O
more	O
probesets	O
with	O
N	O
=	O
3	O
;	O
and	O
17–612	O
times	O
more	O
probesets	O
that	O
had	O
N	O
=	O
4	O
significant	O
outliers	O
(	O
Figure	O
5A	O
;	O
see	O
Table	O
S1	O
)	O
.	O

As	O
rstudenti	O
was	O
distributed	O
as	O
Student	O
's	O
t-distribution	O
with	O
n-p-1	O
degrees	O
of	O
freedom	O
,	O
each	O
rstudenti	O
value	O
was	O
associated	O
with	O
a	O
p-value	O
.	O

The	O
hCNS-SCns	S-cell_type
form	O
neurospheres	S-x
in	O
culture	O
which	O
are	O
greater	O
than	O
90	O
%	O
Nestin	S-GP
and	O
Sox1	S-GP
positive	O
,	O
and	O
differentiate	O
into	O
both	O
neurons	S-cell_type
and	O
glial	B-cell_type
cells	E-cell_type
in	O
vitro	O
[	O
12,23	O
]	O
.	O

At	O
a	O
defined	O
absolute-valued	O
cutoff	O
,	O
genes	O
were	O
divided	O
into	O
three	O
categories	O
:	O
“	O
enriched	O
in	O
hESCs	S-cell_type
,	O
”	O
“	O
enriched	O
in	O
NP	O
,	O
”	O
or	O
“	O
unchanged	O
”	O
(	O
Figure	O
8A	O
)	O
.	O

The	O
lists	O
of	O
known	O
human	S-y
genes	O
(	O
knownGene	O
containing	O
43,401	O
entries	O
)	O
and	O
known	O
isoforms	O
(	O
knownIsoforms	O
containing	O
43,286	O
entries	O
in	O
21,397	O
unique	O
isoform	O
clusters	O
)	O
with	O
annotated	O
exon	O
alignments	O
to	O
human	S-y
hg17	O
genomic	O
sequence	O
were	O
processed	O
as	O
follows	O
.	O

As	O
both	O
common	O
and	O
cell-line	O
specific	O
alternatively	O
spliced	O
exons	O
are	O
likely	O
to	O
be	O
important	O
in	O
regenerative	O
research	O
,	O
in	O
our	O
study	O
two	O
separate	O
hESC	O
lines	O
were	O
used	O
,	O
with	O
independent	O
protocols	O
for	O
differentiating	O
the	O
hESCs	S-cell_type
into	O
NPs	S-cell_type
positive	O
for	O
Sox1	S-GP
,	O
an	O
early	O
neuroectodermal	S-x
marker	O
.	O

After	O
one	O
to	O
two	O
passages	O
,	O
the	O
cells	O
formed	O
a	O
monolayer	O
of	O
homogeneous	O
NPs	S-cell_type
(	O
negative	O
for	O
Sox1	S-GP
immunostaining	O
)	O
.	O

To	O
be	O
a	O
positively	O
validated	O
candidate	O
,	O
the	O
PCR	O
products	O
on	O
a	O
gel	O
had	O
to	O
satisfy	O
all	O
of	O
the	O
following	O
criteria	O
:	O
(	O
i	O
)	O
at	O
least	O
one	O
isoform	O
with	O
the	O
expected	O
size	O
must	O
be	O
visible	O
in	O
each	O
cell	O
type	O
;	O
(	O
ii	O
)	O
the	O
relative	O
abundance	O
of	O
the	O
two	O
isoforms	O
must	O
be	O
altered	O
between	O
two	O
cell	O
types	O
and	O
the	O
direction	O
of	O
change	O
have	O
to	O
be	O
consistent	O
with	O
the	O
REAP	O
studentized	O
residuals	O
:	O
in	O
our	O
study	O
positive	O
residuals	O
implied	O
inclusion	O
in	O
hESCs	S-cell_type
and	O
skipping	O
in	O
NPs	S-cell_type
,	O
and	O
negative	O
residuals	O
implied	O
inclusion	O
in	O
NP	O
and	O
skipping	O
in	O
hESCs	S-cell_type
;	O
and	O
(	O
iii	O
)	O
the	O
results	O
were	O
replicable	O
in	O
at	O
least	O
two	O
experiments.For	O
simplicity	O
of	O
design	O
,	O
we	O
tested	O
candidates	O
predicted	O
from	O
Cyt-ES	S-cell_line
versus	O
hCNS-SCns	S-cell_type
.	O

The	O
AS	O
pattern	O
of	O
the	O
REAP	O
[	O
+	O
]	O
exon	O
in	O
the	O
SLK	S-GP
gene	O
in	O
NPs	S-cell_type
was	O
similar	O
to	O
most	O
differentiated	O
tissues	O
;	O
however	O
,	O
the	O
relatively	O
strong	O
inclusion	O
of	O
the	O
exon	O
in	O
hESCs	S-cell_type
was	O
unique	O
.	O

Multiple	O
hypothesis	O
testing	O
was	O
corrected	O
by	O
controlling	O
for	O
the	O
false	O
discovery	O
rate	O
(	O
Benjamini-Hochberg	O
)	O
.	O

The	O
χ	O
statistic	O
was	O
computed	O
to	O
represent	O
the	O
enrichment	O
of	O
conserved	O
elements	O
in	O
intronic	O
regions	O
flanking	O
REAP	O
[	O
+	O
]	O
NP	O
versus	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
x-axis	O
)	O
,	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
versus	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
y-axis	O
)	O
.	O

Of	O
the	O
5-mers	O
enriched	O
upstream	O
of	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
,	O
we	O
observed	O
CUAAC	O
,	O
which	O
resembled	O
the	O
splicing	O
branch-signal	O
.	O

To	O
avoid	O
inappropriate	O
application	O
of	O
REAP	O
and	O
generating	O
false	O
predictions	O
,	O
we	O
empirically	O
determined	O
that	O
a	O
gene	O
had	O
to	O
have	O
a	O
Pearson	O
correlation	O
coefficient	O
cutoff	O
of	O
0.6	O
before	O
being	O
amenable	O
to	O
REAP	O
analysis	O
.	O

Similar	O
representation	O
as	O
in	O
(	O
B	O
)	O
.	O

(	O
C	O
)	O
Each	O
probeset	O
was	O
summarized	O
by	O
five	O
points	O
.	O

Delta/Notch-like	B-GP
EGF-related	I-GP
receptor	E-GP
(	O
DNER	S-GP
)	O
,	O
a	O
neuron-specific	O
transmembrane	B-cellcomponent
protein	E-cellcomponent
,	O
was	O
recently	O
shown	O
to	O
bind	O
to	O
Notch	S-GP
at	O
cell–cell	O
contacts	O
and	O
activates	O
Notch	S-GP
signaling	O
in	O
vitro	O
[	O
59	O
]	O
.	O

Additional	O
studies	O
in	O
mouse	B-cell_type
ESCs	E-cell_type
and	O
neural	O
derivatives	O
will	O
be	O
necessary	O
to	O
determine	O
if	O
these	O
AS	O
events	O
are	O
indeed	O
preserved	O
in	O
these	O
analogous	O
and	O
orthologous	O
cell	O
types	O
.	O

In	O
conclusion	O
,	O
in	O
order	O
to	O
reduce	O
the	O
FP	O
rate	O
,	O
all	O
points	O
were	O
evaluated	O
according	O
to	O
the	O
metrics	O
described	O
,	O
and	O
points	O
that	O
were	O
significant	O
“	O
outliers	O
”	O
were	O
considered	O
putative	O
AS	O
events.Figure	O
4Sources	O
of	O
False	O
Positives	O
(	O
A	O
)	O
Scatter	O
plot	O
of	O
points	O
for	O
the	O
FIP1L1	S-GP
gene	O
and	O
the	O
line	O
representing	O
the	O
robust	O
regression	O
estimate	O
.	O

In	O
addition	O
,	O
REAP	O
candidate	O
alternative	O
exons	O
are	O
enriched	O
in	O
genes	O
encoding	O
serine/theronine	B-GP
kinases	E-GP
and	O
helicase	S-GP
activities	O
.	O

NPs	S-cell_type
were	O
derived	O
from	O
the	O
hESC	B-cell_type
cell	E-cell_type
lines	O
using	O
protocols	O
optimized	O
for	O
each	O
line	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

Despite	O
such	O
interests	O
,	O
relatively	O
little	O
is	O
understood	O
about	O
the	O
molecular	O
mechanisms	O
defining	O
their	O
pluripotency	O
and	O
the	O
molecular	O
changes	O
important	O
for	O
hESCs	S-cell_type
to	O
differentiate	O
into	O
specific	O
cell	O
types	O
.	O

Scatter	O
plots	O
of	O
signal	O
estimates	O
for	O
probesets	O
that	O
were	O
present	O
in	O
at	O
least	O
one	O
cell	O
type	O
(	O
Cyt-ES	S-cell_line
or	O
hCNS-SCns	S-cell_type
)	O
for	O
the	O
EHBP1	S-GP
gene	O
.	O

The	O
true	O
(	O
false	O
)	O
positive	O
rate	O
was	O
computed	O
as	O
TP	O
(	O
FP	O
)	O
divided	O
by	O
the	O
total	O
number	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
in	O
the	O
experimentally	O
validated	O
set	O
.	O

Finally	O
,	O
an	O
early	O
report	O
estimating	O
that	O
15	O
%	O
of	O
point	O
mutations	O
disrupt	O
splicing	O
underscores	O
the	O
importance	O
of	O
splicing	O
in	O
human	S-y
disease	O
[	O
48	O
]	O
.	O

Each	O
probeset	O
was	O
represented	O
by	O
5	O
points	O
of	O
log-transformed	O
(	O
base	O
2	O
)	O
values	O
;	O
and	O
each	O
point	O
on	O
the	O
scatter	O
plot	O
reflected	O
the	O
extent	O
of	O
inclusion	O
of	O
an	O
exon	O
in	O
hESCs	S-cell_type
and	O
in	O
hCNS-SCns	S-cell_type
(	O
Figure	O
3C	O
)	O
.A	O
classical	O
linear	O
regression	O
model	O
could	O
be	O
proposed	O
to	O
fit	O
the	O
response	O
variable	O
yij	O
,	O
the	O
log2	O
expression	O
of	O
probeset	O
i	O
in	O
cell-type	O
j	O
(	O
for	O
example	O
,	O
j	O
is	O
Cyt-ESC	S-cell_line
)	O
to	O
explanatory	O
variables	O
xik	O
,	O
and	O
the	O
log2	O
expression	O
of	O
probeset	O
i	O
in	O
cell	O
type	O
k	O
(	O
for	O
example	O
,	O
k	O
is	O
hCNS-SCns	S-cell_type
)	O
.	O

For	O
example	O
,	O
the	O
AS	O
exon	O
in	O
the	O
EHBP1	S-GP
(	O
EH	B-GP
domain	I-GP
binding	I-GP
protein	I-GP
1	E-GP
)	O
gene	O
was	O
included	O
in	O
hESCs	S-cell_type
but	O
skipped	O
in	O
hCNS-SCns	S-cell_type
,	O
and	O
both	O
isoforms	O
were	O
present	O
in	O
the	O
derived	O
NPs	O
(	O
Figure	O
7B	O
)	O
.	O

In	O
comparison	O
,	O
the	O
shuffled	O
probesets	O
at	O
the	O
same	O
requirements	O
remained	O
at	O
∼8	O
%	O
,	O
rising	O
slightly	O
to	O
11	O
%	O
at	O
five	O
points	O
,	O
due	O
to	O
small	O
sample	O
sizes	O
.	O

Surprisingly	O
,	O
we	O
observed	O
that	O
the	O
majority	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
specific	O
to	O
the	O
pair	O
of	O
hESC	O
and	O
NP	O
that	O
was	O
compared	O
,	O
likely	O
reflecting	O
differences	O
in	O
genetic	O
origins	O
and/or	O
culturing	O
and	O
differentiation	O
conditions	O
of	O
the	O
cell	O
lines	O
:	O
614	O
REAP	O
[	O
+	O
]	O
events	O
were	O
unique	O
to	O
hCNS-SCns	S-cell_type
versus	O
HUE6-ES	S-cell_line
;	O
220	O
were	O
unique	O
to	O
hCNS-SCns	S-cell_type
versus	O
Cyt-ES	S-cell_line
;	O
439	O
were	O
unique	O
to	O
HUES6	S-cell_line
-NP	O
versus	O
HUES6-ES	S-cell_line
;	O
and	O
250	O
were	O
unique	O
to	O
Cyt-NP	O
versus	O
Cyt-ES	S-cell_line
.	O

Upon	O
confluence	O
,	O
cells	O
will	O
form	O
neurospheres	S-x
that	O
can	O
also	O
be	O
isolated	O
from	O
the	O
neuroepithelial	B-cell_type
precursor	I-cell_type
cells	E-cell_type
(	O
positive	O
for	O
Sox1	S-GP
immunostaining	O
)	O
.	O

AS	O
detection	O
by	O
REAP.The	O
log2	O
signal	O
estimate	O
xij	O
for	O
probeset	O
i	O
in	O
cell-type	O
j	O
had	O
to	O
satisfy	O
two	O
conditions	O
,	O
otherwise	O
the	O
probeset	O
was	O
discarded	O
:	O
(	O
i	O
)	O
2	O
<	O
xij	O
<	O
10,000	O
for	O
all	O
conditions/cell-types	O
j	O
;	O
and	O
(	O
ii	O
)	O
DABG	O
p-value	O
<	O
0.05	O
for	O
all	O
replicates	O
in	O
at	O
least	O
one	O
condition/cell-type	O
j	O
.	O

We	O
considered	O
a	O
point	O
to	O
be	O
an	O
“	O
outlier	O
”	O
if	O
p	O
<	O
0.01	O
.	O

As	O
another	O
example	O
,	O
the	O
AS	O
exon	O
in	O
the	O
SORBS1	S-GP
(	O
sorbin	B-GP
and	I-GP
SH3	I-GP
domain	I-GP
containing	I-GP
1	E-GP
)	O
gene	O
was	O
skipped	O
in	O
hESCs	S-cell_type
and	O
included	O
in	O
hCNS-SCns	S-cell_type
,	O
but	O
exhibited	O
an	O
intermediate	O
pattern	O
in	O
the	O
derived	O
NPs	S-cell_type
.	O

Four-way	O
mammal	O
alignments	O
were	O
extracted	O
for	O
all	O
internal	O
exons	O
,	O
and	O
400	O
bases	O
of	O
flanking	O
intronic	O
sequence	O
,	O
resulting	O
in	O
a	O
total	O
of	O
161,731	O
conserved	O
internal	O
exons	O
.	O

NSCs	S-cell_type
and	O
progenitor	B-cell_type
cells	E-cell_type
(	O
NPs	S-cell_type
)	O
are	O
present	O
throughout	O
development	O
and	O
persist	O
into	O
adulthood	O
[	O
18–20	O
]	O
.	O

Increasing	O
the	O
t-statistic	O
cutoff	O
from	O
one	O
to	O
five	O
,	O
the	O
fraction	O
of	O
REAP	O
[	O
+	O
]	O
genes	O
relative	O
to	O
REAP-analyzed	O
genes	O
remained	O
constant	O
in	O
the	O
“	O
unchanged	O
”	O
categories	O
(	O
Figure	O
8B	O
)	O
.	O

REAP	O
predictions	O
significantly	O
overlapped	O
sets	O
of	O
alternative	O
events	O
identified	O
using	O
expressed	O
sequence	O
tags	O
and	O
evolutionarily	O
conserved	O
AS	O
events	O
.	O

At	O
a	O
χ	O
cutoff	O
of	O
three	O
,	O
which	O
corresponded	O
to	O
a	O
p-value	O
of	O
0.0015	O
,	O
the	O
majority	O
of	O
5-mers	O
were	O
not	O
significantly	O
enriched	O
in	O
either	O
shuffled	O
set	O
.	O

Finally	O
,	O
we	O
identified	O
potential	O
cis-regulatory	O
intronic	O
elements	O
conserved	O
and	O
enriched	O
proximal	O
to	O
the	O
REAP	O
[	O
+	O
]	O
exons	O
.	O

In	O
total	O
,	O
17,430	O
gene	O
models	O
were	O
represented	O
by	O
probesets	O
that	O
satisfied	O
these	O
criteria.Next	O
we	O
asked	O
whether	O
the	O
probeset	O
expression	O
within	O
each	O
gene	O
model	O
was	O
positively	O
correlated	O
for	O
any	O
two	O
cell	O
lines	O
.	O

Greater	O
than	O
90	O
%	O
of	O
derived	O
NP	B-cell_type
cells	E-cell_type
(	O
Cyt-NP	O
from	O
Cyt-ES	S-cell_line
and	O
HUES6	S-cell_line
-NP	O
from	O
HUES6-ES	S-cell_line
)	O
were	O
positive	O
for	O
Sox1	S-GP
,	O
an	O
early	O
neuroectodermal	S-x
marker	O
,	O
and	O
Nestin	S-GP
(	O
Figure	O
1A	O
)	O
,	O
and	O
negative	O
for	O
Oct4	S-GP
(	O
unpublished	O
data	O
)	O
.	O

RNA	S-cellcomponent
preparation	O
and	O
array	O
hybridization.Total	O
RNA	S-cellcomponent
from	O
cells	O
was	O
processed	O
as	O
follows	O
.	O

Identification	O
of	O
motifs.The	O
enrichment	O
score	O
of	O
a	O
sequence	O
element	O
of	O
length	O
k	O
(	O
k-mer	O
)	O
in	O
one	O
set	O
of	O
sequences	O
(	O
set	O
1	O
)	O
versus	O
another	O
set	O
of	O
sequences	O
(	O
set	O
2	O
)	O
was	O
represented	O
by	O
the	O
nonparametric	O
χ2	O
statistic	O
with	O
Yates	O
correction	O
,	O
computed	O
from	O
the	O
two	O
by	O
two	O
contingency	O
table	O
,	O
T	O
(	O
T11	O
:	O
number	O
of	O
occurrences	O
of	O
the	O
element	O
in	O
set	O
1	O
;	O
T12	O
:	O
number	O
of	O
occurrences	O
of	O
all	O
other	O
elements	O
of	O
similar	O
length	O
in	O
set	O
1	O
;	O
T21	O
:	O
number	O
of	O
occurrences	O
of	O
element	O
in	O
set	O
2	O
;	O
T22	O
:	O
number	O
of	O
occurrences	O
of	O
all	O
other	O
elements	O
of	O
similar	O
length	O
in	O
set	O
2	O
.	O

Even	O
in	O
esophagus	S-x
,	O
kidney	S-x
,	O
liver	S-x
,	O
and	O
prostate	S-x
,	O
both	O
isoforms	O
were	O
present	O
.	O

Oct4	S-GP
,	O
reviewed	O
in	O
[	O
63	O
]	O
,	O
and	O
Nanog	S-GP
[	O
64	O
]	O
are	O
crucial	O
for	O
the	O
pluripotency	O
of	O
hESCs	S-cell_type
.	O

Statistical	O
significance	O
for	O
differential	O
gene	O
expression	O
was	O
determined	O
by	O
using	O
t-statistics	O
with	O
Benjamini-Hochberg	O
correction	O
for	O
false	O
discovery	O
rate	O
(	O
p	O
<	O
0.01	O
)	O
.	O

An	O
example	O
is	O
the	O
alternative	O
exon	O
in	O
the	O
SLK	S-GP
(	O
serine/threonine	B-GP
kinase	I-GP
2	E-GP
)	O
gene	O
that	O
is	O
included	O
in	O
hESC	O
,	O
but	O
excluded	O
in	O
NP	O
as	O
well	O
as	O
in	O
other	O
differentiated	O
tissues	O
.	O

ACEScan	O
was	O
utilized	O
to	O
assign	O
ACEScan	O
scores	O
to	O
all	O
∼162,000	O
internal	O
exons	O
in	O
our	O
genes	O
.	O

The	O
sign	O
represented	O
the	O
direction	O
of	O
change	O
,	O
i.e.	O
,	O
positive	O
if	O
enriched	O
in	O
introns	O
flanking	O
REAP	O
[	O
+	O
]	O
versus	O
REAP	O
[	O
−	O
]	O
exon	O
.	O

Probesets	O
were	O
considered	O
present	O
if	O
the	O
DABG	O
p-value	O
was	O
<	O
0.05	O
for	O
all	O
three	O
replicates	O
in	O
the	O
cell	O
type	O
.	O

The	O
boxed	O
points	O
had	O
studentized	O
residuals	O
of	O
1.829	O
,	O
3.104	O
,	O
2.634	O
,	O
3.012	O
,	O
and	O
2.125	O
with	O
p-values	O
of	O
0.034	O
,	O
0.00119	O
,	O
0.00477	O
,	O
0.00158	O
,	O
and	O
0.01780	O
,	O
respectively	O
,	O
computed	O
based	O
on	O
the	O
t-distribution	O
(	O
Figure	O
3C	O
)	O
.	O

The	O
true	O
(	O
false	O
)	O
negative	O
rate	O
was	O
computed	O
as	O
the	O
TN	O
(	O
FN	O
)	O
divided	O
by	O
the	O
total	O
number	O
of	O
REAP	O
[	O
−	O
]	O
exons	O
in	O
the	O
experimentally	O
validated	O
set	O
.	O

Consistent	O
with	O
our	O
computational	O
results	O
,	O
we	O
observed	O
that	O
the	O
AS	O
patterns	O
in	O
hCNS-SCns	S-cell_type
were	O
not	O
always	O
similar	O
to	O
those	O
of	O
the	O
derived	O
NPs	S-cell_type
.	O

This	O
finding	O
confirmed	O
that	O
the	O
derived	O
NPs	S-cell_type
were	O
committed	O
to	O
a	O
neural	S-x
fate	O
and	O
validated	O
the	O
use	O
of	O
hCNS-SCns	S-cell_type
as	O
a	O
benchmark	O
for	O
NPs	S-cell_type
.Next	O
we	O
asked	O
whether	O
the	O
highest	O
enriched	O
genes	O
in	O
hESCs	S-cell_type
relative	O
to	O
NPs	S-cell_type
reflected	O
our	O
existing	O
knowledge	O
in	O
the	O
literature	O
.	O

Our	O
finding	O
that	O
only	O
a	O
minority	O
of	O
AS	O
events	O
was	O
common	O
between	O
various	O
hESC	O
to	O
NP	O
comparisons	O
is	O
intriguing	O
.	O

RT-PCR	O
validation	O
of	O
DNER	S-GP
confirmed	O
array-derived	O
signal	O
estimates	O
,	O
indicating	O
an	O
enrichment	O
of	O
DNER	S-GP
in	O
NPs	S-cell_type
relative	O
to	O
hESCs	S-cell_type
(	O
Figure	O
1C	O
)	O
.	O

Indeed	O
,	O
the	O
disruption	O
of	O
specific	O
AS	O
events	O
has	O
been	O
implicated	O
in	O
several	O
human	S-y
genetic	O
diseases	O
,	O
such	O
as	O
frontotemporal	O
dementia	O
and	O
parkinsonism	O
,	O
Frasier	O
syndrome	O
,	O
and	O
atypical	O
cystic	O
fibrosis	O
[	O
49	O
]	O
.	O

Next	O
,	O
we	O
managed	O
two	O
additional	O
sources	O
of	O
FPs	O
,	O
namely	O
“	O
high-leverage	O
”	O
and	O
“	O
high-influence	O
”	O
points	O
,	O
which	O
we	O
were	O
able	O
to	O
identify	O
by	O
computing	O
the	O
following	O
metrics	O
.	O

They	O
are	O
critical	O
for	O
both	O
basic	O
research	O
and	O
developing	O
approaches	O
to	O
treat	O
neurological	O
disorders	O
,	O
such	O
as	O
Parkinson	O
disease	O
and	O
amyotrophic	O
lateral	O
sclerosis	O
(	O
ALS	O
)	O
,	O
and	O
stroke	O
or	O
head	S-x
injuries	O
[	O
21,22	O
]	O
.	O

For	O
example	O
,	O
in	O
hCNS-SCns	S-cell_type
compared	O
to	O
Cyt-ES	S-cell_line
,	O
approximately	O
0.39	O
%	O
(	O
490	O
of	O
124,604	O
)	O
of	O
probesets	O
had	O
three	O
significant	O
outliers	O
and	O
0.25	O
%	O
(	O
308	O
probesets	O
)	O
had	O
four	O
significant	O
outliers	O
,	O
relative	O
to	O
0.02	O
%	O
and	O
0	O
%	O
of	O
shuffled	O
controls	O
,	O
respectively.Figure	O
5Correlation	O
between	O
“	O
Outliers	O
”	O
(	O
A	O
)	O
The	O
number	O
of	O
probesets	O
with	O
N	O
significant	O
“	O
outliers	O
”	O
was	O
determined	O
for	O
hCNS-SCns	S-cell_type
versus	O
Cyt-ES	S-cell_line
,	O
hCNS-SCns	S-cell_type
versus	O
HUES6-ES	S-cell_line
,	O
Cyt-NPs	S-cell_type
versus	O
Cyt-ES	S-cell_line
,	O
and	O
HUES6-NPs	S-cell_type
versus	O
HUES6-ES	S-cell_line
(	O
N	O
=	O
0	O
,	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
5	O
)	O
.	O

Similar	O
trends	O
were	O
observed	O
with	O
hCNS-SCns	S-cell_type
versus	O
HUES6-ES	S-cell_line
and	O
the	O
derived	O
NPs	S-cell_type
versus	O
hESCs	S-cell_type
(	O
Figure	O
6A	O
)	O
.	O

The	O
relative	O
ratio	O
of	O
the	O
exon-included	O
to	O
exon-skipped	O
isoforms	O
in	O
SLK	S-GP
likely	O
represents	O
an	O
ESC-specific	O
AS	O
signature	O
.	O

To	O
facilitate	O
downstream	O
analyses	O
,	O
instead	O
of	O
utilizing	O
the	O
meta-gene	O
sets	O
available	O
from	O
the	O
manufacturers	O
,	O
we	O
generated	O
our	O
own	O
gene	O
models	O
by	O
clustering	O
alignments	O
of	O
ESTs	O
and	O
mRNAs	O
to	O
annotated	O
known	O
genes	O
from	O
the	O
University	O
of	O
California	O
Santa	O
Cruz	O
(	O
UCSC	O
)	O
Genome	O
Browser	O
Database	O
.	O

Cells	O
were	O
lysed	O
in	O
1	O
mL	O
of	O
RNA-bee	O
(	O
Teltest	O
)	O
.	O

Recently	O
,	O
knockdown	O
of	O
Zfp42/Rex-1	S-GP
in	O
mouse	S-y
ESC	O
caused	O
the	O
cells	O
to	O
differentiate	O
[	O
65	O
]	O
.	O

To	O
understand	O
these	O
events	O
,	O
protocols	O
are	O
still	O
being	O
developed	O
to	O
differentiate	O
ESCs	S-cell_type
into	O
a	O
variety	O
of	O
lineages	O
.	O

As	O
an	O
endogenously	O
occurring	O
population	O
of	O
NPs	S-cell_type
,	O
human	B-cell_type
central	I-cell_type
nervous	I-cell_type
system	I-cell_type
stem	I-cell_type
cells	E-cell_type
grown	O
as	O
neurospheres	S-x
(	O
hCNS-SCns	S-x
)	O
were	O
utilized	O
as	O
a	O
natural	O
benchmark	O
for	O
derived	O
NPs	S-cell_type
.	O

In	O
particular	O
,	O
the	O
FOX1/2	S-GP
binding	O
site	O
,	O
GCUAG	O
,	O
was	O
conserved	O
and	O
enriched	O
in	O
the	O
flanking	O
introns	O
of	O
a	O
subset	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
.	O

Exons	O
annotated	O
as	O
first	O
or	O
last	O
exons	O
in	O
Refseq	O
mRNAs	O
were	O
excluded	O
from	O
our	O
analysis	O
,	O
resulting	O
in	O
4,487	O
positive-scoring	O
exons	O
,	O
2-fold	O
more	O
exons	O
than	O
originally	O
published.Here	O
we	O
repeated	O
our	O
analysis	O
with	O
exons	O
with	O
positive	O
ACEScan	O
scores	O
(	O
ACE	O
[	O
+	O
]	O
)	O
instead	O
of	O
EST-SEs	O
.	O

A	O
total	O
of	O
145,613	O
(	O
90	O
%	O
of	O
total	O
)	O
conserved	O
internal	O
exons	O
were	O
constitutive	O
exons	O
,	O
13,653	O
exons	O
(	O
8	O
%	O
)	O
had	O
evidence	O
of	O
exon-skipping	O
,	O
1,576	O
exons	O
were	O
mutually	O
exclusive	O
alternative	O
events	O
,	O
5,818	O
exons	O
had	O
alternative	O
3′	O
splice	O
sites	O
,	O
5,046	O
exons	O
had	O
alternative	O
5′	O
splice	O
sites	O
,	O
and	O
168	O
exons	O
overlapped	O
another	O
exon	O
.	O

The	O
Affymetrix	O
GeneChip	O
Human	O
Exon	O
1.0	O
ST	O
array	O
contains	O
∼5.4	O
million	O
features	O
used	O
to	O
interrogate	O
∼1	O
million	O
exon	O
clusters	O
(	O
collections	O
of	O
overlapping	O
)	O
of	O
known	O
and	O
predicted	O
exons	O
with	O
more	O
than	O
1.4	O
million	O
probesets	O
,	O
with	O
an	O
average	O
of	O
four	O
probes	O
per	O
exon	O
.	O

We	O
predict	O
it	O
is	O
unlikely	O
that	O
the	O
alternative	O
exon	O
in	O
the	O
SLK	S-GP
gene	O
is	O
the	O
only	O
case	O
common	O
across	O
hESC	O
and	O
different	O
from	O
differentiated	O
tissues	O
,	O
but	O
further	O
studies	O
will	O
be	O
necessary	O
to	O
identify	O
other	O
hESC-specific	O
exons	O
.	O

Confident	O
that	O
no	O
association	O
of	O
k-mers	O
with	O
shuffled	O
REAP	O
exons	O
were	O
found	O
;	O
we	O
repeated	O
the	O
analyses	O
for	O
upstream	O
and	O
downstream	O
intronic	O
5-mers	O
for	O
the	O
original	O
unshuffled	O
sets	O
.	O

Our	O
results	O
also	O
reveal	O
that	O
focusing	O
on	O
differentially	O
expressed	O
genes	O
between	O
hESC	O
and	O
NP	O
will	O
overlook	O
14	O
%	O
of	O
potential	O
AS	O
genes	O
.	O

The	O
RNA	S-cellcomponent
was	O
isolated	O
by	O
chloroform	O
extraction	O
of	O
the	O
aqueous	O
phase	O
,	O
followed	O
by	O
isopropanol	O
precipitation	O
as	O
per	O
the	O
manufacturer	O
's	O
instructions	O
.	O

However	O
,	O
the	O
fraction	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
decreased	O
significantly	O
in	O
“	O
enriched	O
in	O
hESCs	S-cell_type
”	O
and	O
“	O
enriched	O
in	O
NPs	S-cell_type
”	O
categories	O
.	O

A	O
regression	O
line	O
derived	O
from	O
robust	O
linear	O
regression	O
with	O
MM	O
estimation	O
is	O
indicated	O
.	O

However	O
,	O
in	O
some	O
cases	O
,	O
the	O
AS	O
patterns	O
in	O
the	O
derived	O
NPs	S-cell_type
were	O
different	O
from	O
both	O
hESCs	S-cell_type
and	O
hCNS-SCns	S-cell_type
(	O
such	O
as	O
in	O
the	O
AS	O
exon	O
in	O
UNC84A	S-GP
,	O
SIRT1	S-GP
,	O
and	O
MLLT10	S-GP
)	O
.Figure	O
7RT-PCR	O
Validation	O
of	O
REAP-Predicted	O
Alternative	O
Exons	O
(	O
A	O
)	O
Probesets	O
(	O
exons	O
)	O
were	O
considered	O
REAP	O
[	O
+	O
]	O
candidates	O
if	O
they	O
contained	O
at	O
least	O
N	O
=	O
2	O
(	O
white	O
bars	O
)	O
,	O
3	O
(	O
gray	O
bars	O
)	O
,	O
or	O
4	O
(	O
black	O
bars	O
)	O
significant	O
outliers	O
.	O

As	O
many	O
tissue-specific	O
splicing	O
cis-regulatory	O
elements	O
were	O
localized	O
in	O
intronic	O
regions	O
of	O
AS	O
exons	O
,	O
we	O
focused	O
on	O
the	O
identification	O
of	O
intronic	O
splicing	O
regulatory	O
elements	O
(	O
ISREs	O
)	O
proximal	O
to	O
REAP	O
[	O
+	O
]	O
exons	O
.	O

Each	O
conserved	O
5-mer	O
was	O
associated	O
with	O
two	O
numbers	O
:	O
the	O
enrichment	O
in	O
introns	O
proximal	O
to	O
REAP	O
[	O
+	O
]	O
NP	O
versus	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
x-axis	O
)	O
,	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
versus	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
y-axis	O
)	O
.	O

A	O
possible	O
explanation	O
is	O
that	O
the	O
cell	O
lines	O
were	O
not	O
only	O
genetically	O
different	O
,	O
but	O
were	O
also	O
exposed	O
to	O
different	O
isolation	O
and	O
culture	O
conditions	O
.	O

Our	O
gene-level	O
exon	O
array	O
analysis	O
confirmed	O
that	O
the	O
hESCs	S-cell_type
and	O
NPs	S-cell_type
were	O
molecularly	O
distinct.To	O
reveal	O
global	O
functional	O
differences	O
between	O
the	O
enriched	O
genes	O
in	O
hESCs	S-cell_type
or	O
NPs	S-cell_type
,	O
the	O
enriched	O
genes	O
were	O
subjected	O
to	O
a	O
Gene	O
Ontology	O
(	O
GO	O
,	O
http	O
:	O
//www.geneontology.org	O
)	O
analysis	O
as	O
described	O
previously	O
[	O
55	O
]	O
.	O

Gene	O
Ontology	O
“	O
molecular	O
function	O
,	O
”	O
“	O
cellular	O
component	O
,	O
”	O
and	O
“	O
biological	O
process	O
”	O
categories	O
,	O
which	O
differed	O
significantly	O
(	O
p	O
<	O
0.05	O
)	O
in	O
the	O
representation	O
between	O
significantly	O
enriched	O
genes	O
(	O
black	O
bars	O
)	O
and	O
all	O
other	O
genes	O
(	O
white	O
bars	O
)	O
,	O
were	O
shown	O
.	O

Sensitivity	O
was	O
computed	O
as	O
TP/	O
(	O
TP+FN	O
)	O
and	O
specificity	O
was	O
computed	O
as	O
TN/	O
(	O
FP+TN	O
)	O
.	O

Finally	O
,	O
by	O
comparing	O
genomic	O
sequences	O
across	O
multiple	O
mammals	S-x
,	O
the	O
authors	O
identified	O
dozens	O
of	O
conserved	O
candidate	O
binding	O
sites	O
that	O
were	O
enriched	O
proximal	O
to	O
REAP	O
candidate	O
exons	O
.	O

It	O
was	O
important	O
to	O
point	O
out	O
that	O
while	O
transcriptional	O
expression	O
of	O
these	O
genes	O
did	O
not	O
distinguish	O
these	O
cells	O
from	O
one	O
another	O
,	O
in	O
several	O
instances	O
the	O
REAP-predicted	O
AS	O
event	O
was	O
able	O
to	O
separate	O
derived	O
NPs	S-cell_type
and	O
hCNS-SCns	S-cell_type
.	O

hESC	O
line	O
HUES6	S-cell_line
was	O
cultured	O
on	O
MEF	O
feeders	S-cell_type
as	O
previously	O
described	O
(	O
http	O
:	O
//www.mcb.harvard.edu/melton/hues/	O
)	O
or	O
on	O
GFR	O
matrigel	O
coated	O
plates	O
.	O

Target	O
material	O
was	O
prepared	O
using	O
commercially	O
available	O
Affymetrix	O
GeneChip	O
WT	O
cDNA	O
Synthesis	O
Kit	O
,	O
WT	O
cDNA	O
Amplification	O
Kit	O
,	O
and	O
WT	O
Terminal	O
Labeling	O
Kit	O
(	O
Affymetrix	O
)	O
as	O
per	O
manufacturer	O
's	O
instructions	O
.	O

Finally	O
,	O
Sox1	S-GP
,	O
a	O
HMG-box	B-GP
protein	E-GP
related	O
to	O
SRY	S-GP
,	O
was	O
shown	O
to	O
be	O
one	O
of	O
the	O
earliest	O
transcription	O
factors	O
expressed	O
in	O
cells	O
committed	O
to	O
the	O
neural	S-x
fate	O
[	O
60	O
]	O
.	O

The	O
alternative	O
exon	O
in	O
the	O
EHBP1	S-GP
gene	O
was	O
unusual	O
.	O

(	O
B	O
)	O
Boxed	O
point	O
“	O
a	O
”	O
represents	O
a	O
significant	O
“	O
outlier	O
”	O
(	O
with	O
a	O
significantly	O
different	O
studentized	O
residual	O
and	O
low	O
leverage	O
)	O
.	O

Fifteen	O
REAP	O
[	O
+	O
]	O
exons	O
with	O
at	O
least	O
two	O
significant	O
outliers	O
(	O
out	O
of	O
five	O
)	O
were	O
randomly	O
chosen	O
as	O
predicted	O
alternative	O
events	O
and	O
thirty-five	O
exons	O
with	O
less	O
than	O
two	O
significant	O
outliers	O
were	O
randomly	O
chosen	O
as	O
constitutive	O
events	O
(	O
Table	O
S3	O
)	O
.	O

Of	O
particular	O
biomedical	O
interest	O
is	O
in	O
the	O
capacity	O
of	O
hESCs	S-cell_type
to	O
be	O
differentiated	O
into	O
a	O
self-renewing	O
population	O
of	O
NPs	S-cell_type
that	O
can	O
be	O
then	O
further	O
coaxed	O
into	O
a	O
variety	O
of	O
neuronal	S-x
subtypes	O
,	O
such	O
as	O
dopaminergic	B-cell_type
neurons	E-cell_type
that	O
are	O
important	O
in	O
the	O
treatment	O
of	O
Parkinson	O
disease	O
or	O
cholinergic	B-cell_type
neurons	E-cell_type
for	O
ALS	O
(	O
amyotrophic	O
lateral	O
sclerosis	O
)	O
.	O

For	O
every	O
point	O
,	O
we	O
computed	O
(	O
i	O
)	O
the	O
studentized	O
residual	O
(	O
as	O
described	O
above	O
)	O
,	O
(	O
ii	O
)	O
the	O
influence	O
,	O
and	O
(	O
iii	O
)	O
the	O
leverage	O
(	O
see	O
Materials	O
and	O
Methods	O
for	O
more	O
details	O
)	O
.	O

Points	O
above	O
the	O
line	O
represent	O
probesets	O
within	O
exons	O
that	O
were	O
enriched	O
in	O
Cyt-ES	S-cell_line
and	O
points	O
below	O
represent	O
exons	O
that	O
were	O
enriched	O
in	O
hCNS-SCns	S-cell_type
.	O

Further	O
studies	O
will	O
be	O
required	O
to	O
explore	O
the	O
importance	O
of	O
FOX1	S-GP
family	O
members	O
in	O
early	O
neuronal	S-x
differentiation	O
.	O

At	O
a	O
stringent	O
p-value	O
cutoff	O
of	O
0.01	O
,	O
four	O
of	O
the	O
five	O
studentized	O
residuals	O
were	O
designated	O
as	O
significant	O
“	O
outliers	O
,	O
”	O
indicating	O
that	O
the	O
probeset	O
was	O
“	O
unusual.	O
”	O
RT-PCR	O
confirmed	O
that	O
the	O
exon	O
,	O
represented	O
by	O
the	O
probeset	O
,	O
was	O
indeed	O
differentially	O
included	O
in	O
hESCs	S-cell_type
and	O
skipped	O
in	O
hCNS-SCns	S-cell_type
(	O
Figure	O
7B	O
)	O
.	O

The	O
exon	O
was	O
included	O
in	O
hESCs	S-cell_type
but	O
also	O
in	O
frontal	B-x
cortex	E-x
and	O
temporal	B-x
cortex	E-x
,	O
a	O
finding	O
that	O
was	O
unexpected	O
given	O
the	O
exclusion	O
of	O
the	O
exon	O
in	O
hCNS-SCns	S-cell_type
(	O
Figure	O
7C	O
)	O
.	O

If	O
we	O
increased	O
the	O
cutoffs	O
on	O
genes	O
that	O
were	O
randomly	O
assigned	O
as	O
REAP	O
[	O
+	O
]	O
and	O
REAP	O
[	O
−	O
]	O
,	O
controlling	O
for	O
the	O
same	O
number	O
of	O
genes	O
in	O
each	O
category	O
,	O
we	O
observed	O
that	O
the	O
fraction	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
remained	O
unchanged	O
for	O
all	O
three	O
categories	O
(	O
Figure	O
8C	O
)	O
.	O

While	O
insights	O
into	O
the	O
regulation	O
of	O
AS	O
have	O
come	O
predominantly	O
from	O
the	O
molecular	O
dissection	O
of	O
individual	O
genes	O
[	O
36,49	O
]	O
,	O
it	O
is	O
becoming	O
clear	O
that	O
molecular	O
rules	O
can	O
be	O
identified	O
from	O
large-scale	O
studies	O
of	O
both	O
constitutive	O
splicing	O
and	O
AS	O
[	O
40	O
]	O
.	O

Sequence	O
databases.Genome	O
sequences	O
of	O
human	S-y
(	O
hg17	O
)	O
,	O
dog	S-y
(	O
canFam1	O
)	O
,	O
rat	S-y
(	O
rn3	O
)	O
,	O
and	O
mouse	S-y
(	O
mm5	O
)	O
were	O
obtained	O
from	O
UCSC	O
,	O
as	O
were	O
the	O
whole-genome	O
MULTIZ	O
alignments	O
[	O
80	O
]	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
REAP	O
predictions	O
are	O
enriched	O
in	O
genes	O
encoding	O
serine/threonine	B-GP
kinase	E-GP
and	O
helicase	S-GP
activities	O
.	O

NSCs	S-cell_type
and	O
NPCs	S-cell_type
can	O
be	O
isolated	O
from	O
human	B-x
fetal	I-x
brain	E-x
tissue	O
[	O
23–26	O
]	O
,	O
as	O
well	O
as	O
from	O
several	O
regions	O
of	O
the	O
adult	B-x
human	I-x
brain	E-x
,	O
such	O
as	O
the	O
cortex	S-x
,	O
hippocampus	S-x
,	O
and	O
the	O
subventricular	B-x
zone	E-x
(	O
SVZ	S-x
)	O
of	O
the	O
lateral	B-x
ventricles	E-x
[	O
26–35	O
]	O
.	O

Functional	O
and	O
Expression	O
Characteristics	O
of	O
REAP	O
[	O
+	O
]	O
GenesIn	O
total	O
,	O
1,500	O
genes	O
were	O
identified	O
that	O
contained	O
1,737	O
REAP	O
[	O
+	O
]	O
exons	O
,	O
68	O
%	O
of	O
which	O
lacked	O
prior	O
transcript	O
(	O
EST/cDNA	O
)	O
evidence	O
for	O
AS	O
.	O

The	O
precipitated	O
RNA	S-cellcomponent
was	O
washed	O
in	O
75	O
%	O
ethanol	O
and	O
eluted	O
with	O
DEPC-treated	O
water	O
.	O

We	O
developed	O
an	O
approach	O
called	O
REAP	O
(	O
Regression-based	O
Exon	O
Array	O
Protocol	O
)	O
,	O
which	O
is	O
based	O
on	O
robust	O
regression	O
that	O
analyzed	O
signal	O
estimates	O
from	O
Affymetrix	O
exon	O
array	O
data	O
to	O
identify	O
AS	O
exons	O
.	O

Experimental	O
validation	O
of	O
REAP-predicted	O
AS	O
events	O
indicated	O
a	O
threshold-dependent	O
sensitivity	O
ranging	O
from	O
56	O
%	O
to	O
69	O
%	O
,	O
at	O
a	O
specificity	O
of	O
77	O
%	O
to	O
96	O
%	O
.	O

In	O
addition	O
,	O
the	O
different	O
differentiation	O
protocols	O
established	O
as	O
optimal	O
for	O
generating	O
Nestin	S-GP
and	O
Sox1	S-GP
positive	O
neural	B-cell_type
precursors	E-cell_type
may	O
lead	O
to	O
vastly	O
different	O
molecular	O
changes	O
.	O

For	O
every	O
gene	O
,	O
a	O
t-statistic	O
and	O
corresponding	O
p-value	O
were	O
computed	O
representing	O
the	O
relative	O
enrichment	O
of	O
the	O
expression	O
of	O
the	O
gene	O
in	O
hESC	O
versus	O
NP	O
,	O
such	O
as	O
in	O
Cyt-ES	S-cell_line
versus	O
Cyt-NP	O
.	O

(	O
B	O
)	O
Downstream	O
intronic	O
regions	O
,	O
where	O
the	O
association	O
between	O
REAP	O
[	O
+	O
]	O
designation	O
and	O
the	O
exons	O
was	O
shuffled	O
.	O

Boxed	O
point	O
“	O
b	O
”	O
represents	O
a	O
“	O
high	O
leverage	O
”	O
point	O
(	O
low	O
studentized	O
residual	O
and	O
a	O
high	O
leverage	O
)	O
.	O

[	O
81	O
]	O
,	O
we	O
defined	O
the	O
leverage	O
hi	O
of	O
the	O
ith	O
point	O
as	O
hi	O
=	O
n−1	O
+	O
(	O
xi	O
−	O
μx	O
)	O
2	O
/	O
sx2	O
(	O
n	O
−	O
1	O
)	O
.	O

Here	O
the	O
gene-level	O
estimates	O
indicated	O
that	O
Sox1	S-GP
was	O
expressed	O
significantly	O
higher	O
in	O
NPs	S-cell_type
relative	O
to	O
hESCs	S-cell_type
(	O
p-value	O
0.00013	O
,	O
Figure	O
1B	O
)	O
,	O
a	O
finding	O
that	O
was	O
confirmed	O
by	O
RT-PCR	O
(	O
Figure	O
1C	O
)	O
.From	O
these	O
examples	O
,	O
we	O
concluded	O
that	O
RT-PCR	O
validation	O
correlated	O
well	O
with	O
gene-level	O
estimates	O
from	O
the	O
exon	O
array	O
.	O

The	O
vast	O
majority	O
of	O
genes	O
(	O
>	O
80	O
%	O
)	O
was	O
found	O
to	O
have	O
probeset-level	O
Pearson	O
correlation	O
coefficients	O
of	O
greater	O
than	O
0.8	O
(	O
Figure	O
3A	O
)	O
.	O

After	O
generating	O
the	O
points	O
(	O
as	O
described	O
in	O
the	O
Results	O
section	O
)	O
,	O
we	O
utilized	O
the	O
robust	O
regression	O
method	O
rlm	O
in	O
R-package	O
“	O
MASS	O
”	O
(	O
version	O
6.1–2	O
)	O
with	O
M-estimation	O
and	O
a	O
maximum	O
iteration	O
setting	O
of	O
30	O
to	O
estimate	O
the	O
linear	O
function	O
yi	O
=	O
αxi	O
+	O
β	O
.	O

In	O
addition	O
,	O
we	O
wanted	O
to	O
identify	O
both	O
common	O
and	O
cell	O
type–specific	O
ISREs	O
.	O

Five	O
ug	O
of	O
RNA	S-cellcomponent
was	O
treated	O
with	O
RQ1	O
DNAase	S-GP
(	O
Promega	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

Therefore	O
,	O
we	O
concluded	O
that	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
enriched	O
for	O
AS	O
events	O
independently	O
identified	O
by	O
a	O
transcript-based	O
approach.Figure	O
6Comparison	O
of	O
REAP	O
Predictions	O
for	O
hCNS-SCns	S-cell_type
versus	O
Cyt-hES	S-cell_line
,	O
hCNS-SCns	S-cell_type
versus	O
HUES6-ES	S-cell_line
,	O
Cyt-NP	O
versus	O
Cyt-ES	S-cell_line
,	O
and	O
HUES6-NPs	S-cell_type
versus	O
HUES6-ES	S-cell_line
with	O
Alternative	O
Exons	O
Identified	O
by	O
an	O
EST-Based	O
Method	O
and	O
ACEScan	O
(	O
A	O
)	O
Black-filled	O
squares	O
represented	O
the	O
fraction	O
of	O
exons	O
containing	O
probesets	O
with	O
N	O
significant	O
points	O
that	O
had	O
EST	O
evidence	O
for	O
exon	O
inclusion	O
or	O
exclusion	O
(	O
N	O
=	O
0	O
,	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
and	O
5	O
)	O
.	O

The	O
human	B-x
central	I-x
nervous	I-x
system	E-x
is	O
composed	O
of	O
thousands	O
of	O
neuronal	B-cell_type
subtypes	E-cell_type
originating	O
from	O
neural	B-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
NSCs	S-cell_type
)	O
that	O
migrate	O
from	O
the	O
developing	O
neural	B-x
tube	E-x
.	O

A	O
gene	O
had	O
to	O
have	O
five	O
probesets	O
that	O
satisfied	O
the	O
two	O
conditions	O
above	O
in	O
order	O
to	O
be	O
considered	O
for	O
robust	O
regression	O
analysis	O
.	O

Points	O
close	O
to	O
the	O
regression	O
line	O
are	O
not	O
significantly	O
different	O
in	O
Cyt-ES	S-cell_line
versus	O
hCNS-SCns	S-cell_type
.	O

If	O
we	O
required	O
that	O
none	O
of	O
the	O
points	O
per	O
probeset	O
(	O
exon	O
)	O
was	O
significant	O
,	O
2	O
%	O
(	O
1,645	O
of	O
71,731	O
)	O
of	O
exons	O
(	O
after	O
probeset	O
mapping	O
)	O
were	O
ACE	O
[	O
+	O
]	O
(	O
Figure	O
6B	O
)	O
.	O

An	O
example	O
is	O
a	O
REAP-predicted	O
alternative	O
exon	O
in	O
the	O
SLK	S-GP
(	O
serine/threonine	B-GP
kinase	I-GP
2	E-GP
)	O
gene	O
that	O
is	O
differentially	O
included	O
in	O
hESC	O
,	O
but	O
skipped	O
in	O
NP	O
as	O
well	O
as	O
in	O
other	O
differentiated	O
tissues	O
.	O

However	O
,	O
classical	O
linear	O
regression	O
by	O
least-squares	O
estimation	O
is	O
biased	O
because	O
the	O
least	O
squares	O
predictions	O
are	O
strongly	O
influenced	O
by	O
the	O
outliers	O
,	O
leading	O
to	O
completely	O
incorrect	O
regression	O
line	O
estimates	O
,	O
masking	O
of	O
the	O
outliers	O
,	O
and	O
incorrect	O
predictions	O
of	O
outliers	O
.	O

Leverage	O
assessed	O
how	O
far	O
away	O
a	O
value	O
of	O
the	O
independent	O
variable	O
was	O
from	O
the	O
mean	O
value	O
;	O
the	O
farther	O
away	O
the	O
observation	O
the	O
more	O
leverage	O
it	O
had	O
.	O

A	O
notable	O
exception	O
was	O
the	O
alternative	O
exon	O
in	O
the	O
SLK	S-GP
gene	O
,	O
encoding	O
a	O
serine/threonine	B-GP
kinase	E-GP
protein	O
,	O
which	O
was	O
commonly	O
included	O
in	O
both	O
hESCs	S-cell_type
,	O
i.e.	O
,	O
the	O
exon-excluded	O
isoform	O
was	O
not	O
present	O
in	O
hESCs	S-cell_type
compared	O
to	O
NPs	S-cell_type
,	O
as	O
well	O
as	O
in	O
a	O
variety	O
of	O
differentiated	O
tissues	O
.	O

Genes	O
containing	O
less	O
than	O
three	O
exons	O
were	O
removed	O
from	O
further	O
consideration	O
.	O

The	O
AS	O
pattern	O
in	O
hCNS-SCns	S-cell_type
may	O
represent	O
a	O
transient	O
,	O
early	O
neuronal	S-x
molecular	O
change	O
.	O

Boxed	O
point	O
“	O
c	O
”	O
represents	O
a	O
“	O
high	O
influence	O
”	O
point	O
(	O
high	O
studentized	O
residual	O
,	O
high	O
leverage	O
,	O
and	O
high	O
influence	O
)	O
.	O

Statistical	O
significance	O
for	O
GO	O
analysis	O
was	O
assessed	O
by	O
using	O
χ2	O
statistics	O
with	O
Bonferroni	O
correction	O
for	O
multiple	O
hypothesis	O
testing	O
.	O

(	O
C	O
)	O
Upstream	O
intronic	O
regions	O
.	O

Three	O
sets	O
of	O
exons	O
were	O
generated	O
:	O
(	O
i	O
)	O
REAP	O
[	O
+	O
]	O
exons	O
that	O
were	O
predicted	O
to	O
be	O
included	O
in	O
NPs	S-cell_type
and	O
skipped	O
in	O
hESCs	S-cell_type
(	O
REAP	O
[	O
+	O
]	O
NP	O
)	O
;	O
(	O
ii	O
)	O
REAP	O
[	O
+	O
]	O
exons	O
that	O
were	O
predicted	O
to	O
be	O
included	O
in	O
hESCs	S-cell_type
and	O
skipped	O
in	O
NPs	S-cell_type
(	O
REAP	O
[	O
+	O
]	O
hESC	O
)	O
;	O
and	O
(	O
iii	O
)	O
all	O
REAP	O
[	O
−	O
]	O
exons	O
.	O

Exon	O
array	O
analysis.The	O
Affymetrix	O
Power	O
Tools	O
(	O
APT	O
)	O
suite	O
of	O
programs	O
was	O
obtained	O
from	O
http	O
:	O
//www.affymetrix.com/support/developer/powertools/index.affx	O
.	O

Of	O
the	O
5-mers	O
that	O
were	O
significantly	O
enriched	O
upstream	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
exons	O
,	O
we	O
identified	O
a	O
U-rich	O
motif	O
(	O
UUUUU	O
)	O
,	O
a	O
GU-rich	O
motif	O
(	O
GUGUG	O
)	O
,	O
and	O
a	O
CU-rich	O
motif	O
(	O
CCUCU	O
,	O
CUCUC	O
,	O
UCUCU	O
,	O
GCUCU	O
)	O
.	O

One	O
ug	O
of	O
total	O
RNA	S-cellcomponent
for	O
each	O
sample	O
was	O
processed	O
using	O
the	O
Affymetrix	O
GeneChip	O
Whole	O
Transcript	O
Sense	O
Target	O
Labeling	O
Assay	O
(	O
Affymetrix	O
)	O
.	O

A	O
total	O
of	O
236	O
significant	O
probesets	O
overlapped	O
when	O
we	O
compared	O
the	O
derived	O
NPs	S-cell_type
to	O
hESCs	S-cell_type
(	O
Cyt-NP	O
versus	O
Cyt-ES	S-cell_line
and	O
HUES6	S-cell_line
-NP	O
versus	O
HUES6-ES	S-cell_line
)	O
,	O
relative	O
to	O
seven	O
significant	O
probesets	O
(	O
34-fold	O
enrichment	O
)	O
.At	O
a	O
cutoff	O
of	O
two	O
significant	O
outliers	O
,	O
1,737	O
probesets	O
contained	O
in	O
internal	O
exons	O
were	O
defined	O
as	O
positive	O
REAP	O
predictions	O
(	O
hereafter	O
called	O
REAP	O
[	O
+	O
]	O
)	O
exons—candidate	O
AS	O
events	O
that	O
distinguished	O
NP	O
from	O
hESC	O
.	O

To	O
differentiate	O
neuroepithelial	B-cell_type
precursors	E-cell_type
,	O
colonies	O
were	O
removed	O
by	O
treatment	O
with	O
collagenase	B-GP
IV	E-GP
(	O
Sigma	O
)	O
and	O
washed	O
three	O
times	O
in	O
growth	O
media	O
.	O

Circled	O
5-mers	O
in	O
the	O
upper	O
right	O
quadrant	O
represent	O
conserved	O
5-mers	O
enriched	O
in	O
the	O
upstream	O
intronic	O
regions	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
.	O

Boxed	O
points	O
represented	O
the	O
five-point	O
summary	O
of	O
a	O
probeset	O
that	O
was	O
significantly	O
enriched	O
in	O
Cyt-ES	S-cell_line
but	O
was	O
skipped	O
in	O
hCNS-SCns	S-cell_type
.	O

Experimental	O
validation	O
revealed	O
alternative	O
exons	O
that	O
distinguish	O
hESCs	S-cell_type
from	O
NPs	S-cell_type
;	O
some	O
of	O
them	O
also	O
distinguish	O
hESCs	S-cell_type
from	O
a	O
variety	O
of	O
differentiated	O
tissues	O
.	O

Enriched	O
genes	O
in	O
hESCs	S-cell_type
were	O
more	O
likely	O
to	O
be	O
in	O
molecular	O
function	O
categories	O
,	O
such	O
as	O
“	O
RNA	O
binding	O
”	O
(	O
p-value	O
<	O
10−12	O
)	O
,	O
“	O
structural	O
constituent	O
of	O
ribosome	O
”	O
(	O
p-value	O
<	O
10−51	O
)	O
,	O
“	O
exonuclease	O
activity	O
”	O
(	O
p-value	O
<	O
10−6	O
)	O
,	O
“	O
cytochrome-c	O
oxidase	O
activity	O
”	O
(	O
p-value	O
<	O
10−5	O
)	O
,	O
and	O
“	O
ATP	O
binding	O
”	O
(	O
p-value	O
<	O
10−6	O
)	O
,	O
and	O
in	O
biological	O
processes	O
involved	O
with	O
“	O
tRNA	O
processing	O
”	O
(	O
p-value	O
<	O
10−6	O
)	O
and	O
“	O
protein	O
biosynthesis	O
”	O
(	O
p-value	O
<	O
10−48	O
)	O
,	O
consistent	O
with	O
our	O
knowledge	O
of	O
hESCs	S-cell_type
as	O
a	O
rapidly	O
proliferating	O
population	O
of	O
cells	O
(	O
Figure	O
2A	O
)	O
.	O

Next	O
we	O
randomly	O
permuted	O
the	O
association	O
between	O
the	O
median	O
signal	O
estimates	O
and	O
the	O
probesets	O
for	O
each	O
gene	O
in	O
hESCs	S-cell_type
(	O
or	O
hCNS-SCns	S-cell_type
)	O
and	O
observed	O
that	O
the	O
distribution	O
of	O
Pearson	O
correlation	O
coefficients	O
for	O
the	O
permuted	O
sets	O
was	O
centered	O
at	O
zero	O
,	O
as	O
expected	O
(	O
Figure	O
3A	O
)	O
.	O

It	O
is	O
likely	O
that	O
post-transcriptional	O
changes	O
such	O
as	O
AS	O
may	O
be	O
more	O
variable	O
despite	O
the	O
cells	O
being	O
at	O
acknowledged	O
“	O
end-points	O
”	O
defined	O
by	O
a	O
limited	O
set	O
of	O
immunohistochemical	O
markers	O
.	O

Several	O
studies	O
have	O
explored	O
expression	O
patterns	O
of	O
NPCs	S-cell_type
.	O

The	O
influence	O
of	O
a	O
point	O
was	O
related	O
to	O
its	O
covariance	O
ratio	O
:	O
a	O
covariance	O
ratio	O
larger	O
(	O
or	O
smaller	O
)	O
than	O
1	O
implied	O
that	O
the	O
point	O
was	O
closer	O
(	O
or	O
farther	O
)	O
than	O
was	O
typical	O
to	O
the	O
regression	O
line	O
,	O
so	O
removing	O
it	O
would	O
hurt	O
(	O
or	O
help	O
)	O
the	O
accuracy	O
of	O
the	O
line	O
and	O
would	O
increase	O
(	O
or	O
decrease	O
)	O
the	O
error	O
term	O
variance	O
.	O

To	O
do	O
this	O
we	O
calculated	O
the	O
Pearson	O
correlation	O
coefficient	O
between	O
the	O
vectors	O
of	O
median	O
signal	O
estimates	O
across	O
replicates	O
in	O
Cyt-ES	S-cell_line
versus	O
hCNS-SCns	S-cell_type
.	O

To	O
illustrate	O
,	O
at	O
a	O
cutoff	O
of	O
five	O
,	O
10	O
%	O
(	O
29	O
of	O
267	O
)	O
of	O
enriched	O
NP	O
genes	O
were	O
REAP	O
[	O
+	O
]	O
genes	O
and	O
8.8	O
%	O
(	O
102	O
of	O
1,162	O
)	O
of	O
enriched	O
hESC	O
genes	O
were	O
REAP	O
[	O
+	O
]	O
,	O
significantly	O
different	O
(	O
p	O
<	O
0.000005	O
)	O
from	O
the	O
random	O
control	O
where	O
∼14	O
%	O
of	O
enriched	O
NP	O
and	O
enriched	O
hESC	O
genes	O
were	O
REAP	O
[	O
+	O
]	O
.	O

After	O
correcting	O
for	O
multiple	O
hypothesis	O
testing	O
using	O
the	O
Benjamini-Hochberg	O
method	O
,	O
a	O
p-value	O
cutoff	O
of	O
0.01	O
was	O
used	O
to	O
identify	O
enriched	O
genes	O
.	O

Most	O
systematic	O
global	O
analyses	O
on	O
AS	O
have	O
focused	O
on	O
comparisons	O
across	O
differentiated	O
human	S-y
tissues	O
[	O
50–52	O
]	O
.	O

True	O
positive	O
(	O
TP	O
)	O
,	O
true	O
negative	O
(	O
TN	O
)	O
,	O
false	O
positive	O
(	O
FP	O
)	O
,	O
and	O
false	O
negative	O
(	O
FN	O
)	O
rates	O
were	O
calculated	O
from	O
RT-PCR-validated	O
REAP	O
[	O
+	O
]	O
exons	O
at	O
the	O
different	O
cutoffs	O
(	O
N	O
=	O
2	O
,	O
3	O
,	O
4	O
)	O
.	O

Such	O
neuronal	S-x
complexity	O
is	O
generated	O
by	O
a	O
vast	O
repertoire	O
of	O
molecular	O
,	O
genetic	O
,	O
and	O
epigenetic	O
mechanisms	O
,	O
such	O
as	O
the	O
active	O
retrotransposition	O
of	O
transposable	O
elements	O
[	O
1	O
]	O
,	O
alternative	O
promoter	O
usage	O
,	O
alternative	O
RNA	S-cellcomponent
splicing	O
(	O
AS	O
)	O
,	O
alternative	O
polyadenylation	O
,	O
RNA	O
editing	O
,	O
post-translational	O
modifications	O
,	O
and	O
epigenetic	O
modulation	O
[	O
2	O
]	O
.	O

Collectively	O
,	O
these	O
exons	O
represent	O
a	O
set	O
of	O
molecular	O
changes	O
that	O
are	O
likely	O
to	O
be	O
important	O
for	O
studying	O
human	S-y
neural	S-x
differentiation	O
with	O
applications	O
in	O
neuronal	S-x
regenerative	O
medicine	O
.	O

Shuffling	O
the	O
mapping	O
between	O
these	O
probesets	O
and	O
exons	O
resulted	O
in	O
3	O
%	O
(	O
2,044	O
of	O
71,731	O
)	O
of	O
exons	O
being	O
ACE	O
[	O
+	O
]	O
(	O
Figure	O
6B	O
)	O
.	O

(	O
C	O
)	O
Scatter	O
plot	O
of	O
points	O
for	O
the	O
CLCN2	S-GP
gene	O
.	O

While	O
many	O
microarray	O
studies	O
have	O
explored	O
molecular	O
differences	O
between	O
hESCs	S-cell_type
and	O
derived	O
NPs	S-cell_type
,	O
most	O
,	O
if	O
not	O
all	O
,	O
have	O
focused	O
on	O
transcriptional	O
changes	O
.	O

For	O
example	O
,	O
Wright	O
et	O
al	O
.	O

Applying	O
this	O
approach	O
to	O
all	O
gene	O
models	O
revealed	O
that	O
,	O
as	O
expected	O
,	O
the	O
majority	O
of	O
studentized	O
residuals	O
are	O
centered	O
at	O
zero	O
(	O
Figure	O
3E	O
)	O
.	O

For	O
comparison	O
,	O
points	O
to	O
probeset	O
relationships	O
were	O
randomly	O
permuted	O
,	O
retaining	O
the	O
same	O
number	O
of	O
“	O
outliers.	O
”	O
Vertical	O
bars	O
represent	O
the	O
ratio	O
between	O
the	O
number	O
of	O
actual	O
points	O
and	O
the	O
randomly	O
permutated	O
sets	O
.	O

GO	O
categories	O
are	O
ordered	O
from	O
top	O
to	O
bottom	O
in	O
order	O
of	O
decreasingly	O
significant	O
bias	O
toward	O
enriched	O
genes	O
.	O

Human	B-cell_type
central	I-cell_type
nervous	I-cell_type
system	I-cell_type
stem	I-cell_type
cell	E-cell_type
line	O
FBR1664	S-cell_line
(	O
StemCells	O
)	O
which	O
is	O
referred	O
to	O
as	O
hCNS-SCns	S-cell_type
in	O
the	O
main	O
text	O
was	O
cultured	O
as	O
previously	O
described	O
[	O
23	O
]	O
.	O

To	O
correct	O
for	O
multiple	O
hypothesis	O
testing	O
,	O
p-values	O
were	O
multiplied	O
by	O
the	O
total	O
number	O
of	O
comparisons	O
.	O

identified	O
“	O
expressed	O
”	O
and	O
“	O
not	O
expressed	O
”	O
genes	O
in	O
NPCs	S-cell_type
isolated	O
from	O
the	O
human	B-x
embryonic	I-x
cortex	E-x
[	O
24	O
]	O
;	O
Cai	O
et	O
al	O
.	O

Lastly	O
,	O
comparative	O
sequence	O
analysis	O
revealed	O
conserved	O
intronic	O
cis-regulatory	O
elements	O
such	O
as	O
the	O
FOX1/2	S-GP
binding	O
site	O
GCAUG	O
as	O
being	O
proximal	O
to	O
candidate	O
AS	O
exons	O
,	O
suggesting	O
that	O
FOX1/2	S-GP
may	O
participate	O
in	O
the	O
regulation	O
of	O
AS	O
in	O
NP	O
and	O
hESC	O
.	O

Boxed	O
points	O
represent	O
“	O
high	O
leverage	O
”	O
points	O
.	O

Conserved	O
Intronic	O
Splicing	O
Regulatory	O
Elements	O
Proximal	O
to	O
REAP	O
[	O
+	O
]	O
hESC	O
and	O
NP	O
ExonsMany	O
,	O
if	O
not	O
most	O
,	O
alternative	O
exons	O
undergo	O
cell	O
type–specific	O
regulation	O
by	O
the	O
binding	O
of	O
trans-factors	O
to	O
splicing	O
regulatory	O
cis-elements	O
located	O
proximal	O
to	O
or	O
within	O
the	O
exons	O
.	O

Immunohistochemical	O
analysis	O
confirmed	O
that	O
hCNS-SCns	S-cell_type
were	O
negative	O
for	O
Oct4	S-GP
(	O
unpublished	O
data	O
)	O
and	O
positive	O
for	O
Sox1	S-GP
and	O
Nestin	S-GP
(	O
Figure	O
1A	O
)	O
.Figure	O
1Molecular	O
Characterization	O
of	O
Human	B-cell_type
Embryonic	I-cell_type
Stem	I-cell_type
Cell	E-cell_type
Lines	O
and	O
Neuronal	B-cell_type
Progenitors	E-cell_type
(	O
A	O
)	O
Immunohistochemical	O
analysis	O
of	O
markers	O
in	O
NPs	S-cell_type
derived	O
from	O
the	O
hESC	O
lines	O
(	O
Cyt-NP	O
from	O
Cyt-ES	S-cell_line
;	O
and	O
HUES6	S-cell_line
-NP	O
from	O
HUES6-ES	S-cell_line
)	O
and	O
in	O
hCNS-SCns	S-cell_type
.	O

Ribosomal	B-cellcomponent
RNA	E-cellcomponent
was	O
reduced	O
with	O
the	O
RiboMinus	O
Kit	O
(	O
Invitrogen	O
)	O
.	O

(	O
D	O
)	O
Histogram	O
of	O
studentized	O
residuals	O
for	O
points	O
from	O
the	O
scatter	O
plot	O
in	O
(	O
C	O
)	O
in	O
EHBP1	S-GP
.	O

For	O
each	O
probeset	O
,	O
we	O
computed	O
the	O
error	O
term	O
ei	O
,	O
,	O
which	O
was	O
the	O
difference	O
between	O
the	O
actual	O
value	O
yi	O
and	O
the	O
estimated	O
value	O
ξi	O
,	O
from	O
the	O
estimated	O
function	O
ξi	O
=	O
Axi	O
+	O
B	O
,	O
where	O
A	O
and	O
B	O
were	O
estimates	O
of	O
α	O
and	O
β	O
.	O

Increasing	O
the	O
cutoff	O
to	O
three	O
increased	O
the	O
specificity	O
to	O
85	O
%	O
,	O
with	O
a	O
slight	O
decrease	O
in	O
sensitivity	O
to	O
67	O
%	O
(	O
Figure	O
7A	O
)	O
.	O

The	O
pieces	O
of	O
colonies	O
were	O
resuspended	O
in	O
HUES	S-cell_type
growth	O
media	O
without	O
FGF2	S-GP
in	O
an	O
uncoated	O
bacterial	O
Petri	O
dish	O
to	O
form	O
EBs	S-x
.	O

(	O
D	O
)	O
Downstream	O
intronic	O
regions	O
.	O

Only	O
one	O
study	O
,	O
utilizing	O
expressed	O
sequence	O
tag	O
(	O
EST	O
)	O
collections	O
from	O
stem	O
cells	O
,	O
has	O
attempted	O
to	O
find	O
AS	O
differences	O
between	O
embryonic	S-x
and	O
hematopoietic	B-cell_type
stem	I-cell_type
cells	E-cell_type
[	O
53	O
]	O
.	O

(	O
D	O
)	O
Scatter	O
plot	O
of	O
points	O
for	O
the	O
ABCA3	S-GP
gene	O
.	O

A	O
comparison	O
of	O
REAP-predicted	O
alternative	O
events	O
with	O
independent	O
methods	O
,	O
such	O
as	O
using	O
publicly	O
available	O
transcripts	O
(	O
ESTs	O
and	O
mRNAs	S-cellcomponent
)	O
and	O
computational	O
predictions	O
based	O
on	O
genomic	O
sequence	O
information	O
alone	O
[	O
55	O
]	O
,	O
showed	O
a	O
strong	O
concordance	O
of	O
REAP-identified	O
AS	O
exons	O
with	O
AS	O
events	O
identified	O
from	O
these	O
orthogonal	O
methods	O
.	O

It	O
is	O
known	O
that	O
the	O
heterogeneous	B-GP
ribonucleoprotein	I-GP
C	E-GP
(	O
hnRNP	B-GP
C	E-GP
)	O
binding	O
site	O
obtained	O
by	O
SELEX	O
is	O
five	O
“	O
U	O
”	O
s	O
[	O
67	O
]	O
.	O

Circled	O
5-mers	O
in	O
the	O
upper	O
right	O
quadrant	O
represent	O
conserved	O
5-mers	O
enriched	O
in	O
the	O
downstream	O
intronic	O
regions	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
exons.Eighteen	O
conserved	O
5-mers	O
were	O
significantly	O
enriched	O
in	O
the	O
downstream	O
introns	O
of	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
;	O
and	O
76	O
5-mers	O
were	O
enriched	O
downstream	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
exons	O
(	O
Table	O
S4	O
,	O
Figure	O
9D	O
)	O
.	O

Close	O
inspection	O
of	O
all	O
pairs	O
of	O
hESC-NP	O
comparisons	O
revealed	O
a	O
generally	O
significant	O
overlap	O
from	O
31	O
%	O
to	O
85	O
%	O
of	O
the	O
smaller	O
of	O
two	O
compared	O
sets	O
of	O
enriched	O
genes	O
(	O
see	O
Figure	O
S1	O
)	O
.	O

As	O
hESCs	S-cell_type
can	O
theoretically	O
generate	O
all	O
cell	O
types	O
that	O
make	O
up	O
an	O
organism	O
,	O
they	O
serve	O
as	O
an	O
important	O
model	O
for	O
understanding	O
early	O
human	S-y
embryonic	S-x
development	O
.	O

In	O
addition	O
,	O
the	O
derived	O
NPs	S-cell_type
had	O
decreased	O
levels	O
of	O
pluripotent	O
markers	O
Oct4	S-GP
and	O
Nanog	S-GP
but	O
had	O
levels	O
of	O
Sox1	S-GP
that	O
were	O
comparable	O
to	O
hCNS-SCns	S-cell_type
.	O

Therefore	O
,	O
we	O
applied	O
M-estimation	O
robust	O
regression	O
to	O
estimate	O
the	O
line	O
,	O
which	O
is	O
less	O
sensitive	O
to	O
outliers	O
.	O

(	O
A	O
)	O
GO	O
analysis	O
of	O
enriched	O
genes	O
in	O
hESCs	S-cell_type
.	O

Our	O
results	O
are	O
consistent	O
with	O
a	O
recent	O
study	O
that	O
showed	O
that	O
while	O
two	O
well-established	O
hESC	O
lines	O
differentiate	O
into	O
functional	O
neurons	O
,	O
the	O
two	O
lines	O
exhibited	O
distinct	O
differentiation	O
potentials	O
,	O
suggesting	O
that	O
some	O
preprogramming	O
had	O
occurred	O
[	O
76	O
]	O
.	O

Known	O
genes	O
that	O
were	O
mapped	O
to	O
different	O
isoform	O
clusters	O
were	O
discarded	O
.	O

Boxed	O
points	O
represent	O
“	O
high	O
influence	O
”	O
points	O
.	O

Regions	O
of	O
400	O
base	O
pairs	O
flanking	O
the	O
exons	O
were	O
targeted	O
for	O
search	O
.	O

(	O
E	O
)	O
The	O
histogram	O
of	O
studentized	O
residuals	O
for	O
all	O
points	O
for	O
all	O
analyzed	O
probesets	O
(	O
100	O
bins	O
)	O
.	O

used	O
the	O
massively	O
parallel	O
signature	O
sequencing	O
profiling	O
(	O
MPSS	O
)	O
technique	O
to	O
analyze	O
expression	O
of	O
fetal	B-cell_type
NPCs	E-cell_type
in	O
comparison	O
to	O
hESCs	S-cell_type
and	O
astrocyte	B-cell_type
precursors	E-cell_type
[	O
27	O
]	O
;	O
Maisel	O
et	O
al	O
.	O

Thus	O
far	O
in	O
the	O
example	O
,	O
our	O
analysis	O
was	O
based	O
on	O
regression	O
of	O
hESCs	S-cell_type
(	O
y-axis	O
)	O
versus	O
hCNS-SCns	S-cell_type
(	O
x-axis	O
)	O
(	O
Figure	O
3B–3D	O
)	O
.	O

To	O
determine	O
whether	O
genes	O
that	O
contained	O
REAP	O
[	O
+	O
]	O
exons	O
,	O
which	O
we	O
refer	O
to	O
as	O
REAP	O
[	O
+	O
]	O
genes	O
,	O
are	O
biased	O
toward	O
particular	O
biological	O
activities	O
,	O
REAP	O
[	O
+	O
]	O
genes	O
were	O
compared	O
to	O
a	O
set	O
of	O
REAP	O
analyzed	O
genes	O
not	O
found	O
to	O
have	O
REAP	O
[	O
+	O
]	O
exons	O
(	O
REAP	O
[	O
−	O
]	O
genes	O
)	O
.	O

White-filled	O
triangles	O
represented	O
similarly	O
computed	O
fractions	O
with	O
permuted	O
probeset	O
to	O
exon	O
mappings	O
.	O

(	O
B	O
)	O
Nine	O
RT-PCR	O
validated	O
REAP	O
[	O
+	O
]	O
AS	O
events	O
in	O
hESCs	S-cell_type
(	O
Cyt-ES	S-cell_line
and	O
HUES6-ES	S-cell_line
)	O
,	O
derived	O
NPs	S-cell_type
(	O
Cyt-NP	O
and	O
HUES6	S-cell_line
-NP	O
)	O
,	O
and	O
hCNS-SCns	S-cell_type
.	O

Comparison	O
of	O
REAP	O
to	O
EST-Based	O
Method	O
and	O
ACEScanTraditionally	O
,	O
AS	O
exons	O
were	O
discovered	O
by	O
using	O
EST	O
alignments	O
to	O
genomic	O
loci	O
,	O
and	O
also	O
more	O
recently	O
by	O
computational	O
algorithms	O
that	O
used	O
sequence	O
information	O
extracted	O
from	O
multiple	O
genomes	O
.	O

(	O
B	O
)	O
GO	O
analysis	O
of	O
enriched	O
genes	O
in	O
NPs	S-cell_type
.To	O
summarize	O
,	O
firstly	O
immunohistochemical	O
and	O
RT-PCR	O
evidence	O
validated	O
that	O
the	O
cells	O
exhibited	O
expected	O
characteristics	O
;	O
secondly	O
,	O
stage-specific	O
marker	O
gene	O
differences	O
by	O
RT-PCR	O
were	O
reflected	O
accurately	O
by	O
gene-level	O
estimates	O
from	O
the	O
exon	O
arrays	O
;	O
thirdly	O
,	O
the	O
hESC-enriched	O
genes	O
were	O
coherent	O
with	O
known	O
genes	O
that	O
controlled	O
pluripotency	O
and	O
self-renewal	O
;	O
and	O
lastly	O
,	O
the	O
global	O
functional	O
profiles	O
exemplified	O
expected	O
biological	O
differences	O
between	O
hESC	O
and	O
NP	O
cells	O
.	O

Maintenance	O
and	O
differentiation	O
of	O
hESCs	S-cell_type
and	O
hCNS-SCns	S-cell_type
.hESC	O
line	O
Cy203	S-cell_line
(	O
Cythera	O
)	O
was	O
cultured	O
as	O
previously	O
described	O
[	O
12	O
]	O
.	O

Global	O
Identification	O
and	O
Characterization	O
of	O
REAP	O
[	O
+	O
]	O
ExonsREAP	O
was	O
applied	O
to	O
identify	O
AS	O
events	O
in	O
NPs	S-cell_type
compared	O
to	O
hESCs	S-cell_type
:	O
Cyt-NP	O
versus	O
Cyt-ES	S-cell_line
;	O
HUES6	S-cell_line
-NP	O
versus	O
HUES6-ES	S-cell_line
;	O
hCNS-SCns	S-cell_type
versus	O
Cyt-ES	S-cell_line
,	O
and	O
hCNS-SCns	S-cell_type
versus	O
HUES6-ES	S-cell_line
.	O

After	O
one	O
week	O
,	O
EBs	S-x
were	O
plated	O
on	O
polyornathine/	O
laminin	S-GP
coated	O
plates	O
in	O
DMEM/F12	O
supplemented	O
with	O
N2	O
and	O
FGF2	S-GP
.	O

Nine	O
of	O
the	O
fifteen	O
exons	O
(	O
60	O
%	O
)	O
were	O
validated	O
as	O
AS	O
events	O
by	O
our	O
criteria	O
.	O

Experimental	O
Validation	O
of	O
Alternative	O
ExonsThe	O
sensitivity	O
and	O
specificity	O
of	O
REAP	O
in	O
the	O
identification	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
was	O
tested	O
by	O
RT-PCR	O
.	O

To	O
determine	O
if	O
the	O
signal	O
intensity	O
for	O
a	O
given	O
probeset	O
is	O
above	O
the	O
expected	O
level	O
of	O
background	O
noise	O
,	O
we	O
utilized	O
the	O
DABG	O
(	O
detection	O
above	O
background	O
)	O
quantification	O
method	O
available	O
in	O
the	O
apt-probeset-summarize	O
program	O
as	O
part	O
of	O
Affymetrix	O
Power	O
Tools	O
(	O
APT	O
)	O
.	O

All	O
mRNAs	S-cellcomponent
aligned	O
to	O
hg17	O
that	O
were	O
greater	O
than	O
300	O
bases	O
long	O
were	O
clustered	O
together	O
with	O
the	O
known	O
isoforms	O
.	O

GU-rich	O
sequences	O
in	O
flanking	O
intronic	O
regions	O
were	O
shown	O
to	O
bind	O
to	O
splicing	O
factor	O
ETR-3	S-GP
to	O
regulate	O
AS	O
[	O
68	O
]	O
.	O

This	O
indicated	O
that	O
the	O
signal	O
estimates	O
for	O
probesets	O
between	O
hESCs	S-cell_type
and	O
hCNS-SCns	S-cell_type
were	O
highly	O
correlated	O
and	O
suggested	O
that	O
a	O
scatter	O
plot	O
of	O
probeset	O
signal	O
estimates	O
between	O
hESCs	S-cell_type
and	O
hCNS-SCns	S-cell_type
would	O
reveal	O
a	O
linear	O
relationship	O
for	O
the	O
majority	O
of	O
genes	O
.	O

(	O
B	O
)	O
Similar	O
to	O
(	O
A	O
)	O
,	O
except	O
points	O
were	O
counted	O
as	O
“	O
outliers	O
”	O
only	O
if	O
they	O
were	O
“	O
outliers	O
”	O
in	O
both	O
hCNS-SCns	S-cell_type
versus	O
Cyt-ES	S-cell_line
and	O
hCNS-SCns	S-cell_type
versus	O
HUES6-ES	S-cell_line
(	O
combined	O
hCNS-SCns	S-cell_type
versus	O
hESC	O
;	O
blue	O
bars	O
)	O
;	O
in	O
both	O
HUES6	S-cell_line
-NP	O
versus	O
HUES6-ES	S-cell_line
and	O
Cyt-NP	O
versus	O
Cyt-ES	S-cell_line
(	O
combined	O
derived	O
NP	O
versus	O
hESC	O
;	O
red	O
bars	O
)	O
;	O
and	O
in	O
all	O
four	O
comparisons	O
(	O
combined	O
NP	O
versus	O
hESC	O
;	O
yellow	O
bar	O
)	O
.Next	O
we	O
asked	O
whether	O
the	O
overlap	O
between	O
related	O
comparisons	O
was	O
higher	O
than	O
expected	O
.	O

Fitting	O
was	O
performed	O
using	O
an	O
iterated	O
,	O
re-weighted	O
least	O
squares	O
analysis	O
.	O

At	O
a	O
cutoff	O
of	O
five	O
,	O
14	O
%	O
(	O
1,368	O
of	O
9,636	O
)	O
of	O
genes	O
that	O
were	O
expressed	O
at	O
similar	O
levels	O
between	O
hESCs	S-cell_type
and	O
NPs	S-cell_type
were	O
REAP	O
[	O
+	O
]	O
.	O

(	O
F	O
)	O
The	O
scatter	O
plot	O
of	O
studentized	O
residuals	O
generated	O
from	O
comparing	O
Cyt-ES	S-cell_line
versus	O
hCNS-SCns	S-cell_type
and	O
hCNS-SCns	S-cell_type
versus	O
Cyt-ES	S-cell_line
of	O
5,000	O
randomly	O
chosen	O
probesets.Here	O
,	O
a	O
possible	O
representation	O
of	O
the	O
data	O
was	O
explored	O
.	O

However	O
,	O
utilizing	O
ESTs	O
to	O
identify	O
AS	O
has	O
intrinsic	O
problems	O
,	O
as	O
ESTs	O
tend	O
to	O
be	O
biased	O
for	O
the	O
3′	O
ends	O
of	O
genes	O
,	O
and	O
full	O
coverage	O
of	O
the	O
genome	O
by	O
ESTs	O
is	O
severely	O
limited	O
by	O
sequencing	O
costs	O
.	O

Exon	O
(	O
probeset	O
)	O
and	O
gene-level	O
signal	O
estimates	O
were	O
derived	O
from	O
the	O
CEL	O
files	O
by	O
RMA–sketch	O
normalization	O
as	O
a	O
method	O
in	O
the	O
apt-probeset-summarize	O
program	O
.	O

In	O
recent	O
years	O
,	O
AS	O
has	O
gained	O
momentum	O
as	O
being	O
important	O
in	O
development	O
,	O
apoptosis	O
,	O
and	O
cancer	O
.	O

By	O
raising	O
the	O
requirement	O
that	O
probesets	O
had	O
to	O
contain	O
five	O
significant	O
points	O
,	O
the	O
percentage	O
of	O
ACE	O
[	O
+	O
]	O
exons	O
increased	O
from	O
4	O
%	O
to	O
11	O
%	O
.	O

All	O
elements	O
had	O
to	O
be	O
greater	O
than	O
5	O
.	O

(	O
B	O
)	O
Black-filled	O
squares	O
represented	O
the	O
fraction	O
of	O
exons	O
containing	O
probesets	O
with	O
N	O
significant	O
points	O
that	O
had	O
ACEScan	O
positive	O
scores	O
,	O
indicative	O
of	O
evolutionarily	O
conserved	O
alternative	O
exons	O
.	O

The	O
sensitivity	O
and	O
specificity	O
of	O
the	O
algorithm	O
at	O
the	O
cutoff	O
of	O
two	O
is	O
69	O
%	O
and	O
77	O
%	O
.	O

However	O
,	O
robust	O
regression	O
as	O
described	O
was	O
not	O
symmetrical	O
,	O
i.e.	O
,	O
parameter	O
estimation	O
of	O
y	O
as	O
a	O
function	O
of	O
x	O
was	O
not	O
the	O
same	O
as	O
that	O
of	O
x	O
as	O
a	O
function	O
of	O
y	O
.	O

The	O
error	O
term	O
variance	O
was	O
estimated	O
by	O
se2	O
=	O
Σei2/	O
(	O
n	O
−	O
p	O
)	O
,	O
which	O
was	O
used	O
to	O
estimate	O
the	O
variance	O
of	O
the	O
predicted	O
value	O
,	O
sξi2	O
=	O
se2	O
(	O
n−1	O
+	O
(	O
xi	O
−	O
μx	O
)	O
2	O
/	O
sx2	O
(	O
n	O
−	O
1	O
)	O
)	O
.	O

Arrows	O
indicate	O
the	O
larger	O
(	O
exon-included	O
)	O
isoforms	O
and	O
smaller	O
(	O
exon-skipped	O
)	O
isoforms	O
.	O

In	O
summary	O
,	O
a	O
new	O
methodology	O
for	O
exon	O
array	O
analysis	O
was	O
introduced	O
,	O
leading	O
to	O
new	O
insights	O
into	O
the	O
complexity	O
of	O
AS	O
in	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
and	O
their	O
transition	O
to	O
neural	B-cell_type
stem	I-cell_type
cells	E-cell_type
.Author	O
SummaryDeriving	O
neural	B-cell_type
progenitors	E-cell_type
(	O
NP	O
)	O
from	O
human	B-cell_type
embryonic	I-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
hESC	O
)	O
is	O
the	O
first	O
step	O
in	O
creating	O
homogeneous	O
populations	O
of	O
cells	O
that	O
will	O
differentiate	O
into	O
myriad	O
neuronal	S-x
subtypes	O
necessary	O
to	O
form	O
a	O
human	S-y
brain	S-x
.	O

Thus	O
for	O
the	O
purpose	O
of	O
identifying	O
overall	O
pluripotent	O
and	O
neural	O
lineage-specific	O
genes	O
,	O
the	O
collective	O
set	O
of	O
NPs	S-cell_type
(	O
Cyt-NP	O
,	O
HUES6-NP	O
,	O
and	O
hCNS-SCns	S-cell_type
)	O
was	O
compared	O
to	O
the	O
collective	O
set	O
of	O
hESCs	S-cell_type
(	O
Cyt-ES	S-cell_line
and	O
HUES6-ES	S-cell_line
)	O
.	O
Oct4	S-GP
and	O
Nanog	S-GP
,	O
which	O
are	O
important	O
in	O
maintaining	O
the	O
pluripotent	O
state	O
of	O
embryonic	B-cell_type
stem	I-cell_type
cells	E-cell_type
(	O
ESCs	S-cell_type
)	O
,	O
were	O
highly	O
expressed	O
in	O
hESCs	S-cell_type
but	O
were	O
significantly	O
lower	O
in	O
NPs	S-cell_type
(	O
Figure	O
1B	O
)	O
.	O

To	O
differentiate	O
into	O
neuroepithelial	B-cell_type
precursor	I-cell_type
cells	E-cell_type
,	O
colonies	O
were	O
manually	O
isolated	O
from	O
mouse	B-cell_type
embryonic	I-cell_type
fibroblasts	E-cell_type
(	O
MEFs	S-cell_type
)	O
and	O
cut	O
in	O
small	O
pieces	O
.	O

Rosette	B-x
structures	E-x
were	O
manually	O
collected	O
and	O
enzymatically	O
dissociated	O
with	O
TryPLE	O
(	O
Invitrogen	O
)	O
,	O
plated	O
on	O
polyornathine/laminin	O
coated	O
plates	O
,	O
and	O
grown	O
in	O
DMEM/F12	O
supplemented	O
with	O
N2	O
and	O
B27-RA	S-GP
and	O
20	O
ng/mL	O
FGF-2	S-GP
.	O

Our	O
assumption	O
was	O
that	O
most	O
of	O
the	O
points	O
were	O
“	O
correct	O
,	O
”	O
i.e.	O
,	O
that	O
most	O
of	O
the	O
exons	O
were	O
constitutively	O
spliced	O
.	O

Influence	O
was	O
computed	O
as	O
the	O
absolute	O
difference	O
between	O
the	O
covariance	O
ratio	O
and	O
unity	O
.	O

For	O
example	O
,	O
we	O
considered	O
(	O
d	O
,	O
b	O
)	O
,	O
(	O
e	O
,	O
a	O
)	O
,	O
(	O
e	O
,	O
b	O
)	O
,	O
(	O
e	O
,	O
c	O
)	O
,	O
and	O
(	O
f	O
,	O
b	O
)	O
points	O
where	O
b	O
and	O
d	O
were	O
the	O
median	O
intensities	O
for	O
the	O
replicates	O
in	O
Cyt-ES	S-cell_line
and	O
hCNS-SCns	S-cell_type
,	O
respectively	O
(	O
Figure	O
3B	O
)	O
.	O

Hybridization	O
cocktails	O
containing	O
∼5	O
ug	O
of	O
fragmented	O
and	O
labeled	O
DNA	S-cellcomponent
target	O
were	O
prepared	O
and	O
applied	O
to	O
GeneChip	O
Human	S-y
Exon	O
1.0	O
ST	O
arrays	O
.	O

CU-rich	O
sequences	O
were	O
shown	O
to	O
bind	O
the	O
splicing	B-GP
factor	I-GP
PTB	E-GP
[	O
69	O
]	O
.	O

Understanding	O
the	O
processes	O
that	O
generate	O
neuronal	S-x
diversity	O
is	O
key	O
to	O
gaining	O
insights	O
into	O
neuronal	S-x
development	O
and	O
paving	O
new	O
avenues	O
for	O
biomedical	O
research	O
.	O

used	O
Affymetrix	O
Gene	O
Chip	O
arrays	O
to	O
compare	O
adult	O
and	O
fetal	B-cell_type
NPCs	E-cell_type
propagated	O
in	O
neurospheres	S-x
[	O
35	O
]	O
.	O

A	O
study	O
analyzing	O
the	O
expression	O
patterns	O
of	O
the	O
SLK	S-GP
gene	O
suggested	O
a	O
potential	O
functional	O
role	O
during	O
embryonic	S-x
development	O
and	O
in	O
the	O
adult	O
central	B-x
nervous	I-x
system	E-x
[	O
79	O
]	O
;	O
however	O
,	O
to	O
our	O
knowledge	O
,	O
our	O
identification	O
of	O
the	O
SLK	S-GP
alternative	O
exon	O
is	O
the	O
first	O
report	O
of	O
a	O
hESC-biased	O
AS	O
pattern	O
during	O
neuronal	S-x
differentiation	O
and	O
across	O
a	O
myriad	O
of	O
differentiated	O
tissues	O
.	O

REAP	O
,	O
a	O
regression-based	O
method	O
for	O
analyzing	O
exon	O
array	O
data	O
was	O
introduced	O
,	O
and	O
was	O
applied	O
to	O
discover	O
AS	O
events	O
in	O
hESCs	S-cell_type
,	O
their	O
derived	O
NPs	S-cell_type
,	O
and	O
in	O
hCNS-SCns	S-cell_type
.	O

Our	O
results	O
suggested	O
that	O
a	O
strategy	O
of	O
focusing	O
on	O
differentially	O
expressed	O
genes	O
would	O
miss	O
at	O
least	O
14	O
%	O
of	O
transcriptionally	O
unchanged	O
genes	O
that	O
may	O
nevertheless	O
have	O
functional	O
AS	O
differences	O
between	O
hESCs	S-cell_type
and	O
NPs	S-cell_type
.Figure	O
8Analysis	O
of	O
REAP	O
[	O
+	O
]	O
Genes	O
Relative	O
to	O
Transcriptional	O
Differences	O
(	O
A	O
)	O
Histogam	O
of	O
t-statistics	O
computed	O
from	O
gene-level	O
signal	O
estimates	O
measuring	O
the	O
enrichment	O
of	O
genes	O
in	O
hESC	O
and	O
in	O
NP	O
.	O

(	O
C	O
)	O
RT-PCR	O
of	O
REAP	O
[	O
+	O
]	O
alternative	O
exons	O
from	O
EHBP1	S-GP
,	O
SLK	S-GP
,	O
and	O
RAI14	S-GP
across	O
a	O
panel	O
of	O
human	S-y
tissues	O
.	O

In	O
particular	O
,	O
microRNA	O
profiling	O
revealed	O
significant	O
expression	O
differences	O
between	O
the	O
two	O
hESC	O
lines	O
,	O
suggesting	O
that	O
microRNAs	S-cellcomponent
,	O
known	O
post-transcriptional	O
regulators	O
,	O
may	O
sway	O
the	O
differentiation	O
properties	O
of	O
the	O
cell	O
lines	O
[	O
76	O
]	O
.	O

We	O
were	O
not	O
able	O
to	O
identify	O
5-mers	O
that	O
were	O
statistically	O
significantly	O
different.Next	O
,	O
we	O
focused	O
on	O
splicing	O
signals	O
that	O
were	O
conserved	O
across	O
mammalian	S-x
genomes	O
as	O
a	O
way	O
of	O
enhancing	O
the	O
signal	O
of	O
detecting	O
functional	O
splicing	O
regulatory	O
sequences	O
[	O
66	O
]	O
.	O

However	O
,	O
the	O
sample	O
sizes	O
were	O
small	O
.	O

To	O
illustrate	O
further	O
,	O
a	O
point	O
was	O
classified	O
as	O
an	O
“	O
outlier	O
”	O
if	O
it	O
had	O
a	O
large	O
studentized	O
residual	O
(	O
p	O
<	O
0.01	O
)	O
and	O
low	O
leverage	O
(	O
boxed	O
point	O
“	O
a	O
”	O
)	O
;	O
as	O
a	O
“	O
high-leverage	O
”	O
point	O
if	O
it	O
had	O
a	O
low	O
studentized	O
residual	O
and	O
high	O
leverage	O
(	O
boxed	O
point	O
“	O
b	O
”	O
)	O
;	O
and	O
as	O
a	O
“	O
high-influence	O
”	O
point	O
if	O
it	O
had	O
a	O
high	O
studentized	O
residual	O
,	O
high	O
leverage	O
,	O
and	O
high	O
influence	O
(	O
boxed	O
point	O
“	O
c	O
”	O
;	O
Figure	O
4B	O
)	O
.	O

A	O
total	O
of	O
2.7	O
million	O
spliced	O
ESTs	O
were	O
mapped	O
onto	O
the	O
17,478	O
high-quality	O
genes	O
to	O
infer	O
AS	O
.	O

A	O
Gene	O
Ontology	O
analysis	O
revealed	O
that	O
REAP	O
[	O
+	O
]	O
genes	O
are	O
enriched	O
for	O
GO	O
molecular	O
function	O
categories	O
“	O
ATP	O
binding	O
,	O
”	O
“	O
helicase	S-GP
activity	O
,	O
”	O
“	O
protein	O
serine/theronine	O
kinase	O
activity	O
,	O
”	O
“	O
small	B-GP
GTPase	I-GP
regulatory/interacting	I-GP
protein	E-GP
activity	O
,	O
”	O
and	O
“	O
thyroid	B-GP
hormone	I-GP
receptor	E-GP
binding	O
”	O
(	O
Table	O
1	O
)	O
.	O

After	O
removing	O
potential	O
FPs	O
,	O
11,348	O
genes	O
containing	O
158,657	O
probesets	O
were	O
scored	O
by	O
REAP.As	O
described	O
above	O
,	O
for	O
each	O
pair	O
of	O
cell	O
lines	O
compared	O
,	O
each	O
probset	O
was	O
represented	O
by	O
five	O
points	O
,	O
where	O
each	O
point	O
was	O
defined	O
a	O
significant	O
outlier	O
if	O
it	O
had	O
a	O
high	O
residual	O
(	O
p	O
<	O
0.01	O
)	O
,	O
low	O
influence	O
,	O
and	O
high	O
leverage	O
.	O

